0001493152-24-018878.txt : 20240513 0001493152-24-018878.hdr.sgml : 20240513 20240513160600 ACCESSION NUMBER: 0001493152-24-018878 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 111 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHF Holdings, Inc. CENTRAL INDEX KEY: 0001854963 STANDARD INDUSTRIAL CLASSIFICATION: FINANCE SERVICES [6199] ORGANIZATION NAME: 02 Finance IRS NUMBER: 862409612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40524 FILM NUMBER: 24939012 BUSINESS ADDRESS: STREET 1: 1526 COLE BLVD. STREET 2: SUITE 250 CITY: GOLDEN STATE: CO ZIP: 80401 BUSINESS PHONE: (303) 431-3435 MAIL ADDRESS: STREET 1: 1526 COLE BLVD. STREET 2: SUITE 250 CITY: GOLDEN STATE: CO ZIP: 80401 FORMER COMPANY: FORMER CONFORMED NAME: Northern Lights Acquisition Corp. DATE OF NAME CHANGE: 20210402 10-Q 1 form10-q.htm
false --12-31 Q1 0001854963 P5Y P1Y 0001854963 2024-01-01 2024-03-31 0001854963 SHFS:ClassCommonStock0.0001ParValuePerShareMember 2024-01-01 2024-03-31 0001854963 SHFS:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember 2024-01-01 2024-03-31 0001854963 2024-05-13 0001854963 2024-03-31 0001854963 2023-12-31 0001854963 us-gaap:NonrelatedPartyMember 2024-03-31 0001854963 us-gaap:NonrelatedPartyMember 2023-12-31 0001854963 us-gaap:RelatedPartyMember 2024-03-31 0001854963 us-gaap:RelatedPartyMember 2023-12-31 0001854963 2023-01-01 2023-03-31 0001854963 us-gaap:PreferredStockMember 2023-12-31 0001854963 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-12-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001854963 us-gaap:RetainedEarningsMember 2023-12-31 0001854963 us-gaap:PreferredStockMember 2022-12-31 0001854963 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001854963 us-gaap:RetainedEarningsMember 2022-12-31 0001854963 2022-12-31 0001854963 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001854963 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-01-01 2024-03-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001854963 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001854963 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001854963 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001854963 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001854963 us-gaap:PreferredStockMember 2024-03-31 0001854963 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-03-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001854963 us-gaap:RetainedEarningsMember 2024-03-31 0001854963 us-gaap:PreferredStockMember 2023-03-31 0001854963 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-03-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001854963 us-gaap:RetainedEarningsMember 2023-03-31 0001854963 2023-03-31 0001854963 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2024-03-31 0001854963 SHFS:EquipmentAndFurnitureAndFixturesMember srt:MinimumMember 2024-03-31 0001854963 SHFS:EquipmentAndFurnitureAndFixturesMember srt:MaximumMember 2024-03-31 0001854963 SHFS:CreditExpectedCreditLossesTransitionMember 2022-12-31 0001854963 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2023-01-01 2023-01-01 0001854963 SHFS:CreditExpectedCreditLossesTransitionMember 2023-01-01 0001854963 SHFS:AbacaMergerClosingMember 2024-01-01 2024-03-31 0001854963 SHFS:AbacaMergerClosingMember us-gaap:CashMember 2024-01-01 2024-03-31 0001854963 SHFS:AbacaMember SHFS:MergerAgreementMember us-gaap:CommonClassAMember 2024-01-01 2024-03-31 0001854963 SHFS:AbacaMember SHFS:MergerAgreementMember 2023-10-26 2023-10-26 0001854963 SHFS:AbacaMember SHFS:MergerAgreementMember 2023-10-26 0001854963 2023-01-01 2023-12-31 0001854963 us-gaap:DevelopedTechnologyRightsMember 2024-01-01 2024-03-31 0001854963 us-gaap:MarketingRelatedIntangibleAssetsMember 2024-03-31 0001854963 us-gaap:MarketingRelatedIntangibleAssetsMember 2023-12-31 0001854963 us-gaap:CustomerRelationshipsMember 2024-03-31 0001854963 us-gaap:CustomerRelationshipsMember 2023-12-31 0001854963 us-gaap:DevelopedTechnologyRightsMember 2024-03-31 0001854963 us-gaap:DevelopedTechnologyRightsMember 2023-12-31 0001854963 us-gaap:MarketingRelatedIntangibleAssetsMember 2022-12-31 0001854963 us-gaap:CustomerRelationshipsMember 2022-12-31 0001854963 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001854963 SHFS:CommercialRealEstateLoansReceivableMember 2024-03-31 0001854963 SHFS:CommercialRealEstateLoansReceivableMember 2023-12-31 0001854963 SHFS:RiskRateFourMember 2024-03-31 0001854963 SHFS:RiskRateFourMember 2023-12-31 0001854963 SHFS:PCCUAgreementMember 2024-03-31 0001854963 SHFS:PCCUAgreementMember 2023-12-31 0001854963 us-gaap:SecuredDebtMember srt:MinimumMember 2024-03-31 0001854963 us-gaap:SecuredDebtMember srt:MaximumMember 2024-03-31 0001854963 us-gaap:UnsecuredDebtMember 2024-01-01 2024-03-31 0001854963 us-gaap:UnsecuredDebtMember 2024-03-31 0001854963 us-gaap:UnsecuredDebtMember 2023-12-31 0001854963 SHFS:RiskRateThreeMember 2024-03-31 0001854963 SHFS:RiskRateThreeMember 2023-12-31 0001854963 SHFS:RiskRateFiveMember 2024-03-31 0001854963 SHFS:RiskRateFiveMember 2023-12-31 0001854963 SHFS:RiskRateSixMember 2024-03-31 0001854963 SHFS:RiskRateSixMember 2023-12-31 0001854963 SHFS:RiskRateSevenMember 2024-03-31 0001854963 SHFS:RiskRateSevenMember 2023-12-31 0001854963 SHFS:RiskRateEightMember 2024-03-31 0001854963 SHFS:RiskRateEightMember 2023-12-31 0001854963 us-gaap:CommercialRealEstatePortfolioSegmentMember 2024-01-01 2024-03-31 0001854963 SHFS:IndemnityLiabilitySegmentMember 2024-01-01 2024-03-31 0001854963 us-gaap:CommercialRealEstatePortfolioSegmentMember 2023-01-01 2023-03-31 0001854963 SHFS:IndemnityLiabilitySegmentMember 2023-01-01 2023-03-31 0001854963 us-gaap:EquipmentMember 2024-03-31 0001854963 us-gaap:EquipmentMember 2023-12-31 0001854963 us-gaap:SoftwareDevelopmentMember 2024-03-31 0001854963 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001854963 us-gaap:LeaseholdImprovementsMember 2024-03-31 0001854963 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001854963 us-gaap:FurnitureAndFixturesMember 2024-03-31 0001854963 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001854963 SHFS:LoanServicingAgreementMember SHFS:PartnerColoradoCreditUnionMember 2023-03-28 2023-03-29 0001854963 SHFS:SupportServicesAgreementMember 2024-01-01 2024-03-31 0001854963 SHFS:SeniorSecuredPromissoryNoteMember 2023-03-28 2023-03-29 0001854963 SHFS:SeniorSecuredPromissoryNoteMember 2023-03-29 0001854963 SHFS:PartnerColoradoCreditUnionMember SHFS:SecuritiesIssuanceAgreementMember us-gaap:CommonClassAMember 2023-03-28 2023-03-29 0001854963 SHFS:PartnerColoradoCreditUnionMember us-gaap:CommonClassAMember SHFS:SecuritiesIssuanceAgreementMember 2023-03-29 0001854963 SHFS:LoanServicingAgreementMember 2024-01-01 2024-03-31 0001854963 SHFS:CannabisRelatedBusinessesRelatedDepositsMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:CannabisRelatedBusinessesRelatedDepositsMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:CapacityAtSixtyPercentageMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:CapacityAtSixtyPercentageMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:PartnerColoradoCreditUnionMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:PartnerColoradoCreditUnionMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:CapacityAtOnePointThreeOneTwoFiveMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:CapacityAtOnePointThreeOneTwoFiveMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:LimitingCapacityMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:LimitingCapacityMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:PartnerColoradoCreditUnionLoansFundedMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:PartnerColoradoCreditUnionLoansFundedMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 us-gaap:LineOfCreditMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 us-gaap:LineOfCreditMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:AccountServicingAgreementMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 SHFS:AccountServicingAgreementMember us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 SHFS:CommercialAllianceAgreementMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 SHFS:CommercialAllianceAgreementMember us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 SHFS:SupportServicesAgreementMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 SHFS:SupportServicesAgreementMember us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 SHFS:LoanServicingAgreementMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 SHFS:LoanServicingAgreementMember us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 SHFS:SeniorSecuredPromissoryNoteCurrentMember SHFS:SecurityAgreementMember 2024-03-31 0001854963 SHFS:SeniorSecuredPromissoryNoteCurrentMember SHFS:SecurityAgreementMember 2023-12-31 0001854963 SHFS:SeniorSecuredPromissoryNoteNonCurrentMember SHFS:SecurityAgreementMember 2024-03-31 0001854963 SHFS:SeniorSecuredPromissoryNoteNonCurrentMember SHFS:SecurityAgreementMember 2023-12-31 0001854963 SHFS:SecurityAgreementMember 2024-03-31 0001854963 SHFS:SecurityAgreementMember 2023-12-31 0001854963 2023-03-29 0001854963 SHFS:FiftyFourEqualInstallmentsMember 2023-11-05 0001854963 SHFS:SeniorSecuredPromissoryNoteMember 2023-12-31 0001854963 srt:MinimumMember 2024-03-31 0001854963 srt:MaximumMember 2024-03-31 0001854963 SHFS:DepositActivityOnboardingIncomeMember 2024-01-01 2024-03-31 0001854963 SHFS:DepositActivityOnboardingIncomeMember 2023-01-01 2023-03-31 0001854963 SHFS:SafeHarborProgramIncomeMember 2024-01-01 2024-03-31 0001854963 SHFS:SafeHarborProgramIncomeMember 2023-01-01 2023-03-31 0001854963 us-gaap:InvestmentIncomeMember 2024-01-01 2024-03-31 0001854963 us-gaap:InvestmentIncomeMember 2023-01-01 2023-03-31 0001854963 us-gaap:InterestIncomeMember 2024-01-01 2024-03-31 0001854963 us-gaap:InterestIncomeMember 2023-01-01 2023-03-31 0001854963 SHFS:PartnerColoradoCreditUnionMember 2024-01-01 2024-03-31 0001854963 SHFS:PartnerColoradoCreditUnionMember 2023-01-01 2023-03-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-09-28 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-10-13 2022-10-14 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-10-31 2022-10-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-11-01 2022-11-30 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-12-31 2022-12-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2023-01-31 2023-01-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-12-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2023-03-12 2023-03-13 0001854963 SHFS:MidtownEastManagementNLLLCMember us-gaap:CommonClassAMember 2022-06-16 0001854963 SHFS:MidtownEastManagementNLLLCMember us-gaap:CommonClassAMember 2022-06-15 2022-06-16 0001854963 us-gaap:CashMember 2022-06-16 0001854963 2022-06-15 2022-06-16 0001854963 2022-06-16 0001854963 SHFS:ForwardPurchaseAgreementMember 2022-09-30 0001854963 SHFS:VellarMember 2023-12-31 0001854963 SHFS:VellarMember 2024-01-01 2024-03-31 0001854963 SHFS:VellarMember 2024-03-31 0001854963 SHFS:MidtownEastMember 2023-12-31 0001854963 SHFS:MidtownEastMember 2024-01-01 2024-03-31 0001854963 SHFS:MidtownEastMember 2024-03-31 0001854963 SHFS:VerdunMember 2023-12-31 0001854963 SHFS:VerdunMember 2024-01-01 2024-03-31 0001854963 SHFS:VerdunMember 2024-03-31 0001854963 SHFS:PublicWarrantsMember 2024-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2023-12-31 0001854963 SHFS:PublicAndPrivateWarrantsMember 2024-01-01 2024-03-31 0001854963 us-gaap:CommonClassAMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember 2024-01-01 2024-03-31 0001854963 SHFS:AbacaWarrantsMember 2024-03-31 0001854963 SHFS:AbacaWarrantsMember 2023-12-31 0001854963 us-gaap:CommonClassAMember SHFS:AbacaWarrantsMember 2024-03-31 0001854963 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001854963 SHFS:PurchaseAgreementOptionMember 2024-01-01 2024-03-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:PIPEWarrantsMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PIPEWarrantsMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PIPEWarrantsMember 2024-03-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:PIPEWarrantsMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PIPEWarrantsMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PIPEWarrantsMember 2023-12-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:PublicWarrantsMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PublicWarrantsMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PublicWarrantsMember 2024-03-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:PublicWarrantsMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PublicWarrantsMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PublicWarrantsMember 2023-12-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:PrivatePlacementWarrantsMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PrivatePlacementWarrantsMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PrivatePlacementWarrantsMember 2024-03-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:PrivatePlacementWarrantsMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PrivatePlacementWarrantsMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:PrivatePlacementWarrantsMember 2023-12-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:AbacaWarrantMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:AbacaWarrantMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:AbacaWarrantMember 2024-03-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:AbacaWarrantMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:AbacaWarrantMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:AbacaWarrantMember 2023-12-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:ForwardPurchaseDerivativeLiabilityMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:ForwardPurchaseDerivativeLiabilityMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:ForwardPurchaseDerivativeLiabilityMember 2024-03-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:ForwardPurchaseDerivativeLiabilityMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:ForwardPurchaseDerivativeLiabilityMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:ForwardPurchaseDerivativeLiabilityMember 2023-12-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:ThirdAnniversaryPaymentConsiderationMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:ThirdAnniversaryPaymentConsiderationMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:ThirdAnniversaryPaymentConsiderationMember 2024-03-31 0001854963 us-gaap:FairValueMeasurementsRecurringMember SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-12-31 0001854963 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-03-31 0001854963 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel1Member 2024-03-31 0001854963 us-gaap:FairValueInputsLevel2Member 2024-03-31 0001854963 us-gaap:FairValueInputsLevel3Member 2024-03-31 0001854963 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001854963 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001854963 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001854963 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001854963 SHFS:PIPEWarrantsMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember 2023-12-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember 2024-01-01 2024-03-31 0001854963 SHFS:AbacaWarrantMember 2024-01-01 2024-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2024-01-01 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2024-01-01 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2024-01-01 2024-03-31 0001854963 SHFS:PIPEWarrantsMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember 2024-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember 2022-12-31 0001854963 SHFS:AbacaWarrantMember 2022-12-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2022-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2022-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2022-12-31 0001854963 SHFS:PIPEWarrantsMember 2023-01-01 2023-03-31 0001854963 SHFS:AbacaWarrantMember 2023-01-01 2023-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2023-01-01 2023-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-01-01 2023-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2023-01-01 2023-03-31 0001854963 SHFS:PIPEWarrantsMember 2023-03-31 0001854963 SHFS:AbacaWarrantMember 2023-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2023-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2023-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001854963 SHFS:ExpectedTermMember SHFS:PIPEWarrantsMember 2024-03-31 0001854963 SHFS:ExpectedTermMember SHFS:PrivateWarrantsMember 2024-03-31 0001854963 SHFS:ExpectedTermMember SHFS:ThirdAnniversaryPaymentConsiderationMember 2024-03-31 0001854963 SHFS:ExpectedTermMember SHFS:AbacaWarrantMember 2024-03-31 0001854963 SHFS:ExpectedTermMember SHFS:PIPEWarrantsMember 2023-12-31 0001854963 SHFS:ExpectedTermMember SHFS:PrivateWarrantsMember 2023-12-31 0001854963 SHFS:ExpectedTermMember SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-12-31 0001854963 SHFS:ExpectedTermMember SHFS:AbacaWarrantMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:MeasurementInputResetPriceMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:MeasurementInputResetPriceMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputExpectedTermMember 2024-01-01 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:PurchaseAgreementOptionMember SHFS:MeasurementInputAdditionalMaturityPerShareMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:PurchaseAgreementOptionMember SHFS:MeasurementInputAdditionalMaturityPerShareMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:PurchaseAgreementOptionMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:PurchaseAgreementOptionMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:PurchaseAgreementOptionMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:PurchaseAgreementOptionMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:PurchaseAgreementOptionMember us-gaap:MeasurementInputDiscountRateMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:PurchaseAgreementOptionMember us-gaap:MeasurementInputDiscountRateMember 2023-12-31 0001854963 srt:MaximumMember 2024-01-25 0001854963 srt:MinimumMember 2024-01-25 0001854963 SHFS:ForwardPurchaseAgreementMember 2024-03-31 0001854963 SHFS:ForwardPurchaseAgreementMember 2023-12-31 0001854963 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001854963 srt:MinimumMember 2024-01-01 2024-03-31 0001854963 srt:MaximumMember 2024-01-01 2024-03-31 0001854963 2022-10-01 2022-12-31 0001854963 SHFS:ExercisePriceOneMember 2024-03-31 0001854963 SHFS:ExercisePriceOneMember 2023-03-31 0001854963 SHFS:ExercisePriceTwoMember 2024-03-31 0001854963 SHFS:ExercisePriceTwoMember 2023-03-31 0001854963 SHFS:ExercisePriceThreeMember 2024-03-31 0001854963 SHFS:ExercisePriceThreeMember 2023-03-31 0001854963 SHFS:ExercisePriceFourMember 2024-03-31 0001854963 SHFS:ExercisePriceFourMember 2023-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001854963 SHFS:ExercisePriceOneMember us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001854963 SHFS:ExercisePriceOneMember us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001854963 us-gaap:SubsequentEventMember 2024-04-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______to_______

 

Commission File Number: 001-40524

 

SHF Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   86-2409612

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

1526 Cole Blvd., Suite 250

Golden, Colorado

  80410
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (303) 431-3435

 

 

(Former name or former address, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Date File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share   SHFS   The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share   SHFSW   The Nasdaq Stock Market LLC

 

As of May 13, 2024, there were outstanding 55,431,001 shares of the Company’s Class A Common Stock, $0.0001 par value per share.

 

 

 

  

 

 

SHF HOLDINGS, INC.

 

TABLE OF CONTENTS

 

    Page
PART I – FINANCIAL INFORMATION: 1
     
Item 1. Financial Statements: 1
  Condensed Consolidated Balance Sheets as at March 31, 2024 (Unaudited) and December 31, 2023 1
  Condensed Unaudited Consolidated Statements of Operations for the three-months ended March 31, 2024, and March 31, 2023 2
  Condensed Unaudited Consolidated Statements of Stockholders’ Equity for the three-months ended March 31, 2024, and March 31, 2023 3
  Condensed Unaudited Consolidated Statements of Cash Flows for the three-months ended March 31, 2024, and March 31, 2023 4
  Notes to Unaudited Condensed Consolidated Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
Item 3. Quantitative and Qualitative Disclosures About Market Risk 46
Item 4. Controls and Procedures 46
PART II - OTHER INFORMATION: 48
Item 1. Legal Proceedings 48
Item 1A. Risk Factors 48
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 48
Item 3. Defaults Upon Senior Securities 48
Item 4. Mine Safety Disclosures 48
Item 5. Other Information 48
Item 6. Exhibits 49

 

  

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

SHF Holdings, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   March 31, 2024
(Unaudited)
   December 31, 2023 
         
ASSETS          
Current Assets:          
Cash and cash equivalents  $5,626,362   $4,888,769 
Accounts receivable – trade   153,208    121,875 
Accounts receivable – related party   1,111,390    2,095,320 
Prepaid expenses – current portion   506,634    546,437 
Accrued interest receivable   16,891    13,780 
Short-term loans receivable, net   12,620    12,391 
Other current assets   -    82,657 
Total Current Assets  $7,427,105   $7,761,229 
Long-term loans receivable, net   379,863    381,463 
Property, plant and equipment, net   45,366    84,220 
Operating lease right to use assets   820,777    859,861 
Goodwill   6,058,000    6,058,000 
Intangible assets, net   3,564,890    3,721,745 
Deferred tax asset   44,278,374    43,829,019 
Prepaid expenses – long term position   525,000    562,500 
Forward purchase receivable   4,584,221    4,584,221 
Security deposit   18,875    18,651 
Total Assets  $67,702,471   $67,860,909 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities:          
Accounts payable  $179,242   $217,392 
Accounts payable-related party   125,693    577,315 
Accrued expenses   645,635    1,008,987 
Contract liabilities   2,692    21,922 
Lease liabilities – current   142,863    132,546 
Senior secured promissory note – current portion   3,028,738    3,006,991 
Deferred consideration – current portion   2,921,257    2,889,792 
Other current liabilities   62,160    41,639 
Total Current Liabilities  $7,108,280   $7,896,584 
Warrant liabilities   2,908,642    4,164,129 
Deferred consideration – long term portion   594,000    810,000 
Forward purchase derivative liability   7,309,580    7,309,580 
Senior secured promissory note—long term portion   10,241,884    11,004,175 
Net deferred indemnified loan origination fees   421,907    63,275 
Lease liabilities – long term   835,598    875,447 
Indemnity liability   1,315,263    1,382,408 
Total Liabilities  $30,735,154   $33,505,598 
Commitment and Contingencies (Note 13)   -    - 
Stockholders’ Equity          
Convertible preferred stock, $.0001 par value, 1,250,000 shares authorized, 111 and 1,101 shares issued and outstanding on March 31, 2024, and December 31, 2023, respectively   -    - 
Class A common stock, $.0001 par value, 130,000,000 shares authorized, 55,431,001 and 54,563,372 issued and outstanding on March 31, 2024, and December 31, 2023, respectively   5,545    5,458 
Additional paid in capital   107,348,166    105,919,674 
Retained deficit   (70,386,394)   (71,569,821)
Total Stockholders’ Equity  $36,967,317   $34,355,311 
Total Liabilities and Stockholders’ Equity  $67,702,471   $67,860,909 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

 1 

 

 

SHF Holdings, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   2024   2023 
   For the three months ended
March 31,
 
   2024   2023 
         
Revenue  $4,050,799   $4,180,379 
           
Operating Expenses          
Compensation and employee benefits  $2,280,038   $3,659,520 
General and administrative expenses   984,220    1,538,874 
Professional services   460,950    449,246 
Rent expense   69,437    87,742 
Provision (benefit) for credit losses   (68,787)   66,666 
Total operating expenses  $3,725,858   $5,802,048 
Operating income/ (loss)   324,941    (1,621,669)
Other (income) expenses          
Change in the fair value of deferred consideration   (184,535)   190,943 
Interest expense   154,172    643,260 
Change in fair value of warrant liabilities   (1,255,487)   (433,148)
Total other (income)/ expenses  $(1,285,850)  $401,055 
Net income/ (loss) before income tax   1,610,791    (2,022,724)
Income tax benefit  $438,885   $609,277 
Net income/ (loss)   2,049,676    (1,413,447)
Weighted average shares outstanding, basic   55,213,609    25,670,730 
Basic net income/ (loss) per share  $0.04   $(0.06)
Weighted average shares outstanding, diluted   56,268,075    25,670,730 
Diluted income/ (loss) per share  $0.04   $(0.06)

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

 2 

 

 

SHF Holdings, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

 

FOR THE THREE MONTHS ENDED MARCH 31, 2024

 

   Shares   Amount   Shares   Amount   Capital   Earnings   Equity 
   Preferred Stock   Class A
Common Stock
   Additional
Paid-in
   Retained   Total Shareholders’ 
   Shares   Amount   Shares   Amount   Capital   Earnings   Equity 
Balance, December 31, 2023   1,101   $-    54,563,372   $5,458   $105,919,674   $(71,569,821)  $34,355,311 
Conversion of PIPE shares   (990)   -    792,000    79    866,170    (866,249)   - 
Restricted stock units (net of tax)   -    -    75,629    8    (14,325)   -    (14,317)
Stock compensation cost   -    -    -    -    576,647    -    576,647 
Net Income   -    -    -    -    -    2,049,676    2,049,676 
Balance, March 31, 2024   111    -    55,431,001    5,545    107,348,166    (70,386,394)   36,967,317 

 

SHF Holdings, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

 

FOR THE THREE MONTHS ENDED MARCH 31, 2023

 

   Preferred Stock   Class A
Common Stock
   Additional
Paid-in
   Retained   Total Shareholders’ 
   Shares   Amount   Shares   Amount   Capital   Earnings   Equity 
Balance, December 31, 2022   14,616   $1    23,732,889   $2,374   $44,806,031   $(39,695,281)  $5,113,125 
Cumulative effect from adoption of CECL   -    -    -    -    -    (581,321)   (581,321)
Conversion of PIPE shares   (3,720)   -    4,726,200    473    5,004,727    (5,005,200)   - 
Stock option conversion   -    -    629,728    62    1,570,719    -    1,570,781 
Issuance of shares to PCCU (net of tax)   -    -    11,200,000    1,120    38,405,288    -    38,406,408 
Reversal of deferred underwriting cost   -    -    -    -    900,500    -    900,500 
Net loss   -    -    -    -    -    (1,413,447)   (1,413,447)
Balance, March 31, 2023   10,896   $1    40,288,817   $4,029   $90,687,265   $(46,695,249)  $43,996,046 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

 3 

 

 

SHF Holdings, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   2024   2023 
   For the three months ended
March 31,
 
   2024   2023 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income/ (loss)  $2,049,676   $(1,413,447)
Adjustments to reconcile net income/ (loss) to net cash provided by/ (used in) operating activities:          
Depreciation and amortization expense   195,709    751,225 
Stock compensation expense   562,330    1,570,781 
Amortization of deferred origination fees   (27,970)   (14,104)
Interest expense   -    873,289 
(Benefit)/ provision for credit losses   (68,787)   66,666 
Amortization of right of use assets   9,552    17,762 
Income tax benefit   (438,885)   (609,277)
Change in the fair value of deferred consideration   (184,535)   190,943 
Change in fair value of warrant   (1,255,487)   (433,148)
Changes in operating assets and liabilities:          
Accounts receivable – Trade   (31,333)   (30,716)
Accounts receivable – related party   983,930    182,824 
Contract assets   -    (13,019)
Prepaid expenses   77,303    77,436 
Accrued interest receivable   (3,111)   (146,106)
Deferred underwriting payable   -    (550,000)
Other current assets   82,657    150,817 
Other current liabilities   10,048    75,000 
Accounts payable   (38,153)   (533,945)
Accounts Payable – related party   (451,622)   (65,288)
Accrued expenses   (363,347)   (466,849)
Contract liabilities   (19,230)   78,616 
Net deferred indemnified loan origination fees   386,602    8,500 
Security deposit   (224)   - 
Net cash provided by (used in) operating activities   1,475,123    (232,040)
CASH FLOWS PROVIDED BY INVESTING ACTIVITIES:          
Purchase of property and equipment   -    (548,671)
Net repayment of loans   3,014    1,019,268 
Net cash provided by investing activities   3,014    470,597 
CASH FLOWS USED IN FINANCING ACTIVITIES:          
Repayment of senior secured promissory note   (740,544)   - 
Net cash used in financing activities   (740,544)   - 
           
Net increase in cash and cash equivalents   737,593    238,557 
Cash and cash equivalents – beginning of period   4,888,769    8,390,195 
Cash and cash equivalents – end of period  $5,626,362   $8,628,752 
Supplemental disclosure of cash flow information          
Interest paid  $156,414   $- 
Non-Cash transactions:          
Shares issued for the settlement of PCCU debt obligation  $-   $38,406,408 
Cumulative effect from adoption of CECL  $-   $581,321 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

 4 

 

 

SHF Holdings, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

 

Note 1. Organization and Business Operations

 

Business Description

 

SHF Holdings, Inc. (the “Company”) originated as business operations conducted through Partner Colorado Credit Union (“PCCU”), which were transferred to SHF LLC (“SHF”), then an indirect wholly owned subsidiary of PCCU. The Company completed a strategic reorganization on July 1, 2021. This involved transferring select assets and operational activities from Partner Colorado Credit Union (“PCCU”) and its wholly owned subsidiary, Safe Harbor Services, to SHF Holding Co., LLC. Subsequently, these were consolidated into SHF, LLC (“SHF”), with PCCU’s investment managed at the SHF Holding Co., LLC level.

 

On September 28, 2022, the Company concluded a transaction wherein NLIT (“Northern Lights Acquisition Corp.”) acquired all outstanding membership interests of SHF. This acquisition prompted the renaming of NLIT to SHF Holdings, Inc. As a result, PCCU emerged as the largest shareholder of the Company.

 

The Company executed the Abaca Merger Agreement on October 31, 2022, facilitating a two-step merger through which Rockview Digital Solutions, Inc. (“Abaca”) became a direct wholly-owned subsidiary. The transaction expanded the Company’s fintech capabilities and market reach.

 

The Company generates fee income, investment income and loan interest income through providing a variety of services to financial institutions desiring to service the cannabis industry including, among other things, the origination, onboarding, and servicing of cannabis-related deposit business for and on behalf of those partner institutions; Bank Secrecy Act and other regulatory compliance and reporting related to these accounts; onboarding these accounts and responding to account and customer service inquiries; and sourcing, underwriting, and servicing, and administering loans issued to cannabis businesses and related entities. In addition, the Company provides these services to financial institutions under a Safe Harbor Master Program Agreement.

 

Note 2. Basis of Presentation and Summary of Significant Accounting Policies

 

i. Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the “SEC”).

 

The accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary to state fairly the consolidated financial condition, results of operations, statements of shareholders’ equity, and cash flows of the Company for the interim periods presented. Except as otherwise disclosed, all such adjustments consist only of those of a normal recurring nature. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results that may be expected for the current year ending December 31, 2024. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the years ended December 31, 2023, included in the Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”).

 

The company has made certain immaterial reclassifications to the statements of operations for the three months ended March 31, 2023, to conform to the presentation for the three months ended March 31, 2024. These reclassifications, totaling $190,943, were moved from ‘Interest Expense’ to ‘Change in the Fair Value of Deferred Consideration’. Corresponding adjustments have been made to the statement of cash flows and the applicable notes to the unaudited condensed consolidated financial statements.

 

The condensed consolidated financial statements include the accounts of SHF Holdings, Inc., its subsidiaries where we have controlling financial interests. All intercompany balances and transactions have been eliminated.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC and the instructions to Form 10-Q.

 

 5 

 

 

ii. Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Material estimates that are particularly subject to change in the near term include the determination of the allowance for credit losses, indemnification liabilities, useful lives of intangibles and the fair value of financial instruments. Actual results could differ from the estimates.

 

iii. Liquidity and Going Concern

 

As of March 31, 2024, the Company had $5,626,362 in cash and net working capital of $318,825, as compared to $4,888,769 in cash and net working capital deficit of $135,355 as of December 31, 2023. The retained deficit was $70,386,394 on March 31, 2024, and $71,569,821 on December 31, 2023. The Company has also generated operating income of $324,941 for the period ended March 31, 2024.

 

For the period ending March 31, 2024, the Company reported positive operating income and net working capital. However, considering the historical data, where the Company experienced negative operating income and negative net working capital, management acknowledges the need to closely evaluate the financial performance in upcoming quarters to mitigate any going concern risks. As of March 31, 2024, due to these historical trends, there is substantial doubt about the Company’s ability to continue as a going concern for at least twelve months from the date these condensed unaudited consolidated financial statements were issued.

 

If the Company is not able to sustain its present level of operations, it may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned expansion programs. Any of these actions could materially harm the Company’s business, results of operations and future prospects.

 

The accompanying condensed unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result should the Company not continue as a going concern as a result of this uncertainty.

 

iv. Cash and Cash Equivalents

 

Cash and cash equivalents include cash on hand, amounts due from financial institutions, and investments with maturities of three months or less.

 

v. Concentrations of Risk

 

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash. Cash balances are maintained substantially in accounts at Partner Colorado Credit Union (“PCCU”) which is insured by the National Credit Union Share Insurance Fund (“NCUSIF”) up to regulatory limits. From time to time, cash balances may exceed the NCUSIF insurance limit. The Company has not experienced any credit losses associated with its cash balances in the past.

 

Currently the Company only services the cannabis industry. Cannabis remains illegal under federal law, and therefore, strict enforcement of federal laws regarding cannabis would likely result in our inability to execute our business plan.

 

Currently the Company substantially relies on PCCU to hold customer deposits and fund its originated loans. As of this time, majority all of the Company’s revenue is generated by deposits and loans hosted by its PCCU pursuant to various services agreements.

 

The Company had only one loan on its balance sheet as of March 31, 2024, which comprises 100% of the total loan balance. The Company also indemnified 21 loans as of March 31, 2024; three of these indemnified loans were in excess of 10% of the total balance.

 

vi. Accounts Receivable

 

Accounts receivable are recorded based on account fee schedules. While fees are generated from accounts for individual cannabis-related businesses (“CRB”) related accounts, amounts are initially collected by the financial institutional partners and remitted in the subsequent month. Accounts receivable - related party represents amounts due from PCCU under related party contracts disclosed in Note 8 to the unaudited condensed consolidated financial statements.

 

 6 

 

 

vii. Loans Receivable

 

CRB loans that significantly support the Company’s operations are recognized as assets on the balance sheet. These loans, intended to be held either for the foreseeable future or until their maturity or full repayment, are recorded at their outstanding principal balance. This amount is adjusted for any credit loss allowances and net of any deferred loan origination fees and costs, as applicable, to reflect the net investment in these loans. The Company recognizes interest income on CRB Loans over the loan term using the simple-interest method based on outstanding principal amounts. This approach ensures a systematic recognition of income, aligning with the time value of money principle.

 

Interest income recognition is suspended when there is uncertainty regarding full loan repayment, such as in cases of loan impairment or when payments are overdue by ninety days or more. Loans under these conditions are placed on nonaccrual status. Any accrued interest not received by the time a loan is placed on nonaccrual is reversed from interest income. Subsequent interest payments on nonaccrual loans are recorded using either the cash basis or the cost recovery method until the loan meets the criteria for reclassification to accrual status.

 

Loans are returned to accrual status when they become current (less than ninety days past due) and when there is reasonable assurance of future payment compliance, evidenced by the full satisfaction of both principal and interest payments due.

 

Loans are assessed individually for potential charge-off, which typically occurs at the point of foreclosure. Charge offs are executed to reflect the realizable value of loans that are deemed uncollectible.

 

The determination of a loan’s past-due status is based on its contractual repayment terms. Loans are either placed on nonaccrual status or charged-off ahead of their contractual delinquency dates if the collection of principal and interest is deemed doubtful, ceasing the recognition of interest income on such loans.

 

viii. Allowance for Credit Losses (ACL)

 

The Company has adopted Accounting Standards Codification Topic 326 - Financial Instruments - Credit Losses (ASC Topic 326), for estimation of probable credit losses with an expected credit loss methodology that is referred to as the current expected credit loss (“CECL”) methodology.

 

The ACL is a valuation account that is deducted from the amortized cost basis of financial assets carried at their amortized cost, including loans held for investment, to present the net amount that is expected to be collected throughout the life of the financial asset. The estimated ACL is recorded through a provision for credit losses charged against operations. Management periodically evaluates the adequacy of the ACL to maintain it at a level it believes to be reasonable. The Company uses the same methods used to determine the ACL to assess any reserves needed for off-balance sheet credit risks such as unfunded loan commitments including Indemnified loans to PCCU. These reserves for off-balance sheet credit risks are presented in the liabilities section in the unaudited condensed consolidated balance sheets as an “Indemnity liability.”

 

The ACL consists of two components: an asset-specific component for estimating credit losses for individual loans that do not share similar risk characteristics with other loans; and a pooled component for estimating credit losses for pools of loans that share similar risk characteristics. The ACL for the pooled component is derived from an estimate of expected credit losses primarily using an expected loss methodology that incorporates risk parameters such as probability of default (“PD”) and loss given default (“LGD”) which are derived from various vendor models and/or internally developed model estimation approaches for smaller homogenous loans.

 

The PD is quantified by analyzing historical data to determine the rate at which loans have defaulted within the portfolio, relative to the total outstanding loans as of the end of the reporting period. This rate is expressed as a percentage and serves as a key indicator of the likelihood of default across the loan pool. LGD assessments are conducted to estimate the potential loss amount in the event of a default, considering the recoverable value from the collateral liquidation against the remaining loan balance. This involves a detailed analysis of two primary components: the loss on principal, which arises from the gap between the collateral’s liquidation value and the unpaid principal balance of the loan; and the loss associated with various ancillary costs to recover, including, but not limited to, foregone interest, transaction costs, legal and administrative fees, and expenses related to the maintenance and renovation of the property. The Company considers relevant current conditions and reasonable and supportable forecasts that relate to its lending practices and environment and the specific borrower and determines that the significant factor affecting the loan’s performance is the fact that these borrowers are involved in the cannabis business. Despite being legal at the state level in certain jurisdictions, cannabis remains federally illegal in the United States as of the date of this filing. As cannabis related lending is a new practice in the United States, there is very little historical or industry data on which to base a loss forecast. Therefore, significant judgement is required in creating a reasonable loss estimate, using similar non-MRB loans as a baseline and adjusting for the inherent risks in the cannabis industry. While the Company considers other qualitative factors, including national macroeconomic conditions, in its overall risk analysis, it has determined that they are not significant inputs to the overall loss estimate calculations.

 

 7 

 

 

The ACL estimation process also applies an economic forecast scenario, or a composite of scenarios based on management’s judgment and expectations around the current and future macroeconomic outlook. Expected credit losses are estimated over the contractual term of the loans, adjusted for expected prepayments when appropriate. The contractual term of a loan excludes expected extensions, renewals, and modification under certain conditions.

 

Recoveries on loans represent collections received on amounts that were previously charged off against the ACL. Recoveries are credited to the ACL when received, to the extent of the amount previously charged off against the ACL on the related loan. Any amounts collected in excess of this limit are first recognized as interest income, then as a reduction of collection costs, and then as other income.

 

ix. Net Deferred Loan Origination Fees and Cost

 

When included with a new loan origination, the Company receives loan origination fees in conjunction with new loans funded and any indemnified liabilities which are not recorded on the balance sheet from the company financial institution partners. Where applicable, the loan origination fee is netted with loan origination costs associated with originating a specific loan. These loan origination costs are typically incremental direct costs (non-reimbursed) paid to third parties. Net loan origination fees are initially deferred and presented net of loans receivable asset for portfolio loans, or as a separate liability for indemnified loans, and recognized as interest income utilizing the interest method.

 

x. Indemnity Liability

 

Under the Loan Servicing Agreement and Commercial Alliance Agreement with PCCU, the Company had agreed to indemnify PCCU from all claims related to Company’s cannabis-related business, including but not limited to default-related credit losses as defined in the Loan Servicing Agreement. The indemnification component of the Loan Servicing Agreement and the Commercial Alliance Agreement (refer to Note 8 to the unaudited condensed consolidated financial statements) is accounted for in accordance with accounting standards codification (“ASC”) 460 Guarantees. In determining the applicability of ASC 460, the Company considered that the agreement outlines a broad indemnification of all claims related to the cannabis-related business. The most immediate and potentially significant of these are potential default-related credit losses. In the lending industry, it is inherently anticipated future credit losses will result from currently issued debt. The Company’s indemnity obligation is subordinate to financial institution clients’ other means of collecting on the loans including foreclosure of the collateral, recourse against personal and/or corporate guarantors and other default remedies available in the loan agreements. Since borrowers are not party to the agreement between Company and PCCU, any indemnity payments do not relieve borrowers of their obligation to PCCU nor would such payments preclude PCCU’s right to future recoveries from the debtor. Therefore, as defined in ASC 460, the indemnification clause represents a general loss contingency in that it is an existing condition, situation or set of circumstances involving uncertainty as to possible loss to the Company that will ultimately be resolved when one or more future events occur or fail to occur. SHF’s indemnity liability reflects SHF management’s estimate of probable credit losses inherent under the agreement at the balance sheet date. The liability is measured and recognized in accordance with our accounting policies for ACL and ALL.

 

In addition to default-related credit losses, the Company continuously monitors all other circumstances pursuant to the agreement and identifies events that may necessitate a loss contingency under the Loan Servicing Agreement. A loss contingency is reported when it is both probable that a future event will confirm that a loss had been incurred on or before the related balance sheet date and the loss is reasonably estimable.

 

xi. Property and Equipment, net

 

Property and equipment are recorded at historical cost, net of accumulated depreciation. Depreciation is provided over the assets’ useful lives on a straight-line basis 3-5 years for equipment and furniture and fixtures. Repairs and maintenance costs are expensed as incurred.

 

Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.

 

The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.

 

The Company capitalize certain costs related to software developed for internal-use, primarily associated with the ongoing development and enhancement of our technology platform. Costs incurred in the preliminary development and post-development stages are expensed. These costs are amortized on a straight-line basis over the estimated useful life of the related asset, generally five years.

 

 8 

 

 

xii. Right of Use Assets and Lease Liabilities

 

The Company has entered into lease agreements for a certain facility and certain items of equipment, which provide the right to use the underlying asset and require lease payments over the term of the lease. At inception of the lease agreement, the Company assesses whether the agreement conveys the right to control the use of an identified asset for a period in exchange for consideration, in which case it is classified as a lease. Each lease is further analyzed to check whether it meets the classification criteria of a finance or operating lease. All identified leases are recorded on the consolidated balance sheet with a corresponding lease right-of-use asset, net, representing the right to use the underlying asset for the lease term and the operating lease liabilities representing the obligation to make lease payments arising from the lease. The Company has elected not to recognize lease assets and lease liabilities for short-term leases (leases with a term of 12 months or less) and leases of low-value assets. Lease right-of-use assets, net and lease liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term and include options to extend or terminate the lease when they are reasonably certain to be exercised. The present value of lease payments is determined primarily using the incremental borrowing rate based on the information available as of the lease commencement date.

 

Lease expense for operating leases is recorded on a straight-line basis over the lease term and variable lease costs are recorded as incurred. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. Finance lease interest expense is recognized based on an effective interest method and depreciation of assets is recorded on a straight-line basis over the shorter of the lease term and useful life of the asset. Both operating and finance lease right of use assets are reviewed for impairment, consistent with other finite-lived assets, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. After a right of use asset is impaired, any remaining balance of the asset is amortized on a straight-line basis over the shorter of the remaining lease term or the estimated useful life.

 

xiii. Goodwill and Other Intangible Assets

 

The Company’s methodology for allocating the purchase price of an acquisition is based on established valuation techniques that reflect the consideration of a number of factors, including a valuation performed by a third-party appraiser. Goodwill is measured as the excess of the cost of an acquired business over the fair value assigned to identifiable assets acquired and liabilities assumed.

 

Goodwill is tested for impairment at least annually on the elected impairment test date of December 31 unless any events or circumstances indicate it is more likely than not that the fair value of the goodwill is less than its carrying value.

 

Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.

 

Finite-lived intangible assets are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. Intangible assets should be tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.

 

xiv. Stock-based Compensation

 

The Company measures all equity-based payment arrangements to employees and directors in accordance with ASC 718, Compensation–Stock Compensation. The Company’s stock-based compensation cost is measured based on the fair value at the grant date of the stock-based award. It is recognized as expense on a straight-line basis over the requisite service period for the entire award. Forfeitures are recognized as they occur. The Company estimates the fair value of each stock-based award on its measurement date using either the current market price of the stock or Black-Scholes option valuation model, whichever is most appropriate. The Black-Scholes valuation model incorporates assumptions such as expected term of the instrument, volatility of the Company’s future share price, risk free rates, future dividend yields and estimated forfeitures at the initial grant date, by reference to the underlying terms of the instrument, and the Company’s experience with similar instruments. Changes in assumptions used to estimate fair value could result in materially different results.

 

The shares of the Company have been listed on the Nasdaq stock exchange for a limited period of the time and also the stock price has dropped significantly from the date of listing, based on which the Company has considered the expected volatility at 100% for the purpose of stock compensation. The risk-free interest rates are based on quoted U.S. Treasury rates for securities with maturities approximating the awards’ expected lives. The expected term of the options granted is calculated based on the simplified method by taking average of contractual term and vesting period the awards. The expected dividend yield is zero as the Company has never paid dividends and does not currently anticipate paying any in the foreseeable future.

 

 9 

 

 

xv. Fair Value Measurements

 

The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:

 

Level 1 — Quoted prices for identical assets or liabilities in active markets.

 

Level 2 — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 —Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.

 

xvi. Revenue Recognition

 

SHF recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which SHF expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.

 

Revenue is recorded at a point in time when the performance obligation is satisfied, and no contingencies exist. Majority of the revenue consists of fees earned on deposit accounts held at PCCU but serviced by SHF such as bank account charges, onboarding income, account activity fee income and other miscellaneous fees. Under the terms of the Loan Servicing Agreement and the Commercial Alliance Agreement, the Company is responsible for covering account hosting costs associated with the fees generated from deposits held at PCCU. These costs are classified as “General and Administrative Expenses” in the Consolidated Statements of Operations.

 

In addition, SHF recognizes revenue from the Master Program Agreement. The Master Program Agreement is a non-exclusive and non-transferable right to implement and utilize the Safe Harbor Program. The Safe Harbor Program has two performance obligations; an implementation fee recognized when the contract is effective and a service fee recognized ratable over the contract term as the compliance program is executed.

 

SHF recognizes revenue from interest on loans and investment income distributed by PCCU, which is determined by particular customer account balances. As per the Loan Servicing Agreement and the Commercial Alliance Agreement, SHF bears the expenses for hosting investments and servicing loans related to this interest and investment income. These expenses are allocated to “General and Administrative Expenses” in the Consolidated Statements of Operations.

 

Amounts received in advance of the service being provided is recorded as a liability under deferred revenue on the consolidated balance sheets. Typical Safe Harbor Program contracts are three-year contracts with amounts due monthly, quarterly or annually based on contract terms.

 

Customers consist of financial institutions providing services to CRBs. Revenues are concentrated in the United States of America.

 

xvii. Contract Liabilities

 

The Company recognizes a contract liability if the customer’s payment of consideration precedes the reporting entity’s performance. As of March 31, 2024, the Company recorded contract liabilities amounting to $2,692 from contracts with customers. This compares to contract liabilities of $21,922 as reported on December 31, 2023.

 

 10 

 

 

xviii. Warrants Liabilities

 

The Company has evaluated each of the warrant arrangements separately in accordance with “Distinguishing Liabilities from Equity” (“ASC 480”) and “Derivatives and Hedging” (“ASC 815”), to determine classification as either equity instruments or liabilities based on the specific terms and features of each warrant. Warrants are recognized as equity if they are indexed to our own stock and meet the equity classification criteria in ASC 815-40. These warrants are recorded within stockholders’ equity at their issuance date and are not subsequently remeasured at fair value. Conversely, warrants that do not meet the criteria for equity classification under ASC 815-40 are classified as liabilities. Such warrants are initially recorded at fair value on the issuance date and are subject to remeasurement at each balance sheet date thereafter. Any changes in fair value are recognized in the statement of operations. None of our warrant contracts met criteria to be considered indexed to their own stock, and as a result, have each been accounted for as a liability financial instrument. The fair value of warrants classified as liabilities is determined using appropriate valuation models, such as the Black- Scholes model, which incorporates various inputs, including the current stock price, expected volatility, risk-free interest rate, and the expected term of the warrants.

 

xix. Deferred consideration

 

In line with ASC Topic 815, the Company treats the deferred consideration from the Abaca acquisition as a derivative liability, since it does not fulfill the equity classification criteria. As a result, this obligation is recognized as a liability on the balance sheet at fair value and is adjusted to reflect its fair value at the end of each reporting period. The liability will be reassessed at fair value on every balance sheet date until the obligation’s term concludes. Fluctuations in its fair value are recorded in the consolidated statements of operations.

 

xx. Forward purchase derivative

 

The Company accounts for the forward purchase derivative assumed in the business combination in accordance with the guidance contained in ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company classifies the forward purchase derivatives as an assets or liabilities carried at their fair value and adjusts the forward purchase derivatives to fair value at each reporting period. This derivative asset or liability is subject to re-measurement at each balance sheet date until the conditions under the forward purchase agreement are exercised or expire, and any change in fair value is recognized in the unaudited condensed consolidated statement of operations. In December 2023, the company calculated its valuation using a Monte Carlo Simulation set within a risk-neutral environment. Initiated in December 2022, this strategy was applied to assess the fair value of the forward purchase agreement (FPA) derivatives, with an underlying assumption that future stock prices would adhere to a Geometric Brownian Motion trajectory. Throughout the first quarter of 2024, there were no transactions by FPA holders, and no considerable shifts in risk factors that could influence the valuation of FPA derivatives were observed.

 

xxi. Earnings Per Share

 

Basic and diluted earnings per share are computed and disclosed in accordance with ASC Topic 260, Earnings Per Shares. The Company utilizes the two-class method to compute earnings available to common shareholders. Under the two-class method, earnings are adjusted by accretion amounts to redeemable noncontrolling interests recorded at redemption value. The adjustments represent dividend distributions, in substance, to the noncontrolling interest holder as the holders have contractual rights to receive an amount upon redemption other than the fair value of the applicable shares. As a result, earnings are adjusted to reflect this in substance distribution that is different from other common shareholders. In addition, the Company allocates net earnings to each class of common stock and participating security as if all of the net earnings for the period had been distributed. The Company’s participating securities consist of share-based payment awards that contain a non-forfeitable right to receive dividends and therefore are considered to participate in undistributed earnings with common shareholders. Basic earnings per common share excludes dilution and is calculated by dividing net earnings allocated to common shares by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is calculated by dividing net earnings allocable to common shares by the weighted-average number of common shares outstanding for the period, as adjusted for the potential dilutive effect of non-participating share-based awards.

 

xxii. Income Tax

 

Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred tax assets and liabilities are adjusted through the provision for income taxes as changes in tax laws or rates are enacted.

 

 11 

 

 

ASC 740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods. If management is unable to estimate a portion of its ordinary income, but is otherwise able to reliably estimate the remainder, ASC 740-270-25-3 provides that the tax applicable to that item be reported in the interim period in which the item occurs. The tax (or benefit) related to ordinary income (or loss) shall be computed at an estimated annual effective tax rate and the tax (or benefit) related to all other items shall be individually computed and recognized when the items occur. Management is unable to estimate a portion of its ordinary income and as a result had computed the company’s tax provision in accordance with ASC 740-270-25-3.

 

ASC Topic 740 also prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

xxiii. Recently Issued Accounting Standards

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position or results of operations upon adoption.

 

Adopted Standards

 

Current Expected Credit Losses

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduces a model based on expected losses to estimate credit losses for most financial assets and certain other instruments. In November 2019, the FASB issued ASU No. 2019-10 Financial Instruments — Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). The update allows the extension of the initial effective date for entities which have not yet adopted ASU No. 2016-02. The standard is effective for annual reporting periods beginning after December 15, 2022 for private companies and SEC filers classified as smaller reporting entities, with early adoption permitted. Entities apply the standard’s provisions by recording a cumulative effect adjustment to retained deficit. The Company has adopted ASU 2016-13 as of January 1, 2023, utilizing the modified retrospective method.

 

CECL Transition Impact: The table below provides details on the transition impacts of adopting CECL. Other balance sheet lines not presented were not affected by CECL.

 

CECL Transition Impact:

 

Assets   December 31,
2022
    Transition
Adjustment
    January 1,
2023
 
Loans receivable, gross   $ 1,432,560     $ -     $ 1,432,560  
Less: Allowance for credit loss     (21,488 )     (14,980 )     (36,468 )
    $ 14,11,072     $ (14,980 )   $ 1,396,092  

 

Liabilities & Equity  December 31,
2022
   Transition
Adjustment
   January 1,
2023
 
Indemnity liability  $499,465   $566,341   $1,065,806 
Retained deficit   (39,695,281)   (581,321)   (40,276,602)
   $(39,195,816)  $(14,980)  $(39,210,796)

 

Troubled Debt Restructurings and Vintage Disclosures

 

This Accounting Standard Update (ASU 2022-02) eliminates the recognition and measurement guidance on troubled debt restructurings for creditors that have adopted ASC 326 and requires them to make enhanced disclosures about loan modifications for borrowers experiencing financial difficulty. The new guidance also requires public business entities to present current period gross write-offs (on a current year-to-date basis for interim-period disclosures) by year of origination in their vintage disclosures. For entities that have adopted ASU 2016-13, this ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2023 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

 12 

 

 

Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions

 

This Accounting Standard Update (ASU 2022-03) clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered when measuring fair value. Recognizing a contractual restriction on the sale of an equity security as a separate unit of account is not permitted. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2024 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848

 

This Accounting Standard Update (ASU 2022-06) defers the Sunset Date of ASC Topic 848, Reference Rate Reform (Topic 848), which provides temporary optional relief in accounting for the impact of Reference Rate Reform. This ASU is effective upon issuance (December 21, 2022) and generally can be applied through December 31, 2024.This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

Investments-Equity Method and Joint Ventures

 

In March 2023, the FASB issued ASU 2023-02, Investments-Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures using the Proportional Amortization Method. The FASB issued final guidance allowing entities to apply the proportional amortization method to equity investments in all tax credit programs that meet the conditions in ASC 323-740, rather than just investments in qualified affordable projects that generate low income housing tax credits, as was required under the legacy guidance. The guidance is effective for public business entities for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

Standards Pending to be Adopted

 

Business Combinations-Joint Venture Formations

 

In August 2023, the FASB issued 2023-05, Business Combinations-Joint Venture Formations (Subtopic 805-60); Recognition and Initial Measurement. This ASU contains guidance requiring certain joint ventures to apply a new basis of accounting upon formation by recognizing and initially measuring most of their assets and liabilities at fair value. This guidance is effective for all joint venture formations with a formation date on or after January 1, 2025. Early adoption is permitted. Joint Ventures formed before the effective date have the option to apply it retrospectively, while those formed after the effective date are required to apply it prospectively. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.”

 

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ASU amends the disclosure or presentation requirements related to various subtopics in the FASB codification.

 

The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. For all other entities, the amendments will be effective two years later. The amendments in this Update should be applied prospectively. For all entities, if by June 30, 2027, the SEC has not removed the applicable requirement from Regulation S-X or Regulation S-K, the pending content of the related amendment will be removed from the Codification and will not become effective for any entity. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

Segment Reporting

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280). This ASU requires public entities to provide disclosures of significant segment expenses and other segment items. It also requires public entities to provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Public entities with a single reportable segment will have to provide all the disclosures required by ASC 280, including the significant segment expense disclosures. This guidance is applied retrospectively to all periods presented, unless it is impractical. This ASU applies to all public entities and is effective for fiscal years beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

 13 

 

 

Income Taxes

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This ASU requires public business entities to disclose in their rate reconciliation table additional categories of information about income taxes paid, including certain disclosures that would be disaggregated by jurisdiction and other categories. This ASU is effective for fiscal years after December 15, 2024. Early adoption would be permitted. The Company does not expect this ASU to have a material impact on its condensed unaudited consolidated financial statements.

 

ASU 2024-01: Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards

 

ASU 2024-01 clarifies the scope applications of profits interest awards by adding illustrative guidance to ASC 718 “Compensation-Stock Compensation.” The amendments in the ASU apply to all reporting entities that account for profits interest awards as compensation to employees or non-employees in return for goods or services.

 

The term “profits interest” is not explicitly defined in US GAAP. Rather, an IRS Revenue Procedure (Rev Proc 93-27) defines a “Profits Interest” as a “partnership interest other than a capital interest.” Unlike a capital interest, which provides rights to existing net assets of an entity, a profits interest only provides rights to future profits and/or equity appreciation of an entity. This distinction, along with other terms, conditions and characteristics of profits interests often complicates accounting decisions for profits interests, leading to diversity in practice whether to account for profits interests under ASC 718 or other US GAAP.

 

The ASU introduces four (4) illustrative examples of fact patterns that demonstrate how an entity would apply the scope guidance in paragraph 718-10-15-3 to a profits interest or similar award with certain features.

 

The ASUs are effective for public entities for fiscal years beginning after December 15, 2024, including interim periods within those years. For all other entities, adoption is required for fiscal years beginning after December 15, 2025. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

ASU 2024-02: Codification Improvements—Amendments to Remove References to the Concepts Statements

 

The ASU contains amendments to the Codification that remove references to various FASB Concepts Statements. The Board has a standing project on its agenda to address suggestions received from stakeholders on the Accounting Standards Codification and other incremental improvements to GAAP. This effort facilitates Codification updates for technical corrections such as conforming amendments, clarifications to guidance, simplifications to wording or the structure of guidance and other minor improvements. In the Board’s view, removing all references to Concept Statements in the guidance will simplify the codification and draw a distinction between authoritative and non-authoritative literature.

 

The amendments in the Update are effective for public business entities for fiscal years beginning after December 15, 2024. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2025. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

Note 3. Deferred Consideration

 

Under the revised Abaca Merger Agreement, the Company compensated Abaca with $30 million through a mix of cash and stock. The payment structure included $9 million in cash, distributed in three equal installments, with the first installment occurring at the merger closing and the other installments being paid on the first and second anniversaries of the merger closing. Additionally, the common stock consideration was settled through 2,100,000 shares which represented a monetary equivalent calculated against the closing trading price, alongside deferred stock consideration calculated with a 10-day VWAP formula. Adjustments were made via amendments to redefine the terms and conditions of the deferred stock and cash considerations.

 

The revised terms, as of the second amendment on October 26, 2023, stipulated new deferred stock consideration of 5,835,822 shares of Class A common stock issued at the first anniversary based on a recalculated value of $2.00 per share. No changes affected the scheduled cash payments. Furthermore, a third-anniversary consideration of $1.5 million was introduced, payable in cash or stock at the Company’s discretion, alongside an issue of 5 million stock warrants at an exercise price of $2.00 each. The adjustments and additional considerations have been valued and recorded according to ASC 815, reflecting changes in the fair value of deferred consideration in the consolidated statements of operations for the periods ending December 31, 2023.

 

 14 

 

 

The change in the amount of deferred consideration from January 1, 2023, to March 31, 2024, is as follows:

 

   Stock
consideration
   Cash
consideration
   Third Anniversary
Consideration Payment
 
January 1, 2023  $11,456,639   $5,650,775   $- 
Less: Working capital adjustment   (108,691)   -    - 
Less: Issuance of shares and payment to shareholders   (4,085,075)   (3,000,000)   - 
Less: Issuance of Abaca warrants   (1,643,699)   -    - 
Less: Issuance of third anniversary payment consideration   (430,000)   -    430,000 
Less: Gain recognized in the consolidated statements of operations   (5,645,107)   -    - 
Add: Fair value adjustment   455,933    239,017    380,000 
December 31, 2023   -    2,889,792    810,000 
Add: Fair value adjustment   -    31,465    (216,000)
March 31, 2024  $-   $2,921,257   $594,000 

 

Note 4. Goodwill and Finite-lived Intangible Assets

 

The Company’s goodwill was derived from the Abaca acquisition transaction executed on November 15, 2022, where the purchase price exceeded the fair value of the net identifiable assets acquired. Goodwill is tested for impairment at least annually, or more frequently if a triggering event occurs.

 

In 2023, the Company conducted an interim impairment assessment on June 30, 2023, and found that the carrying value of goodwill exceeded its fair value, leading to the recognition of a $13.21 million non-cash goodwill impairment charge in the Company’s consolidated statements of operations. The December 31, 2023, annual impairment test resulted in no additional impairment change recognized, as the fair value did not surpass the carrying value. As of March 31, 2024, and December 31, 2023, the carrying value of the company’s goodwill was $6,058,000.

 

As of March 31, 2024, the Company has not conducted an interim impairment assessment of its assets, due to the absence of any triggering events. Therefore, no additional impairment charges have been recognized in this reporting period.

 

As of March 31, 2024, and December 31, 2023, the Company’s accumulated goodwill impairment was $13,208,276.

 

Finite-lived intangible assets

 

The Company reviews its finite-lived intangible assets for impairment at least annually on December 31st unless any events or circumstances indicate it is more likely than not that the fair value of the finite-lived intangible assets is less than its carrying value.

 

In 2023, following a triggering event in the second quarter, the Company performed an interim goodwill analysis. In accordance with our established policy, an annual review was also conducted on December 31, 2023. The finite-lived intangible assets evaluated include market-related intangibles, customer relationships, and developed technologies. The interim analysis resulted in an impairment charge of $3,680,463, attributed to the carrying values of market-related intangibles and customer relationships surpassing their fair values. The annual review further identified an impairment charge of $2,019,000 related to developed technologies.

 

As of March 31, 2024, the Company has not conducted an interim impairment assessment of its assets, due to the absence of any triggering events. Therefore, no additional impairment changes have been recognized in this reporting period.

 

 15 

 

 

Following is a summary of the Company’s finite-lived intangible assets as of March 31, 2024 and December 31, 2023:

 

   Remaining
Useful life in
Years
  December 31, 2023
(A)
   Acquired in
Acquisition
(B)
   Amortization
(C)
   Impairment
(D)
   March 31, 2024
(A+B-C-D)
 
Market related intangible assets  6.62 Years  $65,216   $-   $2,540   $-   $62,676 
Customer relationships  8.62 Years   56,775    -    1,687    -    55,088 
Developed technology  5.62 Years   3,599,754    -    152,628    -    3,447,126 
Total intangible assets     $3,721,745   $-   $156,855   $-   $3,564,890 

 

   Remaining
Useful life in
Years
  December 31, 2022
(A)
   Acquired in
Acquisition
(B)
   Amortization
(C)
   Impairment
(D)
   December 31, 2023
(A+B-C-D)
 
Market related intangible assets  6.87 Years  $2,066,918   $-   $136,034    1,865,668   $65,216 
Customer relationships  8.87 Years   1,974,795    -    103,225    1,814,795    56,775 
Developed technology  5.87 Years   6,579,374    -    960,619    2,019,001    3,599,754 
Total intangible assets     $10,621,087   $-   $1,199,878    5,699,464   $3,721,745 

 

During the three months ended March 31, 2023, amortization expense and impairment of finite lived intangible assets were $354,911 and $0 respectively.

 

Note 5. Loans Receivable

 

Commercial real estate loans receivable, net consist of the following:

 

   March 31, 2024   December 31, 2023 
Commercial real estate loans receivable, gross  $401,564   $404,577 
Allowance for credit losses   (9,081)   (10,723)
Commercial real estate loans receivable, net   392,483    393,854 
Current portion   (12,620)   (12,391)
Noncurrent portion  $379,863   $381,463 

 

Allowance for Credit Losses

 

The allowance for credit losses is maintained at a level believed to be sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the loan portfolio. The Company’s estimated the allowance for credit losses on the reporting date in accordance with the credit loss policy described in Note 2 to the unaudited condensed consolidated financial statements.

 

 16 

 

 

The allowance for credit losses consists of the following activity for the three months ended March 31, 2024 and three months ended March 31, 2023:

 

   March 31, 2024   March 31, 2023 
Allowance for credit losses          
Beginning balance  $10,723   $21,488 
Cumulative effect from adoption of CECL   -    14,980 
Charge-offs   -    - 
Recoveries   -    (15,390)
Benefit   (1,642)   - 
Ending balance  $9,081   $21,078 
           
Loans receivable:          
Individually evaluated for an allowance for credit loss  $-   $- 
Collectively evaluated for an allowance for credit loss   401,564    413,292 
   $401,564   $413,292 
Allowance for credit losses:          
Individually evaluated for an allowance for credit loss  $-   $- 
Collectively evaluated for an allowance for credit loss   9,081    21,078 
   $9,081   $21,078 

 

On March 31, 2024 and December 31, 2023, no loans were past due or classified as non-accrual.

 

Credit quality of loans:

 

As part of the on-going monitoring of the credit quality of the Company’s loan portfolio, management tracks credit quality indicators based on the loan payment status on monthly basis. The Company continuously evaluates the credit quality of each indemnified loan by assessing the risk factors and assigning a risk rating based on a variety of factors. The detailed breakdown of risk factors described in Note 6 to the unaudited condensed consolidated financial statements.

 

The carrying value, excluding the CECL Reserve, of the Company’s loans held at carrying value within each risk rating is as follows:

 

Risk rating  March 31, 2024   December 31, 2023 
4  $401,564   $404,577 
Grand total  $401,564   $404,577 

 

Note 6. Indemnification Liability

 

As discussed at Note 8 to the unaudited condensed consolidated financial statements, and pursuant to the Commercial Alliance Agreement with PCCU, PCCU funds loans through a third-party vendor. SHF earns the associated interest and pays PCCU a loan hosting payment at an annual rate of 0.35% of the outstanding loan principal funded and serviced by PCCU and 0.25% of the outstanding loan principle serviced by SHF. The below schedule details outstanding amounts funded by PCCU and categorized as either collateralized loans or unsecured loans and lines of credit.

 

   March 31, 2024   December 31, 2023 
Secured term loans  $57,737,288   $55,215,013 
Unsecured loans and lines of credit   431,640    431,640 
Total loans funded by PCCU  $58,168,928   $55,646,653 

 

Secured loans contained an interest rate ranging from 7.35% to 15.25%. Unsecured loans and lines of credit contain variable rates ranging from Prime +1.50% to Prime +6.00%. Unsecured lines of credit had incremental availability of $525,000 and $996,958 on March 31, 2024 and December 31, 2023.

 

 17 

 

 

SHF has agreed to indemnify PCCU for losses on certain PCCU loans. The indemnity liability reflects SHF management’s estimate of probable credit losses inherent under the agreement at the balance sheet date. The Company’s estimated indemnity liability on the reporting date was calculated in accordance with the allowance for credit loss policy described in Note 2 to the unaudited condensed consolidated financial statements.

 

The indemnity liability activity are as follows:

 

   Three Months ended
March 31, 2024
   Three Months ended
March 31, 2023
 
Beginning balance  $1,382,408   $499,465 
Cumulative effect from adoption of CECL   -    566,341 
Charge-offs   -    - 
Recoveries   -    - 
(Benefit)/ Provision   (67,145)   82,026 
Ending balance  $1,315,263   $1,147,832 

 

As of March 31, 2024, all loans within the Company’s portfolio were current and performing. This is in contrast to the situation as of December 31, 2023, when one loan was under nonaccrual status. The Company successfully negotiated an amendment agreement on December 29, 2023, which brought this loan back to current status through the payment of all overdue amounts. Under the terms of the amendment, the loan’s maturity date was extended to November 1, 2024. Interest income from this loan is now recognized on a cash basis. Given that the loan was delinquent for over 300 days, it has been incorporated into the Company’s Current Expected Credit Losses (CECL) methodology, which aids in estimating credit losses for this particular loan and the overall loan portfolio collectively.

 

Credit quality of indemnified loans:

 

As part of the on-going monitoring of the credit quality of the Company’s indemnified loan portfolio, management tracks credit quality indicators based on the loan payment status on monthly basis. The Company continuously evaluates the credit quality of each indemnified loan by assessing the risk factors and assigning a risk rating based on a variety of factors. Risk factors include property type, geographic and local market dynamics, physical condition, projected cash flow, loan structure and exit plan, loan-to-value ratio, fixed charge coverage ratio, project sponsorship, and other factors deemed necessary. Based on a 10-point scale, the Company’s loans are rated “0” through “10,” from less risk to greater risk, which ratings are defined as follows:

 

Risk
rating
  Category   Description
0   Risk Free   Free of repayment risk. The loan is fully guaranteed by the full faith and backing of the US Government or entirely secured by cash controlled by SHF.
1   Highest Quality   High caliber loan with the lowest risk of default. Significant excess cash flow after debt service and moderate to low leverage.
2   Excellent   High quality loan that carry’s a low risk of default. Strong cash flow and relatively few negative individual risk factors.
3   Good   Loans with lower-than-average level of risk. Excess cash flow and other factors contributing to the overall low level of risk in the loan.
4   Average   Risk factors may be mixed with some negative and some positive aspects, but the overall rating will indicate an average level of risk.
5   Fair   Loans in this category have the maximum level of risk that can be accepted while still recommending a new loan for origination. The loan risk factors may contain multiple negative factors, but they are generally outweighed by the positive aspects of the loan.
6   Watch List   There is a temporary and curable condition resulting in a lower risk rating.
7   Special Mention   There is a potential weakness that may result in the deterioration of the prospect of repayment that are not temporary and may require additional collection or workout efforts.
8   Substandard   Loans in this category are inadequately protected by the current net worth and paying capacity of the obligors or of the collateral pledged and have well-defined weaknesses that jeopardize the liquidation of the debt with distinct possibility of loss. SHF may be required to advance additional funds to manage the loan. Escalated collection activities such as foreclosure have been scheduled with anticipated losses up to 20% of the outstanding balance.
9   Doubtful   Collection or liquidation in full highly questionable and improbable. Escalated collection activities such as foreclosure have commenced with anticipated losses from 20% to 50% of the outstanding balance.
10   Loss   Uncollectable loans. A complete write-off is imminent although a partial recovery may be affected in the future.

 

SHF has agreed to indemnify PCCU from all claims related to SHF’s cannabis-related business. Other than potential credit losses, no other circumstances were identified meeting the requirements of a loss contingency.

 

 18 

 

 

The carrying value, excluding the CECL Reserve, of the Company’s indemnified loans held at carrying value within each risk rating is as follows:

 

Risk rating  March 31, 2024  December 31, 2023 
3  $9,988,588  $10,100,000 
4   3,425,158   3,431,640 
5   30,553,007   28,115,013 
6   10,900,000   10,900,000 
7   -   3,100,000 
8   3,302,175   - 
Grand total  $58,168,928  $55,646,653 

 

The provision for credit losses on the statement of operations consists of the following activity for the period ended March 31, 2024 and March 31, 2023:

 

   Commercial
real estate
loans
   Indemnity
liability
   Total   Commercial
real estate
loans
   Indemnity
liability
   Total 
   March 31, 2024   March 31, 2023 
   Commercial
real estate
loans
   Indemnity
liability
   Total   Commercial
real estate
loans
   Indemnity
liability
   Total 
Provision (benefit)  $(1,642)   (67,145)   (68,787)  $(15,390)   82,056    66,666 

 

Note 7. Property and Equipment, Net

 

Property and equipment consist of the following:

 

   March 31, 2024   December 31, 2023 
Equipment  $45,397   $45,397 
Software   51,692    51,692 
Improvement   71,635    71,635 
Office furniture   215,504    215,504 
Property and equipment, gross   384,228    384,228 
Less: accumulated depreciation   (338,862)   (300,008)
Property and equipment, net  $45,366   $84,220 

 

Note 8. Related Party Transactions

 

Commercial Alliance Agreement

 

On March 29, 2023, the Company and PCCU entered into the Commercial Alliance Agreement. This Agreement sets forth the terms and conditions of the lending and account-related services, governing the relationship between the Company and PCCU. The Commercial Alliance Agreement sets forth the application, underwriting, loan approval, and foreclosure process for loans from PCCU to borrowers that are cannabis-related businesses and the loan servicing and monitoring responsibilities provided by the Company and PCCU. In particular, the Commercial Alliance Agreement provides for procedures to be followed upon the default of a loan to ensure that neither the Company nor PCCU will take title to or possession of any cannabis-related assets, including real property, that may be collateral for a loan funded by PCCU pursuant to the Commercial Alliance Agreement. Under the Commercial Alliance agreement, the PCCU has the right to receive monthly fees for managing loans. For SHF-serviced loans, which are CRB loans provided by the PCCU but primarily handled by SHF, a yearly fee of 0.25% of the remaining loan balance is applied. On the other hand, loans both financed and serviced by the PCCU are charged a yearly fee of 0.35% on their outstanding balance. These fees are calculated using the average daily balance of each loan for the preceding month. In addition, the Company’s is obligated by the Commercial Alliance Agreement to indemnify PCCU from certain default-related loan losses (as fully defined in the Commercial Alliance Agreement).

 

 19 

 

 

In addition, the Commercial Alliance Agreement provides for certain fees to be paid to the Company for certain identified account related services to include: all cannabis-related income, including all lending-related income (such as loan origination fees, interest income on CRB-related loans, participation fees and servicing fees), investment income, interest income, account activity fees, processing fees, flat fees, and other revenue generated from cannabis and multi-state hemp accounts that are hosted on PCCU’s core system for a monthly fee equal to $30.96 per account in 2022, $25.32-$27.85 per account in 2023, and $26.08-$28.69 in 2024. In addition, as it pertains to CRB deposits held at PCCU, investment and interest income earned on these deposits (excluding interest income on loans funded by PCCU) will be shared 25% to PCCU and 75% to the Company. Finally, under the Commercial Alliance Agreement, PCCU will continue to allow its ratio of CRB-related deposits to total assets to equal at least 60% unless otherwise dictated by regulatory, regulator or policy requirements. The initial term of the Commercial Alliance Agreement is for a period of two years, with a one-year automatic renewal unless a party provides one hundred twenty days’ written notice prior to the end of the term.

 

The below schedule demonstrates the ratio of CRB related loans funded by PCCU to the relative lending limits:

 

   March 31, 2024
(Unaudited)
   December 31, 2023
(Unaudited)
 
CRB related deposits  $106,692,488   $129,350,998 
Capacity at 60%   64,015,493    77,610,599 
PCCU net worth   83,739,916    81,087,746 
Capacity at 1.3125   109,908,640    106,670,306 
Limiting capacity   64,015,493    77,610,599 
PCCU loans funded   57,737,287    55,660,039 
Amounts available under lines of credit   775,000    525,000 
Incremental capacity  $5,503,206   $21,425,560 

 

The revenue from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Account servicing agreement  $-   $3,261,284 
Commercial alliance agreement   3,585,856    - 
Total  $3,585,856   $3,261,284 

 

The operating expense from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Support services agreement  $-   $378,730 
Loan servicing agreement   -    11,929 
Commercial alliance agreement   300,261    - 
Total  $300,261   $390,659 

 

 20 

 

 

Issuance of shares to PCCU

 

On March 29, 2023, the Company and PCCU entered into the following definitive transaction documents to settle and restructure the deferred obligation:

 

A five-year Senior Secured Promissory Note (the “Note”) in the principal amount of $14,500,000 bearing interest at the rate of 4.25% and a Security Agreement pursuant to which the Company will grant, as collateral for the Note, a first priority security interest in substantially all of the assets of the Company.
   
A Securities Issuance Agreement, pursuant to which the Company issued 11,200,000 shares of the Company’s Class A Common Stock to PCCU. Following the issuance of the Shares, PCCU own 46.39% of the outstanding Class A Common Stock. In connection with the Securities Issuance Agreement, the parties also entered into a Registration Rights Agreement and a Lock-Up Agreement.
   
The Registration Rights Agreement requires the Company to register the Shares for resale pursuant to the Securities Act of 1933, as amended (the “Securities Act”); and the Lock-Up Agreement restricts PCCU from transferring the Shares until the earlier of (i) six (6) months after the date of the Securities Issuance Documents or (ii) the consummation of a transaction with an unaffiliated third party in which all of the Company’s stockholders have the right to exchange their shares of Class A Common Stock for cash, securities, or other property; and
   
A Commercial Alliance Agreement that sets forth the terms and conditions of the lending-related and account-related services governing the relationship between the Company and PCCU which supersedes the Loan Servicing Agreement, as well as the Amended and Restated Support Services Agreement and the Amended and Restated Account Servicing Agreement.

 

The outstanding balances associated with the PCCU disclosed in the balance sheet are as follows:

 

   March 31, 2024   December 31, 2023 
Accounts receivable  $1,111,390   $2,095,320 
Accounts payable   125,693    577,315 
Senior Secured Promissory Note (Refer to Note 9 to the unaudited condensed consolidated financial statements)   13,270,622    14,011,166 

 

Of the $5.6 million and $8.6 million of cash and cash equivalents on March 31, 2024 and December 31, 2023, $5 million and $4.6 million of the cash and cash equivalents were held in deposit accounts at PCCU as a related party.

 

Note 9. Senior Secured Promissory Note

 

   March 31, 2024   December 31, 2023 
Senior Secured Promissory Note (Current)  $3,028,738   $3,006,991 
Senior Secured Promissory Note (long term)   10,241,884    11,004,175 
Total  $13,270,622   $14,011,166 

 

On March 29, 2023, the Company and PCCU entered into definitive transaction documents to settle and restructure the deferred obligation related to business Combination under which the Company has issued the five-year Senior Secured Promissory Note (the “Note”) in the principal amount of $14,500,000 bearing interest at the rate of 4.25% and a Security Agreement pursuant to which the Company will grant, as collateral for the Note, a first priority security interest in substantially all of the assets of the Company.

 

The Note amount will be paid in 54 installments of principal and interest of $295,487 each starting from November 5, 2023 and for the period between March 29, 2023, to October 05, 2023, the Company has paid the interest portion.

 

The repayment schedule of the outstanding principal amount on March 31, 2024, is as follows:

 

      
Year of payment     
2024   $2,266,449 
2025    3,138,931 
2026    3,274,966 
2027    3,416,896 
2028    1,173,380 
Grand total   $13,270,622 

 

 21 

 

 

Note 10. Leases

 

The Company has non-cancellable operating leases for facility space with varying terms. All of the active leases for facility space qualified for capitalization under FASB ASC 842, Leases. These leases have remaining lease terms between one to seven years and may include options to extend the leases for up to ten years. The extension terms are not recognized as part of the right-of-use assets. The Company has elected not to capitalize leases with terms equal to, or less than, one year. As of March 31, 2024, and December 31, 2023, net assets recorded under operating leases were $820,777 and $859,861 on, respectively, and net lease liabilities were $978,461 and $1,007,993, respectively.

 

The Company analyzes contracts above certain thresholds to identify leases and lease components. Lease and non-lease components are not separated for facility space leases. The Company uses its contractual borrowing rate to determine lease discount rates when an implicit rate is not available. Total lease cost for the three months ended March 31, 2024 and March 31, 2023, included in Unaudited Condensed Consolidated Statements of Operations, is detailed in the table below:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Operating lease cost  $-   $- 
Short-term lease cost   69,437    87,742 
Total Lease Cost  $69,437   $87,742 

 

   March 31, 2024   December 31, 2023 
ROU assets that are related to lease properties are presented as follows:          
Beginning balance  $859,861   $1,016,198 
Additions to right-of-use assets   -    - 
Amortization charge for the period   (39,084)   (156,337)
Lease modifications   -    - 
Ending balance  $820,777   $859,861 
           
Further information related to leases is as follows:          
Weighted-average remaining lease term   3.17 Years    3.42 Years 
Weighted-average discount rate   6.87%   6.87%

 

Future minimum lease payments as of March 31, 2024, and December 31, 2023, are as follows:

 

Year         
2024   $151,111   $197,520 
2025    217,925    217,925 
2026    222,275    222,275 
2027    226,705    226,705 
2028    231,216    231,216 
Thereafter    117,710    117,710 
Total future minimum lease payments   $1,166,942   $1,213,351 
Less: Imputed interest    188,481    205,358 
Operating lease liabilities    978,461    1,007,993 
Less: Current portion    142,863    132,546 
Non-current portion of lease liabilities   $835,598   $875,447 

 

 22 

 

 

Note 11. Revenue

 

Disaggregated revenue

 

Revenue by type are as follows:

 

   2024   2023 
   Three months ended
March 31
 
   2024   2023 
Deposit, activity, onboarding income  $1,620,994   $2,245,831 
Safe Harbor Program income   19,230    51,103 
Investment income   773,819    1,417,152 
Loan interest income   1,636,756    466,293 
Total Revenue  $4,050,799   $4,180,379 

 

Account fee income consists of deposit account fees, activity fees and onboarding income, which are recognized on periodic basis as per the fee schedule with financial partner institutions. Safe Harbor Program income consists of outsourced support to other financial institutions providing banking to the cannabis industry whose income is recognized on the basis of usage as per the agreements. Loan interest income consist of interest earned on both direct and indemnified loans pursuant to a commercial alliance agreement with PCCU. Investment income consist of interest earned on the daily deposits balance with financial institution.

 

Under our Commercial Alliance Agreement, we are obligated to remit 25% of the investment hosting fees to PCCU based on this income which is classified as “General and Administrative Expenses” in the Consolidated Statements of Operations. In 2024, PCCU’s contributions to the Company’s revenues included $1,217,675 from deposits, activities, and client onboarding, $731,425 from investment income, and $1,636,756 from loan interest income. The associated expenses for these revenues were $104,259 for account hosting, $160,101 for investment hosting fees, and $35,901 for loan servicing fees, all in accordance with the Loan Servicing Agreement and the Commercial Alliance Agreement, classified as “General and Administrative Expenses” in the Consolidated Statements of Operations. In first quarter March 2023, contributed to the Company’s revenues with $2,245,831 from deposits, activities, and client onboarding, $1,417,152 from investment income, and $466,293 from loan interest income. The related expenses for these revenue streams were $55,425 for account hosting, $323,305 for investment hosting fees, and $11,929 for loan servicing fees, all in compliance with the Loan Servicing Agreement, classified as “General and Administrative Expenses” in the Consolidated Statements of Operations.

 

Note 12. Deferred Underwriter Fee

 

In connection with the business combination, the Company executed a note on September 28, 2022 with EF Hutton related to PIPE financing under which the Company was obligated to pay the principal sum of $2,166,250 on the following schedule: (i) $715,750 on October 14, 2022, and (ii) $362,625 on each of October 31, 2022, November 30, 2022, December 31, 2022, and January 31, 2023.

 

The Company made the payment of its first installment of $715,750 and defaulted on the remaining outstanding amounts. The outstanding balance of the note on December 31, 2022 was $1,450,500. On March 13, 2023, the Company and EF Hutton entered into a settlement agreement pursuant to which the Company paid $550,000 to EF Hutton in full settlement of the amount due and the difference of $900,500 has been accounted for in the “Unaudited Condensed Consolidated Statements of Stockholders’ Equity.”

 

Note 13. Commitments and contingencies

 

The Company is involved in, or has been involved in, arbitrations or various other legal proceedings that arise from the normal course of its business. The ultimate outcome of any litigation is uncertain, and either unfavorable or favorable outcomes could have a material impact on the Company’s results of operations, balance sheets and cash flows due to defense costs, and divert management resources. The Company cannot predict the timing or outcome of these claims and other proceedings.

 

In connection with the Company’s initial public offering (“IPO”), the Company entered into a registration rights agreement dated June 23, 2021 with the Sponsor and the individuals serving as directors and executive officers of the Company at the time of the IPO. Pursuant to this registration rights agreement, the Company has agreed to register for resale upon the expiration of the applicable lock-up period the Company securities acquired by the Sponsor and such individuals in connection with the organization of the Company and the IPO.

 

 23 

 

 

In connection with the issuance of common stock to Abaca shareholders, the Company commits to registering the stock upon the exercise of Warrants if required by law or regulation to ensure the shares can be sold without restrictive legends, known as the Warrant Registration Requirement. Should this requirement arise, the Company is obliged to file a registration statement with the SEC within 45 calendar days of notification of the Warrant Registration Requirement. The failure to file within this timeframe constitutes an event of default. Moreover, the Company is dedicated to making the registration statement effective as promptly as possible and maintaining its effectiveness, along with a current prospectus, until the Warrants expire according to this Agreement’s terms. In the event a registration statement triggered by a Warrant Registration Requirement is not declared effective by the SEC within one year from its filing date, Warrant holders are entitled to exercise their Warrants on a cashless basis from the 366th day post-filing until the statement becomes effective.

 

Note 14. Earnings Per Share

 

Basic net income (loss) per common share is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net income (loss) per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period. For the Company’s diluted earnings per share calculation, the Company uses the “if-converted” method for preferred stock and convertible debt and the “treasury stock” method for Warrants and Options.

 

As the Business Combination and related transactions are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted net income per share assumes that the shares issued in connection with the Business Combination have been outstanding for the entire period presented.

 

For the three month period ended March 31  2024   2023 
Net Income/ (loss)  $2,049,676   $(1,413,447)
Weighted average shares outstanding – basic   55,213,609    25,670,730 
Basic net income/ (loss) per share  $0.04   $(0.06)
Weighted average shares outstanding – diluted   56,268,075    25,670,730 
Diluted net income/ (loss) per share  $0.04   $(0.06)

 

Weighted average shares calculation - basic  2024   2023 
  

Three months ended

March 31

 
Weighted average shares calculation - basic  2024   2023 
Company public shares   3,926,598    3,926,598 
Company initial stockholders   3,403,175    3,403,175 
PCCU stockholders   22,586,139    11,759,472 
Shares issued for abaca acquisition   7,935,800    2,099,977 
Restricted stock units issued   1,308,089    566,755 
Conversion of preferred stock   16,053,808    3,914,753 
Grand total   55,213,609    25,670,730 

 

Weighted average shares calculation - diluted   2024    2023  
  

Three months ended

March 31

 
Weighted average shares calculation - diluted   2024    2023  
Shares used in computation of basic earnings per share    55,213,609      -  
Shares to be issued to Abaca shareholders    750,000      -  
Share based payments    215,666      -  
Conversion of preferred stock    

88,800

      -  
Grand total    

56,268,075

             -  

 

Certain share-based equity awards and warrants were excluded from the computation of dilutive earnings/ (loss) per share because inclusion of these awards would have had an anti-dilutive effect. The following table reflects the awards excluded.

 

   March 31, 2024  

March 31, 2023

 
Warrants   

12,036,588

    

7,036,588

 
Share based payments   

2,284,080

    

2,775,655

 
Shares to be issued to Abaca shareholders   -    6,433,839 
Conversion of preferred stock   -    10,896,000 
Grand total   14,320,668    27,142,082 

 

The holders of Series A Convertible preferred stock shall be entitled to receive, and the Company shall pay, dividends on shares of Series A Convertible preferred stock equal (on an as-if-converted-to-Class-A-common stock basis) to and in the same form as dividends actually paid on shares of the Class A common stock when, as and if such dividends are paid on shares of the Class A common stock. No other dividends shall be paid on shares of Series A convertible preferred stock.

 

 24 

 

 

Note 15. Forward Purchase Agreement

 

On June 16, 2022, the Company entered into a Forward Purchase Agreement with Midtown East Management NL, LLC (“Midtown East”). Subsequent to entering into the Forward Purchase Agreement, the Company and Midtown East entered into assignment and novation agreements with Verdun Investments LLC (“Verdun”) and Vellar Opportunity Fund SPV LLC – Series 1 (“Vellar”), pursuant to which Midtown East assigned its obligations as to 1,666,666 shares of the shares of Class A Stock to be purchased under the Forward Purchase Agreement to each of Verdun and Vellar. As contemplated by the Forward Purchase Agreement:

 

Prior to the closing, Midtown East, Verdun and Vellar purchased approximately 3.8 million shares of Class A common stock directly from investors at market price in the public market. Midtown East and other counter parties waived their redemption rights with respect to the acquired shares;

 

One business day following the closing, the Company paid approximately $39.3 million from the cash held in its trust account to Midtown East; Verdun and Vellar for the shares purchased and approximately $0.3 million in related expense amounts.

 

At the Maturity Date, Midtown East, Verdun and Vellar shall be entitled to (1) the product of the shares then held by them multiplied by the Forward Price, and (2) an amount, in cash or shares at the sole discretion of the Company, equal to (a) in the case of cash, the product of (i)(x) 3.8 million shares less (y) the number of Terminated Shares and (ii) $2.00 (the “Maturity Cash Consideration”) and (b) in the case of shares, (i) the Maturity Cash Consideration divided by (ii) the VWAP Price for the 30 Scheduled Trading Days prior to the Maturity Date.

 

At any time prior to the Maturity Date (defined as the earlier of i) the third anniversary of the Closing of the Business Combination, ii) the shares are delisted from The Nasdaq Stock Market or (iii) during any 30 consecutive Scheduled Trading Day-period following the closing of the Business Combination, the Volume Weighted Average Share Price (VWAP) Price for 20 Scheduled Trading Days during such period shall be less than $3.00 per share), Midtown East, Verdun and Vellar may elect an optional early termination to sell some or all of the shares (the “Terminated Shares”) of Class A Stock in the open market. If Midtown East, Verdun and Vellar sell any shares prior to the Maturity Date, the pro-rata portion of the Reset Price will be released from the escrow account and paid to SHF. Midtown East, Verdun and Vellar shall retain any proceeds in excess of the Reset Price that is paid to SHF.

 

In 2022, an agreement was reached among the Company, its common shareholders, and preferred investors, leading to a reduction in the make-whole price to $1.25 per share. This reset resulted in a significant decrease in the FPA receivable, from $37.9 million as of September 30, 2022, to $4.6 million. During the year 2023 and the first quarter of 2024, there were no share transactions by FPA holders, and management identified no additional impacts on the FPA receivable’s value on December 31, 2023 and March 31, 2024.

 

The reconciliation statement of the Class A common stock held by the parties are as follows:

 

       As at
December 31, 2023
   Shares sold during
the three months ended
March 31, 2024
   As at
March 31, 2024
 
S.no   Name of the party  Opening
Shares
(a)
   Amount   Shares
(b)
   Amount   Shares
(c=a-b)
   Rest price
(iii)
   Amount
(c x iii)
 
1   Vellar   971,204   $1,214,005    -   $-    971,204    1.25   $1,214,005 
2   Midtown East   1,517,924    1,897,405    -    -    1,517,924    1.25    1,897,405 
3   Verdun   1,178,249    1,472,811    -    -    1,178,249    1.25    1,472,811 
Grand total   3,667,377   $4,584,221    -   $-    3,667,377        $4,584,221 

 

Note 16. Warrant Liabilities

 

Public and Private Placement Warrants

 

As of March 31, 2024, and December 31, 2023, the Company has 5,750,000 Public warrants and 264,088 Private Placement Warrants.

 

The Public and Private Placement Warrants may only be exercised for a whole number of shares.

 

 25 

 

 

The Public and Private Placement Warrants became exercisable on September 28, 2022, the date of the Business Combination and will expire on September 28, 2027, or earlier upon redemption or liquidation.

 

No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.

 

Redemption of warrants become exercisable when the price per Class A Common Stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the warrants:

 

in whole and not in part;
at a price of $0.01 per warrant;
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.

 

If and when the warrants become redeemable by the Company, the Company may exercise its redemption rights; this is also the case if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

 

If the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise the Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants.

 

The private placement warrants are identical to the public warrants, except that the private placement warrants and the Class A Common Stock issuable upon the exercise of the private placement warrants were not transferable, assignable or saleable, subject to certain limited exceptions. Additionally, the private placement warrants are exercisable on a cashless basis and non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the private placement warrants are held by someone other than the initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants.

 

PIPE Warrants

 

As of March 31, 2024 and December 31, 2023, the Company has 1,022,500 PIPE Warrants.

 

The PIPE Warrants have an exercise price of $11.50 per share of Class A Common Stock to be paid in cash (except if the shares underlying the warrants are not covered by an effective registration statement after the six-month anniversary of the closing date, in which case cashless exercise is permitted), subject to adjustment to a price equal to the greater of (i)125% of the conversion price if at any time there is an adjustment to the Conversion Price and the exercise price after such adjustment is greater than 125% of the Conversion Price as adjusted and (ii) $5.00. The PIPE Warrants are also subject to adjustment for other customary adjustments for stock dividends, stock splits and similar corporate actions. The PIPE Warrants are exercisable for a period of five years following the Closing, or September 28, 2027. After exercise of a PIPE Warrant, the Company may be required to pay certain penalties if it fails to deliver the Class A Common Stock within a specified period of time.

 

Abaca Warrants

 

As of March 31,2024, and December 31, 2023, the Company has 5,000,000 Abaca warrants.

 

 26 

 

 

The Abaca 5,000,000 warrants have an exercise price of $2.00 per share of Class A common stock to be paid in cash. An Abaca Warrant may be exercised only during the period commencing 1 year of the Effective Date and terminating five (5) years from the effective date of the registration statement. The Company may, in its sole discretion, settle the Abaca Warrant when exercised, in whole or in part, in cash in lieu of issuing shares of common stock underlying the Warrant. The Company may elect to pay the Registered Holder in cash in the amount equal to the difference between the fair market value of the Company’s Class A common stock on the date of exercise and the warrant price ($2.00) multiplied by the number of shares of Class A common stock. The Company commits to promptly registering shares of Class A common stock issued upon Abaca Warrant exercises if required by law, ensuring these shares can be sold without restrictions. This registration must be filed within 45 days of receiving a notification of such a requirement, with failure to do so constituting a default. The Company will endeavor to keep the registration effective until the Warrants expire. If the registration isn’t effective within one year, Abaca Warrant holders may exercise their Warrants on a cashless basis, receiving shares based on a defined fair market value calculation. This process aims to facilitate the straightforward and lawful exercise of the Abaca Warrants, ensuring the shares issued are readily tradable without the need for restrictive legends.

 

Note 17. Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The fair value hierarchy ranks the inputs used in measuring fair value as follows:

 

  Level 1 – Observable, unadjusted quoted prices in active markets
  Level 2 – Inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability
  Level 3 – Unobservable inputs with little or no market activity that require the Company to use reasonable inputs and assumptions

 

The Company uses fair value measurements to record adjustments to certain financial assets and liabilities on a recurring basis. The Company may be required to record certain assets at fair value on a nonrecurring basis in specific circumstances, such as evidence of impairment. Methodologies used to determine fair value might be highly subjective and judgmental in nature; therefore, valuations may not be precise. If the Company determines that a valuation technique change is necessary, the change is assumed to have occurred at the end of the respective reporting period.

 

Assets and Liabilities Reported at Fair Value on a Recurring Basis

 

Public Warrants:

 

Public warrants are recorded at fair value on a recurring basis. The Company obtains exchange traded price, of Level 1 inputs, based on observable data to value these warrants.

 

Private Placement Warrants:

 

Private Placement Warrants are recorded at fair value on a recurring basis. In the first quarter of 2024, the Company internally assessed the value of these derivatives with Level 3 inputs, which are derived from Black-Scholes model. This is a change from the first quarter of 2023, when the valuation was based on third-party reports, also utilizing Level 3 inputs for these derivatives. Management believes that this change was necessary to enhance the precision and control over the valuation process, allowing for a more tailored and responsive approach to the unique characteristics of the derivatives and the evolving market conditions.

 

PIPE Warrants:

 

PIPE Warrants are recorded at fair value on a recurring basis. In the first quarter of 2024, the Company internally assessed the value of these derivatives with Level 3 inputs, which are derived from Black-Scholes model. This is a change the first quarter of 2023, when the valuation was based on third-party reports, also utilizing Level 3 inputs for these derivatives. Management believes that this change was necessary to enhance the precision and control over the valuation process, allowing for a more tailored and responsive approach to the unique characteristics of the derivatives and the evolving market conditions.

 

Abaca Warrants:

 

Abaca Warrants are recorded at fair value on a recurring basis. The Company internally assessed the value of these derivatives with Level 3 inputs. Level 3 inputs, based on unobservable data derived from Black-Scholes model.

 

Third Anniversary Payment Consideration:

 

Third anniversary payment consideration are recorded at fair value on a recurring basis. The Company value these derivatives based on third party reports for Level 3 inputs. Level 3 inputs, based on unobservable data derived from Black Scholes-Merton model.

 

 27 

 

 

Forward Purchase Option Derivatives:

 

Forward purchase option derivatives are recorded at fair value on a recurring basis. In 2022, the Company values these derivatives based on third party reports for Level 3 inputs. In 2023 and 2024, no significant risk factor changes affecting FPA derivative values were noted.

 

The following tables summarize financial assets and liabilities recorded at fair value on a recurring basis, by the level of valuation inputs in the fair value hierarchy on March 31, 2024 and December 31, 2023:

 

   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
   March 31, 2024   December 31, 2023 
   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Description                        
Liabilities:                        
PIPE warrants  $189,220    -    189,220   $273,124    -    273,124 
Public warrants  $430,675    430,675    -   $481,850    481,850    - 
Private placement warrants  $20,315    -    20,315   $25,070    -    25,070 
Abaca warrant  $2,268,432    -    2,268,432   $3,384,085    -    3,384,085 
Forward purchase derivative liability  $7,309,580    -    7,309,580   $7,309,580    -    7,309,580 
Third anniversary payment consideration  $594,000    -    594,000   $810,000    -    810,000 

 

Assets Measured at Fair Value on a Nonrecurring Basis

 

Assets that are measured at fair value on a nonrecurring basis primarily comprises of property, plant and equipment, right-to-use assets, finite lived intangible assets and goodwill. The Company does not record these at fair value on a recurring basis, however, the carrying value of the assets may be reduced to fair value when the Company determines that impairment has occurred.

 

There were no assets or liabilities recorded at fair value on a nonrecurring basis for the period ended March 31, 2024 and March 31, 2023.

 

Fair Value of Financial Instruments

 

The Company uses various methodologies and assumptions to estimate the fair value of certain financial instruments. With the exceptions of loans receivable, warrants and forward purchase option derivatives, the Company considers the carrying amounts of its financial instruments (cash, accounts receivable and accounts payable) in the balance sheet to approximate fair value because of the short-term or highly liquid nature of these financial instruments.

 

 28 

 

 

The following tables present the carrying amounts and fair values of financial instruments, by the level of valuation inputs in the fair value hierarchy, as of the dates indicated:

 

           Level 1   Level 2   Level 3 
   As on March 31, 2024 
   Carrying
amount
   Fair value   Fair value measurement using 
           Level 1   Level 2   Level 3 
Assets                    
Cash and cash equivalents  $5,626,362   $5,626,362   $5,626,362   $-   $- 
Forward purchase receivables   4,584,221    4,584,221    4,584,221    -    - 
Loans   392,483    362,671              362,671 
Liabilities                         
Deferred consideration   2,921,257    2,921,257    2,921,257    -    - 
Senior Secured Promissory note   13,270,622    12,137,875    -    -    12,137,875 
Indemnity liability   1,315,263    1,315,263    1,315,263    -    - 
Public warrants   430,675    430,675    430,675    -    - 
Private placement warrants   20,315    20,315    -    -    20,315 
PIPE Warrants   189,220    189,220    -    -    189,220 
Abaca Warrants   2,268,432    2,268,432    -    -    2,268,432 
Third anniversary payment consideration   594,000    594,000    -    -    594,000 
Forward purchase derivative   7,309,580    7,309,580    -    -    7,309,580 

 

                Level 1     Level 2     Level 3  
    As on December 31, 2023  
    Carrying
amount
    Fair value     Fair value measurement using  
                Level 1     Level 2     Level 3  
Assets                              
Cash and cash equivalents   $ 4,888,769     $ 4,888,769     $ 4,888,769     $ -     $ -  
Forward purchase receivables     4,584,221       4,584,221       4,584,221       -       -  
Loans     330,579       363,561       -       -       363,561  
Liabilities                                        
Deferred consideration     2,889,792       2,889,792       2,889,792       -       -  
Senior secured promissory note     14,011,166       12,750,204       -       -       12,750,204  
Public warrants     481,850       481,850       481,850       -       -  
Private placement warrants     25,070       25,070       -       -       25,070  
PIPE warrants     273,124       273,124       -       -       273,124  
Abaca warrants     3,384,085       3,384,085       -       -       3,384,085  
Forward purchase derivative     7,309,580       7,309,580       -       -       7,309,580  
Third anniversary payment consideration     810,000       810,000       -       -       810,000  

 

 29 

 

 

The change in the assets measured at fair value on a recurring basis for which the Company have utilized Level 3 inputs to determine fair value are presented in the following table:

 

    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
   For the period ended March 31, 2024 
    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
Balance at the beginning of the period  $273,124   $3,384,085   $25,070   $810,000   $7,309,580 
Issued to Abaca shareholders   -    -    -    -    - 
Fair value adjustment   (83,904)   (1,115,653)   (4,755)   (216,000)   - 
Balance at the end of the period  $189,220   $2,268,432   $20,315   $594,000   $7,309,580 

 

    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
   For the period ended March 31, 2023 
    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
Balance at the beginning of the period  $286,300   $-   $19,110   $-   $7,309,580 
Fair value adjustment   (211,538)   -    (11,157)   -    - 
Balance at the end of the period  $74,762   $-   $7,953   $-   $7,309,580 

 

As of March 31, 2024 and on December 31, 2023, the valuation of private placement warrants, PIPE warrants, and Abaca warrants was carried out using the Black-Scholes model, while the fair value of the Abaca third anniversary payment consideration was determined using the Black Scholes Merton Option pricing model. Contrastingly, in the first quarter of 2023, the fair value assessments for both the private placement warrants and PIPE warrants were conducted using the Black-Scholes model and the Black Scholes-Merton model, respectively. Management believes that the change in method for PIPE warrants was necessary to enhance the precision and control over the valuation process, allowing for a more tailored and responsive approach to the unique characteristics of the derivatives and the evolving market conditions. As of March 31, 2024 and December 31, 2023, these warrants were valued for Level 3 inputs, which are based on observable data to value these derivatives.

 

As of December 31, 2023, the Company assessed the fair value of its forward purchase agreement (FPA) derivative utilizing a Monte Carlo Simulation within a risk-neutral setting, which is a particular instance of the Income Approach, based on calculations from December 31, 2022. Throughout the first quarters of both 2023 and 2024, there were no notable alterations in risk factors that would impact the valuation of the FPA derivative. Consequently, management retained the December 31, 2022, valuation for December 31, 2023 and March 31, 2024. The Company will continue to monitor the fair value of the forward option derivative each reporting period with subsequent revisions to be recorded in the Statements of Operations.

 

During the first quarters of both 2023 and 2024, there were no changes in the classification of financial instruments within Level 2 and Level 3 of the fair value hierarchy.

 

 30 

 

 

The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the private placement warrants and public warrants as of their measurement dates:

 

    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
 
       March 31, 2024   December 31, 2023 
    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
 
Exercise price  $5    11.5    -    2   $5    11.5    -    2 
Share Price  $0.97    0.97    0.97    0.97   $1.42    1.42    1.42    1.42 
Expected term (years)   3.49    3.49    1.51    4.57    3.74    3.74    1.76    4.84 
Volatility   76.00%   76.00%   76.00%   76.00%   62.95%   62.95%   62.95%   62.95 
Risk-free rate   4.26%   4.26%   4.26%   4.36%   4.25%   4.25%   4.25%   4.25 

 

The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the forward purchase derivatives as of their measurement dates on March 31, 2024 and December 31, 2023:

 

   March 31, 2024   December 31, 2023 
Reset Price  $1.25   $1.25 
Expected term (years)   1.49    1.74 
Additional Maturity Consideration per share  $2.00   $2.00 
Volatility   46%   46%
Risk-free rate   4.2%   4.2%
Risk-adjusted discount rate   13.4%   13.4%

 

Note 18. Tax

 

For the three months ended March 31, 2024, the Company recorded income tax benefit of $438,885 for continuing operations. The effective tax rate of 28.14% for the three months ended March 31, 2024, varied from the statutory United States federal income tax rate of 21.0% primarily because of state income taxes, net of the federal benefit, and adjustments to the fair market value of warrant liabilities. The Company has net deferred tax assets of $44,278,374 and $43,829,019 as of March 31, 2024, and December 31, 2023, respectively. The Company considers their deferred tax assets to be realizable and has not established a valuation allowance, as it is considered more likely than not that the Company will utilize deferred tax assets in future periods through future taxable income.

 

The Company recognizes income tax benefits from uncertain tax positions where the realization of the ultimate benefit is uncertain. As of both March 31, 2024, and December 31, 2023, the Company has no unrecognized income tax benefits.

 

 31 

 

 

Note 19. 401(k) Plan

 

The Company offers to all employees a tax-qualified retirement contribution plan, with the Company’s 100% matching contribution up to 4% of a participant’s eligible compensation. The Company’s consolidated matching contributions for the three months ended March 31, 2024, amounting to $35,233, and March 31, 2023, amounting to $20,663, respectively.

 

Note 20. Stockholders’ Equity

 

Preferred Stock

 

The Company is authorized to issue 1,250,000 preferred shares with a par value of $0.0001 per share with such designation rights and preferences as may be determined from time to time by the Company’s Board of Directors. As of March 31, 2024, there were 111 Class A preferred shares issued and outstanding and 1,101 preferred shares issued and outstanding on December 31, 2023. The holders of preferred stock shall be entitled to receive, and the Company shall pay, dividends on shares of preferred stock equal(on an as-if-converted-to-Class-A-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Class A Common Stock when, as and if such dividends are paid on shares of the Class A Common Stock. No other dividends shall be paid on the preferred stock. The terms of the preferred stock provide for an initial conversion price of $ 10.00 per share of Class A Common Stock, which conversion price is subject to downward adjustment on each of the dates that are 10 days, 55 days, 100days, 145 days and 190 days after the effectiveness of a registration statement registering the shares of Class A Common Stock issuable upon conversion of the preferred stock to the lower of the Conversion Price and the greater of (i) 80% of the volume weighted average price of the Class A Common Stock for the prior five trading days and (ii) $2.00 (the “Floor Price”), provided that, so long as a preferred stock holders continues to hold any preferred shares, such preferred stock holder will be entitled to receive the aggregate shares of Class A Common Stock that would be issuable based upon its initial purchase of preferred stock at the adjusted Conversion Price. Additionally, on January 25, 2023, at a special meeting of the Company’s stockholders, the stockholders approved a reduction in the floor conversion price of the outstanding preferred stock from $ 2.00 per share to $ 1.25 per share.

 

Common Stock

 

The Company is authorized to issue up to 130,000,000 shares of Class A Common Stock with a par value of $.0001 per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. As of March 31, 2024 and December 31, 2023, there were 55,431,001 and 54,563,372 shares of Class A Common Stock issued or outstanding. As of March 31, 2024 and December 31, 2023, 3,667,377 Class A Common Stock are held by the purchasers under forward purchase agreement dated June 16, 2022, by and among the Company and such purchasers.

 

2022 Equity Incentive Plan

 

Share-based compensation expense recognized for the three months ended March 31, 2024 and March 31, 2023 totaled $0.6 million and $1.6 million, respectively.

 

The 2022 Plan was approved by the Company’s stockholders on June 28, 2022. The 2022 Plan permits the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, stock bonus awards, and performance compensation awards. The Company has not issued stock appreciation rights, restricted stock, stock bonus awards, or performance compensation awards in the three months ended March 31, 2024 and March 31, 2023. In conjunction with the 2024 Plan, as of March 31, 2024, the Company had granted stock options and restricted stock units which are described in more detail below.

 

Stock Options

 

Stock options are awarded to encourage ownership of the Company’s Class A common stock by employees and to provide increased incentive for employees to render services and to exert maximum effort for the success of the Company. The Company’s incentive stock options generally permit net-share settlement upon exercise. The option exercise price, vesting schedule and exercise period are determined for each grant by the administrator (person appointed by board to administer the stock plans) of the applicable plan. The Company’s stock options generally have a 10-year contractual term.

 

 32 

 

 

The assumptions used to determine the fair value of options granted in the three months ended March 31, 2024, using the Black-Scholes-Merton model are as follows:

 

Dividend yield   0%  
Risk-free interest rate   3.62 % to 4.23%  
Expected volatility (weighted-average and range, if applicable)   100%  
Expected term   6 to 6.5 years   

 

The expected term of the options granted is calculated based on the simplified method by taking average of contractual term and vesting period the awards. The shares of the Company were listed on the stock exchange for a limited period of the time and the share price has also dropped significantly from the date of listing. Based on these factors Management has considered the expected volatility at 100% for the current period. The risk-free interest rate used is the current yield on US Treasury notes with a term equal to the expected term of the options at the grant date. The expected dividend yield is based on annualized dividends on the underlying share during the expected term of the option.

 

A summary of the Company’s stock option activities and related information for the three months ended March 31, 2024 is as follows:

 

Stock Option  No. of Stock
Option
   Weighted-
Average Grant
Date Fair Value
Per Stock
Option
   Weighted-
Average
Remaining
Contractual Life
(in Years)
 
December 31, 2023   2,286,010   $5.43    1.65 
Granted   -    -    - 
Exercised   -    -    - 
Expired   -    -    - 
Cancelled / Forfeited   (1,930)   1.56    - 
March 31, 2024   2,284,080   $5.43    1.40 

 

A summary of the Company’s stock option activities and related information for the three months ended March 31, 2023 is as follows:

 

Stock Option  No. of Stock
Option
   Weighted-
Average Grant
Date Fair Value
Per Stock Option
   Weighted-
Average
Remaining
Contractual Life
(in Years)
 
December 31, 2022   2,170,000   $3.53    2.02 
Granted   336,730    1.03    2.76 
Exercised   -    -    - 
Expired   -    -      
Cancelled / Forfeited   (64,875)   3.13    - 
March 31, 2023   2,441,855   $3.20    2.39 

 

The following options were outstanding at their respective exercise price:

 

Exercise price options outstanding   March 31, 2024   March 31, 2023 
$1.56    374,580    359,355 
$2.58    350,000    350,000 
$4.00    309,500    482,500 
$6.67    1,250,000    1,250,000 
Total    2,284,080    2,441,855 

 

 33 

 

 

Restricted Stock Units (“RSUs”)

 

A summary of the Company’s RSU activities and related information for the three months ended March 31, 2024 is as follows:

 

Restricted Stock Units  No. of RSU   Weighted-
Average Grant
Date Fair Value
Per RSU
   Weighted-
Average
Remaining
Contractual
Life
(in Years)
 
December 31, 2023   323,500   $1.31    2.00 
Granted   -    -    - 
Vested   (107,833)   1.31    - 
Expired   -    -    - 
Cancelled / Forfeited   -    -    - 
March 31, 2024   215,667   $1.31    1.75 

 

Restricted Stock Units  No. of RSU   Weighted-
Average Grant
Date Fair Value
Per RSU
   Weighted-
Average
Remaining
Contractual
Life
(in Years)
 
December 31, 2022   -   $-    - 
Granted   963,528    1.31    2.76 
Vested   -    -    - 
Expired   -    -    - 
Cancelled / Forfeited   -    -    - 
March 31, 2023   963,528   $1.31    2.76 

 

The following RSU were outstanding at their respective vest price:

 

Vest price RSU outstanding   March 31, 2024   March 31, 2023 
$1.31    215,667    963,528 
Total    215,667    963,528 

 

Note 21. Subsequent events

 

On April 5, 2024, the Company received a letter from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $1.00 per share for its common stock, as required by Nasdaq Marketplace Rule 5550(a)(2). The Company has been granted a period of 180 days, ending on October 2, 2024, to regain compliance with this requirement. If the Company does not regain compliance by October 2, 2024, the Company may be eligible for second compliance period for up to an additional 180 days. In connection with any extension periods, if it appears that the Company will not be able to regain compliance with Nasdaq Marketplace Rule 5550(a)(2), or if the Company is not otherwise eligible, the Nasdaq staff will provide notice to the Company that its securities will be subject to delisting. At that time, the Company may appeal any such delisting determination to a Hearings Panel. If the Company’s Class A common stock maintains a closing bid price of at least $1.00 for 10 consecutive business days at any point before the deadline, Nasdaq will confirm compliance, and the matter will be resolved. The Company’s Class A common stock will continue to be listed and traded on The Nasdaq Capital Market under the symbol “SHFS” during this period. There is no assurance that the Company will achieve compliance within the given timeframe or maintain compliance with other Nasdaq Listing Rules thereafter.

 

 34 

 

 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References in this section to “we,” “us,” or “our” refer to SHF Holdings, Inc (herein referred to as the “Company”). References to “management” refer to our officers and board of managers. The following discussion and analysis of our financial performance and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements.

 

Forward Looking Statements

 

All statements other than statements of historical facts contained in this report, including statements regarding future operations, are forward-looking statements. In some cases, forward-looking statements may be identified by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “expect,” “objective,” “plan,” “potential,” “seek,” “grow,” “target,” “if,” and similar expressions intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations, objectives, and financial needs.

 

Overview

 

We provide services to a variety of cannabis-industry participants in 41 states, including financial institutions desiring to provide business banking, private banking and commercial banking services to their customers, particularly those customers conducting business in or adjacent to the cannabis industry. Our services include, among other things:

 

  regulatory compliance consulting and software for maintaining “Know Your Customer” (“KYC”) and Bank Secrecy Act (“BSA”) compliance to financial institutions, principally conducted vis-à-vis our proprietary financial services platform;
  the origination, onboarding, verification, and servicing of cannabis-related deposit business for and on behalf of our partner financial institutions; and
  sourcing, underwriting, servicing, and administering loans issued to cannabis businesses and related entities, which are often also our customers, as well as being customers of our partner financial institutions.

 

Financial Services Platform

 

The Company has developed and commercialized a fully compliant financial services platform for financial institutions providing banking services to cannabis-related businesses (“CRBs”) to access and maintain reliable financial services as long as both the financial institution client and the CRB meet regulatory requirements. Our platform has been streamlined and finetuned for the past nine years which enables the Company’s staff to efficiently guide financial institution clients and the CRBs desiring banking services through the onboarding, validation and monitoring process. Our automated platform provides for an efficient and effective management tool allowing our employees to provide continuity of service while enabling compliance staff to monitor BSA activities.

 

Through the Company’s platform, our financial institution clients have the ability to provide CRBs with access to traditional financial services including wires, debit, ACH, remote deposit capture, business checking and savings accounts, courier and vaulting services, cash management accounts and commercial lending. We believe our services have been implemented consistent with applicable law and regulations, ensuring our financial institution clients will be able to provide CRBs with reliable access to these services. We feel our history of developing processes that satisfy regulatory standards has resulted in a solid reputation with related authorities and solidifies our ability to continue to grow existing services and reduces barriers in expanding into new service offerings.

 

 35 

 

 

CRB Deposits

 

The Company maintains relationships with Partner Colorado Credit Union (“PCCU”) and other financial institutions in which the CRB funds are deposited and monetary transactions are performed. The Company’s agreements with the financial institution allow the Company’s platform to interface with the financial institution’s core banking systems and extract data necessary to monitor the deposit accounts onboarded by the Company’s transactions, such as funds transmissions to or from the accounts, occur through PCCU’s and other financial institution client’s infrastructure.

 

When a CRB or ancillary service provider approaches PCCU or other financial institution for which the Company provides its onboarding services, an initial onboarding fee is assessed based on the type and complexity of the business. Onboarding is an important part of the KYC requirements set forth in federal guidance. The onboarding process can require a great deal of time depending on the business complexity and the fee we assess is based upon the complexity and required time to complete the process. Additionally, the Company assesses monthly deposit and activity fees, which have historically been the majority of our revenue. These fees are also based on business type and size. Monitoring and validating deposit activity is paramount to the success of the Company’s platform. We believe our compliance-first focus reassures regulators and law enforcement that the Company continues to focus on the safety and soundness of the financial system.

 

Investment income is also generated when PCCU or other financial institution clients invest CRB deposits. Under our Commercial Alliance Agreement with PCCU, the Company pays 25% of the investment income as a hosting fee to PCCU based on this income. Through its relationship with PCCU, depository amounts invested are typically restricted to low-risk assets with high liquidity and low returns. The investment income is significantly influenced by the levels of CRB deposits and the prevailing interest rate environment for cash and similar assets. We believe that fees based on deposits that we onboard and interest on the daily balance less cash used to collateralize our loan portfolios maintained with financial institutions will represent a significant portion of our revenue by 2024.

 

Commercial Lending Program

 

The level of CRB deposits onboarded by the Company and held at PCCU allows for robust lending capacity. During 2020, the Company implemented a commercial lending program, which will be a strong pillar for future revenue and profit growth. The focus will primarily include senior secured lending with smaller loans considered for unsecured lending. Collateral types would include real estate, equipment, and other business assets. The Company’s commercial lending program is built on:

 

  stringent collateral package requirements with ample loan to value coverage;
     
  strong underwriting of collateral and creditworthiness of borrower; and
     
  a deep knowledge and understanding of the industry, borrowers’ operations and the cannabis industry business cycle.

 

Currently, lending is primarily funded through PCCU using the funds from CRB deposit accounts onboarded by the Company. The Company is currently seeking relationships with additional financial institutions that would fund the Company’s loans and other sources of working capital with which the Company could fund the loans directly. The Company has created a lending program tailored specifically to the unique needs of CRBs while also achieving strong returns on quality loans. While third parties are presently used to provide loan underwriting and servicing, the Company plans on building out a full-service internal lending function to improve the efficiency of our lending process and to increase future profitability.

 

 36 

 

 

We feel we have taken a creative and methodical approach in building the Company’s platform, which has allowed us to nationally scale our business. The platform’s policies, training, monitoring and other processes are well established with talented and expert level knowledge. We also plan to further expand the officer level suite with talent that we believe will further our success. We anticipate this combination will provide a competitive advantage for us as we focus on continued growth.

 

Key Metrics

 

In addition to the measures presented in our condensed unaudited consolidated financial statements, our management regularly monitors certain measures in the operation of our business. These key metrics are discussed below.

 

Earnings Before Interest Taxes Depreciation and Amortization (EBITDA) and Adjusted EBITDA

 

To provide investors with additional information regarding our financial results, we have disclosed EBITDA and Adjusted EBITDA, both of which are non-GAAP financial measures that we calculate as net income before taxes and depreciation and amortization expense in the case of EBITDA and further adjusted to exclude non-cash, unusual and/or infrequent costs in the case of Adjusted EBITDA. Below we have provided a reconciliation of net income (the most directly comparable U.S. GAAP financial measure) to EBITDA and from EBITDA to Adjusted EBITDA.

 

We present EBITDA and Adjusted EBITDA because these metrics are a key measure used by our management to evaluate our operating performance, generate future operating plans, and make strategic decisions regarding the allocation of investment capacity. Accordingly, we believe that EBITDA and Adjusted EBITDA provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management.

 

EBITDA and Adjusted EBITDA have limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are as follows:

 

  although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and both EBITDA and Adjusted EBITDA do not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;

 

 

EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital

needs; and

 

 

EBITDA and Adjusted EBITDA do not reflect tax payments that may represent a reduction in cash available

to us.

 

Because of these limitations, you should consider EBITDA and Adjusted EBITDA alongside other financial performance measures, including net loss and our other U.S. GAAP results.

 

 37 

 

 

A reconciliation of net income to non-GAAP EBITDA and Adjusted EBITDA is as follows:

 

   Three Months Ended March 31, 
   2024   2023 
Net income/(loss)  $2,049,676   $(1,413,447)
Interest expense   154,172    643,260 
Depreciation and amortization   195,709    396,314 
Taxes   (438,885)   (609,277)
EBITDA  $1,960,672   $(983,150)
           
Other adjustments –          
(Benefit)/ Provision for credit losses   (68,787)   66,666 
Change in the fair value of warrants   (1,255,487)   (433,148)
Change in the fair value of deferred consideration   (184,535)   190,943 
Stock based compensation   612,124    1,570,782 
Loan origination fees and costs   23,373    (2,175)
Adjusted EBITDA  $1,087,360   $409,918 

 

For the period ended March 31, 2024, our EBITDA income improved primarily as a result of lower General and Administrative expenses and reduced stock-based compensation. Additionally, the increase in adjusted EBITDA income during this period was mainly attributed to the decrease in General and Administrative expenses. This reduction was driven by lower investment hosting fees, decreased amortization and depreciation expenses, and reduced business insurance costs. Additionally, there were decreases in compensation, employee benefits, marketing expenses, and other insurance costs. These factors contributing to our financial performance are further discussed in the “Discussion of our Results of Operations” section below. Other adjustments include estimated future credit losses not yet realized, including amounts indemnified to PCCU for loans funded by them. The Company had entered into a Commercial alliance agreement with PCCU, pursuant to which the Company agreed to indemnify PCCU for claims associated with CRB activities including any loan default related losses for loans funded by PCCU. Deferred loan origination fees and costs represent the change in net deferred loan origination fees and costs. When included with a new loan origination, we receive an upfront loan origination fee in conjunction with new loans funded by our financial institution partners and incur costs associated with originating a specific loan. For accounting purposes, the cash received for loan origination fees and costs is initially deferred and recognized as interest income utilizing the interest method.

 

Other Metrics

 

For our business operations, we monitor the following key metrics.

 

Total account balances, number of accounts and average account balances

 

Our lending capacity is dependent on the size of our managed deposit base and number of active accounts. In addition, fees are generated based on open accounts and account activity. We monitor account activity including deposits, withdrawals and ending account balance daily. Total account balances represent the balance of onboarded and monitored deposits on hand at financial institution clients at period end. Average account balance represents the total account balance divided by the number of accounts at the period end.

 

Account fees per average active accounts managed

 

Currently a significant amount of our fees is generated from account openings, active accounts and account activity. As a result, we monitor account openings and closings on a daily, weekly and monthly basis. We strive to meet the appropriate balance between depository balances and fees and therefore review account fees per average number of active accounts managed.

 

Three months Ended March 31     2024   2023   Change ($)   Change (%) 
Average monthly ending deposit balance  (1)  $135,467,105    222,857,256    (87,390,151)   -39.21%
Account fees  (2)  $1,303,133    2,120,187    (817,054)   -38.54%
Average active accounts  (3)   744    1,018    (274)   -26.88%
Average account balance  (4)  $181,998    218,917    (36,919)   -16.86%
Average fees per account  (4)  $1,751    2,083    (332)   -15.95%

 

  (1) Represents the average of monthly ending account balances

 

  (2) Reported account activity fee revenue

 

  (3) Represents the average of monthly ending active accounts

 

  (4) Refer to the below section – Discussion of Results of our Operations for additional discussion of trends.

 

 38 

 

 

For the period ending March 31, 2024, there was a decline in the average number of accounts and fees compared to the previous period, primarily due to a decrease in clientele following the termination of an agreement with the Central Bank. We expect this trend to shift as we lead with our lending program typically requiring borrowers to place deposits with financial institutions with which we have relationships.

 

We are focused on enhancing and growing our lending platform. Incremental lending key metrics will be monitored as this portion of our business grows in volume. Metrics will include average loan balance, average life to repayment, average effective interest rate and loan status, amongst others.

 

Components of our Results of Operations

 

Revenue

 

The Company generates interest and fee income through providing a variety of services to PCCU and other financial institutions to facilitate its banking services to CRBs including, among other things, Bank Secrecy Act and other regulatory compliance and reporting, onboarding, responding to account inquiries, responding to customer service inquiries relating to CRB deposit accounts held at financial institution clients, and sourcing and originating loans. In addition, the Company provides these similar services and outsourced support to other financial institutions providing banking to the cannabis industry. These services are provided under the Safe Harbor Master Program Agreement.

 

Operating expenses

 

Operating expenses consist of compensation and benefits, professional services, rent expense, provisions for credit losses and other general and administrative expenses.

 

Compensation and benefits consist of employee wages and associated benefits while professional services consist of legal, general consulting and accounting fees.

 

The Company reports a provision for credit losses both as it relates to loans funded internally and those carried by PCCU or other financial institutions. The Company indemnifies PCCU and other financial institutions for losses on loans to borrowers sourced by the Company and funded by PCCU and other financial institutions. The Company anticipates comparable arrangements with other financial institutions that fund loans to borrowers sourced by the Company.

 

Other general and administrative expenses consist of various miscellaneous items including account hosting fees, insurance expense, advertising and marketing, travel meals and entertainment and other office and operating expense.

 

Discussion of our Results of Operations —2024 Compared to 2023 (Three Months Ended March 31)

 

Revenue

 

Three Months Ended March 31,  2024   2023   Change ($)   Change (%) 
Deposit, activity, onboarding income  $1,620,994   $2,245,831    (624,837)   (27.82)%
Safe Harbor Program income   19,230    51,103    (31,873)   (62.37)%
Investment income   773,819    1,417,152    (643,333)   (45.40)%
Loan interest income   1,636,756    466,293    1,170,463    251.01%
Total Revenue  $4,050,799   $4,180,379    (129,580)   (3.10)%

 

Account fee income consists of deposit account fees, activity fees and onboarding income. We receive a flat fee and lower rates for ancillary accounts, which are accounts provided to businesses servicing the cannabis industry in general but do not manufacture, possess, distribute or transport cannabis.

 

 39 

 

 

The decrease in deposit, activity and onboarding income was primarily attributable to the decrease in the number of accounts related to the Abaca acquisition. In period ended March 2024, PCCU accounted for $1,217,675 of the revenue generated from deposits, activities, and client onboarding. Related to this revenue, the Company recognized $104,259 in account hosting expenses, in accordance with the Commercial Alliance Agreement. In period ended March 2023, PCCU contributed $1,377,839 to the revenue from similar sources, with account hosting expenses amounting to $55,425 as per the Loan Servicing Agreement provisions. These expenses were categorized under “General and administrative expenses” in the Consolidated Statements of Operations.

 

The Company provides similar account services and outsourced support to other financial institutions providing banking to the cannabis industry. These services are provided under the Safe Harbor Master Program Agreement. Revenue has decreased as we narrow the financial institutions and states we allow under this program and instead focus on servicing CRBs directly. The reduction in Safe Harbor Program income is a result of the reduction in the number of accounts.

 

We have agreements with PCCU (related party) and Five Star Bank (FSB) where our financial institution clients pay us interest on the daily account balance as per the rates in the agreements. Under our Commercial Alliance Agreement with PCCU, we pay 25% of the investment income as a hosting fee based on this income. In period ended March 2024, the income derived from investment income associated with PCCU totaled $731,425. In relation to this income, the Company incurred $160,101 in investment hosting fees, consistent with the stipulations of the Commercial Alliance Agreement. In period ended March 2023, PCCU’s contribution to investment income amounted to $1,417,152, against which the Company recorded investment hosting fees of $323,305, as governed by the terms of the Loan Servicing Agreement. These expenses were categorized under “General and administrative expenses” in the Consolidated Statements of Operations.

 

We had a Loan Servicing Agreement with PCCU (related party) where our financial institution carries the loan balances on their financial statement; the Loan Servicing Agreement has since been superseded by the Commercial Alliance Agreement. The loan interest income reflects our share of loan interest on issued loans. We are obligated to pay 0.35% on the total outstanding principal of each loan that is funded and serviced by PCCU. Loan interest earned on the Company’s direct loans and the indemnified loans grew as the Company increased its focus on lending. For the quarter ended March 31, 2024, SHF serviced twenty two loans, as compared to eight loans in the quarter ended March 31, 2023. In quarter ended March 2024, the Company recognized $1,636,756 in loan interest income attributable to PCCU activities. Related expenses for this income included $35,901 in loan servicing fees, in compliance with both the Loan Servicing Agreement and the Commercial Alliance Agreement. In quarter ended March 2023, loan interest income from PCCU operations amounted to $466,293, with associated loan servicing fees totaling $11,929, pursuant to the same agreements. These expenses were categorized under” General and administrative expenses” in the Consolidated Statements of Operations.

 

Operating expenses

 

Three months Ended March 31,  2024   2023   Change ($)   Change (%) 
Compensation and employee benefits  $2,280,038   $3,659,520   $(1,379,482)   (37.70)%
General and administrative expenses   984,220    1,538,874    (554,654)   (36.04)%
Professional services   460,950    449,246    11,704    2.61%
Rent expense   69,437    87,742    (18,305)   (20.86)%
(Benefit)/provision for credit losses   (68,787)   66,666    (135,453)   (203.18)%
Total operating expenses  $3,725,858   $5,802,048   $(2,076,190)   (35.78)%

 

Compensation and employee benefits decreased on account of stock-based compensation and also the decrease in the head count.

 

Rent expenses has been decreased due to reduction in the number of lease properties.

 

(Benefit)/ Provision for credit losses has decreased due to decrease in the loss rate.

 

General and administrative expenses decreased across various categories including: (i) approximately $163,204 in investment hosting fees, (ii) approximately $54,169 in advertising and marketing, (iii) $198,056 in amortization and depreciation, and (iv) $46,378 in business insurance.

 

Financial Condition

 

Cash and cash equivalents

 

Cash and cash equivalents totaled $5,626,362 and $4,888,769 as of March 31, 2024 and December 31, 2023, respectively.

 

 40 

 

 

Cash flows

 

For the three months ended March 31, 2024, the Company generated $1,475,123 in cash from operations, compared to cash used of $232,040 for the three months ended March 31, 2023. This improvement was mainly due to lower operating expenses and the greater number of performing loans at better rates than the previous period.

 

For the three months ended March 31, 2024, the Company generated $3,014 in cash from investing activities, compared to $470,597 for the three months ended March 31, 2023. The decrease was primarily due to the repayment of loans by customers in the previous period.

For the three months ended March 31, 2024, the Company used $740,544 in cash for financing activities, compared to zero cash flow in the corresponding period of 2023. This was mainly due to the repayments on the senior secured promissory note during 2024, which was not in place during the three months ended March 31, 2023.

 

Liquidity and going concern

 

Liquidity refers to our capacity to fulfill anticipated cash demands, encompassing obligations to settle debt, sustain assets and operations, distribute earnings to shareholders, and cover other typical business expenditures. Our cash outflows predominantly settle towards repaying debt principal and interest, distributing dividends to shareholders, and financing our operational activities. The main contributors to our liquidity are the cash inflows from our operational performance. As of the end of the fiscal year on March 31, 2024, the Company reports no significant commitments to capital investments.

 

As of March 31, 2024, the Company had $5,626,362 in cash and net working capital of $318,825, as compared to $4,888,769 in cash and net working capital deficit of $135,355 as at December 31, 2023. The retained deficit was $70,386,394 on March 31, 2024, and $71,569,821 on December 31, 2023. The Company has also generated operating income of $324,941 for the period ended March 31, 2024.

 

For the period ending March 31, 2024, the Company reported positive operating income and net working capital. However, considering the historical data from the four preceding quarters, where the Company experienced negative operating income and negative net working capital, management acknowledges the need to closely evaluate the financial performance in upcoming quarters to mitigate any going concern risks. As of March 31, 2024, due to these historical trends, there is substantial doubt about the Company’s ability to continue as a going concern for at least twelve months from the date these unaudited condensed consolidated financial statements were issued.

 

If the Company is not able to sustain its present level of operations, it may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned expansion programs. Any of these actions could materially harm the Company’s business, results of operations and future prospects.

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result should the Company not continue as a going concern as a result of this uncertainty

 

Critical Accounting Estimates

 

Our unaudited condensed consolidated financial statements and accompanying notes are prepared in accordance with U.S GAAP. Preparing unaudited condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses, as well as disclosure of contingent assets and liabilities. An appreciation of our critical accounting policies is necessary to understand our financial results. In some cases, we could reasonably use different accounting policies and estimates, and changes in our estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates, and our financial condition or results of operations could be affected. We base our estimates on our experience and other assumptions that we believe are reasonable, and we evaluate these estimates on an ongoing basis. We refer to the following accounting estimates as critical accounting estimates, based on their importance to the financial reporting and potential for changes in future periods:

 

Revenue recognition

 

The company records revenue when it meets its service obligations, which include various fees charged for financial services such as account maintenance and transaction fees, along with other miscellaneous fees. When determining transaction prices, the company considers potential variations in these fees, which may fluctuate based on customer usage and specific contract terms. This is in line with ASC 606 standards, which require the allocation of transaction prices to the specific services provided within a contract, such as setup and ongoing fees for certain programs. The company also earns revenue from interest on loans, which includes those directly issued and those backed by a partnership with PCCU under a commercial alliance agreement. Investment income consist of interest earned on the daily deposits balance with financial institution. A strategic change in the fourth quarter of 2023 saw the company adopt a new method for calculating interest on customer deposit balances, excluding certain amounts. The company’s customer base mainly consists of financial institutions that serve cannabis-related businesses (CRBs), with revenue primarily generated in the United States. Under the terms of its Commercial Alliance Agreement with PCCU, the company is obligated to pay PCCU various fees, including a loan servicing fee of 0.35% of the current loan balance, and monthly service fees based on account balances, with rates varying for balances below and above $1 million. Additionally, the company must pass on 25% of its investment hosting fees to PCCU, which are calculated from the returns on PCCU-related deposits.

 

 41 

 

 

Indemnity liability

 

The indemnification component of the Loan Servicing Agreement is accounted for in accordance with ASC 460 Guarantees, which follows guidance in ASC 326 – Financial Instruments – Credit Losses (ASC Topic 326), for estimating expected credit losses under the current expected credit loss (“CECL”) methodology, presented in the liabilities section in the consolidated balance sheets as an” Indemnity liability”. The Company accounts for the indemnification component of the Commercial Alliance Agreement for claims related to cannabis-related businesses, with a particular emphasis on default-related credit losses. The Company’s indemnity is secondary to other recovery methods like foreclosure or guarantor recourse. Indemnity payments don’t absolve borrowers of their obligations, maintaining PCCU’s rights to recoveries. The indemnification is considered a general loss contingency under ASC 460 due to uncertainties that could lead to losses, resolved by future events. The Company’s liability for indemnity is based on management’s estimation of probable credit losses at the balance sheet date, influenced by individual loan risk ratings and economic assumptions in the estimation model. These risk ratings are re-evaluated quarterly. The indemnity liability for the pooled component is derived from an estimate of expected credit losses primarily using an expected loss methodology that incorporates risk parameters such as probability of default (“PD”) and loss given default (“LGD”) which are derived from internally developed model estimation approaches for smaller homogenous loans. The PD is quantified by analyzing historical data to determine the rate at which loans have defaulted within the portfolio, relative to the total outstanding loans as of the end of the reporting period. This rate is expressed as a percentage and serves as a key indicator of the likelihood of default across the loan pool. LGD assessments are conducted to estimate the potential loss amount in the event of a default, considering the recoverable value from the collateral liquidation against the remaining loan balance. This involves a detailed analysis of two primary components: the loss on principal, which arises from the gap between the collateral’s liquidation value and the unpaid principal balance of the loan; and the loss associated with various ancillary costs to recover, including, but not limited to, foregone interest, transaction costs, legal and administrative fees, and expenses related to the maintenance and renovation of the property. Changes in the PD and LGD directly affect the estimated indemnity liability. An increase in PD, indicating a higher likelihood of defaults, necessitates a larger indemnity liability to cover potential losses, impacting the company’s financial reserves. Conversely, a decrease in PD would lower the required indemnity liability, reflecting a more favorable risk outlook. Similarly, a rise in LGD, due to reduced collateral values or higher recovery costs, increases the estimated loss per default, requiring a higher indemnity liability. Conversely, a reduction in LGD suggests more loss recoveries, allowing for a decrease in the indemnity liability.

 

Stock-based compensation

 

In conjunction with the 2022 Plan, as of March 31, 2024, the Company had granted stock options and restricted stock units which are described in more detail below:

 

Stock options

 

The Company awards stock options to incentivize employee ownership and performance, applying ASC 718 for equity-based payments. Options, with a 10-year term with their fair value determined at the grant date, considering either market price or the Black-Scholes model. This model factors in expected option term, stock price volatility (set at 100% due to significant price fluctuations since listing), risk-free interest rates (aligned with U.S. Treasury rates), and an assumed zero dividend yield, given the Company’s history of not paying dividends. The expected option term is derived using the simplified method, averaging the contractual term and vesting period. Compensation cost is recognized over the service period on a straight-line basis, with immediate recognition of forfeitures. Changes in valuation assumptions could significantly alter fair value estimates.

 

Restricted Stock Units / Restricted Stock Awards

 

The Company values equity-based payments under ASC 718, using fair value at grant date for stock awards, recognizing expenses over the service period. Fair value is estimated via the market price or Black-Scholes model, considering variables like expected term, stock volatility, risk-free rates, and forfeiture rates. Given the stock’s limited listing period and significant price drop, volatility is presumed at 100%. Risk-free rates align with U.S. Treasury rates matching the awards’ lifespans. The options’ expected term merges the contractual and vesting durations. The Company assumes zero dividend, reflecting the Company’s history and future dividend outlook, impacting the valuation of stock-based compensation. Changes in valuation assumptions could significantly alter fair value estimates.

 

 42 

 

 

Forward Purchase Agreement

 

The Company, under a Forward Purchase Agreement (FPA) with Midtown East, which was later reassigned to Verdun and Vellar, involved complex transactions around Class A common stock. Initially, about 3.8 million shares were acquired from the market. Post-business combination, the Company disbursed $39.6 million for these shares and associated costs. The FPA allows for an early termination sale of shares by the assignees, with proceeds above the reset price going to them and the rest to the Company. The final settlement at the Maturity Date includes a cash or share payment based on the Forward Price and a Maturity Cash Consideration. In 2022, the reset price adjustment, influenced by the common stock’s trading value and preferred share conversions, significantly reduced the FPA receivable from $37.9 million to $4.6 million. No further transactions or value changes were noted for the period ended March 31, 2024 and year ended December 31, 2023, maintaining the FPA receivable’s value. The value of the forward purchase agreement could diminish if the Company issues any securities at a price below the reset price of $1.25 per share before the agreement expires.

 

Forward Purchase Derivative

 

The Company records the forward purchase derivative from a business combination as per ASC 815, marking it as an asset or liability at fair value, adjusted each reporting period. Fair value adjustments are recognized in the consolidated statement of operations. The Monte-Carlo Simulation, applying Geometric Brownian Motion for stock price projections, was utilized for valuation in the year ended December 31, 2022. In 2022, the company fully accounted for the maximum contractual liability. Through March 31, 2024, there were no notable shifts in risk factors that would impact the values of FPA derivatives.

 

Warrants Liabilities

 

The Company’s accounting for warrants, including Public, Private Placement, PIPE, and Abaca warrants, constitutes a critical accounting estimate due to the significant judgments and assumptions involved in their valuation and the potential impact on our financial statements. These warrants are recorded at fair value on a recurring basis, requiring the use of observable market data and valuation techniques that involve significant estimates and assumptions. For Public warrants, the Company utilizes Level 1 inputs, relying on exchange-traded prices which provide a transparent and observable market valuation. This approach minimizes the level of estimation uncertainty associated with these warrants. For the fiscal year ending December 31, 2023, and the first quarter ending March 31, 2024, the Company shifted its approach to valuing Private Placement and PIPE (Private Investment in Public Equity) Warrants from relying on external third-party reports to conducting in-house evaluations. This internal assessment strategy utilizes Level 3 inputs, which are based on data that is not observable in the market, contrasting with the method used in the quarter ending March 31, 2023, where the valuation was grounded on third-party reports. This shift aims to enhance the precision of the valuation process, allowing for adjustments reflective of the unique characteristics of these warrants and prevailing market conditions. Key assumptions in this valuation include the expected volatility of our stock, the risk-free interest rate, the expected life of the warrants, and the dividend yield. Variability in these assumptions could significantly impact the fair value estimates of these warrants. For Abaca Warrants, the Company also utilizes an internal assessment approach with Level 3 inputs. The valuation assumptions include, but are not limited to, the exercise price, the fair market value of the underlying Class A Common Stock, the expected term of the warrants, and the risk-free interest rate. Future variations in these critical assumptions could arise from changes in market conditions, such as fluctuations in the volatility of the Company’s stock, alterations in the risk-free interest rate reflecting broader economic shifts, or adjustments in the expected life of the warrants due to changes in the holders’ exercise behavior. Additionally, regulatory changes or shifts in the market perception of the Company could also necessitate adjustments to these assumptions. Changes in these assumptions could lead to significant variations in the recorded fair value of the warrants, impacting the Company’s financial position and results of operations. The Company closely monitors these assumptions and market conditions to ensure that the warrant valuations accurately reflect their fair market value on reporting date.

 

 43 

 

 

Deferred consideration

 

The Company’s accounting for the deferred consideration arising from the acquisition of Abaca represents a critical accounting estimate, consistent with ASC Topic 815, “Derivatives and Hedging” (“ASC 815 “). This consideration, due to its failure to meet the equity classification criteria under ASC 815, is accounted for as a derivative liability. This approach necessitates the recognition of this obligation on the balance sheet at its fair value, with subsequent adjustments to fair value reflected at each reporting period end. The determination of fair value involves significant judgments and assumptions, particularly in light of the complex terms outlined in the Abaca merger agreement and its amendments. The deferred consideration includes cash payments scheduled at various anniversaries of the merger closing, the issuance of common stock based on specified conditions, and the introduction of additional consideration and stock warrants as per the latest amendments to the agreement. The fair value assessment of these components is influenced by several factors, including the Company’s stock price, the volatility of the stock, the risk-free interest rate, and the specific terms of the deferred and stock considerations as amended. Future variations in the fair value of this derivative liability could arise from changes in the Company’s stock price, fluctuations in market volatility, alterations in the risk-free interest rate, or changes in the terms of the agreement as negotiated with the Abaca stockholders. Such changes could be prompted by evolving business strategies, market conditions, or regulatory environments that impact the financial and operational aspects of the agreement. These estimates and assumptions are subject to inherent uncertainties and the exercise of management’s judgment. Changes in these critical assumptions could lead to significant adjustments in the recorded fair value of the derivative liability associated with the Abaca acquisition’s deferred consideration. These adjustments could materially impact the Company’s financial position and results of operations, emphasizing the importance of the estimates and assumptions used in the valuation of this complex financial instrument. The Company closely monitors related developments and market conditions to ensure the derivative liability is accurately valued, providing transparency and reliability on the reporting date.

 

Emerging Growth Company Status

 

We are an “emerging growth company,” or “EGC”, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

In addition, Section 107 of the JOBS Act also provides that an EGC can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act, for complying with new or revised accounting standards. In other words, an EGC can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period, for as long as it is available. We will remain an EGC until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the date of the first sale of our common equity securities pursuant to an effective registration statement under the Securities Act and (b) in which we have total annual gross revenue of at least $1.07 billion, (2) the date on which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter, and (3) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. References herein to “emerging growth company” have the meaning provided in the JOBS Act.

 

Internal Control Over Financial Reporting

 

In connection with our management assessment of internal control over financial reporting as of and for the three months ended March 31, 2024, the Company has identified two (2) material weaknesses within our internal controls associated with Revenue Recognition and Complex Financial Instrument. Refer to Item 9A of this Quarterly Report on Form 10-Q for additional details.

 

Related Party Relationships

 

Account Servicing Agreement

 

The Company had an Account Servicing Agreement with PCCU. SHF provides services as per the agreement to CRB accounts at PCCU. In addition to providing the services, SHF assumed the costs associated with the CRB accounts. These costs include employees to manage account onboarding, monitoring and compliance, rent and office expense, insurance and other operating expenses necessary to service these accounts. Under the agreement, PCCU agreed to pay SHF all revenue generated from CRB accounts. Amounts due to SHF were due monthly in arrears and upon receipt of invoice. This agreement was replaced and superseded in its entirety by Commercial Alliance Agreement entered on March 29, 2023, between PCCU and the Company.

 

Support Services Agreement

 

On July 1, 2021, SHF entered into a Support Services Agreement with PCCU. In connection with PCCU hosting the depository accounts and the related loans and providing certain infrastructure support, PCCU receives (and SHF pays) a monthly fee per depository account. In addition, 25% of any investment income associated with CRB deposits is paid to PCCU. This agreement was replaced and superseded in its entirety by Commercial Alliance Agreement entered on March 29, 2023, between PCCU and the Company.

 

 44 

 

 

Loan Servicing Agreement

 

Effective February 11, 2022, SHF entered into a Loan Servicing Agreement with PCCU. The agreement sets forth the application, underwriting and approval process for loans from PCCU to CRB customers and the loan servicing and monitoring responsibilities provided by both PCCU and SHF. PCCU receives a monthly servicing fee at the annual rate of 0.25% of the then-outstanding principal balance of each loan funded and serviced by PCCU. For the loans that are subject to this agreement, SHF originates the loans and performs all compliance analysis, credit analysis of the potential borrower, due diligence and underwriting and all administration, including hiring and incurring the costs of all related personnel or third-party vendors necessary to perform these services. Under the Loan Servicing Agreement, SHF has agreed to indemnify PCCU from all claims related to default-related credit losses as defined in the Loan Servicing Agreement. This agreement was replaced and superseded in its entirety by Commercial Alliance Agreement entered on March 29, 2023, between PCCU and the Company.

 

Commercial Alliance Agreement

 

On March 29, 2023, the Company and PCCU entered into the Commercial Alliance Agreement. This Agreement sets forth the terms and conditions of the lending and account-related services, governing the relationship between the Company and PCCU. The Commercial Alliance Agreement replaces and supersedes, in their entirety, the following agreements entered into between the aforementioned parties: the Amended and Restated Loan Servicing Agreement (the “Loan Servicing Agreement”, dated September 21, 2022); the Second Amended and Restated Account Servicing Agreement (“the “Account Servicing Agreement,” dated May 23, 2022, effective February 11, 2022) and the Second Amended and Restated Support Services Agreement (the “Support Agreement,” dated May 23, 2022, effective February 11, 2022).

 

The Commercial Alliance Agreement sets forth the application, underwriting, loan approval, and foreclosure process for loans from PCCU to borrowers that are cannabis-related businesses and the loan servicing and monitoring responsibilities provided by the Company and PCCU. In particular, the Commercial Alliance Agreement provides for procedures to be followed upon the default of a loan to ensure that neither the Company nor PCCU will take title to or possession of any cannabis-related assets, including real property, that may be collateral for a loan funded by PCCU pursuant to the Commercial Alliance Agreement. Under the Commercial Alliance agreement, the PCCU has the right to receive monthly fees for managing loans. For SHF-serviced loans, which are CRB loans provided by the PCCU but primarily handled by SHF, a yearly fee of 0.25% of the remaining loan balance is applied. On the other hand, loans both financed and serviced by the PCCU are charged a yearly fee of 0.35% on their outstanding balance. These fees are calculated using the average daily balance of each loan for the preceding month. In addition, the Company’s is obligated by the Commercial Alliance Agreement to indemnify PCCU from certain default-related loan losses (as fully defined in the Commercial Alliance Agreement).

 

In addition, the Commercial Alliance Agreement provides for certain fees to be paid to the Company for certain identified account related services to include: all cannabis-related income, including all lending-related income (such as loan origination fees, interest income on CRB-related loans, participation fees and servicing fees), investment income, interest income, account activity fees, processing fees, flat fees, and other revenue generated from cannabis and multi-state hemp accounts that are hosted on PCCU’s core system for a monthly fee equal to $30.96 per account in 2022, $25.32-$27.85 per account in 2023, and $26.08-$28.69 in 2024. In addition, as it pertains to CRB deposits held at PCCU, investment and interest income earned on these deposits (excluding interest income on loans funded by PCCU) will be shared 25% to PCCU and 75% to the Company. Finally, under the Commercial Alliance Agreement, PCCU will continue to allow its ratio of CRB-related deposits to total assets to equal at least 60% unless otherwise dictated by regulatory, regulator or policy requirements. The initial term of the Commercial Alliance Agreement is for a period of two years, with a one-year automatic renewal unless a party provides one hundred twenty days’ written notice prior to the end of the term.

 

The below schedule demonstrates the ratio of CRB related loans funded by PCCU to the relative lending limits on March 31, 2024 and December 31, 2023.

 

   March 31, 2024
(Unaudited)
   December 31, 2023
(Unaudited)
 
CRB related deposits  $106,692,488   $129,350,998 
Capacity at 60%   64,015,493    77,610,599 
PCCU net worth   83,739,916    81,087,746 
Capacity at 1.3125   109,908,640    106,670,306 
Limiting capacity   64,015,493    77,610,599 
PCCU loans funded   57,737,287    55,660,039 
Amounts available under lines of credit   775,000    525,000 
Incremental capacity  $5,503,206   $21,425,560 

 

 45 

 

 

The revenue from operation on the statement of operations consists of the following agreement mentioned above for the three months ended March 31, 2024, and March 31, 2023:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Account Servicing Agreement  $-   $3,261,284 
Commercial Alliance Agreement   3,585,856    - 
Total  $3,585,856   $3,261,284 

 

The operating expense on the statement of operations consists of the following agreement mentioned above for the three months ended March 31, 2024, and March 31, 2023:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Support Services Agreement  $-   $378,730 
Loan Servicing Agreement   -    11,929 
Commercial Alliance Agreement   300,261    - 
Total  $300,261   $801,347 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

The Company is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information otherwise required with respect to market risk.

 

Item 4. Controls and Procedures.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer, to allow timely decisions regarding required disclosure.

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of March 31, 2024 due to the material weaknesses described below. In light of these material weaknesses, we performed additional analysis as deemed necessary to ensure that our unaudited interim financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the periods presented.

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, solely due to the below-mentioned material weaknesses, the Company’s disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of March 31, 2024.

 

 46 

 

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Prior to March 31, 2024, the Company has the following material weakness outstanding which we consider remediated as of and during the three-month ended March 31, 2024:

 

Credit Losses: As of March 31, 2023, the Company did not update its provision for credit losses correctly. The initial shortcomings included a lack of supportive documentation for the model used in our calculations and an error in applying the modified retrospective adoption method. Specifically, adjustments were made through the Consolidated Statements of Operations instead of the Consolidated Stockholders’ Equity on January 1, 2023. To address this material weakness, from June 30, 2023, to December 31, 2023, the Company improved the documentation for its allowance model. Additionally, a robust quarterly process was established, featuring enhanced management review controls for performing and reviewing the Current Expected Credit Loss (CECL) calculations. These processes and calculations are now regularly reviewed by senior management, ensuring accuracy in documentation and disclosures. On March 31, 2024, these corrective actions successfully remediated the identified material weakness.

 

We consider the following material weaknesses to be outstanding as of March 31, 2024:

 

Revenue Recognition: During the three months ended March 31, 2024 and March 31, 2023, the Company’s revenue was earned through certain related party contracts with PCCU that define contractually the revenue earned by the Company from PCCU for account servicing. The Company has identified a material weakness in our internal control over financial reporting related to the need to enhance the design and operating effectiveness of internal controls over the review of revenue recognition from allocations that occurs on a monthly basis between the Company and PCCU.

 

To remediate this material weakness, the Company has implemented a monthly process with enhanced management review controls to perform and review revenue recognition. The analysis and disclosures are assessed by senior management of the Company performing review of the documentation and disclosures.

 

Complex Financial Instruments: During the three months ended March 31, 2024 and March 31, 2023, the Company had a material weakness with regard to the ineffectiveness in management review controls of the accounting, disclosure and valuation of complex financial instruments (warrants, deferred consideration, forward purchase agreement, and stock-based compensation).

 

To remediate this material weakness, the Company has implemented a quarterly process with enhanced management review controls to perform and review complex financial instruments. The analysis and disclosures are assessed by senior management of the Company performing review of the documentation and disclosures.

 

With the implementation of our remediation plans for each material weakness, we believe, in subsequent periods, these material weaknesses can be remediated.

 

We plan to continue to assess and improve our internal controls and procedures and to take further action as necessary or appropriate to address any other matters we identify.

 

Completion of remediation does not provide assurance that our remediation or other controls will continue to operate properly. A failure to maintain effective internal controls over financial reporting could result in errors in its financial statements that could require the Company to restate past financial statements, cause the Company to fail to meet its reporting obligations and cause investors to lose confidence in the Company’s reported financial information, all of which could materially and adversely affect the Company.

 

Changes in Internal Control over Financial Reporting

 

Other than as noted above in the March 31, 2024 material weaknesses, there was no changes in our internal control over financial reporting that occurred during the period ended March 31, 2024 covered by this Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

The Company’s management has expended, and will continue to expend, a substantial amount of effort and resources for their mediation of the material weaknesses and improvement of our internal control over financial reporting. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we have expanded and will continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards.

 

 47 

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 1A. Risk Factors

 

As of the date of this Quarterly Report on Form 10-Q, there have been no material changes in the risk factors disclosed by us under Part I, Item 1A except the notice related to the Nasdaq Listing Qualifications Department, mentioned as follows:

 

We have been notified by The Nasdaq Stock Market LLC of our failure to comply with certain continued listing requirements and, if we are unable to regain compliance with all applicable continued listing requirements and standards of Nasdaq, our Class A common stock and redeemable warrants could be delisted from Nasdaq, which would have an adverse impact on the trading, liquidity, and market price of our Class A common stock and redeemable warrants.

 

On April 5, 2024, the Company received a letter from Nasdaq Stock Market LLC (“Nasdaq”) that the Company did not maintain a minimum closing bid price of $1 per share for its common stock, as required by Nasdaq listing rule 5550(a)(2). The Company had 180 calendar days, or until October 2, 2024, to regain compliance.

 

The notification has no immediate effect on the listing of the Company’s common stock, and its common stock will continue to trade on The Nasdaq Capital Market under the symbol “SHFS” at this time. The Company has a period of an additional 180 calendar days, or until October 2, 2024, to regain compliance with the Minimum Bid Price Requirement. If at any time before October 2, 2024, the bid price of the Company’s common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Staff will provide written confirmation that the Company has achieved compliance and the matter will be closed.

 

There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement or will otherwise be in compliance with other Nasdaq Listing Rules. However, the Company intends to actively monitor the closing bid price for its common stock and will consider available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement, including initiating a reverse stock split. If the Company chooses to implement a reverse stock split, we must complete the reverse stock split no later than 10 business days prior to the expiration date of the additional compliance period on October 2, 2024 in order to timely regain compliance.

 

With respect to the Risk Factors contained in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023, we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

 

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds.

 

(a) Unregistered Sales of Equity Securities

 

None, except as previously disclosed in the Company’s Current Reports on Form 8-K.

 

(b) Use of Proceeds from the Public Offering

 

None.

 

(c) Purchase of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not Applicable

 

Item 5. Other Information

 

None.

 

 48 

 

 

Item 6. Exhibits

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

No.   Description of Exhibit
1   Form of Code of Ethics and Business Conduct
2.1 †   Unit Purchase Agreement dated February 11, 2022 (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on February 14, 2022).
2.2   First Amendment to Unit Purchase Agreement dated September 19, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 19, 2022).
2.3   Second Amendment to Unit Purchase Agreement dated September 22, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 23, 2022).
2.4   Third Amendment to Unit Purchase Agreement dated September 28, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on September 29, 2022).
2.5†   Agreement and Plan of Merger, dated October 31, 2022, by and among SHF Holdings, Inc., Merger Sub I, Merger Sub II, Rockview Digital Solutions, Inc. d/b/a Abaca and Dan Roda, solely in such individual’s capacity as the representative of Abaca security holders (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K, filed on October 31, 2022).
2.6   Amendment to Agreement and Plan of Merger, dated November 11, 2022, by and among SHF Holdings, Inc., Merger Sub I, Merger Sub II, Rockview Digital Solutions, Inc. d/b/a Abaca and Dan Roda, solely in such individual’s capacity as the representative of the Abaca security holders (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K, filed on November 16, 2022).
2.7   Second Amendment to Agreement and Plan of Merger, dated October 26, 2023, by and among SHF Holdings, Inc., Merger Sub I, Merger Sub II, Rockview Digital Solutions, Inc. d/b/a Abaca and Dan Roda, solely in such individual’s capacity as the representative of the Abaca security holders (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K, filed on October 27, 2023).
2.8*   First amendment to second amendment to agreement and plan of merger warrant agreement and lock-up agreement
3   Amended and Restated - 2022 Equity Incentive Plan
3.1   Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K, filed on September 29, 2022).
3.2   Certificate of Designation (incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 8-K, filed on September 29, 2022).
4   Form SHF Holdings, Inc. Stock Option Agreement
4.1   Warrant Agreement, dated June 23, 2021, between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on June 25, 2021).
4.2   Registration Rights Agreement, dated March 29, 2023, by and between the Company and Partner Colorado Credit Union (incorporated by reference to Exhibit 2 of the Company’s Quarterly Report on Form 10-Q, filed May 15, 2023).
4.3   Security Agreement, dated March 29, 2023, by and between the Company and Partner Colorado Credit Union (incorporated by reference to Exhibit 3 of the Company’s Quarterly Report on Form 10-Q, filed May 15, 2023).
4.4   Senior Secured Promissory Note, dated March 29, 2023, by and between the Company and Partner Colorado Credit Union (incorporated by reference to Exhibit 4 of the Company’s Quarterly Report on Form 10-Q, filed May 15, 2023)
4.5   Securities Issuance Agreement, dated March 29, 2023, by and among the Company and Partner Colorado Credit Union (incorporated by reference to Exhibit 5 of the Company’s Quarterly Report on Form 10-Q, filed May 15, 2023).
4.5   Warrant Agreement, dated October 26, 2023, by and among the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 2.2 of the Company’s Current Report on Form 8-K, filed on October 27, 2023).
4.6   Description of Registered Securities

 

 49 

 

 

5   Form of SHF Holdings, Inc. Restricted Stock Unit Agreement
7   By Laws
10.1   Letter Agreement, dated June 23, 2021, among the Company, its officers and directors and 5AK, LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 25, 2021).
10.2 †   Registration Rights Agreement, dated June 23, 2021, by and among the Company and certain securityholders (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on June 25, 2021).
10.3   Form of Indemnity Agreement (incorporated by reference to Exhibit 10.7 to the Company’s Registration Statement on Form S-1 filed on June 2, 2021).
10.4   Forward Purchase Agreement dated June 16, 2022 (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed on June 17, 2022).
10.5   Registration Rights Agreement dated September 28, 2022 (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed on October 4, 2022).
10.6 †   Lock-Up Agreement dated September 28, 2022 (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K, filed on October 4, 2022).
10.7   Non-Competition Agreement dated September 28, 2022 (incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K, filed on October 4, 2022).
10.8†   Form of Amended and Restated Securities Purchase Agreement (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K, filed on September 29, 2022).
10.9   SHF Holdings, Inc. 2022 Stock Incentive Plan (incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K, filed on October 4, 2022).
10.10   Forbearance Agreement, dated as of October 27, 2022 by and between SHF Holdings, Inc., Partner Colorado Credit Union and Luminous Capital USA Inc. (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K, filed on November 1, 2022).
10.11   Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed on November 16, 2022).
10.12   Executive Employment Agreement, dated January 10, 2023, by and between the Company and Donnie Emmi (incorporated by reference to Exhibit 10.12 of the Company’s Annual Report on Form 10-K, filed on April 14, 2023).
10.13   Executive Employment Agreement, dated January 10, 2023, by and between the Company and James H. Dennedy (incorporated by reference to Exhibit 10.13 of the Company’s Annual Report on Form 10-K, filed on April 14, 2023).
10.14   Commercial Alliance Agreement, dated March 29, 2023, between the Company and Partner Colorado Credit Unit (incorporated by reference to Exhibit 1 of the Company’s Quarterly Report on Form 10-Q, filed on May 15, 2023).
10.15   Executive Employment Agreement, dated August 16, 2023, by and between the Company and Tyler Beuerlein (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed on August 22, 2023).
21.1   Subsidiaries of the Registrant
23.1   Consent of Marcum LLP, independent registered public accounting firm
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
97   Clawback policy
101.INS*   Inline XBRL Instance Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.
** Furnished.
Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

 

 50 

 

 

SIGNATURES

 

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Signature   Title   Date
         
/s/ Sundie Seefried   Chief Executive Officer

(Principal Executive Officer)

  May 13th, 2024
Sundie Seefried        
         
/s/ James H. Dennedy   Chief Financial Officer

(Principal Financial and Accounting Officer)

  May 13th, 2024
James H. Dennedy        

 

 51 

 

EX-2.8 2 ex2-8.htm

 

Exhibit 2.8

 

FIRST AMENDMENT

 

TO

 

SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGER

 

WARRANT AGREEMENT

 

AND

 

LOCK-UP AGREEMENT

 

This FIRST AMENDMENT TO SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGER, WARRANT AGREEMENT, AND LOCK-UP AGREEMENT (this “Amendment”) is dated effective as of February 27, 2024, and is made and entered into by and among SHF Holdings, Inc., a Delaware corporation (“Parent”), SHF Merger Sub I Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Merger Sub I”), SHF Merger Sub II LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of Parent (“Merger Sub II”), Rockview Digital Solutions, Inc., a Delaware corporation, d/b/a Abaca (the “Company”), and Dan Roda, solely in such individual’s capacity as the representative of the Company Securityholders (the “Company Stockholders’ Representative” and together with Parent, Merger Sub I, Merger Sub II and the Company, collectively, the “Parties”).

 

WHEREAS, the Parties entered into that certain Agreement and Plan of Merger, dated as of October 29, 2022 (the “Original Agreement”), which was subsequently amended on November 11, 2022 (the “First Amendment”), and amended again on October 26, 2023 (the “Second Amendment”);

 

WHEREAS, pursuant to Section 5 of the Second Amendment, Parent was to prepare, pay, and file with the U.S. Securities and Exchange Commission (the “Commission”), a Registration Statement registering the resale from time to time by the holders of the Registrable Securities of all Registrable Securities then held by such holders (the “Registration Statement Rights”);

 

WHEREAS, pursuant to Section 4 of the Second Amendment, on October 26, 2023, Parent entered into that certain Warrant Agreement by and between Parent and the Company Stockholders’ Representative (the “Warrant Agreement”), which was attached to the Second Amendment as Exhibit A thereto;

 

WHEREAS, Section 6. Redemption contained in the Warrant Agreement, including related references throughout, was not intended to be a term of agreement between the Parties and should not have been included in the Second Amendment, and as such, is being formally struck by this Amendment; and

 

WHEREAS, the Parties intend to amend the Form of Lock-Up Agreement entered into on November 14, 2022 (the “Lock-up Agreement”);

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, the Parties agree as follows:

 

1. Capitalized Terms. All capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Original Agreement, First Amendment, and/or Second Amendment, as applicable.

 

 
 

 

2. Amendment to the Second Amendment.

 

a. Section 5 of the Second Amendment is amended as follows:

 

5. Registration. The Parent agrees that in the event that law or regulation requires a registration of the Parent Common Stock, such that the issued shares are saleable without restrictive legends (the “Registration Requirement”), and subject to the Securities Act, within 45 calendar days after being notified of a Registration Requirement, it shall use its reasonable best efforts to file with the Commission a registration statement for the registration, under the Securities Act, of the shares of Parent Common Stock. Failure to file such registration statement within 45 calendar days after the notice of a Registration Requirement shall constitute an event of default. Parent shall use commercially reasonable efforts to cause the registration statement in connection with the Registration Requirement to be declared effective as soon as possible after filing, and once effective, to keep the registration statement continuously effective under the Securities Act at all times until the earlier of (i) the first anniversary of the date of filing “Form 10 information” (as defined in Rule 144 of the Securities Act) reflecting the consummation of the transactions contemplated by this Second Amendment or (ii) the date of which all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by the Commission)). For purposes of this section, the registration statement in connection with the Registration Requirement means a registration statement filed by the Parent with the Commission in compliance with the Securities Act and the rules and regulations promulgated thereunder for a public offering and sale of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities (other than a registration statement on Form S-4 or Form S-8, or their successors, or any registration statement covering only securities proposed to be issued in exchange for securities or assets of another entity).

 

3. Amendments to the Warrant Agreement.

 

a. Section 3.2 of the Warrant Agreement is amended as follows:

 

“3.2 Duration of Warrants. A Warrant may be exercised only during the period (the “Exercise Period”) commencing October 26, 2023 and terminating October 25, 2028 (the “Expiration Date). Each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Parent in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, that the Parent shall provide at least twenty (20) days prior written notice of any such extension to Registered Holders of the Warrants.”

 

2
 

 

b. Section 6 is hereby deleted in its entirety, and any related references to redemption contained in the Warrant Agreement, including without limitation the second paragraph of the form “Election to Purchase (To be Executed Upon Exercise of Warrant),” are hereby deleted in their entirety.

 

c. Section 7.4.1 of the Warrant Agreement is hereby amended to read as follows:

 

7.4.1 Registration of the Common Stock. The Parent agrees that in the event that law or regulation requires the registration of Parent Common Stock issued upon exercise of the Warrants, such that the common stock issued in connection with the warrant exercise are saleable without restrictive legends (the “Warrant Registration Requirement), that within 45 calendar days after being notified of a Warrant Registration Requirement, it shall use its reasonable best efforts to file with the Commission a registration statement for the registration, under the Securities Act, of the shares of common stock issuable upon exercise of the Warrants. Failure to file such registration statement within 45 calendar days after the notice of a Warrant Registration Requirement shall constitute an event of default. The Parent shall use its reasonable best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement. If any such registration statement filed pursuant to a Warrant Registration Requirement has not been declared effective by the 1 year anniversary following its filing date, holders of the Warrants shall have the right, during the period beginning on the 366th day after the filing of such registration statement and ending upon such registration statement being declared effective by the Commission, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) or another exemption) for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value” (as defined below) over the Warrant Price by (y) the Fair Market Value. Solely for purposes of this subsection 7.4.1, “Fair Market Value” shall mean the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Warrant, the Parent shall, upon request, provide the Warrant Agent with an opinion of counsel for the Parent (which shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act (or any successor rule)) of the Parent and, accordingly, shall not be required to bear a restrictive legend.

 

3
 

 

4. Consideration. In consideration of the foregoing amendments, Parent has agreed to modify the Lock-Up Agreement and shall accelerate the Lock-up Period as defined in Section 1(a) of the Lock-up Agreement to expire contemporaneous with the effective date of this Amendment and to cooperate in the removal of any related restrictive legends such that the issued Parent Common Stock are saleable without restrictive legends, subject the Securities Act. For the avoidance of doubt, no other provisions of the Lock-Up Agreement shall be amended by this Amendment.

 

5. Representations and Warranties. Each Party, including the Company Stockholders’ Representative on behalf of each of the Company Stockholders, hereby represents and warrants to the other Parties that:

 

  a. It has the full right, power, and authority to enter into this Amendment and to perform its obligations hereunder and under the agreements amended by this Amendment;

 

  b. the execution of this Amendment by the individual whose signature is set forth at the end of this Amendment on behalf of such Party, and the delivery of this Amendment by such Party, have been duly authorized by all necessary action on the part of such Party; and

 

  c. this Amendment has been executed and delivered by such Party and (assuming due authorization, execution, and delivery by the other Party) constitutes the legal, valid, and binding obligation of such Party, enforceable against such Party in accordance with its terms, except as may be limited by any applicable bankruptcy, insolvency, reorganization, moratorium, or similar laws and equitable principles related to or affecting creditors’ rights generally or the effect of general principles of equity.

 

4
 

 

  d. EXCEPT FOR THE EXPRESS REPRESENTATIONS AND WARRANTIES SET FORTH IN THE ORIGINAL AGREEMENT AND IN THIS SECTION 5 OF THIS AMENDMENT, (A) NO PARTY HERETO NOR ANY PERSON ON SUCH PARTY’S BEHALF HAS MADE OR MAKES ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY WHATSOEVER, EITHER ORAL OR WRITTEN, WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE, OR OTHERWISE, ALL OF WHICH ARE EXPRESSLY DISCLAIMED, AND (B) EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS NOT RELIED UPON ANY REPRESENTATION OR WARRANTY MADE BY THE OTHER PARTY, OR ANY OTHER PERSON ON SUCH OTHER PARTY’S BEHALF, EXCEPT AS SPECIFICALLY PROVIDED IN THIS SECTION 5.

 

6. No Other Amendments; Conflict. Except as amended herein, the Second Amendment, the Warrant Agreement, and the Lock-Up Agreement shall remain in full force and effect in accordance with their original terms. Furthermore, the Original Agreement, the First Amendment, the Second Amendment, and the Warrant Agreement shall be interpreted consistent with this Amendment. In the event of any conflict between the Original Agreement, the First Amendment, the Second Amendment, and the Warrant Agreement and this Amendment, this Amendment shall prevail.

 

7. Governing Law. This Amendment is governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflict of laws provisions of such State.

 

8. Entire Agreement. The Original Agreement, the First Amendment, the Second Amendment, the Warrant Agreement, and this Amendment (including any Exhibits and Disclosure Schedules thereto) shall constitute the full and entire understanding and agreement between the Parties with respect to the subject matter hereof and thereof and supersede any and all other written or oral agreements.

 

9. Costs. Each Party shall pay its own costs and expenses in connection with this Amendment (including the fees and expenses of its advisors, accountants, and legal counsel).

 

10. Counterparts. This Amendment may be executed in any number of counterparts, each of which so executed are deemed to be an original, but all of which together constitute one and the same instrument. A signed copy of this Amendment delivered by facsimile, email, or other means of electronic transmission is deemed to have the same legal effect as delivery of an original signed copy of this Amendment.

 

[SIGNATURE PAGE FOLLOWS]

 

5
 

 

IN WITNESS WHEREOF, the Parties have duly acknowledged, certified, and executed this Amendment as of the date first written above.

 

  SHF HOLDINGS, INC.
     
    /s/ Sundie Seefried
  Name: Sundie Seefried
  Title: Chief Executive Officer
     
  SHF MERGER SUB I
     
    /s/ Sundie Seefried
  Name: Sundie Seefried
  Title: Chief Executive Officer
     
  SHF MERGER SUB II
     
    /s/ Sundie Seefried
  Name: Sundie Seefried
  Title: Chief Executive Officer
     
  ROCKVIEW DIGITAL SOLUTIONS, INC.
     
    /s/ Dan Roda
  Name: Dan Roda
  Title: Chief Executive Officer
     
  COMPANY STOCKHOLDERS’ REPRESENTATIVE
     
    /s/ Dan Roda
  Name: Dan Roda
     
  SHFxABACA LLC, successor in interest to ROCKVIEW DIGITAL SOLUTIONS, INC.
     
    /s/ Sundie Seefried
  Name: Sundie Seefried
  Title: Chief Executive Officer

 

6

 

EX-31.1 3 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Sundie Seefried, certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2024 of SHF Holdings, Inc.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 13, 2024 /s/ Sundie Seefried
  Sundie Seefried
 

Chief Executive Officer

(Principal Executive Officer)

 

 

 

EX-31.2 4 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, James H. Dennedy, certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2024 of SHF Holdings, Inc.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 13, 2024 /s/ James H. Dennedy
  James H. Dennedy
 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 

 

EX-32.1 5 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of SHF Holdings, Inc. on Form 10-Q for the annual period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sundie Seefried, Chief Executive Officer of SHF Holdings, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 13, 2024

/s/ Sundie Seefried
  Sundie Seefried
  Chief Executive Officer
  (Principal Executive Officer)

 

 

 

 

EX-32.2 6 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of SHF Holdings, Inc. on Form 10-Q for the quarterly period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James H. Dennedy, Chief Financial Officer of SHF Holdings, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 13, 2024 /s/ James H. Dennedy
  James H. Dennedy
 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 

 

EX-101.SCH 7 shfs-20240331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Business Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Deferred Consideration link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Goodwill and Finite-lived Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Loans Receivable link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Indemnification Liability link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Senior Secured Promissory Note link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Deferred Underwriter Fee link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Commitments and contingencies link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Forward Purchase Agreement link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Warrant Liabilities link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Tax link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 401(k) Plan link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Subsequent events link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Deferred Consideration (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Goodwill and Finite-lived Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Loans Receivable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Indemnification Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Senior Secured Promissory Note (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Forward Purchase Agreement (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Schedule of Current Expected Credit Losses Transition Impact (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of Change in Deferred Consideration (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Deferred Consideration (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Schedule of Finite Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Goodwill and Finite-lived Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Schedule of Commercial Real Estate Loans Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Schedule of Allowance For Loan Losses (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Schedule of Risk Rating (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Schedule of Outstanding Amounts (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Schedule of Indemnity Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Schedule of Indemnified Loans Risk Rating (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Schedule of Provision for Loan Losses (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Indemnification Liability (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Schedule of Demonstrated Deposit Capacity (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Schedule of Revenue from Operations (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Schedule of Operating Expense from Operations (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - Schedule of Outstanding Balances from Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - Schedule of Senior Secured Promissory Note (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - Schedule of Outstanding Amount on Debt (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - Senior Secured Promissory Note (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - Schedule of Right Of Use Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - Schedule of Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - Schedule of Disaggregated Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - Revenue (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - Deferred Underwriter Fee (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - Schedule of Earning Per Shares, Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - Schedule of Weighted Average Shares Outstanding - Basic And Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - Schedule of Forward Purchase Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - Forward Purchase Agreement (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - Warrant Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 00000081 - Disclosure - Schedule of Fair Value Assets Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 00000082 - Disclosure - Schedule of Level 3 Fair Value Measurement Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 00000083 - Disclosure - Schedule of Level 3 Fair Value Measurements Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 00000084 - Disclosure - Tax (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000085 - Disclosure - 401(k) Plan (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000086 - Disclosure - Schedule of Fair Value of Options Granted Black-Scholes-Merton Model (Details) link:presentationLink link:calculationLink link:definitionLink 00000087 - Disclosure - Schedule of Stock Option and Related Information (Details) link:presentationLink link:calculationLink link:definitionLink 00000088 - Disclosure - Schedule of Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000089 - Disclosure - Schedule of Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 00000090 - Disclosure - Schedule of Exercise Price of Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 00000091 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000092 - Disclosure - Subsequent events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 shfs-20240331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 shfs-20240331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 shfs-20240331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Class A Common Stock, $0.0001 par value per share Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share Related and Nonrelated Parties [Axis] Nonrelated Party [Member] Related Party [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Common Class A [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Revision of Prior Period [Axis] Revision of Prior Period, Reclassification, Adjustment [Member] Long-Lived Tangible Asset [Axis] Equipment and Furniture and Fixtures [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Financial Instrument [Axis] Credit Expected Credit Losses Transition [Member] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption, Adjustment [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Abaca Merger Closing [Member] Cash and Cash Equivalents [Axis] Cash [Member] Business Acquisition [Axis] Abaca [Member] Merger Agreement [Member] Finite-Lived Intangible Assets by Major Class [Axis] Developed Technology Rights [Member] Marketing-Related Intangible Assets [Member] Customer Relationships [Member] Debt Instrument [Axis] Commercial Real Estate Loans Receivable [Member] Internal Credit Assessment [Axis] Risk Rate 4 [Member] P C C U Agreement [Member] Long-Term Debt, Type [Axis] Secured Debt [Member] Unsecured Debt [Member] Risk Rate 3 [Member] Risk Rate 5 [Member] Risk Rate Six [Member] Risk Rate 7 [Member] Risk Rate 8 [Member] Financing Receivable Portfolio Segment [Axis] Commercial Real Estate Portfolio Segment [Member] Indemnity Liability Segment [Member] Equipment [Member] Software Development [Member] Leasehold Improvements [Member] Furniture and Fixtures [Member] Loan Servicing Agreement [Member] Consolidated Entities [Axis] Partner Colorado Credit Union [Member] Support Services Agreement [Member] Senior Secured Promissory Note [Member] Investment, Name [Axis] Securities Issuance Agreement [Member] Related Party Transaction [Axis] Cannabis Related Businesses Related Deposits [Member] Capacity at 60% [Member] Capacity at 1.3125 [Member] Limiting Capacity [Member] Partner Colorado Credit Union Loans Funded [Member] Line of Credit [Member] Product and Service [Axis] Account Servicing Agreement [Member] Commercial Alliance Agreement [Member] Senior Secured Promissory Note Current [Member] Security Agreement [Member] Senior Secured Promissory Note Non Current [Member] Scenario [Axis] 54 Equal Installments [Member] Statement of Income Location, Balance [Axis] Deposit Activity Onboarding Income [Member] Safe Harbor Program Income [Member] Investment Income [Member] Interest Income [Member] Legal Entity [Axis] Benchmark Investments LLC [Member] Midtown East Management NL LLC [Member] Forward Purchase Agreement [Member] Vellar [Member] Midtown East [Member] Verdun [Member] Public Warrants [Member] Private Placement Warrants [Member] Public and Private Warrants [Member] PIPE Warrants [Member] Abaca Warrants [Member] Warrant [Member] Purchase Agreement Option [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Asset Class [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 3 [Member] Abaca Warrant [Member] Forward Purchase Derivative Liability [Member] Third Anniversary Payment Consideration [Member] Measurement Basis [Axis] Reported Value Measurement [Member] Estimate of Fair Value Measurement [Member] Fair Value, Inputs, Level 2 [Member] Forward Purchase Derivative [Member] Measurement Input Type [Axis] Measurement Input, Exercise Price [Member] Private Warrants [Member] Measurement Input, Share Price [Member] Expected Term [Member] Measurement Input, Price Volatility [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input Reset Price [Member] Measurement Input, Expected Term [Member] Measurement Input Additional Maturity Per Share [Member] Measurement Input, Discount Rate [Member] Award Type [Axis] Share-Based Payment Arrangement, Option [Member] Exercise Price Range [Axis] Exercise Price One [Member] Exercise Price Two [Member] Exercise Price Three [Member] Exercise Price Four [Member] Restricted Stock Units (RSUs) [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current Assets: Cash and cash equivalents Accounts receivable Prepaid expenses – current portion Accrued interest receivable Short-term loans receivable, net Other current assets Total Current Assets Long-term loans receivable, net Property, plant and equipment, net Operating lease right to use assets Goodwill Intangible assets, net Deferred tax asset Prepaid expenses – long term position Forward purchase receivable Security deposit Total Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable Accrued expenses Contract liabilities Lease liabilities – current Senior secured promissory note – current portion Deferred consideration – current portion Other current liabilities Total Current Liabilities Warrant liabilities Deferred consideration – long term portion Forward purchase derivative liability Senior secured promissory note—long term portion Net deferred indemnified loan origination fees Lease liabilities – long term Indemnity liability Total Liabilities Commitment and Contingencies (Note 13) Stockholders’ Equity Convertible preferred stock, $.0001 par value, 1,250,000 shares authorized, 111 and 1,101 shares issued and outstanding on March 31, 2024, and December 31, 2023, respectively Class A common stock, $.0001 par value, 130,000,000 shares authorized, 55,431,001 and 54,563,372 issued and outstanding on March 31, 2024, and December 31, 2023, respectively Additional paid in capital Retained deficit Total Stockholders’ Equity Total Liabilities and Stockholders’ Equity Statement of Financial Position [Abstract] Convertible preferred stock, par value Convertible preferred stock, shares authorized Convertible preferred stock, shares issued Convertible preferred stock, shares outstanding Class A common stock, par value Class A common stock, shares authorized Class A common stock, shares issued Class A common stock, shares outstanding Income Statement [Abstract] Revenue Operating Expenses Compensation and employee benefits General and administrative expenses Professional services Rent expense Provision (benefit) for credit losses Total operating expenses Operating income/ (loss) Other (income) expenses Change in the fair value of deferred consideration Interest expense Change in fair value of warrant liabilities Total other (income)/ expenses Net income/ (loss) before income tax Income tax benefit Net income/ (loss) Weighted average shares outstanding, basic Basic net income/ (loss) per share Weighted average shares outstanding, diluted Diluted income/ (loss) per share Balance Balance, shares Conversion of PIPE shares Conversion of PIPE shares, shares Restricted stock units (net of tax) Restricted stock units (net of tax), shares Stock compensation cost Net loss Cumulative effect from adoption of CECL Stock option conversion Stock option conversion, shares Issuance of shares to PCCU (net of tax) Issuance of shares to PCCU (net of tax), shares Reversal of deferred underwriting cost Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net income/ (loss) Adjustments to reconcile net income/ (loss) to net cash provided by/ (used in) operating activities: Depreciation and amortization expense Stock compensation expense Amortization of deferred origination fees Interest expense (Benefit)/ provision for credit losses Amortization of right of use assets Income tax benefit Change in fair value of warrant Changes in operating assets and liabilities: Accounts receivable – Trade Accounts receivable – related party Contract assets Prepaid expenses Accrued interest receivable Deferred underwriting payable Other current assets Other current liabilities Accounts payable Accounts Payable – related party Accrued expenses Contract liabilities Net deferred indemnified loan origination fees Security deposit Net cash provided by (used in) operating activities CASH FLOWS PROVIDED BY INVESTING ACTIVITIES: Purchase of property and equipment Net repayment of loans Net cash provided by investing activities CASH FLOWS USED IN FINANCING ACTIVITIES: Repayment of senior secured promissory note Net cash used in financing activities Net increase in cash and cash equivalents Cash and cash equivalents – beginning of period Cash and cash equivalents – end of period Supplemental disclosure of cash flow information Interest paid Non-Cash transactions: Shares issued for the settlement of PCCU debt obligation Cumulative effect from adoption of CECL Accounting Policies [Abstract] Organization and Business Operations Basis of Presentation and Summary of Significant Accounting Policies Deferred Consideration Deferred Consideration Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Finite-lived Intangible Assets Receivables [Abstract] Loans Receivable Indemnification Liability Indemnification Liability Property, Plant and Equipment [Abstract] Property and Equipment, Net Related Party Transactions [Abstract] Related Party Transactions Debt Disclosure [Abstract] Senior Secured Promissory Note Leases Leases Revenue from Contract with Customer [Abstract] Revenue Deferred Underwriter Fee Deferred Underwriter Fee Commitments and Contingencies Disclosure [Abstract] Commitments and contingencies Earnings Per Share [Abstract] Earnings Per Share Forward Purchase Agreement Forward Purchase Agreement Warrant Liabilities Warrant Liabilities Investments, All Other Investments [Abstract] Financial Instruments Income Tax Disclosure [Abstract] Tax Retirement Benefits [Abstract] 401(k) Plan Equity [Abstract] Stockholders’ Equity Subsequent Events [Abstract] Subsequent events Basis of Presentation Use of Estimates Liquidity and Going Concern Cash and Cash Equivalents Concentrations of Risk Accounts Receivable Loans Receivable Allowance for Credit Losses (ACL) Net Deferred Loan Origination Fees and Cost Indemnity Liability Property and Equipment, net Right of Use Assets and Lease Liabilities Goodwill and Other Intangible Assets Stock-based Compensation Fair Value Measurements Revenue Recognition Contract Liabilities Warrants Liabilities Deferred consideration Forward purchase derivative Earnings Per Share Income Tax Recently Issued Accounting Standards Schedule of Current Expected Credit Losses Transition Impact Schedule of Change in Deferred Consideration Schedule of Finite Lived Intangible Assets Schedule of Commercial Real Estate Loans Receivable Schedule of Allowance For Loan Losses Schedule of Risk Rating Schedule of Outstanding Amounts Schedule of Indemnity Liability Schedule of Indemnified Loans Risk Rating Schedule of Provision for Loan Losses Schedule of Property and Equipment Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Schedule of Demonstrated Deposit Capacity Schedule of Revenue from Operations Schedule of Operating Expense from Operations Schedule of Outstanding Balances from Balance Sheet Schedule of Senior Secured Promissory Note Schedule of Outstanding Amount on Debt Schedule of Lease Cost Schedule of Right Of Use Assets Schedule of Future Minimum Lease Payments Schedule of Disaggregated Revenue Schedule of Earning Per Shares, Basic and Diluted Schedule of Weighted Average Shares Outstanding - Basic And Diluted Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings Schedule of Forward Purchase Agreement Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Schedule of Carrying Amounts and Fair Values of Financial Instruments Schedule of Fair Value Assets Measured on Recurring Basis Schedule of Level 3 Fair Value Measurements Inputs Schedule of Fair Value of Options Granted Black-Scholes-Merton Model Schedule of Stock Option and Related Information Schedule of Options Outstanding Schedule of Restricted Stock Units Schedule of Exercise Price of Restricted Stock Units Loans receivable, gross Loans receivable, gross Less: Allowance for credit loss Allowance for loan losses Loans receivable, net Loans receivable, net Indemnity liability Retained earning Retained earning Liabilities & Equity Liabilities & Equity Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Accounts receivable trade Cash Working capital deficit Retained deficit Operating income Percentage of total loans receivables Percentage of loans receivables Property and equipment useful life Expected volatility rate Schedule Of Change In Deferred Consideration Deferred stock consideration, Balance Deferred cash consideration, Balance Deferred consideration payment, Balance Stock consideration, Working capital adjustment Cash consideration, Working capital adjustment Stock consideration, Issuance of shares and payment to shareholders Cash consideration, Issuance of shares and payment to shareholders Stock consideration, Issuance of payment consideration Stock consideration, Issuance of payment consideration Consideration payment, Issuance of payment consideration Stock consideration, Gain recognized in the consolidated statements of operations Stock consideration, Fair value adjustment Cash consideration, Fair value adjustment Consideration payment, Fair value adjustment Deferred stock consideration, Balance Deferred cash consideration, Balance Deferred consideration payment, Balance Payments to acquire businesses Stock issued during period, shares, acquisitions Number of shares issued for acquisition Share issued price per share Number of warrant issued Warrant exercise price Intangible Asset, Finite-Lived [Table] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Accumulated Amortization Intangible Assets, Net (Excluding Goodwill) Finite-lived intangible assets, net Remaining useful life in years Non-cash goodwill impairment charge Goodwill impairment Impairment charge Impairment Short-Term Debt [Table] Short-Term Debt [Line Items] Commercial real estate loans receivable, gross Allowance for credit losses Commercial real estate loans receivable, net Current portion Noncurrent portion Allowance for credit losses, beginning balance Cumulative effect from adoption of CECL Charge-offs Recoveries Provision Allowance for credit losses,ending balance Individually evaluated for impairment Collectively evaluated for impairment Loans receivable Individually evaluated for impairment Collectively evaluated for impairment Allowance for loan losses Financing Receivable, Credit Quality Indicator [Table] Financing Receivable, Credit Quality Indicator [Line Items] Grand total Secured term loans Unsecured loans and lines of credit Total loans funded by PCCU Schedule Of Indemnity Liability Beginning balance Cumulative effect from adoption of CECL Charge-offs Recoveries (Benefit)/ Provision Ending balance Grand total Financing Receivable, Past Due [Table] Financing Receivable, Past Due [Line Items] Provision (benefit) Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Interest rate Variable rate description Lines of credit Property and equipment, gross Less: accumulated depreciation Property and equipment, net Related Party Transaction [Table] Related Party Transaction [Line Items] Incremental capacity Revenue Operating expense Senior Secured Promissory Note (Refer to Note 9 to the unaudited condensed consolidated financial statements) Servicing fee Yearly fee percentage Alliance agreement, description Debt instrument term Debt instrument, face amount Debt instrument, interest rate, effective percentage Number of shares issued Ownwership percentage Cash and cash equivalents Deposits Total 2024 2025 2026 2027 2028 Deferred consideration payable Schedule Of Lease Cost Operating lease cost Short-term lease cost Total Lease Cost Schedule Of Right Of Use Assets Beginning balance Additions to right-of-use assets Amortization charge for the period Lease modifications Ending balance Weighted-average remaining lease term Weighted-average discount rate 2024 2025 2026 2027 2028 Thereafter Total future minimum lease payments Less: Imputed interest Operating lease liabilities Less: Current portion Non-current portion of lease liabilities Lease term Operating lease liablities Total Revenue Investment hosting fees remit percent Proceeds from deposits Investment income Loan interest income Account hosting expenses Investment hosting fee Loan servicing fees Notes payable Periodic payment Repayments of debt Deferred underwriting cost Net Income/ (loss) Weighted average shares outstanding – basic Weighted average shares outstanding – diluted Diluted net income/ (loss) per share Company public shares Company initial stockholders PCCU stockholders Shares issued for abaca acquisition Restricted stock units issued Conversion of preferred stock Weighted average shares outstanding - basic Shares used in computation of basic earnings per share Shares to be issued to Abaca shareholders Share based payments Conversion of preferred stock Grand total Warrants Share based payments Shares to be issued to Abaca shareholders Conversion of preferred stock Grand total Number of shares on the date of acquisition Number of shares on the date of acquisition value Sale of stock, number of shares issued in transaction Sale of stock, consideration received on transaction Common stock held by subsidiary shares Share price Common stock held by subsidiary Sale of stock, number of shares issued in transaction shares Shares, issued Number of new stock issued Asset held with trust Related expense amounts Maturity date, description Shares per share Decrease in receivables Receivables Warrants outstanding Warrants description Shares issued, price per share Warrants execise price Warrants term Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Liabilities Fair Value, by Balance Sheet Grouping [Table] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Assets Cash and cash equivalents Forward purchase receivables Loans Liabilities Deferred consideration Senior secured promissory note Public warrants Private placement warrants PIPE warrants Abaca warrants Third anniversary payment consideration Forward purchase derivative Impairment Effects on Earnings Per Share [Table] Impairment Effects on Earnings Per Share [Line Items] Balance at the beginning of the period Issued to Abaca shareholders Fair value adjustment Balance at the end of the period Warrants and rights outstanding, measurement input Expected term (years) Derivative liability, measurement input Expected term (years) Effective income tax rate reconciliation other adjustments Effective income tax rate, federal Deferred tax assets liabilities net Defined contribution plan employee percent Defined contribution plan employee matching contribution Defined contribution plan amount Dividend yield Risk-free interest rate, minimum Risk-free interest rate, maximum Expected volatility Expected term No. of Stock Option, Beginning Balance Weighted Average Grant Date Fair Value Per Stock Option, Beginning Balance Weighted-Average Remaining Contractual Life, Ending No. of Stock Option, Granted Weighted Average Grant Date Fair Value Per Stock Option, Granted No. of Stock Option, Exercised Weighted Average Grant Date Fair Value Per Stock Option, Exercised No. of Stock Option, Expired Weighted Average Grant Date Fair Value Per Stock Option, Expired No. of Stock Option, Cancelled/Forfeited Weighted Average Grant Date Fair Value Per Stock Option, Cancelled/Forfeited No. of Stock Option, Ending Balance Weighted Average Grant Date Fair Value Per Stock Option, Ending Balance Weighted-Average Remaining Contractual Life, Granted Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Exercise price options Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] No. of RSU, Beginning Balance Weighted Average Grant Date Fair Value Per RSU, Beginning Balance Weighted-Average Remaining Contractual Life, Beginning No. of RSU, Granted Weighted Average Grant Date Fair Value Per RSU, Granted No. of RSU, Vested Weighted Average Grant Date Fair Value Per RSU, Vested No. of RSU, Expired Weighted Average Grant Date Fair Value Per RSU, Expired No. of RSU, Cancelled/Forfeited Weighted Average Grant Date Fair Value Per RSU, Cancelled/Forfeited No. of RSU, Ending Balance Weighted Average Grant Date Fair Value Per RSU, Ending Balance No. of RSU, Vested Exercise price options Preferred stock, shares authorized Preferred stock, par value Conversion Price Conversion of stock description Share price Common stock held for purchase Share based compensation Contractual term Expected volatility Subsequent Event [Table] Subsequent Event [Line Items] Safe Harbour Financial LLC [Member] Forward purchase receivable. Warrant liabilities noncurrent. Net deferred indemnified loan origination fees. Indemnity liability. Abaca [Member] Merger Agreement [Member] Weighted average shares basic initial stockholders. Weighted average number of diluted related party stockholders. Weighted average shares diluted shares issued for acquisition. Liquidity And Going Concern [Policy Text Block] Working capital. Shares Used In Computation of Basic Earnings Per Share [Member] Forward purchase Agreement [Text Block] Midtown East Management NL LLC [Member] Decrease in receivables. Forward Purchase Agreement [Member] Schedule of Forward Purchase Agreement [Table Text Block] Indemnity Liability [Policy Text Block] Number of shares on the date of acquisition. Vellar [Member] Midtown East [Member] Verdun [Member] Number of shares on the date of acquisition value. Equipment and Furniture and Fixtures [Member] Sale of stock consideration received on transaction shares. Common stock held by subsidiary shares. Right Of Use Assets And Lease Lliability [Policy Text Block] Rent expense. Change in the fair value of deferred consideration. Provision for loan losses. Contract liabilities [policy text block] Warrant Liabilities [Text Block] Public Warrants [Member] Private Placement Warrants [Member] Warrants description. Public and Private Warrants [Member] Warrants Liability [Policy Text Block] Forward Purchase Derivative [Policy Text Block] PIPE Warrants [Member] Annual servicing fee percentage. Loan Servicing Agreement [Member] Partner Colorado Credit Union [Member] Abaca Warrants [Member] Stock issued during period value cumulative effect from adoption. Commercial real estate loans receivable gross Credit Expected Credit Losses Transition [Member] Allowance for loan losses Commercial real estate loans receivable gross adjustment. Allowance for loan losses adjustment. Notes receivable net adjustment. Stock issued during period value reversal of deferred underwriting cost. Indemnity liability adjustment. Retained earnings accumulated deficit adjustment. Liabilities and stockholders equity adjustment. Deferred Consideration Disclosure [Text Block] Alliance agreement description. Support Services Agreement [Member] Abaca Merger Closing [Member] Increase decrease in deferred underwriting payable. Shares issued for the settlement of debt obligation. Cumulative effect from adoption. Public warrants fair value disclosure. Private placement warrants fair value disclosure. Pipe warrants fair value disclosure. Warrants fair value disclosure. Third Anniversary Payment Consideration Fair Value Disclosure. Schedule of Deferred Consideration [Table Text Block] Deferred stock consideration. Deferred stock consideration working capital adjustment. Deferred stock consideration issuance of payment to share holders. Deferred stock consideration issuance of warrants. Deferred stock consideration issuance of payment consideration. Deferred stock consideration gain recognized. Deferred stock consideration fair value adjustment. Deferred cash consideration. Deferred cash consideration working capital adjustment. Deferred cash consideration issuance of payment to share holders. Deferred cash consideration fair value adjustment. Deferred consideration payment. Deferred consideration payment issuance of payment consideration. Deferred consideration payment fair value adjustment. Abaca Warrant [Member] Third Anniversary Payment Consideration [Member] Forward Purchase Derivative [Member] Change in fair value of warrant. Amortization of deferred origination fees. Private Warrants [Member] Expected Term [Member] Schedule Of Demonstrates Deposit Capacity [Table Text Block] Derivative liability expected term. Schedule Of Revenue From Operations [Table Text Block] Schedule Of Operating Expense From Operations [Table Text Block] Senior Secured Promissory Note [Member] Securities Issuance Agreement [Member] Schedule of Outstanding Balances from Balance Sheet [Table Text Block] Increase decrease in net deferred indemnified loan origination fees. Commercial Real Estate Loans Receivable [Member] Commercial Real Estate Loans Receivable Current. Commercial Real Estate Loans Receivable Non Current. Allowance for loan and lease losses from cumulative effect. Allowance for loans and lease losses write-offs. Allowance for loan and lease loss recovery of bad debt. Loans and leases receivables gross carrying amount. Deferred consideration payable. Fifty Four Equal Installments [Member] Schedule of Risk Rating [Table Text Block] Indemnification Liability [Text Block] Proceeds from repayments of loans. Unsecured loans and lines of credit. Loss contingency accrual cumulative effect. Loss contingency accrual recoveries. Schedule of Indemnified LoansRisk Rating [Table Text Block] Conversion Preferred [Member] Abaca Acquisition [Member] PCCU Stockholders [Member] Risk Rate Three [Member] Risk Rate Four [Member] Risk Rate Five [Member] Risk Rate Seven [Member] Risk Rate Eight [Member] Company Initial Stockholders [Member] Schedule of Provision for Loan Losses [Table Text Block] Indemnity Liability Segment [Member] Company Public Shares [Member] Schedule Of Current Expected Credit Losses Transition Impact [Table Text Block] Schedule of Lease Cost and Right of Use Assets Related to Lease and Future Minimum Lease Payments. Schedule Of Right Of Use Assets [Table Text Block] Additions to right of use assets Right of use assets lease modifications Net Deferred Loan Origination Fees and Cost [Policy Text Block] Number of warrants. Net deferred loan origination fees and cost [policy text block] Share based payments. Investment hosting fees remit percent. Shares to be issued to acquisition. Percentage of weighted average price. Account hosting expenses. Investment hosting fees. Conversion of preferred stock. Deferred Underwriter Fee [Text Block] Benchmark Investments LLC [Member] Deferred underwriter fee payable noncurrent. Exercise Price One [Member] Exercise Price Two [Member] Exercise Price Three [Member] Exercise Price Four [Member] Share based compensation arrangement by share based payment award equity instruments other than options exercised in period. Share based compensation arrangement by share based payment award equity instruments other than options expired in period weighted average grant date fair value. Share based compensation arrangement by share based payment award equity instruments other than options expried in period. Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date. Capacity at 60% [Member] Capacity at 1.3125 [Member] Assets, Current Assets [Default Label] Liabilities, Current Liabilities [Default Label] Equity, Attributable to Parent Liabilities and Equity ChangeInFairValueOfDeferredConsideration Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Amortization of Deferred Loan Origination Fees, Net Interest Expense, Debt Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Receivable, Related Parties Increase (Decrease) in Contract with Customer, Asset Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accrued Interest Receivable, Net IncreaseDecreaseInDeferredUnderwritingPayable Increase (Decrease) in Other Current Assets Increase (Decrease) in Other Current Liabilities Increase (Decrease) in Accounts Payable, Trade Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability IncreaseDecreaseInNetDeferredIndemnifiedLoanOriginationFees Increase (Decrease) in Security Deposits Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Senior Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations CumulativeEffectFromAdoption DeferredConsiderationDisclosureTextBlock IndemnificationLiabilityTextBlock Lessee, Operating Leases [Text Block] Revenue from Contract with Customer [Text Block] DeferredUnderwriterFeeTextBlock Forward purchase Agreement [Text Block] WarrantLiabilitiesTextBlock Equity [Text Block] Policy Loans Receivable, Policy [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] CommercialRealEstateLoansReceivableGrossAdjustment NotesReceivableNetAdjustment IndemnityLiabilityAdjustment DeferredStockConsideration DeferredCashConsideration DeferredConsiderationPayment DeferredStockConsiderationWorkingCapitalAdjustment DeferredStockConsiderationIssuanceOfPaymentToShareHolders DeferredCashConsiderationIssuanceOfPaymentToShareHolders DeferredStockConsiderationIssuanceOfWarrants DeferredStockConsiderationIssuanceOfPaymentConsideration DeferredConsiderationPaymentIssuanceOfPaymentConsideration DeferredStockConsiderationGainRecognized Financing Receivable, Allowance for Credit Loss AllowanceForLoanAndLeaseLossesFromCumulativeEffect Financing Receivable, Allowance for Credit Loss, Writeoff, after Recovery Financing Receivable, Allowance for Credit Loss, Individually Evaluated Financing Receivable, Allowance for Credit Loss, Collectively Evaluated Loss Contingency Accrual LossContingencyAccrualCumulativeEffect Loss Contingency Accrual, Payments LossContingencyAccrualRecoveries Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Revenues Cash Equivalents, at Carrying Value Lease, Cost Operating Lease, Right-of-Use Asset, Periodic Reduction Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid, Year Five Lessee, Operating Lease, Liability, to be Paid WeightedAverageNumberOfSharesConversionOfPreferredStockDiluted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrants WeightedAverageSharesDilutedSharesToBeIssuedForAcquisition Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Cash and Cash Equivalents, Fair Value Disclosure Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price EX-101.PRE 11 shfs-20240331_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 13, 2024
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 001-40524  
Entity Registrant Name SHF Holdings, Inc.  
Entity Central Index Key 0001854963  
Entity Tax Identification Number 86-2409612  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 1526 Cole Blvd  
Entity Address, Address Line Two Suite 250  
Entity Address, City or Town Golden  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80410  
City Area Code (303)  
Local Phone Number 431-3435  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   55,431,001
Class A Common Stock, $0.0001 par value per share    
Title of 12(b) Security Class A Common Stock, $0.0001 par value per share  
Trading Symbol SHFS  
Security Exchange Name NASDAQ  
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share    
Title of 12(b) Security Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share  
Trading Symbol SHFSW  
Security Exchange Name NASDAQ  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 5,626,362 $ 4,888,769
Prepaid expenses – current portion 506,634 546,437
Accrued interest receivable 16,891 13,780
Short-term loans receivable, net 12,620 12,391
Other current assets 82,657
Total Current Assets 7,427,105 7,761,229
Long-term loans receivable, net 379,863 381,463
Property, plant and equipment, net 45,366 84,220
Operating lease right to use assets 820,777 859,861
Goodwill 6,058,000 6,058,000
Intangible assets, net 3,564,890 3,721,745
Deferred tax asset 44,278,374 43,829,019
Prepaid expenses – long term position 525,000 562,500
Forward purchase receivable 4,584,221 4,584,221
Security deposit 18,875 18,651
Total Assets 67,702,471 67,860,909
Current Liabilities:    
Accrued expenses 645,635 1,008,987
Contract liabilities 2,692 21,922
Lease liabilities – current 142,863 132,546
Senior secured promissory note – current portion 3,028,738 3,006,991
Deferred consideration – current portion 2,921,257 2,889,792
Other current liabilities 62,160 41,639
Total Current Liabilities 7,108,280 7,896,584
Warrant liabilities 2,908,642 4,164,129
Deferred consideration – long term portion 594,000 810,000
Forward purchase derivative liability 7,309,580 7,309,580
Senior secured promissory note—long term portion 10,241,884 11,004,175
Net deferred indemnified loan origination fees 421,907 63,275
Lease liabilities – long term 835,598 875,447
Indemnity liability 1,315,263 1,382,408
Total Liabilities 30,735,154 33,505,598
Commitment and Contingencies (Note 13)
Stockholders’ Equity    
Convertible preferred stock, $.0001 par value, 1,250,000 shares authorized, 111 and 1,101 shares issued and outstanding on March 31, 2024, and December 31, 2023, respectively
Class A common stock, $.0001 par value, 130,000,000 shares authorized, 55,431,001 and 54,563,372 issued and outstanding on March 31, 2024, and December 31, 2023, respectively 5,545 5,458
Additional paid in capital 107,348,166 105,919,674
Retained deficit (70,386,394) (71,569,821)
Total Stockholders’ Equity 36,967,317 34,355,311
Total Liabilities and Stockholders’ Equity 67,702,471 67,860,909
Nonrelated Party [Member]    
Current Assets:    
Accounts receivable 153,208 121,875
Current Liabilities:    
Accounts payable 179,242 217,392
Related Party [Member]    
Current Assets:    
Accounts receivable 1,111,390 2,095,320
Current Liabilities:    
Accounts payable $ 125,693 $ 577,315
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Convertible preferred stock, par value $ 0.0001 $ 0.0001
Convertible preferred stock, shares authorized 1,250,000 1,250,000
Convertible preferred stock, shares issued 111 1,101
Convertible preferred stock, shares outstanding 111 1,101
Class A common stock, par value $ 0.0001 $ 0.0001
Class A common stock, shares authorized 130,000,000 130,000,000
Class A common stock, shares issued 55,431,001 54,563,372
Class A common stock, shares outstanding 55,431,001 54,563,372
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 4,050,799 $ 4,180,379
Operating Expenses    
Compensation and employee benefits 2,280,038 3,659,520
General and administrative expenses 984,220 1,538,874
Professional services 460,950 449,246
Rent expense 69,437 87,742
Provision (benefit) for credit losses (68,787) 66,666
Total operating expenses 3,725,858 5,802,048
Operating income/ (loss) 324,941 (1,621,669)
Other (income) expenses    
Change in the fair value of deferred consideration (184,535) 190,943
Interest expense 154,172 643,260
Change in fair value of warrant liabilities (1,255,487) (433,148)
Total other (income)/ expenses (1,285,850) 401,055
Net income/ (loss) before income tax 1,610,791 (2,022,724)
Income tax benefit 438,885 609,277
Net income/ (loss) $ 2,049,676 $ (1,413,447)
Weighted average shares outstanding, basic 55,213,609 25,670,730
Basic net income/ (loss) per share $ 0.04 $ (0.06)
Weighted average shares outstanding, diluted 56,268,075 25,670,730
Diluted income/ (loss) per share $ 0.04 $ (0.06)
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Common Class A [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 1 $ 2,374 $ 44,806,031 $ (39,695,281) $ 5,113,125
Balance, shares at Dec. 31, 2022 14,616 23,732,889      
Conversion of PIPE shares $ 473 5,004,727 (5,005,200)
Conversion of PIPE shares, shares (3,720) 4,726,200      
Net loss (1,413,447) (1,413,447)
Cumulative effect from adoption of CECL (581,321) (581,321)
Stock option conversion $ 62 1,570,719 1,570,781
Stock option conversion, shares   629,728      
Issuance of shares to PCCU (net of tax) $ 1,120 38,405,288 38,406,408
Issuance of shares to PCCU (net of tax), shares   11,200,000      
Reversal of deferred underwriting cost 900,500 900,500
Balance at Mar. 31, 2023 $ 1 $ 4,029 90,687,265 (46,695,249) 43,996,046
Balance, shares at Mar. 31, 2023 10,896 40,288,817      
Balance at Dec. 31, 2023 $ 5,458 105,919,674 (71,569,821) 34,355,311
Balance, shares at Dec. 31, 2023 1,101 54,563,372      
Conversion of PIPE shares $ 79 866,170 (866,249)
Conversion of PIPE shares, shares (990) 792,000      
Restricted stock units (net of tax) $ 8 (14,325) (14,317)
Restricted stock units (net of tax), shares   75,629      
Stock compensation cost 576,647 576,647
Net loss 2,049,676 2,049,676
Balance at Mar. 31, 2024 $ 5,545 $ 107,348,166 $ (70,386,394) $ 36,967,317
Balance, shares at Mar. 31, 2024 111 55,431,001      
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income/ (loss) $ 2,049,676 $ (1,413,447)
Adjustments to reconcile net income/ (loss) to net cash provided by/ (used in) operating activities:    
Depreciation and amortization expense 195,709 751,225
Stock compensation expense 562,330 1,570,781
Amortization of deferred origination fees (27,970) (14,104)
Interest expense 873,289
(Benefit)/ provision for credit losses (68,787) 66,666
Amortization of right of use assets 9,552 17,762
Income tax benefit (438,885) (609,277)
Change in the fair value of deferred consideration (184,535) 190,943
Change in fair value of warrant (1,255,487) (433,148)
Changes in operating assets and liabilities:    
Accounts receivable – Trade (31,333) (30,716)
Accounts receivable – related party 983,930 182,824
Contract assets (13,019)
Prepaid expenses 77,303 77,436
Accrued interest receivable (3,111) (146,106)
Deferred underwriting payable (550,000)
Other current assets 82,657 150,817
Other current liabilities 10,048 75,000
Accounts payable (38,153) (533,945)
Accounts Payable – related party (451,622) (65,288)
Accrued expenses (363,347) (466,849)
Contract liabilities (19,230) 78,616
Net deferred indemnified loan origination fees 386,602 8,500
Security deposit (224)
Net cash provided by (used in) operating activities 1,475,123 (232,040)
CASH FLOWS PROVIDED BY INVESTING ACTIVITIES:    
Purchase of property and equipment (548,671)
Net repayment of loans 3,014 1,019,268
Net cash provided by investing activities 3,014 470,597
CASH FLOWS USED IN FINANCING ACTIVITIES:    
Repayment of senior secured promissory note (740,544)
Net cash used in financing activities (740,544)
Net increase in cash and cash equivalents 737,593 238,557
Cash and cash equivalents – beginning of period 4,888,769 8,390,195
Cash and cash equivalents – end of period 5,626,362 8,628,752
Supplemental disclosure of cash flow information    
Interest paid 156,414
Non-Cash transactions:    
Shares issued for the settlement of PCCU debt obligation 38,406,408
Cumulative effect from adoption of CECL $ 581,321
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Organization and Business Operations
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Organization and Business Operations

Note 1. Organization and Business Operations

 

Business Description

 

SHF Holdings, Inc. (the “Company”) originated as business operations conducted through Partner Colorado Credit Union (“PCCU”), which were transferred to SHF LLC (“SHF”), then an indirect wholly owned subsidiary of PCCU. The Company completed a strategic reorganization on July 1, 2021. This involved transferring select assets and operational activities from Partner Colorado Credit Union (“PCCU”) and its wholly owned subsidiary, Safe Harbor Services, to SHF Holding Co., LLC. Subsequently, these were consolidated into SHF, LLC (“SHF”), with PCCU’s investment managed at the SHF Holding Co., LLC level.

 

On September 28, 2022, the Company concluded a transaction wherein NLIT (“Northern Lights Acquisition Corp.”) acquired all outstanding membership interests of SHF. This acquisition prompted the renaming of NLIT to SHF Holdings, Inc. As a result, PCCU emerged as the largest shareholder of the Company.

 

The Company executed the Abaca Merger Agreement on October 31, 2022, facilitating a two-step merger through which Rockview Digital Solutions, Inc. (“Abaca”) became a direct wholly-owned subsidiary. The transaction expanded the Company’s fintech capabilities and market reach.

 

The Company generates fee income, investment income and loan interest income through providing a variety of services to financial institutions desiring to service the cannabis industry including, among other things, the origination, onboarding, and servicing of cannabis-related deposit business for and on behalf of those partner institutions; Bank Secrecy Act and other regulatory compliance and reporting related to these accounts; onboarding these accounts and responding to account and customer service inquiries; and sourcing, underwriting, and servicing, and administering loans issued to cannabis businesses and related entities. In addition, the Company provides these services to financial institutions under a Safe Harbor Master Program Agreement.

 

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basis of Presentation and Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies

Note 2. Basis of Presentation and Summary of Significant Accounting Policies

 

i. Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the “SEC”).

 

The accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary to state fairly the consolidated financial condition, results of operations, statements of shareholders’ equity, and cash flows of the Company for the interim periods presented. Except as otherwise disclosed, all such adjustments consist only of those of a normal recurring nature. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results that may be expected for the current year ending December 31, 2024. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the years ended December 31, 2023, included in the Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”).

 

The company has made certain immaterial reclassifications to the statements of operations for the three months ended March 31, 2023, to conform to the presentation for the three months ended March 31, 2024. These reclassifications, totaling $190,943, were moved from ‘Interest Expense’ to ‘Change in the Fair Value of Deferred Consideration’. Corresponding adjustments have been made to the statement of cash flows and the applicable notes to the unaudited condensed consolidated financial statements.

 

The condensed consolidated financial statements include the accounts of SHF Holdings, Inc., its subsidiaries where we have controlling financial interests. All intercompany balances and transactions have been eliminated.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC and the instructions to Form 10-Q.

 

 

ii. Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Material estimates that are particularly subject to change in the near term include the determination of the allowance for credit losses, indemnification liabilities, useful lives of intangibles and the fair value of financial instruments. Actual results could differ from the estimates.

 

iii. Liquidity and Going Concern

 

As of March 31, 2024, the Company had $5,626,362 in cash and net working capital of $318,825, as compared to $4,888,769 in cash and net working capital deficit of $135,355 as of December 31, 2023. The retained deficit was $70,386,394 on March 31, 2024, and $71,569,821 on December 31, 2023. The Company has also generated operating income of $324,941 for the period ended March 31, 2024.

 

For the period ending March 31, 2024, the Company reported positive operating income and net working capital. However, considering the historical data, where the Company experienced negative operating income and negative net working capital, management acknowledges the need to closely evaluate the financial performance in upcoming quarters to mitigate any going concern risks. As of March 31, 2024, due to these historical trends, there is substantial doubt about the Company’s ability to continue as a going concern for at least twelve months from the date these condensed unaudited consolidated financial statements were issued.

 

If the Company is not able to sustain its present level of operations, it may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned expansion programs. Any of these actions could materially harm the Company’s business, results of operations and future prospects.

 

The accompanying condensed unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result should the Company not continue as a going concern as a result of this uncertainty.

 

iv. Cash and Cash Equivalents

 

Cash and cash equivalents include cash on hand, amounts due from financial institutions, and investments with maturities of three months or less.

 

v. Concentrations of Risk

 

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash. Cash balances are maintained substantially in accounts at Partner Colorado Credit Union (“PCCU”) which is insured by the National Credit Union Share Insurance Fund (“NCUSIF”) up to regulatory limits. From time to time, cash balances may exceed the NCUSIF insurance limit. The Company has not experienced any credit losses associated with its cash balances in the past.

 

Currently the Company only services the cannabis industry. Cannabis remains illegal under federal law, and therefore, strict enforcement of federal laws regarding cannabis would likely result in our inability to execute our business plan.

 

Currently the Company substantially relies on PCCU to hold customer deposits and fund its originated loans. As of this time, majority all of the Company’s revenue is generated by deposits and loans hosted by its PCCU pursuant to various services agreements.

 

The Company had only one loan on its balance sheet as of March 31, 2024, which comprises 100% of the total loan balance. The Company also indemnified 21 loans as of March 31, 2024; three of these indemnified loans were in excess of 10% of the total balance.

 

vi. Accounts Receivable

 

Accounts receivable are recorded based on account fee schedules. While fees are generated from accounts for individual cannabis-related businesses (“CRB”) related accounts, amounts are initially collected by the financial institutional partners and remitted in the subsequent month. Accounts receivable - related party represents amounts due from PCCU under related party contracts disclosed in Note 8 to the unaudited condensed consolidated financial statements.

 

 

vii. Loans Receivable

 

CRB loans that significantly support the Company’s operations are recognized as assets on the balance sheet. These loans, intended to be held either for the foreseeable future or until their maturity or full repayment, are recorded at their outstanding principal balance. This amount is adjusted for any credit loss allowances and net of any deferred loan origination fees and costs, as applicable, to reflect the net investment in these loans. The Company recognizes interest income on CRB Loans over the loan term using the simple-interest method based on outstanding principal amounts. This approach ensures a systematic recognition of income, aligning with the time value of money principle.

 

Interest income recognition is suspended when there is uncertainty regarding full loan repayment, such as in cases of loan impairment or when payments are overdue by ninety days or more. Loans under these conditions are placed on nonaccrual status. Any accrued interest not received by the time a loan is placed on nonaccrual is reversed from interest income. Subsequent interest payments on nonaccrual loans are recorded using either the cash basis or the cost recovery method until the loan meets the criteria for reclassification to accrual status.

 

Loans are returned to accrual status when they become current (less than ninety days past due) and when there is reasonable assurance of future payment compliance, evidenced by the full satisfaction of both principal and interest payments due.

 

Loans are assessed individually for potential charge-off, which typically occurs at the point of foreclosure. Charge offs are executed to reflect the realizable value of loans that are deemed uncollectible.

 

The determination of a loan’s past-due status is based on its contractual repayment terms. Loans are either placed on nonaccrual status or charged-off ahead of their contractual delinquency dates if the collection of principal and interest is deemed doubtful, ceasing the recognition of interest income on such loans.

 

viii. Allowance for Credit Losses (ACL)

 

The Company has adopted Accounting Standards Codification Topic 326 - Financial Instruments - Credit Losses (ASC Topic 326), for estimation of probable credit losses with an expected credit loss methodology that is referred to as the current expected credit loss (“CECL”) methodology.

 

The ACL is a valuation account that is deducted from the amortized cost basis of financial assets carried at their amortized cost, including loans held for investment, to present the net amount that is expected to be collected throughout the life of the financial asset. The estimated ACL is recorded through a provision for credit losses charged against operations. Management periodically evaluates the adequacy of the ACL to maintain it at a level it believes to be reasonable. The Company uses the same methods used to determine the ACL to assess any reserves needed for off-balance sheet credit risks such as unfunded loan commitments including Indemnified loans to PCCU. These reserves for off-balance sheet credit risks are presented in the liabilities section in the unaudited condensed consolidated balance sheets as an “Indemnity liability.”

 

The ACL consists of two components: an asset-specific component for estimating credit losses for individual loans that do not share similar risk characteristics with other loans; and a pooled component for estimating credit losses for pools of loans that share similar risk characteristics. The ACL for the pooled component is derived from an estimate of expected credit losses primarily using an expected loss methodology that incorporates risk parameters such as probability of default (“PD”) and loss given default (“LGD”) which are derived from various vendor models and/or internally developed model estimation approaches for smaller homogenous loans.

 

The PD is quantified by analyzing historical data to determine the rate at which loans have defaulted within the portfolio, relative to the total outstanding loans as of the end of the reporting period. This rate is expressed as a percentage and serves as a key indicator of the likelihood of default across the loan pool. LGD assessments are conducted to estimate the potential loss amount in the event of a default, considering the recoverable value from the collateral liquidation against the remaining loan balance. This involves a detailed analysis of two primary components: the loss on principal, which arises from the gap between the collateral’s liquidation value and the unpaid principal balance of the loan; and the loss associated with various ancillary costs to recover, including, but not limited to, foregone interest, transaction costs, legal and administrative fees, and expenses related to the maintenance and renovation of the property. The Company considers relevant current conditions and reasonable and supportable forecasts that relate to its lending practices and environment and the specific borrower and determines that the significant factor affecting the loan’s performance is the fact that these borrowers are involved in the cannabis business. Despite being legal at the state level in certain jurisdictions, cannabis remains federally illegal in the United States as of the date of this filing. As cannabis related lending is a new practice in the United States, there is very little historical or industry data on which to base a loss forecast. Therefore, significant judgement is required in creating a reasonable loss estimate, using similar non-MRB loans as a baseline and adjusting for the inherent risks in the cannabis industry. While the Company considers other qualitative factors, including national macroeconomic conditions, in its overall risk analysis, it has determined that they are not significant inputs to the overall loss estimate calculations.

 

 

The ACL estimation process also applies an economic forecast scenario, or a composite of scenarios based on management’s judgment and expectations around the current and future macroeconomic outlook. Expected credit losses are estimated over the contractual term of the loans, adjusted for expected prepayments when appropriate. The contractual term of a loan excludes expected extensions, renewals, and modification under certain conditions.

 

Recoveries on loans represent collections received on amounts that were previously charged off against the ACL. Recoveries are credited to the ACL when received, to the extent of the amount previously charged off against the ACL on the related loan. Any amounts collected in excess of this limit are first recognized as interest income, then as a reduction of collection costs, and then as other income.

 

ix. Net Deferred Loan Origination Fees and Cost

 

When included with a new loan origination, the Company receives loan origination fees in conjunction with new loans funded and any indemnified liabilities which are not recorded on the balance sheet from the company financial institution partners. Where applicable, the loan origination fee is netted with loan origination costs associated with originating a specific loan. These loan origination costs are typically incremental direct costs (non-reimbursed) paid to third parties. Net loan origination fees are initially deferred and presented net of loans receivable asset for portfolio loans, or as a separate liability for indemnified loans, and recognized as interest income utilizing the interest method.

 

x. Indemnity Liability

 

Under the Loan Servicing Agreement and Commercial Alliance Agreement with PCCU, the Company had agreed to indemnify PCCU from all claims related to Company’s cannabis-related business, including but not limited to default-related credit losses as defined in the Loan Servicing Agreement. The indemnification component of the Loan Servicing Agreement and the Commercial Alliance Agreement (refer to Note 8 to the unaudited condensed consolidated financial statements) is accounted for in accordance with accounting standards codification (“ASC”) 460 Guarantees. In determining the applicability of ASC 460, the Company considered that the agreement outlines a broad indemnification of all claims related to the cannabis-related business. The most immediate and potentially significant of these are potential default-related credit losses. In the lending industry, it is inherently anticipated future credit losses will result from currently issued debt. The Company’s indemnity obligation is subordinate to financial institution clients’ other means of collecting on the loans including foreclosure of the collateral, recourse against personal and/or corporate guarantors and other default remedies available in the loan agreements. Since borrowers are not party to the agreement between Company and PCCU, any indemnity payments do not relieve borrowers of their obligation to PCCU nor would such payments preclude PCCU’s right to future recoveries from the debtor. Therefore, as defined in ASC 460, the indemnification clause represents a general loss contingency in that it is an existing condition, situation or set of circumstances involving uncertainty as to possible loss to the Company that will ultimately be resolved when one or more future events occur or fail to occur. SHF’s indemnity liability reflects SHF management’s estimate of probable credit losses inherent under the agreement at the balance sheet date. The liability is measured and recognized in accordance with our accounting policies for ACL and ALL.

 

In addition to default-related credit losses, the Company continuously monitors all other circumstances pursuant to the agreement and identifies events that may necessitate a loss contingency under the Loan Servicing Agreement. A loss contingency is reported when it is both probable that a future event will confirm that a loss had been incurred on or before the related balance sheet date and the loss is reasonably estimable.

 

xi. Property and Equipment, net

 

Property and equipment are recorded at historical cost, net of accumulated depreciation. Depreciation is provided over the assets’ useful lives on a straight-line basis 3-5 years for equipment and furniture and fixtures. Repairs and maintenance costs are expensed as incurred.

 

Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.

 

The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.

 

The Company capitalize certain costs related to software developed for internal-use, primarily associated with the ongoing development and enhancement of our technology platform. Costs incurred in the preliminary development and post-development stages are expensed. These costs are amortized on a straight-line basis over the estimated useful life of the related asset, generally five years.

 

 

xii. Right of Use Assets and Lease Liabilities

 

The Company has entered into lease agreements for a certain facility and certain items of equipment, which provide the right to use the underlying asset and require lease payments over the term of the lease. At inception of the lease agreement, the Company assesses whether the agreement conveys the right to control the use of an identified asset for a period in exchange for consideration, in which case it is classified as a lease. Each lease is further analyzed to check whether it meets the classification criteria of a finance or operating lease. All identified leases are recorded on the consolidated balance sheet with a corresponding lease right-of-use asset, net, representing the right to use the underlying asset for the lease term and the operating lease liabilities representing the obligation to make lease payments arising from the lease. The Company has elected not to recognize lease assets and lease liabilities for short-term leases (leases with a term of 12 months or less) and leases of low-value assets. Lease right-of-use assets, net and lease liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term and include options to extend or terminate the lease when they are reasonably certain to be exercised. The present value of lease payments is determined primarily using the incremental borrowing rate based on the information available as of the lease commencement date.

 

Lease expense for operating leases is recorded on a straight-line basis over the lease term and variable lease costs are recorded as incurred. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. Finance lease interest expense is recognized based on an effective interest method and depreciation of assets is recorded on a straight-line basis over the shorter of the lease term and useful life of the asset. Both operating and finance lease right of use assets are reviewed for impairment, consistent with other finite-lived assets, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. After a right of use asset is impaired, any remaining balance of the asset is amortized on a straight-line basis over the shorter of the remaining lease term or the estimated useful life.

 

xiii. Goodwill and Other Intangible Assets

 

The Company’s methodology for allocating the purchase price of an acquisition is based on established valuation techniques that reflect the consideration of a number of factors, including a valuation performed by a third-party appraiser. Goodwill is measured as the excess of the cost of an acquired business over the fair value assigned to identifiable assets acquired and liabilities assumed.

 

Goodwill is tested for impairment at least annually on the elected impairment test date of December 31 unless any events or circumstances indicate it is more likely than not that the fair value of the goodwill is less than its carrying value.

 

Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.

 

Finite-lived intangible assets are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. Intangible assets should be tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.

 

xiv. Stock-based Compensation

 

The Company measures all equity-based payment arrangements to employees and directors in accordance with ASC 718, Compensation–Stock Compensation. The Company’s stock-based compensation cost is measured based on the fair value at the grant date of the stock-based award. It is recognized as expense on a straight-line basis over the requisite service period for the entire award. Forfeitures are recognized as they occur. The Company estimates the fair value of each stock-based award on its measurement date using either the current market price of the stock or Black-Scholes option valuation model, whichever is most appropriate. The Black-Scholes valuation model incorporates assumptions such as expected term of the instrument, volatility of the Company’s future share price, risk free rates, future dividend yields and estimated forfeitures at the initial grant date, by reference to the underlying terms of the instrument, and the Company’s experience with similar instruments. Changes in assumptions used to estimate fair value could result in materially different results.

 

The shares of the Company have been listed on the Nasdaq stock exchange for a limited period of the time and also the stock price has dropped significantly from the date of listing, based on which the Company has considered the expected volatility at 100% for the purpose of stock compensation. The risk-free interest rates are based on quoted U.S. Treasury rates for securities with maturities approximating the awards’ expected lives. The expected term of the options granted is calculated based on the simplified method by taking average of contractual term and vesting period the awards. The expected dividend yield is zero as the Company has never paid dividends and does not currently anticipate paying any in the foreseeable future.

 

 

xv. Fair Value Measurements

 

The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:

 

Level 1 — Quoted prices for identical assets or liabilities in active markets.

 

Level 2 — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 —Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.

 

xvi. Revenue Recognition

 

SHF recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which SHF expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.

 

Revenue is recorded at a point in time when the performance obligation is satisfied, and no contingencies exist. Majority of the revenue consists of fees earned on deposit accounts held at PCCU but serviced by SHF such as bank account charges, onboarding income, account activity fee income and other miscellaneous fees. Under the terms of the Loan Servicing Agreement and the Commercial Alliance Agreement, the Company is responsible for covering account hosting costs associated with the fees generated from deposits held at PCCU. These costs are classified as “General and Administrative Expenses” in the Consolidated Statements of Operations.

 

In addition, SHF recognizes revenue from the Master Program Agreement. The Master Program Agreement is a non-exclusive and non-transferable right to implement and utilize the Safe Harbor Program. The Safe Harbor Program has two performance obligations; an implementation fee recognized when the contract is effective and a service fee recognized ratable over the contract term as the compliance program is executed.

 

SHF recognizes revenue from interest on loans and investment income distributed by PCCU, which is determined by particular customer account balances. As per the Loan Servicing Agreement and the Commercial Alliance Agreement, SHF bears the expenses for hosting investments and servicing loans related to this interest and investment income. These expenses are allocated to “General and Administrative Expenses” in the Consolidated Statements of Operations.

 

Amounts received in advance of the service being provided is recorded as a liability under deferred revenue on the consolidated balance sheets. Typical Safe Harbor Program contracts are three-year contracts with amounts due monthly, quarterly or annually based on contract terms.

 

Customers consist of financial institutions providing services to CRBs. Revenues are concentrated in the United States of America.

 

xvii. Contract Liabilities

 

The Company recognizes a contract liability if the customer’s payment of consideration precedes the reporting entity’s performance. As of March 31, 2024, the Company recorded contract liabilities amounting to $2,692 from contracts with customers. This compares to contract liabilities of $21,922 as reported on December 31, 2023.

 

 

xviii. Warrants Liabilities

 

The Company has evaluated each of the warrant arrangements separately in accordance with “Distinguishing Liabilities from Equity” (“ASC 480”) and “Derivatives and Hedging” (“ASC 815”), to determine classification as either equity instruments or liabilities based on the specific terms and features of each warrant. Warrants are recognized as equity if they are indexed to our own stock and meet the equity classification criteria in ASC 815-40. These warrants are recorded within stockholders’ equity at their issuance date and are not subsequently remeasured at fair value. Conversely, warrants that do not meet the criteria for equity classification under ASC 815-40 are classified as liabilities. Such warrants are initially recorded at fair value on the issuance date and are subject to remeasurement at each balance sheet date thereafter. Any changes in fair value are recognized in the statement of operations. None of our warrant contracts met criteria to be considered indexed to their own stock, and as a result, have each been accounted for as a liability financial instrument. The fair value of warrants classified as liabilities is determined using appropriate valuation models, such as the Black- Scholes model, which incorporates various inputs, including the current stock price, expected volatility, risk-free interest rate, and the expected term of the warrants.

 

xix. Deferred consideration

 

In line with ASC Topic 815, the Company treats the deferred consideration from the Abaca acquisition as a derivative liability, since it does not fulfill the equity classification criteria. As a result, this obligation is recognized as a liability on the balance sheet at fair value and is adjusted to reflect its fair value at the end of each reporting period. The liability will be reassessed at fair value on every balance sheet date until the obligation’s term concludes. Fluctuations in its fair value are recorded in the consolidated statements of operations.

 

xx. Forward purchase derivative

 

The Company accounts for the forward purchase derivative assumed in the business combination in accordance with the guidance contained in ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company classifies the forward purchase derivatives as an assets or liabilities carried at their fair value and adjusts the forward purchase derivatives to fair value at each reporting period. This derivative asset or liability is subject to re-measurement at each balance sheet date until the conditions under the forward purchase agreement are exercised or expire, and any change in fair value is recognized in the unaudited condensed consolidated statement of operations. In December 2023, the company calculated its valuation using a Monte Carlo Simulation set within a risk-neutral environment. Initiated in December 2022, this strategy was applied to assess the fair value of the forward purchase agreement (FPA) derivatives, with an underlying assumption that future stock prices would adhere to a Geometric Brownian Motion trajectory. Throughout the first quarter of 2024, there were no transactions by FPA holders, and no considerable shifts in risk factors that could influence the valuation of FPA derivatives were observed.

 

xxi. Earnings Per Share

 

Basic and diluted earnings per share are computed and disclosed in accordance with ASC Topic 260, Earnings Per Shares. The Company utilizes the two-class method to compute earnings available to common shareholders. Under the two-class method, earnings are adjusted by accretion amounts to redeemable noncontrolling interests recorded at redemption value. The adjustments represent dividend distributions, in substance, to the noncontrolling interest holder as the holders have contractual rights to receive an amount upon redemption other than the fair value of the applicable shares. As a result, earnings are adjusted to reflect this in substance distribution that is different from other common shareholders. In addition, the Company allocates net earnings to each class of common stock and participating security as if all of the net earnings for the period had been distributed. The Company’s participating securities consist of share-based payment awards that contain a non-forfeitable right to receive dividends and therefore are considered to participate in undistributed earnings with common shareholders. Basic earnings per common share excludes dilution and is calculated by dividing net earnings allocated to common shares by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is calculated by dividing net earnings allocable to common shares by the weighted-average number of common shares outstanding for the period, as adjusted for the potential dilutive effect of non-participating share-based awards.

 

xxii. Income Tax

 

Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred tax assets and liabilities are adjusted through the provision for income taxes as changes in tax laws or rates are enacted.

 

 

ASC 740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods. If management is unable to estimate a portion of its ordinary income, but is otherwise able to reliably estimate the remainder, ASC 740-270-25-3 provides that the tax applicable to that item be reported in the interim period in which the item occurs. The tax (or benefit) related to ordinary income (or loss) shall be computed at an estimated annual effective tax rate and the tax (or benefit) related to all other items shall be individually computed and recognized when the items occur. Management is unable to estimate a portion of its ordinary income and as a result had computed the company’s tax provision in accordance with ASC 740-270-25-3.

 

ASC Topic 740 also prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

xxiii. Recently Issued Accounting Standards

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position or results of operations upon adoption.

 

Adopted Standards

 

Current Expected Credit Losses

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduces a model based on expected losses to estimate credit losses for most financial assets and certain other instruments. In November 2019, the FASB issued ASU No. 2019-10 Financial Instruments — Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). The update allows the extension of the initial effective date for entities which have not yet adopted ASU No. 2016-02. The standard is effective for annual reporting periods beginning after December 15, 2022 for private companies and SEC filers classified as smaller reporting entities, with early adoption permitted. Entities apply the standard’s provisions by recording a cumulative effect adjustment to retained deficit. The Company has adopted ASU 2016-13 as of January 1, 2023, utilizing the modified retrospective method.

 

CECL Transition Impact: The table below provides details on the transition impacts of adopting CECL. Other balance sheet lines not presented were not affected by CECL.

 

CECL Transition Impact:

 

Assets   December 31,
2022
    Transition
Adjustment
    January 1,
2023
 
Loans receivable, gross   $ 1,432,560     $ -     $ 1,432,560  
Less: Allowance for credit loss     (21,488 )     (14,980 )     (36,468 )
    $ 14,11,072     $ (14,980 )   $ 1,396,092  

 

Liabilities & Equity  December 31,
2022
   Transition
Adjustment
   January 1,
2023
 
Indemnity liability  $499,465   $566,341   $1,065,806 
Retained deficit   (39,695,281)   (581,321)   (40,276,602)
   $(39,195,816)  $(14,980)  $(39,210,796)

 

Troubled Debt Restructurings and Vintage Disclosures

 

This Accounting Standard Update (ASU 2022-02) eliminates the recognition and measurement guidance on troubled debt restructurings for creditors that have adopted ASC 326 and requires them to make enhanced disclosures about loan modifications for borrowers experiencing financial difficulty. The new guidance also requires public business entities to present current period gross write-offs (on a current year-to-date basis for interim-period disclosures) by year of origination in their vintage disclosures. For entities that have adopted ASU 2016-13, this ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2023 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

 

Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions

 

This Accounting Standard Update (ASU 2022-03) clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered when measuring fair value. Recognizing a contractual restriction on the sale of an equity security as a separate unit of account is not permitted. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2024 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848

 

This Accounting Standard Update (ASU 2022-06) defers the Sunset Date of ASC Topic 848, Reference Rate Reform (Topic 848), which provides temporary optional relief in accounting for the impact of Reference Rate Reform. This ASU is effective upon issuance (December 21, 2022) and generally can be applied through December 31, 2024.This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

Investments-Equity Method and Joint Ventures

 

In March 2023, the FASB issued ASU 2023-02, Investments-Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures using the Proportional Amortization Method. The FASB issued final guidance allowing entities to apply the proportional amortization method to equity investments in all tax credit programs that meet the conditions in ASC 323-740, rather than just investments in qualified affordable projects that generate low income housing tax credits, as was required under the legacy guidance. The guidance is effective for public business entities for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

Standards Pending to be Adopted

 

Business Combinations-Joint Venture Formations

 

In August 2023, the FASB issued 2023-05, Business Combinations-Joint Venture Formations (Subtopic 805-60); Recognition and Initial Measurement. This ASU contains guidance requiring certain joint ventures to apply a new basis of accounting upon formation by recognizing and initially measuring most of their assets and liabilities at fair value. This guidance is effective for all joint venture formations with a formation date on or after January 1, 2025. Early adoption is permitted. Joint Ventures formed before the effective date have the option to apply it retrospectively, while those formed after the effective date are required to apply it prospectively. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.”

 

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ASU amends the disclosure or presentation requirements related to various subtopics in the FASB codification.

 

The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. For all other entities, the amendments will be effective two years later. The amendments in this Update should be applied prospectively. For all entities, if by June 30, 2027, the SEC has not removed the applicable requirement from Regulation S-X or Regulation S-K, the pending content of the related amendment will be removed from the Codification and will not become effective for any entity. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

Segment Reporting

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280). This ASU requires public entities to provide disclosures of significant segment expenses and other segment items. It also requires public entities to provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Public entities with a single reportable segment will have to provide all the disclosures required by ASC 280, including the significant segment expense disclosures. This guidance is applied retrospectively to all periods presented, unless it is impractical. This ASU applies to all public entities and is effective for fiscal years beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

 

Income Taxes

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This ASU requires public business entities to disclose in their rate reconciliation table additional categories of information about income taxes paid, including certain disclosures that would be disaggregated by jurisdiction and other categories. This ASU is effective for fiscal years after December 15, 2024. Early adoption would be permitted. The Company does not expect this ASU to have a material impact on its condensed unaudited consolidated financial statements.

 

ASU 2024-01: Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards

 

ASU 2024-01 clarifies the scope applications of profits interest awards by adding illustrative guidance to ASC 718 “Compensation-Stock Compensation.” The amendments in the ASU apply to all reporting entities that account for profits interest awards as compensation to employees or non-employees in return for goods or services.

 

The term “profits interest” is not explicitly defined in US GAAP. Rather, an IRS Revenue Procedure (Rev Proc 93-27) defines a “Profits Interest” as a “partnership interest other than a capital interest.” Unlike a capital interest, which provides rights to existing net assets of an entity, a profits interest only provides rights to future profits and/or equity appreciation of an entity. This distinction, along with other terms, conditions and characteristics of profits interests often complicates accounting decisions for profits interests, leading to diversity in practice whether to account for profits interests under ASC 718 or other US GAAP.

 

The ASU introduces four (4) illustrative examples of fact patterns that demonstrate how an entity would apply the scope guidance in paragraph 718-10-15-3 to a profits interest or similar award with certain features.

 

The ASUs are effective for public entities for fiscal years beginning after December 15, 2024, including interim periods within those years. For all other entities, adoption is required for fiscal years beginning after December 15, 2025. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

ASU 2024-02: Codification Improvements—Amendments to Remove References to the Concepts Statements

 

The ASU contains amendments to the Codification that remove references to various FASB Concepts Statements. The Board has a standing project on its agenda to address suggestions received from stakeholders on the Accounting Standards Codification and other incremental improvements to GAAP. This effort facilitates Codification updates for technical corrections such as conforming amendments, clarifications to guidance, simplifications to wording or the structure of guidance and other minor improvements. In the Board’s view, removing all references to Concept Statements in the guidance will simplify the codification and draw a distinction between authoritative and non-authoritative literature.

 

The amendments in the Update are effective for public business entities for fiscal years beginning after December 15, 2024. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2025. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Deferred Consideration
3 Months Ended
Mar. 31, 2024
Deferred Consideration  
Deferred Consideration

Note 3. Deferred Consideration

 

Under the revised Abaca Merger Agreement, the Company compensated Abaca with $30 million through a mix of cash and stock. The payment structure included $9 million in cash, distributed in three equal installments, with the first installment occurring at the merger closing and the other installments being paid on the first and second anniversaries of the merger closing. Additionally, the common stock consideration was settled through 2,100,000 shares which represented a monetary equivalent calculated against the closing trading price, alongside deferred stock consideration calculated with a 10-day VWAP formula. Adjustments were made via amendments to redefine the terms and conditions of the deferred stock and cash considerations.

 

The revised terms, as of the second amendment on October 26, 2023, stipulated new deferred stock consideration of 5,835,822 shares of Class A common stock issued at the first anniversary based on a recalculated value of $2.00 per share. No changes affected the scheduled cash payments. Furthermore, a third-anniversary consideration of $1.5 million was introduced, payable in cash or stock at the Company’s discretion, alongside an issue of 5 million stock warrants at an exercise price of $2.00 each. The adjustments and additional considerations have been valued and recorded according to ASC 815, reflecting changes in the fair value of deferred consideration in the consolidated statements of operations for the periods ending December 31, 2023.

 

 

The change in the amount of deferred consideration from January 1, 2023, to March 31, 2024, is as follows:

 

   Stock
consideration
   Cash
consideration
   Third Anniversary
Consideration Payment
 
January 1, 2023  $11,456,639   $5,650,775   $- 
Less: Working capital adjustment   (108,691)   -    - 
Less: Issuance of shares and payment to shareholders   (4,085,075)   (3,000,000)   - 
Less: Issuance of Abaca warrants   (1,643,699)   -    - 
Less: Issuance of third anniversary payment consideration   (430,000)   -    430,000 
Less: Gain recognized in the consolidated statements of operations   (5,645,107)   -    - 
Add: Fair value adjustment   455,933    239,017    380,000 
December 31, 2023   -    2,889,792    810,000 
Add: Fair value adjustment   -    31,465    (216,000)
March 31, 2024  $-   $2,921,257   $594,000 

 

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Finite-lived Intangible Assets
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Finite-lived Intangible Assets

Note 4. Goodwill and Finite-lived Intangible Assets

 

The Company’s goodwill was derived from the Abaca acquisition transaction executed on November 15, 2022, where the purchase price exceeded the fair value of the net identifiable assets acquired. Goodwill is tested for impairment at least annually, or more frequently if a triggering event occurs.

 

In 2023, the Company conducted an interim impairment assessment on June 30, 2023, and found that the carrying value of goodwill exceeded its fair value, leading to the recognition of a $13.21 million non-cash goodwill impairment charge in the Company’s consolidated statements of operations. The December 31, 2023, annual impairment test resulted in no additional impairment change recognized, as the fair value did not surpass the carrying value. As of March 31, 2024, and December 31, 2023, the carrying value of the company’s goodwill was $6,058,000.

 

As of March 31, 2024, the Company has not conducted an interim impairment assessment of its assets, due to the absence of any triggering events. Therefore, no additional impairment charges have been recognized in this reporting period.

 

As of March 31, 2024, and December 31, 2023, the Company’s accumulated goodwill impairment was $13,208,276.

 

Finite-lived intangible assets

 

The Company reviews its finite-lived intangible assets for impairment at least annually on December 31st unless any events or circumstances indicate it is more likely than not that the fair value of the finite-lived intangible assets is less than its carrying value.

 

In 2023, following a triggering event in the second quarter, the Company performed an interim goodwill analysis. In accordance with our established policy, an annual review was also conducted on December 31, 2023. The finite-lived intangible assets evaluated include market-related intangibles, customer relationships, and developed technologies. The interim analysis resulted in an impairment charge of $3,680,463, attributed to the carrying values of market-related intangibles and customer relationships surpassing their fair values. The annual review further identified an impairment charge of $2,019,000 related to developed technologies.

 

As of March 31, 2024, the Company has not conducted an interim impairment assessment of its assets, due to the absence of any triggering events. Therefore, no additional impairment changes have been recognized in this reporting period.

 

 

Following is a summary of the Company’s finite-lived intangible assets as of March 31, 2024 and December 31, 2023:

 

   Remaining
Useful life in
Years
  December 31, 2023
(A)
   Acquired in
Acquisition
(B)
   Amortization
(C)
   Impairment
(D)
   March 31, 2024
(A+B-C-D)
 
Market related intangible assets  6.62 Years  $65,216   $-   $2,540   $-   $62,676 
Customer relationships  8.62 Years   56,775    -    1,687    -    55,088 
Developed technology  5.62 Years   3,599,754    -    152,628    -    3,447,126 
Total intangible assets     $3,721,745   $-   $156,855   $-   $3,564,890 

 

   Remaining
Useful life in
Years
  December 31, 2022
(A)
   Acquired in
Acquisition
(B)
   Amortization
(C)
   Impairment
(D)
   December 31, 2023
(A+B-C-D)
 
Market related intangible assets  6.87 Years  $2,066,918   $-   $136,034    1,865,668   $65,216 
Customer relationships  8.87 Years   1,974,795    -    103,225    1,814,795    56,775 
Developed technology  5.87 Years   6,579,374    -    960,619    2,019,001    3,599,754 
Total intangible assets     $10,621,087   $-   $1,199,878    5,699,464   $3,721,745 

 

During the three months ended March 31, 2023, amortization expense and impairment of finite lived intangible assets were $354,911 and $0 respectively.

 

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Loans Receivable
3 Months Ended
Mar. 31, 2024
Receivables [Abstract]  
Loans Receivable

Note 5. Loans Receivable

 

Commercial real estate loans receivable, net consist of the following:

 

   March 31, 2024   December 31, 2023 
Commercial real estate loans receivable, gross  $401,564   $404,577 
Allowance for credit losses   (9,081)   (10,723)
Commercial real estate loans receivable, net   392,483    393,854 
Current portion   (12,620)   (12,391)
Noncurrent portion  $379,863   $381,463 

 

Allowance for Credit Losses

 

The allowance for credit losses is maintained at a level believed to be sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the loan portfolio. The Company’s estimated the allowance for credit losses on the reporting date in accordance with the credit loss policy described in Note 2 to the unaudited condensed consolidated financial statements.

 

 

The allowance for credit losses consists of the following activity for the three months ended March 31, 2024 and three months ended March 31, 2023:

 

   March 31, 2024   March 31, 2023 
Allowance for credit losses          
Beginning balance  $10,723   $21,488 
Cumulative effect from adoption of CECL   -    14,980 
Charge-offs   -    - 
Recoveries   -    (15,390)
Benefit   (1,642)   - 
Ending balance  $9,081   $21,078 
           
Loans receivable:          
Individually evaluated for an allowance for credit loss  $-   $- 
Collectively evaluated for an allowance for credit loss   401,564    413,292 
   $401,564   $413,292 
Allowance for credit losses:          
Individually evaluated for an allowance for credit loss  $-   $- 
Collectively evaluated for an allowance for credit loss   9,081    21,078 
   $9,081   $21,078 

 

On March 31, 2024 and December 31, 2023, no loans were past due or classified as non-accrual.

 

Credit quality of loans:

 

As part of the on-going monitoring of the credit quality of the Company’s loan portfolio, management tracks credit quality indicators based on the loan payment status on monthly basis. The Company continuously evaluates the credit quality of each indemnified loan by assessing the risk factors and assigning a risk rating based on a variety of factors. The detailed breakdown of risk factors described in Note 6 to the unaudited condensed consolidated financial statements.

 

The carrying value, excluding the CECL Reserve, of the Company’s loans held at carrying value within each risk rating is as follows:

 

Risk rating  March 31, 2024   December 31, 2023 
4  $401,564   $404,577 
Grand total  $401,564   $404,577 

 

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Indemnification Liability
3 Months Ended
Mar. 31, 2024
Indemnification Liability  
Indemnification Liability

Note 6. Indemnification Liability

 

As discussed at Note 8 to the unaudited condensed consolidated financial statements, and pursuant to the Commercial Alliance Agreement with PCCU, PCCU funds loans through a third-party vendor. SHF earns the associated interest and pays PCCU a loan hosting payment at an annual rate of 0.35% of the outstanding loan principal funded and serviced by PCCU and 0.25% of the outstanding loan principle serviced by SHF. The below schedule details outstanding amounts funded by PCCU and categorized as either collateralized loans or unsecured loans and lines of credit.

 

   March 31, 2024   December 31, 2023 
Secured term loans  $57,737,288   $55,215,013 
Unsecured loans and lines of credit   431,640    431,640 
Total loans funded by PCCU  $58,168,928   $55,646,653 

 

Secured loans contained an interest rate ranging from 7.35% to 15.25%. Unsecured loans and lines of credit contain variable rates ranging from Prime +1.50% to Prime +6.00%. Unsecured lines of credit had incremental availability of $525,000 and $996,958 on March 31, 2024 and December 31, 2023.

 

 

SHF has agreed to indemnify PCCU for losses on certain PCCU loans. The indemnity liability reflects SHF management’s estimate of probable credit losses inherent under the agreement at the balance sheet date. The Company’s estimated indemnity liability on the reporting date was calculated in accordance with the allowance for credit loss policy described in Note 2 to the unaudited condensed consolidated financial statements.

 

The indemnity liability activity are as follows:

 

   Three Months ended
March 31, 2024
   Three Months ended
March 31, 2023
 
Beginning balance  $1,382,408   $499,465 
Cumulative effect from adoption of CECL   -    566,341 
Charge-offs   -    - 
Recoveries   -    - 
(Benefit)/ Provision   (67,145)   82,026 
Ending balance  $1,315,263   $1,147,832 

 

As of March 31, 2024, all loans within the Company’s portfolio were current and performing. This is in contrast to the situation as of December 31, 2023, when one loan was under nonaccrual status. The Company successfully negotiated an amendment agreement on December 29, 2023, which brought this loan back to current status through the payment of all overdue amounts. Under the terms of the amendment, the loan’s maturity date was extended to November 1, 2024. Interest income from this loan is now recognized on a cash basis. Given that the loan was delinquent for over 300 days, it has been incorporated into the Company’s Current Expected Credit Losses (CECL) methodology, which aids in estimating credit losses for this particular loan and the overall loan portfolio collectively.

 

Credit quality of indemnified loans:

 

As part of the on-going monitoring of the credit quality of the Company’s indemnified loan portfolio, management tracks credit quality indicators based on the loan payment status on monthly basis. The Company continuously evaluates the credit quality of each indemnified loan by assessing the risk factors and assigning a risk rating based on a variety of factors. Risk factors include property type, geographic and local market dynamics, physical condition, projected cash flow, loan structure and exit plan, loan-to-value ratio, fixed charge coverage ratio, project sponsorship, and other factors deemed necessary. Based on a 10-point scale, the Company’s loans are rated “0” through “10,” from less risk to greater risk, which ratings are defined as follows:

 

Risk
rating
  Category   Description
0   Risk Free   Free of repayment risk. The loan is fully guaranteed by the full faith and backing of the US Government or entirely secured by cash controlled by SHF.
1   Highest Quality   High caliber loan with the lowest risk of default. Significant excess cash flow after debt service and moderate to low leverage.
2   Excellent   High quality loan that carry’s a low risk of default. Strong cash flow and relatively few negative individual risk factors.
3   Good   Loans with lower-than-average level of risk. Excess cash flow and other factors contributing to the overall low level of risk in the loan.
4   Average   Risk factors may be mixed with some negative and some positive aspects, but the overall rating will indicate an average level of risk.
5   Fair   Loans in this category have the maximum level of risk that can be accepted while still recommending a new loan for origination. The loan risk factors may contain multiple negative factors, but they are generally outweighed by the positive aspects of the loan.
6   Watch List   There is a temporary and curable condition resulting in a lower risk rating.
7   Special Mention   There is a potential weakness that may result in the deterioration of the prospect of repayment that are not temporary and may require additional collection or workout efforts.
8   Substandard   Loans in this category are inadequately protected by the current net worth and paying capacity of the obligors or of the collateral pledged and have well-defined weaknesses that jeopardize the liquidation of the debt with distinct possibility of loss. SHF may be required to advance additional funds to manage the loan. Escalated collection activities such as foreclosure have been scheduled with anticipated losses up to 20% of the outstanding balance.
9   Doubtful   Collection or liquidation in full highly questionable and improbable. Escalated collection activities such as foreclosure have commenced with anticipated losses from 20% to 50% of the outstanding balance.
10   Loss   Uncollectable loans. A complete write-off is imminent although a partial recovery may be affected in the future.

 

SHF has agreed to indemnify PCCU from all claims related to SHF’s cannabis-related business. Other than potential credit losses, no other circumstances were identified meeting the requirements of a loss contingency.

 

 

The carrying value, excluding the CECL Reserve, of the Company’s indemnified loans held at carrying value within each risk rating is as follows:

 

Risk rating  March 31, 2024  December 31, 2023 
3  $9,988,588  $10,100,000 
4   3,425,158   3,431,640 
5   30,553,007   28,115,013 
6   10,900,000   10,900,000 
7   -   3,100,000 
8   3,302,175   - 
Grand total  $58,168,928  $55,646,653 

 

The provision for credit losses on the statement of operations consists of the following activity for the period ended March 31, 2024 and March 31, 2023:

 

   Commercial
real estate
loans
   Indemnity
liability
   Total   Commercial
real estate
loans
   Indemnity
liability
   Total 
   March 31, 2024   March 31, 2023 
   Commercial
real estate
loans
   Indemnity
liability
   Total   Commercial
real estate
loans
   Indemnity
liability
   Total 
Provision (benefit)  $(1,642)   (67,145)   (68,787)  $(15,390)   82,056    66,666 

 

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment, Net
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net

Note 7. Property and Equipment, Net

 

Property and equipment consist of the following:

 

   March 31, 2024   December 31, 2023 
Equipment  $45,397   $45,397 
Software   51,692    51,692 
Improvement   71,635    71,635 
Office furniture   215,504    215,504 
Property and equipment, gross   384,228    384,228 
Less: accumulated depreciation   (338,862)   (300,008)
Property and equipment, net  $45,366   $84,220 

 

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related Party Transactions

Note 8. Related Party Transactions

 

Commercial Alliance Agreement

 

On March 29, 2023, the Company and PCCU entered into the Commercial Alliance Agreement. This Agreement sets forth the terms and conditions of the lending and account-related services, governing the relationship between the Company and PCCU. The Commercial Alliance Agreement sets forth the application, underwriting, loan approval, and foreclosure process for loans from PCCU to borrowers that are cannabis-related businesses and the loan servicing and monitoring responsibilities provided by the Company and PCCU. In particular, the Commercial Alliance Agreement provides for procedures to be followed upon the default of a loan to ensure that neither the Company nor PCCU will take title to or possession of any cannabis-related assets, including real property, that may be collateral for a loan funded by PCCU pursuant to the Commercial Alliance Agreement. Under the Commercial Alliance agreement, the PCCU has the right to receive monthly fees for managing loans. For SHF-serviced loans, which are CRB loans provided by the PCCU but primarily handled by SHF, a yearly fee of 0.25% of the remaining loan balance is applied. On the other hand, loans both financed and serviced by the PCCU are charged a yearly fee of 0.35% on their outstanding balance. These fees are calculated using the average daily balance of each loan for the preceding month. In addition, the Company’s is obligated by the Commercial Alliance Agreement to indemnify PCCU from certain default-related loan losses (as fully defined in the Commercial Alliance Agreement).

 

 

In addition, the Commercial Alliance Agreement provides for certain fees to be paid to the Company for certain identified account related services to include: all cannabis-related income, including all lending-related income (such as loan origination fees, interest income on CRB-related loans, participation fees and servicing fees), investment income, interest income, account activity fees, processing fees, flat fees, and other revenue generated from cannabis and multi-state hemp accounts that are hosted on PCCU’s core system for a monthly fee equal to $30.96 per account in 2022, $25.32-$27.85 per account in 2023, and $26.08-$28.69 in 2024. In addition, as it pertains to CRB deposits held at PCCU, investment and interest income earned on these deposits (excluding interest income on loans funded by PCCU) will be shared 25% to PCCU and 75% to the Company. Finally, under the Commercial Alliance Agreement, PCCU will continue to allow its ratio of CRB-related deposits to total assets to equal at least 60% unless otherwise dictated by regulatory, regulator or policy requirements. The initial term of the Commercial Alliance Agreement is for a period of two years, with a one-year automatic renewal unless a party provides one hundred twenty days’ written notice prior to the end of the term.

 

The below schedule demonstrates the ratio of CRB related loans funded by PCCU to the relative lending limits:

 

   March 31, 2024
(Unaudited)
   December 31, 2023
(Unaudited)
 
CRB related deposits  $106,692,488   $129,350,998 
Capacity at 60%   64,015,493    77,610,599 
PCCU net worth   83,739,916    81,087,746 
Capacity at 1.3125   109,908,640    106,670,306 
Limiting capacity   64,015,493    77,610,599 
PCCU loans funded   57,737,287    55,660,039 
Amounts available under lines of credit   775,000    525,000 
Incremental capacity  $5,503,206   $21,425,560 

 

The revenue from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Account servicing agreement  $-   $3,261,284 
Commercial alliance agreement   3,585,856    - 
Total  $3,585,856   $3,261,284 

 

The operating expense from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Support services agreement  $-   $378,730 
Loan servicing agreement   -    11,929 
Commercial alliance agreement   300,261    - 
Total  $300,261   $390,659 

 

 

Issuance of shares to PCCU

 

On March 29, 2023, the Company and PCCU entered into the following definitive transaction documents to settle and restructure the deferred obligation:

 

A five-year Senior Secured Promissory Note (the “Note”) in the principal amount of $14,500,000 bearing interest at the rate of 4.25% and a Security Agreement pursuant to which the Company will grant, as collateral for the Note, a first priority security interest in substantially all of the assets of the Company.
   
A Securities Issuance Agreement, pursuant to which the Company issued 11,200,000 shares of the Company’s Class A Common Stock to PCCU. Following the issuance of the Shares, PCCU own 46.39% of the outstanding Class A Common Stock. In connection with the Securities Issuance Agreement, the parties also entered into a Registration Rights Agreement and a Lock-Up Agreement.
   
The Registration Rights Agreement requires the Company to register the Shares for resale pursuant to the Securities Act of 1933, as amended (the “Securities Act”); and the Lock-Up Agreement restricts PCCU from transferring the Shares until the earlier of (i) six (6) months after the date of the Securities Issuance Documents or (ii) the consummation of a transaction with an unaffiliated third party in which all of the Company’s stockholders have the right to exchange their shares of Class A Common Stock for cash, securities, or other property; and
   
A Commercial Alliance Agreement that sets forth the terms and conditions of the lending-related and account-related services governing the relationship between the Company and PCCU which supersedes the Loan Servicing Agreement, as well as the Amended and Restated Support Services Agreement and the Amended and Restated Account Servicing Agreement.

 

The outstanding balances associated with the PCCU disclosed in the balance sheet are as follows:

 

   March 31, 2024   December 31, 2023 
Accounts receivable  $1,111,390   $2,095,320 
Accounts payable   125,693    577,315 
Senior Secured Promissory Note (Refer to Note 9 to the unaudited condensed consolidated financial statements)   13,270,622    14,011,166 

 

Of the $5.6 million and $8.6 million of cash and cash equivalents on March 31, 2024 and December 31, 2023, $5 million and $4.6 million of the cash and cash equivalents were held in deposit accounts at PCCU as a related party.

 

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Senior Secured Promissory Note
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Senior Secured Promissory Note

Note 9. Senior Secured Promissory Note

 

   March 31, 2024   December 31, 2023 
Senior Secured Promissory Note (Current)  $3,028,738   $3,006,991 
Senior Secured Promissory Note (long term)   10,241,884    11,004,175 
Total  $13,270,622   $14,011,166 

 

On March 29, 2023, the Company and PCCU entered into definitive transaction documents to settle and restructure the deferred obligation related to business Combination under which the Company has issued the five-year Senior Secured Promissory Note (the “Note”) in the principal amount of $14,500,000 bearing interest at the rate of 4.25% and a Security Agreement pursuant to which the Company will grant, as collateral for the Note, a first priority security interest in substantially all of the assets of the Company.

 

The Note amount will be paid in 54 installments of principal and interest of $295,487 each starting from November 5, 2023 and for the period between March 29, 2023, to October 05, 2023, the Company has paid the interest portion.

 

The repayment schedule of the outstanding principal amount on March 31, 2024, is as follows:

 

      
Year of payment     
2024   $2,266,449 
2025    3,138,931 
2026    3,274,966 
2027    3,416,896 
2028    1,173,380 
Grand total   $13,270,622 

 

 

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases
3 Months Ended
Mar. 31, 2024
Leases  
Leases

Note 10. Leases

 

The Company has non-cancellable operating leases for facility space with varying terms. All of the active leases for facility space qualified for capitalization under FASB ASC 842, Leases. These leases have remaining lease terms between one to seven years and may include options to extend the leases for up to ten years. The extension terms are not recognized as part of the right-of-use assets. The Company has elected not to capitalize leases with terms equal to, or less than, one year. As of March 31, 2024, and December 31, 2023, net assets recorded under operating leases were $820,777 and $859,861 on, respectively, and net lease liabilities were $978,461 and $1,007,993, respectively.

 

The Company analyzes contracts above certain thresholds to identify leases and lease components. Lease and non-lease components are not separated for facility space leases. The Company uses its contractual borrowing rate to determine lease discount rates when an implicit rate is not available. Total lease cost for the three months ended March 31, 2024 and March 31, 2023, included in Unaudited Condensed Consolidated Statements of Operations, is detailed in the table below:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Operating lease cost  $-   $- 
Short-term lease cost   69,437    87,742 
Total Lease Cost  $69,437   $87,742 

 

   March 31, 2024   December 31, 2023 
ROU assets that are related to lease properties are presented as follows:          
Beginning balance  $859,861   $1,016,198 
Additions to right-of-use assets   -    - 
Amortization charge for the period   (39,084)   (156,337)
Lease modifications   -    - 
Ending balance  $820,777   $859,861 
           
Further information related to leases is as follows:          
Weighted-average remaining lease term   3.17 Years    3.42 Years 
Weighted-average discount rate   6.87%   6.87%

 

Future minimum lease payments as of March 31, 2024, and December 31, 2023, are as follows:

 

Year         
2024   $151,111   $197,520 
2025    217,925    217,925 
2026    222,275    222,275 
2027    226,705    226,705 
2028    231,216    231,216 
Thereafter    117,710    117,710 
Total future minimum lease payments   $1,166,942   $1,213,351 
Less: Imputed interest    188,481    205,358 
Operating lease liabilities    978,461    1,007,993 
Less: Current portion    142,863    132,546 
Non-current portion of lease liabilities   $835,598   $875,447 

 

 

XML 29 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue

Note 11. Revenue

 

Disaggregated revenue

 

Revenue by type are as follows:

 

   2024   2023 
   Three months ended
March 31
 
   2024   2023 
Deposit, activity, onboarding income  $1,620,994   $2,245,831 
Safe Harbor Program income   19,230    51,103 
Investment income   773,819    1,417,152 
Loan interest income   1,636,756    466,293 
Total Revenue  $4,050,799   $4,180,379 

 

Account fee income consists of deposit account fees, activity fees and onboarding income, which are recognized on periodic basis as per the fee schedule with financial partner institutions. Safe Harbor Program income consists of outsourced support to other financial institutions providing banking to the cannabis industry whose income is recognized on the basis of usage as per the agreements. Loan interest income consist of interest earned on both direct and indemnified loans pursuant to a commercial alliance agreement with PCCU. Investment income consist of interest earned on the daily deposits balance with financial institution.

 

Under our Commercial Alliance Agreement, we are obligated to remit 25% of the investment hosting fees to PCCU based on this income which is classified as “General and Administrative Expenses” in the Consolidated Statements of Operations. In 2024, PCCU’s contributions to the Company’s revenues included $1,217,675 from deposits, activities, and client onboarding, $731,425 from investment income, and $1,636,756 from loan interest income. The associated expenses for these revenues were $104,259 for account hosting, $160,101 for investment hosting fees, and $35,901 for loan servicing fees, all in accordance with the Loan Servicing Agreement and the Commercial Alliance Agreement, classified as “General and Administrative Expenses” in the Consolidated Statements of Operations. In first quarter March 2023, contributed to the Company’s revenues with $2,245,831 from deposits, activities, and client onboarding, $1,417,152 from investment income, and $466,293 from loan interest income. The related expenses for these revenue streams were $55,425 for account hosting, $323,305 for investment hosting fees, and $11,929 for loan servicing fees, all in compliance with the Loan Servicing Agreement, classified as “General and Administrative Expenses” in the Consolidated Statements of Operations.

 

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Deferred Underwriter Fee
3 Months Ended
Mar. 31, 2024
Deferred Underwriter Fee  
Deferred Underwriter Fee

Note 12. Deferred Underwriter Fee

 

In connection with the business combination, the Company executed a note on September 28, 2022 with EF Hutton related to PIPE financing under which the Company was obligated to pay the principal sum of $2,166,250 on the following schedule: (i) $715,750 on October 14, 2022, and (ii) $362,625 on each of October 31, 2022, November 30, 2022, December 31, 2022, and January 31, 2023.

 

The Company made the payment of its first installment of $715,750 and defaulted on the remaining outstanding amounts. The outstanding balance of the note on December 31, 2022 was $1,450,500. On March 13, 2023, the Company and EF Hutton entered into a settlement agreement pursuant to which the Company paid $550,000 to EF Hutton in full settlement of the amount due and the difference of $900,500 has been accounted for in the “Unaudited Condensed Consolidated Statements of Stockholders’ Equity.”

 

XML 31 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies

Note 13. Commitments and contingencies

 

The Company is involved in, or has been involved in, arbitrations or various other legal proceedings that arise from the normal course of its business. The ultimate outcome of any litigation is uncertain, and either unfavorable or favorable outcomes could have a material impact on the Company’s results of operations, balance sheets and cash flows due to defense costs, and divert management resources. The Company cannot predict the timing or outcome of these claims and other proceedings.

 

In connection with the Company’s initial public offering (“IPO”), the Company entered into a registration rights agreement dated June 23, 2021 with the Sponsor and the individuals serving as directors and executive officers of the Company at the time of the IPO. Pursuant to this registration rights agreement, the Company has agreed to register for resale upon the expiration of the applicable lock-up period the Company securities acquired by the Sponsor and such individuals in connection with the organization of the Company and the IPO.

 

 

In connection with the issuance of common stock to Abaca shareholders, the Company commits to registering the stock upon the exercise of Warrants if required by law or regulation to ensure the shares can be sold without restrictive legends, known as the Warrant Registration Requirement. Should this requirement arise, the Company is obliged to file a registration statement with the SEC within 45 calendar days of notification of the Warrant Registration Requirement. The failure to file within this timeframe constitutes an event of default. Moreover, the Company is dedicated to making the registration statement effective as promptly as possible and maintaining its effectiveness, along with a current prospectus, until the Warrants expire according to this Agreement’s terms. In the event a registration statement triggered by a Warrant Registration Requirement is not declared effective by the SEC within one year from its filing date, Warrant holders are entitled to exercise their Warrants on a cashless basis from the 366th day post-filing until the statement becomes effective.

 

XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings Per Share
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Earnings Per Share

Note 14. Earnings Per Share

 

Basic net income (loss) per common share is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net income (loss) per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period. For the Company’s diluted earnings per share calculation, the Company uses the “if-converted” method for preferred stock and convertible debt and the “treasury stock” method for Warrants and Options.

 

As the Business Combination and related transactions are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted net income per share assumes that the shares issued in connection with the Business Combination have been outstanding for the entire period presented.

 

For the three month period ended March 31  2024   2023 
Net Income/ (loss)  $2,049,676   $(1,413,447)
Weighted average shares outstanding – basic   55,213,609    25,670,730 
Basic net income/ (loss) per share  $0.04   $(0.06)
Weighted average shares outstanding – diluted   56,268,075    25,670,730 
Diluted net income/ (loss) per share  $0.04   $(0.06)

 

Weighted average shares calculation - basic  2024   2023 
  

Three months ended

March 31

 
Weighted average shares calculation - basic  2024   2023 
Company public shares   3,926,598    3,926,598 
Company initial stockholders   3,403,175    3,403,175 
PCCU stockholders   22,586,139    11,759,472 
Shares issued for abaca acquisition   7,935,800    2,099,977 
Restricted stock units issued   1,308,089    566,755 
Conversion of preferred stock   16,053,808    3,914,753 
Grand total   55,213,609    25,670,730 

 

Weighted average shares calculation - diluted   2024    2023  
  

Three months ended

March 31

 
Weighted average shares calculation - diluted   2024    2023  
Shares used in computation of basic earnings per share    55,213,609      -  
Shares to be issued to Abaca shareholders    750,000      -  
Share based payments    215,666      -  
Conversion of preferred stock    

88,800

      -  
Grand total    

56,268,075

             -  

 

Certain share-based equity awards and warrants were excluded from the computation of dilutive earnings/ (loss) per share because inclusion of these awards would have had an anti-dilutive effect. The following table reflects the awards excluded.

 

   March 31, 2024  

March 31, 2023

 
Warrants   

12,036,588

    

7,036,588

 
Share based payments   

2,284,080

    

2,775,655

 
Shares to be issued to Abaca shareholders   -    6,433,839 
Conversion of preferred stock   -    10,896,000 
Grand total   14,320,668    27,142,082 

 

The holders of Series A Convertible preferred stock shall be entitled to receive, and the Company shall pay, dividends on shares of Series A Convertible preferred stock equal (on an as-if-converted-to-Class-A-common stock basis) to and in the same form as dividends actually paid on shares of the Class A common stock when, as and if such dividends are paid on shares of the Class A common stock. No other dividends shall be paid on shares of Series A convertible preferred stock.

 

 

XML 33 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Forward Purchase Agreement
3 Months Ended
Mar. 31, 2024
Forward Purchase Agreement  
Forward Purchase Agreement

Note 15. Forward Purchase Agreement

 

On June 16, 2022, the Company entered into a Forward Purchase Agreement with Midtown East Management NL, LLC (“Midtown East”). Subsequent to entering into the Forward Purchase Agreement, the Company and Midtown East entered into assignment and novation agreements with Verdun Investments LLC (“Verdun”) and Vellar Opportunity Fund SPV LLC – Series 1 (“Vellar”), pursuant to which Midtown East assigned its obligations as to 1,666,666 shares of the shares of Class A Stock to be purchased under the Forward Purchase Agreement to each of Verdun and Vellar. As contemplated by the Forward Purchase Agreement:

 

Prior to the closing, Midtown East, Verdun and Vellar purchased approximately 3.8 million shares of Class A common stock directly from investors at market price in the public market. Midtown East and other counter parties waived their redemption rights with respect to the acquired shares;

 

One business day following the closing, the Company paid approximately $39.3 million from the cash held in its trust account to Midtown East; Verdun and Vellar for the shares purchased and approximately $0.3 million in related expense amounts.

 

At the Maturity Date, Midtown East, Verdun and Vellar shall be entitled to (1) the product of the shares then held by them multiplied by the Forward Price, and (2) an amount, in cash or shares at the sole discretion of the Company, equal to (a) in the case of cash, the product of (i)(x) 3.8 million shares less (y) the number of Terminated Shares and (ii) $2.00 (the “Maturity Cash Consideration”) and (b) in the case of shares, (i) the Maturity Cash Consideration divided by (ii) the VWAP Price for the 30 Scheduled Trading Days prior to the Maturity Date.

 

At any time prior to the Maturity Date (defined as the earlier of i) the third anniversary of the Closing of the Business Combination, ii) the shares are delisted from The Nasdaq Stock Market or (iii) during any 30 consecutive Scheduled Trading Day-period following the closing of the Business Combination, the Volume Weighted Average Share Price (VWAP) Price for 20 Scheduled Trading Days during such period shall be less than $3.00 per share), Midtown East, Verdun and Vellar may elect an optional early termination to sell some or all of the shares (the “Terminated Shares”) of Class A Stock in the open market. If Midtown East, Verdun and Vellar sell any shares prior to the Maturity Date, the pro-rata portion of the Reset Price will be released from the escrow account and paid to SHF. Midtown East, Verdun and Vellar shall retain any proceeds in excess of the Reset Price that is paid to SHF.

 

In 2022, an agreement was reached among the Company, its common shareholders, and preferred investors, leading to a reduction in the make-whole price to $1.25 per share. This reset resulted in a significant decrease in the FPA receivable, from $37.9 million as of September 30, 2022, to $4.6 million. During the year 2023 and the first quarter of 2024, there were no share transactions by FPA holders, and management identified no additional impacts on the FPA receivable’s value on December 31, 2023 and March 31, 2024.

 

The reconciliation statement of the Class A common stock held by the parties are as follows:

 

       As at
December 31, 2023
   Shares sold during
the three months ended
March 31, 2024
   As at
March 31, 2024
 
S.no   Name of the party  Opening
Shares
(a)
   Amount   Shares
(b)
   Amount   Shares
(c=a-b)
   Rest price
(iii)
   Amount
(c x iii)
 
1   Vellar   971,204   $1,214,005    -   $-    971,204    1.25   $1,214,005 
2   Midtown East   1,517,924    1,897,405    -    -    1,517,924    1.25    1,897,405 
3   Verdun   1,178,249    1,472,811    -    -    1,178,249    1.25    1,472,811 
Grand total   3,667,377   $4,584,221    -   $-    3,667,377        $4,584,221 

 

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Warrant Liabilities
3 Months Ended
Mar. 31, 2024
Warrant Liabilities  
Warrant Liabilities

Note 16. Warrant Liabilities

 

Public and Private Placement Warrants

 

As of March 31, 2024, and December 31, 2023, the Company has 5,750,000 Public warrants and 264,088 Private Placement Warrants.

 

The Public and Private Placement Warrants may only be exercised for a whole number of shares.

 

 

The Public and Private Placement Warrants became exercisable on September 28, 2022, the date of the Business Combination and will expire on September 28, 2027, or earlier upon redemption or liquidation.

 

No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.

 

Redemption of warrants become exercisable when the price per Class A Common Stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the warrants:

 

in whole and not in part;
at a price of $0.01 per warrant;
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.

 

If and when the warrants become redeemable by the Company, the Company may exercise its redemption rights; this is also the case if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

 

If the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise the Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants.

 

The private placement warrants are identical to the public warrants, except that the private placement warrants and the Class A Common Stock issuable upon the exercise of the private placement warrants were not transferable, assignable or saleable, subject to certain limited exceptions. Additionally, the private placement warrants are exercisable on a cashless basis and non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the private placement warrants are held by someone other than the initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants.

 

PIPE Warrants

 

As of March 31, 2024 and December 31, 2023, the Company has 1,022,500 PIPE Warrants.

 

The PIPE Warrants have an exercise price of $11.50 per share of Class A Common Stock to be paid in cash (except if the shares underlying the warrants are not covered by an effective registration statement after the six-month anniversary of the closing date, in which case cashless exercise is permitted), subject to adjustment to a price equal to the greater of (i)125% of the conversion price if at any time there is an adjustment to the Conversion Price and the exercise price after such adjustment is greater than 125% of the Conversion Price as adjusted and (ii) $5.00. The PIPE Warrants are also subject to adjustment for other customary adjustments for stock dividends, stock splits and similar corporate actions. The PIPE Warrants are exercisable for a period of five years following the Closing, or September 28, 2027. After exercise of a PIPE Warrant, the Company may be required to pay certain penalties if it fails to deliver the Class A Common Stock within a specified period of time.

 

Abaca Warrants

 

As of March 31,2024, and December 31, 2023, the Company has 5,000,000 Abaca warrants.

 

 

The Abaca 5,000,000 warrants have an exercise price of $2.00 per share of Class A common stock to be paid in cash. An Abaca Warrant may be exercised only during the period commencing 1 year of the Effective Date and terminating five (5) years from the effective date of the registration statement. The Company may, in its sole discretion, settle the Abaca Warrant when exercised, in whole or in part, in cash in lieu of issuing shares of common stock underlying the Warrant. The Company may elect to pay the Registered Holder in cash in the amount equal to the difference between the fair market value of the Company’s Class A common stock on the date of exercise and the warrant price ($2.00) multiplied by the number of shares of Class A common stock. The Company commits to promptly registering shares of Class A common stock issued upon Abaca Warrant exercises if required by law, ensuring these shares can be sold without restrictions. This registration must be filed within 45 days of receiving a notification of such a requirement, with failure to do so constituting a default. The Company will endeavor to keep the registration effective until the Warrants expire. If the registration isn’t effective within one year, Abaca Warrant holders may exercise their Warrants on a cashless basis, receiving shares based on a defined fair market value calculation. This process aims to facilitate the straightforward and lawful exercise of the Abaca Warrants, ensuring the shares issued are readily tradable without the need for restrictive legends.

 

XML 35 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Financial Instruments
3 Months Ended
Mar. 31, 2024
Investments, All Other Investments [Abstract]  
Financial Instruments

Note 17. Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The fair value hierarchy ranks the inputs used in measuring fair value as follows:

 

  Level 1 – Observable, unadjusted quoted prices in active markets
  Level 2 – Inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability
  Level 3 – Unobservable inputs with little or no market activity that require the Company to use reasonable inputs and assumptions

 

The Company uses fair value measurements to record adjustments to certain financial assets and liabilities on a recurring basis. The Company may be required to record certain assets at fair value on a nonrecurring basis in specific circumstances, such as evidence of impairment. Methodologies used to determine fair value might be highly subjective and judgmental in nature; therefore, valuations may not be precise. If the Company determines that a valuation technique change is necessary, the change is assumed to have occurred at the end of the respective reporting period.

 

Assets and Liabilities Reported at Fair Value on a Recurring Basis

 

Public Warrants:

 

Public warrants are recorded at fair value on a recurring basis. The Company obtains exchange traded price, of Level 1 inputs, based on observable data to value these warrants.

 

Private Placement Warrants:

 

Private Placement Warrants are recorded at fair value on a recurring basis. In the first quarter of 2024, the Company internally assessed the value of these derivatives with Level 3 inputs, which are derived from Black-Scholes model. This is a change from the first quarter of 2023, when the valuation was based on third-party reports, also utilizing Level 3 inputs for these derivatives. Management believes that this change was necessary to enhance the precision and control over the valuation process, allowing for a more tailored and responsive approach to the unique characteristics of the derivatives and the evolving market conditions.

 

PIPE Warrants:

 

PIPE Warrants are recorded at fair value on a recurring basis. In the first quarter of 2024, the Company internally assessed the value of these derivatives with Level 3 inputs, which are derived from Black-Scholes model. This is a change the first quarter of 2023, when the valuation was based on third-party reports, also utilizing Level 3 inputs for these derivatives. Management believes that this change was necessary to enhance the precision and control over the valuation process, allowing for a more tailored and responsive approach to the unique characteristics of the derivatives and the evolving market conditions.

 

Abaca Warrants:

 

Abaca Warrants are recorded at fair value on a recurring basis. The Company internally assessed the value of these derivatives with Level 3 inputs. Level 3 inputs, based on unobservable data derived from Black-Scholes model.

 

Third Anniversary Payment Consideration:

 

Third anniversary payment consideration are recorded at fair value on a recurring basis. The Company value these derivatives based on third party reports for Level 3 inputs. Level 3 inputs, based on unobservable data derived from Black Scholes-Merton model.

 

 

Forward Purchase Option Derivatives:

 

Forward purchase option derivatives are recorded at fair value on a recurring basis. In 2022, the Company values these derivatives based on third party reports for Level 3 inputs. In 2023 and 2024, no significant risk factor changes affecting FPA derivative values were noted.

 

The following tables summarize financial assets and liabilities recorded at fair value on a recurring basis, by the level of valuation inputs in the fair value hierarchy on March 31, 2024 and December 31, 2023:

 

   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
   March 31, 2024   December 31, 2023 
   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Description                        
Liabilities:                        
PIPE warrants  $189,220    -    189,220   $273,124    -    273,124 
Public warrants  $430,675    430,675    -   $481,850    481,850    - 
Private placement warrants  $20,315    -    20,315   $25,070    -    25,070 
Abaca warrant  $2,268,432    -    2,268,432   $3,384,085    -    3,384,085 
Forward purchase derivative liability  $7,309,580    -    7,309,580   $7,309,580    -    7,309,580 
Third anniversary payment consideration  $594,000    -    594,000   $810,000    -    810,000 

 

Assets Measured at Fair Value on a Nonrecurring Basis

 

Assets that are measured at fair value on a nonrecurring basis primarily comprises of property, plant and equipment, right-to-use assets, finite lived intangible assets and goodwill. The Company does not record these at fair value on a recurring basis, however, the carrying value of the assets may be reduced to fair value when the Company determines that impairment has occurred.

 

There were no assets or liabilities recorded at fair value on a nonrecurring basis for the period ended March 31, 2024 and March 31, 2023.

 

Fair Value of Financial Instruments

 

The Company uses various methodologies and assumptions to estimate the fair value of certain financial instruments. With the exceptions of loans receivable, warrants and forward purchase option derivatives, the Company considers the carrying amounts of its financial instruments (cash, accounts receivable and accounts payable) in the balance sheet to approximate fair value because of the short-term or highly liquid nature of these financial instruments.

 

 

The following tables present the carrying amounts and fair values of financial instruments, by the level of valuation inputs in the fair value hierarchy, as of the dates indicated:

 

           Level 1   Level 2   Level 3 
   As on March 31, 2024 
   Carrying
amount
   Fair value   Fair value measurement using 
           Level 1   Level 2   Level 3 
Assets                    
Cash and cash equivalents  $5,626,362   $5,626,362   $5,626,362   $-   $- 
Forward purchase receivables   4,584,221    4,584,221    4,584,221    -    - 
Loans   392,483    362,671              362,671 
Liabilities                         
Deferred consideration   2,921,257    2,921,257    2,921,257    -    - 
Senior Secured Promissory note   13,270,622    12,137,875    -    -    12,137,875 
Indemnity liability   1,315,263    1,315,263    1,315,263    -    - 
Public warrants   430,675    430,675    430,675    -    - 
Private placement warrants   20,315    20,315    -    -    20,315 
PIPE Warrants   189,220    189,220    -    -    189,220 
Abaca Warrants   2,268,432    2,268,432    -    -    2,268,432 
Third anniversary payment consideration   594,000    594,000    -    -    594,000 
Forward purchase derivative   7,309,580    7,309,580    -    -    7,309,580 

 

                Level 1     Level 2     Level 3  
    As on December 31, 2023  
    Carrying
amount
    Fair value     Fair value measurement using  
                Level 1     Level 2     Level 3  
Assets                              
Cash and cash equivalents   $ 4,888,769     $ 4,888,769     $ 4,888,769     $ -     $ -  
Forward purchase receivables     4,584,221       4,584,221       4,584,221       -       -  
Loans     330,579       363,561       -       -       363,561  
Liabilities                                        
Deferred consideration     2,889,792       2,889,792       2,889,792       -       -  
Senior secured promissory note     14,011,166       12,750,204       -       -       12,750,204  
Public warrants     481,850       481,850       481,850       -       -  
Private placement warrants     25,070       25,070       -       -       25,070  
PIPE warrants     273,124       273,124       -       -       273,124  
Abaca warrants     3,384,085       3,384,085       -       -       3,384,085  
Forward purchase derivative     7,309,580       7,309,580       -       -       7,309,580  
Third anniversary payment consideration     810,000       810,000       -       -       810,000  

 

 

The change in the assets measured at fair value on a recurring basis for which the Company have utilized Level 3 inputs to determine fair value are presented in the following table:

 

    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
   For the period ended March 31, 2024 
    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
Balance at the beginning of the period  $273,124   $3,384,085   $25,070   $810,000   $7,309,580 
Issued to Abaca shareholders   -    -    -    -    - 
Fair value adjustment   (83,904)   (1,115,653)   (4,755)   (216,000)   - 
Balance at the end of the period  $189,220   $2,268,432   $20,315   $594,000   $7,309,580 

 

    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
   For the period ended March 31, 2023 
    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
Balance at the beginning of the period  $286,300   $-   $19,110   $-   $7,309,580 
Fair value adjustment   (211,538)   -    (11,157)   -    - 
Balance at the end of the period  $74,762   $-   $7,953   $-   $7,309,580 

 

As of March 31, 2024 and on December 31, 2023, the valuation of private placement warrants, PIPE warrants, and Abaca warrants was carried out using the Black-Scholes model, while the fair value of the Abaca third anniversary payment consideration was determined using the Black Scholes Merton Option pricing model. Contrastingly, in the first quarter of 2023, the fair value assessments for both the private placement warrants and PIPE warrants were conducted using the Black-Scholes model and the Black Scholes-Merton model, respectively. Management believes that the change in method for PIPE warrants was necessary to enhance the precision and control over the valuation process, allowing for a more tailored and responsive approach to the unique characteristics of the derivatives and the evolving market conditions. As of March 31, 2024 and December 31, 2023, these warrants were valued for Level 3 inputs, which are based on observable data to value these derivatives.

 

As of December 31, 2023, the Company assessed the fair value of its forward purchase agreement (FPA) derivative utilizing a Monte Carlo Simulation within a risk-neutral setting, which is a particular instance of the Income Approach, based on calculations from December 31, 2022. Throughout the first quarters of both 2023 and 2024, there were no notable alterations in risk factors that would impact the valuation of the FPA derivative. Consequently, management retained the December 31, 2022, valuation for December 31, 2023 and March 31, 2024. The Company will continue to monitor the fair value of the forward option derivative each reporting period with subsequent revisions to be recorded in the Statements of Operations.

 

During the first quarters of both 2023 and 2024, there were no changes in the classification of financial instruments within Level 2 and Level 3 of the fair value hierarchy.

 

 

The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the private placement warrants and public warrants as of their measurement dates:

 

    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
 
       March 31, 2024   December 31, 2023 
    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
 
Exercise price  $5    11.5    -    2   $5    11.5    -    2 
Share Price  $0.97    0.97    0.97    0.97   $1.42    1.42    1.42    1.42 
Expected term (years)   3.49    3.49    1.51    4.57    3.74    3.74    1.76    4.84 
Volatility   76.00%   76.00%   76.00%   76.00%   62.95%   62.95%   62.95%   62.95 
Risk-free rate   4.26%   4.26%   4.26%   4.36%   4.25%   4.25%   4.25%   4.25 

 

The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the forward purchase derivatives as of their measurement dates on March 31, 2024 and December 31, 2023:

 

   March 31, 2024   December 31, 2023 
Reset Price  $1.25   $1.25 
Expected term (years)   1.49    1.74 
Additional Maturity Consideration per share  $2.00   $2.00 
Volatility   46%   46%
Risk-free rate   4.2%   4.2%
Risk-adjusted discount rate   13.4%   13.4%

 

XML 36 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Tax
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Tax

Note 18. Tax

 

For the three months ended March 31, 2024, the Company recorded income tax benefit of $438,885 for continuing operations. The effective tax rate of 28.14% for the three months ended March 31, 2024, varied from the statutory United States federal income tax rate of 21.0% primarily because of state income taxes, net of the federal benefit, and adjustments to the fair market value of warrant liabilities. The Company has net deferred tax assets of $44,278,374 and $43,829,019 as of March 31, 2024, and December 31, 2023, respectively. The Company considers their deferred tax assets to be realizable and has not established a valuation allowance, as it is considered more likely than not that the Company will utilize deferred tax assets in future periods through future taxable income.

 

The Company recognizes income tax benefits from uncertain tax positions where the realization of the ultimate benefit is uncertain. As of both March 31, 2024, and December 31, 2023, the Company has no unrecognized income tax benefits.

 

 

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
401(k) Plan
3 Months Ended
Mar. 31, 2024
Retirement Benefits [Abstract]  
401(k) Plan

Note 19. 401(k) Plan

 

The Company offers to all employees a tax-qualified retirement contribution plan, with the Company’s 100% matching contribution up to 4% of a participant’s eligible compensation. The Company’s consolidated matching contributions for the three months ended March 31, 2024, amounting to $35,233, and March 31, 2023, amounting to $20,663, respectively.

 

XML 38 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Equity
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Stockholders’ Equity

Note 20. Stockholders’ Equity

 

Preferred Stock

 

The Company is authorized to issue 1,250,000 preferred shares with a par value of $0.0001 per share with such designation rights and preferences as may be determined from time to time by the Company’s Board of Directors. As of March 31, 2024, there were 111 Class A preferred shares issued and outstanding and 1,101 preferred shares issued and outstanding on December 31, 2023. The holders of preferred stock shall be entitled to receive, and the Company shall pay, dividends on shares of preferred stock equal(on an as-if-converted-to-Class-A-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Class A Common Stock when, as and if such dividends are paid on shares of the Class A Common Stock. No other dividends shall be paid on the preferred stock. The terms of the preferred stock provide for an initial conversion price of $ 10.00 per share of Class A Common Stock, which conversion price is subject to downward adjustment on each of the dates that are 10 days, 55 days, 100days, 145 days and 190 days after the effectiveness of a registration statement registering the shares of Class A Common Stock issuable upon conversion of the preferred stock to the lower of the Conversion Price and the greater of (i) 80% of the volume weighted average price of the Class A Common Stock for the prior five trading days and (ii) $2.00 (the “Floor Price”), provided that, so long as a preferred stock holders continues to hold any preferred shares, such preferred stock holder will be entitled to receive the aggregate shares of Class A Common Stock that would be issuable based upon its initial purchase of preferred stock at the adjusted Conversion Price. Additionally, on January 25, 2023, at a special meeting of the Company’s stockholders, the stockholders approved a reduction in the floor conversion price of the outstanding preferred stock from $ 2.00 per share to $ 1.25 per share.

 

Common Stock

 

The Company is authorized to issue up to 130,000,000 shares of Class A Common Stock with a par value of $.0001 per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. As of March 31, 2024 and December 31, 2023, there were 55,431,001 and 54,563,372 shares of Class A Common Stock issued or outstanding. As of March 31, 2024 and December 31, 2023, 3,667,377 Class A Common Stock are held by the purchasers under forward purchase agreement dated June 16, 2022, by and among the Company and such purchasers.

 

2022 Equity Incentive Plan

 

Share-based compensation expense recognized for the three months ended March 31, 2024 and March 31, 2023 totaled $0.6 million and $1.6 million, respectively.

 

The 2022 Plan was approved by the Company’s stockholders on June 28, 2022. The 2022 Plan permits the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, stock bonus awards, and performance compensation awards. The Company has not issued stock appreciation rights, restricted stock, stock bonus awards, or performance compensation awards in the three months ended March 31, 2024 and March 31, 2023. In conjunction with the 2024 Plan, as of March 31, 2024, the Company had granted stock options and restricted stock units which are described in more detail below.

 

Stock Options

 

Stock options are awarded to encourage ownership of the Company’s Class A common stock by employees and to provide increased incentive for employees to render services and to exert maximum effort for the success of the Company. The Company’s incentive stock options generally permit net-share settlement upon exercise. The option exercise price, vesting schedule and exercise period are determined for each grant by the administrator (person appointed by board to administer the stock plans) of the applicable plan. The Company’s stock options generally have a 10-year contractual term.

 

 

The assumptions used to determine the fair value of options granted in the three months ended March 31, 2024, using the Black-Scholes-Merton model are as follows:

 

Dividend yield   0%  
Risk-free interest rate   3.62 % to 4.23%  
Expected volatility (weighted-average and range, if applicable)   100%  
Expected term   6 to 6.5 years   

 

The expected term of the options granted is calculated based on the simplified method by taking average of contractual term and vesting period the awards. The shares of the Company were listed on the stock exchange for a limited period of the time and the share price has also dropped significantly from the date of listing. Based on these factors Management has considered the expected volatility at 100% for the current period. The risk-free interest rate used is the current yield on US Treasury notes with a term equal to the expected term of the options at the grant date. The expected dividend yield is based on annualized dividends on the underlying share during the expected term of the option.

 

A summary of the Company’s stock option activities and related information for the three months ended March 31, 2024 is as follows:

 

Stock Option  No. of Stock
Option
   Weighted-
Average Grant
Date Fair Value
Per Stock
Option
   Weighted-
Average
Remaining
Contractual Life
(in Years)
 
December 31, 2023   2,286,010   $5.43    1.65 
Granted   -    -    - 
Exercised   -    -    - 
Expired   -    -    - 
Cancelled / Forfeited   (1,930)   1.56    - 
March 31, 2024   2,284,080   $5.43    1.40 

 

A summary of the Company’s stock option activities and related information for the three months ended March 31, 2023 is as follows:

 

Stock Option  No. of Stock
Option
   Weighted-
Average Grant
Date Fair Value
Per Stock Option
   Weighted-
Average
Remaining
Contractual Life
(in Years)
 
December 31, 2022   2,170,000   $3.53    2.02 
Granted   336,730    1.03    2.76 
Exercised   -    -    - 
Expired   -    -      
Cancelled / Forfeited   (64,875)   3.13    - 
March 31, 2023   2,441,855   $3.20    2.39 

 

The following options were outstanding at their respective exercise price:

 

Exercise price options outstanding   March 31, 2024   March 31, 2023 
$1.56    374,580    359,355 
$2.58    350,000    350,000 
$4.00    309,500    482,500 
$6.67    1,250,000    1,250,000 
Total    2,284,080    2,441,855 

 

 

Restricted Stock Units (“RSUs”)

 

A summary of the Company’s RSU activities and related information for the three months ended March 31, 2024 is as follows:

 

Restricted Stock Units  No. of RSU   Weighted-
Average Grant
Date Fair Value
Per RSU
   Weighted-
Average
Remaining
Contractual
Life
(in Years)
 
December 31, 2023   323,500   $1.31    2.00 
Granted   -    -    - 
Vested   (107,833)   1.31    - 
Expired   -    -    - 
Cancelled / Forfeited   -    -    - 
March 31, 2024   215,667   $1.31    1.75 

 

Restricted Stock Units  No. of RSU   Weighted-
Average Grant
Date Fair Value
Per RSU
   Weighted-
Average
Remaining
Contractual
Life
(in Years)
 
December 31, 2022   -   $-    - 
Granted   963,528    1.31    2.76 
Vested   -    -    - 
Expired   -    -    - 
Cancelled / Forfeited   -    -    - 
March 31, 2023   963,528   $1.31    2.76 

 

The following RSU were outstanding at their respective vest price:

 

Vest price RSU outstanding   March 31, 2024   March 31, 2023 
$1.31    215,667    963,528 
Total    215,667    963,528 

 

XML 39 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent events
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Subsequent events

Note 21. Subsequent events

 

On April 5, 2024, the Company received a letter from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $1.00 per share for its common stock, as required by Nasdaq Marketplace Rule 5550(a)(2). The Company has been granted a period of 180 days, ending on October 2, 2024, to regain compliance with this requirement. If the Company does not regain compliance by October 2, 2024, the Company may be eligible for second compliance period for up to an additional 180 days. In connection with any extension periods, if it appears that the Company will not be able to regain compliance with Nasdaq Marketplace Rule 5550(a)(2), or if the Company is not otherwise eligible, the Nasdaq staff will provide notice to the Company that its securities will be subject to delisting. At that time, the Company may appeal any such delisting determination to a Hearings Panel. If the Company’s Class A common stock maintains a closing bid price of at least $1.00 for 10 consecutive business days at any point before the deadline, Nasdaq will confirm compliance, and the matter will be resolved. The Company’s Class A common stock will continue to be listed and traded on The Nasdaq Capital Market under the symbol “SHFS” during this period. There is no assurance that the Company will achieve compliance within the given timeframe or maintain compliance with other Nasdaq Listing Rules thereafter.

XML 40 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation

i. Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the “SEC”).

 

The accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary to state fairly the consolidated financial condition, results of operations, statements of shareholders’ equity, and cash flows of the Company for the interim periods presented. Except as otherwise disclosed, all such adjustments consist only of those of a normal recurring nature. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results that may be expected for the current year ending December 31, 2024. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the years ended December 31, 2023, included in the Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”).

 

The company has made certain immaterial reclassifications to the statements of operations for the three months ended March 31, 2023, to conform to the presentation for the three months ended March 31, 2024. These reclassifications, totaling $190,943, were moved from ‘Interest Expense’ to ‘Change in the Fair Value of Deferred Consideration’. Corresponding adjustments have been made to the statement of cash flows and the applicable notes to the unaudited condensed consolidated financial statements.

 

The condensed consolidated financial statements include the accounts of SHF Holdings, Inc., its subsidiaries where we have controlling financial interests. All intercompany balances and transactions have been eliminated.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC and the instructions to Form 10-Q.

 

 

Use of Estimates

ii. Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Material estimates that are particularly subject to change in the near term include the determination of the allowance for credit losses, indemnification liabilities, useful lives of intangibles and the fair value of financial instruments. Actual results could differ from the estimates.

 

Liquidity and Going Concern

iii. Liquidity and Going Concern

 

As of March 31, 2024, the Company had $5,626,362 in cash and net working capital of $318,825, as compared to $4,888,769 in cash and net working capital deficit of $135,355 as of December 31, 2023. The retained deficit was $70,386,394 on March 31, 2024, and $71,569,821 on December 31, 2023. The Company has also generated operating income of $324,941 for the period ended March 31, 2024.

 

For the period ending March 31, 2024, the Company reported positive operating income and net working capital. However, considering the historical data, where the Company experienced negative operating income and negative net working capital, management acknowledges the need to closely evaluate the financial performance in upcoming quarters to mitigate any going concern risks. As of March 31, 2024, due to these historical trends, there is substantial doubt about the Company’s ability to continue as a going concern for at least twelve months from the date these condensed unaudited consolidated financial statements were issued.

 

If the Company is not able to sustain its present level of operations, it may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned expansion programs. Any of these actions could materially harm the Company’s business, results of operations and future prospects.

 

The accompanying condensed unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result should the Company not continue as a going concern as a result of this uncertainty.

 

Cash and Cash Equivalents

iv. Cash and Cash Equivalents

 

Cash and cash equivalents include cash on hand, amounts due from financial institutions, and investments with maturities of three months or less.

 

Concentrations of Risk

v. Concentrations of Risk

 

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash. Cash balances are maintained substantially in accounts at Partner Colorado Credit Union (“PCCU”) which is insured by the National Credit Union Share Insurance Fund (“NCUSIF”) up to regulatory limits. From time to time, cash balances may exceed the NCUSIF insurance limit. The Company has not experienced any credit losses associated with its cash balances in the past.

 

Currently the Company only services the cannabis industry. Cannabis remains illegal under federal law, and therefore, strict enforcement of federal laws regarding cannabis would likely result in our inability to execute our business plan.

 

Currently the Company substantially relies on PCCU to hold customer deposits and fund its originated loans. As of this time, majority all of the Company’s revenue is generated by deposits and loans hosted by its PCCU pursuant to various services agreements.

 

The Company had only one loan on its balance sheet as of March 31, 2024, which comprises 100% of the total loan balance. The Company also indemnified 21 loans as of March 31, 2024; three of these indemnified loans were in excess of 10% of the total balance.

 

Accounts Receivable

vi. Accounts Receivable

 

Accounts receivable are recorded based on account fee schedules. While fees are generated from accounts for individual cannabis-related businesses (“CRB”) related accounts, amounts are initially collected by the financial institutional partners and remitted in the subsequent month. Accounts receivable - related party represents amounts due from PCCU under related party contracts disclosed in Note 8 to the unaudited condensed consolidated financial statements.

 

 

Loans Receivable

vii. Loans Receivable

 

CRB loans that significantly support the Company’s operations are recognized as assets on the balance sheet. These loans, intended to be held either for the foreseeable future or until their maturity or full repayment, are recorded at their outstanding principal balance. This amount is adjusted for any credit loss allowances and net of any deferred loan origination fees and costs, as applicable, to reflect the net investment in these loans. The Company recognizes interest income on CRB Loans over the loan term using the simple-interest method based on outstanding principal amounts. This approach ensures a systematic recognition of income, aligning with the time value of money principle.

 

Interest income recognition is suspended when there is uncertainty regarding full loan repayment, such as in cases of loan impairment or when payments are overdue by ninety days or more. Loans under these conditions are placed on nonaccrual status. Any accrued interest not received by the time a loan is placed on nonaccrual is reversed from interest income. Subsequent interest payments on nonaccrual loans are recorded using either the cash basis or the cost recovery method until the loan meets the criteria for reclassification to accrual status.

 

Loans are returned to accrual status when they become current (less than ninety days past due) and when there is reasonable assurance of future payment compliance, evidenced by the full satisfaction of both principal and interest payments due.

 

Loans are assessed individually for potential charge-off, which typically occurs at the point of foreclosure. Charge offs are executed to reflect the realizable value of loans that are deemed uncollectible.

 

The determination of a loan’s past-due status is based on its contractual repayment terms. Loans are either placed on nonaccrual status or charged-off ahead of their contractual delinquency dates if the collection of principal and interest is deemed doubtful, ceasing the recognition of interest income on such loans.

 

Allowance for Credit Losses (ACL)

viii. Allowance for Credit Losses (ACL)

 

The Company has adopted Accounting Standards Codification Topic 326 - Financial Instruments - Credit Losses (ASC Topic 326), for estimation of probable credit losses with an expected credit loss methodology that is referred to as the current expected credit loss (“CECL”) methodology.

 

The ACL is a valuation account that is deducted from the amortized cost basis of financial assets carried at their amortized cost, including loans held for investment, to present the net amount that is expected to be collected throughout the life of the financial asset. The estimated ACL is recorded through a provision for credit losses charged against operations. Management periodically evaluates the adequacy of the ACL to maintain it at a level it believes to be reasonable. The Company uses the same methods used to determine the ACL to assess any reserves needed for off-balance sheet credit risks such as unfunded loan commitments including Indemnified loans to PCCU. These reserves for off-balance sheet credit risks are presented in the liabilities section in the unaudited condensed consolidated balance sheets as an “Indemnity liability.”

 

The ACL consists of two components: an asset-specific component for estimating credit losses for individual loans that do not share similar risk characteristics with other loans; and a pooled component for estimating credit losses for pools of loans that share similar risk characteristics. The ACL for the pooled component is derived from an estimate of expected credit losses primarily using an expected loss methodology that incorporates risk parameters such as probability of default (“PD”) and loss given default (“LGD”) which are derived from various vendor models and/or internally developed model estimation approaches for smaller homogenous loans.

 

The PD is quantified by analyzing historical data to determine the rate at which loans have defaulted within the portfolio, relative to the total outstanding loans as of the end of the reporting period. This rate is expressed as a percentage and serves as a key indicator of the likelihood of default across the loan pool. LGD assessments are conducted to estimate the potential loss amount in the event of a default, considering the recoverable value from the collateral liquidation against the remaining loan balance. This involves a detailed analysis of two primary components: the loss on principal, which arises from the gap between the collateral’s liquidation value and the unpaid principal balance of the loan; and the loss associated with various ancillary costs to recover, including, but not limited to, foregone interest, transaction costs, legal and administrative fees, and expenses related to the maintenance and renovation of the property. The Company considers relevant current conditions and reasonable and supportable forecasts that relate to its lending practices and environment and the specific borrower and determines that the significant factor affecting the loan’s performance is the fact that these borrowers are involved in the cannabis business. Despite being legal at the state level in certain jurisdictions, cannabis remains federally illegal in the United States as of the date of this filing. As cannabis related lending is a new practice in the United States, there is very little historical or industry data on which to base a loss forecast. Therefore, significant judgement is required in creating a reasonable loss estimate, using similar non-MRB loans as a baseline and adjusting for the inherent risks in the cannabis industry. While the Company considers other qualitative factors, including national macroeconomic conditions, in its overall risk analysis, it has determined that they are not significant inputs to the overall loss estimate calculations.

 

 

The ACL estimation process also applies an economic forecast scenario, or a composite of scenarios based on management’s judgment and expectations around the current and future macroeconomic outlook. Expected credit losses are estimated over the contractual term of the loans, adjusted for expected prepayments when appropriate. The contractual term of a loan excludes expected extensions, renewals, and modification under certain conditions.

 

Recoveries on loans represent collections received on amounts that were previously charged off against the ACL. Recoveries are credited to the ACL when received, to the extent of the amount previously charged off against the ACL on the related loan. Any amounts collected in excess of this limit are first recognized as interest income, then as a reduction of collection costs, and then as other income.

 

Net Deferred Loan Origination Fees and Cost

ix. Net Deferred Loan Origination Fees and Cost

 

When included with a new loan origination, the Company receives loan origination fees in conjunction with new loans funded and any indemnified liabilities which are not recorded on the balance sheet from the company financial institution partners. Where applicable, the loan origination fee is netted with loan origination costs associated with originating a specific loan. These loan origination costs are typically incremental direct costs (non-reimbursed) paid to third parties. Net loan origination fees are initially deferred and presented net of loans receivable asset for portfolio loans, or as a separate liability for indemnified loans, and recognized as interest income utilizing the interest method.

 

Indemnity Liability

x. Indemnity Liability

 

Under the Loan Servicing Agreement and Commercial Alliance Agreement with PCCU, the Company had agreed to indemnify PCCU from all claims related to Company’s cannabis-related business, including but not limited to default-related credit losses as defined in the Loan Servicing Agreement. The indemnification component of the Loan Servicing Agreement and the Commercial Alliance Agreement (refer to Note 8 to the unaudited condensed consolidated financial statements) is accounted for in accordance with accounting standards codification (“ASC”) 460 Guarantees. In determining the applicability of ASC 460, the Company considered that the agreement outlines a broad indemnification of all claims related to the cannabis-related business. The most immediate and potentially significant of these are potential default-related credit losses. In the lending industry, it is inherently anticipated future credit losses will result from currently issued debt. The Company’s indemnity obligation is subordinate to financial institution clients’ other means of collecting on the loans including foreclosure of the collateral, recourse against personal and/or corporate guarantors and other default remedies available in the loan agreements. Since borrowers are not party to the agreement between Company and PCCU, any indemnity payments do not relieve borrowers of their obligation to PCCU nor would such payments preclude PCCU’s right to future recoveries from the debtor. Therefore, as defined in ASC 460, the indemnification clause represents a general loss contingency in that it is an existing condition, situation or set of circumstances involving uncertainty as to possible loss to the Company that will ultimately be resolved when one or more future events occur or fail to occur. SHF’s indemnity liability reflects SHF management’s estimate of probable credit losses inherent under the agreement at the balance sheet date. The liability is measured and recognized in accordance with our accounting policies for ACL and ALL.

 

In addition to default-related credit losses, the Company continuously monitors all other circumstances pursuant to the agreement and identifies events that may necessitate a loss contingency under the Loan Servicing Agreement. A loss contingency is reported when it is both probable that a future event will confirm that a loss had been incurred on or before the related balance sheet date and the loss is reasonably estimable.

 

Property and Equipment, net

xi. Property and Equipment, net

 

Property and equipment are recorded at historical cost, net of accumulated depreciation. Depreciation is provided over the assets’ useful lives on a straight-line basis 3-5 years for equipment and furniture and fixtures. Repairs and maintenance costs are expensed as incurred.

 

Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.

 

The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.

 

The Company capitalize certain costs related to software developed for internal-use, primarily associated with the ongoing development and enhancement of our technology platform. Costs incurred in the preliminary development and post-development stages are expensed. These costs are amortized on a straight-line basis over the estimated useful life of the related asset, generally five years.

 

 

Right of Use Assets and Lease Liabilities

xii. Right of Use Assets and Lease Liabilities

 

The Company has entered into lease agreements for a certain facility and certain items of equipment, which provide the right to use the underlying asset and require lease payments over the term of the lease. At inception of the lease agreement, the Company assesses whether the agreement conveys the right to control the use of an identified asset for a period in exchange for consideration, in which case it is classified as a lease. Each lease is further analyzed to check whether it meets the classification criteria of a finance or operating lease. All identified leases are recorded on the consolidated balance sheet with a corresponding lease right-of-use asset, net, representing the right to use the underlying asset for the lease term and the operating lease liabilities representing the obligation to make lease payments arising from the lease. The Company has elected not to recognize lease assets and lease liabilities for short-term leases (leases with a term of 12 months or less) and leases of low-value assets. Lease right-of-use assets, net and lease liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term and include options to extend or terminate the lease when they are reasonably certain to be exercised. The present value of lease payments is determined primarily using the incremental borrowing rate based on the information available as of the lease commencement date.

 

Lease expense for operating leases is recorded on a straight-line basis over the lease term and variable lease costs are recorded as incurred. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. Finance lease interest expense is recognized based on an effective interest method and depreciation of assets is recorded on a straight-line basis over the shorter of the lease term and useful life of the asset. Both operating and finance lease right of use assets are reviewed for impairment, consistent with other finite-lived assets, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. After a right of use asset is impaired, any remaining balance of the asset is amortized on a straight-line basis over the shorter of the remaining lease term or the estimated useful life.

 

Goodwill and Other Intangible Assets

xiii. Goodwill and Other Intangible Assets

 

The Company’s methodology for allocating the purchase price of an acquisition is based on established valuation techniques that reflect the consideration of a number of factors, including a valuation performed by a third-party appraiser. Goodwill is measured as the excess of the cost of an acquired business over the fair value assigned to identifiable assets acquired and liabilities assumed.

 

Goodwill is tested for impairment at least annually on the elected impairment test date of December 31 unless any events or circumstances indicate it is more likely than not that the fair value of the goodwill is less than its carrying value.

 

Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.

 

Finite-lived intangible assets are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. Intangible assets should be tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.

 

Stock-based Compensation

xiv. Stock-based Compensation

 

The Company measures all equity-based payment arrangements to employees and directors in accordance with ASC 718, Compensation–Stock Compensation. The Company’s stock-based compensation cost is measured based on the fair value at the grant date of the stock-based award. It is recognized as expense on a straight-line basis over the requisite service period for the entire award. Forfeitures are recognized as they occur. The Company estimates the fair value of each stock-based award on its measurement date using either the current market price of the stock or Black-Scholes option valuation model, whichever is most appropriate. The Black-Scholes valuation model incorporates assumptions such as expected term of the instrument, volatility of the Company’s future share price, risk free rates, future dividend yields and estimated forfeitures at the initial grant date, by reference to the underlying terms of the instrument, and the Company’s experience with similar instruments. Changes in assumptions used to estimate fair value could result in materially different results.

 

The shares of the Company have been listed on the Nasdaq stock exchange for a limited period of the time and also the stock price has dropped significantly from the date of listing, based on which the Company has considered the expected volatility at 100% for the purpose of stock compensation. The risk-free interest rates are based on quoted U.S. Treasury rates for securities with maturities approximating the awards’ expected lives. The expected term of the options granted is calculated based on the simplified method by taking average of contractual term and vesting period the awards. The expected dividend yield is zero as the Company has never paid dividends and does not currently anticipate paying any in the foreseeable future.

 

 

Fair Value Measurements

xv. Fair Value Measurements

 

The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:

 

Level 1 — Quoted prices for identical assets or liabilities in active markets.

 

Level 2 — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 —Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.

 

Revenue Recognition

xvi. Revenue Recognition

 

SHF recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which SHF expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.

 

Revenue is recorded at a point in time when the performance obligation is satisfied, and no contingencies exist. Majority of the revenue consists of fees earned on deposit accounts held at PCCU but serviced by SHF such as bank account charges, onboarding income, account activity fee income and other miscellaneous fees. Under the terms of the Loan Servicing Agreement and the Commercial Alliance Agreement, the Company is responsible for covering account hosting costs associated with the fees generated from deposits held at PCCU. These costs are classified as “General and Administrative Expenses” in the Consolidated Statements of Operations.

 

In addition, SHF recognizes revenue from the Master Program Agreement. The Master Program Agreement is a non-exclusive and non-transferable right to implement and utilize the Safe Harbor Program. The Safe Harbor Program has two performance obligations; an implementation fee recognized when the contract is effective and a service fee recognized ratable over the contract term as the compliance program is executed.

 

SHF recognizes revenue from interest on loans and investment income distributed by PCCU, which is determined by particular customer account balances. As per the Loan Servicing Agreement and the Commercial Alliance Agreement, SHF bears the expenses for hosting investments and servicing loans related to this interest and investment income. These expenses are allocated to “General and Administrative Expenses” in the Consolidated Statements of Operations.

 

Amounts received in advance of the service being provided is recorded as a liability under deferred revenue on the consolidated balance sheets. Typical Safe Harbor Program contracts are three-year contracts with amounts due monthly, quarterly or annually based on contract terms.

 

Customers consist of financial institutions providing services to CRBs. Revenues are concentrated in the United States of America.

 

Contract Liabilities

xvii. Contract Liabilities

 

The Company recognizes a contract liability if the customer’s payment of consideration precedes the reporting entity’s performance. As of March 31, 2024, the Company recorded contract liabilities amounting to $2,692 from contracts with customers. This compares to contract liabilities of $21,922 as reported on December 31, 2023.

 

 

Warrants Liabilities

xviii. Warrants Liabilities

 

The Company has evaluated each of the warrant arrangements separately in accordance with “Distinguishing Liabilities from Equity” (“ASC 480”) and “Derivatives and Hedging” (“ASC 815”), to determine classification as either equity instruments or liabilities based on the specific terms and features of each warrant. Warrants are recognized as equity if they are indexed to our own stock and meet the equity classification criteria in ASC 815-40. These warrants are recorded within stockholders’ equity at their issuance date and are not subsequently remeasured at fair value. Conversely, warrants that do not meet the criteria for equity classification under ASC 815-40 are classified as liabilities. Such warrants are initially recorded at fair value on the issuance date and are subject to remeasurement at each balance sheet date thereafter. Any changes in fair value are recognized in the statement of operations. None of our warrant contracts met criteria to be considered indexed to their own stock, and as a result, have each been accounted for as a liability financial instrument. The fair value of warrants classified as liabilities is determined using appropriate valuation models, such as the Black- Scholes model, which incorporates various inputs, including the current stock price, expected volatility, risk-free interest rate, and the expected term of the warrants.

 

Deferred consideration

xix. Deferred consideration

 

In line with ASC Topic 815, the Company treats the deferred consideration from the Abaca acquisition as a derivative liability, since it does not fulfill the equity classification criteria. As a result, this obligation is recognized as a liability on the balance sheet at fair value and is adjusted to reflect its fair value at the end of each reporting period. The liability will be reassessed at fair value on every balance sheet date until the obligation’s term concludes. Fluctuations in its fair value are recorded in the consolidated statements of operations.

 

Forward purchase derivative

xx. Forward purchase derivative

 

The Company accounts for the forward purchase derivative assumed in the business combination in accordance with the guidance contained in ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company classifies the forward purchase derivatives as an assets or liabilities carried at their fair value and adjusts the forward purchase derivatives to fair value at each reporting period. This derivative asset or liability is subject to re-measurement at each balance sheet date until the conditions under the forward purchase agreement are exercised or expire, and any change in fair value is recognized in the unaudited condensed consolidated statement of operations. In December 2023, the company calculated its valuation using a Monte Carlo Simulation set within a risk-neutral environment. Initiated in December 2022, this strategy was applied to assess the fair value of the forward purchase agreement (FPA) derivatives, with an underlying assumption that future stock prices would adhere to a Geometric Brownian Motion trajectory. Throughout the first quarter of 2024, there were no transactions by FPA holders, and no considerable shifts in risk factors that could influence the valuation of FPA derivatives were observed.

 

Earnings Per Share

xxi. Earnings Per Share

 

Basic and diluted earnings per share are computed and disclosed in accordance with ASC Topic 260, Earnings Per Shares. The Company utilizes the two-class method to compute earnings available to common shareholders. Under the two-class method, earnings are adjusted by accretion amounts to redeemable noncontrolling interests recorded at redemption value. The adjustments represent dividend distributions, in substance, to the noncontrolling interest holder as the holders have contractual rights to receive an amount upon redemption other than the fair value of the applicable shares. As a result, earnings are adjusted to reflect this in substance distribution that is different from other common shareholders. In addition, the Company allocates net earnings to each class of common stock and participating security as if all of the net earnings for the period had been distributed. The Company’s participating securities consist of share-based payment awards that contain a non-forfeitable right to receive dividends and therefore are considered to participate in undistributed earnings with common shareholders. Basic earnings per common share excludes dilution and is calculated by dividing net earnings allocated to common shares by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is calculated by dividing net earnings allocable to common shares by the weighted-average number of common shares outstanding for the period, as adjusted for the potential dilutive effect of non-participating share-based awards.

 

Income Tax

xxii. Income Tax

 

Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred tax assets and liabilities are adjusted through the provision for income taxes as changes in tax laws or rates are enacted.

 

 

ASC 740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods. If management is unable to estimate a portion of its ordinary income, but is otherwise able to reliably estimate the remainder, ASC 740-270-25-3 provides that the tax applicable to that item be reported in the interim period in which the item occurs. The tax (or benefit) related to ordinary income (or loss) shall be computed at an estimated annual effective tax rate and the tax (or benefit) related to all other items shall be individually computed and recognized when the items occur. Management is unable to estimate a portion of its ordinary income and as a result had computed the company’s tax provision in accordance with ASC 740-270-25-3.

 

ASC Topic 740 also prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

Recently Issued Accounting Standards

xxiii. Recently Issued Accounting Standards

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position or results of operations upon adoption.

 

Adopted Standards

 

Current Expected Credit Losses

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduces a model based on expected losses to estimate credit losses for most financial assets and certain other instruments. In November 2019, the FASB issued ASU No. 2019-10 Financial Instruments — Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). The update allows the extension of the initial effective date for entities which have not yet adopted ASU No. 2016-02. The standard is effective for annual reporting periods beginning after December 15, 2022 for private companies and SEC filers classified as smaller reporting entities, with early adoption permitted. Entities apply the standard’s provisions by recording a cumulative effect adjustment to retained deficit. The Company has adopted ASU 2016-13 as of January 1, 2023, utilizing the modified retrospective method.

 

CECL Transition Impact: The table below provides details on the transition impacts of adopting CECL. Other balance sheet lines not presented were not affected by CECL.

 

CECL Transition Impact:

 

Assets   December 31,
2022
    Transition
Adjustment
    January 1,
2023
 
Loans receivable, gross   $ 1,432,560     $ -     $ 1,432,560  
Less: Allowance for credit loss     (21,488 )     (14,980 )     (36,468 )
    $ 14,11,072     $ (14,980 )   $ 1,396,092  

 

Liabilities & Equity  December 31,
2022
   Transition
Adjustment
   January 1,
2023
 
Indemnity liability  $499,465   $566,341   $1,065,806 
Retained deficit   (39,695,281)   (581,321)   (40,276,602)
   $(39,195,816)  $(14,980)  $(39,210,796)

 

Troubled Debt Restructurings and Vintage Disclosures

 

This Accounting Standard Update (ASU 2022-02) eliminates the recognition and measurement guidance on troubled debt restructurings for creditors that have adopted ASC 326 and requires them to make enhanced disclosures about loan modifications for borrowers experiencing financial difficulty. The new guidance also requires public business entities to present current period gross write-offs (on a current year-to-date basis for interim-period disclosures) by year of origination in their vintage disclosures. For entities that have adopted ASU 2016-13, this ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2023 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

 

Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions

 

This Accounting Standard Update (ASU 2022-03) clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered when measuring fair value. Recognizing a contractual restriction on the sale of an equity security as a separate unit of account is not permitted. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2024 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848

 

This Accounting Standard Update (ASU 2022-06) defers the Sunset Date of ASC Topic 848, Reference Rate Reform (Topic 848), which provides temporary optional relief in accounting for the impact of Reference Rate Reform. This ASU is effective upon issuance (December 21, 2022) and generally can be applied through December 31, 2024.This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

Investments-Equity Method and Joint Ventures

 

In March 2023, the FASB issued ASU 2023-02, Investments-Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures using the Proportional Amortization Method. The FASB issued final guidance allowing entities to apply the proportional amortization method to equity investments in all tax credit programs that meet the conditions in ASC 323-740, rather than just investments in qualified affordable projects that generate low income housing tax credits, as was required under the legacy guidance. The guidance is effective for public business entities for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.

 

Standards Pending to be Adopted

 

Business Combinations-Joint Venture Formations

 

In August 2023, the FASB issued 2023-05, Business Combinations-Joint Venture Formations (Subtopic 805-60); Recognition and Initial Measurement. This ASU contains guidance requiring certain joint ventures to apply a new basis of accounting upon formation by recognizing and initially measuring most of their assets and liabilities at fair value. This guidance is effective for all joint venture formations with a formation date on or after January 1, 2025. Early adoption is permitted. Joint Ventures formed before the effective date have the option to apply it retrospectively, while those formed after the effective date are required to apply it prospectively. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.”

 

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ASU amends the disclosure or presentation requirements related to various subtopics in the FASB codification.

 

The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. For all other entities, the amendments will be effective two years later. The amendments in this Update should be applied prospectively. For all entities, if by June 30, 2027, the SEC has not removed the applicable requirement from Regulation S-X or Regulation S-K, the pending content of the related amendment will be removed from the Codification and will not become effective for any entity. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

Segment Reporting

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280). This ASU requires public entities to provide disclosures of significant segment expenses and other segment items. It also requires public entities to provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Public entities with a single reportable segment will have to provide all the disclosures required by ASC 280, including the significant segment expense disclosures. This guidance is applied retrospectively to all periods presented, unless it is impractical. This ASU applies to all public entities and is effective for fiscal years beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

 

Income Taxes

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This ASU requires public business entities to disclose in their rate reconciliation table additional categories of information about income taxes paid, including certain disclosures that would be disaggregated by jurisdiction and other categories. This ASU is effective for fiscal years after December 15, 2024. Early adoption would be permitted. The Company does not expect this ASU to have a material impact on its condensed unaudited consolidated financial statements.

 

ASU 2024-01: Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards

 

ASU 2024-01 clarifies the scope applications of profits interest awards by adding illustrative guidance to ASC 718 “Compensation-Stock Compensation.” The amendments in the ASU apply to all reporting entities that account for profits interest awards as compensation to employees or non-employees in return for goods or services.

 

The term “profits interest” is not explicitly defined in US GAAP. Rather, an IRS Revenue Procedure (Rev Proc 93-27) defines a “Profits Interest” as a “partnership interest other than a capital interest.” Unlike a capital interest, which provides rights to existing net assets of an entity, a profits interest only provides rights to future profits and/or equity appreciation of an entity. This distinction, along with other terms, conditions and characteristics of profits interests often complicates accounting decisions for profits interests, leading to diversity in practice whether to account for profits interests under ASC 718 or other US GAAP.

 

The ASU introduces four (4) illustrative examples of fact patterns that demonstrate how an entity would apply the scope guidance in paragraph 718-10-15-3 to a profits interest or similar award with certain features.

 

The ASUs are effective for public entities for fiscal years beginning after December 15, 2024, including interim periods within those years. For all other entities, adoption is required for fiscal years beginning after December 15, 2025. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

 

ASU 2024-02: Codification Improvements—Amendments to Remove References to the Concepts Statements

 

The ASU contains amendments to the Codification that remove references to various FASB Concepts Statements. The Board has a standing project on its agenda to address suggestions received from stakeholders on the Accounting Standards Codification and other incremental improvements to GAAP. This effort facilitates Codification updates for technical corrections such as conforming amendments, clarifications to guidance, simplifications to wording or the structure of guidance and other minor improvements. In the Board’s view, removing all references to Concept Statements in the guidance will simplify the codification and draw a distinction between authoritative and non-authoritative literature.

 

The amendments in the Update are effective for public business entities for fiscal years beginning after December 15, 2024. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2025. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.

XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of Current Expected Credit Losses Transition Impact

 

Assets   December 31,
2022
    Transition
Adjustment
    January 1,
2023
 
Loans receivable, gross   $ 1,432,560     $ -     $ 1,432,560  
Less: Allowance for credit loss     (21,488 )     (14,980 )     (36,468 )
    $ 14,11,072     $ (14,980 )   $ 1,396,092  

 

Liabilities & Equity  December 31,
2022
   Transition
Adjustment
   January 1,
2023
 
Indemnity liability  $499,465   $566,341   $1,065,806 
Retained deficit   (39,695,281)   (581,321)   (40,276,602)
   $(39,195,816)  $(14,980)  $(39,210,796)
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Deferred Consideration (Tables)
3 Months Ended
Mar. 31, 2024
Deferred Consideration  
Schedule of Change in Deferred Consideration

The change in the amount of deferred consideration from January 1, 2023, to March 31, 2024, is as follows:

 

   Stock
consideration
   Cash
consideration
   Third Anniversary
Consideration Payment
 
January 1, 2023  $11,456,639   $5,650,775   $- 
Less: Working capital adjustment   (108,691)   -    - 
Less: Issuance of shares and payment to shareholders   (4,085,075)   (3,000,000)   - 
Less: Issuance of Abaca warrants   (1,643,699)   -    - 
Less: Issuance of third anniversary payment consideration   (430,000)   -    430,000 
Less: Gain recognized in the consolidated statements of operations   (5,645,107)   -    - 
Add: Fair value adjustment   455,933    239,017    380,000 
December 31, 2023   -    2,889,792    810,000 
Add: Fair value adjustment   -    31,465    (216,000)
March 31, 2024  $-   $2,921,257   $594,000 
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Finite-lived Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite Lived Intangible Assets

Following is a summary of the Company’s finite-lived intangible assets as of March 31, 2024 and December 31, 2023:

 

   Remaining
Useful life in
Years
  December 31, 2023
(A)
   Acquired in
Acquisition
(B)
   Amortization
(C)
   Impairment
(D)
   March 31, 2024
(A+B-C-D)
 
Market related intangible assets  6.62 Years  $65,216   $-   $2,540   $-   $62,676 
Customer relationships  8.62 Years   56,775    -    1,687    -    55,088 
Developed technology  5.62 Years   3,599,754    -    152,628    -    3,447,126 
Total intangible assets     $3,721,745   $-   $156,855   $-   $3,564,890 

 

   Remaining
Useful life in
Years
  December 31, 2022
(A)
   Acquired in
Acquisition
(B)
   Amortization
(C)
   Impairment
(D)
   December 31, 2023
(A+B-C-D)
 
Market related intangible assets  6.87 Years  $2,066,918   $-   $136,034    1,865,668   $65,216 
Customer relationships  8.87 Years   1,974,795    -    103,225    1,814,795    56,775 
Developed technology  5.87 Years   6,579,374    -    960,619    2,019,001    3,599,754 
Total intangible assets     $10,621,087   $-   $1,199,878    5,699,464   $3,721,745 
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Loans Receivable (Tables)
3 Months Ended
Mar. 31, 2024
Receivables [Abstract]  
Schedule of Commercial Real Estate Loans Receivable

Commercial real estate loans receivable, net consist of the following:

 

   March 31, 2024   December 31, 2023 
Commercial real estate loans receivable, gross  $401,564   $404,577 
Allowance for credit losses   (9,081)   (10,723)
Commercial real estate loans receivable, net   392,483    393,854 
Current portion   (12,620)   (12,391)
Noncurrent portion  $379,863   $381,463 
Schedule of Allowance For Loan Losses

The allowance for credit losses consists of the following activity for the three months ended March 31, 2024 and three months ended March 31, 2023:

 

   March 31, 2024   March 31, 2023 
Allowance for credit losses          
Beginning balance  $10,723   $21,488 
Cumulative effect from adoption of CECL   -    14,980 
Charge-offs   -    - 
Recoveries   -    (15,390)
Benefit   (1,642)   - 
Ending balance  $9,081   $21,078 
           
Loans receivable:          
Individually evaluated for an allowance for credit loss  $-   $- 
Collectively evaluated for an allowance for credit loss   401,564    413,292 
   $401,564   $413,292 
Allowance for credit losses:          
Individually evaluated for an allowance for credit loss  $-   $- 
Collectively evaluated for an allowance for credit loss   9,081    21,078 
   $9,081   $21,078 
Schedule of Risk Rating

The carrying value, excluding the CECL Reserve, of the Company’s loans held at carrying value within each risk rating is as follows:

 

Risk rating  March 31, 2024   December 31, 2023 
4  $401,564   $404,577 
Grand total  $401,564   $404,577 
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Indemnification Liability (Tables)
3 Months Ended
Mar. 31, 2024
Indemnification Liability  
Schedule of Outstanding Amounts

 

   March 31, 2024   December 31, 2023 
Secured term loans  $57,737,288   $55,215,013 
Unsecured loans and lines of credit   431,640    431,640 
Total loans funded by PCCU  $58,168,928   $55,646,653 
Schedule of Indemnity Liability

The indemnity liability activity are as follows:

 

   Three Months ended
March 31, 2024
   Three Months ended
March 31, 2023
 
Beginning balance  $1,382,408   $499,465 
Cumulative effect from adoption of CECL   -    566,341 
Charge-offs   -    - 
Recoveries   -    - 
(Benefit)/ Provision   (67,145)   82,026 
Ending balance  $1,315,263   $1,147,832 
Schedule of Indemnified Loans Risk Rating

The carrying value, excluding the CECL Reserve, of the Company’s indemnified loans held at carrying value within each risk rating is as follows:

 

Risk rating  March 31, 2024  December 31, 2023 
3  $9,988,588  $10,100,000 
4   3,425,158   3,431,640 
5   30,553,007   28,115,013 
6   10,900,000   10,900,000 
7   -   3,100,000 
8   3,302,175   - 
Grand total  $58,168,928  $55,646,653 
Schedule of Provision for Loan Losses

The provision for credit losses on the statement of operations consists of the following activity for the period ended March 31, 2024 and March 31, 2023:

 

   Commercial
real estate
loans
   Indemnity
liability
   Total   Commercial
real estate
loans
   Indemnity
liability
   Total 
   March 31, 2024   March 31, 2023 
   Commercial
real estate
loans
   Indemnity
liability
   Total   Commercial
real estate
loans
   Indemnity
liability
   Total 
Provision (benefit)  $(1,642)   (67,145)   (68,787)  $(15,390)   82,056    66,666 
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment, Net (Tables)
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment consist of the following:

 

   March 31, 2024   December 31, 2023 
Equipment  $45,397   $45,397 
Software   51,692    51,692 
Improvement   71,635    71,635 
Office furniture   215,504    215,504 
Property and equipment, gross   384,228    384,228 
Less: accumulated depreciation   (338,862)   (300,008)
Property and equipment, net  $45,366   $84,220 
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions (Tables)
3 Months Ended
Mar. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Schedule of Revenue from Operations

The revenue from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Account servicing agreement  $-   $3,261,284 
Commercial alliance agreement   3,585,856    - 
Total  $3,585,856   $3,261,284 
Schedule of Operating Expense from Operations

The operating expense from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:

 

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Support services agreement  $-   $378,730 
Loan servicing agreement   -    11,929 
Commercial alliance agreement   300,261    - 
Total  $300,261   $390,659 
Schedule of Outstanding Balances from Balance Sheet

The outstanding balances associated with the PCCU disclosed in the balance sheet are as follows:

 

   March 31, 2024   December 31, 2023 
Accounts receivable  $1,111,390   $2,095,320 
Accounts payable   125,693    577,315 
Senior Secured Promissory Note (Refer to Note 9 to the unaudited condensed consolidated financial statements)   13,270,622    14,011,166 
Loan Servicing Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Schedule of Demonstrated Deposit Capacity

The below schedule demonstrates the ratio of CRB related loans funded by PCCU to the relative lending limits:

 

   March 31, 2024
(Unaudited)
   December 31, 2023
(Unaudited)
 
CRB related deposits  $106,692,488   $129,350,998 
Capacity at 60%   64,015,493    77,610,599 
PCCU net worth   83,739,916    81,087,746 
Capacity at 1.3125   109,908,640    106,670,306 
Limiting capacity   64,015,493    77,610,599 
PCCU loans funded   57,737,287    55,660,039 
Amounts available under lines of credit   775,000    525,000 
Incremental capacity  $5,503,206   $21,425,560 
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Senior Secured Promissory Note (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Senior Secured Promissory Note

   March 31, 2024   December 31, 2023 
Senior Secured Promissory Note (Current)  $3,028,738   $3,006,991 
Senior Secured Promissory Note (long term)   10,241,884    11,004,175 
Total  $13,270,622   $14,011,166 
Schedule of Outstanding Amount on Debt

The repayment schedule of the outstanding principal amount on March 31, 2024, is as follows:

 

      
Year of payment     
2024   $2,266,449 
2025    3,138,931 
2026    3,274,966 
2027    3,416,896 
2028    1,173,380 
Grand total   $13,270,622 
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases (Tables)
3 Months Ended
Mar. 31, 2024
Leases  
Schedule of Lease Cost

   Three months ended
March 31, 2024
   Three months ended
March 31, 2023
 
Operating lease cost  $-   $- 
Short-term lease cost   69,437    87,742 
Total Lease Cost  $69,437   $87,742 
Schedule of Right Of Use Assets

   March 31, 2024   December 31, 2023 
ROU assets that are related to lease properties are presented as follows:          
Beginning balance  $859,861   $1,016,198 
Additions to right-of-use assets   -    - 
Amortization charge for the period   (39,084)   (156,337)
Lease modifications   -    - 
Ending balance  $820,777   $859,861 
           
Further information related to leases is as follows:          
Weighted-average remaining lease term   3.17 Years    3.42 Years 
Weighted-average discount rate   6.87%   6.87%
Schedule of Future Minimum Lease Payments

Future minimum lease payments as of March 31, 2024, and December 31, 2023, are as follows:

 

Year         
2024   $151,111   $197,520 
2025    217,925    217,925 
2026    222,275    222,275 
2027    226,705    226,705 
2028    231,216    231,216 
Thereafter    117,710    117,710 
Total future minimum lease payments   $1,166,942   $1,213,351 
Less: Imputed interest    188,481    205,358 
Operating lease liabilities    978,461    1,007,993 
Less: Current portion    142,863    132,546 
Non-current portion of lease liabilities   $835,598   $875,447 
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue (Tables)
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregated Revenue

Revenue by type are as follows:

 

   2024   2023 
   Three months ended
March 31
 
   2024   2023 
Deposit, activity, onboarding income  $1,620,994   $2,245,831 
Safe Harbor Program income   19,230    51,103 
Investment income   773,819    1,417,152 
Loan interest income   1,636,756    466,293 
Total Revenue  $4,050,799   $4,180,379 
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Earning Per Shares, Basic and Diluted

 

For the three month period ended March 31  2024   2023 
Net Income/ (loss)  $2,049,676   $(1,413,447)
Weighted average shares outstanding – basic   55,213,609    25,670,730 
Basic net income/ (loss) per share  $0.04   $(0.06)
Weighted average shares outstanding – diluted   56,268,075    25,670,730 
Diluted net income/ (loss) per share  $0.04   $(0.06)
Schedule of Weighted Average Shares Outstanding - Basic And Diluted
Weighted average shares calculation - basic  2024   2023 
  

Three months ended

March 31

 
Weighted average shares calculation - basic  2024   2023 
Company public shares   3,926,598    3,926,598 
Company initial stockholders   3,403,175    3,403,175 
PCCU stockholders   22,586,139    11,759,472 
Shares issued for abaca acquisition   7,935,800    2,099,977 
Restricted stock units issued   1,308,089    566,755 
Conversion of preferred stock   16,053,808    3,914,753 
Grand total   55,213,609    25,670,730 

 

Weighted average shares calculation - diluted   2024    2023  
  

Three months ended

March 31

 
Weighted average shares calculation - diluted   2024    2023  
Shares used in computation of basic earnings per share    55,213,609      -  
Shares to be issued to Abaca shareholders    750,000      -  
Share based payments    215,666      -  
Conversion of preferred stock    

88,800

      -  
Grand total    

56,268,075

             -  
Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings

Certain share-based equity awards and warrants were excluded from the computation of dilutive earnings/ (loss) per share because inclusion of these awards would have had an anti-dilutive effect. The following table reflects the awards excluded.

 

   March 31, 2024  

March 31, 2023

 
Warrants   

12,036,588

    

7,036,588

 
Share based payments   

2,284,080

    

2,775,655

 
Shares to be issued to Abaca shareholders   -    6,433,839 
Conversion of preferred stock   -    10,896,000 
Grand total   14,320,668    27,142,082 
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Forward Purchase Agreement (Tables)
3 Months Ended
Mar. 31, 2024
Forward Purchase Agreement  
Schedule of Forward Purchase Agreement

The reconciliation statement of the Class A common stock held by the parties are as follows:

 

       As at
December 31, 2023
   Shares sold during
the three months ended
March 31, 2024
   As at
March 31, 2024
 
S.no   Name of the party  Opening
Shares
(a)
   Amount   Shares
(b)
   Amount   Shares
(c=a-b)
   Rest price
(iii)
   Amount
(c x iii)
 
1   Vellar   971,204   $1,214,005    -   $-    971,204    1.25   $1,214,005 
2   Midtown East   1,517,924    1,897,405    -    -    1,517,924    1.25    1,897,405 
3   Verdun   1,178,249    1,472,811    -    -    1,178,249    1.25    1,472,811 
Grand total   3,667,377   $4,584,221    -   $-    3,667,377        $4,584,221 
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis

The following tables summarize financial assets and liabilities recorded at fair value on a recurring basis, by the level of valuation inputs in the fair value hierarchy on March 31, 2024 and December 31, 2023:

 

   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
   March 31, 2024   December 31, 2023 
   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
   Total Fair
Value
   Quoted
Prices in
Active
Markets
(Level 1)
   Significant
Other
Unobservable
Inputs
(Level 3)
 
Description                        
Liabilities:                        
PIPE warrants  $189,220    -    189,220   $273,124    -    273,124 
Public warrants  $430,675    430,675    -   $481,850    481,850    - 
Private placement warrants  $20,315    -    20,315   $25,070    -    25,070 
Abaca warrant  $2,268,432    -    2,268,432   $3,384,085    -    3,384,085 
Forward purchase derivative liability  $7,309,580    -    7,309,580   $7,309,580    -    7,309,580 
Third anniversary payment consideration  $594,000    -    594,000   $810,000    -    810,000 
Schedule of Carrying Amounts and Fair Values of Financial Instruments

The following tables present the carrying amounts and fair values of financial instruments, by the level of valuation inputs in the fair value hierarchy, as of the dates indicated:

 

           Level 1   Level 2   Level 3 
   As on March 31, 2024 
   Carrying
amount
   Fair value   Fair value measurement using 
           Level 1   Level 2   Level 3 
Assets                    
Cash and cash equivalents  $5,626,362   $5,626,362   $5,626,362   $-   $- 
Forward purchase receivables   4,584,221    4,584,221    4,584,221    -    - 
Loans   392,483    362,671              362,671 
Liabilities                         
Deferred consideration   2,921,257    2,921,257    2,921,257    -    - 
Senior Secured Promissory note   13,270,622    12,137,875    -    -    12,137,875 
Indemnity liability   1,315,263    1,315,263    1,315,263    -    - 
Public warrants   430,675    430,675    430,675    -    - 
Private placement warrants   20,315    20,315    -    -    20,315 
PIPE Warrants   189,220    189,220    -    -    189,220 
Abaca Warrants   2,268,432    2,268,432    -    -    2,268,432 
Third anniversary payment consideration   594,000    594,000    -    -    594,000 
Forward purchase derivative   7,309,580    7,309,580    -    -    7,309,580 

 

                Level 1     Level 2     Level 3  
    As on December 31, 2023  
    Carrying
amount
    Fair value     Fair value measurement using  
                Level 1     Level 2     Level 3  
Assets                              
Cash and cash equivalents   $ 4,888,769     $ 4,888,769     $ 4,888,769     $ -     $ -  
Forward purchase receivables     4,584,221       4,584,221       4,584,221       -       -  
Loans     330,579       363,561       -       -       363,561  
Liabilities                                        
Deferred consideration     2,889,792       2,889,792       2,889,792       -       -  
Senior secured promissory note     14,011,166       12,750,204       -       -       12,750,204  
Public warrants     481,850       481,850       481,850       -       -  
Private placement warrants     25,070       25,070       -       -       25,070  
PIPE warrants     273,124       273,124       -       -       273,124  
Abaca warrants     3,384,085       3,384,085       -       -       3,384,085  
Forward purchase derivative     7,309,580       7,309,580       -       -       7,309,580  
Third anniversary payment consideration     810,000       810,000       -       -       810,000  
Schedule of Fair Value Assets Measured on Recurring Basis

The change in the assets measured at fair value on a recurring basis for which the Company have utilized Level 3 inputs to determine fair value are presented in the following table:

 

    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
   For the period ended March 31, 2024 
    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
Balance at the beginning of the period  $273,124   $3,384,085   $25,070   $810,000   $7,309,580 
Issued to Abaca shareholders   -    -    -    -    - 
Fair value adjustment   (83,904)   (1,115,653)   (4,755)   (216,000)   - 
Balance at the end of the period  $189,220   $2,268,432   $20,315   $594,000   $7,309,580 

 

    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
   For the period ended March 31, 2023 
    PIPE
Warrants
    Abaca
Warrant
    Private
Placement
Warrants
    Third
Anniversary
Payment
Consideration
    Forward
Purchase
Derivative
 
Balance at the beginning of the period  $286,300   $-   $19,110   $-   $7,309,580 
Fair value adjustment   (211,538)   -    (11,157)   -    - 
Balance at the end of the period  $74,762   $-   $7,953   $-   $7,309,580 
Purchase Agreement Option [Member]  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]  
Schedule of Level 3 Fair Value Measurements Inputs

The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the forward purchase derivatives as of their measurement dates on March 31, 2024 and December 31, 2023:

 

   March 31, 2024   December 31, 2023 
Reset Price  $1.25   $1.25 
Expected term (years)   1.49    1.74 
Additional Maturity Consideration per share  $2.00   $2.00 
Volatility   46%   46%
Risk-free rate   4.2%   4.2%
Risk-adjusted discount rate   13.4%   13.4%
Warrant [Member]  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]  
Schedule of Level 3 Fair Value Measurements Inputs

The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the private placement warrants and public warrants as of their measurement dates:

 

    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
 
       March 31, 2024   December 31, 2023 
    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
    PIPE
Warrants
    Private
Warrants
    Third
Anniversary
Payment
Consideration
    Abaca
Warrants
 
Exercise price  $5    11.5    -    2   $5    11.5    -    2 
Share Price  $0.97    0.97    0.97    0.97   $1.42    1.42    1.42    1.42 
Expected term (years)   3.49    3.49    1.51    4.57    3.74    3.74    1.76    4.84 
Volatility   76.00%   76.00%   76.00%   76.00%   62.95%   62.95%   62.95%   62.95 
Risk-free rate   4.26%   4.26%   4.26%   4.36%   4.25%   4.25%   4.25%   4.25 
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Fair Value of Options Granted Black-Scholes-Merton Model

The assumptions used to determine the fair value of options granted in the three months ended March 31, 2024, using the Black-Scholes-Merton model are as follows:

 

Dividend yield   0%  
Risk-free interest rate   3.62 % to 4.23%  
Expected volatility (weighted-average and range, if applicable)   100%  
Expected term   6 to 6.5 years   
Schedule of Stock Option and Related Information

A summary of the Company’s stock option activities and related information for the three months ended March 31, 2024 is as follows:

 

Stock Option  No. of Stock
Option
   Weighted-
Average Grant
Date Fair Value
Per Stock
Option
   Weighted-
Average
Remaining
Contractual Life
(in Years)
 
December 31, 2023   2,286,010   $5.43    1.65 
Granted   -    -    - 
Exercised   -    -    - 
Expired   -    -    - 
Cancelled / Forfeited   (1,930)   1.56    - 
March 31, 2024   2,284,080   $5.43    1.40 

 

A summary of the Company’s stock option activities and related information for the three months ended March 31, 2023 is as follows:

 

Stock Option  No. of Stock
Option
   Weighted-
Average Grant
Date Fair Value
Per Stock Option
   Weighted-
Average
Remaining
Contractual Life
(in Years)
 
December 31, 2022   2,170,000   $3.53    2.02 
Granted   336,730    1.03    2.76 
Exercised   -    -    - 
Expired   -    -      
Cancelled / Forfeited   (64,875)   3.13    - 
March 31, 2023   2,441,855   $3.20    2.39 
Schedule of Options Outstanding

The following options were outstanding at their respective exercise price:

 

Exercise price options outstanding   March 31, 2024   March 31, 2023 
$1.56    374,580    359,355 
$2.58    350,000    350,000 
$4.00    309,500    482,500 
$6.67    1,250,000    1,250,000 
Total    2,284,080    2,441,855 
Schedule of Restricted Stock Units

A summary of the Company’s RSU activities and related information for the three months ended March 31, 2024 is as follows:

 

Restricted Stock Units  No. of RSU   Weighted-
Average Grant
Date Fair Value
Per RSU
   Weighted-
Average
Remaining
Contractual
Life
(in Years)
 
December 31, 2023   323,500   $1.31    2.00 
Granted   -    -    - 
Vested   (107,833)   1.31    - 
Expired   -    -    - 
Cancelled / Forfeited   -    -    - 
March 31, 2024   215,667   $1.31    1.75 

 

Restricted Stock Units  No. of RSU   Weighted-
Average Grant
Date Fair Value
Per RSU
   Weighted-
Average
Remaining
Contractual
Life
(in Years)
 
December 31, 2022   -   $-    - 
Granted   963,528    1.31    2.76 
Vested   -    -    - 
Expired   -    -    - 
Cancelled / Forfeited   -    -    - 
March 31, 2023   963,528   $1.31    2.76 
Schedule of Exercise Price of Restricted Stock Units

The following RSU were outstanding at their respective vest price:

 

Vest price RSU outstanding   March 31, 2024   March 31, 2023 
$1.31    215,667    963,528 
Total    215,667    963,528 
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Current Expected Credit Losses Transition Impact (Details) - USD ($)
Jan. 01, 2023
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]        
Indemnity liability   $ 1,315,263 $ 1,382,408  
Retained earning   (70,386,394) (71,569,821)  
Liabilities & Equity   $ (67,702,471) $ (67,860,909)  
Cumulative Effect, Period of Adoption, Adjustment [Member]        
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]        
Loans receivable, gross      
Allowance for loan losses (14,980)      
Loans receivable, net (14,980)      
Indemnity liability 566,341      
Retained earning (581,321)      
Liabilities & Equity (14,980)      
Credit Expected Credit Losses Transition [Member]        
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]        
Loans receivable, gross 1,432,560     $ 1,432,560
Less: Allowance for credit loss (36,468)     (21,488)
Loans receivable, net 1,396,092     1,411,072
Indemnity liability 1,065,806     499,465
Retained earning (40,276,602)     (39,695,281)
Liabilities & Equity $ (39,210,796)     $ (39,195,816)
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Property, Plant and Equipment [Line Items]      
Cash $ 5,626,362   $ 4,888,769
Working capital deficit 318,825   135,355
Retained deficit 70,386,394   71,569,821
Operating income $ 324,941 $ (1,621,669)  
Percentage of total loans receivables 100.00%    
Percentage of loans receivables 10.00%    
Expected volatility rate 100.00%    
Contract liabilities $ 2,692   $ 21,922
Equipment and Furniture and Fixtures [Member] | Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Property and equipment useful life 3 years    
Equipment and Furniture and Fixtures [Member] | Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Property and equipment useful life 5 years    
Revision of Prior Period, Reclassification, Adjustment [Member]      
Property, Plant and Equipment [Line Items]      
Accounts receivable trade $ 190,943    
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Change in Deferred Consideration (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Deferred Consideration    
Deferred stock consideration, Balance $ 11,456,639
Deferred cash consideration, Balance 2,889,792 5,650,775
Deferred consideration payment, Balance 810,000
Stock consideration, Working capital adjustment   (108,691)
Cash consideration, Working capital adjustment  
Stock consideration, Issuance of shares and payment to shareholders   (4,085,075)
Cash consideration, Issuance of shares and payment to shareholders   (3,000,000)
Stock consideration, Issuance of payment consideration   (1,643,699)
Stock consideration, Issuance of payment consideration   (430,000)
Consideration payment, Issuance of payment consideration   430,000
Stock consideration, Gain recognized in the consolidated statements of operations   (5,645,107)
Stock consideration, Fair value adjustment 455,933
Cash consideration, Fair value adjustment 31,465 239,017
Consideration payment, Fair value adjustment (216,000) 380,000
Deferred stock consideration, Balance
Deferred cash consideration, Balance 2,921,257 2,889,792
Deferred consideration payment, Balance $ 594,000 $ 810,000
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Deferred Consideration (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Oct. 26, 2023
Mar. 31, 2024
Common Class A [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Warrant exercise price   $ 11.50
Abaca Merger Closing [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Payments to acquire businesses   $ 30.0
Abaca Merger Closing [Member] | Cash [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Payments to acquire businesses   $ 9.0
Merger Agreement [Member] | Abaca [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Payments to acquire businesses $ 1.5  
Number of shares issued for acquisition 5,835,822  
Share issued price per share $ 2.00  
Number of warrant issued 5,000,000  
Warrant exercise price $ 2.00  
Merger Agreement [Member] | Abaca [Member] | Common Class A [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Stock issued during period, shares, acquisitions   2,100,000
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Finite Lived Intangible Assets (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross  
Finite-Lived Intangible Assets, Accumulated Amortization 156,855 1,199,878  
Intangible Assets, Net (Excluding Goodwill) 5,699,464  
Finite-lived intangible assets, net 3,564,890 3,721,745 $ 10,621,087
Marketing-Related Intangible Assets [Member]      
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross  
Finite-Lived Intangible Assets, Accumulated Amortization 2,540 136,034  
Intangible Assets, Net (Excluding Goodwill) 1,865,668  
Finite-lived intangible assets, net $ 62,676 $ 65,216 2,066,918
Remaining useful life in years 6 years 7 months 13 days 6 years 10 months 13 days  
Customer Relationships [Member]      
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross  
Finite-Lived Intangible Assets, Accumulated Amortization 1,687 103,225  
Intangible Assets, Net (Excluding Goodwill) 1,814,795  
Finite-lived intangible assets, net $ 55,088 $ 56,775 1,974,795
Remaining useful life in years 8 years 7 months 13 days 8 years 10 months 13 days  
Developed Technology Rights [Member]      
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross  
Finite-Lived Intangible Assets, Accumulated Amortization 152,628 960,619  
Intangible Assets, Net (Excluding Goodwill) 2,019,001  
Finite-lived intangible assets, net $ 3,447,126 $ 3,599,754 $ 6,579,374
Remaining useful life in years 5 years 7 months 13 days 5 years 10 months 13 days  
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Finite-lived Intangible Assets (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]      
Non-cash goodwill impairment charge     $ 13,210,000
Goodwill $ 6,058,000   6,058,000
Goodwill impairment 13,208,276   $ 13,208,276
Impairment charge 3,680,463    
Impairment 354,911 $ 0  
Developed Technology Rights [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment charge $ 2,019,000    
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Commercial Real Estate Loans Receivable (Details) - Commercial Real Estate Loans Receivable [Member] - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Short-Term Debt [Line Items]    
Commercial real estate loans receivable, gross $ 401,564 $ 404,577
Allowance for credit losses (9,081) (10,723)
Commercial real estate loans receivable, net 392,483 393,854
Current portion (12,620) (12,391)
Noncurrent portion $ 379,863 $ 381,463
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Allowance For Loan Losses (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Receivables [Abstract]      
Allowance for credit losses, beginning balance $ 10,723 $ 21,488  
Cumulative effect from adoption of CECL 14,980  
Charge-offs  
Recoveries (15,390)  
Provision (1,642)  
Allowance for credit losses,ending balance 9,081 21,078  
Individually evaluated for impairment  
Collectively evaluated for impairment 401,564 413,292 $ 404,577
Loans receivable 401,564 413,292  
Individually evaluated for impairment  
Collectively evaluated for impairment 9,081 21,078  
Allowance for loan losses $ 9,081 $ 21,078 $ 10,723
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Risk Rating (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Financing Receivable, Credit Quality Indicator [Line Items]      
Grand total $ 401,564 $ 404,577 $ 413,292
Risk Rate 4 [Member]      
Financing Receivable, Credit Quality Indicator [Line Items]      
Grand total $ 401,564 $ 404,577  
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Outstanding Amounts (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total loans funded by PCCU $ 58,168,928 $ 55,646,653
P C C U Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Secured term loans 57,737,288 55,215,013
Unsecured loans and lines of credit 431,640 431,640
Total loans funded by PCCU $ 58,168,928 $ 55,646,653
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Indemnity Liability (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Indemnification Liability    
Beginning balance $ 1,382,408 $ 499,465
Cumulative effect from adoption of CECL 566,341
Charge-offs
Recoveries
(Benefit)/ Provision (67,145) 82,026
Ending balance $ 1,315,263 $ 1,147,832
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Indemnified Loans Risk Rating (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Financing Receivable, Credit Quality Indicator [Line Items]    
Grand total $ 58,168,928 $ 55,646,653
Risk Rate 3 [Member]    
Financing Receivable, Credit Quality Indicator [Line Items]    
Grand total 9,988,588 10,100,000
Risk Rate 4 [Member]    
Financing Receivable, Credit Quality Indicator [Line Items]    
Grand total 3,425,158 3,431,640
Risk Rate 5 [Member]    
Financing Receivable, Credit Quality Indicator [Line Items]    
Grand total 30,553,007 28,115,013
Risk Rate Six [Member]    
Financing Receivable, Credit Quality Indicator [Line Items]    
Grand total 10,900,000 10,900,000
Risk Rate 7 [Member]    
Financing Receivable, Credit Quality Indicator [Line Items]    
Grand total 3,100,000
Risk Rate 8 [Member]    
Financing Receivable, Credit Quality Indicator [Line Items]    
Grand total $ 3,302,175
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Provision for Loan Losses (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Financing Receivable, Past Due [Line Items]    
Provision (benefit) $ (68,787) $ 66,666
Commercial Real Estate Portfolio Segment [Member]    
Financing Receivable, Past Due [Line Items]    
Provision (benefit) (1,642) (15,390)
Indemnity Liability Segment [Member]    
Financing Receivable, Past Due [Line Items]    
Provision (benefit) $ (67,145) $ 82,056
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Indemnification Liability (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Secured Debt [Member] | Minimum [Member]    
Debt Instrument [Line Items]    
Interest rate 7.35%  
Secured Debt [Member] | Maximum [Member]    
Debt Instrument [Line Items]    
Interest rate 15.25%  
Unsecured Debt [Member]    
Debt Instrument [Line Items]    
Variable rate description Unsecured loans and lines of credit contain variable rates ranging from Prime +1.50% to Prime +6.00%.  
Lines of credit $ 525,000 $ 996,958
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Property and Equipment (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 384,228 $ 384,228
Less: accumulated depreciation (338,862) (300,008)
Property and equipment, net 45,366 84,220
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 45,397 45,397
Software Development [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 51,692 51,692
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 71,635 71,635
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 215,504 $ 215,504
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Demonstrated Deposit Capacity (Details) - Loan Servicing Agreement [Member] - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Related Party Transaction [Line Items]    
Incremental capacity $ 5,503,206 $ 21,425,560
Cannabis Related Businesses Related Deposits [Member]    
Related Party Transaction [Line Items]    
Incremental capacity 106,692,488 129,350,998
Capacity at 60% [Member]    
Related Party Transaction [Line Items]    
Incremental capacity 64,015,493 77,610,599
Partner Colorado Credit Union [Member]    
Related Party Transaction [Line Items]    
Incremental capacity 83,739,916 81,087,746
Capacity at 1.3125 [Member]    
Related Party Transaction [Line Items]    
Incremental capacity 109,908,640 106,670,306
Limiting Capacity [Member]    
Related Party Transaction [Line Items]    
Incremental capacity 64,015,493 77,610,599
Partner Colorado Credit Union Loans Funded [Member]    
Related Party Transaction [Line Items]    
Incremental capacity 57,737,287 55,660,039
Line of Credit [Member]    
Related Party Transaction [Line Items]    
Incremental capacity $ 775,000 $ 525,000
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Revenue from Operations (Details) - Related Party [Member] - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Related Party Transaction [Line Items]    
Revenue $ 3,585,856 $ 3,261,284
Account Servicing Agreement [Member]    
Related Party Transaction [Line Items]    
Revenue 3,261,284
Commercial Alliance Agreement [Member]    
Related Party Transaction [Line Items]    
Revenue $ 3,585,856
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Operating Expense from Operations (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Related Party Transaction [Line Items]    
Operating expense $ 3,725,858 $ 5,802,048
Related Party [Member]    
Related Party Transaction [Line Items]    
Operating expense 300,261 390,659
Support Services Agreement [Member] | Related Party [Member]    
Related Party Transaction [Line Items]    
Operating expense 378,730
Loan Servicing Agreement [Member] | Related Party [Member]    
Related Party Transaction [Line Items]    
Operating expense 11,929
Commercial Alliance Agreement [Member] | Related Party [Member]    
Related Party Transaction [Line Items]    
Operating expense $ 300,261
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Outstanding Balances from Balance Sheet (Details) - Related Party [Member] - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Related Party Transaction [Line Items]    
Accounts receivable $ 1,111,390 $ 2,095,320
Accounts payable 125,693 577,315
Senior Secured Promissory Note (Refer to Note 9 to the unaudited condensed consolidated financial statements) $ 13,270,622 $ 14,011,166
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended
Mar. 29, 2023
Mar. 31, 2024
Dec. 31, 2023
Debt instrument, face amount $ 14,500,000    
Debt instrument, interest rate, effective percentage 4.25%    
Cash and cash equivalents   $ 5,600,000 $ 8,600,000
Deposits   $ 5,000,000 $ 4,600,000
Senior Secured Promissory Note [Member]      
Debt instrument term 5 years    
Debt instrument, face amount $ 14,500,000    
Debt instrument, interest rate, effective percentage 4.25%    
Loan Servicing Agreement [Member] | Partner Colorado Credit Union [Member]      
Servicing fee 0.25%    
Yearly fee percentage 0.35%    
Support Services Agreement [Member]      
Alliance agreement, description   In addition, the Commercial Alliance Agreement provides for certain fees to be paid to the Company for certain identified account related services to include: all cannabis-related income, including all lending-related income (such as loan origination fees, interest income on CRB-related loans, participation fees and servicing fees), investment income, interest income, account activity fees, processing fees, flat fees, and other revenue generated from cannabis and multi-state hemp accounts that are hosted on PCCU’s core system for a monthly fee equal to $30.96 per account in 2022, $25.32-$27.85 per account in 2023, and $26.08-$28.69 in 2024. In addition, as it pertains to CRB deposits held at PCCU, investment and interest income earned on these deposits (excluding interest income on loans funded by PCCU) will be shared 25% to PCCU and 75% to the Company. Finally, under the Commercial Alliance Agreement, PCCU will continue to allow its ratio of CRB-related deposits to total assets to equal at least 60% unless otherwise dictated by regulatory, regulator or policy requirements. The initial term of the Commercial Alliance Agreement is for a period of two years, with a one-year automatic renewal unless a party provides one hundred twenty days’ written notice prior to the end of the term.  
Securities Issuance Agreement [Member] | Partner Colorado Credit Union [Member] | Common Class A [Member]      
Number of shares issued 11,200,000    
Ownwership percentage 46.39%    
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Senior Secured Promissory Note (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Mar. 29, 2023
Short-Term Debt [Line Items]      
Total     $ 14,500,000
Security Agreement [Member]      
Short-Term Debt [Line Items]      
Total $ 13,270,622 $ 14,011,166  
Senior Secured Promissory Note Current [Member] | Security Agreement [Member]      
Short-Term Debt [Line Items]      
Total 3,028,738 3,006,991  
Senior Secured Promissory Note Non Current [Member] | Security Agreement [Member]      
Short-Term Debt [Line Items]      
Total $ 10,241,884 $ 11,004,175  
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Outstanding Amount on Debt (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Short-Term Debt [Line Items]    
Total loans funded by PCCU $ 58,168,928 $ 55,646,653
Senior Secured Promissory Note [Member]    
Short-Term Debt [Line Items]    
2024   2,266,449
2025   3,138,931
2026   3,274,966
2027   3,416,896
2028   1,173,380
Total loans funded by PCCU   $ 13,270,622
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Senior Secured Promissory Note (Details Narrative) - USD ($)
Nov. 05, 2023
Mar. 29, 2023
Debt instrument, face amount   $ 14,500,000
Debt instrument, interest rate, effective percentage   4.25%
54 Equal Installments [Member]    
Deferred consideration payable $ 295,487  
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Lease Cost (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Leases    
Operating lease cost
Short-term lease cost 69,437 87,742
Total Lease Cost $ 69,437 $ 87,742
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Right Of Use Assets (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Leases    
Beginning balance $ 859,861 $ 1,016,198
Additions to right-of-use assets
Amortization charge for the period (39,084) (156,337)
Lease modifications
Ending balance $ 820,777 $ 859,861
Weighted-average remaining lease term 3 years 2 months 1 day 3 years 5 months 1 day
Weighted-average discount rate 6.87% 6.87%
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Future Minimum Lease Payments (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Leases    
2024 $ 151,111 $ 197,520
2025 217,925 217,925
2026 222,275 222,275
2027 226,705 226,705
2028 231,216 231,216
Thereafter 117,710 117,710
Total future minimum lease payments 1,166,942 1,213,351
Less: Imputed interest 188,481 205,358
Operating lease liabilities 978,461 1,007,993
Less: Current portion 142,863 132,546
Non-current portion of lease liabilities $ 835,598 $ 875,447
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases (Details Narrative) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating lease right to use assets $ 820,777 $ 859,861 $ 1,016,198
Operating lease liablities $ 978,461 $ 1,007,993  
Minimum [Member]      
Lease term 1 year    
Maximum [Member]      
Lease term 7 years    
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Disaggregated Revenue (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Total Revenue $ 4,050,799 $ 4,180,379
Deposit Activity Onboarding Income [Member]    
Total Revenue 1,620,994 2,245,831
Safe Harbor Program Income [Member]    
Total Revenue 19,230 51,103
Investment Income [Member]    
Total Revenue 773,819 1,417,152
Interest Income [Member]    
Total Revenue $ 1,636,756 $ 466,293
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue (Details Narrative) - Partner Colorado Credit Union [Member] - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Investment hosting fees remit percent 25.00%  
Proceeds from deposits $ 1,217,675 $ 2,245,831
Investment income 731,425 1,417,152
Loan interest income 1,636,756 466,293
Account hosting expenses 104,259 55,425
Investment hosting fee 160,101 323,305
Loan servicing fees $ 35,901 $ 11,929
XML 84 R72.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Deferred Underwriter Fee (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Mar. 13, 2023
Jan. 31, 2023
Dec. 31, 2022
Oct. 31, 2022
Oct. 14, 2022
Nov. 30, 2022
Mar. 31, 2023
Sep. 28, 2022
Deferred underwriting cost             $ 900,500  
Benchmark Investments LLC [Member]                
Notes payable     $ 1,450,500         $ 2,166,250
Periodic payment   $ 362,625 $ 362,625 $ 362,625 $ 715,750 $ 362,625    
Repayments of debt $ 550,000              
XML 85 R73.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Earning Per Shares, Basic and Diluted (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Net Income/ (loss) $ 2,049,676 $ (1,413,447)
Weighted average shares outstanding – basic 55,213,609 25,670,730
Basic net income/ (loss) per share $ 0.04 $ (0.06)
Weighted average shares outstanding – diluted 56,268,075 25,670,730
Diluted net income/ (loss) per share $ 0.04 $ (0.06)
XML 86 R74.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Weighted Average Shares Outstanding - Basic And Diluted (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Company public shares 3,926,598 3,926,598
Company initial stockholders 3,403,175 3,403,175
PCCU stockholders 22,586,139 11,759,472
Shares issued for abaca acquisition 7,935,800 2,099,977
Restricted stock units issued 1,308,089 566,755
Conversion of preferred stock 16,053,808 3,914,753
Weighted average shares outstanding - basic 55,213,609 25,670,730
Shares used in computation of basic earnings per share 55,213,609 25,670,730
Shares to be issued to Abaca shareholders 750,000  
Share based payments 215,666  
Conversion of preferred stock 88,800  
Grand total 56,268,075 25,670,730
XML 87 R75.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Warrants 12,036,588 7,036,588
Share based payments 2,284,080 2,775,655
Shares to be issued to Abaca shareholders 6,433,839
Conversion of preferred stock 10,896,000
Grand total 14,320,668 27,142,082
XML 88 R76.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Forward Purchase Agreement (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Number of shares on the date of acquisition   3,667,377
Number of shares on the date of acquisition value   $ 4,584,221
Sale of stock, consideration received on transaction  
Common stock held by subsidiary shares 3,667,377  
Common stock held by subsidiary $ 4,584,221  
Sale of stock, number of shares issued in transaction shares  
Vellar [Member]    
Number of shares on the date of acquisition   971,204
Number of shares on the date of acquisition value   $ 1,214,005
Sale of stock, number of shares issued in transaction  
Sale of stock, consideration received on transaction  
Common stock held by subsidiary shares 971,204  
Share price $ 1.25  
Common stock held by subsidiary $ 1,214,005  
Midtown East [Member]    
Number of shares on the date of acquisition   1,517,924
Number of shares on the date of acquisition value   $ 1,897,405
Sale of stock, number of shares issued in transaction  
Sale of stock, consideration received on transaction  
Common stock held by subsidiary shares 1,517,924  
Share price $ 1.25  
Common stock held by subsidiary $ 1,897,405  
Verdun [Member]    
Number of shares on the date of acquisition   1,178,249
Number of shares on the date of acquisition value   $ 1,472,811
Sale of stock, number of shares issued in transaction  
Sale of stock, consideration received on transaction  
Common stock held by subsidiary shares 1,178,249  
Share price $ 1.25  
Common stock held by subsidiary $ 1,472,811  
XML 89 R77.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Forward Purchase Agreement (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Jun. 16, 2022
Mar. 31, 2024
Dec. 31, 2022
Sep. 30, 2022
Related expense amounts $ 0.3      
Maturity date, description   At the Maturity Date, Midtown East, Verdun and Vellar shall be entitled to (1) the product of the shares then held by them multiplied by the Forward Price, and (2) an amount, in cash or shares at the sole discretion of the Company, equal to (a) in the case of cash, the product of (i)(x) 3.8 million shares less (y) the number of Terminated Shares and (ii) $2.00 (the “Maturity Cash Consideration”) and (b) in the case of shares, (i) the Maturity Cash Consideration divided by (ii) the VWAP Price for the 30 Scheduled Trading Days prior to the Maturity Date.    
Shares per share $ 3.00   $ 1.25  
Forward Purchase Agreement [Member]        
Decrease in receivables       $ 37.9
Receivables       $ 4.6
Cash [Member]        
Asset held with trust $ 39.3      
Midtown East Management NL LLC [Member] | Common Class A [Member]        
Shares, issued 1,666,666      
Number of new stock issued 3,800,000      
XML 90 R78.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Warrant Liabilities (Details Narrative) - $ / shares
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Common Class A [Member]    
Shares issued, price per share $ 18.00  
Warrants execise price $ 11.50  
Public Warrants [Member]    
Warrants outstanding 5,750,000  
Warrants execise price $ 0.01  
Private Placement Warrants [Member]    
Warrants outstanding   264,088
Public and Private Warrants [Member]    
Warrants description The Public and Private Placement Warrants became exercisable on September 28, 2022, the date of the Business Combination and will expire on September 28, 2027, or earlier upon redemption or liquidation.  
PIPE Warrants [Member]    
Warrants outstanding 1,022,500 1,022,500
Warrants description (i)125% of the conversion price if at any time there is an adjustment to the Conversion Price and the exercise price after such adjustment is greater than 125% of the Conversion Price as adjusted and (ii) $5.00.  
Abaca Warrants [Member]    
Warrants outstanding 5,000,000 5,000,000
Warrants execise price $ 2.00  
Abaca Warrants [Member] | Common Class A [Member]    
Warrants execise price $ 2.00  
Number of warrant issued 5,000,000  
Warrants term 5 years  
XML 91 R79.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)
Mar. 31, 2024
Dec. 31, 2023
PIPE Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities $ 189,220 $ 273,124
PIPE Warrants [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities
PIPE Warrants [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 189,220 273,124
Public Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 430,675 481,850
Public Warrants [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 430,675 481,850
Public Warrants [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities
Private Placement Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 20,315 25,070
Private Placement Warrants [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities
Private Placement Warrants [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 20,315 25,070
Abaca Warrant [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 2,268,432 3,384,085
Abaca Warrant [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities
Abaca Warrant [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 2,268,432 3,384,085
Forward Purchase Derivative Liability [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 7,309,580 7,309,580
Forward Purchase Derivative Liability [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities
Forward Purchase Derivative Liability [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 7,309,580 7,309,580
Third Anniversary Payment Consideration [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities 594,000 810,000
Third Anniversary Payment Consideration [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities
Third Anniversary Payment Consideration [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities $ 594,000 $ 810,000
XML 92 R80.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Liabilities    
Deferred consideration $ 2,921,257 $ 2,889,792
Indemnity liability 1,315,263 1,382,408
Forward purchase derivative 7,309,580 7,309,580
Fair Value, Inputs, Level 1 [Member]    
Assets    
Cash and cash equivalents 5,626,362 4,888,769
Forward purchase receivables 4,584,221 4,584,221
Loans  
Liabilities    
Deferred consideration 2,921,257 2,889,792
Senior secured promissory note
Indemnity liability 1,315,263  
Public warrants 430,675 481,850
Private placement warrants
PIPE warrants
Abaca warrants
Third anniversary payment consideration
Forward purchase derivative
Fair Value, Inputs, Level 2 [Member]    
Assets    
Cash and cash equivalents
Forward purchase receivables
Loans  
Liabilities    
Deferred consideration
Senior secured promissory note
Indemnity liability  
Public warrants
Private placement warrants
PIPE warrants
Abaca warrants
Third anniversary payment consideration
Forward purchase derivative
Fair Value, Inputs, Level 3 [Member]    
Assets    
Cash and cash equivalents
Forward purchase receivables
Loans 362,671 363,561
Liabilities    
Deferred consideration
Senior secured promissory note 12,137,875 12,750,204
Indemnity liability  
Public warrants
Private placement warrants 20,315 25,070
PIPE warrants 189,220 273,124
Abaca warrants 2,268,432 3,384,085
Third anniversary payment consideration 594,000 810,000
Forward purchase derivative 7,309,580 7,309,580
Reported Value Measurement [Member]    
Assets    
Cash and cash equivalents 5,626,362 4,888,769
Forward purchase receivables 4,584,221 4,584,221
Loans 392,483 330,579
Liabilities    
Deferred consideration 2,921,257 2,889,792
Senior secured promissory note 13,270,622 14,011,166
Indemnity liability 1,315,263  
Public warrants 430,675 481,850
Private placement warrants 20,315 25,070
PIPE warrants 189,220 273,124
Abaca warrants 2,268,432 3,384,085
Third anniversary payment consideration 594,000 810,000
Forward purchase derivative 7,309,580 7,309,580
Estimate of Fair Value Measurement [Member]    
Assets    
Cash and cash equivalents 5,626,362 4,888,769
Forward purchase receivables 4,584,221 4,584,221
Loans 362,671 363,561
Liabilities    
Deferred consideration 2,921,257 2,889,792
Senior secured promissory note 12,137,875 12,750,204
Indemnity liability 1,315,263  
Public warrants 430,675 481,850
Private placement warrants 20,315 25,070
PIPE warrants 189,220 273,124
Abaca warrants 2,268,432 3,384,085
Third anniversary payment consideration 594,000 810,000
Forward purchase derivative $ 7,309,580 $ 7,309,580
XML 93 R81.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Fair Value Assets Measured on Recurring Basis (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
PIPE Warrants [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Balance at the beginning of the period $ 273,124 $ 286,300
Issued to Abaca shareholders  
Fair value adjustment (83,904) (211,538)
Balance at the end of the period 189,220 74,762
Abaca Warrant [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Balance at the beginning of the period 3,384,085
Issued to Abaca shareholders  
Fair value adjustment (1,115,653)
Balance at the end of the period 2,268,432
Private Placement Warrants [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Balance at the beginning of the period 25,070 19,110
Issued to Abaca shareholders  
Fair value adjustment (4,755) (11,157)
Balance at the end of the period 20,315 7,953
Third Anniversary Payment Consideration [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Balance at the beginning of the period 810,000
Issued to Abaca shareholders  
Fair value adjustment (216,000)
Balance at the end of the period 594,000
Forward Purchase Derivative [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Balance at the beginning of the period 7,309,580 7,309,580
Issued to Abaca shareholders  
Fair value adjustment
Balance at the end of the period $ 7,309,580 $ 7,309,580
XML 94 R82.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Level 3 Fair Value Measurement Inputs (Details)
Mar. 31, 2024
$ / shares
Dec. 31, 2023
$ / shares
PIPE Warrants [Member] | Measurement Input, Exercise Price [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 5 5
PIPE Warrants [Member] | Measurement Input, Share Price [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 0.97 1.42
PIPE Warrants [Member] | Expected Term [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Expected term (years) 3 years 5 months 26 days 3 years 8 months 26 days
PIPE Warrants [Member] | Measurement Input, Price Volatility [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 76.00 62.95
PIPE Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 4.26 4.25
Private Warrants [Member] | Measurement Input, Exercise Price [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 11.5 11.5
Private Warrants [Member] | Measurement Input, Share Price [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 0.97 1.42
Private Warrants [Member] | Expected Term [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Expected term (years) 3 years 5 months 26 days 3 years 8 months 26 days
Private Warrants [Member] | Measurement Input, Price Volatility [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 76.00 62.95
Private Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 4.26 4.25
Third Anniversary Payment Consideration [Member] | Measurement Input, Exercise Price [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input
Third Anniversary Payment Consideration [Member] | Measurement Input, Share Price [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 0.97 1.42
Third Anniversary Payment Consideration [Member] | Expected Term [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Expected term (years) 1 year 6 months 3 days 1 year 9 months 3 days
Third Anniversary Payment Consideration [Member] | Measurement Input, Price Volatility [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 76.00 62.95
Third Anniversary Payment Consideration [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 4.26 4.25
Abaca Warrant [Member] | Measurement Input, Exercise Price [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 2 2
Abaca Warrant [Member] | Measurement Input, Share Price [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 0.97 1.42
Abaca Warrant [Member] | Expected Term [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Expected term (years) 4 years 6 months 25 days 4 years 10 months 2 days
Abaca Warrant [Member] | Measurement Input, Price Volatility [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 76.00 62.95
Abaca Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Warrants and rights outstanding, measurement input 4.36 4.25
XML 95 R83.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Level 3 Fair Value Measurements Inputs (Details) - Forward Purchase Derivative [Member]
3 Months Ended 12 Months Ended
Mar. 31, 2024
$ / shares
Dec. 31, 2023
$ / shares
Measurement Input Reset Price [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Derivative liability, measurement input 1.25 1.25
Measurement Input, Expected Term [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Expected term (years) 1 year 5 months 26 days 1 year 8 months 26 days
Measurement Input Additional Maturity Per Share [Member] | Purchase Agreement Option [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Derivative liability, measurement input 2.00 2.00
Measurement Input, Price Volatility [Member] | Purchase Agreement Option [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Derivative liability, measurement input 46 46
Measurement Input, Risk Free Interest Rate [Member] | Purchase Agreement Option [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Derivative liability, measurement input 4.2 4.2
Measurement Input, Discount Rate [Member] | Purchase Agreement Option [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Derivative liability, measurement input 13.4 13.4
XML 96 R84.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Tax (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
Income tax benefit $ 438,885 $ 609,277  
Effective income tax rate reconciliation other adjustments 28.14%    
Effective income tax rate, federal 21.00%    
Deferred tax assets liabilities net $ 44,278,374   $ 43,829,019
XML 97 R85.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
401(k) Plan (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Retirement Benefits [Abstract]    
Defined contribution plan employee percent 100.00%  
Defined contribution plan employee matching contribution 4.00%  
Defined contribution plan amount $ 35,233 $ 20,663
XML 98 R86.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Fair Value of Options Granted Black-Scholes-Merton Model (Details)
3 Months Ended
Mar. 31, 2024
Dividend yield 0.00%
Risk-free interest rate, minimum 3.62%
Risk-free interest rate, maximum 4.23%
Expected volatility 100.00%
Minimum [Member]  
Expected term 6 years
Maximum [Member]  
Expected term 6 years 6 months
XML 99 R87.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Stock Option and Related Information (Details) - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Equity [Abstract]        
No. of Stock Option, Beginning Balance 2,286,010 2,170,000   2,170,000
Weighted Average Grant Date Fair Value Per Stock Option, Beginning Balance $ 5.43 $ 3.53   $ 3.53
Weighted-Average Remaining Contractual Life, Ending 1 year 4 months 24 days 2 years 4 months 20 days 2 years 7 days 1 year 7 months 24 days
No. of Stock Option, Granted 336,730    
Weighted Average Grant Date Fair Value Per Stock Option, Granted $ 1.03    
No. of Stock Option, Exercised    
Weighted Average Grant Date Fair Value Per Stock Option, Exercised    
No. of Stock Option, Expired    
Weighted Average Grant Date Fair Value Per Stock Option, Expired    
No. of Stock Option, Cancelled/Forfeited (1,930) (64,875)    
Weighted Average Grant Date Fair Value Per Stock Option, Cancelled/Forfeited $ 1.56 $ 3.13    
No. of Stock Option, Ending Balance 2,284,080 2,441,855 2,170,000 2,286,010
Weighted Average Grant Date Fair Value Per Stock Option, Ending Balance $ 5.43 $ 3.20 $ 3.53 $ 5.43
Weighted-Average Remaining Contractual Life, Granted   2 years 9 months 3 days    
XML 100 R88.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Options Outstanding (Details) - shares
Mar. 31, 2024
Mar. 31, 2023
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price options 2,284,080 2,441,855
Exercise Price One [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price options 374,580 359,355
Exercise Price Two [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price options 350,000 350,000
Exercise Price Three [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price options 309,500 482,500
Exercise Price Four [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price options 1,250,000 1,250,000
XML 101 R89.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Restricted Stock Units (Details) - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Weighted-Average Remaining Contractual Life, Ending 1 year 4 months 24 days 2 years 4 months 20 days 2 years 7 days 1 year 7 months 24 days  
Weighted-Average Remaining Contractual Life, Granted   2 years 9 months 3 days      
Restricted Stock Units (RSUs) [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
No. of RSU, Beginning Balance 323,500    
Weighted Average Grant Date Fair Value Per RSU, Beginning Balance $ 1.31    
Weighted-Average Remaining Contractual Life, Beginning       2 years
No. of RSU, Granted 963,528      
Weighted Average Grant Date Fair Value Per RSU, Granted $ 1.31      
No. of RSU, Vested (107,833)      
Weighted Average Grant Date Fair Value Per RSU, Vested $ 1.31      
No. of RSU, Expired      
Weighted Average Grant Date Fair Value Per RSU, Expired      
No. of RSU, Cancelled/Forfeited      
Weighted Average Grant Date Fair Value Per RSU, Cancelled/Forfeited      
No. of RSU, Ending Balance 215,667 963,528 323,500
Weighted Average Grant Date Fair Value Per RSU, Ending Balance $ 1.31 $ 1.31      
Weighted-Average Remaining Contractual Life, Ending 1 year 9 months 2 years 9 months 3 days      
Weighted-Average Remaining Contractual Life, Granted 2 years 9 months 3 days        
No. of RSU, Vested 107,833      
XML 102 R90.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Exercise Price of Restricted Stock Units (Details) - Restricted Stock Units (RSUs) [Member] - shares
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise price options 215,667 323,500 963,528
Exercise Price One [Member]        
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise price options 215,667   963,528  
XML 103 R91.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Jan. 25, 2024
Dec. 31, 2023
Preferred stock, shares authorized 1,250,000     1,250,000
Preferred stock, par value $ 0.0001     $ 0.0001
Convertible preferred stock, shares issued 111     1,101
Convertible preferred stock, shares outstanding 111     1,101
Conversion Price $ 10.00      
Conversion of stock description 80% of the volume weighted average price of the Class A Common Stock for the prior five trading days and (ii) $2.00 (the “Floor Price”), provided that, so long as a preferred stock holders continues to hold any preferred shares, such preferred stock holder will be entitled to receive the aggregate shares of Class A Common Stock that would be issuable based upon its initial purchase of preferred stock at the adjusted Conversion Price      
Class A common stock, shares authorized 130,000,000     130,000,000
Class A common stock, par value $ 0.0001     $ 0.0001
Class A common stock, shares issued 55,431,001     54,563,372
Class A common stock, shares outstanding 55,431,001     54,563,372
Common stock held for purchase 3,667,377      
Share based compensation $ 0.6 $ 1.6    
Expected volatility 100.00%      
Share-Based Payment Arrangement, Option [Member]        
Contractual term 10 years      
Forward Purchase Agreement [Member]        
Common stock held for purchase 3,667,377     3,667,377
Maximum [Member]        
Share price     $ 2.00  
Minimum [Member]        
Share price     $ 1.25  
XML 104 R92.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent events (Details Narrative)
Apr. 05, 2024
$ / shares
Subsequent Event [Member]  
Subsequent Event [Line Items]  
Share price $ 1.00
EXCEL 105 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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

&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6/LWHBTK P VP8 M !D ("!V1(! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6!MXN^9!! M0L !D M ("!G!T! 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ M8"M6/#WQD-4!0 C0\ !D ("!TRD! 'AL+W=O M+P$ >&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6%6@ MGJ+0 @ @8 !D ("!*S&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6&B13C%V" F1X !D M ("!@$(! 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ M8"M6)>GKS_Q! ^AD !D ("! M 58! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ M8"M6(<__D9-!0 QB( !D ("!160! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6$F S'<- M! :A( !D ("!=W ! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6):76I\$ P =@D !D M ("!I7H! 'AL+W=O&PO=V]R M:W-H965T2! 0!X;"]W;W)K&UL M4$L! A0#% @ M8"M6&<#I$1B P 4 T !D ("!+H4! M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MM8"M6!S[=*'X @ 00L !D ("!%)$! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6%*@X+N/ @ ^@8 !D M ("!\:@! 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ M8"M6. SD--4 P 2PL !D ("!W+$! 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M M6!Y@$P<: P W @ !D ("!J[L! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6"A'?6L)! ]@T M !D ("!!,8! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6!V;$PPX!0 ,Q< !D M ("!M](! 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ M8"M6"9S#UMJ" AD, !D ("!N.,! 'AL+W=O M M'@ &0 @(%9[ $ >&PO=V]R:W-H965T+Q M 0!X;"]W;W)K&UL4$L! A0#% @ M8"M6$\* M%KHV! 118 !D ("!#OD! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M8"M6+.7?V?" @ ]P< !D M ("!C ," 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ M8"M6.O-TY'1!0 ?2P !D ("! M[@X" 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ M8"M6%FFCT$& @ LP0 !D ("!>AX" 'AL+W=O&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$" M% ,4 " "U@*U8S1YDO$ " !Z- $P @ $W+P( 6T-O F;G1E;G1?5'EP97-=+GAM;%!+!08 9 !D ',; "H,0( ! end XML 106 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 107 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 109 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 336 421 1 false 107 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://shfinancial.org/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://shfinancial.org/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://shfinancial.org/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://shfinancial.org/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://shfinancial.org/role/StatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://shfinancial.org/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Business Operations Sheet http://shfinancial.org/role/OrganizationAndBusinessOperations Organization and Business Operations Notes 7 false false R8.htm 00000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Deferred Consideration Sheet http://shfinancial.org/role/DeferredConsideration Deferred Consideration Notes 9 false false R10.htm 00000010 - Disclosure - Goodwill and Finite-lived Intangible Assets Sheet http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssets Goodwill and Finite-lived Intangible Assets Notes 10 false false R11.htm 00000011 - Disclosure - Loans Receivable Sheet http://shfinancial.org/role/LoansReceivable Loans Receivable Notes 11 false false R12.htm 00000012 - Disclosure - Indemnification Liability Sheet http://shfinancial.org/role/IndemnificationLiability Indemnification Liability Notes 12 false false R13.htm 00000013 - Disclosure - Property and Equipment, Net Sheet http://shfinancial.org/role/PropertyAndEquipmentNet Property and Equipment, Net Notes 13 false false R14.htm 00000014 - Disclosure - Related Party Transactions Sheet http://shfinancial.org/role/RelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 00000015 - Disclosure - Senior Secured Promissory Note Sheet http://shfinancial.org/role/SeniorSecuredPromissoryNote Senior Secured Promissory Note Notes 15 false false R16.htm 00000016 - Disclosure - Leases Sheet http://shfinancial.org/role/Leases Leases Notes 16 false false R17.htm 00000017 - Disclosure - Revenue Sheet http://shfinancial.org/role/Revenue Revenue Notes 17 false false R18.htm 00000018 - Disclosure - Deferred Underwriter Fee Sheet http://shfinancial.org/role/DeferredUnderwriterFee Deferred Underwriter Fee Notes 18 false false R19.htm 00000019 - Disclosure - Commitments and contingencies Sheet http://shfinancial.org/role/CommitmentsAndContingencies Commitments and contingencies Notes 19 false false R20.htm 00000020 - Disclosure - Earnings Per Share Sheet http://shfinancial.org/role/EarningsPerShare Earnings Per Share Notes 20 false false R21.htm 00000021 - Disclosure - Forward Purchase Agreement Sheet http://shfinancial.org/role/ForwardPurchaseAgreement Forward Purchase Agreement Notes 21 false false R22.htm 00000022 - Disclosure - Warrant Liabilities Sheet http://shfinancial.org/role/WarrantLiabilities Warrant Liabilities Notes 22 false false R23.htm 00000023 - Disclosure - Financial Instruments Sheet http://shfinancial.org/role/FinancialInstruments Financial Instruments Notes 23 false false R24.htm 00000024 - Disclosure - Tax Sheet http://shfinancial.org/role/Tax Tax Notes 24 false false R25.htm 00000025 - Disclosure - 401(k) Plan Sheet http://shfinancial.org/role/KPlan 401(k) Plan Notes 25 false false R26.htm 00000026 - Disclosure - Stockholders??? Equity Sheet http://shfinancial.org/role/StockholdersEquity Stockholders??? Equity Notes 26 false false R27.htm 00000027 - Disclosure - Subsequent events Sheet http://shfinancial.org/role/SubsequentEvents Subsequent events Notes 27 false false R28.htm 00000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 28 false false R29.htm 00000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 29 false false R30.htm 00000030 - Disclosure - Deferred Consideration (Tables) Sheet http://shfinancial.org/role/DeferredConsiderationTables Deferred Consideration (Tables) Tables http://shfinancial.org/role/DeferredConsideration 30 false false R31.htm 00000031 - Disclosure - Goodwill and Finite-lived Intangible Assets (Tables) Sheet http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsTables Goodwill and Finite-lived Intangible Assets (Tables) Tables http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssets 31 false false R32.htm 00000032 - Disclosure - Loans Receivable (Tables) Sheet http://shfinancial.org/role/LoansReceivableTables Loans Receivable (Tables) Tables http://shfinancial.org/role/LoansReceivable 32 false false R33.htm 00000033 - Disclosure - Indemnification Liability (Tables) Sheet http://shfinancial.org/role/IndemnificationLiabilityTables Indemnification Liability (Tables) Tables http://shfinancial.org/role/IndemnificationLiability 33 false false R34.htm 00000034 - Disclosure - Property and Equipment, Net (Tables) Sheet http://shfinancial.org/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://shfinancial.org/role/PropertyAndEquipmentNet 34 false false R35.htm 00000035 - Disclosure - Related Party Transactions (Tables) Sheet http://shfinancial.org/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://shfinancial.org/role/RelatedPartyTransactions 35 false false R36.htm 00000036 - Disclosure - Senior Secured Promissory Note (Tables) Sheet http://shfinancial.org/role/SeniorSecuredPromissoryNoteTables Senior Secured Promissory Note (Tables) Tables http://shfinancial.org/role/SeniorSecuredPromissoryNote 36 false false R37.htm 00000037 - Disclosure - Leases (Tables) Sheet http://shfinancial.org/role/LeasesTables Leases (Tables) Tables http://shfinancial.org/role/Leases 37 false false R38.htm 00000038 - Disclosure - Revenue (Tables) Sheet http://shfinancial.org/role/RevenueTables Revenue (Tables) Tables http://shfinancial.org/role/Revenue 38 false false R39.htm 00000039 - Disclosure - Earnings Per Share (Tables) Sheet http://shfinancial.org/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://shfinancial.org/role/EarningsPerShare 39 false false R40.htm 00000040 - Disclosure - Forward Purchase Agreement (Tables) Sheet http://shfinancial.org/role/ForwardPurchaseAgreementTables Forward Purchase Agreement (Tables) Tables http://shfinancial.org/role/ForwardPurchaseAgreement 40 false false R41.htm 00000041 - Disclosure - Financial Instruments (Tables) Sheet http://shfinancial.org/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://shfinancial.org/role/FinancialInstruments 41 false false R42.htm 00000042 - Disclosure - Stockholders??? Equity (Tables) Sheet http://shfinancial.org/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://shfinancial.org/role/StockholdersEquity 42 false false R43.htm 00000043 - Disclosure - Schedule of Current Expected Credit Losses Transition Impact (Details) Sheet http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails Schedule of Current Expected Credit Losses Transition Impact (Details) Details 43 false false R44.htm 00000044 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) Sheet http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) Details http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 44 false false R45.htm 00000045 - Disclosure - Schedule of Change in Deferred Consideration (Details) Sheet http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails Schedule of Change in Deferred Consideration (Details) Details 45 false false R46.htm 00000046 - Disclosure - Deferred Consideration (Details Narrative) Sheet http://shfinancial.org/role/DeferredConsiderationDetailsNarrative Deferred Consideration (Details Narrative) Details http://shfinancial.org/role/DeferredConsiderationTables 46 false false R47.htm 00000047 - Disclosure - Schedule of Finite Lived Intangible Assets (Details) Sheet http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails Schedule of Finite Lived Intangible Assets (Details) Details 47 false false R48.htm 00000048 - Disclosure - Goodwill and Finite-lived Intangible Assets (Details Narrative) Sheet http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative Goodwill and Finite-lived Intangible Assets (Details Narrative) Details http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsTables 48 false false R49.htm 00000049 - Disclosure - Schedule of Commercial Real Estate Loans Receivable (Details) Sheet http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails Schedule of Commercial Real Estate Loans Receivable (Details) Details 49 false false R50.htm 00000050 - Disclosure - Schedule of Allowance For Loan Losses (Details) Sheet http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails Schedule of Allowance For Loan Losses (Details) Details 50 false false R51.htm 00000051 - Disclosure - Schedule of Risk Rating (Details) Sheet http://shfinancial.org/role/ScheduleOfRiskRatingDetails Schedule of Risk Rating (Details) Details 51 false false R52.htm 00000052 - Disclosure - Schedule of Outstanding Amounts (Details) Sheet http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails Schedule of Outstanding Amounts (Details) Details 52 false false R53.htm 00000053 - Disclosure - Schedule of Indemnity Liability (Details) Sheet http://shfinancial.org/role/ScheduleOfIndemnityLiabilityDetails Schedule of Indemnity Liability (Details) Details 53 false false R54.htm 00000054 - Disclosure - Schedule of Indemnified Loans Risk Rating (Details) Sheet http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails Schedule of Indemnified Loans Risk Rating (Details) Details 54 false false R55.htm 00000055 - Disclosure - Schedule of Provision for Loan Losses (Details) Sheet http://shfinancial.org/role/ScheduleOfProvisionForLoanLossesDetails Schedule of Provision for Loan Losses (Details) Details 55 false false R56.htm 00000056 - Disclosure - Indemnification Liability (Details Narrative) Sheet http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative Indemnification Liability (Details Narrative) Details http://shfinancial.org/role/IndemnificationLiabilityTables 56 false false R57.htm 00000057 - Disclosure - Schedule of Property and Equipment (Details) Sheet http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails Schedule of Property and Equipment (Details) Details 57 false false R58.htm 00000058 - Disclosure - Schedule of Demonstrated Deposit Capacity (Details) Sheet http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails Schedule of Demonstrated Deposit Capacity (Details) Details 58 false false R59.htm 00000059 - Disclosure - Schedule of Revenue from Operations (Details) Sheet http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails Schedule of Revenue from Operations (Details) Details 59 false false R60.htm 00000060 - Disclosure - Schedule of Operating Expense from Operations (Details) Sheet http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails Schedule of Operating Expense from Operations (Details) Details 60 false false R61.htm 00000061 - Disclosure - Schedule of Outstanding Balances from Balance Sheet (Details) Sheet http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails Schedule of Outstanding Balances from Balance Sheet (Details) Details 61 false false R62.htm 00000062 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://shfinancial.org/role/RelatedPartyTransactionsTables 62 false false R63.htm 00000063 - Disclosure - Schedule of Senior Secured Promissory Note (Details) Sheet http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails Schedule of Senior Secured Promissory Note (Details) Details 63 false false R64.htm 00000064 - Disclosure - Schedule of Outstanding Amount on Debt (Details) Sheet http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails Schedule of Outstanding Amount on Debt (Details) Details 64 false false R65.htm 00000065 - Disclosure - Senior Secured Promissory Note (Details Narrative) Sheet http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative Senior Secured Promissory Note (Details Narrative) Details http://shfinancial.org/role/SeniorSecuredPromissoryNoteTables 65 false false R66.htm 00000066 - Disclosure - Schedule of Lease Cost (Details) Sheet http://shfinancial.org/role/ScheduleOfLeaseCostDetails Schedule of Lease Cost (Details) Details 66 false false R67.htm 00000067 - Disclosure - Schedule of Right Of Use Assets (Details) Sheet http://shfinancial.org/role/ScheduleOfRightOfUseAssetsDetails Schedule of Right Of Use Assets (Details) Details 67 false false R68.htm 00000068 - Disclosure - Schedule of Future Minimum Lease Payments (Details) Sheet http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails Schedule of Future Minimum Lease Payments (Details) Details 68 false false R69.htm 00000069 - Disclosure - Leases (Details Narrative) Sheet http://shfinancial.org/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://shfinancial.org/role/LeasesTables 69 false false R70.htm 00000070 - Disclosure - Schedule of Disaggregated Revenue (Details) Sheet http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails Schedule of Disaggregated Revenue (Details) Details 70 false false R71.htm 00000071 - Disclosure - Revenue (Details Narrative) Sheet http://shfinancial.org/role/RevenueDetailsNarrative Revenue (Details Narrative) Details http://shfinancial.org/role/RevenueTables 71 false false R72.htm 00000072 - Disclosure - Deferred Underwriter Fee (Details Narrative) Sheet http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative Deferred Underwriter Fee (Details Narrative) Details http://shfinancial.org/role/DeferredUnderwriterFee 72 false false R73.htm 00000073 - Disclosure - Schedule of Earning Per Shares, Basic and Diluted (Details) Sheet http://shfinancial.org/role/ScheduleOfEarningPerSharesBasicAndDilutedDetails Schedule of Earning Per Shares, Basic and Diluted (Details) Details 73 false false R74.htm 00000074 - Disclosure - Schedule of Weighted Average Shares Outstanding - Basic And Diluted (Details) Sheet http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails Schedule of Weighted Average Shares Outstanding - Basic And Diluted (Details) Details 74 false false R75.htm 00000075 - Disclosure - Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings (Details) Sheet http://shfinancial.org/role/ScheduleOfShare-basedEquityAwardsAndWarrantsExcludedFromComputationOfEarningsDetails Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings (Details) Details 75 false false R76.htm 00000076 - Disclosure - Schedule of Forward Purchase Agreement (Details) Sheet http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails Schedule of Forward Purchase Agreement (Details) Details 76 false false R77.htm 00000077 - Disclosure - Forward Purchase Agreement (Details Narrative) Sheet http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative Forward Purchase Agreement (Details Narrative) Details http://shfinancial.org/role/ForwardPurchaseAgreementTables 77 false false R78.htm 00000078 - Disclosure - Warrant Liabilities (Details Narrative) Sheet http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative Warrant Liabilities (Details Narrative) Details http://shfinancial.org/role/WarrantLiabilities 78 false false R79.htm 00000079 - Disclosure - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Details) Details 79 false false R80.htm 00000080 - Disclosure - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) Sheet http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) Details 80 false false R81.htm 00000081 - Disclosure - Schedule of Fair Value Assets Measured on Recurring Basis (Details) Sheet http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails Schedule of Fair Value Assets Measured on Recurring Basis (Details) Details 81 false false R82.htm 00000082 - Disclosure - Schedule of Level 3 Fair Value Measurement Inputs (Details) Sheet http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails Schedule of Level 3 Fair Value Measurement Inputs (Details) Details 82 false false R83.htm 00000083 - Disclosure - Schedule of Level 3 Fair Value Measurements Inputs (Details) Sheet http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails Schedule of Level 3 Fair Value Measurements Inputs (Details) Details 83 false false R84.htm 00000084 - Disclosure - Tax (Details Narrative) Sheet http://shfinancial.org/role/TaxDetailsNarrative Tax (Details Narrative) Details http://shfinancial.org/role/Tax 84 false false R85.htm 00000085 - Disclosure - 401(k) Plan (Details Narrative) Sheet http://shfinancial.org/role/KPlanDetailsNarrative 401(k) Plan (Details Narrative) Details http://shfinancial.org/role/KPlan 85 false false R86.htm 00000086 - Disclosure - Schedule of Fair Value of Options Granted Black-Scholes-Merton Model (Details) Sheet http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails Schedule of Fair Value of Options Granted Black-Scholes-Merton Model (Details) Details 86 false false R87.htm 00000087 - Disclosure - Schedule of Stock Option and Related Information (Details) Sheet http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails Schedule of Stock Option and Related Information (Details) Details 87 false false R88.htm 00000088 - Disclosure - Schedule of Options Outstanding (Details) Sheet http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails Schedule of Options Outstanding (Details) Details 88 false false R89.htm 00000089 - Disclosure - Schedule of Restricted Stock Units (Details) Sheet http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails Schedule of Restricted Stock Units (Details) Details 89 false false R90.htm 00000090 - Disclosure - Schedule of Exercise Price of Restricted Stock Units (Details) Sheet http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails Schedule of Exercise Price of Restricted Stock Units (Details) Details 90 false false R91.htm 00000091 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://shfinancial.org/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://shfinancial.org/role/StockholdersEquityTables 91 false false R92.htm 00000092 - Disclosure - Subsequent events (Details Narrative) Sheet http://shfinancial.org/role/SubsequentEventsDetailsNarrative Subsequent events (Details Narrative) Details http://shfinancial.org/role/SubsequentEvents 92 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentTerm, us-gaap:LesseeOperatingLeaseRemainingLeaseTerm - form10-q.htm 108, 109 form10-q.htm shfs-20240331.xsd shfs-20240331_cal.xml shfs-20240331_def.xml shfs-20240331_lab.xml shfs-20240331_pre.xml http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 true true JSON 112 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "SHFS", "nsuri": "http://shfinancial.org/20240331", "dts": { "inline": { "local": [ "form10-q.htm" ] }, "schema": { "local": [ "shfs-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "shfs-20240331_cal.xml" ] }, "definitionLink": { "local": [ "shfs-20240331_def.xml" ] }, "labelLink": { "local": [ "shfs-20240331_lab.xml" ] }, "presentationLink": { "local": [ "shfs-20240331_pre.xml" ] } }, "keyStandard": 319, "keyCustom": 102, "axisStandard": 31, "axisCustom": 0, "memberStandard": 41, "memberCustom": 58, "hidden": { "total": 201, "http://fasb.org/us-gaap/2024": 143, "http://shfinancial.org/20240331": 54, "http://xbrl.sec.gov/dei/2024": 4 }, "contextCount": 336, "entityCount": 1, "segmentCount": 107, "elementCount": 684, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 981, "http://xbrl.sec.gov/dei/2024": 34 }, "report": { "R1": { "role": "http://shfinancial.org/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://shfinancial.org/role/BalanceSheets", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R3": { "role": "http://shfinancial.org/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R4": { "role": "http://shfinancial.org/role/StatementsOfOperations", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EmployeeBenefitsAndShareBasedCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R5": { "role": "http://shfinancial.org/role/StatementsOfStockholdersEquity", "longName": "00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_PreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_PreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R6": { "role": "http://shfinancial.org/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R7": { "role": "http://shfinancial.org/role/OrganizationAndBusinessOperations", "longName": "00000007 - Disclosure - Organization and Business Operations", "shortName": "Organization and Business Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R8": { "role": "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies", "longName": "00000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://shfinancial.org/role/DeferredConsideration", "longName": "00000009 - Disclosure - Deferred Consideration", "shortName": "Deferred Consideration", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:DeferredConsiderationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:DeferredConsiderationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssets", "longName": "00000010 - Disclosure - Goodwill and Finite-lived Intangible Assets", "shortName": "Goodwill and Finite-lived Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://shfinancial.org/role/LoansReceivable", "longName": "00000011 - Disclosure - Loans Receivable", "shortName": "Loans Receivable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://shfinancial.org/role/IndemnificationLiability", "longName": "00000012 - Disclosure - Indemnification Liability", "shortName": "Indemnification Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:IndemnificationLiabilityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:IndemnificationLiabilityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://shfinancial.org/role/PropertyAndEquipmentNet", "longName": "00000013 - Disclosure - Property and Equipment, Net", "shortName": "Property and Equipment, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://shfinancial.org/role/RelatedPartyTransactions", "longName": "00000014 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://shfinancial.org/role/SeniorSecuredPromissoryNote", "longName": "00000015 - Disclosure - Senior Secured Promissory Note", "shortName": "Senior Secured Promissory Note", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://shfinancial.org/role/Leases", "longName": "00000016 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://shfinancial.org/role/Revenue", "longName": "00000017 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://shfinancial.org/role/DeferredUnderwriterFee", "longName": "00000018 - Disclosure - Deferred Underwriter Fee", "shortName": "Deferred Underwriter Fee", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:DeferredUnderwriterFeeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:DeferredUnderwriterFeeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R19": { "role": "http://shfinancial.org/role/CommitmentsAndContingencies", "longName": "00000019 - Disclosure - Commitments and contingencies", "shortName": "Commitments and contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://shfinancial.org/role/EarningsPerShare", "longName": "00000020 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R21": { "role": "http://shfinancial.org/role/ForwardPurchaseAgreement", "longName": "00000021 - Disclosure - Forward Purchase Agreement", "shortName": "Forward Purchase Agreement", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ForwardPurchaseAgreementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ForwardPurchaseAgreementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R22": { "role": "http://shfinancial.org/role/WarrantLiabilities", "longName": "00000022 - Disclosure - Warrant Liabilities", "shortName": "Warrant Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:WarrantLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:WarrantLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R23": { "role": "http://shfinancial.org/role/FinancialInstruments", "longName": "00000023 - Disclosure - Financial Instruments", "shortName": "Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R24": { "role": "http://shfinancial.org/role/Tax", "longName": "00000024 - Disclosure - Tax", "shortName": "Tax", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R25": { "role": "http://shfinancial.org/role/KPlan", "longName": "00000025 - Disclosure - 401(k) Plan", "shortName": "401(k) Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DefinedContributionPlanTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DefinedContributionPlanTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R26": { "role": "http://shfinancial.org/role/StockholdersEquity", "longName": "00000026 - Disclosure - Stockholders\u2019 Equity", "shortName": "Stockholders\u2019 Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R27": { "role": "http://shfinancial.org/role/SubsequentEvents", "longName": "00000027 - Disclosure - Subsequent events", "shortName": "Subsequent events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R28": { "role": "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "28", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R29": { "role": "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "longName": "00000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfCurrentExpectedCreditLossesTransitionImpactTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfCurrentExpectedCreditLossesTransitionImpactTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R30": { "role": "http://shfinancial.org/role/DeferredConsiderationTables", "longName": "00000030 - Disclosure - Deferred Consideration (Tables)", "shortName": "Deferred Consideration (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfDeferredConsiderationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SHFS:DeferredConsiderationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfDeferredConsiderationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SHFS:DeferredConsiderationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R31": { "role": "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsTables", "longName": "00000031 - Disclosure - Goodwill and Finite-lived Intangible Assets (Tables)", "shortName": "Goodwill and Finite-lived Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R32": { "role": "http://shfinancial.org/role/LoansReceivableTables", "longName": "00000032 - Disclosure - Loans Receivable (Tables)", "shortName": "Loans Receivable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R33": { "role": "http://shfinancial.org/role/IndemnificationLiabilityTables", "longName": "00000033 - Disclosure - Indemnification Liability (Tables)", "shortName": "Indemnification Liability (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R34": { "role": "http://shfinancial.org/role/PropertyAndEquipmentNetTables", "longName": "00000034 - Disclosure - Property and Equipment, Net (Tables)", "shortName": "Property and Equipment, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R35": { "role": "http://shfinancial.org/role/RelatedPartyTransactionsTables", "longName": "00000035 - Disclosure - Related Party Transactions (Tables)", "shortName": "Related Party Transactions (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfRevenueFromOperationsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfRevenueFromOperationsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R36": { "role": "http://shfinancial.org/role/SeniorSecuredPromissoryNoteTables", "longName": "00000036 - Disclosure - Senior Secured Promissory Note (Tables)", "shortName": "Senior Secured Promissory Note (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R37": { "role": "http://shfinancial.org/role/LeasesTables", "longName": "00000037 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfLeaseCostRightOfUseAssetsRelatedToLeaseAndFutureMinimumLeasePaymentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfLeaseCostRightOfUseAssetsRelatedToLeaseAndFutureMinimumLeasePaymentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R38": { "role": "http://shfinancial.org/role/RevenueTables", "longName": "00000038 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R39": { "role": "http://shfinancial.org/role/EarningsPerShareTables", "longName": "00000039 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R40": { "role": "http://shfinancial.org/role/ForwardPurchaseAgreementTables", "longName": "00000040 - Disclosure - Forward Purchase Agreement (Tables)", "shortName": "Forward Purchase Agreement (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfForwardPurchaseAgreeementTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SHFS:ForwardPurchaseAgreementTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:ScheduleOfForwardPurchaseAgreeementTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SHFS:ForwardPurchaseAgreementTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R41": { "role": "http://shfinancial.org/role/FinancialInstrumentsTables", "longName": "00000041 - Disclosure - Financial Instruments (Tables)", "shortName": "Financial Instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R42": { "role": "http://shfinancial.org/role/StockholdersEquityTables", "longName": "00000042 - Disclosure - Stockholders\u2019 Equity (Tables)", "shortName": "Stockholders\u2019 Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R43": { "role": "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails", "longName": "00000043 - Disclosure - Schedule of Current Expected Credit Losses Transition Impact (Details)", "shortName": "Schedule of Current Expected Credit Losses Transition Impact (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "SHFS:IndemnityLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-01-01_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember", "name": "SHFS:AllowanceForLoanLossesAdjustment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfCurrentExpectedCreditLossesTransitionImpactTableTextBlock", "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R44": { "role": "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000044 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "SHFS:WorkingCapital", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "SHFS:LiquidityAndGoingConcernPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R45": { "role": "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails", "longName": "00000045 - Disclosure - Schedule of Change in Deferred Consideration (Details)", "shortName": "Schedule of Change in Deferred Consideration (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "SHFS:DeferredStockConsideration", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfDeferredConsiderationTableTextBlock", "SHFS:DeferredConsiderationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "SHFS:DeferredStockConsideration", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfDeferredConsiderationTableTextBlock", "SHFS:DeferredConsiderationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R46": { "role": "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "longName": "00000046 - Disclosure - Deferred Consideration (Details Narrative)", "shortName": "Deferred Consideration (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_CommonClassAMember", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "SHFS:WarrantLiabilitiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_AbacaMergerClosingMember", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "span", "p", "SHFS:DeferredConsiderationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R47": { "role": "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails", "longName": "00000047 - Disclosure - Schedule of Finite Lived Intangible Assets (Details)", "shortName": "Schedule of Finite Lived Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R48": { "role": "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative", "longName": "00000048 - Disclosure - Goodwill and Finite-lived Intangible Assets (Details Narrative)", "shortName": "Goodwill and Finite-lived Intangible Assets (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2023-01-012023-12-31", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R49": { "role": "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails", "longName": "00000049 - Disclosure - Schedule of Commercial Real Estate Loans Receivable (Details)", "shortName": "Schedule of Commercial Real Estate Loans Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "AsOf2024-03-31_custom_CommercialRealEstateLoansReceivableMember", "name": "us-gaap:NotesReceivableGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_CommercialRealEstateLoansReceivableMember", "name": "us-gaap:NotesReceivableGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRealEstatePropertiesTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R50": { "role": "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails", "longName": "00000050 - Disclosure - Schedule of Allowance For Loan Losses (Details)", "shortName": "Schedule of Allowance For Loan Losses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R51": { "role": "http://shfinancial.org/role/ScheduleOfRiskRatingDetails", "longName": "00000051 - Disclosure - Schedule of Risk Rating (Details)", "shortName": "Schedule of Risk Rating (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FinancingReceivableCollectivelyEvaluatedForImpairment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_RiskRateFourMember", "name": "us-gaap:FinancingReceivableCollectivelyEvaluatedForImpairment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfRiskRatingTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R52": { "role": "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails", "longName": "00000052 - Disclosure - Schedule of Outstanding Amounts (Details)", "shortName": "Schedule of Outstanding Amounts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfIndemnifiedLoansRiskRatingTableTextBlock", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_PCCUAgreementMember", "name": "us-gaap:SecuredLongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R53": { "role": "http://shfinancial.org/role/ScheduleOfIndemnityLiabilityDetails", "longName": "00000053 - Disclosure - Schedule of Indemnity Liability (Details)", "shortName": "Schedule of Indemnity Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R54": { "role": "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails", "longName": "00000054 - Disclosure - Schedule of Indemnified Loans Risk Rating (Details)", "shortName": "Schedule of Indemnified Loans Risk Rating (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfIndemnifiedLoansRiskRatingTableTextBlock", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_RiskRateThreeMember", "name": "us-gaap:LongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfIndemnifiedLoansRiskRatingTableTextBlock", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R55": { "role": "http://shfinancial.org/role/ScheduleOfProvisionForLoanLossesDetails", "longName": "00000055 - Disclosure - Schedule of Provision for Loan Losses (Details)", "shortName": "Schedule of Provision for Loan Losses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ProvisionForLoanLeaseAndOtherLosses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfProvisionForLoanLossesTableTextBlock", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ProvisionForLoanLeaseAndOtherLosses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfProvisionForLoanLossesTableTextBlock", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R56": { "role": "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative", "longName": "00000056 - Disclosure - Indemnification Liability (Details Narrative)", "shortName": "Indemnification Liability (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_SecuredDebtMember_srt_MinimumMember", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_SecuredDebtMember_srt_MinimumMember", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R57": { "role": "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails", "longName": "00000057 - Disclosure - Schedule of Property and Equipment (Details)", "shortName": "Schedule of Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R58": { "role": "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails", "longName": "00000058 - Disclosure - Schedule of Demonstrated Deposit Capacity (Details)", "shortName": "Schedule of Demonstrated Deposit Capacity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2024-03-31_custom_LoanServicingAgreementMember", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfDemonstratesDepositCapacityTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_LoanServicingAgreementMember", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfDemonstratesDepositCapacityTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R59": { "role": "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails", "longName": "00000059 - Disclosure - Schedule of Revenue from Operations (Details)", "shortName": "Schedule of Revenue from Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_RelatedPartyMember", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfRevenueFromOperationsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_RelatedPartyMember", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfRevenueFromOperationsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R60": { "role": "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "longName": "00000060 - Disclosure - Schedule of Operating Expense from Operations (Details)", "shortName": "Schedule of Operating Expense from Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OperatingExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_RelatedPartyMember", "name": "us-gaap:OperatingExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfOperatingExpenseFromOperationsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R61": { "role": "http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails", "longName": "00000061 - Disclosure - Schedule of Outstanding Balances from Balance Sheet (Details)", "shortName": "Schedule of Outstanding Balances from Balance Sheet (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_RelatedPartyMember", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_RelatedPartyMember", "name": "us-gaap:SecuredDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfOutstandingBalancesFromBalanceSheetTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R62": { "role": "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "longName": "00000062 - Disclosure - Related Party Transactions (Details Narrative)", "shortName": "Related Party Transactions (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "AsOf2023-03-29", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R63": { "role": "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails", "longName": "00000063 - Disclosure - Schedule of Senior Secured Promissory Note (Details)", "shortName": "Schedule of Senior Secured Promissory Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "AsOf2023-03-29", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_SecurityAgreementMember", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R64": { "role": "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails", "longName": "00000064 - Disclosure - Schedule of Outstanding Amount on Debt (Details)", "shortName": "Schedule of Outstanding Amount on Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfIndemnifiedLoansRiskRatingTableTextBlock", "SHFS:IndemnificationLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_SeniorSecuredPromissoryNoteMember", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R65": { "role": "http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative", "longName": "00000065 - Disclosure - Senior Secured Promissory Note (Details Narrative)", "shortName": "Senior Secured Promissory Note (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2023-03-29", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-05_custom_FiftyFourEqualInstallmentsMember", "name": "SHFS:DeferredConsiderationPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R66": { "role": "http://shfinancial.org/role/ScheduleOfLeaseCostDetails", "longName": "00000066 - Disclosure - Schedule of Lease Cost (Details)", "shortName": "Schedule of Lease Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShortTermLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfLeaseCostRightOfUseAssetsRelatedToLeaseAndFutureMinimumLeasePaymentsTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShortTermLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfLeaseCostRightOfUseAssetsRelatedToLeaseAndFutureMinimumLeasePaymentsTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R67": { "role": "http://shfinancial.org/role/ScheduleOfRightOfUseAssetsDetails", "longName": "00000067 - Disclosure - Schedule of Right Of Use Assets (Details)", "shortName": "Schedule of Right Of Use Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfRightOfUseAssetsTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R68": { "role": "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails", "longName": "00000068 - Disclosure - Schedule of Future Minimum Lease Payments (Details)", "shortName": "Schedule of Future Minimum Lease Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfFutureMinimumRentalPaymentForOperatingLeasesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfFutureMinimumRentalPaymentForOperatingLeasesTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R69": { "role": "http://shfinancial.org/role/LeasesDetailsNarrative", "longName": "00000069 - Disclosure - Leases (Details Narrative)", "shortName": "Leases (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_srt_MaximumMember", "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R70": { "role": "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails", "longName": "00000070 - Disclosure - Schedule of Disaggregated Revenue (Details)", "shortName": "Schedule of Disaggregated Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_DepositActivityOnboardingIncomeMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R71": { "role": "http://shfinancial.org/role/RevenueDetailsNarrative", "longName": "00000071 - Disclosure - Revenue (Details Narrative)", "shortName": "Revenue (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "From2024-01-012024-03-31_custom_PartnerColoradoCreditUnionMember", "name": "SHFS:InvestmentHostingFeesRemitPercent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_PartnerColoradoCreditUnionMember", "name": "SHFS:InvestmentHostingFeesRemitPercent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R72": { "role": "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative", "longName": "00000072 - Disclosure - Deferred Underwriter Fee (Details Narrative)", "shortName": "Deferred Underwriter Fee (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "From2023-01-012023-03-31", "name": "SHFS:StockIssuedDuringPeriodValueReversalOfDeferredUnderwritingCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_BenchmarkInvestmentsLLCMember", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "SHFS:DeferredUnderwriterFeeTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R73": { "role": "http://shfinancial.org/role/ScheduleOfEarningPerSharesBasicAndDilutedDetails", "longName": "00000073 - Disclosure - Schedule of Earning Per Shares, Basic and Diluted (Details)", "shortName": "Schedule of Earning Per Shares, Basic and Diluted (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R74": { "role": "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails", "longName": "00000074 - Disclosure - Schedule of Weighted Average Shares Outstanding - Basic And Diluted (Details)", "shortName": "Schedule of Weighted Average Shares Outstanding - Basic And Diluted (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R75": { "role": "http://shfinancial.org/role/ScheduleOfShare-basedEquityAwardsAndWarrantsExcludedFromComputationOfEarningsDetails", "longName": "00000075 - Disclosure - Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings (Details)", "shortName": "Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:WarrantsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "SHFS:WarrantsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R76": { "role": "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails", "longName": "00000076 - Disclosure - Schedule of Forward Purchase Agreement (Details)", "shortName": "Schedule of Forward Purchase Agreement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "SHFS:NumberOfSharesOnTheDateOfAcquisition", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfForwardPurchaseAgreeementTableTextBlock", "SHFS:ForwardPurchaseAgreementTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "SHFS:NumberOfSharesOnTheDateOfAcquisition", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "SHFS:ScheduleOfForwardPurchaseAgreeementTableTextBlock", "SHFS:ForwardPurchaseAgreementTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R77": { "role": "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "longName": "00000077 - Disclosure - Forward Purchase Agreement (Details Narrative)", "shortName": "Forward Purchase Agreement (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "From2022-06-152022-06-16", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "td", "tr", "table", "SHFS:ForwardPurchaseAgreementTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-06-152022-06-16", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "td", "tr", "table", "SHFS:ForwardPurchaseAgreementTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R78": { "role": "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative", "longName": "00000078 - Disclosure - Warrant Liabilities (Details Narrative)", "shortName": "Warrant Liabilities (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_CommonClassAMember", "name": "us-gaap:SharePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "SHFS:WarrantLiabilitiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_CommonClassAMember", "name": "us-gaap:SharePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "SHFS:WarrantLiabilitiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R79": { "role": "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "longName": "00000079 - Disclosure - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Details)", "shortName": "Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember", "name": "us-gaap:LiabilitiesFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember", "name": "us-gaap:LiabilitiesFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R80": { "role": "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "longName": "00000080 - Disclosure - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)", "shortName": "Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:DeferredCompensationLiabilityCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_FairValueInputsLevel1Member", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R81": { "role": "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "longName": "00000081 - Disclosure - Schedule of Fair Value Assets Measured on Recurring Basis (Details)", "shortName": "Schedule of Fair Value Assets Measured on Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_PIPEWarrantsMember30316109", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_PIPEWarrantsMember30316109", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R82": { "role": "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "longName": "00000082 - Disclosure - Schedule of Level 3 Fair Value Measurement Inputs (Details)", "shortName": "Schedule of Level 3 Fair Value Measurement Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "AsOf2024-03-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R83": { "role": "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails", "longName": "00000083 - Disclosure - Schedule of Level 3 Fair Value Measurements Inputs (Details)", "shortName": "Schedule of Level 3 Fair Value Measurements Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "AsOf2024-03-31_custom_ForwardPurchaseDerivativeMember_custom_MeasurementInputResetPriceMember", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_ForwardPurchaseDerivativeMember_custom_MeasurementInputResetPriceMember", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R84": { "role": "http://shfinancial.org/role/TaxDetailsNarrative", "longName": "00000084 - Disclosure - Tax (Details Narrative)", "shortName": "Tax (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R85": { "role": "http://shfinancial.org/role/KPlanDetailsNarrative", "longName": "00000085 - Disclosure - 401(k) Plan (Details Narrative)", "shortName": "401(k) Plan (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:DefinedContributionPlanTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:DefinedContributionPlanTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R86": { "role": "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails", "longName": "00000086 - Disclosure - Schedule of Fair Value of Options Granted Black-Scholes-Merton Model (Details)", "shortName": "Schedule of Fair Value of Options Granted Black-Scholes-Merton Model (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R87": { "role": "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails", "longName": "00000087 - Disclosure - Schedule of Stock Option and Related Information (Details)", "shortName": "Schedule of Stock Option and Related Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R88": { "role": "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails", "longName": "00000088 - Disclosure - Schedule of Options Outstanding (Details)", "shortName": "Schedule of Options Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R89": { "role": "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails", "longName": "00000089 - Disclosure - Schedule of Restricted Stock Units (Details)", "shortName": "Schedule of Restricted Stock Units (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R90": { "role": "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "longName": "00000090 - Disclosure - Schedule of Exercise Price of Restricted Stock Units (Details)", "shortName": "Schedule of Exercise Price of Restricted Stock Units (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_ExercisePriceOneMember_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R91": { "role": "http://shfinancial.org/role/StockholdersEquityDetailsNarrative", "longName": "00000091 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockConvertibleConversionPrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R92": { "role": "http://shfinancial.org/role/SubsequentEventsDetailsNarrative", "longName": "00000092 - Disclosure - Subsequent events (Details Narrative)", "shortName": "Subsequent events (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "AsOf2024-04-05_us-gaap_SubsequentEventMember", "name": "us-gaap:SharePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-04-05_us-gaap_SubsequentEventMember", "name": "us-gaap:SharePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } } }, "tag": { "SHFS_AbacaMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AbacaMember", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Abaca [Member]", "documentation": "Abaca [Member]" } } }, "auth_ref": [] }, "SHFS_AbacaMergerClosingMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AbacaMergerClosingMember", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Abaca Merger Closing [Member]", "documentation": "Abaca Merger Closing [Member]" } } }, "auth_ref": [] }, "SHFS_AbacaWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AbacaWarrantMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "label": "Abaca Warrant [Member]", "documentation": "Abaca Warrant [Member]" } } }, "auth_ref": [] }, "SHFS_AbacaWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AbacaWarrantsMember", "presentation": [ "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Abaca Warrants [Member]", "documentation": "Abaca Warrants [Member]" } } }, "auth_ref": [] }, "SHFS_AccountHostingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AccountHostingExpenses", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/RevenueDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Account hosting expenses", "documentation": "Account hosting expenses." } } }, "auth_ref": [] }, "SHFS_AccountServicingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AccountServicingAgreementMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Account Servicing Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsAndOtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Short-term loans receivable, net", "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r56", "r831" ] }, "us-gaap_AccountsPayableTradeCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableTradeCurrent", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts receivable trade", "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r14", "r56" ] }, "us-gaap_AccountsReceivableFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableFairValueDisclosure", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Forward purchase receivables", "documentation": "Fair value portion of amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties." } } }, "auth_ref": [ "r560" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Accounts receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r915" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r59" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r31", "r159", "r653" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r70", "r831", "r1023" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r695", "r901", "r902", "r903", "r905", "r966", "r1026" ] }, "SHFS_AdditionsToRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AdditionsToRightOfUseAssets", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Additions to right-of-use assets", "documentation": "Additions to right of use assets" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock compensation cost", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r43", "r44", "r449" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income/ (loss) to net cash provided by/ (used in) operating activities:" } } }, "auth_ref": [] }, "SHFS_AllianceAgreementDescription": { "xbrltype": "stringItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AllianceAgreementDescription", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Alliance agreement, description", "documentation": "Alliance agreement description." } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r481", "r486" ] }, "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "presentation": [ "http://shfinancial.org/role/LoansReceivableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Allowance For Loan Losses", "documentation": "Tabular disclosure of allowance for credit loss on financing receivable." } } }, "auth_ref": [ "r123", "r924" ] }, "SHFS_AllowanceForLoanAndLeaseLossRecoveryOfBadDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AllowanceForLoanAndLeaseLossRecoveryOfBadDebt", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Recoveries", "documentation": "Allowance for loan and lease loss recovery of bad debt." } } }, "auth_ref": [] }, "SHFS_AllowanceForLoanAndLeaseLossesFromCumulativeEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AllowanceForLoanAndLeaseLossesFromCumulativeEffect", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cumulative effect from adoption of CECL", "documentation": "Allowance for loan and lease losses from cumulative effect.", "label": "AllowanceForLoanAndLeaseLossesFromCumulativeEffect" } } }, "auth_ref": [] }, "SHFS_AllowanceForLoanLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AllowanceForLoanLosses", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails", "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Less: Allowance for credit loss", "negatedLabel": "Allowance for credit losses", "documentation": "Allowance for loan losses" } } }, "auth_ref": [] }, "SHFS_AllowanceForLoanLossesAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AllowanceForLoanLossesAdjustment", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Allowance for loan losses", "documentation": "Allowance for loan losses adjustment." } } }, "auth_ref": [] }, "SHFS_AllowanceForLoansAndLeaseLossesWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AllowanceForLoansAndLeaseLossesWriteOffs", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Charge-offs", "documentation": "Allowance for loans and lease losses write-offs." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDeferredLoanOriginationFeesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfDeferredLoanOriginationFeesNet", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of deferred origination fees", "label": "Amortization of Deferred Loan Origination Fees, Net", "documentation": "The net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments." } } }, "auth_ref": [ "r892", "r916" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r863" ] }, "SHFS_AnnualServicingFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "AnnualServicingFeePercentage", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Servicing fee", "documentation": "Annual servicing fee percentage." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://shfinancial.org/role/ScheduleOfShare-basedEquityAwardsAndWarrantsExcludedFromComputationOfEarningsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Grand total", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r227" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/FinancialInstrumentsTables", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsTables", "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails", "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails", "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r521" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment charge", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r4", "r30" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets [Default Label]", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r110", "r122", "r163", "r190", "r232", "r236", "r245", "r246", "r286", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r522", "r524", "r561", "r644", "r731", "r793", "r794", "r831", "r848", "r953", "r954", "r980" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r154", "r172", "r190", "r286", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r522", "r524", "r561", "r831", "r953", "r954", "r980" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueAdjustment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair value adjustment", "documentation": "Amount of addition (reduction) to the amount at which an asset could be incurred (settled) in a current transaction between willing parties." } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsHeldInTrustCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsHeldInTrustCurrent", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Asset held with trust", "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited." } } }, "auth_ref": [ "r893" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r863" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r452", "r453", "r454", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r476", "r477", "r478", "r479", "r480" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "SHFS_BenchmarkInvestmentsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "BenchmarkInvestmentsLLCMember", "presentation": [ "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Benchmark Investments LLC [Member]", "documentation": "Benchmark Investments LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r329", "r330", "r331", "r332", "r333", "r517", "r814", "r815" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r45", "r46", "r329", "r330", "r331", "r332", "r333", "r517", "r814", "r815" ] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued for acquisition", "documentation": "Number of shares of equity interests issued or issuable to acquire entity." } } }, "auth_ref": [ "r109" ] }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "presentation": [ "http://shfinancial.org/role/OrganizationAndBusinessOperations" ], "lang": { "en-us": { "role": { "label": "Organization and Business Operations", "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r55", "r88", "r89" ] }, "SHFS_CannabisRelatedBusinessesRelatedDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CannabisRelatedBusinessesRelatedDepositsMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "label": "Cannabis Related Businesses Related Deposits [Member]" } } }, "auth_ref": [] }, "SHFS_CapacityAtOnePointThreeOneTwoFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CapacityAtOnePointThreeOneTwoFiveMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "label": "Capacity at 1.3125 [Member]", "documentation": "Capacity at 1.3125 [Member]" } } }, "auth_ref": [] }, "SHFS_CapacityAtSixtyPercentageMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CapacityAtSixtyPercentageMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "label": "Capacity at 60% [Member]", "documentation": "Capacity at 60% [Member]" } } }, "auth_ref": [] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Reported Value Measurement [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r48", "r49" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "verboseLabel": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r16", "r156", "r788" ] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r156" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r968", "r969" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r17" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents \u2013 beginning of period", "periodEndLabel": "Cash and cash equivalents \u2013 end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r16", "r84", "r186" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r84" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r886", "r990" ] }, "us-gaap_CashMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashMember", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash [Member]", "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits." } } }, "auth_ref": [ "r156" ] }, "SHFS_ChangeInFairValueOfDeferredConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ChangeInFairValueOfDeferredConsideration", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 }, "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in the fair value of deferred consideration", "documentation": "Change in the fair value of deferred consideration.", "label": "ChangeInFairValueOfDeferredConsideration" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "SHFS_ClassCommonStock0.0001ParValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ClassCommonStock0.0001ParValuePerShareMember", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class A Common Stock, $0.0001 par value per share" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://shfinancial.org/role/Cover", "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/StatementsOfStockholdersEquity", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r142", "r164", "r165", "r166", "r190", "r216", "r220", "r224", "r226", "r234", "r235", "r286", "r356", "r358", "r359", "r360", "r363", "r364", "r396", "r397", "r400", "r403", "r410", "r561", "r686", "r687", "r688", "r689", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r717", "r740", "r762", "r775", "r776", "r777", "r778", "r779", "r869", "r894", "r906" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant exercise price", "verboseLabel": "Warrants execise price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r411" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrant issued", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r411" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsTables", "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r521" ] }, "SHFS_CommercialAllianceAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CommercialAllianceAgreementMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Commercial Alliance Agreement [Member]" } } }, "auth_ref": [] }, "SHFS_CommercialRealEstateLoansReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CommercialRealEstateLoansReceivableCurrent", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Current portion", "documentation": "Commercial Real Estate Loans Receivable Current." } } }, "auth_ref": [] }, "SHFS_CommercialRealEstateLoansReceivableGross": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CommercialRealEstateLoansReceivableGross", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Loans receivable, gross", "documentation": "Commercial real estate loans receivable gross" } } }, "auth_ref": [] }, "SHFS_CommercialRealEstateLoansReceivableGrossAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CommercialRealEstateLoansReceivableGrossAdjustment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Loans receivable, gross", "documentation": "Commercial real estate loans receivable gross adjustment.", "label": "CommercialRealEstateLoansReceivableGrossAdjustment" } } }, "auth_ref": [] }, "SHFS_CommercialRealEstateLoansReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CommercialRealEstateLoansReceivableMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Commercial Real Estate Loans Receivable [Member]", "documentation": "Commercial Real Estate Loans Receivable [Member]" } } }, "auth_ref": [] }, "SHFS_CommercialRealEstateLoansReceivableNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CommercialRealEstateLoansReceivableNonCurrent", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Noncurrent portion", "documentation": "Commercial Real Estate Loans Receivable Non Current." } } }, "auth_ref": [] }, "us-gaap_CommercialRealEstatePortfolioSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommercialRealEstatePortfolioSegmentMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfProvisionForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Commercial Real Estate Portfolio Segment [Member]", "documentation": "Portfolio segment of the company's total financing receivables related to commercial real estate." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitment and Contingencies (Note 13)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r66", "r114", "r646", "r716" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r94", "r347", "r348", "r781", "r941", "r946" ] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonClassAMember", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/StatementsOfStockholdersEquity", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r1026" ] }, "us-gaap_CommonStockHeldBySubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockHeldBySubsidiary", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Common stock held by subsidiary", "documentation": "Value of entity shares held by subsidiary, which are purchased for the purpose of granting the shares to senior employees as part of an employee stock option plan approved by the Entity's Board of Directors. Presented as a reduction of shareholders' equity at their cost to the subsidiary." } } }, "auth_ref": [ "r69" ] }, "SHFS_CommonStockHeldBySubsidiaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CommonStockHeldBySubsidiaryShares", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock held by subsidiary shares", "verboseLabel": "Common stock held for purchase", "documentation": "Common stock held by subsidiary shares." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r838", "r839", "r840", "r842", "r843", "r844", "r845", "r901", "r902", "r905", "r966", "r1022", "r1026" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://shfinancial.org/role/BalanceSheetsParenthetical", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class A common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r69" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://shfinancial.org/role/BalanceSheetsParenthetical", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class A common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r69", "r717" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://shfinancial.org/role/BalanceSheetsParenthetical", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class A common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r69" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://shfinancial.org/role/BalanceSheetsParenthetical", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class A common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r69", "r717", "r737", "r1026", "r1027" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Class A common stock, $.0001 par value, 130,000,000 shares authorized, 55,431,001 and 54,563,372 issued and outstanding on March 31, 2024, and December 31, 2023, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r69", "r648", "r831" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentrations of Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r54", "r134" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r194", "r522", "r523", "r524", "r525", "r600", "r782", "r952", "r955", "r956" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "auth_ref": [ "r194", "r522", "r523", "r524", "r525", "r600", "r782", "r952", "r955", "r956" ] }, "SHFS_ContractLiabilitiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ContractLiabilitiesPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Contract Liabilities", "documentation": "Contract liabilities [policy text block]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contract liabilities", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r413", "r414", "r433" ] }, "us-gaap_ConversionOfStockDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockDescription", "presentation": [ "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion of stock description", "documentation": "A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r18", "r19", "r20" ] }, "us-gaap_ConvertibleNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayable", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Notes payable", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r13", "r113", "r989" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "SHFS_CreditExpectedCreditLossesTransitionMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CreditExpectedCreditLossesTransitionMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Credit Expected Credit Losses Transition [Member]", "documentation": "Credit Expected Credit Losses Transition [Member]" } } }, "auth_ref": [] }, "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditLossFinancialInstrumentPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable", "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status." } } }, "auth_ref": [ "r291", "r292", "r293", "r295", "r296", "r300", "r302", "r303", "r304", "r305", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r316" ] }, "SHFS_CumulativeEffectFromAdoption": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "CumulativeEffectFromAdoption", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Cumulative effect from adoption of CECL", "documentation": "Cumulative effect from adoption.", "label": "CumulativeEffectFromAdoption" } } }, "auth_ref": [] }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "auth_ref": [ "r150", "r198", "r204", "r212", "r287", "r290", "r338", "r503", "r504", "r512", "r514", "r527", "r528", "r529", "r531", "r532", "r533", "r536", "r538", "r539", "r540", "r589" ] }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CumulativeEffectPeriodOfAdoptionAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "auth_ref": [ "r150", "r198", "r204", "r212", "r287", "r290", "r338", "r503", "r504", "r512", "r514", "r527", "r528", "r529", "r531", "r532", "r533", "r536", "r538", "r539", "r540", "r589" ] }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CumulativeEffectPeriodOfAdoptionDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "auth_ref": [ "r150", "r198", "r204", "r212", "r287", "r290", "r338", "r503", "r504", "r512", "r514", "r527", "r528", "r529", "r531", "r532", "r533", "r536", "r538", "r539", "r540", "r589" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerRelationshipsMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r47", "r931", "r932", "r933", "r934", "r935", "r936", "r938", "r939" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/SeniorSecuredPromissoryNote" ], "lang": { "en-us": { "role": { "label": "Senior Secured Promissory Note", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r95", "r188", "r340", "r341", "r342", "r343", "r344", "r354", "r355", "r365", "r371", "r372", "r373", "r374", "r375", "r376", "r381", "r388", "r389", "r391", "r570" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails", "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails", "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r13", "r58", "r59", "r112", "r113", "r194", "r366", "r367", "r368", "r369", "r370", "r372", "r377", "r378", "r379", "r380", "r382", "r383", "r384", "r385", "r386", "r387", "r804", "r805", "r806", "r807", "r808", "r829", "r895", "r942", "r943", "r944", "r976", "r977" ] }, "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentDescriptionOfVariableRateBasis", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Variable rate description", "documentation": "Description of reference rate used for variable rate of debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails", "http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument, face amount", "verboseLabel": "Total", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r366", "r570", "r571", "r805", "r806", "r829" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Senior secured promissory note", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r379", "r560", "r805", "r806", "r969", "r970", "r971", "r972", "r973" ] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Yearly fee percentage", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r61", "r384", "r976" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument, interest rate, effective percentage", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r61", "r393", "r570", "r571", "r829" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r61", "r367" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentLineItems", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r194", "r366", "r367", "r368", "r369", "r370", "r372", "r377", "r378", "r379", "r380", "r382", "r383", "r384", "r385", "r386", "r387", "r390", "r804", "r805", "r806", "r807", "r808", "r829", "r895", "r976", "r977" ] }, "us-gaap_DebtInstrumentMaturityDateDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentMaturityDateDescription", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maturity date, description", "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities." } } }, "auth_ref": [ "r62" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails", "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails", "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r13", "r194", "r366", "r367", "r368", "r369", "r370", "r372", "r377", "r378", "r379", "r380", "r382", "r383", "r384", "r385", "r386", "r387", "r804", "r805", "r806", "r807", "r808", "r829", "r895", "r942", "r943", "r944", "r976", "r977" ] }, "us-gaap_DebtInstrumentPeriodicPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPeriodicPayment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Periodic payment", "documentation": "Amount of the required periodic payments including both interest and principal payments." } } }, "auth_ref": [ "r13", "r53" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTable", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r13", "r33", "r34", "r52", "r97", "r98", "r194", "r366", "r367", "r368", "r369", "r370", "r372", "r377", "r378", "r379", "r380", "r382", "r383", "r384", "r385", "r386", "r387", "r390", "r804", "r805", "r806", "r807", "r808", "r829", "r895", "r976", "r977" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTerm", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables", "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]", "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r924" ] }, "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables", "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r924" ] }, "SHFS_DecreaseInReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DecreaseInReceivables", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Decrease in receivables", "documentation": "Decrease in receivables." } } }, "auth_ref": [] }, "SHFS_DeferredCashConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredCashConsideration", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Deferred cash consideration, Balance", "periodEndLabel": "Deferred cash consideration, Balance", "documentation": "Deferred cash consideration.", "label": "DeferredCashConsideration" } } }, "auth_ref": [] }, "SHFS_DeferredCashConsiderationFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredCashConsiderationFairValueAdjustment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Cash consideration, Fair value adjustment", "documentation": "Deferred cash consideration fair value adjustment." } } }, "auth_ref": [] }, "SHFS_DeferredCashConsiderationIssuanceOfPaymentToShareHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredCashConsiderationIssuanceOfPaymentToShareHolders", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash consideration, Issuance of shares and payment to shareholders", "documentation": "Deferred cash consideration issuance of payment to share holders.", "label": "DeferredCashConsiderationIssuanceOfPaymentToShareHolders" } } }, "auth_ref": [] }, "SHFS_DeferredCashConsiderationWorkingCapitalAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredCashConsiderationWorkingCapitalAdjustment", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Cash consideration, Working capital adjustment", "documentation": "Deferred cash consideration working capital adjustment." } } }, "auth_ref": [] }, "us-gaap_DeferredChargesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredChargesPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Deferred consideration", "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges." } } }, "auth_ref": [ "r162" ] }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred consideration \u2013 long term portion", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer)." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredCompensationLiabilityCurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred consideration \u2013 current portion", "verboseLabel": "Deferred consideration", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date." } } }, "auth_ref": [ "r35", "r100" ] }, "SHFS_DeferredConsiderationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredConsiderationDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/DeferredConsideration" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred Consideration", "documentation": "Deferred Consideration Disclosure [Text Block]", "label": "DeferredConsiderationDisclosureTextBlock" } } }, "auth_ref": [] }, "SHFS_DeferredConsiderationPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredConsiderationPayable", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred consideration payable", "documentation": "Deferred consideration payable." } } }, "auth_ref": [] }, "SHFS_DeferredConsiderationPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredConsiderationPayment", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Deferred consideration payment, Balance", "periodEndLabel": "Deferred consideration payment, Balance", "documentation": "Deferred consideration payment.", "label": "DeferredConsiderationPayment" } } }, "auth_ref": [] }, "SHFS_DeferredConsiderationPaymentFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredConsiderationPaymentFairValueAdjustment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Consideration payment, Fair value adjustment", "documentation": "Deferred consideration payment fair value adjustment." } } }, "auth_ref": [] }, "SHFS_DeferredConsiderationPaymentIssuanceOfPaymentConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredConsiderationPaymentIssuanceOfPaymentConsideration", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Consideration payment, Issuance of payment consideration", "documentation": "Deferred consideration payment issuance of payment consideration.", "label": "DeferredConsiderationPaymentIssuanceOfPaymentConsideration" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred tax asset", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r491", "r492" ] }, "SHFS_DeferredStockConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredStockConsideration", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Deferred stock consideration, Balance", "periodEndLabel": "Deferred stock consideration, Balance", "documentation": "Deferred stock consideration.", "label": "DeferredStockConsideration" } } }, "auth_ref": [] }, "SHFS_DeferredStockConsiderationFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredStockConsiderationFairValueAdjustment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Stock consideration, Fair value adjustment", "documentation": "Deferred stock consideration fair value adjustment." } } }, "auth_ref": [] }, "SHFS_DeferredStockConsiderationGainRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredStockConsiderationGainRecognized", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock consideration, Gain recognized in the consolidated statements of operations", "documentation": "Deferred stock consideration gain recognized.", "label": "DeferredStockConsiderationGainRecognized" } } }, "auth_ref": [] }, "SHFS_DeferredStockConsiderationIssuanceOfPaymentConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredStockConsiderationIssuanceOfPaymentConsideration", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock consideration, Issuance of payment consideration", "documentation": "Deferred stock consideration issuance of payment consideration.", "label": "DeferredStockConsiderationIssuanceOfPaymentConsideration" } } }, "auth_ref": [] }, "SHFS_DeferredStockConsiderationIssuanceOfPaymentToShareHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredStockConsiderationIssuanceOfPaymentToShareHolders", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock consideration, Issuance of shares and payment to shareholders", "documentation": "Deferred stock consideration issuance of payment to share holders.", "label": "DeferredStockConsiderationIssuanceOfPaymentToShareHolders" } } }, "auth_ref": [] }, "SHFS_DeferredStockConsiderationIssuanceOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredStockConsiderationIssuanceOfWarrants", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock consideration, Issuance of payment consideration", "documentation": "Deferred stock consideration issuance of warrants.", "label": "DeferredStockConsiderationIssuanceOfWarrants" } } }, "auth_ref": [] }, "SHFS_DeferredStockConsiderationWorkingCapitalAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredStockConsiderationWorkingCapitalAdjustment", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfChangeInDeferredConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock consideration, Working capital adjustment", "documentation": "Deferred stock consideration working capital adjustment.", "label": "DeferredStockConsiderationWorkingCapitalAdjustment" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/TaxDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets liabilities net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r961" ] }, "SHFS_DeferredUnderwriterFeeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DeferredUnderwriterFeeTextBlock", "presentation": [ "http://shfinancial.org/role/DeferredUnderwriterFee" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred Underwriter Fee", "documentation": "Deferred Underwriter Fee [Text Block]", "label": "DeferredUnderwriterFeeTextBlock" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "presentation": [ "http://shfinancial.org/role/KPlanDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Defined contribution plan employee matching contribution", "documentation": "Percentage employer matches of the employee's percentage contribution matched." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/KPlanDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Defined contribution plan amount", "documentation": "Maximum amount the employee may contribute to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "presentation": [ "http://shfinancial.org/role/KPlanDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Defined contribution plan employee percent", "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedContributionPlanTextBlock", "presentation": [ "http://shfinancial.org/role/KPlan" ], "lang": { "en-us": { "role": { "label": "401(k) Plan", "documentation": "The entire disclosure for defined contribution plan." } } }, "auth_ref": [ "r443", "r444" ] }, "SHFS_DepositActivityOnboardingIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DepositActivityOnboardingIncomeMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Deposit Activity Onboarding Income [Member]" } } }, "auth_ref": [] }, "us-gaap_Deposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Deposits", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others." } } }, "auth_ref": [ "r111" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization expense", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r4", "r232", "r241", "r246", "r793", "r794" ] }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Forward purchase derivative liability", "verboseLabel": "Forward purchase derivative", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r173" ] }, "SHFS_DerivativeLiabilityExpectedTerm": { "xbrltype": "durationItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DerivativeLiabilityExpectedTerm", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Expected term (years)", "documentation": "Derivative liability expected term." } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilityMeasurementInput", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative liability, measurement input", "documentation": "Value of input used to measure derivative liability." } } }, "auth_ref": [ "r545", "r546", "r547" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r108", "r931", "r932", "r933", "r934", "r935", "r936", "r938", "r939" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://shfinancial.org/role/RevenueTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Disaggregated Revenue", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r958" ] }, "SHFS_DisclosureDeferredConsiderationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DisclosureDeferredConsiderationAbstract", "lang": { "en-us": { "role": { "label": "Deferred Consideration", "verboseLabel": "Schedule Of Change In Deferred Consideration" } } }, "auth_ref": [] }, "SHFS_DisclosureDeferredUnderwriterFeeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DisclosureDeferredUnderwriterFeeAbstract", "lang": { "en-us": { "role": { "label": "Deferred Underwriter Fee" } } }, "auth_ref": [] }, "SHFS_DisclosureForwardPurchaseAgreementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DisclosureForwardPurchaseAgreementAbstract", "lang": { "en-us": { "role": { "label": "Forward Purchase Agreement" } } }, "auth_ref": [] }, "SHFS_DisclosureIndemnificationLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DisclosureIndemnificationLiabilityAbstract", "lang": { "en-us": { "role": { "label": "Indemnification Liability", "verboseLabel": "Schedule Of Indemnity Liability" } } }, "auth_ref": [] }, "SHFS_DisclosureLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DisclosureLeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases", "verboseLabel": "Schedule Of Lease Cost", "terseLabel": "Schedule Of Right Of Use Assets" } } }, "auth_ref": [] }, "SHFS_DisclosureWarrantLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "DisclosureWarrantLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Warrant Liabilities" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r862" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r860", "r862", "r863" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r861" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r849" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r862" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r862" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r864" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r852" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://shfinancial.org/role/ScheduleOfEarningPerSharesBasicAndDilutedDetails", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic net income/ (loss) per share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r181", "r201", "r202", "r204", "r205", "r206", "r208", "r214", "r216", "r224", "r225", "r226", "r231", "r515", "r520", "r540", "r541", "r641", "r659", "r790" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://shfinancial.org/role/ScheduleOfEarningPerSharesBasicAndDilutedDetails", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Diluted income/ (loss) per share", "verboseLabel": "Diluted net income/ (loss) per share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r181", "r201", "r202", "r204", "r205", "r206", "r208", "r216", "r224", "r225", "r226", "r231", "r515", "r520", "r540", "r541", "r641", "r659", "r790" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings Per Share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r24", "r25", "r228" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://shfinancial.org/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r213", "r227", "r229", "r230" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://shfinancial.org/role/TaxDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective income tax rate, federal", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r191", "r494", "r505", "r817" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "presentation": [ "http://shfinancial.org/role/TaxDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective income tax rate reconciliation other adjustments", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r817", "r897", "r959", "r960" ] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Compensation and employee benefits", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r855" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r851" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/RevenueDetailsNarrative", "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r851" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r868" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r851" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r865" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r863" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r851" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r851" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r851" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r851" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r866" ] }, "SHFS_EquipmentAndFurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "EquipmentAndFurnitureAndFixturesMember", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equipment and Furniture and Fixtures [Member]", "documentation": "Equipment and Furniture and Fixtures [Member]" } } }, "auth_ref": [] }, "us-gaap_EquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquipmentMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services." } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r150", "r177", "r178", "r179", "r195", "r196", "r197", "r200", "r206", "r209", "r211", "r233", "r287", "r290", "r338", "r412", "r503", "r504", "r512", "r513", "r514", "r516", "r519", "r520", "r527", "r528", "r529", "r530", "r531", "r533", "r539", "r562", "r563", "r564", "r565", "r566", "r567", "r573", "r576", "r591", "r657", "r672", "r673", "r674", "r695", "r762" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "auth_ref": [ "r283", "r284", "r285", "r511", "r871", "r872", "r873", "r962", "r963", "r964", "r965" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownwership percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r283" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r379", "r560", "r805", "r806" ] }, "SHFS_ExercisePriceFourMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ExercisePriceFourMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Four [Member]", "documentation": "Exercise Price Four [Member]" } } }, "auth_ref": [] }, "SHFS_ExercisePriceOneMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ExercisePriceOneMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price One [Member]", "documentation": "Exercise Price One [Member]" } } }, "auth_ref": [] }, "SHFS_ExercisePriceThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ExercisePriceThreeMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Three [Member]", "documentation": "Exercise Price Three [Member]" } } }, "auth_ref": [] }, "SHFS_ExercisePriceTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ExercisePriceTwoMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Two [Member]", "documentation": "Exercise Price Two [Member]" } } }, "auth_ref": [] }, "SHFS_ExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ExpectedTermMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "label": "Expected Term [Member]", "documentation": "Expected Term [Member]" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 3.0 }, "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Change in fair value of warrant liabilities", "verboseLabel": "Change in fair value of warrant", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r1", "r4" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r543", "r544", "r555", "r818" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r543", "r544", "r555", "r818" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Level 3 Fair Value Measurements Inputs", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r545", "r546", "r822" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value Assets Measured on Recurring Basis", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r968", "r969" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class of asset." } } }, "auth_ref": [ "r548", "r549", "r550", "r551", "r552", "r553", "r556", "r820" ] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r548", "r549", "r550", "r551", "r552", "r553", "r556", "r820" ] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r48", "r49" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Carrying Amounts and Fair Values of Financial Instruments", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r48" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r379", "r436", "r437", "r438", "r439", "r440", "r441", "r542", "r544", "r545", "r546", "r547", "r554", "r555", "r557", "r607", "r608", "r609", "r805", "r806", "r811", "r812", "r813", "r818", "r822" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r379", "r805", "r806" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r543", "r544", "r545", "r547", "r818", "r971", "r974" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r379", "r436", "r441", "r544", "r555", "r607", "r811", "r812", "r813", "r818" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r379", "r436", "r441", "r544", "r545", "r555", "r608", "r805", "r806", "r811", "r812", "r813", "r818" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r379", "r436", "r437", "r438", "r439", "r440", "r441", "r544", "r545", "r546", "r547", "r555", "r609", "r805", "r806", "r811", "r812", "r813", "r818", "r822" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "auth_ref": [ "r543", "r544", "r545", "r547", "r818", "r971", "r974" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Issued to Abaca shareholders", "documentation": "Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r551", "r556", "r820" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at the beginning of the period", "periodEndLabel": "Balance at the end of the period", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r548", "r556", "r820" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r379", "r436", "r437", "r438", "r439", "r440", "r441", "r542", "r544", "r545", "r546", "r547", "r554", "r555", "r557", "r607", "r608", "r609", "r805", "r806", "r811", "r812", "r813", "r818", "r822" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r818", "r968", "r969", "r970", "r971", "r972", "r974" ] }, "SHFS_FiftyFourEqualInstallmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "FiftyFourEqualInstallmentsMember", "presentation": [ "http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "54 Equal Installments [Member]", "documentation": "Fifty Four Equal Installments [Member]" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of right of use assets", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r579", "r581", "r830" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentAxis", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables", "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r296", "r297", "r300", "r301", "r306", "r315", "r316", "r317", "r390", "r408", "r534", "r558", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r658", "r801", "r818", "r820", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r832", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r917", "r918", "r919", "r920", "r967", "r970", "r971", "r972", "r973", "r974" ] }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentsDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/FinancialInstruments" ], "lang": { "en-us": { "role": { "label": "Financial Instruments", "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures." } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Provision", "label": "Financing Receivable, Allowance for Credit Loss, Writeoff, after Recovery", "documentation": "Amount, after recovery, of writeoff of financing receivable, charged against allowance for credit loss." } } }, "auth_ref": [ "r148", "r799", "r924" ] }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableAllowanceForCreditLosses", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Allowance for credit losses, beginning balance", "periodEndLabel": "Allowance for credit losses,ending balance", "verboseLabel": "Allowance for loan losses", "label": "Financing Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement." } } }, "auth_ref": [ "r124", "r145", "r147", "r149", "r169", "r294", "r298", "r299", "r988" ] }, "us-gaap_FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Collectively evaluated for impairment", "label": "Financing Receivable, Allowance for Credit Loss, Collectively Evaluated", "documentation": "Amount of allowance for credit loss on financing receivable evaluated on collective basis. Excludes financing receivable evaluated on individual basis." } } }, "auth_ref": [ "r126", "r796", "r922" ] }, "us-gaap_FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Individually evaluated for impairment", "label": "Financing Receivable, Allowance for Credit Loss, Individually Evaluated", "documentation": "Amount of allowance for credit loss on financing receivable evaluated on individual basis. Excludes financing receivable evaluated on collective basis." } } }, "auth_ref": [ "r126", "r796", "r922" ] }, "us-gaap_FinancingReceivableCollectivelyEvaluatedForImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableCollectivelyEvaluatedForImpairment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails", "http://shfinancial.org/role/ScheduleOfRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Collectively evaluated for impairment", "verboseLabel": "Grand total", "documentation": "Amount of financing receivable collectively evaluated for credit loss. Excludes financing receivable individually evaluated for credit loss." } } }, "auth_ref": [ "r251", "r796" ] }, "us-gaap_FinancingReceivableIndividuallyEvaluatedForImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableIndividuallyEvaluatedForImpairment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Individually evaluated for impairment", "documentation": "Amount of financing receivable individually evaluated for credit loss. Excludes financing receivable collectively evaluated for credit loss." } } }, "auth_ref": [ "r252", "r796" ] }, "us-gaap_FinancingReceivablePortfolioSegmentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivablePortfolioSegmentAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfProvisionForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable Portfolio Segment [Axis]", "documentation": "Information by the level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses." } } }, "auth_ref": [ "r143", "r144", "r148", "r149", "r296", "r297", "r797", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r883", "r884", "r885" ] }, "us-gaap_FinancingReceivablePortfolioSegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivablePortfolioSegmentDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfProvisionForLoanLossesDetails" ], "lang": { "en-us": { "role": { "documentation": "Level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses." } } }, "auth_ref": [ "r143", "r144", "r148", "r149", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r883", "r884", "r885" ] }, "us-gaap_FinancingReceivableRecordedInvestmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableRecordedInvestmentLineItems", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails", "http://shfinancial.org/role/ScheduleOfRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Credit Quality Indicator [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r128", "r799", "r926" ] }, "us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancingReceivableRecordedInvestmentPastDueLineItems", "presentation": [ "http://shfinancial.org/role/ScheduleOfProvisionForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Past Due [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r800", "r925" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r161", "r320", "r334", "r803" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite Lived Intangible Assets", "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r327", "r329", "r330", "r331", "r333", "r334", "r335", "r336", "r638", "r639", "r785" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r320", "r334", "r639", "r803" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r327", "r334", "r335", "r336", "r337", "r638", "r785", "r803" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r327", "r329", "r330", "r331", "r333", "r334", "r335", "r336", "r785" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "verboseLabel": "Finite-lived intangible assets, net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r638", "r936" ] }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "presentation": [ "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Remaining useful life in years", "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r638" ] }, "SHFS_ForwardPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ForwardPurchaseAgreementMember", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreement [Member]", "documentation": "Forward Purchase Agreement [Member]" } } }, "auth_ref": [] }, "SHFS_ForwardPurchaseAgreementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ForwardPurchaseAgreementTextBlock", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreement" ], "lang": { "en-us": { "role": { "verboseLabel": "Forward Purchase Agreement", "documentation": "Forward purchase Agreement [Text Block]", "label": "Forward purchase Agreement [Text Block]" } } }, "auth_ref": [] }, "SHFS_ForwardPurchaseDerivativeLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ForwardPurchaseDerivativeLiabilityMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Derivative Liability [Member]" } } }, "auth_ref": [] }, "SHFS_ForwardPurchaseDerivativeMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ForwardPurchaseDerivativeMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Derivative [Member]", "documentation": "Forward Purchase Derivative [Member]" } } }, "auth_ref": [] }, "SHFS_ForwardPurchaseDerivativePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ForwardPurchaseDerivativePolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Forward purchase derivative", "documentation": "Forward Purchase Derivative [Policy Text Block]" } } }, "auth_ref": [] }, "SHFS_ForwardPurchaseReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ForwardPurchaseReceivable", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Forward purchase receivable", "documentation": "Forward purchase receivable." } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r77", "r742" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r160", "r321", "r640", "r794", "r802", "r819", "r831", "r928", "r929" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Goodwill and Finite-lived Intangible Assets", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r927", "r930" ] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Goodwill impairment", "documentation": "Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r323", "r325", "r802" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-cash goodwill impairment charge", "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r4", "r322", "r324", "r326", "r802", "r819" ] }, "us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentEffectsOnEarningsPerShareLineItems", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Impairment Effects on Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ImpairmentEffectsOnEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentEffectsOnEarningsPerShareTable", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Impairment Effects on Earnings Per Share [Table]", "documentation": "Disclosure of information about the effects of asset impairment charge on per share or per unit basis." } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r328", "r892", "r940" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Other Intangible Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r93" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net income/ (loss) before income tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r75", "r117", "r121", "r642", "r655", "r792", "r793", "r908", "r909", "r910", "r911", "r912" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r339", "r345", "r346", "r549", "r553", "r556", "r669", "r671", "r747", "r785", "r821", "r993" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "documentation": "Location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r345", "r346", "r549", "r553", "r556", "r669", "r671", "r747", "r785", "r821", "r993" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/Tax" ], "lang": { "en-us": { "role": { "label": "Tax", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r191", "r488", "r494", "r495", "r496", "r497", "r498", "r501", "r506", "r508", "r509", "r510", "r691", "r817" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows", "http://shfinancial.org/role/StatementsOfOperations", "http://shfinancial.org/role/TaxDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax benefit", "label": "Income tax benefit", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r131", "r140", "r210", "r211", "r232", "r242", "r246", "r493", "r494", "r507", "r660", "r817" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r176", "r489", "r490", "r498", "r499", "r500", "r502", "r685" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts Payable \u2013 related party", "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableTrade", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable, Trade", "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable \u2013 Trade", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivableRelatedParties", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable \u2013 related party", "label": "Increase (Decrease) in Accounts Receivable, Related Parties", "documentation": "The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedInterestReceivableNet", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accrued interest receivable", "label": "Increase (Decrease) in Accrued Interest Receivable, Net", "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued expenses", "label": "Increase (Decrease) in Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInContractWithCustomerAsset", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Contract assets", "label": "Increase (Decrease) in Contract with Customer, Asset", "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r891" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Contract liabilities", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r636", "r891" ] }, "SHFS_IncreaseDecreaseInDeferredUnderwritingPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "IncreaseDecreaseInDeferredUnderwritingPayable", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred underwriting payable", "documentation": "Increase decrease in deferred underwriting payable.", "label": "IncreaseDecreaseInDeferredUnderwritingPayable" } } }, "auth_ref": [] }, "SHFS_IncreaseDecreaseInNetDeferredIndemnifiedLoanOriginationFees": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "IncreaseDecreaseInNetDeferredIndemnifiedLoanOriginationFees", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Net deferred indemnified loan origination fees", "documentation": "Increase decrease in net deferred indemnified loan origination fees.", "label": "IncreaseDecreaseInNetDeferredIndemnifiedLoanOriginationFees" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r891" ] }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Other current liabilities", "label": "Increase (Decrease) in Other Current Liabilities", "documentation": "Amount of increase (decrease) in current liabilities classified as other." } } }, "auth_ref": [ "r891" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidExpense", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses", "label": "Increase (Decrease) in Prepaid Expense", "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInSecurityDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInSecurityDeposits", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Security deposit", "label": "Increase (Decrease) in Security Deposits", "documentation": "The increase (decrease) during the reporting period in security deposits." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock", "presentation": [ "http://shfinancial.org/role/ScheduleOfShare-basedEquityAwardsAndWarrantsExcludedFromComputationOfEarningsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Conversion of preferred stock", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method." } } }, "auth_ref": [ "r221", "r222", "r226" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "presentation": [ "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Share based payments", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r217", "r218", "r219", "r226", "r451" ] }, "SHFS_IndemnificationLiabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "IndemnificationLiabilityTextBlock", "presentation": [ "http://shfinancial.org/role/IndemnificationLiability" ], "lang": { "en-us": { "role": { "verboseLabel": "Indemnification Liability", "documentation": "Indemnification Liability [Text Block]", "label": "IndemnificationLiabilityTextBlock" } } }, "auth_ref": [] }, "SHFS_IndemnityLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "IndemnityLiability", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails", "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Indemnity liability", "documentation": "Indemnity liability." } } }, "auth_ref": [] }, "SHFS_IndemnityLiabilityAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "IndemnityLiabilityAdjustment", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Indemnity liability", "documentation": "Indemnity liability adjustment.", "label": "IndemnityLiabilityAdjustment" } } }, "auth_ref": [] }, "SHFS_IndemnityLiabilityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "IndemnityLiabilityPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Indemnity Liability", "documentation": "Indemnity Liability [Policy Text Block]" } } }, "auth_ref": [] }, "SHFS_IndemnityLiabilitySegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "IndemnityLiabilitySegmentMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfProvisionForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Indemnity Liability Segment [Member]", "documentation": "Indemnity Liability Segment [Member]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r327", "r936", "r937" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest expense", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r232", "r236", "r240", "r243", "r246", "r569", "r793", "r794" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest expense", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r81", "r385", "r394", "r807", "r808" ] }, "us-gaap_InterestIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Interest Income [Member]", "documentation": "Primary financial statement caption in which reported facts about interest income have been included." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r182", "r184", "r185" ] }, "us-gaap_InterestReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestReceivableCurrent", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued interest receivable", "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r888" ] }, "us-gaap_InternalCreditAssessmentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InternalCreditAssessmentAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails", "http://shfinancial.org/role/ScheduleOfRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Internal Credit Assessment [Axis]", "documentation": "Information by entity-defined rating." } } }, "auth_ref": [ "r127", "r128", "r129", "r526", "r798", "r799", "r926" ] }, "us-gaap_InternalCreditAssessmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InternalCreditAssessmentDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails", "http://shfinancial.org/role/ScheduleOfRiskRatingDetails" ], "lang": { "en-us": { "role": { "documentation": "Entity defined credit risk rating." } } }, "auth_ref": [] }, "SHFS_InvestmentHostingFee": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "InvestmentHostingFee", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/RevenueDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment hosting fee", "documentation": "Investment hosting fees." } } }, "auth_ref": [] }, "SHFS_InvestmentHostingFeesRemitPercent": { "xbrltype": "percentItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "InvestmentHostingFeesRemitPercent", "presentation": [ "http://shfinancial.org/role/RevenueDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment hosting fees remit percent", "documentation": "Investment hosting fees remit percent." } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentIncomeInterest", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/RevenueDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan interest income", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r232", "r239", "r246", "r793", "r889" ] }, "us-gaap_InvestmentIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentIncomeMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Investment Income [Member]", "documentation": "Primary financial statement caption encompassing investment income." } } }, "auth_ref": [ "r11" ] }, "us-gaap_InvestmentIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentIncomeNet", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/RevenueDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment income", "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r78", "r79", "r81" ] }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentsAllOtherInvestmentsAbstract", "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://shfinancial.org/role/ScheduleOfLeaseCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Lease Cost", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r580", "r830" ] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r92", "r587" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/RevenueDetailsNarrative", "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total future minimum lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r586" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r586" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r586" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r586" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r586" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r586" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r586" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Less: Imputed interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r586" ] }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "presentation": [ "http://shfinancial.org/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease term", "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r588", "r978" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://shfinancial.org/role/Leases" ], "lang": { "en-us": { "role": { "verboseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r575" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities [Default Label]", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r13", "r58", "r59", "r60", "r64", "r65", "r66", "r67", "r190", "r286", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r523", "r524", "r525", "r561", "r715", "r791", "r848", "r953", "r980", "r981" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Stockholders\u2019 Equity", "negatedLabel": "Liabilities & Equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r74", "r115", "r650", "r831", "r896", "r921", "r975" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "SHFS_LiabilitiesAndStockholdersEquityAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "LiabilitiesAndStockholdersEquityAdjustment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities & Equity", "documentation": "Liabilities and stockholders equity adjustment." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r60", "r155", "r190", "r286", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r523", "r524", "r525", "r561", "r831", "r953", "r980", "r981" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r544", "r968" ] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Liabilities" } } }, "auth_ref": [] }, "SHFS_LimitingCapacityMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "LimitingCapacityMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "label": "Limiting Capacity [Member]" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lines of credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r13", "r113", "r989" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "label": "Incremental capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r57", "r63" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "SHFS_LiquidityAndGoingConcernPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "LiquidityAndGoingConcernPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Liquidity and Going Concern", "documentation": "Liquidity And Going Concern [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_LoanProcessingFee": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LoanProcessingFee", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/RevenueDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan servicing fees", "documentation": "Expenses paid for obtaining loans which includes expenses such as application and origination fees." } } }, "auth_ref": [] }, "SHFS_LoanServicingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "LoanServicingAgreementMember", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsTables", "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails", "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Loan Servicing Agreement [Member]", "documentation": "Loan Servicing Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_LoansAndLeasesReceivableAllowanceForLoanLossesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LoansAndLeasesReceivableAllowanceForLoanLossesPolicy", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Allowance for Credit Losses (ACL)", "documentation": "Disclosure of accounting policy for estimating the allowance for losses on loans and lease receivables. The disclosure may include (a) how the entity determines each element of the allowance, (b) which loans are evaluated individually and which loans are evaluated as a group, (c) how the entity determines both the allocated and unallocated portions of the allowance, (d) how the entity determines the loss factors applied to graded loans in order to develop a general allowance, and (e) what self-correcting mechanism the entity uses to reduce differences between estimated and actual losses." } } }, "auth_ref": [ "r29" ] }, "SHFS_LoansAndLeasesReceivablesGrossCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "LoansAndLeasesReceivablesGrossCarryingAmount", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfAllowanceForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Loans receivable", "documentation": "Loans and leases receivables gross carrying amount." } } }, "auth_ref": [] }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/LoansReceivable" ], "lang": { "en-us": { "role": { "label": "Loans Receivable", "documentation": "The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses." } } }, "auth_ref": [ "r570", "r914" ] }, "us-gaap_LoansPayableFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LoansPayableFairValueDisclosure", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Loans", "documentation": "Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates." } } }, "auth_ref": [ "r969", "r973" ] }, "us-gaap_LoansReceivableBasisSpreadOnVariableRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LoansReceivableBasisSpreadOnVariableRate", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of total loans receivables", "documentation": "Percentage added to reference rate used to compute variable rate on loan receivable." } } }, "auth_ref": [] }, "us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LoansReceivableBasisSpreadOnVariableRateDuringPeriod", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of loans receivables", "documentation": "The percentage points added to the reference rate or index during the adjustment period to compute the variable [fully indexed] rate on the loans receivable realized during the reporting period. This may be an effective margin for the period depending on the specific terms of the underlying loan agreement (for example, an annual disclosure for a loan with a quarterly adjustment period)." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails", "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails", "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total loans funded by PCCU", "label": "Grand total", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r13", "r113", "r378", "r392", "r805", "r806", "r829", "r989" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r194", "r383" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails" ], "lang": { "en-us": { "role": { "label": "2028", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r194", "r383" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails" ], "lang": { "en-us": { "role": { "label": "2027", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r194", "r383" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r194", "r383" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r194", "r383" ] }, "us-gaap_LongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermInvestments", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term loans receivable, net", "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)." } } }, "auth_ref": [ "r157" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r13", "r942", "r943", "r944" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r13", "r32", "r942", "r943", "r944" ] }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyAccrualAtCarryingValue", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnityLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Loss Contingency Accrual", "documentation": "Amount of loss contingency liability." } } }, "auth_ref": [ "r349", "r870" ] }, "SHFS_LossContingencyAccrualCumulativeEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "LossContingencyAccrualCumulativeEffect", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnityLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cumulative effect from adoption of CECL", "documentation": "Loss contingency accrual cumulative effect.", "label": "LossContingencyAccrualCumulativeEffect" } } }, "auth_ref": [] }, "us-gaap_LossContingencyAccrualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyAccrualPayments", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnityLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Charge-offs", "label": "Loss Contingency Accrual, Payments", "documentation": "Amount of cash outflow reducing loss contingency liability." } } }, "auth_ref": [ "r947" ] }, "us-gaap_LossContingencyAccrualProvision": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyAccrualProvision", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnityLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "(Benefit)/ Provision", "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges." } } }, "auth_ref": [ "r947" ] }, "SHFS_LossContingencyAccrualRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "LossContingencyAccrualRecoveries", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnityLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Recoveries", "documentation": "Loss contingency accrual recoveries.", "label": "LossContingencyAccrualRecoveries" } } }, "auth_ref": [] }, "us-gaap_MarketingRelatedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MarketingRelatedIntangibleAssetsMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Marketing-Related Intangible Assets [Member]", "documentation": "Marketing-related asset, including, but not limited to, internet domain name, newspaper mast head, and trademark." } } }, "auth_ref": [ "r12", "r931", "r932", "r933", "r934", "r935", "r936", "r938", "r939" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative", "http://shfinancial.org/role/LeasesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r350", "r351", "r352", "r353", "r445", "r487", "r547", "r635", "r668", "r670", "r682", "r707", "r708", "r770", "r771", "r772", "r773", "r774", "r783", "r784", "r795", "r809", "r816", "r822", "r823", "r827", "r828", "r834", "r957", "r982", "r983", "r984", "r985", "r986", "r987" ] }, "SHFS_MeasurementInputAdditionalMaturityPerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "MeasurementInputAdditionalMaturityPerShareMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Additional Maturity Per Share [Member]" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r970", "r971", "r972" ] }, "us-gaap_MeasurementInputExercisePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputExercisePriceMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Exercise Price [Member]", "documentation": "Measurement input using agreed upon price for exchange of underlying asset." } } }, "auth_ref": [ "r970", "r971", "r972" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r970", "r971", "r972" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r822", "r970", "r971", "r972" ] }, "SHFS_MeasurementInputResetPriceMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "MeasurementInputResetPriceMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Reset Price [Member]" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r970", "r971", "r972" ] }, "us-gaap_MeasurementInputSharePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputSharePriceMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Share Price [Member]", "documentation": "Measurement input using share price of saleable stock." } } }, "auth_ref": [ "r970", "r971", "r972" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r545", "r546", "r547", "r822" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r545", "r546", "r547", "r822" ] }, "SHFS_MergerAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "MergerAgreementMember", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Merger Agreement [Member]", "documentation": "Merger Agreement [Member]" } } }, "auth_ref": [] }, "SHFS_MidtownEastManagementNLLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "MidtownEastManagementNLLLCMember", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Midtown East Management NL LLC [Member]", "documentation": "Midtown East Management NL LLC [Member]" } } }, "auth_ref": [] }, "SHFS_MidtownEastMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "MidtownEastMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Midtown East [Member]", "documentation": "Midtown East [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative", "http://shfinancial.org/role/LeasesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r350", "r351", "r352", "r353", "r445", "r487", "r547", "r635", "r668", "r670", "r682", "r707", "r708", "r770", "r771", "r772", "r773", "r774", "r783", "r784", "r795", "r809", "r816", "r822", "r823", "r827", "r834", "r957", "r982", "r983", "r984", "r985", "r986", "r987" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r183" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS USED IN FINANCING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r183" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS PROVIDED BY INVESTING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r84", "r85", "r87" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "auth_ref": [] }, "SHFS_NetDeferredIndemnifiedLoanOriginationFees": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "NetDeferredIndemnifiedLoanOriginationFees", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Net deferred indemnified loan origination fees", "documentation": "Net deferred indemnified loan origination fees." } } }, "auth_ref": [] }, "SHFS_NetDeferredLoanOriginationFeesAndCostPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "NetDeferredLoanOriginationFeesAndCostPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Net Deferred Loan Origination Fees and Cost", "documentation": "Net deferred loan origination fees and cost [policy text block]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfEarningPerSharesBasicAndDilutedDetails", "http://shfinancial.org/role/StatementsOfCashFlows", "http://shfinancial.org/role/StatementsOfOperations", "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Net income/ (loss)", "label": "Net loss", "verboseLabel": "Net income/ (loss)", "terseLabel": "Net Income/ (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r76", "r87", "r118", "r153", "r174", "r175", "r179", "r190", "r199", "r201", "r202", "r204", "r205", "r206", "r210", "r211", "r223", "r286", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r515", "r520", "r541", "r561", "r656", "r739", "r760", "r761", "r846", "r953" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Issued Accounting Standards", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-Cash transactions:" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total other (income)/ expenses", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r80" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other (income) expenses" } } }, "auth_ref": [] }, "us-gaap_NonrelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonrelatedPartyMember", "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Nonrelated Party [Member]", "documentation": "Party not related to reporting entity." } } }, "auth_ref": [ "r898", "r899" ] }, "us-gaap_NotesReceivableGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesReceivableGross", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Commercial real estate loans receivable, gross", "documentation": "Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease." } } }, "auth_ref": [ "r128", "r130", "r145", "r146", "r168", "r250", "r300", "r307", "r799", "r800", "r882", "r923" ] }, "us-gaap_NotesReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesReceivableNet", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails", "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Loans receivable, net", "verboseLabel": "Commercial real estate loans receivable, net", "documentation": "Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease." } } }, "auth_ref": [ "r307", "r726", "r915", "r991" ] }, "SHFS_NotesReceivableNetAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "NotesReceivableNetAdjustment", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Loans receivable, net", "documentation": "Notes receivable net adjustment.", "label": "NotesReceivableNetAdjustment" } } }, "auth_ref": [] }, "SHFS_NumberOfSharesOnTheDateOfAcquisition": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "NumberOfSharesOnTheDateOfAcquisition", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares on the date of acquisition", "documentation": "Number of shares on the date of acquisition." } } }, "auth_ref": [] }, "SHFS_NumberOfSharesOnTheDateOfAcquisitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "NumberOfSharesOnTheDateOfAcquisitionValue", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares on the date of acquisition value", "documentation": "Number of shares on the date of acquisition value." } } }, "auth_ref": [] }, "SHFS_NumberOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "NumberOfWarrants", "presentation": [ "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Shares to be issued to Abaca shareholders", "documentation": "Number of warrants." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating expense", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income/ (loss)", "label": "Operating income", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r121", "r792", "r908", "r909", "r910", "r911", "r912" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://shfinancial.org/role/ScheduleOfLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r582", "r830" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/LeasesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities", "verboseLabel": "Operating lease liablities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r578" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities \u2013 current", "verboseLabel": "Less: Current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r578" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities \u2013 long term", "verboseLabel": "Non-current portion of lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r578" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/LeasesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease right to use assets", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r577" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization charge for the period", "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r892" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://shfinancial.org/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-average discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r585", "r830" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://shfinancial.org/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-average remaining lease term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r584", "r830" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other current assets", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r171", "r831" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other current liabilities", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r59", "r831" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Receivables", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r167", "r725", "r794", "r991" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r862" ] }, "SHFS_PCCUAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PCCUAgreementMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "P C C U Agreement [Member]" } } }, "auth_ref": [] }, "SHFS_PIPEWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PIPEWarrantsMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "PIPE Warrants [Member]", "documentation": "PIPE Warrants [Member]" } } }, "auth_ref": [] }, "SHFS_PartnerColoradoCreditUnionLoansFundedMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PartnerColoradoCreditUnionLoansFundedMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "label": "Partner Colorado Credit Union Loans Funded [Member]" } } }, "auth_ref": [] }, "SHFS_PartnerColoradoCreditUnionMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PartnerColoradoCreditUnionMember", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/RevenueDetailsNarrative", "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "label": "Partner Colorado Credit Union [Member]", "documentation": "Partner Colorado Credit Union [Member]" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments to acquire businesses", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r15", "r518" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r82" ] }, "SHFS_PipeWarrantsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PipeWarrantsFairValueDisclosure", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "PIPE warrants", "documentation": "Pipe warrants fair value disclosure." } } }, "auth_ref": [] }, "us-gaap_PolicyLoansReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PolicyLoansReceivablePolicy", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Loans Receivable", "label": "Policy Loans Receivable, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for policy loans receivable, including the basis for determining the amount reported for loans made to policyholders against and secured by future policy benefits. May also disclose the range of interest rates charged to policyholders on such loans." } } }, "auth_ref": [] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r559" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r856" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r858" ] }, "us-gaap_PreferredStockConvertibleConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockConvertibleConversionPrice", "presentation": [ "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion Price", "documentation": "Per share conversion price of preferred stock." } } }, "auth_ref": [ "r398" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockMember", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r838", "r839", "r842", "r843", "r844", "r845", "r1022", "r1026" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://shfinancial.org/role/BalanceSheetsParenthetical", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock, par value", "verboseLabel": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r68", "r396" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://shfinancial.org/role/BalanceSheetsParenthetical", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock, shares authorized", "verboseLabel": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r68", "r717" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://shfinancial.org/role/BalanceSheetsParenthetical", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock, shares issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r68", "r396" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://shfinancial.org/role/BalanceSheetsParenthetical", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r68", "r717", "r737", "r1026", "r1027" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock, $.0001 par value, 1,250,000 shares authorized, 111 and 1,101 shares issued and outstanding on March 31, 2024, and December 31, 2023, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r68", "r647", "r831" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses \u2013 current portion", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r170", "r318", "r319", "r789" ] }, "us-gaap_PrepaidExpenseNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseNoncurrent", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses \u2013 long term position", "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r887" ] }, "SHFS_PrivatePlacementWarrantsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PrivatePlacementWarrantsFairValueDisclosure", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Private placement warrants", "documentation": "Private placement warrants fair value disclosure." } } }, "auth_ref": [] }, "SHFS_PrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PrivatePlacementWarrantsMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Member]", "documentation": "Private Placement Warrants [Member]" } } }, "auth_ref": [] }, "SHFS_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PrivateWarrantsMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "label": "Private Warrants [Member]", "documentation": "Private Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromDepositsWithOtherInstitutions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromDepositsWithOtherInstitutions", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/RevenueDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from deposits", "documentation": "Cash received from refund of deposits with other institutions during the period." } } }, "auth_ref": [ "r86" ] }, "SHFS_ProceedsFromRepaymentsOfLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ProceedsFromRepaymentsOfLoans", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net repayment of loans", "documentation": "Proceeds from repayments of loans." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r247", "r637", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r787", "r810", "r833", "r834", "r835", "r836", "r837", "r949", "r950", "r958", "r992", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "auth_ref": [ "r247", "r637", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r787", "r810", "r833", "r834", "r835", "r836", "r837", "r949", "r950", "r958", "r992", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfessionalFees", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Professional services", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r793", "r846", "r1024", "r1025" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r5", "r587" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/PropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "Property and Equipment, Net", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r91", "r135", "r138", "r139" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r92", "r158", "r654" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r587" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment, net", "totalLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r5", "r587", "r643", "r654", "r831" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment, net", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r5", "r135", "r138", "r652" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://shfinancial.org/role/PropertyAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Property and Equipment", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r92", "r587" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property and equipment useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_ProvisionForLoanLeaseAndOtherLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForLoanLeaseAndOtherLosses", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfProvisionForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Provision (benefit)", "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value." } } }, "auth_ref": [ "r3", "r116", "r125" ] }, "SHFS_ProvisionForLoanLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ProvisionForLoanLosses", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 5.0 }, "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Provision (benefit) for credit losses", "verboseLabel": "(Benefit)/ provision for credit losses", "documentation": "Provision for loan losses." } } }, "auth_ref": [] }, "SHFS_PublicAndPrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PublicAndPrivateWarrantsMember", "presentation": [ "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Public and Private Warrants [Member]", "documentation": "Public and Private Warrants [Member]" } } }, "auth_ref": [] }, "SHFS_PublicWarrantsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PublicWarrantsFairValueDisclosure", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Public warrants", "documentation": "Public warrants fair value disclosure." } } }, "auth_ref": [] }, "SHFS_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PublicWarrantsMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Public Warrants [Member]", "documentation": "Public Warrants [Member]" } } }, "auth_ref": [] }, "SHFS_PurchaseAgreementOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "PurchaseAgreementOptionMember", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails" ], "lang": { "en-us": { "role": { "label": "Purchase Agreement Option [Member]" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative", "http://shfinancial.org/role/LeasesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r350", "r351", "r352", "r353", "r435", "r445", "r477", "r478", "r479", "r487", "r547", "r610", "r619", "r635", "r668", "r670", "r682", "r707", "r708", "r770", "r771", "r772", "r773", "r774", "r783", "r784", "r795", "r809", "r816", "r822", "r823", "r827", "r828", "r834", "r840", "r945", "r957", "r971", "r983", "r984", "r985", "r986", "r987" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative", "http://shfinancial.org/role/LeasesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "auth_ref": [ "r350", "r351", "r352", "r353", "r435", "r445", "r477", "r478", "r479", "r487", "r547", "r610", "r619", "r635", "r668", "r670", "r682", "r707", "r708", "r770", "r771", "r772", "r773", "r774", "r783", "r784", "r795", "r809", "r816", "r822", "r823", "r827", "r828", "r834", "r840", "r945", "r957", "r971", "r983", "r984", "r985", "r986", "r987" ] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "auth_ref": [] }, "SHFS_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails", "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r250", "r442", "r595", "r596", "r645", "r651", "r710", "r711", "r712", "r713", "r714", "r736", "r738", "r769" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails", "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r192", "r193", "r595", "r596", "r597", "r598", "r645", "r651", "r710", "r711", "r712", "r713", "r714", "r736", "r738", "r769" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related expense amounts", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r51", "r595" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r595", "r596", "r979" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails", "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails", "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r250", "r743", "r744", "r747" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails", "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r250", "r442", "r595", "r596", "r645", "r651", "r710", "r711", "r712", "r713", "r714", "r736", "r738", "r769", "r979" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r592", "r593", "r594", "r596", "r599", "r692", "r693", "r694", "r745", "r746", "r747", "r766", "r768" ] }, "SHFS_RentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RentExpense", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Rent expense", "documentation": "Rent expense." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfDebt", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Repayments of debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r890" ] }, "us-gaap_RepaymentsOfSeniorDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfSeniorDebt", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of senior secured promissory note", "label": "Repayments of Senior Debt", "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period." } } }, "auth_ref": [ "r83" ] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RestatementAxis", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "auth_ref": [ "r151", "r195", "r196", "r197", "r199", "r200", "r201", "r202", "r203", "r204", "r207", "r208", "r209", "r210", "r211", "r212", "r231", "r288", "r289", "r513", "r514", "r515", "r516", "r519", "r520", "r537", "r539", "r540", "r541", "r572", "r574", "r590", "r591", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r683", "r913" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RestatementDomain", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r151", "r195", "r196", "r197", "r199", "r200", "r201", "r202", "r203", "r204", "r207", "r208", "r209", "r210", "r211", "r212", "r231", "r288", "r289", "r513", "r514", "r515", "r516", "r519", "r520", "r537", "r539", "r540", "r541", "r572", "r574", "r590", "r591", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r683", "r913" ] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r156" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Retained deficit", "verboseLabel": "Retained earning", "negatedLabel": "Retained deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r71", "r99", "r649", "r676", "r681", "r690", "r718", "r831" ] }, "SHFS_RetainedEarningsAccumulatedDeficitAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RetainedEarningsAccumulatedDeficitAdjustment", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "label": "Retained earning", "documentation": "Retained earnings accumulated deficit adjustment." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r150", "r195", "r196", "r197", "r200", "r206", "r209", "r211", "r287", "r290", "r338", "r503", "r504", "r512", "r513", "r514", "r516", "r519", "r520", "r527", "r529", "r530", "r533", "r539", "r573", "r576", "r672", "r674", "r695", "r1026" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://shfinancial.org/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue", "verboseLabel": "Total Revenue", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r119", "r120", "r232", "r237", "r238", "r244", "r246", "r247", "r248", "r249", "r431", "r432", "r637" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r141", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r786" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://shfinancial.org/role/Revenue" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r141", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r434" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r119", "r120", "r180", "r190", "r232", "r237", "r238", "r244", "r246", "r247", "r248", "r249", "r286", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r561", "r642", "r793", "r953" ] }, "srt_RevisionOfPriorPeriodReclassificationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RevisionOfPriorPeriodReclassificationAdjustmentMember", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Reclassification, Adjustment [Member]" } } }, "auth_ref": [ "r152", "r913" ] }, "SHFS_RightOfUseAssetsAndLeaseLliabilityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RightOfUseAssetsAndLeaseLliabilityPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Right of Use Assets and Lease Liabilities", "documentation": "Right Of Use Assets And Lease Lliability [Policy Text Block]" } } }, "auth_ref": [] }, "SHFS_RightOfUseAssetsLeaseModifications": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RightOfUseAssetsLeaseModifications", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Lease modifications", "documentation": "Right of use assets lease modifications" } } }, "auth_ref": [] }, "SHFS_RiskRateEightMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RiskRateEightMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Risk Rate 8 [Member]", "documentation": "Risk Rate Eight [Member]" } } }, "auth_ref": [] }, "SHFS_RiskRateFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RiskRateFiveMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Risk Rate 5 [Member]", "documentation": "Risk Rate Five [Member]" } } }, "auth_ref": [] }, "SHFS_RiskRateFourMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RiskRateFourMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails", "http://shfinancial.org/role/ScheduleOfRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Risk Rate 4 [Member]", "documentation": "Risk Rate Four [Member]" } } }, "auth_ref": [] }, "SHFS_RiskRateSevenMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RiskRateSevenMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Risk Rate 7 [Member]", "documentation": "Risk Rate Seven [Member]" } } }, "auth_ref": [] }, "SHFS_RiskRateSixMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RiskRateSixMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Risk Rate Six [Member]" } } }, "auth_ref": [] }, "SHFS_RiskRateThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "RiskRateThreeMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Risk Rate 3 [Member]", "documentation": "Risk Rate Three [Member]" } } }, "auth_ref": [] }, "SHFS_SafeHarborProgramIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "SafeHarborProgramIncomeMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Safe Harbor Program Income [Member]" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Sale of stock, consideration received on transaction", "documentation": "Cash received on stock transaction after deduction of issuance costs." } } }, "auth_ref": [] }, "SHFS_SaleOfStockConsiderationReceivedOnTransactionShares": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "SaleOfStockConsiderationReceivedOnTransactionShares", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Sale of stock, number of shares issued in transaction shares", "documentation": "Sale of stock consideration received on transaction shares." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Sale of stock, number of shares issued in transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative" ], "auth_ref": [ "r212", "r446", "r870", "r904" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://shfinancial.org/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r24" ] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsTables", "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r521" ] }, "SHFS_ScheduleOfCurrentExpectedCreditLossesTransitionImpactTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfCurrentExpectedCreditLossesTransitionImpactTableTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Current Expected Credit Losses Transition Impact", "documentation": "Schedule Of Current Expected Credit Losses Transition Impact [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Outstanding Amounts", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r13", "r33", "r34", "r52", "r97", "r98", "r805", "r807", "r900", "r976" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://shfinancial.org/role/SeniorSecuredPromissoryNoteTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Senior Secured Promissory Note", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "SHFS_ScheduleOfDeferredConsiderationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfDeferredConsiderationTableTextBlock", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Change in Deferred Consideration", "documentation": "Schedule of Deferred Consideration [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan [Table]", "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r7", "r36", "r37", "r38", "r39" ] }, "SHFS_ScheduleOfDemonstratesDepositCapacityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfDemonstratesDepositCapacityTableTextBlock", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Demonstrated Deposit Capacity", "documentation": "Schedule Of Demonstrates Deposit Capacity [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://shfinancial.org/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earning Per Shares, Basic and Diluted", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r907" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r283", "r284", "r285", "r511", "r871", "r872", "r873", "r962", "r963", "r964", "r965" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r968", "r969" ] }, "us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable", "presentation": [ "http://shfinancial.org/role/ScheduleOfIndemnifiedLoansRiskRatingDetails", "http://shfinancial.org/role/ScheduleOfRiskRatingDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Credit Quality Indicator [Table]", "documentation": "Disclosure of information about credit quality indicator for financing receivable." } } }, "auth_ref": [ "r128", "r799", "r926" ] }, "us-gaap_ScheduleOfFinancingReceivablesPastDueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFinancingReceivablesPastDueTable", "presentation": [ "http://shfinancial.org/role/ScheduleOfProvisionForLoanLossesDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Past Due [Table]", "documentation": "Disclosure of information about aging analysis for financing receivable." } } }, "auth_ref": [ "r800", "r925" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://shfinancial.org/role/GoodwillAndFinite-livedIntangibleAssetsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Asset, Finite-Lived [Table]", "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset." } } }, "auth_ref": [ "r327", "r334", "r335", "r336", "r337", "r638", "r785", "r803" ] }, "SHFS_ScheduleOfForwardPurchaseAgreeementTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfForwardPurchaseAgreeementTableTextBlock", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Forward Purchase Agreement", "documentation": "Schedule of Forward Purchase Agreement [Table Text Block]" } } }, "auth_ref": [] }, "SHFS_ScheduleOfFutureMinimumRentalPaymentForOperatingLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfFutureMinimumRentalPaymentForOperatingLeasesTableTextBlock", "presentation": [ "http://shfinancial.org/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Future Minimum Lease Payments", "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date." } } }, "auth_ref": [] }, "SHFS_ScheduleOfIndemnifiedLoansRiskRatingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfIndemnifiedLoansRiskRatingTableTextBlock", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Indemnified Loans Risk Rating", "documentation": "Schedule of Indemnified LoansRisk Rating [Table Text Block]" } } }, "auth_ref": [] }, "SHFS_ScheduleOfLeaseCostRightOfUseAssetsRelatedToLeaseAndFutureMinimumLeasePaymentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfLeaseCostRightOfUseAssetsRelatedToLeaseAndFutureMinimumLeasePaymentsTableTextBlock", "presentation": [ "http://shfinancial.org/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Lease Cost", "documentation": "Schedule of Lease Cost and Right of Use Assets Related to Lease and Future Minimum Lease Payments." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfLossContingenciesByContingencyTextBlock", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Indemnity Liability", "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date." } } }, "auth_ref": [ "r947", "r948", "r949", "r951" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://shfinancial.org/role/SeniorSecuredPromissoryNoteTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Outstanding Amount on Debt", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://shfinancial.org/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Exercise Price of Restricted Stock Units", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units." } } }, "auth_ref": [ "r104" ] }, "SHFS_ScheduleOfOperatingExpenseFromOperationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfOperatingExpenseFromOperationsTableTextBlock", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Operating Expense from Operations", "documentation": "Schedule Of Operating Expense From Operations [Table Text Block]" } } }, "auth_ref": [] }, "SHFS_ScheduleOfOutstandingBalancesFromBalanceSheetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfOutstandingBalancesFromBalanceSheetTableTextBlock", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Outstanding Balances from Balance Sheet", "documentation": "Schedule of Outstanding Balances from Balance Sheet [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5", "r587" ] }, "SHFS_ScheduleOfProvisionForLoanLossesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfProvisionForLoanLossesTableTextBlock", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Provision for Loan Losses", "documentation": "Schedule of Provision for Loan Losses [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRealEstatePropertiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRealEstatePropertiesTableTextBlock", "presentation": [ "http://shfinancial.org/role/LoansReceivableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Commercial Real Estate Loans Receivable", "documentation": "Tabular disclosure of real estate properties and units in those properties that are included in the discussion of the nature of an entity's operations." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails", "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails", "http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails", "http://shfinancial.org/role/ScheduleOfRevenueFromOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r50", "r51", "r743", "r744", "r747" ] }, "SHFS_ScheduleOfRevenueFromOperationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfRevenueFromOperationsTableTextBlock", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenue from Operations", "documentation": "Schedule Of Revenue From Operations [Table Text Block]" } } }, "auth_ref": [] }, "SHFS_ScheduleOfRightOfUseAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfRightOfUseAssetsTableTextBlock", "presentation": [ "http://shfinancial.org/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Right Of Use Assets", "documentation": "Schedule Of Right Of Use Assets [Table Text Block]" } } }, "auth_ref": [] }, "SHFS_ScheduleOfRiskRatingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ScheduleOfRiskRatingTableTextBlock", "presentation": [ "http://shfinancial.org/role/LoansReceivableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Risk Rating", "documentation": "Schedule of Risk Rating [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r448", "r450", "r452", "r453", "r454", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r476", "r477", "r478", "r479", "r480" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://shfinancial.org/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Restricted Stock Units", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r101" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "presentation": [ "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]", "documentation": "Disclosure of information about share-based payment arrangement by range of exercise prices." } } }, "auth_ref": [ "r40" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "presentation": [ "http://shfinancial.org/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Options Outstanding", "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms." } } }, "auth_ref": [ "r40" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://shfinancial.org/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock Option and Related Information", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r9", "r10", "r101" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://shfinancial.org/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value of Options Granted Black-Scholes-Merton Model", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r107" ] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails", "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails", "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Table]", "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability." } } }, "auth_ref": [ "r58" ] }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "presentation": [ "http://shfinancial.org/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Weighted Average Shares Outstanding - Basic And Diluted", "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)." } } }, "auth_ref": [ "r23" ] }, "us-gaap_SecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuredDebt", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfOutstandingBalancesFromBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Senior Secured Promissory Note (Refer to Note 9 to the unaudited condensed consolidated financial statements)", "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower." } } }, "auth_ref": [ "r13", "r113", "r989" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuredDebtMember", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_SecuredLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuredLongTermDebt", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Secured term loans", "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets." } } }, "auth_ref": [ "r13" ] }, "SHFS_SecuritiesIssuanceAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "SecuritiesIssuanceAgreementMember", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities Issuance Agreement [Member]", "documentation": "Securities Issuance Agreement [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r850" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r854" ] }, "SHFS_SecurityAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "SecurityAgreementMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails" ], "lang": { "en-us": { "role": { "label": "Security Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_SecurityDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecurityDeposit", "crdr": "debit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Security deposit", "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease." } } }, "auth_ref": [ "r887" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r853" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r859" ] }, "us-gaap_SeniorLongTermNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeniorLongTermNotes", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Senior secured promissory note\u2014long term portion", "documentation": "Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders." } } }, "auth_ref": [ "r13", "r831" ] }, "us-gaap_SeniorNotesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeniorNotesCurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Senior secured promissory note \u2013 current portion", "documentation": "Carrying value as of the balance sheet date of the portion of long-term notes having the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment." } } }, "auth_ref": [ "r59", "r831" ] }, "SHFS_SeniorSecuredPromissoryNoteCurrentMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "SeniorSecuredPromissoryNoteCurrentMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails" ], "lang": { "en-us": { "role": { "label": "Senior Secured Promissory Note Current [Member]" } } }, "auth_ref": [] }, "SHFS_SeniorSecuredPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "SeniorSecuredPromissoryNoteMember", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails" ], "lang": { "en-us": { "role": { "label": "Senior Secured Promissory Note [Member]", "documentation": "Senior Secured Promissory Note [Member]" } } }, "auth_ref": [] }, "SHFS_SeniorSecuredPromissoryNoteNonCurrentMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "SeniorSecuredPromissoryNoteNonCurrentMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails" ], "lang": { "en-us": { "role": { "label": "Senior Secured Promissory Note Non Current [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://shfinancial.org/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stock compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r3" ] }, "SHFS_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value Per RSU, Expired", "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options expired in period weighted average grant date fair value." } } }, "auth_ref": [] }, "SHFS_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpriedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpriedInPeriod", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "No. of RSU, Expired", "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options expried in period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "No. of RSU, Cancelled/Forfeited", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r469" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value Per RSU, Cancelled/Forfeited", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r469" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "No. of RSU, Granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r467" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value Per RSU, Granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r467" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "No. of RSU, Beginning Balance", "periodEndLabel": "No. of RSU, Ending Balance", "verboseLabel": "Exercise price options", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r464", "r465" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Grant Date Fair Value Per RSU, Beginning Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r464", "r465" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "No. of RSU, Vested", "label": "No. of RSU, Vested", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r468" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value Per RSU, Vested", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r468" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails" ], "lang": { "en-us": { "role": { "label": "Dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r478" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected volatility rate", "verboseLabel": "Expected volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r477" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate, maximum", "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate, minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails" ], "lang": { "en-us": { "role": { "label": "Expected volatility", "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement." } } }, "auth_ref": [ "r477" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r448", "r450", "r452", "r453", "r454", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r476", "r477", "r478", "r479", "r480" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "label": "No. of Stock Option, Expired", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r463" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "No. of Stock Option, Cancelled/Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r462" ] }, "SHFS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrants": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrants", "presentation": [ "http://shfinancial.org/role/ScheduleOfShare-basedEquityAwardsAndWarrantsExcludedFromComputationOfEarningsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share based payments", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrants" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "label": "No. of Stock Option, Granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r460" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "No. of Stock Option, Beginning Balance", "periodEndLabel": "No. of Stock Option, Ending Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r456", "r457" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Grant Date Fair Value Per Stock Option, Beginning Balance", "periodEndLabel": "Weighted Average Grant Date Fair Value Per Stock Option, Ending Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r456", "r457" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares per share", "documentation": "Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r40" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r452", "r453", "r454", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r476", "r477", "r478", "r479", "r480" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value Per Stock Option, Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r461" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value Per Stock Option, Expired", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired." } } }, "auth_ref": [ "r463" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value Per Stock Option, Cancelled/Forfeited", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r462" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value Per Stock Option, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r460" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock-based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r447", "r455", "r474", "r475", "r476", "r477", "r480", "r482", "r483", "r484", "r485" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "presentation": [ "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Axis]", "documentation": "Information by range of option prices pertaining to options granted." } } }, "auth_ref": [ "r41" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "presentation": [ "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r42" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "presentation": [ "http://shfinancial.org/role/ScheduleOfExercisePriceOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "presentation": [ "http://shfinancial.org/role/ScheduleOfOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price options", "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices." } } }, "auth_ref": [ "r102", "r103" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharePrice", "presentation": [ "http://shfinancial.org/role/StockholdersEquityDetailsNarrative", "http://shfinancial.org/role/SubsequentEventsDetailsNarrative", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued, price per share", "verboseLabel": "Share price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails" ], "lang": { "en-us": { "role": { "label": "Expected term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r476" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted Average Grant Date Fair Value Per RSU, Ending Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "documentation": "Weighted average grant-date fair value of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Remaining Contractual Life, Ending", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r105" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Remaining Contractual Life, Granted", "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r106" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://shfinancial.org/role/ScheduleOfRestrictedStockUnitsDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Remaining Contractual Life, Beginning", "verboseLabel": "Contractual term", "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r105" ] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssued", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares, issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r8" ] }, "SHFS_SharesIssuedForSettlementOfDebtObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "SharesIssuedForSettlementOfDebtObligation", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Shares issued for the settlement of PCCU debt obligation", "documentation": "Shares issued for the settlement of debt obligation." } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Share issued price per share", "verboseLabel": "Share price", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtLineItems", "presentation": [ "http://shfinancial.org/role/ScheduleOfCommercialRealEstateLoansReceivableDetails", "http://shfinancial.org/role/ScheduleOfOutstandingAmountOnDebtDetails", "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://shfinancial.org/role/ScheduleOfLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Short-term lease cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r583", "r830" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation and Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r88", "r187" ] }, "us-gaap_SoftwareDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SoftwareDevelopmentMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Software Development [Member]", "documentation": "Internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r857" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://shfinancial.org/role/Cover", "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/StatementsOfStockholdersEquity", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r142", "r164", "r165", "r166", "r190", "r216", "r220", "r224", "r226", "r234", "r235", "r286", "r356", "r358", "r359", "r360", "r363", "r364", "r396", "r397", "r400", "r403", "r410", "r561", "r686", "r687", "r688", "r689", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r717", "r740", "r762", "r775", "r776", "r777", "r778", "r779", "r869", "r894", "r906" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r69", "r72", "r73", "r150", "r177", "r178", "r179", "r195", "r196", "r197", "r200", "r206", "r209", "r211", "r233", "r287", "r290", "r338", "r412", "r503", "r504", "r512", "r513", "r514", "r516", "r519", "r520", "r527", "r528", "r529", "r530", "r531", "r533", "r539", "r562", "r563", "r564", "r565", "r566", "r567", "r573", "r576", "r591", "r657", "r672", "r673", "r674", "r695", "r762" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://shfinancial.org/role/Cover", "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/LeasesDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/RevenueDetailsNarrative", "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails", "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails", "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails", "http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative", "http://shfinancial.org/role/StatementsOfStockholdersEquity", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r195", "r196", "r197", "r233", "r576", "r637", "r684", "r706", "r709", "r710", "r711", "r712", "r713", "r714", "r717", "r720", "r721", "r722", "r723", "r724", "r727", "r728", "r729", "r730", "r732", "r733", "r734", "r735", "r736", "r738", "r741", "r742", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r762", "r841" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StatementScenarioAxis", "presentation": [ "http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r212", "r446", "r870", "r874", "r904" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://shfinancial.org/role/Cover", "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/LeasesDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/RevenueDetailsNarrative", "http://shfinancial.org/role/ScheduleOfDisaggregatedRevenueDetails", "http://shfinancial.org/role/ScheduleOfFairValueOfOptionsGrantedBlack-scholes-mertonModelDetails", "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails", "http://shfinancial.org/role/SeniorSecuredPromissoryNoteDetailsNarrative", "http://shfinancial.org/role/StatementsOfStockholdersEquity", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r195", "r196", "r197", "r233", "r250", "r576", "r637", "r684", "r706", "r709", "r710", "r711", "r712", "r713", "r714", "r717", "r720", "r721", "r722", "r723", "r724", "r727", "r728", "r729", "r730", "r732", "r733", "r734", "r735", "r736", "r738", "r741", "r742", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r762", "r841" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued during period, shares, acquisitions", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r68", "r69", "r99" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Conversion of PIPE shares, shares", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r33", "r69", "r72", "r99", "r382" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock option conversion, shares", "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r8", "r33", "r68", "r69", "r99" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of shares to PCCU (net of tax), shares", "verboseLabel": "Number of shares issued", "terseLabel": "Number of new stock issued", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r8", "r68", "r69", "r99", "r686", "r762", "r776" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Restricted stock units (net of tax), shares", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r8", "r99" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://shfinancial.org/role/ScheduleOfStockOptionAndRelatedInformationDetails" ], "lang": { "en-us": { "role": { "label": "No. of Stock Option, Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r8", "r68", "r69", "r99", "r461" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Conversion of PIPE shares", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r69", "r72", "r73", "r99" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock option conversion", "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r8", "r69", "r72", "r73", "r99" ] }, "SHFS_StockIssuedDuringPeriodValueCumulativeEffectFromAdoption": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "StockIssuedDuringPeriodValueCumulativeEffectFromAdoption", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Cumulative effect from adoption of CECL", "documentation": "Stock issued during period value cumulative effect from adoption." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of shares to PCCU (net of tax)", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r8", "r68", "r69", "r99", "r695", "r762", "r776", "r847" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Restricted stock units (net of tax)", "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period." } } }, "auth_ref": [ "r8", "r68", "r69", "r99" ] }, "SHFS_StockIssuedDuringPeriodValueReversalOfDeferredUnderwritingCost": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "StockIssuedDuringPeriodValueReversalOfDeferredUnderwritingCost", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/DeferredUnderwriterFeeDetailsNarrative", "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Reversal of deferred underwriting cost", "verboseLabel": "Deferred underwriting cost", "documentation": "Stock issued during period value reversal of deferred underwriting cost." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets", "http://shfinancial.org/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders\u2019 Equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r69", "r72", "r73", "r90", "r719", "r737", "r763", "r764", "r831", "r848", "r896", "r921", "r975", "r1026" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://shfinancial.org/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Stockholders\u2019 Equity", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r96", "r189", "r395", "r397", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r409", "r412", "r535", "r765", "r767", "r780" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventLineItems", "presentation": [ "http://shfinancial.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r568", "r602" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://shfinancial.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r568", "r602" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTable", "presentation": [ "http://shfinancial.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r568", "r602" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://shfinancial.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r568", "r602" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://shfinancial.org/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r568", "r602" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://shfinancial.org/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r601", "r603" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://shfinancial.org/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information" } } }, "auth_ref": [] }, "SHFS_SupportServicesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "SupportServicesAgreementMember", "presentation": [ "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/ScheduleOfOperatingExpenseFromOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Support Services Agreement [Member]", "documentation": "Support Services Agreement [Member]" } } }, "auth_ref": [] }, "SHFS_ThirdAnniversaryPaymentConsiderationFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ThirdAnniversaryPaymentConsiderationFairValueDisclosure", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Third anniversary payment consideration", "documentation": "Third Anniversary Payment Consideration Fair Value Disclosure." } } }, "auth_ref": [] }, "SHFS_ThirdAnniversaryPaymentConsiderationMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "ThirdAnniversaryPaymentConsiderationMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "label": "Third Anniversary Payment Consideration [Member]", "documentation": "Third Anniversary Payment Consideration [Member]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables", "http://shfinancial.org/role/ScheduleOfCurrentExpectedCreditLossesTransitionImpactDetails" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r390", "r408", "r534", "r558", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r658", "r818", "r820", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r832", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r917", "r918", "r919", "r920", "r967", "r970", "r971", "r972", "r973", "r974" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfArrangementAxis", "presentation": [ "http://shfinancial.org/role/DeferredConsiderationDetailsNarrative", "http://shfinancial.org/role/FinancialInstrumentsTables", "http://shfinancial.org/role/ForwardPurchaseAgreementDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsDetailsNarrative", "http://shfinancial.org/role/RelatedPartyTransactionsTables", "http://shfinancial.org/role/ScheduleOfDemonstratedDepositCapacityDetails", "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementsInputsDetails", "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails", "http://shfinancial.org/role/ScheduleOfSeniorSecuredPromissoryNoteDetails", "http://shfinancial.org/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r521" ] }, "us-gaap_UnsecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnsecuredDebtMember", "presentation": [ "http://shfinancial.org/role/IndemnificationLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unsecured Debt [Member]", "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets." } } }, "auth_ref": [] }, "SHFS_UnsecuredLoansAndLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "UnsecuredLoansAndLinesOfCredit", "crdr": "credit", "calculation": { "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/ScheduleOfOutstandingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Unsecured loans and lines of credit", "documentation": "Unsecured loans and lines of credit." } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r26", "r27", "r28", "r132", "r133", "r136", "r137" ] }, "SHFS_VellarMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "VellarMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Vellar [Member]", "documentation": "Vellar [Member]" } } }, "auth_ref": [] }, "SHFS_VerdunMember": { "xbrltype": "domainItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "VerdunMember", "presentation": [ "http://shfinancial.org/role/ScheduleOfForwardPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Verdun [Member]", "documentation": "Verdun [Member]" } } }, "auth_ref": [] }, "SHFS_WarrantLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WarrantLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://shfinancial.org/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://shfinancial.org/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Warrant liabilities", "documentation": "Warrant liabilities noncurrent." } } }, "auth_ref": [] }, "SHFS_WarrantLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WarrantLiabilitiesTextBlock", "presentation": [ "http://shfinancial.org/role/WarrantLiabilities" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrant Liabilities", "documentation": "Warrant Liabilities [Text Block]", "label": "WarrantLiabilitiesTextBlock" } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantMember", "presentation": [ "http://shfinancial.org/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r838", "r839", "r842", "r843", "r844", "r845" ] }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingMeasurementInput", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants and rights outstanding, measurement input", "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur." } } }, "auth_ref": [ "r970", "r971", "r972" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://shfinancial.org/role/ScheduleOfLevel3FairValueMeasurementInputsDetails", "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants term", "verboseLabel": "Expected term (years)", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r970", "r971", "r972" ] }, "SHFS_WarrantsDescription": { "xbrltype": "stringItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WarrantsDescription", "presentation": [ "http://shfinancial.org/role/WarrantLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants description", "documentation": "Warrants description." } } }, "auth_ref": [] }, "SHFS_WarrantsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WarrantsFairValueDisclosure", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/ScheduleOfCarryingAmountsAndFairValuesOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Abaca warrants", "documentation": "Warrants fair value disclosure." } } }, "auth_ref": [] }, "SHFS_WarrantsLiabilityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WarrantsLiabilityPolicyTextBlock", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Warrants Liabilities", "documentation": "Warrants Liability [Policy Text Block]" } } }, "auth_ref": [] }, "SHFS_WarrantsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WarrantsOutstandingNumber", "presentation": [ "http://shfinancial.org/role/ScheduleOfShare-basedEquityAwardsAndWarrantsExcludedFromComputationOfEarningsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants" } } }, "auth_ref": [] }, "SHFS_WeightedAverageNumberOfDilutedRelatedPartyStockholders": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WeightedAverageNumberOfDilutedRelatedPartyStockholders", "presentation": [ "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "PCCU stockholders", "documentation": "Weighted average number of diluted related party stockholders." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://shfinancial.org/role/ScheduleOfEarningPerSharesBasicAndDilutedDetails", "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding, diluted", "verboseLabel": "Weighted average shares outstanding \u2013 diluted", "totalLabel": "Grand total", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r215", "r226" ] }, "SHFS_WeightedAverageNumberOfSharesConversionOfPreferredStock": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WeightedAverageNumberOfSharesConversionOfPreferredStock", "presentation": [ "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Conversion of preferred stock", "documentation": "Conversion of preferred stock." } } }, "auth_ref": [] }, "SHFS_WeightedAverageNumberOfSharesConversionOfPreferredStockDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WeightedAverageNumberOfSharesConversionOfPreferredStockDiluted", "presentation": [ "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Conversion of preferred stock", "label": "WeightedAverageNumberOfSharesConversionOfPreferredStockDiluted" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesIssuedBasic", "presentation": [ "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Company public shares", "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic)." } } }, "auth_ref": [ "r21", "r22" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://shfinancial.org/role/ScheduleOfEarningPerSharesBasicAndDilutedDetails", "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails", "http://shfinancial.org/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding, basic", "verboseLabel": "Weighted average shares outstanding \u2013 basic", "totalLabel": "Weighted average shares outstanding - basic", "terseLabel": "Shares used in computation of basic earnings per share", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r214", "r226" ] }, "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesRestrictedStock", "presentation": [ "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Restricted stock units issued", "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends." } } }, "auth_ref": [ "r22" ] }, "SHFS_WeightedAverageSharesBasicInitialStockholders": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WeightedAverageSharesBasicInitialStockholders", "presentation": [ "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Company initial stockholders", "documentation": "Weighted average shares basic initial stockholders." } } }, "auth_ref": [] }, "SHFS_WeightedAverageSharesDilutedSharesIssuedForAcquisition": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WeightedAverageSharesDilutedSharesIssuedForAcquisition", "presentation": [ "http://shfinancial.org/role/ScheduleOfWeightedAverageSharesOutstanding-BasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Shares issued for abaca acquisition", "documentation": "Weighted average shares diluted shares issued for acquisition." } } }, "auth_ref": [] }, "SHFS_WeightedAverageSharesDilutedSharesToBeIssuedForAcquisition": { "xbrltype": "sharesItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WeightedAverageSharesDilutedSharesToBeIssuedForAcquisition", "presentation": [ "http://shfinancial.org/role/ScheduleOfShare-basedEquityAwardsAndWarrantsExcludedFromComputationOfEarningsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares to be issued to Abaca shareholders", "documentation": "Shares to be issued to acquisition.", "label": "WeightedAverageSharesDilutedSharesToBeIssuedForAcquisition" } } }, "auth_ref": [] }, "SHFS_WorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://shfinancial.org/20240331", "localname": "WorkingCapital", "crdr": "credit", "presentation": [ "http://shfinancial.org/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working capital deficit", "documentation": "Working capital." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://shfinancial.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r867" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-13" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-13" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-9" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483043/710-10-30-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483070/710-10-25-9" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-7A" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1404", "Paragraph": "a", "Publisher": "SEC" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1404", "Paragraph": "b", "Publisher": "SEC" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "a", "Subparagraph": "(1)", "Publisher": "SEC" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "a", "Subparagraph": "(2)", "Publisher": "SEC" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "a", "Subparagraph": "(3)", "Publisher": "SEC" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "a", "Subparagraph": "(4)", "Publisher": "SEC" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "c", "Publisher": "SEC" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11C" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11C" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479391/326-20-30-4A" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479391/326-20-30-5A" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479366/326-20-35-8A" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-5" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-17" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-21" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3C" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3D" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.M.2.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483530/326-20-S99-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479175/326-30-30-1B" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "13A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479148/326-30-35-13A" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479148/326-30-35-7A" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3A" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3C" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3D" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/715-70/tableOfContent" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.1.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/842-20/tableOfContent" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 6.L.5.a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-4" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-10" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-15" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "79", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-79" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "80", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-80" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r830": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r831": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r832": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4" }, "r833": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r834": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r835": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r836": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r837": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r838": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r840": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r843": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r844": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r845": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r846": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r847": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r848": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r869": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r870": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r871": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r872": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r873": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r874": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(2)", "Publisher": "SEC" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "SEC" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1404", "Paragraph": "a", "Publisher": "SEC" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "a", "Subparagraph": "(1)", "Publisher": "SEC" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "a", "Subparagraph": "(2)", "Publisher": "SEC" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "a", "Subparagraph": "(3)", "Publisher": "SEC" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/310-10/tableOfContent" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481655/310-20-35-2" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479391/326-20-30-2" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 113 0001493152-24-018878-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-018878-xbrl.zip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�#&+,>BJKXFZ.4K4T@7VBI#^HZZMKRLS>7 M&Z;*&[6G"1N^D\=+-L/F.R^K^N2[D\PM8^887L8()V+FQ_ZXN8_UJ98]N0O& MG:,(\5N5,ZUK(Y(IU075S6.,6,"=IFQB$-@.2TTL+ABIGB;NFCITD[E@3+'8 MGH8A:NG2;0A=,*AE+%7/E5N/O75Z-\P3(^MC^\#;D.R&\L:R_AKCOO TL+A@ MY"E:)H_7)P;UFU)<4%GL!C?KW)SD@M+:B")/ M)]5K3#N1"X:4B]A<^$ZI7!O4CZ%HC^@.YALBK9. -GH7S+M9(Q),,68*$@K( MH[HP?19CB@+U^%?5P%X<+IAH1,02.*>,:1\T'!XKLABH&TBB6@A84XH+*M=O M8;F"%"8B_JX>LM-)YZ(YTR 0\6<@O ")<#4U1S$.X'/!W&K )(;U2F=(=4[U MF_NX1?5RJGNJZ^$]+>G.J:]'@9F375"^-H(5,7:&(:Y"T&F /&&29$D+^4 D M,P0N4))9)=.B&,.$30V>P";]CLVO,?:EKS@SJX-FL&6^V,!Z-M.^\I<\Y>7^ M^7OG,.!;97."5@B+ZG(*(^Q=SL1KG:?K+_W(0S$"^-7<*,>RYLO1;Q.:5!H)7+5./E&BFS.ISSP($DD M"6_"BV2^"-&J,CCT87"VKMN, #]K+U]<*](X:$^96 +\O#NW)@?J5V9Q_]6< MI. W#>'5DT1J-.A;F',#'Y*CD(U51;"&-?T6"]4D$_.D4.:=IZ]NKU"S?S.: MW1S. 6I264/2AM Y".5[GF; ZNG.P:/W%-6W_+I[%A.]>Z8V*FSL4BJG!9TCEAD M##RAZ#W,[HGMWO6%X]<'$E7 MOMCL4;^OUQ!VCLM#1#A7#F*.SU=I]?F_N@WB)A84XJI"?COA!<(H2B/Q485! M=]:59\G#N9*L&]<]YG?0.V=A!1T>^P-"!0^_R#/K$*3GN\OZK62Y5S(-GD?I M>NPJ!FM&1VRVN-Z0R:.T6'%;TSL:CFEKP33X5RJ/)O>UO<+I:FC!- SC>YY1 M8Q2=,=75:,9FA74,+>B-L[!=\9=B M, Q. ,%L#*13WY?!*_QNKB5B*RG=UIX\SMI>WMK"@?[*DFYY+PY7J_.WF'R7 MMV(A-A'*/;OUKZYVIIE_3I1^8Q!R*X7K9LT 7;=:U43@O%%E?=74NS6VJJ!Q MW32]DE5;DMZ)#.)TMA,U5DO;8NC#Z'PIZ)AFMWK.EZI.W\0B#O:+'#>Z*T6W M .=+18.X9Z$,X'>^3-J SG99^U2.$L]/;7O3=0<#&LE/<]JH;?CK5RJ#)#A? M+CK6G]GB@RTBXQ5&O\.@NVYH]#^AS?EYNC[3B68F5YPG9+'N=-;VC! M-M9;L[E: !;.RUGU3'HOCI_7V5M?*MS?HA*I.3 MU(K3U8I?-X96K?G&#P;,ETNCZ[N%_FQ.3L M$%\!K=1FJ=B6J/XC71![QRY" V'^<^CY)06CJQ*RI':[(31:HMHB*S3H+.F=MG&+,=,V? M)3B%L'CD(^^9VFFVV$G?2#E/T^56GR$XAM0GJ')FN8/FI0_XF.:ZY?L4.FA< M[3FR^][H35P/T\G!:25Q=:2OJRK&KXLXR$_?YO994;IJ9G%-_)>8)K(/8*-T MA!+5$Q1[Q-V$;O07\CT6I:4*NBPJHRGU9P*H#1.'3?D&>4N!P90-GFR D3=J M' &*_#/,>@@V$)7VI/.MW9Y,0_MZ>;W'DQOY->5W ,Z7QRA,V5<5Q\D?0WJT ML-:>VS&S)4Q*[=K5*5/_1XKD69Q6D&VX'3,[PTOJS(9R?BT4D\G/-Y0]G1UP M6["_M.&9JO7=GH;O+ZWJP$)6U6]+J HI+UX,"I%2,+XTHGX\LHG@I947Q;RPO.>>?JY4TB>3]M+%TMUOWL1'<+N> MMT7"2YM?;81S?+.&QX#[$!L,M:2U7V>]F$5B9Z2/61F#JVM(OBL08]%=?H%A MP!H?DX0"Q*1+L\K;!UV$+PS@->"'%?3M3.GXA %#B)]$!C[_6+5N&.M+M\'B MSL.2;[=P:C0G.NKES4; !@]3<])+.Y:JCS+EVZ;%/3B9^C:$KG8/IH>;VLSM MQ>*LX6@#;8SM)'/50 OC?D[#;)[!:3%Z.+NK!=+PTE'Y99=BO.@B&]CC9E]? M%9;$2EL MK:U[Q(J.3YSS9O6'E'Y?C;9SL L]GV2.JQ[+3="PY*1I>?&Q*=4%UOO^"(9G% M84Q $,OHGEN,E&M";_=:$F:P&TD.'*M1NL^C#83Z]I8;6%[Z:EP$8G%!M^J M]N*%N;QGZ:9S(BZC^=)P%>&DO]MF3^[JFO&UL[3UI;^0VEM\7V/_ ]0"+!)AJM^V^D]Y!^>HQQFT;/I+= M3X$LL:JXK9(<4O(QOWY)ZBA=I$B5*-*[&R!)M\WW^ [R722??OW;\SH$CQ 3 M%$=?=_;>O-T!,/+C $7+KSMW-[/YS='9V0X@B1<%7AA'\.M.%._\[3_^]5\ M_>?7?YO-P"F"8? %',?^["Q:Q+^ "V\-OX!O,(+82V+\"_C-"U/VD_@4A1"# MHWC]$,($TE]D$W\![]_L[]^#V4P![V\P"F)\=WU6XETER0/YLKO[]/3T)HH? MO:<8_R!O_'BMAO F\9*4E-C>/K_-_\G ?PU1].,+^\^]1R"@\HK(EV>"ONZP M>?-IGP[>Q'BYN__V[=[N?WX_O_%7<.W-4,3DYL.= HIAZ8+;^_SY\R[_;3&T M-?+Y'H?%' >[!3DE9OI;)!E?H82@+X23=Q[[7L+5WCL-$(Y@?YL5PV;L1[.] M_=G!WIMG$NP4PN<2Q'$(K^$"L/]3[96SDM4"190VY&5HV>]WCV*Z)BFQ''*% MX>+K#AU'Z 3[[]X>9.C_4AN4O#S0M4D06UH[8'?XU(=>R"1ULX(P(7TD= XV M0\J5AV&4K&""?"_4HJL369V&\9.6(%M HY%VB9=>A/[)M32/@L.4H @2 MHJYO900C;AZ"J$RN,"14.L7$-^EZ[>$7JD^TC-""[H@HF?M^G$8)=7E7<8A\ M!!6V_?:X1V/T&"X@QC XHE)$02[//@ZD0*.1]BV.@R<4AE0XIRA"":2NXA$& M9U1FT1+=AW!.B(*5U40S&OGGL1>1:^A#].C=,UQR,@7#1R/G+ K@.EM83%OG MR+M'H8(9ZX,;C< K'-/]G+Q0/3$3^<#,T@5,^NCK 1N-O&L84EL94'>8O-QB MJBO/5[)=?7#C.0 8H1C?0#^E.Y-*98T(B?'+19STKCT%T/&V!:2Q7J_4ZJ-& M5.(CC-)>>32&C6YL[^B>PD^8VB)\"GNID4.-1AQ-K-8HX<$ W4O4M#._0],Y M!8^F #H:F2<>CBAV<@7QS8K&IGVTB<:/1M!IC)\\'%REV%_113M?8LA#JC[" M^N!&(_!W#U.[DQ266T&?8HCQI%;\Z(PFESCE:Z=78A*8T0B[]9[[Z*@,&6W: M?US1G*MOXMJ@$3,'_=3&?#J3WA/X9TI5?/*HLC9$XYW("*;(#(QE"-L0=YY5["KK05U7%,G ;I:V1*MB?T2K]<0L]]>0R\\(>SP MLI$!Z.\:;9P&&)N'8?S$CMRI"V>39Y99FQ MI@F_B40GFZ^9U=>7<"\* V3G^6/R4F:.VF3WHC!']@+!(-M/PQ>),BH#;-!$ M[1&Q:V;;;4TE-,8+%KHN0!>/&?FW*A)#I-^'Q #IQW =LP2'52F.X4-,H^PC MCX;80W:P.BX3]CW+R$]QO-Y#5%G,9+@+J62A>/ 8*T<-G@*'?(3-?,)@_TA!P"3,J M*HYOMBV'6TY@(LYA),S8BYT@.QF9LU,G=O$OOS9&3I[], U@P()(]EPKS4KP MI;KT[>SXH83"P<#V'^?C"+@.BJ MKM#QG;IN%H9>1MBH[;2@()?PXI754K%_C MWW8*\SHWI65[>CVGD5%X4)*3$\*D>Q91ZZS/F2;"25DBH_/4C7',6\ZZ)E(" M,NXM:%W"I$ FMRZK!O(JTS?F.V!P&'K^CQGQ5W0\F:TA3N+H>QS #WLPH(F0B.U82[;2C@]H![<@\)(/9XZ*L0N\G 1 MWD5H2-VE'XF)!/"9';83>$6G'HL3?9P&KY=IEQJ5,1A[6J%-LB*\C&#?"_TT MS$\5HQ\U"/B1K1&PX<$)6Q\WH9C#\Q8SPX>UM$_YB--$M/=U:%& MU#ZEI'QZSZFB4T0TN65_(G&( F8*08X)Y*ARF@NJP]BO41JRCAQQH^]%T=V$ M]]U8>.2>TYF2V=+S'G:96G=AF)#B)US17,GY#_[(PLC\_F"!._3N8 M,8^'_=J::7=!R4?L$G8_D:&9(;HR"O@%CM=BC8>P4E4)I6('//%J$Z?> MC@KS^YB5VU<7,.E??5(H-87M6U68"M\NZ>D*PP*^"!,/5-'-@53-2 M3EU2R1G-#S"-?39+J%CEU23['#J5F^3%80;X@F.B:N!UQ- M;>^=L'5*DG!)A9Q:Q8"H:ZR:2%HK+JZS*F0BZ''5%7#(H-P(O8<35 MS[!+"BJOA/);-HW[3!(/(0=S(P 3>0D5EEW24?&82:R.S0@W8BB!Y)N,N"1D MR=LWJ:WJ@W,C;A(H1(UIE]14W ([B_QX#6^]9P45R6#4U//1CGKZF75)-?5B MPT4<^7J5E2J$FEH^V?+QK,B: 4C&JTGZ\\22 M[B':O<7/[]OS S#^ODF\YEL#%=.\MW;6NH OET1?N0G66]GH&FNWI';EO2B5 M.T7C;5<)Q-(75,ZZ&79I05%*<0H#G74E ;%=1M!1D)QMEW3$^K1BST]^1\GJ M*"4)C8]P^<2W5UUJT+8+#P-0.11S#_(R$OFXI62,'OF%9]5]6'+? ^A0["U4 MH!+O+JDK"T:+,W\>E/:%W8W!#L7=TH"[DT?S3NF"=0DJ#EMJ#=LN,5JBB'-X M"CO%SA!HP#L43G>Y*VU)N+1/!/FTBF%3 '4HNM:K)]@XHFJW;11LG:Z!MH__ M>O:(F#>7-H/X0S<=/J-CK+53Y,SZ<))Z7KUT#K:=?DD^,-0Z1Q:QZM(Z8EV& MXTA%'>V1MG,S95V(F'1)$?,@X+WNO?#*0]0['WD/*/$DU\*$ +:S+&6U]+#L MDG:NV4O2" 9%SYZY[Z?K-,R:GBZ0+[L4H )K.[%2UIFZ(%Q27\7EL\\M:/C. M?DC;'DF5-W&5T$6-*7RXL]M%"8%L>ZN!>E+^@FF?WBP6VW3X[?N"HXC-7W>; M7)[3OT_UFO[*8PG8"B;(KSBPVM/Z@R%/Z\%/-]!U]AY MI\;.!B6(%V"#%/QT%WDI]?\P^-E._X!FOVR)7>D8:LQ(GL!;3L\5?4I2L EI5WA> $)X;F+H'!F45B1AP<.=ONE '_YUFO34N%T6K?K%N>L!LQ_2Z MFE*2@E-ZVSB>PJNB**7<;BI*AW 18UB^IH;DY)EZ7BIZ%'GXY8R*C]\#8_XX M#D,NJ&RYRG:DP4EM&^ ))"J*#3JB""?#GNE%U+^1'?)L%S!126(:PVRO^TZJ M6Y[,O.(=4F3)1K[8\D)JGV'L +"]8]65*^2VQ^U-?LY4/921'([5#F?>#SF< MJ2+_=^\A)K^ ;([:6R:\W0&PP;1V6P6^GF/@ZI+: M%+H<(S;&J1JUBQCY"K5P?S ;;/IW;6H<2$?RO.B U M]^9KN I>U\EI]CE$V-7852UJ449@^RW8UIM*4U0N:7GJ6H2Y=V8CF$;=0L7( MYM&QPTAS?2JW,Z$CG$[^WSP0,]CW'\/L_V=1^]--4BNJ M *VH5H<+,SI2?ZGTRL/RLN$07(JJ=[B:,UR"CB^$KCMF/9]XT$*B MJ'J'ZT #9.:XSNMMRG44W814U*[#92!5Z3BNTKQ%;_O;<=*2GRX>174[73$: M(KDQE2_LBM(DK$@#[B(JU2>,&']YBVQ!SJ2)0U&;KA:?!DG,\6W,NU_FC1?[ MO@:G!JVH9(?K43I2>D7J5>H>JH%"4=%NEZSTY/4Z,NC< MUB+QB40]?A%=7L M8KE+D]-7J./MU*_UX MQK;E$>V>AONOJCJF)+LI>DTV"=NVG^M6&!4U[6(Q;&O>7\..;WS33,N:MV$5 MM?VJBF,B";FD5P';V0>QM[LPZ9()RJ/S)&V;_,KCUZ(>2' MU23!R*=Y-OL%M7GU'U1&7D&,XJ = .3=1TZ>?7YQZ9KF[">+!?1EWU2?4;LL3)E+<[*MJLO"E)E@MYJW7N*E%^6WH*G #E."(DA( M7]/3CV &CA'QPYBD&-*_5/$ +PI @0E449E\,GOH$43]V!6&A&JX8.B&+2;\ M0OT;6K*$WF?A<5:L90>J<8AJ#81K3'YJ,LFG8,]GJY-P;O-I^.OAS41@,Q/8 M3&52"/+KMC7N/C>Y*V"!X$ZR"7J_Q7'PA$+6\Y+N&;K?9R%ZY!<8Z/9#]R%L M'(E6.=A[V^2@P,954L4'-@A!\S#9!%L\P.^X1UDC?Z])/H<"7==,3=!8UKC\ M'&.SH%DC=K]); ,<=-2 35!=Y+G5%+=ZN:5&]$&3Z *:+Y 2_J^@=B'(!-F5 M Z&76TS5[/EBZ[KWKDEW#@XX/*@C,-J&@"<%O$Y&B:<>&!$2XQ?VV;)NRM\W M*<\P@!P%V. &1*CNY#Y=(&(/[0V7S[8["K@[1"[*6JYU'+T% ZCO&8$\2D4 M4-CRAZ7'J$ ##FZ29)4/ =3H;GFZ"@9N"?SN#R28(+[X7 @-0/F;[$Z*]UN> MK0 #% [D@";)/(WQDX>#JQ330)C ^1)#6*LFULAM>;(<'!3PH(+ )-GMK]!V M$]SR9CD@Z#R_-B+@XD=G$4U14KX6NVEM.;$2%-1@35);[XFIN5\WKW=^^G'SR"#,-NN1ZD=T7[+Z]1:#?WET_[>QZ+7D&&"TWL" M_TQ9+^Y'\=)KN:0-&("/YI?=-BF=-+7;-Y+:@9^*/QGN#K6-7&Y99B&02LM1 MCB.5;$K#,NG,?"7,'K1\;'?^.Q'YBHFPC*&6%]9(AR?BLI$7R[AIN>AF=CP1 MR:(T649[RV4+D^6)F!!DS3(>6IY=DCM/Q(4HB9:QT8H)Q*GT1%Q(=8LH[L50V0@DRT9GD/+"&R% CG,1!0V$T(9J2W_W$X+)Z):E!]* MJ'_7'E(G\4 MPQZI\J,Z:LY0DK5?XO:9?QOW;/U [?0Q^^IJ*."QY7:+*7C'TVP24,P"LFE M-@_83 2RFL>,$^%-8MEI8G'R>JSR<'Y>S3K9>\S4QGR"]= M(>WR='6%<+0 1<),8)H5(6.K1]6M(*&'$PO*R_*0\Z[D1JJZ=BVBHKH,*3@7 M)3?3*$XQAU-392LLT+V&F/WV&GKA"6%MIQMIGU3/K1BGMD5+Y(!A M!QGZCM1P&H5ON)Z'8?S$.LW5F@?*&'W?"H>JC);X6)#$^2L2L72/RXYI? MLY*RTXJ-JNPP'"!#,CT#EVE"ETG$OS.VYJ_TI(RT(Z4*(Q5<($=680KR6WV&MC[+4C3E+5=4([AQL^S9D%^G-3LMB)LT_$;N+2#$]M8C4#YVS M.UC4*/-85W %OP_(]JU)F=!5Z%<1_O0?LRC-4UX;3%[*HJ#4/$F3G!)7M<(X MM;UM/)XCB@ZDE:9T,,9P%M[>IDOI[A4L94^:>I3XP,*.NQ=5N95BU?>MM$-2 M[[87F785P:4JDZ85PV\& \!F8M'66',K2DT 13=^P] ,J?7"V0P@5#;4_ M0*X@"I?>D#[?!FP((86[S.?>FKM-G'0]>'Y?E-2JGE1-=Q4IR+&" JV%!'OSD>S-6PDI=](:27%\Q19:Y?&% MA;R[\05L=08_2&LC)5Z0(W: U4U9X- +6=V&O_G-_WRS@E ::7R0%D^J-8<" M>\9R_C? )YB*:]$IO%*H^*%579&=Q]N+%26']%)%2K.SOA-[ZX6QRXCEV%(& MI5E:NSH&8G::1A&<2T&T%D/_!3U\^Q2/M !*;+:#X['UWA#3ZU8W MG5C2A',H/MOONHVHO"JJ5ZWTTSC%(^H\0V?[^X"66'D/C')WM MKR4:T7@UZ7#LM*A)FS3?U=I,G?C]WJ.8R/.(]G7F2A[!40"&PWK>4# C MV8&;(78L2ED/42"V:ZSUV+Y)=L,0B/ESR:[?K&*<,'NEH(6NL=8C[1XMB/ES MS=96;B[5/O@I+SE*#_LX)G"Y '=DZDN%E9N3*76"\#N*T#K-M%!T@90R)BV% M9SA!CC0WO 5:^\:72AK6MW]YDESRGLJB(V4,EH)!1?HTZCR#,=IW WK:;H:+ M6XK2)5^BRDM_T4<7D7TO-,DB<+D,I,-"3P5('Y7UXL^$^G>V)J3!1$\Y2!N3 M]4K0=/IWMD"DPX.\-J2-R7I9:$+U*U>+W%3_?)% /-X::*!36PCFOJ8XT4+H M%*)C^6SV7EZM3-BZ&%0\MK=7#J3D>,LEADMVRR._FR3+5S]*[_[4L&U>ZD]U M\Z5*O5P5'UM7>IK$3J:+[A9_:ERTKNN(6O[97&)Y%X2B@P)A[YO]>10WE'\?HAS9Z]EZM'6D3[*'V]49DGY\ND( 4%&1W]RHT5)::C;*B MH)6'5![2XQM97X]IN.OAJOV,G%J69S3F#(\**60T\:4<191[R)G7/K0G6,& M!U4!5+"##+U+#!,%CJ7!GIQC,C'+M]ZSDEW_U-6!=WH[SKORJA$LZ]+KA -B M+U?X X1OS#_"X##T_!\SXJ_H>#);0YS$T?QZ7%=AR_7%\TW-U M\LS: !%X18D9P.1G:0!4( <&UL[7WKT;L3$3<:NK7-7U MZIG9&^E7MV.JG+ZVJWOO?G%@4#JY12*W -LY?_U* C))X.A! A+9S(=IERV) M<\Y/C_/2T=__XV45.D^(Q &._O'#T8]O?G!0Y&$_B![^\<.WFU>SFY.+BQ^< M.'$CWPUQA/[Q0X1_^(__\S__AT/_]_?_]>J5JXMH@?_F7+HK M]+/S"XH0<1-,_N;\YH8I^PT^#T)$G!.\>@Q1@N@?L@__[+S_\>W;>^?5*X5Q M?T.1C\FWZXO-N,LD>8Q_?OWZ^?GYQP@_N<^8?(]_]/!*;<";Q$W2>#/:FY4?SS2QS\XP?VW?RSS^]^Q.3A]=LW;XY>_]^O M7VZ\)5JYKX*(RM5T>P5^]6KH[>O MWAW]^!+[/Q0X<6$3'*)KM'#8?RG0FZ_&RT404=H"-QN6_?WU":;3EQ++>RX) M6OSC!]HNIA]X^].;=]GP_[;3*%D_TFDD@A/WZH6XFP1[ MWY^+&R_,0/VL)LM:I,]+FY,&-@G]QE&:1?YS& M083B6!UOY0$Z7#QQ0&5R15!,I5-\^"9=K5RRIG@&#U&PH"LB2F:>A],HH:?C M%0X#+T *RW[_L3MC]!0M$"'(/Z%2#/QD']!918]!/$8N5Z2GN7K%]W!P"* DQND)?2E4FEL@KB&)/U)4ZD]C]$=*(3Y[4ID;4'LK+((A+(/> M+(1]B+IEJFRO;.]^H5^S2(T;A:Y#FTAJA+<:K"]S28UD8:?>320YA7:O0J#]"QJ:6XDAK:=FUVJ>+:T+@W\T&-)G&OWDT) M-2+5>O>JP2L2*NW9HVZKN%@E_;HCT%LB/PW1?'&2$A9I.7MY1![=UT[H+A$D M7W#,EB7;W@*VNUVL'NDV=XH2-PCE3'0PMA5J9$[3)3-+$ZJ3]*E00M_J _$E M5:S01=2H,>ICK#%:OWJR+EQ:@_2 0Z;M?FE2=K514!]K:"- %Y4]A^UCO>#5 M"A'VUVODAFSG5F;%Z5A>B#_.HB_ M7[ML$]4F&>S: YGS-.%)2_1CLQ7;]?4E+!VB![)S^S%9;RQ';;*E0_1']B) M?K:>VD\2Y:%Z8(,::D\!RTC;;VDJ#=.[PT+W"- =IQ_YUSP2;:0O&Z0'TD_1 M"C,#AWDI3M$CIEKVB4M5[#8K6'VL/O;WS"(_)WBU3;G1W^H51NECU\^^%3TP MXR>*]^5":[A^#[$\32]F))13]O8YU13'[-T%J+M3Z8[3 S("_YXV(NIC#:$G MS:DQ=K_7M!*,,X2#5GOU*9=I2LNJBMWS9V0^M:^ZE =^_1U)[2X5Q^Z3Q"[#P\$/;!=.3_Y M]94>^2!=ARCTSQUAMYXSQ]HZVM1&Z6%:Y'&4(HP2,T>M1[7RTR!,N6:K.4/T MQNN!H=\1V[Z0/WNB*N #RJ@H'7RO]N5PSP_TH>Q*,Q?\!B[]?;;[;_9QK@#Q-_U316V@WL..NMN+[C@] M9CCJDJX^0A\3QPT(OVJ8:4!T5I?H^$J/;J:&SJ-KIH\2;J3%00M=I8.O].'4 MIP)>;_VI+-I0$!KS<$HM5*SOX]_W$_UCWA?*YG#]0C6C\-V&G)P0)MV+B.[. M^IQI#C@H2W'G/#6/V&66L^X6*>C2;1:T+F'"3GTN7>8-Y%ZF7]C9@?SCT/6^ MOXJ])6T?OUHADN#H*_91V'X5M_U$'WH?2XG)J*$[:.YP8[?FR:I=PH+F@+WX MAKEL2^IT"W^P9(A>_/'TH I8(@\7X;TPOTW8U*H_0V]4*;9(5^XL(=HE7T-S4N$P 4#VB*&+!RD:\YW0MZ1#$2^_1 M*S^@1VC,[R3G'RH+93-*$"6O:=/7>9O7C0/T3_?F8Z]\O'(#3:+KO0>@F'^) M'C^K>U9#0XOF25O09=$ZBA9N&2>M)673?I9G^ MFN64\:2"Z/L.W>@E09&/_()R-J!&O9X]"OEG[_+&36U?FZ7ZMER40$!QWJY*[1;O&2GHSB>+XHK, M9NC/'J9J\$MR%O*OT5F.'LJ79A<$KZ2BS,6&A1R494L)^<'!A)[1__CAZ,V6 MEA#'R/_'#PE)&U@>&*"3T(V+2C.SET!E=M6[= I;XW$J@VE7^@!$$*\-:)G" MI4SB:7XP0X TM>T4B;J.((,!E#"64@Y!\?;-.+&X.VH@O"LXBM-QW]VM-5Z< M.PBR=VTA:S :?CV_R8!@&=('I#; MU5X!5 2K N_!";C'M=WD )2ND8_0BNW#F^":ZRU_9RZG_!>YQ"<':HR\'Q_PTVL?!=G^ M37_8;MOT'W>%SGY+1VR8(;1)N<7=>S/PR97+)D(AV79R/LI%.Z/$^(R@\]!] M:);M3A.KA5NGM%=-4$.ZIRCV2/!8KHP'"+G4\1$ D*YY2AD7R,8$OE/PXK\/U.7 M)(B$:Q6I5QJ/0O!--$.R?S^PHK*Y1J\B_&KK44B_D6A(_!^&%?_-$H4AR_MS M(Z797V\_"@@ LB$0/IH#@8<&3]U$HKTW=AD=%+N40VA\&A8-:M4%V*<\$04< M*HU'@4 3S9#L/YN0_5GDJTH^;SHBN91![;IC1=TY_UQ0$*3%2 M:SX*\3=3W;ES<"\(_@NY1!F 3>,1B7^79E#X UG >7FG+6G"G0=J;;7XA42# M\A_(YCV+DB!9LZ>,+E/ ITV;55M9+>]&8D$Y#V3H9D05KH\H8:\UB62]VW($ M\FX@&)3Y0 9N1M@))9^P*Q(^>ODG6HN$7FDZ JDW40R*?2##-J/LB@2L9-U- MX,DWEFK;$0B^D610\@-9LQEIM^[+A4^9V!2_D0, =!D!#B+*03@&,F9=MK4?CSRKY,-HC"0U9S/ M".9&@=*N=II8+>LZI:!X!S*-V9DS(\B%IW6YA=W"K1(*RG8@._<+9E&=)8Z$ M/N1J*ZMEW$@L*.>AS%5VO3 &MX?-GZV6["Z5D$A;7]_0%.GO)$@H/2S//(UR M#Q(0^6ML:K6H88I!L0]D*OE \2N&&SS.OMK!8X0"XH[8&LRRN" M^%L15,GGR7#LCC*9+Q;03@VWMUKZ$K)!% 8R,ROD7<1QBH@N%K5>8T*DF7@0 MEX%,3EXKF:I41V_O;]D%?& GJK2R6NZ-Q()R'LC,O,2WQ&55AF[6JWLV!Z6]^F%,>_6#PEX]D*59$)4EZM-U-[\/@P<7OA$HZ# *Z4-T M0T#\--2-5WY?JU19\)S^T Q!8U.KA0]3#(I]J*NPJ1^PRN6&A2A: 72Q&A$YY2 <@T9.?\-A M&B4NX2FW!%@;C4U'(/XFBD&Q#QHDS=/*-R<78PJZM2#J,0(0!(2#6 P:/+V( M$D38NUU/Z-1-W)Q>$1;-/4: A8!P$(M!$X_Y0CVA_#Q@<>[ 3L,12+Y.+RCP M0?.-;U9N&!ZG,64@%NX_.PU'(/ ZO:# !\TH/ELA\D"WP5\(?DZ6^45>D> ; M.XP )AN$(A!,X?/7K:%!;);C4(4:JW' $$ST9#\FQCJ0_Z;>B:>QU)-,IT@ M\ET"( "WMQH#"=D@"@.9R?-DB4A9*^.D,69$B2"R7E8CHD0\B,N@9G*YS(/P M6"ZULUKV +F@M >U@J_2^S#PSD/L"O7^4K,1R+I*+2CJ02W?8S?Z3M+'Q%M? M$>PAQ )#\69-*AA?2@., !YU/D#@AKV*NRWG67L-4NBX$/0; 4Q2\D%T!BY% M%6^O["'_>'W-WEQER1NWZ"4YIA_Z+E:NI-VMQDJ/"Q"RDNG]]]<5!NGGOQ=_ M:_C3SJ#Z;TF4'[W?,KCSIL1;YY6S$09_5()^(HJ1SWZ*<1CXC&DG'\G)AS)2 M^?R4B88"@"+Z0\+?20MB]FQ!2E -QGHQ=,7NAEX^V+X372,SWM(9RUZNT!NF MTX6WS\,66M!6'U)H([KF\DX%]18\A9&_('?EDF3-[6WF8*4KDFT_V[^(W\;0 M&:/3J:#U6$8K^'!K1D'\;4!:]J!#4]N^7G,0/Z[10N0P9O:^MK$?.#:_MM$# M@/T\O[$WAIU:DRVMRC^0-=]O=?30C_WUTQ 8.(#B,;5,9C;F+1A642G-3 MV,#R;<*AB6CKU+(3-U[.(I_]ASUE^^2&S!,P2TY<0M9!], ?-H+A4>IN%BX! M#+@E+^!98VQ196&R^!IYB!).38A+E,#^X$(^@EXCP4S* JBGF8+JBJ!'-_#/ M7AZ9_TF*46/SD8 #TPXJ":90XJKBB"CX2 M"-2EWTD"8QOI?\'1PRTBJXOHB>["T.V:O'5#8]N-((AD"(A.$AC;:63X$9%D MS6SMA.ZI3/E_9/32S52DF,&];(=&2KLH>F3HX* $NRRYXPMR8W0=/"R3^>); MC#C+@C-$U,UVF.3$@S@9\R?\@K'_'(1-U^[S)D4+VZ6_0R5$/XA0]XC@0S/U*0VM!$) +2M^P)2XSP<<;DA2+ MW9P)'KCW04B%AY@OC>%)U1'&")T6;R"XQLSZ$OG*T6:X MCRD VX PJ@3D3:7C%:XMZ_,C\@D,;!GS;^A =4@HZ0+4UA," MN%I_=PE[E[I$A="[S?J(NHP0!R660#B,^2[$6W/HQG&P")"O$JO0'FJ$*._% M*H2^N9M(RAXI[3I"2+58 ]%LZRD!UF ^L9+UAA!@L=4;CA " 2.@P(WY04I\*MEA M(X]>BE$PYL1@U;&"+#&:73O$O,PEBCPA*H).8T1)Q@Z(FC%71ILL@N0&U"4[@H5MYIXH9U/>=TRX*7(#0F@L(Z/.K([*,":( .I!2(PY$F06 M7_O,SS%J=DH\@2"6_ ND(J+,;0>A$:*K3O1^5RYB.,4^:LZ%M>V$>8++?7L/9CNS=WX-EDV3S(9G'W$T%QW+'.!!WVP*BN95.! MS^YK%" 6N(+R-Y:0+YW!W@$O&&ROB*FQ! MD!M+@)_Y_YWFE<%O,>"WXXS=N_'NK @]E0KA&'G[(@))D ME/;]9>NGT2 "@":.G6;60UFG%I)[Q]4%A/IGEI$9/*&S MQ0)YR3EE;^;CQZ3DJ*Q< VL[G+T [KA0ITC=CNX(;S15%JX5M$B7AF3I?HX03'4 FF_0:U%\:. M> .Q-7?_H)S9SIZ//0_Q,Y"L_Z%-0CL;T^&##I:L/R6*[A%4G 4_-^EJY9+U M?'$3/+#B)QY[""NKPLPF)<6A? U_E\=/51[Y)QA.Y8]P9O//\$L)VP\YVR\Y MVT_U*(-M8:PH#OQ<[,W,?:XR5_1U*IU[)+=X>8GBE+WW\RIL>O"GD8&C-U4& MBM$X(.7QG.V 3C%BCURQZCIQ_;637>J/JM3S7DZY6X\D;FH!>;NUTYII?5NE MM=+=*?7OD>CB,3O@Y;Y=FM]5:2YZ\]FQZ?_O#A^A1ZJO$;^P>N72;]\2BK'K MP=OJT4]5LO/N#N_O[ [0YQ4N7M>+AXXH[50%".(8DS4K\-5,^/LJX=D(3CZ$ MLQW#R0;IN-O4>*%6KH[))=.]]*(_ ]P-L=HT?:BQQ8J@)S&Z:1X+>U\ZSHYM!^ M3MZQ1RHK#UG-'@A"Y;RY76IKYU?>W2GZ.Z4!>J2Z7O.UF=[:&99W='9Z]BG> MXE<749R0=.<9X%U2:T?7IJNST[='8F_=EV;::N<3;]DC)?]D%]N;::D=.3^] M.?K+][\Z68]>[S;Z/6/@U $ HM>.Q&Z%DG^Q7)(U& MKH#7=[63M=G4'89Z19M7Q$_M[-6P?(=ALF("BYBI')A> ,9!$+M?-<8"8/PP1D+XNXJ&D"L-6\9<+0E8PP=.\QXX$_ESGX(B\HTNU7#,7"O"7RTQ"Q7-:]N9&5,^GA6]:41.ECRE4#=KUA M97U!EELZ]GQ18D5\;11H;N[*:'_(817&092-I:K6.'>;F97>K]<=R,QE53$N M>#^6('0-/CEK"%Z;[[_V. 7ZN1@+Y&@PPR'+5:8VZ<;[" +)^HBZF+K_VG:5 M80VVP&VW[;X+I4G5\O@4/>(X2$[<1]22+93MOR'Y0ZPQV^)AK2P-4MGH#?WO9/"^@&S,BRS5Z=6> [HA_@FG02B2@RF4N M;9XR(B*[%DO+N@SE0>6GA8B^6D@L[S,,@=5\"!&E MM3A5/2MB&**A] @!\3_5 D]PDL1 3#0D(8@8J&=Y-*4B&/:IGZ+[9%ODX%=$ M;6"ZB2?LW^M9&.)GME-2R9_0#2-(V.5)!1?Z7H.:\6W42;[%7X4D2]SBK0>T MQO?=P=2H/5"[EY"M]VU^(L!I_UKFNN7:Y0(0_Z5%X?^:+ MQCV?DA$W_TE6VZ_;KYAQ>LLPQ3UR;)]/?'SSQF9ONKFY96D5RCS15A90V6EF MRO?>RU+'$CX[=\;_V8/:W2H FI%K8Y?'I\CU%+F>(M>CC%S7G$IS7AI(&+H6 M]C'U?D,'L6LY7^#:-%=X9>.N/W<#PFL<9-G65 :E^T5?DLH^XA1?<;+/.-EWG.V'G.Q+ MSE_R;TUAUBG,.H59IS#K07E9IS#K%&:=PJQVS1N;7;^'%F8%/,/9YBE61(5N M8O4!#+V-W6?(55\ PYPV,4E*.P;]UW:WH/^XJSX7D)7.G2^*)P, 38%V5>LY M=I5!F=%A?#E[H@GNZ IL&CK?=0%0QVW@X]LX=%8>L7W#.V2BTKY;[>;Y)/"4 M59%6993!TYOT5Y[&5MO$7.OQ09> :N>%9S*JI5XI/0<_'<>5 ML?L!^*>UV>TZ"+HG@MMIMB>6VX'^9*A6&.]:U07P+3/$J,IT;P##YL8'@I. MN:X552TLI"M+UNV@\5%<-<9>4F;77DLKO500O^&]PUK; X!.S!N$5]OGCH&5 M5?^Z=%6)NAP +$HL0NBT?9P80">ORYFL:P]=5#"I-SP0) #&(/FW?2E86?[2 MU2'J=EQB'R3ZGXO4!P]LC['@"L>KQ"^';\ M?*^<&NEJU!GB &!LQ3*$IK$W?$N)9RRV CY:4%^KLIX' +$.IZ"EW'4!0PDQ MTF6J/L !(-B"816OY, YD_N\[Y#G UZR.S;,/]NE_YB^*Z#GY=A=K(N MU*/C-4NG$R>=*W4>W0FDPUS7@;G^\&0TRY*#E3J;R17704,1Q[I$;$H'[QM( M*\_+(< >-#][\WWVG%]*J&RIC2^TV3P+1R8K%A 'K@9#WI9XJO[(I5LN^LD6R,/DNQ[5T)XOHH+T< ZYR"3GL@>N E1V#LE+J/#D5UKKIVRP#6P.^8?*??/7$?@\0- :U_M]%X MA [0;IV'I.W>+>'I!#>/!+G^//K-)0'[Y36=7X+\(L411H>A%F.@7F@[L*+UM0BT@[JQESY*5:Q>F*WZY-RX*9_R&V1U@EJ0NWMH' M^/CH9M)0,H%F8MM\\OVM5APEQ/62WX-D>9+&"55KR.:R@]3AH-)[='-!F2D( MS%(Z^=#E/;?U,9=LYEY$U(! E&(ZK:,X\/.W:845,=\+*V+R89T@ZY4PHCQ[-D^'K)M6LE=?L5T1FX'W"CG[G;W+6NR?/M\ M.[E'^8$N1+L*B[+@_(B?;NH1N;U>=3*6OS>]ZC2]ZM0#O%;F O0_!0;-#9O= MNY[[%9$'1$[HR1!$#\)L,*BYH;J<'3SE).)HH(A<]O7-6U)" !K;CO@E+9@? M '>1K*;?RL[\_8;U8Q^HP!;-7Z[ MO^ALTGCLFPHVZT*#3A=+'Y!FM,KPW[8Q]71T)^NTOL6KU%0UMJT?IU2I0W$\ M\RA'62EU\9$-=CC\\UHB*XLR;YHH93]2/5)V+TFAJYEC5R9].5:-$K#I8.T3 M-IN/R(ZA->$BD'L%3)JBZJNA;OO;_&AS<0O\A-WJGB]X]2#Q\27H M%J4HEDF4;7Y-;M2CRDR0][SX8PJC_X+\2ZQ#6 MQI83@771_@95.RMD>4%/)LI!$F>\ MS0G[+Z^IGC*1TUV/>MRK>=W'AY.YN0Z>%@FFTFY*;5[XH8A\H_7>;LX;R@*K^XW\ '/ MD"XD8ZO)O,O4V0M[6"I&?!UL_KCAY$AS]LB&^[/-&25Y0#.E=$W0V$6 8Y$7K*M0:Q MP'>NC!YNSZ9UUJ: ^BWME^Y*&C_4'LB,?[T-6LIXBR1FDSO>%.@V._('GQB6 M^OV_NN0[8B5(KA$O$%-C11(+4.MO**&][=K%+5FT;KLOKAMSRIG-L@P>I9 * M.IF*\W0#I(PQ^Q(63M$3"O$C\F^1MXQPB!_6F9THPU#2T52!X6YP5&$.=+;8 MJ'I)(GNRGG='3>>'63AE5I0:3];%[ 1DEZJLS5:8),&_^";3"E9@K ,#6LBE M=6=IE?I+E)R]>&'J4\W@%XS]YR!LJO^8=U?I/49XU?FR+C@FX%KXI+JXWQA! M5.'(NBB8@.AKQ 1&9V!Y6\G2 @3QBY8#'AC@*C8:_.<$X>Q4* MXA.2@CZ?JH&*8G3^7F9Y?$&DPGB5GREF,<4LIIC%%+.88A93S&**64PQBT.* M64Q>T3[E[:^/J&2\0O;P: MT_'Z0'[)9]INR0B&&#%X:KQ9YX+D3&X)/5FZY $)H&QN/T+_2K%DW[IHM"S>U->P5WZ%+V S;U MLL;S)X8&]/7!DK#>N\+]-!=(E4<+W / M,VXU@9A%>-CM)NL.%IL=7WM#-VB%)P5E0EC_2;F_H:Q:Z?K +7FQ;M.[Q DJ M42I)TVMJ?6)H;Y2V M8QP$4!5V;/;Y-&_((C?/^SW(4J+WA" _ M2/XS=4->L<@/.$TZZ6][?L,:)UF[:2)*E.M$^M:[VGB9J\@-,UZ8[SZ.Y4XW M<2\+W&^=X5>[[R"5ED6:/$2NS$LDZV?&A:Z]SF$=U-V7 M:UM4C4R)T*]7;VC(@:>X)K",=.MVNX8]G]7Y0AZ[B!&NSY[<,&6I(51!WT:N MM11&^7!W[XU%\?=7?]ISK. J-&;IS=.$VJJ1GUUJ2B-QI;+W;T5V46DL)Q_, MM'TT/>BM;UM-#WI/#WI;:Y'=KJ<'O:<'O:<'O:<'O:<'O0T_Z'UUTE?B>2T/+T07$*[1WO>'UD')@J()[)SD' MO11IE\F8VH5J,MXT-%5': \9[](.R;AUF2")C&^"%R41;]J9>C6NO81W28<$ M_*$O :,G%*F)>-OR[M/HA%PA'A+SIY[$?,;J;2F)N=22GLYCDW.->MBV&Y.' M\FC,J5MU3A0\_<:\D%<$/P5,6U:_?/->Y+';C.X- UW'!-0K1>A=; R-7F"0+' ;X)A.MM&RSV@!V M.MZ:49-FXHID9)&/38%RA9J]JD,8*]&LA8XVMO;ZXX:$UV8OW4!3P-(2S$U7 MP:L,2-\95![#W/.1FNL4[\'@0+[#>OQ?!A?K)NG5PT+M%R%5GD!0C!VO-RMT-EB%M#.=695-^RSD3>:)YV8C[N;HB)\N>O^A:B)7 MAFM(TS'^4-%N-3$%$QCL8$,%/HDUV]C8&K-5 H6PUMZX+%#F+$N*TIST.V)S ML[FU,=M2)/BZ3Q!BTR*+L4JFS'Z VINQ!85"%N-AKY77#20VVV][PV:I99;G M_3-:9098K:DA.TNR+!KO->P2;=V6MLGI5\&AH;&I- TM*""ZP>VL6SABDI2@ MH/_:PD#_<7?-4OF!@YW^O?1GFT_R74I!R0XN6'!.%P0;NH+:*"_<3-I QVZ' MXK3R0%47^9!'ID3J7ZG(5NE*)/>=)D,?CV[P/!X4)SP#BOF8_2MZ M$_N _*K@C1&*:2[?9Q1TCY47#] MF<3T%,4>"1Z9?.>+WUP2<'\HY>/8C=7?0A&/,D9<%3BRSA9@' HN/A>:=ZG5 M.)"I4:QP IE,.*-Z>;*>1?[9'VGPF$TF0;K91TFZ&1_-<2/?V8QG.M>LH.HJ M=*.DS&@-R<;(D+2OZ2PRD$;E'#+9"-:XXM6A!-/%U*1EO:L>9.-X+??<*W6V M($E,$:M:E%-5,A:=AC"K"FYFI(H&\@K?1U# &VI8&%#:4R M=W:EH:&@@LZJPC+ZK=M%;_ B>78).D5/*,1*L(!=3,4:VB,D9F6@\(..!V$]2 MR. ^IBSZ]HA)>($ :WV#M3]]1/)LH[C?W9&AU-;6%J */]9Y/V>>EZ[2D#EJ M3]$C05[ $Q;ISR'B8H[\V0J3)/@7_SW((PQS5U\8WX3HEG/K5"&07N&SE:)> MXX-8SHW-OME3M,+,ZYS/4!P'R8G[Z'JRVH2?1"[:\J!./JI3#&O:4WN-^'*\ M4_37EJ POAXO?,759>MUG#6^&]5 0:]MRVD:+TK%^!)[,(5 M=K+ ==L&**S.H77'+4"MS.$GZ6;&9ZLB>26L[/72]@&7S9[9CB$=M'3>B1M% M[GT0YQ0=IS$K!!ZCXA>Y%@.[(?@CS5J#&'+.JBTCO ]776^<(&:91CE+;H(7 MJH!OLHPD( E[F?+(MH!%SD?G[ECHJ0Y*=83("0XQ<7V*5,^H_;9RPMJ:C8VY13=8]E(N>G<\,B?9J2.H>-'<[Q,HDZ6CI695"*1PYB-(YM*'QPK58C^ +3T'FN9 M4)FGN=[6@H0I882NF6(+=SGN-A*>6ED+4_7H6SH8=LBVV0^8^^JBA[.71[J' M:#@$/[P1.00WXSKYP)-K<'(-3J[!R34XN08GU^#D&IQ<@X!OZB9]?,0D*2A0 MMZ=UG\QAH.'J:Z;?:5YLF<>)&/J7YV V9LA0S M=VW^\\T2(6$M\P]'0H?M=G"G&#WSV>;_\0,9%?NFI&K#-9N^Y'"U,"$=6NJ]#*RP$K8-AH9%%7*%5PH QOLT!F: M&\Z7[#)Q$CQMU=8=(_UMU4C/AW/X>$YYP(TM[FS&-&25\[<5&RL4-TR]AK:& M5DI!B5C2?J:JQW8!CQ)O M$$(_=1O)EF3RGE!.V5&,4TJQ@!YL!0)1++6H_?$*[ M5+AB'.S*:N\."BM5M*[@&E01ZZLV^?!)O@KS7Z,&>CDKEGH>F MMI8>(@**P65@!P27[DKZH#3+ZX2;#W76Q]";I8>KK)"8> M>6\*ES*),G6_J:T9^TLN82REW#X#;#\LK#R'.L/+TG1C=M$=1YS&GK4H(*"D=1ZH:;T.XY0MLW*(%#7M3%U$U&>3Z7$N60U"UQ M&%W0+8%0!>::,GN:$LH"I3_ /KP@U/K;BYH^&Q"$'0>\:T4W3E'LD> Q*:DV MU74CZ&(O DJ46QZ"N$5DI;I&6%M[T1"3;'D8XMRE4VC%K@.H@K'M,3)(*H0/ MXU+KY%PY6RR0QQ+BA7J =%]N&&9D$*IP8YVMR?5-EFZ$_/+)>+-T*2N7Z)G_ M2>@04.EO/9(:;$ 0?C %8;,K59:D\A/5 ZG$"8?G1F.WJQDO& MPI,;\D3"Y,0E9$WGXV]NF H %/>S'C4%\B&H/ID[$1]Q'"3"5)6LA?7BWR$4 M$O1G"\KR"*+/PG(\[T3E>+)!G7Q49SNLP\8U787G9HD)5]B9LE$#LN% !MJ; MKKBS0Y=R89VF7O;<"11" U;-@25A_2W!\2;JJ4B_?=J>L1#>E+9G9=1H2ML; M5=I>7F2B;?;>3G=#5_8ZRN&KL3*0=UQ TB6.]L2G.L+(\RP;V0'W0&-'T]@K M"NAK#)KU!8S%.J;Z E-]@:F^P"CK"^17A-=:EZ6KK<=;54# D'6[;(>A3$,/ M,FKY-X3$0^!85NH[HW@>,5Z$_L2?5,M[9R,Z.'+8F),O5X!'[9FRN/SU%QP]%#OU5S?)ZRQ=HT=WS0V2^>**!%1'?'3# MB^B2SMS;9Q0^H:]T&B\%!]->PYKR0VKI&OMSJ*#\6SP7_@NYY/89=S0%\M$. M#_DR8^->_)P3^F&!3=%NO ,%?<.:=1X8;5[.<2IPA[8:[C!!WW &*ESCP;Q4 M'KX+S.EP!XIYP1F$N;&["656U* <'4)"P;\WYT65YF-*GF!X7W.DJB5C3L\P M3,\PC.89!EF9JH+4&P]%+@FPH/Y4I\06Z,3G LSL[Y M(,K.X4,X;(Q2-LZ6LSZIOPX>ELE\\2U&LSA&22QDXJ.("3Z2,U\X="PG&VQP M;L[3A!+VE0Z]2E=YZTC(UR<17]F83CYHCE4Q[$ <\H\JOB#YNN)DT.YP).N*T MU6&@*/(A:V]*I)Z?UB*Y[S0Q\(9.TUS%,'56[ U?W1>I6,M-3#A9)'*MD6>? M"^4+HMHSFC]R0RAZX/K;-6)\%_\2UP)4ZW_WWE:34)\-ZYPM%:IWC2P8.6$W MZP&34S_,)M8:IR^!>Q^$0;)616C38638[-)MLW>%6K+NPP-!#^RIN6OTA*)4 M6%;IXQN1+;\SFI,/9_P&U&0/3_9P]P!=1!Y>H2V7["-,RL)+3<).EMK0*J1; M=_ U,JNT4BZF;GBI")Y):SLO?#4!UQ66OO]0#IHPD!>.7+&HG=4Q9E']]@E M[.9S1J(P:T"IKZ$+46J+!K=@9J"8YHV[0+^ZY!Z3*X(?B+M2 $38QU3*K#82 MNL3UDM^#9'F2Q@DEG9R]>&'*"WO$,7-P^;?N"XQ;B\'N MCH9VNNH:5*V94G#S#>RHV/5(B"/S'X^JKHFJ V(*S4^N"-M=$3'R?GS 3Z]] M%&38T!^VD-!_W'U!#VYX%B6L)E:SLX&VJC6RU+G01&JOS@2Y?#-20-.3-MEM M,;!30" Q#%#8K[W?M42MM-NUI7X0+S$/K.A $U?GV>7AS.VM.?,KCI/LJ MB1+6;Y2'L!? 5IQ8Z-S?=21B&3S(;4&B\".HPU'T&!TF.X2# M!WVW1\[,\]@%J'SC/7MYI&I-XTM]_$'6QL;VREE",^@B[/]4USC([18O2#$D M7&-O5'[!;L1/J3@&,2CRV*I-[<5 2#'H:C7F?2ONC7VCW<@S">B&1XE5<\:] MK3KCBL&NQVM)^/)HI[MK_!B7R)=C[?A''*?)/ M4T)-Q&P^\(?164X#B=V0D56QSFA#5N,".%'V&]1BQ+IB3L&'9^R:SIE+HHRK MFZ5+4'SLQH$WB_S3($P3RK/HQH[P(?1\8(>.[&1#_[O#!W?O,_([ M8I?;D#^CR+D/*".L],;2*QW^A0\W%5]R\D_E0MAYT.E5+I&908EPLE[=N]2: M/?LC94KNLTM\]J;:[_Q%M23.TKJ0GZ5]K1[3A*?];>:.L$3+QWI1UI*02A]W M$/^ZX_+/\TE2$. 4%#AL$3LE&DH3S4#-&DP8K5\!@."^ M!GZ"GZ,S-Q:_VEMK-W@,4T&&S42"<[!C4?Z&B)^*\QG+30:_?:,T"2OT0;)K M?;L&D-UERCZ96Q'Q/+I=HE-Z:LX7,X^J\S&7""!3E:YW1]9&W/58Z-H9N@<< MW'6Q!R:\_P$ 4^+#.@?HC2AX0OY<&U?Y,*,"5I4=!8]J%]OI"5ZM<,0I^Q6%_O'Z)KVG] 4N M66=3#]A&I?TL!D6#?@@%8V]WE?>#*Q)XJ'!K"]82U,5BB-1(A] QEGDIF%6B MV#C8R7Z$I,2#:GK7]3LT=ECASM9B)(MAVHLC"+N/QJ)ZDH"$)*^V]D: 0C1B MRJR=XA)37&**2TQQB2DN<5!QB;)'VHWC&<:Z^B0ND"KI8NI/+";?.P54F459BLZFMF3*H<@EC*>7]G@C#8V'EF=$9 M7D,^>*+M(>'DSF2% >MM#54W%:R&)F](E6+[]C W7LXBG_V')40^N2%+UA8? M+J(^=I\N;0HA%JBD-T!N<21N_U-*1(BW4JU!S)SD(IQP?NQ9-^Q:0I>FP_''J? MH#Y+*/PG]%B*.]U]-',*MEUI6(LQ,()KSJ]92NE0RUFY^VQKIA/4Q" MPJUSIEVCD+W8R(HKKTO[]FS%BC'&\X52OJO&(-;#I\N+=3ZXW7HB7]V$[A7) MFF77GZ+8(\&C&$NE[M:CJ,Z%=08>W\^/V8U[=H^>JM#9^W!;]>IXO6V2EXGA M)0&*[-)*"06>>5JDXA?:EDQYZ?W[UL^@ <4 3<&VB<#@ZWT>84\47^2ID\P9 M J61-K:U%S,QR9!\VR;Q[KW$>;%U,0AYTVI+>R$0$0S:<<8RAZ_&IH29G8:<>ED#'(I>3#TJ_:_%S]&>1G].D,8KGM,USU*ER<,E578Y[Y'+V7]NEHZ^5$X)].58A MOJEJB#R63A*@^,0-0^0?KZML:6*O/O!(9X$N@Z#_P-1\*,B<17Y&9^D$OD5D M!0,NZVD_HFH<0)"5DEB,O:%S[@:$5Y/-1!A=.JXA)U-N:7[1Y,8++(16>1&;BANHEFF8=1J;,9]Z\.&@".]@FVI6[F)\GBS>6CZ*P_.9A-3-F["1^O^>&4>=-5S]IJ MES_#"=LL)HN\?1590/;AMPC?QXCP-/>+Z#%-Z)\Q-4'#@-\4*3.JO(=W_D7C M)SB ME!9[USB5A[VHY]=(U$KC,[ 89-8]T@T,ZPP]+7PQ:EJP[WKOF]^\=!/ MVIG !^(;@NA#UQCUD:5L*$]V4. 41 #J[6\[!K&<,ZF<$%I0^NGPP8+8!@'Z MU#% E;(_IXC/GN )%0;'6J<<$MC][JVAU.DAP=03!GC4_=0QQ+?+@/BS***$ MD-@EZ_QV_,[K/4*0U0>X>_?F\&'6%0>L;YJWJ8_7FQ]_#2CM=.:NOZ G%"K[ M3(3]_PP.% 4!6I1)T^C9J[/0QLTM&,:XWT,%) 47J$Q05GHV!D1Z)#Z(GF># M[7$.?O+%G.4CY?!&O9.I.Y_M5B: )\ 6J'^;CVR4*'[7!KUW9J^,]H5>F2UP M,S:&7DG[V!"_35B# 13WNWMGZ,[D$"E#*JQ#0)>D8BS+\81:]6O&>U:JD(I@ MPT8\7YP77;=E\80ICI_>B%(\,/6F52& M(TTDY%MHFR3"4D?SUKD*/BJY@35I6)22VAY(#.Q^)H"E=G6A?%VC1\H+\C,=K,4\T!S(4)) FQ5;?6!)FT_K M=O6S. E65"TIW69J@;C.**;<+?OCKL9 #\Z8?6>U-;Z+X;1OTWIHM#=47>F6VP+5G%7I[1;),IY;U%,GJ MI7)G1T^'->COL_LX(:XG?4-,T-58\8V>_-"*#"M$L8;V:#0]FJP5N%0>XM P MUV3<.L?&S/-X"''[:(P6[DK=#PUS#::M,X*_8#>*K]RU-M*2CH>&L1*[H+)E M9]Z)_,A6ZW]P6&MP#6IHYAZ<7"!"=M_)VUQ D+[SJM+[T.!6YQD"N^W3@!V_ M+KJ1CPC?Q@Z'!ZF 30C%M@\0 O=N+B(?K:CXUINYU +:UEO>#!PB-B#8/C8 M+0R[%UG55)SZ!=A#UG TN(4P^S3,W5\-]-1'."P<=?F&$/W<,:+!(VJ!HKC7 M82&GPBOH+NBILKPZ5'\6F-I#U/%C2RK74-7A:SG:04&[EPQ V(UY=NKWSZD] M>XDC3VX#"CL>#.8Z[(+PEEP[MA34;E-"^].17@EMBTMF7ZP>*;G\S=/% GE) M/(_.7!)1^N(K1/CK%K4I45\$>J.86>$*-$KNBZB/8,V=D3;P5E:\KMS&=$=D MS&4OM7'9NZJE^22(T=<=M""C<:IJ>;"S:R19E%-5RZFJI7Y5RQZ?7]8NMG?X MV !<#^6OZ:.>I>FL8_/E+(=\.7[80GH'CZRF-, #KF.4P2J.[0IA6I*C;++\ MI=7YS$U9W+\'R;(FDGA7)KL"Y/*1I%YT_:6[=X8.[0X\,/W( II=YNVP_=F\ MB.,4J?ASNOK4-+UJPK#.BU2Y8##S_SN-DY4PN -V&3/>$J9 !=&"V$UVY:=I MPF835!BT>2L*VO"1G7?EX$UI="<;?@K66,3I%*R9@C53L,:^8_9PW.E3L&8* MUDS!FBE8,P5K3 =KD]NZ;?$EA7<8ZR&E4P&%M4>:")5IKN*^IBQ;:0"E^-C MKW'2+40V&PB=P6AIR;LJP6J,IX E60UH]\[PUMXRI2W,N6M6#^[;'9+VS(#!\U;Z><. MUN$':A4D8-TA-<5LIYCM%+.U%R*;#T?+8[; Z59SY"*ZLXLC>:R?K)OU 5A5 M)JS?\Y1"?V"XN194&VL F %A*_C &R5G)GOFQL(R _6 -ES4'>L&2T2EB!PVN!9[TO5LI$""?$"^_J-0 MMA2RN/$E/@AA;5ZLII"Y[LC0W?(.LAR M4&8/@K7CM=9 3]E- :PV2:]1 J3,ET)$:. \LUOW)<_NNF0;#*._.9'LIVHB M&>VYR0QS-IW_6N*D>VK_>16ZD1J][ZOT_O3FZ"_?_^JP$0:GN^']D/DBVX[C M7UA^(O*/0]?[_BKVEK1]3"A6C7T4"M/[/B@^)4+_E7_.R;_G9!^\R3_X ME7_0X5\TG?"W>5:FMN#J>WY36S-'UX8228I>M9TUB7BPV"L'43.G9I+J8I*4 MP*'_V@)#_W%WS50FP,BF?R_]V9A1#4@3-Q&I<'X,)%-0HRX(-F32-LH+-Y,V MD&G:H3BM-"'513[D=5V)U+]2D:U2.*1(V^PT&;P$##!9L8 \<'<8='OXZKY( M)5MN,GA,5B[9&GG@3F$LE8L;),?4NM]Y2KWD-3A>;YODI5]F+&&MG".7KC*= ML#!43H.GP*>J+?.D"Q28OC]MRN>BK@ -(H&NS7B[YEQC^"W;T@::>@(*_EPS M4":(8;1.JR9B=@*8G(@9!=-$+ L"/(8/8B+^CM@%5>3/GA!Q'TK9)@,>QT(: M_ER342X*ZP+7G+E[.?_W.GH)\UX?2:9?+]\ MOF=HU]VNBO9\':_KG,D""3U_UY[ 1*_3L[JI#X*F]14(.F9>G.?8R\?,!72& MF4$JJF\G>%EO^+?<"63W]'KYF)D,SSYG1V?S4(:033FD8Y^(5@82#V&R#IKM MND/$/!)?OFMN;.@F:Y_;!%;AN>NC306AVV>LCM"FL:D[JR8@VF6Z\ZBK$DBT MJ<9"*C4WYJ\R 52%;=!7U2=4YS@EZDAM6YNZA6H"J K7$$[FRDEW*I3+E'$Z M7Y1\:[F[;2#M"B;@[LA0$=5AO2=#"E,A0<*8@_P:Q0EE)$$^Y_,;_82X4.MG MD<]X.UKN'^?CV>DV5@BWM781ZXUMISNX?+,+8F)/SZ_&)RQW\K:93)H.76T\ MK/?=9B1+:[M5FEGK+]4'"(OX'(E34X7K+6>1S\[02W?5TIFT[]?,N#6;D=7, M"=E#NO9[),HF:)/?9W1:2ZF;9GQ?0K5S(Z^EJK;TR]7]<16I7",V M#>B?3ZB:15PO2=V0Y;6^U4TC'IS PUP2EL@5-)H.[XC@^T)\$5TA$F#?Q#&P M2\%ASNNA! <:8(<^<:U4<#1)G*9^KY(%(_^'MS9^XQJ@R4U]EX)I9N\C.&CB MOC_TB6OEIJY)XC3U>Y4LF";4;397?TR?O3R20+A7,P(&^_[A3-?AQ0;-Q8\C MFHL!V6_[[5WJ6@1.L[E'N4+3_=/AJ27GF"Q08%BEKA%Q.+/;D.R@&?SY8&=P M2E#5$VJ'5JU#WS3O^Q.K*''0IH"00NV2KF.@@]!PF'-[.-&!\]=LZ&8/ 91" M67T%+WLE9IK1'T:X42T^8+38=T_?Z]31.P+S_EH-*$YK/! M^GA,@DL<4C+BC"6EQ]P_']4"-J6!_O>_?7I[]/%O3C9@X]ONTS/F^E1/SYA/ MSYCKV);3,^8=6EC3,^:#FQKC?,9<]['M)O(L>FS[G4BRPSYCKOM _-#5WS4? MB.^E2OO>V@:SW^:+D@(L=J0"S2T]],1$6V=MEHUN:E-3B\+=_N:6_A2['KTHW1[($@3I8P MMBCN9,H?TW:E82W&(&#>3Z'$#D\^Q="?O664K _:3*$_\P?K^&>1S4?T%/K; MF6QGJ\<0KQ$JQ2)D^AK8Y>Z332&77F)^8MXA>#\9TP*NZ#"(D#Q$68U"P1B+ M^]&Y; AI55^\"OT*X2R38%VY9$XXPSZ_.'N%".=#%32H_]C $_,QC.M_SQ5W M$<>I[FK+^HP-K#KMUKFEF@@N7?;50ZG4<9Q0U1BPSJC:I?J$Y260)*!&8O8C M4PIYPH0JBY%<4 M^L?KF_0^#OS )9FWK"EJQ#I*^UD,@@;]( SF0GHA'Y=J_XT.S[,7]J/@%%+K M;S%Z+?@ 4;2LTES+"P*'_'26]?/0*D&!$]W>:#@4E=G4BIQ1Y66UJ7V-V%6K MWW!(APF#9'U-4=HCK+G_QT@^T"Z'M$&EO;B#<2B/"LWD>KJM+=\7/@%QX>+X]_ M_Y]OFP2]XKR(L_0_OGG_AQ^^03@-LRA.G__CF\\/[U8/9U=7WZ"B#-(H2+(4 M_\O3.P^PM.HRS_ M?'_5VGTIRVWQX_???_GRY0]I]AI\R?+?BC^$V<;,X$,9E+NBM?;#VP_U_ZG4 M_SV)T]]^I/_S%!08D?>5%C^^%?%_?$.?6S_VR\<_9/GS]Q]^^.']]__OI^N' M\ 5O@G=Q2M];B+]IM*@5D=[[/__YS]^S7QM13O+M*4^:9WS\OH'36B:_Q@KY M'I(B_K%@\*ZS,"C99]<^!DDEZ-_>-6+OZ#^]>__AW8)XE M^!ZO$7/SQW*_)50J8LJ$;^I_>\GQ6@PFR?/OJ?[W*7X.2AS1!_V9/NC]O] ' M_5/]S]?!$TZ^0522\$/JUY\'MFJE[UV#O<-YG$47Z3348VU/\$G;R+WFM!_O"9_ M&D#$;R7IP'#4@*0F%!&8/8%U#+7MUGH6#NPF-)IG.>\[[1F9S750/#'#N^+= M!'FH>16UQ/=A1CJR;?DNJ5YZI;[.LXT1C/J=90;" M?TN>6OO52R80)(X,Q')<9+L\Q%;?N.^-Z5NM$6X2HD$3-IR^^_SPS?]@8BA; M(R:(_DI%_\^_?]^9GL*EXF5=,(+\\+'JWO_IX>?+A[^Q9Y&,;I.E[&D__(%D M3N_O@IRE4R3*/[P$.?Z$-T\X'[DW0=\%B2:[14EEK>R=9%,1BTFW0I65BGHG MZ+]5EM VR-$KM86V9 104&L+$?(>1YADMT\)_C7(\R MBXL@?/GU)6O_X>(- MYV%<4)'+++]-,7/N=CU^":M&$M_E<4@$WK__PY]^T%/:-0)GC<+/JVV;E=O' MPVB87GP>-^T.!&I0G"!,<* O% CZ4OTCPAT4M,YRE*6X:NJT+Q+%!Q24*$@; M/1(;*#(J_-\8N/EBQ<&)T#U.V*B%#%?VC\39(@CIV+DXW?=_461&-@96>SNR33I_D!R9S!&(=+_,$*OC"N0*1 AA6F: <$ZP219TLE([LCIC! M>8XCEC$JPY%8U"6A5&#[/!+)@:&/ MR8-:UH,]4$)3#U!CY*R@CD7/)%"K-/ M%DX(#%-DR+BYH?Z8#QA'V+AT94"2H:![EHB \C3I2P'CB0":A"C-7 $8JJRB M**:CQ""Y"^+H*CT+MG$9)$K6:'1<$L@(?I]+2@4PM#)!.698IX.HTKN8L*U2 M@\.V>UP&<8JCBR!/X_2YT(S!Q,)NQV$JP,.QF$@2#*.4\/@Q626,&NF%&53D M98\]Y&\=<\A?"/:BR?L%HR^AA N.**!18@A^]LX&.2:> J\QW<%&YZSO\CC+ M4;6O9='!DY8'%:;;-4-4 ;K'(>U3XW5<;?I:1?^U*TKJG3"X'&#'':<.<+-C MW@0C0/@Y';DIBT_0V. )ZDS"Z2_O\FR+\W)_1[PJ5VE$YS*V%.+I_I$\5C$7 M9:3I=@+!V)7A?()6S3MK[;&.>7J=I<_OKN-7TN4^DG^/Z3KCJBAPN>P6EQ8@ M 7NY(UU]NO6W MVH#G+(_ %46TT6_.>N$QG+9G;7[PS@H1FO%WIS/F<5&27BY!GW!0D.]<=7'^ MTKA/<1IO=AMI>C;ZW=4'%\)J/OK@1Q ?7H1H_/%K&;_M^E/PIO[2 ;Q6VF6:JH'<3TTEHM[I M8H9O3)Y6&G7B"V^PSG$4EQ=O6QR6.*K^=IV1K+=@NY?89*9B>[6%MKO-U=8N M=5NKC56]$VP:7FY%A*F@Q@*J_U[90)T1O[W7V6ZS2T@*]8HOUFL"M)H_N%VO MHFS+)B+$":N9FJN^SL:)I@LTT?'.1$N@' 5;553IGC2SG-D:-?H^4V6M;_K) M3GL38%BIF>*TU3\.MII-;!HQ%^:<)IT*(_[2C?7/LC4=C:S+A% )MY\."@6] M<\X$';]7(2':65[QJZ?#9HOZ?[\M7W".RI<@14.E11/'U5,0!I]P_HSSLR0K MXO19GB;*99TEA3JX;0HH$_1.(A-TW'8$*HXJ>50KP E"9T'QLDHC^A\Z,_H: M))J]O2H%ISNFM, '.Z>DTMXY90R1BTY$D@4B]H>>#I1]O127>M==3\ U=Q2[ M[-I?07%#G091"H )*J<[$N1P4:Q"0LIJ\*J(*%)IEY300.[S0R(*ABQJ?&/F M--*H)^XD:]$D*GYR$U4Z B(B2 ")DXZY H+D0U8YS>HYQU@Z\E8).ONX2J#M M9Q9*P?C@*FC5:;;"<+J%RSB-2\QV=URE9;V]@^WN*$[WGX+_RO)J_[AR M9<3<@N/5$EO71BLHINK>"3D=LV"EA5BHM_MT-JH-/P5ZVB-FICXK "2I/<>O M.,FVM&Y5^))F2?:\OX^?7TKU%FZMEDNR&KK0)ZA&!0PIS7".B=AJH4X-57IP MHN>G(/\-EW'Z7!\4'CA5G[7'!#G(R48 MCI[MBC+;X)Q!I24W7N*MFIA*#:=S GKH@TD"N3@8WNDQ\JLIE08:J,#AUSE^ M*HVVT(@$W7:Q,J##7G4L!88[4FA\W_E4NMLIDVTVM)!4D-SC(+E@YW>NLR M M[G&(XU=:EDJQ4<9*34)KNC8<*6/J %464#,!.ILP E5 MI)?&>1HDU6X>VE$7A29HJ55G9U]-IA) M%8HY^^8*D.U'%\C ^.IR8%S)&W1&_N]GB%.H]'P<"4D;FG5I#CZ*15WV(BJP M_=Y#).>=,P;@A(<7'XDLHL(GB(I#F;9\P.&.]&$4F'(\+I!S6JY-!G-0HFTL M!(8L,F3<8;1*CO$$3G#YG!:&+!%*NN2) FJ?*0(Q,%R18QNSI96? I!<^MF3\?[Q-<#D">A'5Y_],GXU^.I]*?=##@XB/^1H16!] M<@Z7_(O_R=47?XC?]!^\)^3\>W, N<_=2L#ZVF-8\H]-))U];OR*%<<)A6+N M/SD/DO_HG0RPS\X!DW_X?W7UV2_H;6?2[+"_761)G#_C9[*RZ7MO#V753EP1GV76JWIDW#:_DK'OZ MW%]":?51;0#*'(9H#6GLK'JS@84!U]5_[1P;5P4VTP;#6FO(ALN! NHNV[M> MI1'>I'&YOXZ#IS@A?U#QT$S%6:]K"+[M@37RWMEE 9)?Z*NU4*LV.X4.CG]M MZ3)ED..D7$8R"<1^N!J)>&>-&I>\?!P86CQDZ_)+D.-Z%ZN6( IYIU/].MB# M*7^9,!CZZ!!R2P"U/.HIP.'4-0X*_)(ET=5FFV>O;!54O9%3J>%TU5$/?;#X M*!<'PRT]1FXILM% ?14X_#(NLFJBX'1H:51252\-AEO6!507+IDJ2;3I1K\' MG+_&=+1JL%%&+>\LQ3:!W>;7*F'O?#%%R&^*"%+4ZCC;4Z.K)Y6E!1DG1O1 MQ45:QO1>3UD%,ZFHL_I0&K!M'2B)G'?N&(#C!_B=.&KDE]UT22]>3'%^EB59 M'D19M>7S54JHT5J@XY*1!Q.*YO4.L3OR M9>*BR/+]358J]F48*+FCD*D#'8MT&D"(9 B3W^U']5"SZ:_31%35;R+T$+[@ M:)?@VW5U/>PG7+YDT57ZBJMRB?R_8GP3;&3W$QQFSE5"-8?33=)UB"WOM)[) M 7XVO5$^051TV;R-M2N6'UX5Q2X@7]ZDP]4K.0R8A@[T J9&PSNSK& *MT=7 M&7^C"/$P1O]J=U:F.P@UICH+ M'V(.TC1XBHOZ\4T!-MS\PSG>9D4LF6Z?9,'=<>9)KG5GFJW4O3-O.F:^?&-E M!#64[,RT_]086GK\<19L@Y#T^*OR(7XK]W>8O*FT#)Y5)^MU*@X): 2^QSBE M/!2*F8#D.55IH:!$__+#?W='F]L4WV5Q6K+C#>0OCU\R]:$"8U4/-#)R1D G MI1XT6IF 5='K_1\^OO^P^'F%ZW@3TT)(S9,5BS\227?+/DJHW8*/4 P&.Y38 MN$6>6ABUK%CZN+QT5IA5!+G$VRNMMU!52]G48@Z'07C13H8/,,)^6=7%IH?.Q*,;TLIF:/U]G8 MNSR+=F%YF]?+#I)95K&8J]E3%R6(#DBJ]76HON>M$6R%LE26PX%VZ@Y*$@GL8! M02$\B08,*IG"5)QT:11!K$6?[?)6P/:FZ_E\:*N5_!D8,?K=F,Y*+11@9.LT>U!!*.;+#TD'O'J$$*2S"F3 MJ#36A<(P6\"6L8E8F3T^3=M60X^CTD;Q$.(TR.-,ME]&+.=L(XP*9KO#123D MG5 Z9!QS:I%EAW"7\;K1 M&EDZ^UBIHT;M!)T&"1OK+1JNZCT%J[",7TDN=YL^94$>Q>ES!4<>LPP5G04N M*T?:Z&6DY9UAUE#Y*QJ8+FJ44:?=\&[IU#U8XY^#_"G+2<;VG <;';\T"N[2 MS^1I',)^V=&,80N8O,&QW44T)$ M:_%KL..HS+ZD%T%1?@K2X)F-Z6ZNE9Q* M"35:[M;'?L%)$BBN"QO^[HP8(E@M#?H_POCH D3C3UR)N.Q6C/H1GQV'OJ< M](EEL)1]P>*--X]VBD(SP]\=-EX>5J_Q=C_"^+("1'SCI2*+GT_8/25Q^&N0 MYX%R[4\LY^[$@0)F=[1 ( 3CSJ"0]LX+8XA\QL#-%U9:<"+( M91#GOP3)#I_N/^&@V.4,YF6.?]_A-!2MB%II.BWC;N[*H)Z[7LT[ ^VQ MG3AJY:%< M:ZU4-9W-/S 'F/"+JP7*+*405,=T3 MU&J #(BKHL#E61(4HC+R!O*>@I\8MB3D#87A\4N"D$O0J1!B4N""VNF^_>// M,<[)&WW97],+@LQ8I53V1#$#AR1\4VA"))\>KCR\H5:'S1G=K'X!1\VK=+LK M"^;2>[-N5J3AA81RZ$+F\>+PZ";%J.I"*Z43Q-30>X =:<^MC]8D^PB%9!_M M2/;Q"$CV<2+)/KJ<^C2;^?0Z\6DP[PF$#6I>"?IJV5?%.1CNO]]G#[?8WIU%HY6&UH& MKW7R/"[")*/0E9F]M1679)SH8I^#B2!10/X#];3*1]\ MT-, NFXZY0,P\NDQFD^G?/ VM)XPHH8SD+8=/P-AD 5(F]$RF#C5"YZ,YH_D M68IAB5S<9832@>Z')YFL=V89 E0-/9@\H@I0QA]C9R[>:.'D M_E<:A.UXPT M?9),X8J*;P(UL-238]6R\ 0URHAI.SK=8WRHQ_=9'K,C/!"W75N=N5CJH,7L M@>GA)<@G1"5>S6=(DCFABD=C'>\DLP1J$(F8IILP=/&VQ6&)HT><;^0Q2"3E M+ #)(;;1AQ?QS@HU+FYFH!9$5!)NT&&4_"5+R!A ND)JJ>LS_"C=4<4@H:)W MRDU!:Q"-JCC4Z<.EYWU<_':98]Q4>KLG7;D51U4&?!)5[YB*K7)ML)350C;@ M+;5!SQY@U%;^HV86K[DR=@47N)0G:H8Z[BJR&,+O"K1H%+QSS :E?K*"*&7D(:GV8[ RAQA(BINJA+=C 21=RZ98$Z\Q1 MI.@S<,H=405.7LL[3:VA&@3.1G?>?/!@,J[H:IMF_6HDXY)B0GA]-@T$P!!' MA(K;><[6.2&M0UULMDFVQ_BAS,+?%$48#.2=[@S2P1YL Y()@^&.#B%WRP7M MW=Z=!@6]5Z[>U;NB*PE5!> 3<.48&&"&]RS;;'%:L+W'[%^+U:Y\R?+X[SCZ MG$8D"^C>P1UQNCC=#U;;[JF3BL"UR)-<4GO!5]5O% L\!DQS6LXW?CY]L);+ MQ)O!>_R2&9*A)^F' M#!Q4,1E:,8!D&&/3D(&(NR4#$36-#0-93X3@X4HHT0E") 6'3D<+JN"4&/1J M44->]$7]T(('*V9%)P>0%!PX#2>H/)S,_1X7)8%5XHBE2I_3N"SN'SXK!XD: M'9?9M!'\?EZL5/#.+AN4_'&F1@=D\%J^-67KR2_]', M4TFEG0[9U) 'PRZQ*!ABJ?%Q\Q"M-&+BH*:V1JXH(Y9$UB.)Y!%** B50.II MK#%]X 2AYK[KQ^ IP3)71T).V2($.*#)0 (./T2PY->-_Y6) 2+$=9SB*_)' M:81;N-G5'.7*(_]G5_:HB4,WE MJOW?O']S"2#N4OA:A*47CC_PBCPX8M6(D^!9 '_TNZM/+(35?./!CR ^L@@1 MMSC:R" JY.LSG^,BS&.V(*#R8R#F_*,+0'+?OB<#BP(\,#D3>K*> OL]?H[) MN+E:06IZ'$48D\B[#OU*V..^0"@,@C0F"*6]15\)M5J>>+1*TUV05"5E%(X. MQ5RS1@1R3):^#"B."(!)J5')HDK8$R/^]R[(2YPG>RTI.$G7O)! '5-C) :* M'6)L4H*TXGXY\I@':<$VN&I)PHLZ'VY(P')#CY$<*)Y(P,F')*V\7Z8\O. D MH=M=@E0?4$3"KMDB!SSF"R\)BC%2>%+., U4J\"A#9N#/2=IDJ&S/7F?Y.%@ MJ_C3"H.ET!BA(8NJ"72JYXE)=SB/LXBDV;F.0YRD:_9(H(YY,Q(#Q1@Q-BE7 M*G'$Y/V3Y"*-C"C2RODAR BFF!ZU$$!R#)'IJ$&D?1+C,B["(*FP7))_&R^O M:&1=$T0*=TP23A 4463HI&2I%!K.,!6OA/E/'.1F=.E)^B$+!U5,E58,(%'& MV'0TH?)>2'*VR_,!:GF/(Q=U11,=V(8G,CD01-& &S.E%A\0Q5,/=)&6<;F_ MC!-\LQ/L$!*+N.*&#%S#B?'O(+@@ <5M>V5BB,JA2M#+EV]6"=+R)MB((H18 MS"T#Q""'+!C* &*"$)B$#9TLHL)>&'%&(E,>)%=IA-_^%]Y+_>+DW')" G-( MBI$0(%:(D4EH40LC)HV(N!=BW.7Q)LCW#W&HZ2IX0;?4D $=OV1 2//1PM6/_DGST90T'T&3 MYN,DTM#CZCYI)L_9E]$F[.EDEXHPT,5$J83@T<7#IN.+%2!YC-4Q2=- M6&)UF]_EV6N?-B%N]+S&FBHIUS:21LQ/ ME!F"%(>82@8>28; M,&EDO9)B;NL*(/D_XNWRH&X6-@+/82 A2092,*CB@B> MCC"5#B)*/@;6-5WI@H;P*-GH=V>KS2)8[1)S_T<0)! AXA:3Z]F32LCU9Z8< MS7$@B0C#GYU]9 &H]AOW?H/QB7E W!=F[9K(^&C(UQG=(_62I?(- KR(JR\M M ]=\[?'O(+ZX!-3XJS,QQ.0\S<:_E3@MQ.&[]YNSGGT,I^W(FQ] ?-TQ&K[< M6?V[XZ_Y:QZ7Y,EGV6:S2^M5'M&^08F_"G@:J5!#3\4N; MJZ+8X=R*/ (53Q22@I<0B9.'2"<92"VI*D6?W'K (;O.Z/V'I\>XY(K0B46< M]4D2<&V/-/H=!#?_CVZ3O4:#G^_#?98QY$I$M\V&^>LD12 M?4HHY8H$"H@-#P0B(*@@QS5FPTV&:E%4R?JH3C4 *W!G]+LK @AA-9]^\".( MCRY"Q#7^P;?V%/(OWL(7>I.(Y$""6,QUZ!>!'(?_O@P("BB <8.26A0ULCX. M)'1=UK,^"7CVE@0\:Y* 9XA)P+-I$O#L+0EH'EN5""%QZ?8IB9\#27%"I;1K M4B@@C_DA$ 5%%3D^:430CKE=QQA9# M\"UQ-/(P.&0&DJ-3I=;4,FP5NU*7KJ?2JPT8O^(D^5]I]B5]P$&1I3BJYE)$ M*T5J>;<[9C2PAYMF),(@Z&2"4+)UABJ]^XUJH4:MG@GSPJ1?LF27ED'.SI+G MHL@DD7/+' G,(6-&0H"8(D8F84@KC"II/P>TJ^H1;9)% YZP!(Q:W/%Q;27H MT:EMH2P@SB@!RLYPUS4_NMRXTO)TQ++$>1"6\2L^#\J@QB;U5R;N^E"E"O3X M-*5(%A"%E "EYR=;'5HJ)F@XY:UD3'Y&4JWG3+%+?"3EOG ,!Y&O'=.* **' M")>B@DR.&EDO7'C8!$ERNBOB%!?RCF@DY98+0HA#+@Q$ '%!A$O"!2:*&EDO M7+C8X/R9=&\_Y=F7\J6NSRKU32+MEAM*R$.."$4!<46%3\*91@55.DU)73_D M>>L*BE=5%N6>"D0=TT8*=L093@X2863@.+8DF%V>>I.5Z#%#GPN,RA>,V';6 MB/Q[KQ)\9>WCD@!/<)(@B*2%)[^'I-5 MC8ICUMP2#N?]<1P#0>_2DYYVT*NX8I I^(9'.GD0;#($.>844QL.KIDBNQ?1 M9S6C?G%[>8HW$'*<&0L CA+CG@0(CDAAR=+B_ET!?FKG[9Z2.+Q,LD ^RS*0 M<5PQCX7[GP;I;_EN6X;[NSP+,::[K(HV6NGF MWPRUW7+&RJ4AFXQ4 ?',!J^$@9T)U+-QTNNQ?$[FT4WCM)I;%O[V\!*0%WB[ M*PO:@Q)@\EEPI9+CY04#!T:+# H-0-0S@"E;<&":B*F>H$H9];0]C<^*K@H@ MCD[W]WB-Y!ZE[B0#WBE\"&J.RI4FJE41U271(AA:VJ UHF.GCOY*#;#9C\(_/5=%@8D2(8QMF@Y1A(E! 9H**0_@%WZMZY6"]6%?N3-3<1K+ M#, /0II"'@S/#$!R/6&M@O)6QSNQ[G*\#>+HXFV+TP*K&261=4DE)=P^AX2" M8,BC0B>HCT%E$:Z$"_3/__1O']Z__PL*Z_Z2S>'.?,9M"I78#E%^24EK8?5I)A<%02X=0$)3R'1G*Q;4>I.#4!$S2G]- MW!%UB$I%, RT0P=8>(&)5F0]KO*$Y3B>1>HIE"2>308U4C>@DC0 M)=GD0/O,XJ7 T$@*3;S[IND- Z;AG2;;%>;FGL^PEZ57IO,:6.D2Z4^D 0Z7B=L2F!S\#9+0$8T.U US@H\'W\_%+>KC\7F(5/62^MUG&:\9C 'R0_*@4P M7#-!R:5$C0Y*J!+*J18J,[0C?P&2(?V49=&7.)&YW?WLDD-C4'VZ-+^!8<8( MT)@$S<_>O_1EG,8EOHY?<725E@1B3+K6*B>3]V Z)9>L,'.@SQ6U!A@&&<$< M\ZJ3K$,)C-[KG.[IRJDC8;;!C\&;CF$J!UI'>V&,$;XH3T4I@NG['C,R]9$N&\ MH%-,Y5ZS<=%EDLJ53@QEF0UTP$<82,#<7?;4ZO;J^>KRZ>$"KFW/T\'A[ M]K]^OKT^O[A_8!G-O_X%7?SOSU>/_PF)JV;;:E4*GOAHL,%6+@V1J*"J* S M4*1WW)+7$!=%EN]12I3![OUO5G!HF2O2G;,;5@P#F)FJCP4Y$V=$2W,J/3", MM K7:XC[[*((Q8:LQ0L-]G^8./1@53:^>9MLY&!1!0,S]3XU'NY(25GQ@3R MS1TSVGAFC';*WI@QPYW>U_,Q1K+*^VN0YT%:]AXDW1Q@(.]LK=<$=KOQSC2;C^98 =.0J5PTSR[$ACQSM1#D5OF7?V- M+C RKW.R"2IW TNNZVJ$=ZD M+ Q?9T%ZF\?/<5I=*HLYZM@J.TORK!UJ,SYC3>^^LNLOK%)]A5)5K M%4HZ/KDG@SHZM#<6 \,<.3;!YJM73 ;V] 3QMM%"1757R'_[PP\__/ >;8,< MO5(;)^C]R8<__7!"_A45U3TBP:Y\(6.TO^.(_/C^/8ML[T_>$ZU:("X*NK60 M_GO6W3F"R'#N$WDY+^CC^Q-$V7+"1,YQB.D-;TJEZM$)A=;F-G+ ?&5UEE/W3GT[^2*A& ME2C]_O3'DS_]R\>3C__ZX2OC[2J*V'';(+D+XN@J/0NV,HXQ2%E8)W&MWC,J"735P$>4JO+5N%X6ZS2^A5 M/O0:BE!Z1M9$T26YS!WI\TRO!89RQE#'[&L4Z9PL%?/..3X+-DZ7?8\_S,8= ML&9&I/C$$R2 AQRZTY_ZJ2&)&J3SNII9-Z$.+,(9HM7.S[$\## ='TH2?.GL MS^WZ,DZ#-(Q).E!70='.L)BHNHUUYLX,HY]>#TP?:@&6GXFI55&V1JTR:K31 M7QM]_U=R#><*[H+\-F?H(S;\NL,YNS'4:*)!KNQO_D;GD'Q*1Z8)AI]6<*TF M?MH!-#!V5I?7KMH!O-&+X97\L5'F@)R%8PV@[)/ M&(=-S\#DGU7;&+(XJ4T M"KY9-P2N8UPE#9IM XA3F%;-\8%DF?S>=6,MWWR3W+QNJ *:>?J[UTWHERUT M!_N!"QN6*:"1IJ?E#YODST -#"?-L9JMF\#)]WJ>&29[2@U/O#-)\Q3B$'EF MFN )^04OL^,\4Z9U4FFO_)(G=!)1N+Q2IW(J3@')X3B/] F<6L4KLS2IFTH> M+L<,DC85T2!E:U4U]W:243-]+)5V>[6G$O+P8D^A*!AFJ?'Q.\JI-.IFA '- M_=[C5YSN\"7Y4J("7A=O8;*CA*<5>^=L>\ZEO)B@TD5 A[^7PE0RV\-#56!@,KW0(Y3=B74 I.'FQ MV2;9'N-3G.)US+;TLZ3A-"B&M0(DK\!"WR71K-WJ$\]8&0P1;1$+3FBT(M6E M@+5!]%1;]$[4GPB0/$B(9ZMH$ZMFOM!G M))1YC2EC+FEAD""]SFB"+X(KDW3V<=50V^\L%H/QR978!*VY$D;?UBG&=VB= MY2C,<127*&&ZWH,_E^";#@0\#ZN,AE.P=L/*X(FWOV;M2 I,HM Z4,U[4?;K M7.U+>N$+#U7(F$X,*&AG$.=L2<;ONJC[VBC6* M.F]S76 9%U6V9:/;O!1E]KKT$J&A8-\ZWLX@\-N@-(L0L?ICKA6CTM(OWR*UUF. M*[G'X T7%V\DL\SR*$Z#?']5X@TKBTR7K[,D86^E"MW*O1H+/=']_IE%7QV_ M!V>1Q\$:/"_OJ*C@[7#XC9[8(^I_167P!J2E$G?K>%,OJ2I?HD#:?0N10N;9 MS8E"&0F9P91L-"/L:9:KO;.(4%T[#3B2<9HXB. -DH6^ *RX)8*FCS3>&?$K MCI]?".U7KR2\/N.;':V:=;OF=NB>!D4<2ERWM.&249/"=Q$U1I>:LE8JL$EFGN\!4< <[OD2"8$BF0C221I,^=QLB/_:GJ(Q-H*@&BH<]$@'LI,@"'K--R38F)4V?1. MZ''[K'TU;,VMM,_(.(*LBHVU*!C"J?%QUY=5OTZ*C@M^C\DE]#XX_0[D-<59 M]% &>:E*T14X^?Z*_#7TWRF9=CN>.Q:CKL-OYV#*$<.>H"9([G."^8_ZRU9&J]@7=U7:[[M7!>* 7C:EN,3G0IO-:GX>ZS\6TJ0;!=$)S M>"&NI,+V2&9K='=U=P&\#51->N9&8&P40"NP? $&S<#0(O1V8.>&<4,XBD[A M'A=E'H=E74=I12\N_2F73PM/M 6 _F;NF@9_J2'H9#="SY^&:.2KZ@MHE\9E M@;ZE,SF$]&7PYG\*6]FX9Z*YUA@ GALZ;!S>CY;I9O G4!U,8._V.Q6/F>0V M"_86GL8G;>\Q&?@6<4FZ-W94K7IC]SC,GE-F176-SO*/=7NAB9N7.+P99=EG M@FF:CAP5WKA&ZP5UY\;#K% NO,-9SW8[::;Z>F)"UNCR% M'N5>KW%8TKU"JRC;RLX13+?E[%S!H>ZVYPRF&O+.OCG0#3O% M<"?2 /Z<1SK_059+T^2SC#OW,8A'$ ,S<=:-AF-Z< M=T[/YX.H6"E5')P!W_5T?4[93-[Q]-'#;I:+5'E<18%RPGXG>-N'?&PRT[UR M*4CX&XC:RQ7/@N+E,LF^Z*KWJE4\77\I!2^Y]I*3]QYY+4 JK[FD2HAI02IQ M?H-+"HP56HMP=+K_7.#H*FTK(:W",GZM;I_5E!J:8,CQ8;:)CHY6""RM@.'O M9.C<'.[JX6=T>7W[ZP.ZO+_]A&[O+NY7CU/5+U>/5Q$1Q<'"PPTM7!-(P3/'#G,9LGTBSS*&]+W3._+.GR]DS/ M 1//%G1NW-YZCZ*3 'GS,-$).O([_=>0]O;;^LGH:4]^WQ7L1,EWO;*408M M&3"=M.!SO"6.Q6R5GOPYP>P>[S1:;;*\C/^N*N]OINJRA=DXTV\Q)GI@6H % M6.Z 4T^U*JS>TP%3YLOJC@D(%TJ8WQX!_*H(JWLA!+M\H#"HWQ2ZF3%:=_HV MCY_CE/U R\F3?D/6SUB9<)I&3'!ND!Y8Z$.K_3(!.]>K]T->?_(SZRR@-08P M&32JTGB.G^25A@22'FMA]J$JZF%2,6A#,3G$0\IC+K5:V:C$?H97*E08IMK.VT MCJF=2X.*IF:J8!(B.[RZKB:G%N@?R)@0!=2(DI^+QNN#J\+!V2>M0WA82;@E M&]*\!8'!A',[N):U@;U'=$*?G,:#U5!^IT-\\;&S <:E(2\=&<<)0 M&U+@L(,LIFI!N=J;W6.!G4VO],I8^Y_IX[U=A6&V(TWQ'H$GF=?1-5 MOUR5.Z-F*:\';=!K@9G+0&I!.GE=2Z)__J=_^_#^_5_08QY$_J=J3)R[QPE] M1W=!KB@1,<40-,:*';7E[]#*,;)9Z($-M_/* -H2"WN '!?=-,Y&%<8O36'! M+ZNUKJGI+%6'SV,==$'I$B9O,!3T1-.['&^#.-)=PJ-3\TM(L1-J%@YUX%-/ MB)>_5I,)@;KX@N\*\AU=K:^F5KL>0;Y08VO$>Y^O=5#;WTLMP">J 7I!/T]5 MR""KGF_O^ON%CE_PL$6;Z^^"O6#(-,6 L\,5DQQK5Q&LM*%0<3)R?N^$Z)#$ MMM(!&$K9]9)G.P(Y+5D68CYP$JEZGHB2.J.9@N+TH/!R F;Q!:)A)0DWB>S[ M<]U-B$UZ'P-].)04N&7.RYXRM E\6^!JAD*ZU$\^"U'W FQVS'H*8ZCL/=64 M.F0VI=37A$]-!6KIU!'<[GODS8%3H!(KH AZR.2GT 3@=283W%+2UDI',]E9 M#^"F]/TB5>^DE3AC-&P_JLY>BEDV1 <\LR2:G&T#/OG(OVL^^M M"?B$-8$OG86?,3TUGE>ZP64SKW"51GB3QNM8N)_9;%;#PIS'.2=KIQ4S4,:V MH)!W)C]$9T/;G>QQ9P$EQ 3$K>WC%U 7^M^?XVU6R$O5F2CZC<(R1]2!=ZP% MA:[6B+E30K4882>3\TX]\P/QDE=A8P!FJ0,1)+ M!YLJ'D[X?1?LFZ+UX>^[.,?$?](.R_T=\:EOS MV%P;VBJ7-7)N[PH!]4+R#GH08%OKLBW6N%%<:,Q&@(881P6M_1T!BBJ'//&UG*'3H<.J;^^^!N 6I_?5@_?10Y MJ!RW40X:-^I'D'E6YR1GR#R5A@ PVGQ](UGEU@RZO M;E8W9]"RSGZG\H#3.,L5)1=DPBXYJ@;L%DR;_"7=T M I2$T4U<%%F^1VE6^E_>-V]+!S=&J%'RL.AX%/V]'+>TOZ^GF="Z4874UU,? MZ?^G8[/7(,'LB%9S/2/]@8S;AO_0DZQJE//3QF&RHQ69+]Y"=G;VGL2$ZAHI MR;MV#<)EZ_'S@OLMT"T"6*W8B^^2FJY,FP8"%A7HO ;[ ^X>>-S1H'TQYW&Q MS8H@^2G/=ENB0?Y.&@H9Y>QP5,_99]R\BA\(1Q,))K[* Y?,]W!?P4 9Y MN5@LF.8_-TR2M?QVG]\3?H[3E"8)=!*4.>:I<,T_%%T!7G#AQ7][PF+RHQ%5 MW925W6VW";N7(4B:JQRNTG66;YBCNFLV3+6=%IZU;A=* M3QM%A.=)5NQRMIK$V+LFUDCZU9KS3M;F@"R]JEMU]GDDY:/FYPBBJ-YG+0*& M3&)*-=L+=7-_I#)*M6X,))%-E,,RS M1MXB5!:T,DBTD4?/'4NNX:078I5W3QWF>4/N"R3^BXD.C%[^Y3$ MSZ+JI;;*[BX7M'6HNT?05-,[TR;!Y?K+ZNK+F!E@577+%XR*U@SM.-FEF!&Q MAK+6W$)$5%TY+W)?+>^,;B:P6X:IA*'L!C8%R@T56A6$F0ZB;PD%M1:[)^WB M[-I['UL?L:.U(+(D#@TN)5(H.+T30 M\< . 5-I[]#*&*#D=26='&@U(%^Z= M[HHXQ45QCHLPC[?UE2VG01$7M^L[\O;HT(3^ZR-^*T\)AM\D+V:*(9=,G.YH MGZ'V5L P=S)TKGA"_ARD3?5P.L_26$;=Y(QW7C_$S_2@44AW<7)-5L=E4V6G M4RI6#@UF5(PTP?#4"BY_;RZA,TL">X1F)'W8;39!OJ>_]9Z !.%YH5SQO)W= M:0[4G9&&$D=UDY%TZ':JSC)(2V?:9-)0SSL9)X"5UN4:*"U%+A' #K\LX%GJ MNJ.7I3L=OPP500U<+$&[(=K!/?!/619]B9.$)!E7)!"GS_%34MU04G2^:88Q MEC9<]L>3W.MWRU8&O ?$0U"/"=O88/UR9P559E!G!]) R12J,-MY)P8&'K) ML?$[QUM)2)&/G6.[R4HR^J*EZT@S8>43>VC- ^!$6RXI=Y"[?5).,@2&MH>@ M'Q.;V4+W2Y?'[@"UI6I"E@NWI9;,!MEZ;0_C;%.7!$-MG:IWSDW#RV^+&*BA M5F^QJEEBF,K!MH&2PPI8A@[TZEQI-$"-JTW1.B/2X?4G9-4)-'F<@9[3:A.F M;@R*3.B4O(I"R@BE#IHG@G8F0)#3,.VST8=/6?,D M[ZY?_:35/T$WV']MM5X=X_UC;X.:=OBK4W,[%C9S8C@P5NN (: A4'[(7)68 M9GJHKP@I7LJ<,P^75A8@D-(P6%JH@Z>J>:B4L]8[5>DN3./E&9FP2P*J ?>Y M)I8$0RLE/'[-[ZD$NE R]$,7V*32_CBD#%@24: LT@6BJI@)>JC+D]QUY4EN M9BA/HIVFNZ:GRV5)F$;6PQ2<&*Y@PFTHZ)T;)NBX*5LFY#V87..BP+@MFENA MTBXR:)2_1;!I>/@5GVM5YC_:JC2_$ &HL0$JJ-,[JAX^FZH#(JADXFNE"BY>6 MN"6T=;9%N;V&%N>76#8V(TODH00G"ZRNV'-X6;!LLXE+5K1SE=*MU30]Q2D]X&$\ MOV5IPVEAKBGN#4H5V1CP'N@.0!#FM#D=K4[+Z#9JH*Q=W24@=Z#[U9+)@2*8!.*93 M(XZ(/&(*D&+AV!E=V%/(^R24,IA)A<%22A>B>$XM/HB]S/(O01XU5_2LGG., M%9OEK+4]#&1-71(,976JWIDU#>^89[4::B]F:A47XIL,IW)(:Z#DC%W&#K2D MTFJ &MB:HO7.I([[OP9Y'J1E[X)SLYBETO,0K?1N".*47 E:A-(B'3.J5D#7 MB]_HS4-3AB.EN#/B&(!N^:*0!15\]#@=D&2&JJ^T+&0U2$T2=A"L_T_J\9RI MLML:L38.#4O'FFAZ#U63X/('85K)$T34$=-'O7^&-"ZLZY4&R55*(.T8/O/) M,6-MES2U=*G/4T-5,$2UP\OE:HTVZJE[9^15&F8;_!B\&:\X*#7(Q__J 8B*D"7!00NZ>*<6L4SQ901324/F62ZV$6$O1/I+-ML<5H$ M=57(>US&.1Z>_]*OE9I;<+RR9.O::%G)5!T,">TQ\_N,&A5TBE.\CF&E>N<$ M4_^^,/[;W_[CIU_ M]DXR>H956C)$)N1T14D(<+",-) 0PXA+&[!B E!BCH/)2'N2Y9$."\J=/24 MC'GJ9:'OM+*PK5N#XL*FRE!FY:8"YXY.]?39O6+_^A=4V?'/T]U3@7_?D<[[ MXM5@?DXN[O;*,#7HX1UA8EDP 4X#D+\%K!%'E3RHJ#?R11OEY/(^^:2.8C)A ML(S2AJ>.4O@5Q&18?=/ J*;[OOI?[>T2ALI.;Y2P!.46':M\UC();G$ /LD&DJ (8L0UI@41(A2HA5;:!7\.B8) M642'&FGT4T:(>T9??)ZJ8XZ=JK/5<4MGVI5R0SWO!)H ECM7W&BS3=!,']4& MO$><^O;CT9W'9KV?H:[KB^&-W1E?D:U5]$[&*6BE]U"S/_34_7.1?E]Z^)3V MQ?=Q\=M9CDFSH7^2SB@K--S.YFNA#V?OI>)P.*;%R!_WZ&FPY(H*^Z<5PWV= M%85@,=\PTEF9<$J\":]J E]Q_.6?[[\/JE##FK2MZAJOY1\B*4 M&DZKD^JA#XJ1RL6A3FQ)(NE#5M^F K9(D^T*:#SW30&5H@\*% MDG#33#F_)V&BL]PU"99VP 3( \!S@;)18==:5Y$757KHV]79]7<+#9)O<-D< MXJ=(;_/XF<1ZFEE<8ER=22TTO?'5[27!+;[^/FEO%U_+NK[YYK, MXCJQ"'03C#@+?),=; .AM07O;#P(-KR'^#L8(_[!#O>"3X#>.5U MFLVI,VCW:+(J%J>DW47]#=>WVWK;]16;I"6>T^Y'/=J?9,GI;IKIK@[VV=B; M $4K*I75>"=E6?3)4S#!C,*MJ=XSQ^#=C01A^ES'5]U;?3NB,KZV3;6[J#7@/9B-:XV:13.MEL_JKP;Q3*,";?^.&=SER\+.5U3%<'): M*NZEF(K))+-$UGL<,P0H+]/CG3LW^$OOF%2>I>2/835_8C.19F_&)=>F.MGG MH*T-,-R<")R?K:#3Q717%CN1UG4WT4 9I1+KBI0:?#^$+CG8)OEV?[4A. MF987;ULS:-FJ,C_8\=O91]8#%FT,[,NN/L6R(;V3 \4M'!.0V4 ; M&FW-(2L)^D)^P2A.N^V.9W,.O^>H>!J7F"VN=ZOC]?Z239:7\=\93MK T@(K MF3R/2<>U40]V?E0P=;(][_R?T0E5BZC,(V8?XH:,-@#8VD.5003N(%'_^$@_Y[I- MZW-XZ7.'UHS8AYET2?0YG.\3_Q![8!K"#$ZH&D9W^(C8KPYU5/873[KIR>5[ M=G>\3:8MU_*07NM<$.34,A7O?+/#J:(45465KO=XVA\9/)6]$O'FZ8!;KO_JJ=&IY@ MQP]!+=T4\]70"$#ZVB%7L7F!LW':7KE^YCJNCHL6TWII>FU;%P6]N*D) M[_0\#+Z&GCFH":)NK0:&F! M647)U@PKI##C6&:Y$\63SQ)#.T4\[?PP'$9:0]4047!^V#L+>ZM[64)@9#G; MY;6BNUB?<7,3_0UA@>1GMC(7A*SX&&N=VF1HO@?YR67G?E'B9'>NIX!I18NY MQF_=[^FCG@'6]/I_K\Z2EB^D4Q@J_979]U]N?88W=1VG^*K$&UE=XWD?X;;Z MX_PO9U@N\4=786YV']J/2YWCPRG9!VECPP M:K3(C;;V@)'Z8D.F*XT-D8K:M=_0\RN]U'E<%G5<2,7?HK?-3C=>WCLI M+4"JB/> TSC+R7_"'=V7?$=>6%P46;Y']!I#0'S[%)2[G)V)KTJ!/>)\,X&# MIF;\\-+.23%7S6P Y*\5<+MM&RBC>^^?EC_ZP1[RB^5>FR !F?]AWAN3*P]5K:ZJ M'+I@M>[^;L*A6W8[/M6Z7O9]FK@CW/VI4H3&2B.TZIV@M&;M;;]F[>)4&S20 M>WKO9%*WD,LL;T>CU;4--C0\Q*X'BA[^&@3TG6X4&K4/]D1Y6(H91[7U.LXV M8=I[AGX>%\'S2D45INJ.NT7)2-.X.J42:*WGD[!:UR2:.S0T:/ MM17OG.P:YKB8#+U%."1YSWF<[&@B9#=XM+3F9PPYR67Q4-+*%!AN'X9?Q?;: M7E=CJ#A!S"9;GJZM F+_KYAF3#A:O9(>Z!G?[#9/.+]=5] MN6]ERP_S)[@K MYKV%(8"LMT>OXGQC#=7F:N(/)EG>U:U@!;(5K-(RCBBJ^!6S>4XVQW3Q%B:[ M"$=5L>#-=E?67>$X:)@WD?D>Y*?]S/VBQ(UKKJ< ;'DSNZ:U__/N. MW55.ZRY6M[BTI62;9U=K2;VG][HS!X/H84G)%4D8<;4WS&;$;&K$Q_#8SD'1 M6-C,@G?2'P1;.FSX.?+\#\5*+.W FB!M^5V;O&Y F27N *9F\Y_TK*;*-\ M)=>:K>0'6?3;,*Q=5S<.8W. &XBM#_,VDNOY-H#/. II;]/I[NWKROS7]^-$ MM^D]]3IG6XN*V':,/LLS_(P]9GP]XF''# \ T^*6\$J9FW4W.?6OBNR>U%SP M%-&-%NW#V*R _Q6*]AV=[OM[]'[*L]V6'E7753(T5O=R%YFA4\*KR#2Z8/AN M"5A9N8V,C/>]>BZ,R1V_B[HZ(:V$%22H5S<&#HVK)BAMW*9T-C;CA=:63@KI M;6@#'LWM@-M%[J.(U(:]677P,!^\':I?E>G%X4L:_[XS7.EP]&R/C6G9UZEH M@Z]$(ZV-,D M"'][1^0)[N+=)YR7I,O]E$4X =D&^S=(]]_4*BSC5]V!]CD-^VYKTUZ$KGW9 M607=IB:YHES,I$;J]L,&9/4^==)EK;-\ ^.2!.V;8/LB5KOR)1SB>UK/XN V-<.#0;6YV5ZD59L\^*G'TV;G4AVNW57PG0WS%1%D=OK-'[*LV*\ <)2U]G>-EMWVBUMIHK> M>3D%[9A_5:7JO)4]0<]4VC/%5M%_[8J23GL4&[,/@ M^^5F?Z-/5W-;Y*!,TAG'U%!;'HG%8(0M)3:."+@H?AQMF JK#5.):T*H0Y-> MQS-)%&%'IP"9.-I8,B1/0DOA)S!*X=,J1;W0>(/'Q%().KWL7 IT<)TY)^6= M-UIH^HXG/;QRF23*\*#4$48M[RRZF,!N(XM*&%3J8@#4)U?:^X_:ZX_47%'+ M.^.*">R6*RIA4%PQ #KF2G=_56)R?]6"L?P>ET&T#E&\T ?/XZ"[5J/4)U*[?3=];JI[C51@$;9>_YQ53$ MA_!MP=C0V_NU2JMYS97+!CNJ+(H--Q%1?^7'VEM"KGHHH+QHBY#K]W M:."?@\WV+ZA26"@ZZ'"J8X.-MK/(8.]2&Q?,56%$!6N\KM@VXQ*9_(8PQ1EB MQMIN.2? ?0^\13B M8!BGQ\C-(M<:O?D>5%(U3ZGZ65"\D*9"_T,9_QHD[#:SLCDCR'9VBSZ/D2*\ MP;P=;.YN-J*V4);^:Y;_1IY_%FSC,A!F@F,)9]FV&%J;40]_]MXVY9C&7[,6 M0F$EA:)JE/VU3:A]A#9PML LG>#P^ZW:*G3C M]][=.14S8>]YT&@["#M ^+#-<1#=IK\$>4S_\9XP2C9W8ZSN,D.R=6HP?V:H M"X9^EH"YG!T3+&E)JW%F:U1F-( GHY4T_TOSIDZ>[^@Q6.)3G$4'OJ^A*8CT M%3D[A>A^X8+F##2]5I/NF/\E(SDI M6V-79!).GNQT!MO=JQQ,?B__6#!-T9VOXZ;<"*/75AK1N[@=CZ/8&/T\+L(D MH[4YR*@/YSE]&VD11_4UMJLG>DUXR*_@&>K!F7N:A%IZS.=VC*%'0%;W0 MK[*%!L86FJ)J'L86(0=V'6T+E38]((A)US1@J8HPPG"98Q,J12PH1$P1-?^@^M M.T&E:T)Y]ZQ1P.:)(Q"&RQTY6#E]^CIH6RFY8A ?'H?+ NJ-3U.L .C7="X: M]'QWL'P1:M/8.A M*=_JKLB(E,;TVW7=-3QF; S[<[59T:X):XT!"+2&#AO$6XVE(PF[9EX81=_& M%)WV+JJKUNC48YT^H#*K_K7>!^LZ(A_ ='M;_N/S5)[;&@))\XE.F,1N4"17 M->?F(K6IX:#3!Q6UQVY9!>I&&21I+8!;A^.&G@,1_\G& ;.1.EN@2*MR=TJF MX6'6:OY$PV1""R2Q13,JTZD]Q1J(Z;&)]+8W!9+@D]W@D@SQ7)MODO,-^*<@ MIC[(DXQ+4XJJK=NKN;T"(:A$X/S%QH=[WVO M)5#NY$6M1E>#@DH1/;6:WGG'.B0ZOX2C_G&F^FX=BK>(V?!=\E8L])V>@+!U M:W".P509##=M$8N'S3$S@")F 54!^:1>V#RIR%N;\4[;INWU?*M*8EVE)29P MRZ)Z&[B 3IBFK>*766!$71;DZXS>_CYY>R;3KTEFA6O_ L2!(Z;30RU MH"R].-BJ2WK.] H&)9H.,PF&ZO/X(0^W7RJ%NG' ; R#BRB[;3R-C^]M7IW> MEG?BF[JKI;O.$&R2&Z+G"EO5A,;-=7 LWGLG=E@D45,^ 15AMXQ2V!JORJ\ MN]94?S53=,"42;+$*PDP"0LP!#$MA]P/?M5*G&QR9[(U(#VHBC#5FSAYM=D&<^/< 9NR3FH4 9*2SWB,5-_X@GJ MG9DL>'?HSUA[D=%0)NST#AXEX,'U.T)),&Q2PN.R>G AK4-TNQ[G E6:P/)8 MV0#'5-OIT-+.I<'HTDP5#/GL\,K9Z)V&W3K.PPO).Q]QOCG'3X;7+HI4_*RZ MR<&+U]EX>3#4,@#)[^PA@N^H)**B8!;/!@Y<:Y;+9,)N=XBI ^WAXDDX9!( M!4]+GVM ZUPW68E[MVFHUK;$HB[YHP+;9X](#@QW%.#XTX";#=U@$B0HQ^1_ M,#N]SUU4=8M6"WP4=NIGE239%WI$YS++Z<4L='B!^8I/8C$X-XZ;@.0N MFFS$V?[AD RXXI)\&MVY$7?-0S);S4O!FZ%68)S<1F:8GI8K]F, \R9+#^-9WP D MJO&.V;"MTSX:PG&0!;/*X;RTFV/IC?2&6C!.[U9I=(V# E?(+\D'/ZNF MR^-7?+%>XU 81:=8<19*I[LHS=3U)J#DCH?!YSOU1@QA)H?H>T9!E+%+P>BI MEK.+LVM'7"V&?OR:QR6^7:^%%8/-=;WQ4N>.E(TR11@=NR5:CG)LY>1=1B0\ MA$!:#:W=>XT(R=('STPX<5 M@*I%'0+?9F"!TVC&0<42(>Z*('R-HUV0)/L+6MV/M@+B>K=^;?[J3&QY#FCF M[FI8KC?DO9.> SV_=;Y31+C19,P'M&-+X/%9EB1D!$7&4H?SW,269YZ;NZOA MN=X09)X;H^=7=#K%Q7@N&2$-AFV]"=GJ2.%9D.?[:@_Y3CS);J?O;'PTQ:UV M>&2C[)V04Q&/27@]6C^$&%=EZ9*^AU$<>)GU(2"'4%8O:&+";? $*/.FBWKW MU>0PLE\;=OP:OG/.@^)X-= M9^[+3XW]I'-Q>40/9K[BZOZ"RMO_3?H"5M\SBADFX_)4!S[ 6_FJ65Z,M+S5 M0=:]9^^+N20XRUZ919W=$U390;4AU%H"L^/?Z&UNE@961Q=9^ESW0Y7K;YZCS,& <9? M9-&%%&^QA/41JH[)()(\4ALU,]:[E&0NZ&F/[L[./GNY:2LN0C(N)FPE"0_> MI/&:9CUQEE['P5-,,Z'54U'F@6 /K+DJG 1B*G"N.ZA'7NAVC6HC)&=L]0$T M[Z(XR]*2I$@X#?>K,,Q)7KLJFT4==LVBE,-&NFX#@H4[PTAAH CQ-($-\#$Y M3QT=%1!C-#D>8*KI<.77QI7>FJ^)&JC@9P79TW;_A<)?#F#:JOXSF*\? U\:M3@$(;&[" ]^]+6-_LK[9K M*YT6@, T=L$@,C4JW@?Z=CC']/KV%*=X'9???8]\;Y1?.$L&N#G>#OCXTUT8 M;WV',M?A]A.H&XL %NB)==5::7$7%.7Y#D]>51\9 +-J+G3,>%5\H V&>M:0 MS=;_J"(BFL>UBEV[>SW'8C9O"]R:MLQ=ZZ7ML2$P[#X$O2W1KP%5V&N3IZ:L M&-V4ODJCV_(%Y\IZ*$::+IELX4J?MP9J8%AJCE5ZFA1]^U1GSMZY1Y.8J[0H M\QUM7*HD0"CIDEL*J'TN"<3 <$>.3;K*DJT133A[U4$[ P68#GOHF*Y+EDK[ MHY.R6Y6( J65KFL_!'G,DE6"\S0H8K.P MIS/ACYQFSLGIJ=8'2E CT&.*-G*,HBCJ3'BG*XWIDIUS8A&G,^D"<(.)O][O M8.@B ,4="0:VTXT,.+8X+_=W!&5)AB@7O^_B+26[JHB[3LGQ<-+ @=%(4J$! MADQ&, 7C1Z;$=E7B1L.@MKN;BYBZRZ3.\3;'8YKYI0RNAYK)-K1*7C/[Q05I7!0_HJ!WUW'4>XJGI3"I$Y(2_2IY MQTMEVHW!1EA-8QV$*V2[59A[S!AT%Q"DCWF0%D%(252<[@>_&"VM6=GRL\HV MP5WQ@IN%(3!=]B'H^8TY5>1A@JAG \R$GL1'W7LTE$J MP<4'+O:SIP3]EF2C =UL=_&VQ:ED&9L3 K1K38YM_*);280K4>]-K#Z!K#\1 M[NTDN.8$.,23W\H3WVF[S&.2JSZJ]_IG\J M7S#:I<&.!'>B05Y<1)G#_E1D21Q5U:6J33DD>K,KC=@2]L%;(&0W&:3I+D@> MNQ'07_NHY MQWBT%"EL4TIYES>J:&'W+U"1"GMGC"E"09T]IH*"1N<$U!KP:+<9SC=FV]*8 MH,>=?3V@BHU]1,H[<[30A'NOXF[O%:VI XPG9&R.A>7+]>+^.,.#EC.GDP7* M'PZ@AD4G:!W0*,14@+&IW^]6Y^OC5WDF/M$&C/Q)X9Y9&B4P )2A9JBUM(W[ M._Q.ZKH*M,*"6&_P%_:3< [(3!-.6:") MN+GKAG>;)YS3O4\%TT Q,^4]&M'%YG+_"9\0T>V7%.?%2[S51B(+?9=1 MR-JM/D6-E<%$'UO$W)3FE_1+)3KC<.Y@;IX%Q0OU[#5(Z$R868DJG9)+%IHY MT*>>6@-:3#1"RY5J(4ILUTI(_X [=>]\.\?;K(BE18"ZG]WF4T-0PU2I^@U, M'!H!XA.R MK##>!LE5>H/?RL^3L9$[7=HZ3RD/P @;_Z0@93!XL+R0[S1AL%O<= M/HS'U-(1,[D'7\#E?SD^+E^2%SK7VZEL@69RW]V#B$P-'2^/>^@%-/[7(Z1Q M_#I;1*YLP:9QS]W#:$P,'3&-._0"&O_;0MLVSNDFN!Q'9UE:Q!';,IFE=\%> M<-C'0-[9M@T3V-T]!PIA[WPQ11 A=O36RGO;5@+3;XY/6$\ M"2'PY.$ER]FN'QU/1().=ZM+@0Z6L#DI,#R10N,B"A5\5UU9!HZC[O?I]_/Q2TC]\)M]C5138 MVRK9L*MAN&[7!!4#I>\V1PI>2L-KKU R@^SK\J15%,7LP/QC-H(FO&5$*>YN MN[L>=+?;72[KO29.&H":VSG!UDK*+L0M%OW."8&Y^R MJ+V*41@$3;2!$1F-E+?AT)CML4U.CN&S/ T^^\ M\=!A_8JI%SA:O9)_?<;W>!/$:?,C'?"^-WH7)F;\=5CF3LKIJ;?A/9 <"'S, MVT;Q75!IHKQ1K:U*HPZW[0\),9#7]O+K9M;.L]WV'3+YF1S;B< #W-Z.%\XS1:4%:R9 M_("Y2]/0)\T&35LK$*FLVI9I9^)8B7L,>S)M7%%MQ[2W Y:STDV8MD:.FK?@ M=V!:.*/:?&EM!BIOI5LN+6T<,VO![[>T\46QU=+:#%C2RC986MHX:M(NN[O2 M&6E7ZQ+G,S%W9 LB?87N3N'PP!"8R8A#T'-;15YPC@,J>#1D/O"MP*3L(2R% MMCG)"K5X[])Z5^YRC#9Q2FMDUW.]S29XV$S]G#:3>CBZ> N)J+*BV$1;8#BL M<]>8T#)#QQ%V->C%%_%<;;8[6ANXJ07EG=@2YXPFQ7O2_I8E.,CRU8=6% S! MU/ATN\&36C[&,!;?6_QGNSPW6@\::\ YV6&)5]S::RFTI9MOO-VV)7'AAFA: M?Z=.Z6@^E0 R5\XM2]^%PV]%:[M9M3)O:0B_M&[1FXF4?2<:4>2[@PN"BDBPM>.]_ZBIA+\H]G6-;B YX!ML5U9QY^SHJSNBBA( M/(A+\88A4R5GFV*-'6CWQ&HUO,=J*YC\;5V-'GJI%.E]"@7=OA:731U.[PG$ M79Z%&$<%;2A-_3[:4&[+%YS3NG-QN1/MRIZ@[_CF;#NW1K?+FBE[)^A4Q(+K M9ID^HF^17@BLK>/HA)Q=$[I*0Q*V>[X\O M,.QW]3))=Z]4T&/C3J%5PFV"5-^X>'#/8Y%DFZ9\GE-IH^P9 M!@,4R,QR9.^]"0U.+"4J"B%)%')N"Z9)8 Z+H8V$O)-$ATS8513]:Q']9Z9G M&6%N7L9/"::7@!;BPF=:::>W%:@A#ZXI$(N"88X:'S^93T1,ZIMYN!^JNF4F M#NM-$1)_-3K^[G^2P)=7VA\I@&&4"4INT%Q+-9M2O%.K7R-2<5DT+^;V:G8Q MR.$,]% &#$TDP/B[VALQNFH8$4$?Y9! EUHRH'^3F-UL&8P!V>%8$YGI+4U=ST-;>VU!5O;#:Z'X]=9(9SK' C\[8\PZFVI MP7'].RY1)?8]^C8ADLH[U1=\V:,SP=6=<+?KZ@ZYVUU9E &KP7 :%'$H^AA6 M!N"TJ,/@RPY(H^: ='VC7M890/_\3__VX?W[OZ G:@G6USZ/$[JACW/:XGO+ M3!S-%][6KHJ\K$87W%75 N5ZN^AVEN)FY M;0(O7=:LOIWW9%@9C*J>?Q"';6+90-UE\FSKE''GTM,%DVQ; N8N(LPVVR#= MH^WN*2&#M"JB+#2Q/():063@KE*2 P8)RS=?LH1DA<*5!TL#SJ:B)SG6#AFL MM+WS;C)D&?/B2@,5/14W!!QUQ/@C! 0:<).]^\QT69QR'UG3:T*0D/9P),WBEQSCCW'.E[ MY^\!H/F)X$:JBK!H1U*"ALAN4X$*=K5R5I &0Z^1JFSUT:!+EYL&Y6*P+#FVI::675\[83N./TT\%/FV-Y!G%%=ZBL# M6^R8!EZ2*NT*=J8&VO,!: $>XEJ"1,*#/TA)O4F?QEQ3)G]M5G&N_-L'D[S#%=+@^2LVRS MR=(*^JHDN=,38>]3@A\S]F^$^W1@R];65]3[9Z8G.YPRAV&W&\+G>A'#K>.' M6O7.^]E=$386&AY)(YFKQLR\^?EHH6F&_*^U"#U;%ZRQS6 .RBK/6RI2U0E&#TV%5LA@N;"[^*(#W(4.F:3WKLX( M'C>VJ^47(D+7H]*E+9P6;$#1ZU9/]WRG^R7(H]LM.W7ZDS3[G\NR,XK-^RJZ MS96SF 75IJLA") JSR M4#O[>KL>[[)4EH2=R;;+1C+KZ^@WE5D,PQH#SNF2^W'A:&DB?7S!YT&);]>: MW,=,S_GTOXD;W)* 2@G&&-("*7>BAJG2F-NL$:;L8N"(Z--_G7'?S0$48X>U MIGI>*X,BV\ A*\8QS>.A71_N =Q#K]2.]SS@(4B(>RR/$>U1OTH?240N@E 0 M%J>9<-FK3W&NWWG;Z'LG\ &@N?$=,<%(3(VC6CLLF-CR1V=P]"9OU!B#2V1BUAL]AWP[*:T,L5L]'9TEN M4 \P*9"?<1*=[A]V3P1,'.35A*)PHME R5DN8.Q FP-H-;QSS0JFX, ,T:NW MR+X03?2T1T6K:W!V:\F@T8O\=WD)5^NN+)1A>T& M?V$_"?>)FFFZWDZEVS9OB5H^W93B+W5W-,_QK,/7EXH"EP7M3^F$PZXH1[=H MC=<4I.).5X$TH <+.Q)9,&U> Y"K9DS%JV3F2UR^D'YA!^!"O_YQ\%[?5ZTA M%;=K_8R.E06WM02M71N6&316!T-)>\S\F51FH:FUC8)*U3M/AR4X/P4E717= MT[6#;Q5,-10UU^A5(T[\H*I$D4P?+1!.V9B(\W6=DY0U"EX)^/DS8O- M),IHPQB;8&E6$>[(!WBABJI4T\'#G>?\SEXH-YI8_,E@&J13=R6[&I<^5WJ. MPYQ>N7=5#^OI]C+A1(U$T-E4C!)H.]DBE/).*"TTOOAM)4NG1/).VGLL9Y=@ MR8DB%W-ZA[4$Y. FS9&,=XIH@/&9)QQ2G"5!4;1GJ&_S>QKT! ?/QA/=6C6G M*PF&3@R6$S0Z8$AE"%1V%*I?UV+A\W'R\8EJ=!5)(RA)Q)]4BM5D>ZCH^7[SA/(R+)K%NCWI6 MOQ;OC8.VSA"\+0>'N2%M\O@-4P- =B8TL%9I5'G0Z[/Z=]>/WHU>S6G!/T,G M!N?R-3I@@HDA4"G?2B+CG6:709RS?=35(@7QI;FQ/L;%)S(.V^5TM?N>GBZA MRV)$X"9+\^:OM(I4\:BXLVQ&^RZ)._MKZ3-\-N-@FL+<'HW;#+6/V -.4&L$ MT0-*?3/HK\S&__DJ&M5UG.*K$F]D\PPS/^/8&A?W>N9N8.T#OJI&-O9*U="J MQ[!6UGL0:IY$=VDKVB)['/HK?2!B3_3?+'M>M._R/"[")*,.2=ZZ3LGI3:U& M#@RN;55J@*&V$4SN0M=.R3NU6M2G^]. H SQPPO&Y4]YMMO2=- D0U*J>HG/ M!LX(PZY"#PSE+,"J@N33'M7JB.FCQ@"\9$3DYF6$@1U3-1-Q&3E!K';7F46,?5O)094."WFGU5)1Y M$*KW4RKUW&^L-'"#WV&I4 )#95.DPCV7_M.(LZ!X(6D[_<_%[[OX-4AH13+S M9-5"W^D"HZU;@TEK4V5PT]26P+FS3421C:M"^@?W4J\.44- M=9W&1!MW!G'11!%.;+1 R_7E64XW=Z%MO7,+U,ZZKEGUG*>0E-YF>J#&<&294#FFE"ZX.M4$^<8%KPW ;5'O%D2@3/7CK^E:H^6VC=57'04T1[Q%D>+"AY:#T#4BD_1TYX2#+ M#YFTHF#Z'C4^;O,/3N,L1P5=PZ %H@(6)\?@2Y]$J36-:E#W(]_7IP4&='4/23#;E MC% '.MN2;:(=&$0\#/R8I,P:"CISS=4MYD._14=/K%,FV'K3!S=$3S5:5ZI M'*B; =;.(D>M(>\#]:O-EC"0TNABO<9A6=RFXWKYJET\YNI.;QRQ=&IPM8BA MKO<0,Q'PF)R=.JKUZ0['Q@(B)E!5N1+*QAX#?Z\UFWCL3 !C+N><)7NOP6W$ MF0!Z.HNO 6VN:3O_>G,Q&P['YJ[&4A'\<9U?Y"O0!QM M3EQ%_[4KRHVN%*=0WN.641ZV8JMH)PR&BCJ$PFW,[(H@%+2RGB87CC(%<#M] M476K%VGD- 60S7B,D@"<1L"Z?]4A]M[+82]#\C+M3$ I/R!SSK04P5@?3'R; M %I:HH#N/LZ9D7X=I!.TZ>R@F!KR% \7J2\!;KK5&/'X.UZ\;7%(B_324A/H MVST.\N([[R&'GSW>&T8:(TVW6Z6,75%/^'-J8,*).59^1UZCB9)&U3)T'%3< MD\/=- =!^1PS%8<%/XW ]TI_*N6]D\D"Y''$L&INE;ARE8;9!C\&;_=!B8?) M(BMGV0TO9!,CTTRYC'*'.-L/>U/L>*?N#. Y2C>F2 "DME 9O*&<;N3*!^90 M1NWU1IW^IS!,WL*JO,1T$9Z=&-X1#/N!\ 'O5VL96JLP?!6VC41C]JC:C)DO MQDWH!*TK<]Z;2G,@@3A233GU]TI@>8JKT7*;WAJY(#IY(E$!0TTSG-)#)I1N M054?*>D448K]7]1#,,8I/423EGG\M*-M[(XX\2EXBS>[S2I-=T'2_Y$N+5]L MMDFVQ_3NSE ^'SV+9M5C#A^J%E([6 F7P1MA5JFF_):;;I3/46XUJ=S MH*%F,MUGDZG]S#\%9?@2I\^#WROHMVOVH]W+M;$+H+G8OP:#QF)N%'I3L?9D M0D/9U+8',E";C5'LJ&X:6R H-88!-)P)+V*N;J:R"KWIV+MBWG:J^^B\MY') M]RCUJWWN-E5%K&8N[#Q^C2.<1HKAM(/G'L6]7[:O<98KOTP?"J9]NO*4:[ZU M"-K'./&_&#[K:[B/B]\N5&+W:Q=JY\^M?9TDU< MEFZ]>&VE833O)_U+>;(9J=#M)^]57V&A!SIOOHN^.*ZY+O(T6,US21>5.Z%@ M-,0IT>FV\KBWA_5FMWG"^=Q14/ZWJQ/='Q-[6^4&PQNTES^8ZB??J1MU>25+M2"58_^RMNU M@>O<49=:!=4ZZ"=ZU *=T]V8W04F5=V$8X@(4Q(2[8N\QYL@3INU[2 L=T%" M,Y4/^:$-(:0#T+Z#I>XQ-TP9X( M(U8<$'19E"RNZ 87$N-_RK-"=KQAD2<=4U:@>%5S9@""Q\!JJXOX9I2\,W5\ M!,O+A=5[6")MGQ,!J$8Z_ZNU:KSS/?YX&O7L/L^6NX,)"!155;+F?$?+2E2O M@KVU@OUXVTP/5F\CDGV+"8:<-L_)C@Y:F;45.(UE*G2C#JY5\L_H0X-"XXK7 M7LX2Q%%U=)->\*Q]G14"."W8A]NS]7A'%"&TKW$;5P6^VQ>YT*A#^"10;7WZ MJYISY"EXS/&TVLF^&7;,1/T8&IT^>''OP4_'; D#5'-=Z"7/W#E;83B>AKZ, MXS-VT$<2*32O\3++US@N=SE>NGL6/@E4>Y_^JN;LG@6/<=-J_URUVA0_$_8K MRW$NYZ)1+WU&EV^3!$??UX:.H1WJXIG@G?CHL:UA@&K!"[WD67ML2PQ?3X\] MS?'9>FS+J &X(_*TQQ!@7>CEG#0;+C)-DPU%Q\$FJ+O@OF[F&;D^W\#%F+,> M-\%5ZRRK7?F2Y?'?6W:AQ2B*P8NZI^^]_A=:#?Y6>(QFGHUQ'M#Y MWRSG[9/H-] YAP8K)P/S/@[:: =FC3]\P=&.O(*U.,0;O=S3/?]Z5;=1+OU0 MI^'#R0L<1(5%GPBGL;MP<]R&F=%W[%FH3F-0+\LYX58L$;.+F&$P5V\>\,+X MUW6MN:1SJ8?YGVF9ZX7IQQ"'/@E.HUW2O9D;ZS6@&T9G?6_5V/YVW1MTU1F. MBZ^F>OK1MFG]*UVLDJV__,'SNG5O6>O.*F'_35J3OYA,)1^21%O8 MAY0O6[\6F]38V#B"4%S'+3/BQ9*P37%%EI[+6I&E,\#-4@_=T\?LN+O=7:5'F.Q9! MV#5$CR]!6G?K-UGZBHL21\L46K%__E&TSZFO=99F;/OPKZJPPT3G)4NL]P^? MP59K6/;MC*;;V8PX7=!K"U#Y^W &T+ZR(&'\,1S'#RVN?]#08OI>#EA(AQR9 MYEH$Y"<9("VA'X+N:)?0#_\DBRVA3X<&:[@#YGTAB88(6F1>#\L0N"\ MNQD__NM(>L0OU4UB,WPVK+#@SF'56 C,SAA'KP3>,,@:W]<8%H -B"S!_<,% M%E?CH:\_.OW"QI?>4H[QX[^.V")^J6Y"Q_#97\WARFE^JS*/2N$?IFG#2SRL M\7V-P0%8XF$)[A\@\9CV1@Y-/.8)3L7+NF 1YX>/']^SJ//P\^7#@B_KXFV; MQ])TPO7#7<0+/R^4!@.W3_;>TKVXJ\H?9BJ2XJ.-4MQ3\P)PZ+Z.5C[ID[@) M U;0_@'BQ)3W<6@^6ECFL']==4 M%&BR\\K1]S%4^C&_ &R>;=*. /C?;+CDBYWS3CO0&YM-VKM+WP\>(Q]UP;IC M6E0&ML'5I8XC MMI]\O--%CW M2L(?_#D*%G9S2 Y&7\E.#JCP4]W*$HL&ZN M[G((8.N4G*)R73 )C27@,3<[J:KZE7=&=H!NU\REB3LMGQJLNW^VCPK9ISJ@N@ME"^@D ME]UD*:/'SSB)2 Z[>RKB* [R*IL=U(DQTX#S&2SQ\JV!:M;-X(7HHG66HRT! M^$)R?.\1=Y4PNS@2CTPNWN@?91F J;++*&SG4#\&F&F"BS%_XM\? 3&>["O%75+(?S M$,5$6B["V*AJ>9F(EE(UO&0O&4* M LX]K:[4,\ M/VUM\W25TN2NB/(E2]=\4$/S;ZCA%LZ;$Q=L4]76O#!H19+F M52[M))",BR!%)X.LN) @F*IV5?O&-O<:>#H)+I2L^@WA: G;0;4/TN>+ERB. M+/N WM]P];*NV+![!470Y?P396O*%FM&Q2'I9'R+%6^."\@AJ\? M0HY\X%&"PNS1#IO:E,JY2K.:__:19O!6\!"Q:C\%;$\QJ%&?UH91^',A#MZV M$RF0[\Z%1'#MX:L8-DN01J\:+W^X+3F++\H/]$OU4?,FZL M&O2>?+BPGJ;T$-R6FW!V(OB)$D!^E2((R"!"2)A5O&"_0[.B75I%F3Y>#_Z, M"QNC;MKXDD0DEE3.$7-LLI3RN833([P3U5+MY4KL"ZXC!L^,9>/8Z;C1G"7G MM E(9C;S,%7(1"&X+.^(%AB=)DH"LLAM3GK28#,@Y)%&H @TDEX6B&Y2V].( M?>H?Y< %KZ^ZHS>LO8-:X&G^4YI4Q=?\.BJK3U$>R9?K^SO[(\48 R[$/+75 MSM.2C0 ?Z1C)_5WPYXHK&C/*;>@V[R[V]8.5D0H7-"X5AW@TM/P W'N="'/@ ML4T"EO'B)L<%B9>NMLGMP3"Y!1PG7;U24ZODM U&9%^<)DO !>9<]5V%65U8 M"V&A3RWZ.\#8Z7.4 Q>JONK:WSU:1BPGS>;&3.YXE_G3AD(@_7+ENB_R8<*% MW 2-M3?$]A)0W?KP0T"UH22!? /\MZ%O?OY)LRQBE@6P_T=VZ*X,C0A'B7:4*9Z EY2*<)-V 6Y644=P$X^LEIN@Q< M$,]O@.[T*D].,B0S[@M3-QDT$2.ZDZ?&>9!A_![!M:B0]55W/++V94_*EC-"_#!:J#/ MA9Z,N!"9J+4V,PIVN)F'7>D*LA^*;:CP66H.MKRV& M_"#=7&HJ6&I>PGD#:<$K=L 5&,)&6"P=, MC1*6+&DV&ER V!6TS%-E/Q5:F%V7&*K\$*7LPFN:LI'C0L-+5\O4!;=]S4A! M-3Z\G\W'&'!AY:FM=1BA>S,?N'1<46%,Z2L=P\V7$1=^$[4>=5'J!& !].'V MX7IL=UE'VF[#6-TWQ]0R'%<@R-7.M7:BYB7$AX M:*H%[@H64C8\$(U.=BU7F("B(LK;1HSY6;J(<:'CH:D6+P37-BT/$@]+B&G, M*;LLLH)%27'):))6SSEOM6T"&V' !9.GMMKD)ME(PT,\I>0 A9@XP@ M<(I)ODG+*7^2SS+"441X9UFF7']69)!.U5L#52Z,;2Y3];.403HA81?-+"N^ M0M$V][.AF0P78$X=M=6S(1X^&V*>+!?)O^JRVIKRQ$T7@0N\V?H?-97R-;(1 M%R9+EM%D'3"/,> "U5-;[[$9&J[[HJ(]@[RGE0,J%S$NF#PTU6LO'O.18L\Z2>-DW59'>#ZL^*"=K+>>D*M MSB$+'M?[:?$(%3)"PVKTJ;U*RYCOW6KFR$/@RX@+THE:ZQD_U'IXP$\Z <'] M[O@N/(5->/L8X_(M[0I6R2S8@@* MQVTNTRQUJ9E,1YZ':&\LCS&)&Q=P3-B0O;J6I;$C'V$NU"G%/9BI&G]Q?^_ZVD,"^* M4QZ2S^>Q>,:#\"7"]][#\(8VU*[;S^K>,F,/Z\R&"BEK(8;Y\((U128S@:B MZ?!\P8?,TR9ER2+/4_&,P?:JR.W!C8T/:C/EX$+TN$8,T1;22$\<4?(&]V$@ MD0B1O:NQ,.>*-MVH\>;/.]>J!SH[LJQ:KGYQ)%?M5%.3XUDO;;627'A M-ZJG]6K:D-,IZ,N"WH+#2AB.AZ/I(LX%Q!']IX!+OA[6#,'RHJ0W&FX[X$9^ MN5++QE,AKC'^8:G#-5O2N5B!7S,F&4.J1,*26K0N@&; M]'.FJ GJ^>OS>FU!PY\5%TJ3]9[[1H^H)'>7]]"O6NV0'A>"?LI.2@;I 541 M'[2,_QQ51=N3&T97__L?Y695?O_SCS___<=??OGIAV]E\I_2EU6OM* &OZEY M+FICC[^+5_&HRJ[J%XH4E]F,ZFFO<'%8W4*] CF7R2.L9;$M6)7^*=K1.9L?I'0[I:[A"BT&; 59PSL?@SY>O*:0IS8XH8K,#/:(/+ EIQ1,G# M:@LT3R&>-Z[Y-OF!_SXMRX+M(?6:+:GKHY9PT<:1B0Y.GKS3%V5590G?&KX$&6@8@DS@_KW MYPVEE?^\.U46,IB/;H@K!*@GDS1"90R[^HD(N4CF83UYQCVMFLL/E3YOE=($ M,IR.7?H<(0N7@1S?$*_\(I!6M+TI2CNQ,BLLBJLCC\S%MLSHOIRXH)^JMB-# M,P@@4@(1(D@G(^BBX-'&RYH;Y;Q,W(KU[& ]U'LNKDH*UL%Z7^1'0-MQGQVZ MFNIS >:"@H(\3#N^R),[6%!D^G'8O0R3[NB/,Y-%X()[MOX>N=@A_V@F%FB5 ME5WLW+0B-"B@+P\;_H4?0?B>=C5>X,+&B!OF$:W'P2UU="&I&_V^X%)0(-IO M(<1"O5*V7ZX^1 DD.YLTCC5NW-CZJ#YY](I8,) $Q[*7*!&9WH(50VS-M[@(S+I1G:&XJGM@;M_VR#*4JN?ZCCK+;G._LL@S:;7.%&&/ !9*GMIHK M'; 1X"."D?0YD5Q:/J;E[X_B.+^*8\75U]#K&CPT7;I-TUO?TL&OON*&. M#[ CN68QMTV=2E/#N]<8PSE IVGK#1IK.0/[C@T>YLH9FT=?$;@0G:V_:W/9 M$T5:6?-VF\<$W10YQ&?!J9.I@^7AF>WP&^\M%DI]7O; MQ$/$JIRRRR(K6)04%-UN#V#729!V^UB8>J_;?2/3W[O;/T-HR$B_]VAP=KRNH+WG!2V* MKK].UQN;A[R!!F?7ZPK:NU[0OGL^AF*[B_+];Z.Y8'5KRF<+Y5KBO2&\G[BLF''1>4LW1W72VU M8H3C#@@B4A*N5\QJW[[2?:9K1Y33"#TN-/V4M;Q?5OO>RZ7B.]$\+TL-RGJ> MHQ.\B?C4,[M=X>&4KE/B,IDQ-6V3N*H.J6JPXIB]E>MV$RLO+Q+4/,:B7-Y- MW7+]8_]PN-DR<<'\=@UR!2@KV:1-$R*E-RM )Y_(#R!9$[K.$7)35S6CG](\W=9;\4N58\Y_M_#V'\-J<^_6 M4M=.1' 3^*IP(A"?AM_SCQ/Y=:(^#QFN)3402A6(TD']H=$B= J-0?]-\)QS M,6*U&R^MG3DS!.C+ ]!QS#F+)$EE%HABV$K]P[W-%X3+>H]LQ-.I[6G7% M7<6512_PGT#DO]@8B*W$KU)DZ.7COH;SEJ-*5LFA-&R.5=QSBOQ_X2I.AI_J= ML^$( RY#\]16&&K@M3 +>&?NWB:;M:NQQ<&![7 M"$>0!]2::^,\1-WFH DXGO.$,I'5AW$KM1^U1^AQ@>>GK#431X\-;JJ"AYQ_ MH'F\V4;L]VZV*._N+BU.$DYJ7#CYJ#I$J>4A/2;"N=[;K\9L5"JYRSV'\#!/ MX+@]&EA/MCN=V)B1:4#CPV5FTY2V3@MU;UK@BW23HH?DK80@,_GU-TC#6,IM M]S*WQ0J8R7 !Y=11KYLCB8F@)IP\<,FBGNY/7PL?&%HRQ# ,=1R!@9,C@L$1 M+&8CQ S%:-C8$(S@L6,'^CL"R"QTB,$8#24;8.$=3W;$%J6[=0>74GZ.%TU9 MP#/?6M16^+#7+N874!_T^H\ZK?:0T(S5,NU/M:'L:1/ERYUP/F@:D]SF#Y2E M16)T,CKEYT^V50K0J9VSV>F^C6NHG;[AKH>IN*<#B3HER,N>E/H#%HE$S5TJ M5"%IIPLI0!E2;>!Q5JI#:*,/5#C8"8W".$2^8X_O4M;U]^!FY2/X(%Q!D&A3 MH?:DHV"::O\^@V16OX0;0T+=;@3I+PMK474^@6C+KJ[Q7V^@L330:G+PY7^C M86)H=L!1 -J$7D=:3_.#N(-'0"A3O7M3L+;NGLQU[>UT/U\H,J-\NQ8-[8T3 MU5G$2)*6<5:4$'A1K,A*AF!L50A&FZF3@7&IR9/;%(G6:T;7,$^"MQ@$G-(H MWH $^.L*TC.4=0Q9/\5C%?]&E)$]C5@IB(NVGJ+*/[Z)7N&G5 4HFFQV7[?LIJ;VA-M>2H(O_SXW^%K0C5MF"9TX/I:.!*V>/)A MA"@6W M7II'AZ"Z: )'@W:RO7?1=>M(?Y)?K^@JJK.*W %W*-MML@FDU&7 .A6B[G8H MI^70[4A#VW-/E9$>Q]G5/GV,Q,;[.6SD$>('R!C/;[^@@<=;5==@@<.() ^R ]W U<%MWE[! M+5?&XD/Z%M23$0%<\_35-J"> @(-M?LB;\_,MWE<;*GRV#6-,2LQHD5G7$G&_L3'+\CAQTCSM5 [(^%]O*RKLN*K#U?(N#$:$B&8R<=U,\<= M79 >;:B3[+9@5?JGL))NZ3!$Z]Y3\VW"!'Y$8W66VMK9N2<$;EC=&0'X<*.A MAE8SLM6R,ZP?ZR!#A)E+.WU>E+1$$5\0( ^WVC*XB;^B\O]ORHX:\7&M/:%N!)&O7!)I1%W( MG&MH,'Z JH]IXCBTCO&@1M.BJB>$BKM98]& )HK8@>.*W -TA,B$Z=>\D9=&;^:SP=/GE=(+U)X@-,@V M^W4U;SRQ*)EXDNUSHL;4J?#4XXT28SJ?-BAM*D[<6N$<4R: M3FAMF8[Y1]-6!&IH_30_\HC:"L2Q ^YEV1Q4?![<97OLA[UEX=T=3V_"^%[9 M6R::6> SC6N^I]]?T5U1IK[[YB$7ZK%N5=9S>#?\I!$0RD>"5I=1N1%UL!*: M?-@_B_C--CAB$5?IJW4U]N=&!.8,I4T)@4$&:81 D-'?GF6HZ7>D%44Z68'P M;>N1%"(A):-<8ZY=M7_@#:H6N8C$VFTMWJ[^W(CPG:&TEDNQ">&I"J*$D$;* M!1%R+EHO-2$*U_"5^9OF#E\#-R)X9R@]+5BL;&$7Q: M#1#96:"&Z^%TY>9"6FM//K@ -)\FDD349SO\Y2&'U(D8MOX7I-6,-*JI0M5" MN7,T_K9%5VG)SS)1]I$5]8YS\)]CZ0]*D\X;],U-?^+W$5P>!&WV^YE]9]J- M2D3H)#C[6O5\@X,$>-3;.N.??U4S GA,+Q*9ZT&[IG(1(S E?QTUW!U,(=,F M'T2.7+6)%L;S)X\Q8D%KLKZVM*EC @(6+&]*Z[6WU7;X1CFPX.:OJ*5DN9TS M5"PB+4M*AXE03$CY<2#:4WHJJD4A"K:+W@V>Y R9J+P[0+]2OGHV\3W#ER8G M;KZ\B!"*D.,E.L9*6-_B(4C4Z>\X1=J0B?NBHB.;^\G,B!:OZ3J;DU=@V'?(&JG@;] +M9&_-+X9VLD1 >2C MI?8J*"N["J8#?W3UA_#%EIO674<,L@#"Y:B(]G54^_5D002=KZ;:B%)\<#U+ M!"WJ^\P- HL6%A5]!Z^S[D0/-H MHKS7_!Y*%#$Z/%PZ>CV(*"9+U?*&)\*<>[XA[P8F #ZB"3\V/LVP-\$1B2B6A?G&L)40=CL M8+;^WHLN8BMPF:RZHITW!33,V-">I/.<@=X(P8JJ,L&YYQ.WH'-"VZG_$5,\ MZOWV3#N8+@J;)1S1@BD[>;S6H%ONQRC-'VEJ7,^*1]G$1$3Z=OU) C9X$+THB_(!%\@#1?P&XQM+S- MD_0U3>HHR_;74.D4LH-RFMOM+DH9[$I^.G*%\/C".5K4M(8=;6']CY'V:_CM MZ[+(,@JQD-3624>:U_@'SM.Z)K3K:./J?RNX<8%*LNS"FN;Q7F2'BK)%=1DQ MMN>_U I_3V)$L)&9IZ_FV<^Y28^=*/X06U)S2T:WH7YL"!";HZT)KW%V5&.N MR1KB/]@:#D13KJ>BOL/K@C2L> ::VFVFAJ1D8PRX!Y=!3[]AU3&&J@03QW)D MT^2*[AB-4QG42'<9%27E\Z1?\&12$J.WDHUHD+YYD[3#?OE%_7OL,]T4U%3 H7#1 @1 M)+V1K$3P!HOOC4IZ69CKXK5_1(2 KI,>H!M!026@"=2IAS'%C^EZ4RU7SR45 M><_[\Z&C;L=4&8@@FJWZ$,E!B/4%$;*^+U;?/T- (8AK,NFD,3^9)W40;8W_!./Q9ZD'&FR!^H_B; @\1SP#U]/7K(@XQSQ;VO^MO@ MSB4BQ_T8O,\0YS?"-TA>$ K'"YHL7KF&:WI?;U\H6ZYD,>S+(N>_+D4]Y@?6 M]U6[2K.Z,GCP'2<. ?1OV0HM F/%H]@;I%VKJQ9_O!4?*#@ MORQ<$D1%@3(U>H7/%X7E:>H-6C RGTP0&;(D#MAGE$$NBB*76BZJBJ4O=25J MN!7VB="TJSA2)((YY*U;8JRT(^42*5AF>2E)7S1L0X3I\,VE2KH-!0:Z[\%/ M[1>)^&2H1]&\2A.EJJH7E-+R^AMD6>:&+A(C;G>\697HIF%>G,46ZOT97T3? M0C BBWK;]FAOH3WII!-/&OE-@LGV"V!!IF1#\CL!W^T6^3")^$V4,O%"U:4F MLSWA>3$C,HKI.AL?]N )6W_A S'R:8]T@D)YES9-^L2/7+6< B%3ZG->O)24 M"7?&VYP;)Z39X>+X<4R8Z2.8,N-&RC=4:2D>7*QON&_]#02;E7=OFN9FVMK, M!>E]2V:D[7^-R,^1P^]!1G[U12(^>2$?R8*^,!^[9U_R=E9\B/%&R5.BR?C> M_".(K._]VF8\7GTOY)#^MTCO8U"=IT^G/DC$%^%V1WR3_Z/[Z@61WSU_ QR< M,JZ_00JYDCZP-#;.B2?Z]%_36+U:?#(3;K0A2AW2Z$.$0F=JV_PHO*)IQ=>9 M\C:7GA3O8<>&SR#:!KYGZ][3/GO?A7JQ\LOG9H@RB?%M7E:LEJ7_J@UE3YLH M5^V\+T2M19J\P^H_]>.(0K-/W^9W,&65P;JG#!':D(JKTQEZJ]&Y[B3\^WRP MZ(D+ZZNHHNT1))#]C^KU5YC/WZ,[4(P:;?,B%":@<>^>(N2H>AF'Z\6R_+[! MV#G)U[&-D-,V^MTV0FY#']VE]W]UQ__%?]W\BO\'.H#_YO\!4$L#!!0 ( M +: K5C-J2@W0&@ &!&UL[;WK M?C-+,R_RO3".R-^_B>)O_O?_^G_^ MQXS^WW_]SS=O9A%B=_F_WFA3G[ M37P1A"29G<;K34@R0O]0?/BOLQ^_???N8?;F#8#N;R3RX^33[>6.[E.6;=*_ M?O?=ER]?OHWB9^]+G'Q.OUW&:QC!N\S+\G1'[?N7[\O_*[K_5QA$G__*_N?! M2\F,RBM*__J2!G__AGVW_.R7]]_&R>-W[[[__NUW_^_'J[OE$UE[;X*(R6U) MOJEZ,2JB?F\_?/CP'?]KU;35\N4A":MOO/^N&LZ.,OUKH&A?&TD:_#7EP[N* MEU[&8==^9B9MP?[UIFKVAOWJS=MW;]Z__?8E];^IA,\EF,0AN26K&?LO16_W MU?1I%41T;(%7D&5__^XTICI)!\M[/B5D]?=O:+N4?N#=#]^_+\C_VT&C;+NA MNID&3+6^F7W7_=,G7L@D=?=$2);JAB!L;&PYV"#9 M]"%K^H%TL5ILV)2G.J45G+J7E<'=9?'R\U,<^G31.?\S#[*MR2#EO:T,]M1+ MGR["^(N1(%N=!AO:(GGTHN!?'*5YY)_D:1"1-(7C#28PX.1) RJ3FX2D5#K5 MA^_R]=I+MA3/X#$*5G1&1-E\N8SS**-;WDTQ%Z2U9DN#9>V"TU,.4-!]L.)>13]:%8C&TK@+O(0@!RYBNWV #O$EB M.I^S+<6)+9$;MBQ=DTPW/DVWP89W2T*Z5OIT.\RV]PG%REN"UBY=O^$V !(% M<7)'ECF=F50JZR!-XV1['6=:W0-T'6Y:$&KK::5VV&I $)])E&OET6@V^&+[ MBR^Z<=2:#/;9?]Y0GTOWX8-& M WH.YJZ-?7.! M3TMVK; R:KI M-]P ET_$ST.R6)WF"3MI.7_9D"5=UT[I*A%D5W'*IB5;W@*VNEVN-W29.R.9 M%X1Z)@:@[80968[IFKFE&;5);!J4LF_90/R)&E;D,A):C.88&U"S:R>;PF5$ MQ (.A;5[)3)VC5& TSJV$V"*2D^R-N9+O%Z3A/WUEGCA>@/FL,:9I M@;%Y&,9?V)$[W<+9QXN5V9@7$!D+P[\-TL^W'EM$C80,7&JE]\*WIDSD^4]N7"B)S=3:Q,TTO9$.HI>WUV M-2!-ZR% TY7*E(X%9!3Q/6-$X+2.82%L>A#3W]J&D M!H[IFRJTNI<-VR=(O1&"W\%EOLX. M_TT;^XKD_,U\5X$1LG[L:+J\F-*QF.%H.G0X!1N*XP4)OS]86$!4JVOC^$BW M;F:&+J);9H\FW$E+@PZVR@!?L1'4IP+>[N.I[+2A&FC*CU-:1\7F,?Z^G["/ MN2V4\7"]HI91^'XWG'(@3+J7$5V=S3DS)'A4EM+!>1)3'#++V72)5'09-@O: M=&#*3C:G+HL&\BC3KVSO(/Y)Z"T_OTF73[1]^F9-DBR./L8^";O/XJZ?L&'W ML9288C1T!2T#;NPJ?++NEK!@2-!*;)C+MF9.=X@':TA8BL: >WZ^B/1(&R4DJD(AO(1%2I;?/L;/W_DD^(X)A_W I<0E1/_Q!__0_(&=V2UW=[I" M[X&$G/X?M$VCR7>]1[7RT@P-DN"E*V^&[#"T^\63X%X4X35M2[EXFO M_&"L''6?O\]NKRIVI-+^F,*D'FM+;+<)7)5"[\V_!* =PX !E5_/PC63_L]]&:Y!D-,Q(Z0';K@"4H MY I586#.4TN)AD3HEOB$K-GTW86TO>73[\S1*W]1VKFLR46<+*+B,&"Q:C(Q MSQH6\=NWW_[X/0CC8P\"J"7O<;4$!YJ^>F9HKU8V\CVE*#97#UL H;.%G-R, MJI!KC1A%K'/Z?9^-X2+T'L5R;30!"O8MJF2%;&&)]HRDRR38U(M0221\T!)[ MBS(3M(!)I!7BECP&/!4U8*M:R8-ZR9!TP5[^C181)=M(4,RC*&IC'2)5V ./SB M' XMMI&@H+Y:$/N4C00 0JLQ4/P?G!"_A%54P9]'/E3LNZ9@A\HAJ3?X1)+Y M19 NO; 8T07]G2A$7ANZH#E4]KC>K)9?5/G_7^(E8.G7&D-EC^O@:G@]LN3+ M0BG[P2@7''EKJ.QQ75L=MT<6_GF4!=F6/?-QG4N"U+19NQ54V+CNK(P[%"%7 MP8PH8\^8J 3=; D5-JX7J^(21>"G=, )RS'VRQKYRV==TA.*"Z\D:R %G;GO4[FEY7\8)V]5F B; M@T^Q'$!"P:\C\G]G)O]WKA:?AV1_WLS^;^'RQ_7R]7RBRG_4_KC(KF/ MOTB.SZ6-H;+']7(UO&)*GH]_D?#J8,4#BSKQMWI ,7#!^55SC3H%"HL HO]5 M2ZC@77"$Q5QB"OPF3C,O_/^"C'"M\%EUC%\;'#FX4"L+B(+%>JT00J M:%PO6,C7L67+H$Z()U?HPQ90R>*ZMB*NCBS8JY@=RCS%D3(LW&X%%3"NCRKC M[MB+,[MSETI7A=J?P4E[N$MODY\CR_/W),CH"%CN=QZ5\2#) 9ZD*53.N(ZE MDL\CR_R.E_!GQ3D_TI$GP?Z]ZD.!B]I!I8WK1LHY/+*H;Q+"*Z=3\YUGK+'[ MNLEBM9*MSJKV4-'C>I%ZCG$AN$S3G"2F0 AZ0>' =2BAW!]["6)5=JC)]/;= MPSV[ABY9@%JMH$+'=29EW!U9R-?Q?>*Q4AMWV_5#',IOU@@;0D6-ZSHJ>#RR MM _&(99SHPE4PK@^HY OI.7B_&7)7^^1)V.(6T(EC>M#JKA$6Y\?0>OSH^'Z MC.M+RKA#$G*1.T_GV.(A#!X]^?T\90?P724G1*_@^=C7(_FUJ5H]K0OZ@UC^ MDJ90R2-?157Q>6R9YW[ BO7R(>T*2^[8D 0 ]+V@2"#?505RCW+N\#L)PW]& M\9?HCGAI'!&_&)[D*1URJEQV&@VA MTG8A UC((XJTS]:3KW:])_"5[*N_0JJ0NZ0"5O@MYODJ><5!XV5_E+VX5 M*B$0M :7C'!!_E)NL:JC[![WOF.UF;U$(GY5>R@ ;EQ@E7-\9 @6V1-)ZE87 M'PP;OBJ'0]\+"@>N(PSE'FNDN_D'\+" !*#8N.#Y&LD$ M)R*QKXO9>M9,&9=0]H-BY()3#)$ DNV4[F_-$?]D>\M>#F3)%O?D)3NA'_JL M-J4 W:% N5$3"BP/ 5[_]5V+0?K)S]5?A7\\H&;^($+][>8]6P&6;*^]UG43%YZ&XHF%)L[*WDC%Z&LO MO%,8J6J1B/Z0L2>-TK,@788Q>Q$JU3W.8$;&L6KI %2;I>S-^,5_]:$]S/TH M6\M/&U]@=T=P[:+3#8"!#.._)B%[>)YM$?N_J)^7,*'Q>B VX1K]?8KZD'3O M4XC:N@&;N;(J,!OHP8K>T%S'45(;EO1]@[*]I#EV*6JY@C4@4+([J+/0=Y[H MD!"UQ2Z1#(9!SB@Z!N7[OEJ[N-D.*'M;HC:%O"468E=Q]'A/DO5E]$P7:-FEF+*U ML#$0/6L9B2!W2,$F^J2Y2>(-2;(M<[$SNMPR^W_#ADC7696YINH%]E%148%P MC@[/@@[18SD:5\1+R6WP^)0M5I]2PCE4[#+J;E" <*,((-[1$?HUCOTO02BZ M#%\VV;> RMUR4$ C]R9'Z"*^"*(@(U?!,_&I,>]%CP$U! M6E*N4KA\4#LM> MOP8.&/?H()V5I@=+C5F3>^\% )"J#Q0 M@F+9\3>*Q+0Y[@N)Y-'VBSCYXB7^39XLG]B&M?-9!9)F'13MH7*V[*S+Y*P9 MO2.*7U5A.",;ED@DU_=60ZCX+7ODNKPG,7_H/KQ4QQ2R:?,(35=Q[QMO"SJBD;6'0F7-P0?(6ASQ%W/N C!)3M?T%EM* M;&1=H/!8BP-T@4?-/SI"IW'$&?@]R)Y.\S2C[EA2#7>K!0O6&XJ;M8"!,6XF M4D&'\##@!P=/UP\*F[50@C%L,$F@ W9'HB!.KN,,L!R*VD*!L19., 9&SC$Z M&%4HBMUU)E%:7AZ#SB%8;RA@UN(2QH"92 4=0GZX;F)C2#M @;(6P>AIJVLD M@8Z4"4A]\+$6^QC^HSEA#Z;)&$ R(H(Z H%\QAAD4X^ E0Z MEN9=J439=O=IR003-80*_QBA#^.9).<M:I_NGOGK9;@V['.("'C%AV&N>_S M4F->>.,%U#TX]39!)GPRMCH0EW6 @F*Q1K0A*!K>T;&Y)9G'EN1S+XE8W=+Y M6 \G], M!69M&O]4UHN$#]?GQM@-27CA::@_(.^/7#RL1RU9,PFA[ZZ'PRW*AL_S["E. M@G_M9[<.R'8_["IC@R$H$XF3R/''& U1J_I@EQL;&+%#43B)EOJ! @5O75XH ML/^2RC"XV7ZSH&>(Q7S+ W7&+E/6 T0#X;@$)'RK4W;"KF,V#'#.;G*M,>IV M.&D'[.)E0P+EV-YF^/*.C*LNNYK]UUP&@ NVI2&XY/NWU!>K,A>"NM9B=_P' MF#N^)SF+5[,]T=E?/D5>\: [DE->%-C8C4_OATL[8 6QGTF4DPNJJ:([6>4EF !%!]7=$%VQ4W MPTW+.SHZY^M-&&\)*:.]/&K+UOD3+SU,F9:C94 "VRW7XQ%W95 KOBLR4$+;/<7+,W6R*U*D8+V'##,+E@BOQ==Q9?@$PK#?&KM/=T0YN M\SMB%*_C*#YDK%11O8<#Z(I=R]L,8; L+&U2IT]>]$@NHPLO2'BXGC^_6%[\ MC-+ +V,WDFT+WAV]FC="=P8 M7!DGCI@J.WV;^_^=%\7^%ZORTKUBR]-T0R\%>P MM&+HNTC>HULP>W.L"BT'44[9W1]UG)!5G)!=/6^2GK]0F5',@LA+MCP5E-TP M94'I. RYI(J52'<48>FCZ'72NZ_@UJ$8L:F]X[H49AF0U2F9H -ZS78SNUK# M^*CMM&N20?S?1C/T8O"&CI&(R1'/Q-\)>WF&^/-GNBX]DNN^\6+62 TZ\ M-%C*034D@UZ"W@ST3D)"M_NJ^U-5IIL&0DES]#KV9E IF4:'1*)(9T&8T]\: M)"@9$T(O3C_(C-,)"AW@IOJ5 X;/NET']'KT_>9=@W'WM@:&8NKYAU3!1ZUMHYAWB@@X105/L1-4N<$@Y1L="4E)'AXNF&W9":A>, M0)) QZM94$<'E*P]=GIJ%X34O*-#LV.)5RXO#7^@@=;NXI@M #+.VES4%F.D MO:8V))U5)FKK& PRU6KN-P).T&VQ8A/D0YO#]OW#MLYL_% 0I/PZL%0=I=:9 M?9.X%9"P7^)L0Y(@IG:UEV2HIWT&)PS=SQ#L3R8M@H#S@9$"R'2SN&)_EB>4 MLQL^,)Z$=AI'SU1E*1B+5?%S%M -N'Q(6UEENB=99TQWT-3N*SXW5N(V%X76 M#Z\%8+K.^ <=UE]+(DS<5X>FI?7;PDU6M,@HTM6\APL M2<'W+5G&CQ&GHBG%;O_+V'<6P3IT+!#0MM.#OO&H1Z=?OPY,G6@/L4G.N\'<,%*,NCW%@?W MN0[DXRJJ;1>A&ZQ2.NA7%H=WHD8!+%?':_*%_Z7C-*UU1[_2.,CT;,G#5?0* MI>L.7ZL_^BW'8:;AX !VL'E8L;LD]<+]%?5/$17>%Q9,B1Y/8^'=0IUE "&* M?G>POP$$EYT;,[/S\= ?[QRXRM?CA(B-?Y CAO,(]Q)?GQ,B$Q =B ^)AF\) M0^2[#J=>^G01QE\DY7-_ZG+%@=&<<:).W6G8L6ITE4'0"RT.P\;"*Y91N$^V MGU+VGO>NX-)\2;WAXCTF?5&B#K3<>=M&"F0[M--18NA;IMT+T]8J(G07N,VK MU-10>HA3@KIY'H2+6:R7KLDA.>#S/AYL?MOY&G:2QV#J91,,]*7CC%!SO:O/2M4NDN"1VO;L#ZS ,A6.8C\PHH*=MG%$]+N(=]25>!KE \_(@[*T MDJ Q=I;'$;5#(2Q,8]2!ZMW6\B^.@:Y1X>_QN1K%PT_DBM!-[9;52EFLJ(C8 M@S$9S 8$$\!.\CCB4F H5'2[X>AE]*SEBAQUO8>6X)L*6KL*Y5=7 QNW\+*U M6.(QUW;#6LWC,PFHS!*V.@,>3Y MB*0!571RNR5ZX />;-'U1,\HLJ - M8NF\,A6@JV.2,W.KB*_N%TGE*88I'1=*B5O85[22PU0628RCS8@H:_7&VTI, M3T;$D(8+UIP M%7@/0:BI6F% PH6:ZC850R"O5Q;1JCRN): M<1'-F!!42<84Q03)SL%4J#8GU#VN_*=+ZC^MHV 5"!/]P,ZG 46H:C@8M>S- M.[Z.6%A3RHIOVS.RB5-ED0=(7ZAZC"F,*9/0J!4!?@%%KA F-*"*82V .>2% M+D/)C?CA3 FSE]$S20>ZJ:FD!54;^\6W>M_5!,@,W0.A_E%5!F[Y9QXDA#)! M]3K;WH1>E,TCG]4!V+ FB($[45^5D[:&PV:\6!H=-S?NH#Q7A&CG$ M[(7#;[_0F(U9^PJ6=<8I^__,TGSV0L)3-JL"X.P/U H]_$6M95&.K1W\6(8Y MJQIU_K+D%U%N*01%E5JY4AU['%#%M%]1#:Z8.%A]K)\ M0WO0?R_CB!IX.?'+ $XL]'2&@,UX%%#%ME]E[DB*W1>]W]/4IMT$1Q??V M'TAP4[U?3[7-?+,)N:"]L!+T9;2*DW6!M;Z&(90 5*5<"A<;2@?=G:SRM=GS M()H<]T9#*#KVWFHP%+6XA$J#<71 KN-H29G9QZHB?^?@\-*P@"@.G 2XGI9# M4\Q80K8*B/-BO$45[(LXN2-9%I:LL+#$XB$,'E7U$0SZ0V&R%YHUEGGI$\>E%9!(>*YR1/@XBDJ<#O.*@O M_?/LS8P9FP[-)-' 9+6!U611^#RTB!=K&YJ.G%/=>"$CN&SG+LNM)"K2.M!;.R"W>4E6%T1YJ5@ MI'3\=_EZ[27;Q>HN>&2Y>TMVW-X2C7C*_M*=![3L]I\3 MCE,Q>5AW<.\AC5'AI_8C44T//F9P=ZS98239MG5J*I_Q6ZJ_QK'_)0C#PH@/ M,O(FI+8YNU'O18_L.>_&'=KZI'O[?7/25=3X?E>G-]L3G)4447:'&KM-%O>, MZ+<]0S(X.R%HD( =T90.\L[8">+&9ME-=&YLFCR?4%"3ZV#FOFW.7-YK5NN& ME&=4?1]@>PH;XTPU+KWK.*.6%+L^3-6&WS:OC=!HQG4DASSQ%. UIE8UP(/I]JXYW1K=9_O^5@Q4V6C!-JJ>P+ 7%L5?T]FG@'YN&*90 M/ [O'0*%,GZCM+KX4+_S4#\N.YA;[YMSJ^K-C=!=__^<,0HX5V)D]SCT>QR@ M*](U']G C#8Z,RK(^QL8QN:]G@ZBG"'Z21;$\_M4(>16,K#E=!&^Q>-9LC13%(FA*RJT)0# H2 MKM#T<\/G$D/2C$R 1#!^#^N6/),HE^PAK324JC62C<,_SA*%A+7! <8;D "6 M#:<<'LB @U) M]Z,H&P9<6:"&O\L;=4X)LD%D4S:5B+*[@"\UGO&NEL] C\< MJO$9N*R[C4/PPV]!S[ZEO=S8Y6 XB,Z\->(8_VPZC=?KH'@%:1ZQ(WZVPY-( MFMOUMI534J/ @XO+ QHX][[D3)EX6(9DD.ZX008)V"]-Z2#OFIT@;EXZZR0Z M-YRZU"^ M@!5K439 M9<=9O:>5"=4>(7@JJ;H..8G:W]%-'V4/-R:.7N[U*0,0P?@GRT7UJ\N(2B+G M-J=XNK0R-W9=9_6^2%?4V>W&PF .0YZ>5O\5X'U@6'^D5[(%&!FY4& "R-:> M&8S-E[#-I.2&)7COO8AG6RL]@[7$JB ?KPG]O$F$0MD)K1)^#&S/@G2\ 2SXU6UL0/W[_]R^?_F/$>6+$N]N1I=47UEF1!0@Z3 MQD!1/3@1K&0*BA2_<)4EP4/.1LJ$#LJJT/7$C]N90MC*N8 )QXWY=9?1(3W% M(15JRG(<)L]4=X&Z>=3ZH($&?M)%=Y1= (7674&,+T( M\&'B0[J*TU1P-@"?YK"',@.0D)'MAA7HW9*\4LYD,I.0-RLO;Q@ MC!M ! ,'2A"*M- MH;C4LV=Q'H;Q%ZJG+ N&M6&:6[I\"NR[40,JA;7W"HR5 MHH_0+%FMM>>V!6]L\_36%+ 8,UK=2 %!M/9"@)D]VT=?#H".;]X<$*UTZ^G%"RJ\NN7W&^F;+#51VNW=B(&!=R=\$\/F:'C M?4%5]3=9.4 MK;=[RA'4$O9A!A2D(Q0;!P)$4):L@E%>GD@-?49]-R@0#@1E8 PYLNCMBNG3 MK?@1,G/V68_*?E"\'(B_ #FR.F\:]_3.2!(\\P>X8/,'WAV*BR.Q%U.YH,^G MYE5D\(32=@0?T.,C!V7I%9Q7[&Y6P+UY:0\HP@Z$9[2\.#(=K\F7&E-)'-$? ME]P720V=-7-*4#C="2][VMZ7JX XDJ$[GP=)UGY;#7;%:*4:&=W%=OO1?45/#TW MA%C=6 H:F82J*=\JG-1\C@YY7H_U7;K]1G)+O/ \I=B2,E>E\DP@-Q6-J*#7 MF(:^0M=%..A1AWK>9=W07D1ELG7T6), %.%^5+$O6<$A'T)ZEL+T-6T,TL^W M_/D!0Y-8WA'[!A8 (2@K+NUPTB?Y%%M=J^B9]"E(RWZCJV]"#KCIL3=K:K6[ MC+8Z>5\WG$K3)R0-&'1DJ]L/E2W2!S6K3[;[?T(B[!U(H6UJ \-L*#OKN]N. MH>(Z0MIYMX,30MO]^C_ZVEUNUH&DIO)SD+)K)/4;0(8@PHB@73X>$D 3>;EA MWDB>X559-ZTBDXK'>)%]^J_J5=X^]W,<,'W@JX2E M_/5=]&#::WN&MW84&H=TV''"$\GF+%'SD52OKES'T5+RYQ;($%-VN&_IIG5K M;E@*$G1ZV]>&0.HW#+$*@O3FA2Y$Y#(C:T6YI&&_XH8:V9N,K8(E0PJOGF.) MHW+WE/9B51OI_"50Z(ZD^5>F!!(IU*(#2.<$+4X],7,?R?J!)'*8C0FYH0!* M96Z>"IBRN#=S!ZW&1IW".Y(\!^P88O>1*V)4TCZ@#7<7M1A3NCD1!G-R199X0_X8. M/$C3..%O":@"<>WG+3B=64EHMJ*D!49[F.YJRMA_D1R_+$UXZH*B]KNCB0\F8 )DXAU8 XT MY9;)+"Q5Y2).=HY0;7V$@]:'M"-I3R: ]I>D&WMA&>Y0;8:M1X/*/NB'\\KZ M6Y S>B !I*)$0>H]/B;DL:@'N*HC!:E-!.N.?@?&",1FM2(3$;DQWYKE8%03 MKU5SH>H\H[UGO#OR'&QR WB)4MH#V^5KCHP5N%A2Z^HL"'-F;AE[?H8$L=^K MU$ I]0 [R.EP\-"*'[?1W!KV#T!R" M?!YE@<_4,W@F/-C) QCG+\LPIXMYL1FM-WE6;BNM-=M$'X;[%O:13&=E&5K< M;NSDC:I\NR-_Q8[^0ZL.2TED5E&9[\ M/73JSBN'?J5/ >]%U U]Z#D_M IB(!#\+&[!^J[.XY9V>(W@2IE%3]CF^34K MDK TG%W&*[4Q1-LU'48J_M,95=4@DH,][%?50,],\-Y:4SX& MH$OB;S3#]GEMZ'H#9J%@T(,EK^F*S; +L_H>S;OI'LUTCP8:U6AY\\6K7\J+ M-)H^V#F[ ]RD 4D%?8&L!5>J1[[V#S3N7QXJ'_[R%]$M6X$2GF&4 8T)5KQ\O)MIZ#_FL2YQM61\?@63TM!>PSJ.%UPE1Z[L!= MJ*Y460U@!U/"MK MPF\H3=?40+N"%?MK?81_I\]@6 MBG6%LXN;&VP&Z0MHRL8;Z#G>HD!%EJ M6 XI6_0]1L16_=WI.EMSZJD]0TH'*$1F2AO;&NVL&]V$Z+X^\(RN>9X]Q4GP M+^)_HOM$4N./OTI^LCU_("\OMT2 M*JF /<[%^?L4!=2@8NOMT(N1\8>P[=9!-*FC>!U2&VHYLP0*X@M9Z:PDG<@" M5>('1U2BA^@<\3JZ/.1W1C(O""6>2>N-@^H3[/7*\B.SZBNSXC.SXCNS_8=F MQ9=F?RF_]36_9SGED U]HF+^AON4-S;EC4UY8U/>V)0W-N6-(>>-23(?"EU6 MFV_*- @3 M@Q)9M)9*:RL.G/I4E66P?HO_9K /W''Z?Y.@]YL;;SU8H.]88D M0>PO5G,_YE$,R2).N\)ZNC%7!UK-P5S;R3OK":5TD0:PYK&;E] MYZ#_WWEQ.T6Z^D($TZ*"%H8UP,-\ DJ$9:F,SVF\7K, KQ?N7X%MO%S\:T+7 M$]F.">[^>I+$S/AV KV]4O7$L4X(VP)"@K0MRQJX5 ;4)J,?O"KD*^64L_E, MDH$SU>02L32GVA_4SB=U%R F/XX $SVSSNY9Y?NB MV7;WLJ@$3%%#((0_C01"N2PLS:GV![5S2MT%",C/HP7$K3DU0.7+C#JLQ*\* M)_D,U_<$1P-& #"8Z:[3^T,QO2-69+9L._!C>IJA:R>W M"0$H]&.)!)D+SXU,-G[G9[&ZJ8N?CC]?K[UDNUC=!8]10)K67!:G-G6>M^>?Y*EM=4_RA^[+S_+_E;[\&S_Y5GUZ5V&VVSW]2G7;9"T M5OG#[]!'MG44W#@>-GK!H2F2ML %,*HI20SS>$H M2XNFF[PBH8RV:C4:-R@BCNQDBL&%K\H>$#3#3Q20*(Y8QIC'_[?D.4AYD>6; M)(B3XD#[EBQ#+TWYM@_/ >A("NTD4@R" *@>$D+W&J5S_V3+,LO4:;*@SN-> M[4PX12_H)6>-?E27!@OJ[ :8!DH+Q;'.I)T$UMVG^/MK212PYZ#8S\$+^TE> M9(WUAG;&/NPRT,"Z4VXF&Y1<5'X[5F'D[?_LQASI8][M>:DE&AQ9U$I+HM[ M 6.NJ1I-60Y4$["3,,L'YU3B;#1!6T.:XFH)4\@+RFKPT7O12O6P"=H9MEZJ M(E[0#=,R[)/>>%M^OSCQ?%)>K]7&Z\2=D)-4X:&>9NE1O230T3KUTB?*$_L/ MX^O9"]D%E'EVZB7)-H@>>;$K.6[ [MA)J9TA-!*/@P?*O\?)9SK,4V\39%XH ML5&;C; S3,W1$G'AR 1S)(/#6L9IYZEE,U%CN)/4N51Y%\ :;@K&^O ]!4 M2*-!]2QGU3B+B&]_A ^I8>>\6D=;)#QTY*5&CC9BFMTU@OS5G4YJVORO\7L:B?+#E:OZ$?Y.';&;6J!^EV*N#6; >F.GWG;WB0V$XT8*7JV8W!/3ULOHK'0C*"]IX',S-8Z4 MY>-^5):/XV1G032K",\.*/,1U:=X^N;!]V2C5'1P MX[E>D.SK@0J]##H'DC;<*+O+O"2S$$S:<>JE3R;8"=JC!00'PDXJ M>AJX^Y MW*1UZ F[H,4(AP)0(0C',6RO&X>A3^TM@BZ$T,*,UA9;G= 80%H2FHD>)=ZG _SUE'#BU$ M>;R-82#?[7C[@L!=Z:4570BB12PM^GRCUXRVLO_J!>P!PO@Q8@\(&:\.S>YX M)02L+0=B"8T*Y/VA2G=O7T@#KVR -;@5LK+LY;6L47/88"2@J+D;CS.0E&W0 M!-M$!]R@5*#0.1M:,Y37T0,KQNOB'^_@J#@;\!*S-4B ^SPZ:@C$=($T@<_9 MX):0JS&@-\P!DPF&[L:B)(Q9@A$AL4*51J$I6O13,Y]"DSG1MPS1"',H!JPY M=!J'=.AQ(/@/ ;(J!(M5;:3J^B:2YE^9$DBD@/XZ8)M3 M3\R<])9V=<'6E) ;"J!4YN8=8E,6[=1 F3]X2^\C21Y)U*$2!7J.+E91+ O[LIG"8XM_JMK!^5-W0#[W6MZY^]V':2C$>PTFN M@[7>!KN4A^(A7/6Z*^W@QJ0ZVJ(KE8.=$F(] M(64_TKU?5Q,1T-4-F#5J"\"JP995^U]O\KMA:((U1V#7.[6JW555;$]95=K% MBI_JJ=AU' M?&1SK5DG:(N]ULDUJ143EC&*OLR5AZ/I?5PNT]4"3E+9.]?5+79M3^3J@38. M2YH%/H#20X>9ZRC+N"5^O8@,OX]1WZN5NQN8!':H\0C(&PL4704$EEGQ?--E ME!$ZZ"PMV%DD/#.;/92:LZ6*+G"*O1H9_)_K83OL1E&=8*- UJSZHFR18 M$CH7^.\4BXF\"_JN?H3%0RKN!K;E&-X"%,8N?"J@8Y\GVH_??<5*$N)1!['>NVMM4>!QH3<@+N#FL/Q%C..'8G_Z"6?":L7?TOX,P"M46NB\]#^ MV('!CJK=@-=,6OAN6%DIEH^6N1-/P4:+J+(3=HAF&!@!$/^> M+)^B.(P?MX7[IL-/VQ';+1X&0Z!\T'%4<*LY9M/W1#YF,S'TX?ND6\=GBH'6 M'L^9K^,D"_XENSJM9UI*R^%]LP?&&M&AH]X<[S7)SE^68>[3K;]RZ.4XPWIC MGW;U0-9$/.A8*OBDX^XT6WD_ATVA'C.S)A+,I_5LHGY+F%E!5;6^]!2'^(HS MB,X$L8^M[.@)1(ANG"_4 K %/V]"Q0F#IH+"+\VCAHKZS(O\69V^XJRA;UF% MZ=1A.G683AVF4X?IU&$Z=9A.':93A_&=.DS!S=<1W*S,C,OUQ@L2_I"=,J0I M:S_>0*9: LX I(=DU*%&YX).AVI!_%K L]M<49(8<2C16%#HT'*^]F,[??*2 M1Z+ 4=9^Q/%#M0C0$=J/;+%JLE9PS2,TB@ ^E,"(8WN&0G(CEE>_QKQ>LRQG M+[PE7GB>LDNQCCR35!^N$C;%# M0D>N7$H\!XTN2@CB M/5]9+L>@/[8OK-.J>@T=8[&@&^C7<49JH]/DP8E;(X>,U/MC8Z*H^+54N70> MAO$7]LC:19PP96 NM-!+Y568)(VQ9P%,R"H.6C(^^BMC0T\69D'0'L&X M%@42+_NJP,^/WZL"/SMZ,TJ0QWMF!;FXB;"Z=-3 I);F(&A#R '1_ME) MM.'RLF38'=B4M0!-<5?^U$N2;7$3+Y?&LD;,O1+S/J M"ZN#?@>H$Q^=4J-XSC\1ZN,)C1 MP&Z<65$(U+.;VR#]?.NQ8FK*\YJWJO,:1F-6$)E.: :X']_42!8)H5/&OXR> M29KQ7'^NE_^';IC\T0(_X&,RN3_?\QMNY,AU2?3MSSM^6C"(ARO0?7LC.FZ@ M/OQF*S;'BZ]&9=/S?0 MA>@M$"^[2<^EF41MPCQ19C>+&F(?CL-TJ![2D;/K8N#&W4BJQ1N''0P 2S'6 MT?M BSQ+,R_R=U%*=>[:.Y4O5*,U*XGU](DD*])^!'2;(^LH6+&]CHO&>PC8 M]J=P@!@%$P+83M'0S^6JG*/AOH6\QYJ"K'&K&HC5?MFDN9?F1)(I(#NE;4Y]<3,Z2II&1-R0P&4RMPL M4V+*HAT/[N;T]-/\,2'\LTH73M@2VX?KJ'%UITXA 72OCK^J23V(.'JL[LTH M;#51X]?_V+E"1I8R7CY%:?7-,L6#/9M,5WT>2)!,'UTG[)ED$RD(_X[,.-A4 MZS3'QOPTN&9VF<4ZLCCS0I%>G8T9KMB$V1CLZ3,4U/ MXXB=H)-HN9TOETGNA?.L2I[[S0MS1? "V!UKBQPD$&$D(D>OZ(EY %[+@W9& MVU_[P6S"HI40M LS_L;;\OW,=*KO^Z%MT18G>5,J#M[%% ^\O,(42$N^Z+NA M7>VS-9O;,GF-\SB)GX-4^0R=MB/:_3Z;,[DI%P?<(/N6%^IEO.,97Q:OYKG@ M-*V"TJ4'ILS^ '">&,VJH.U@2;1?KQLU9=%B'A!/F;539NV463MEUDZ9M0Z@ M.[K,VGO:2ETX6-@2^S2I>VZM@&%+QWC'2%ZV5EO(I>1EG7R#9Y@&UQMB5VGI M(=\6NY;E>Q>\@,1;:X==\:*[=%O,VA8N>2813+SUEMCU"'H(N,VP91&?L\<# M02(^:(E^G;J[C 4<.Q#QLY;XX/1U#V#>$&JH;1;>_RX MEV#@-W&2K>(PB._(HSX$!B;P>I$6\XL>^ *,%/#&.Y2$&_ :JK,YMJZ\Z2YZ M4*(Y5MVE%!,:V/$W8V5N73,SE9Z,#X@[1US*EMO" M*F'.(W^1/9%$5UP-U'D,#JC,)FS,. -AN>&>RJS^TH.\9A>Q6':JV#_]J>F? M-L@)LN=G.Y*3=]KG&5"-&RIL_!K\32%C^([EX; KJ.T@QLVI4+9E( XY>>Q MJ&!6O?I+OZ-VZL2MQP:'F MTOZPY+)T3)FOO!APJQ=+@X8HO55ZX9D5J=Q'>+VZRBV]:[Z[00&(2-L3,8C(!0L&L'BC3):C#0?^TAH/_XXY9= MHI5L"O3OM3^[L>P =H'#8=<JW=%)F!^#*%CG M:Y4X&TW0EN:FN%K"%/*",O$_>B]:J1XV00LUZ:4JX@5]9SMKW[PDX$$S.O03 M+U6Y6&94L(W,/J#")(0.*V-*4?*F,O(.6F%'WV$]:N%1]L._Z=4=++PETL*3,\4>>.Q@5 M93_DH"362#0"V()^7NFG2)7_%>V.'4X5>)FC!> M3W7I,[*.6="YG AQ&F2GWL9;ZLI,_Z(*U=:)SDJJLXHL=L3VEO!9?^-1C.M5 MQB%O#^MZ8L=K92,\V1[\!1J\-2+G1I0!BJXTD&O$,WY45S)<0$Q7W],-1'MI M=P-F/<_XP5W)&-5!766GKP9'1R*ZDM'I8KF:;FZ@"-!.&%9V*Y2=>E'D/01I M^?&3/&4/NJ2D^D5IE,AC%XR**1%L9PBD=_6[>MVD9.DR964?SK.[X(6:W[MD M(0U&FE[8T=L.H(#D8 D%-LZ()*=Q&">>'Q<))I\B.F+U^VO:;MAQ66,#>V '8'M,#)!=+Z%P%ZX"5_:Y&HP1#UAB[ M#INQ[-5<'WU%XD78+W(6^NBX. DHH%=N&W"AD@H(/<9]54M?U![W"=I"47)C M6U[+CK];UTW-_1E#!JYP*2R1G1])CQV!XS9HOQ'4F> U:3 _:JL;H+ MMKLYP//&$)F@KXWU9?N"VCVLFD-Y.^DD3I+X2\TB@NUB>BK(1^S0J+)B@X-* MRK5+"[>LQ'!.+JA(%AN2\ ^HJYE^4!V%E>1F3,2S/<'I$&PZ!)L.P:9#,(<. M3ZZL'X)I;B_?)+&?+[-%4E@$B@H&XI:O""DICW;.MF# ,".O'$PJ/988.@K879M4$K=K4/0$@_[:"[;N*HO,P#*AQ M2&#R!_1#.W\R10 L W2'#+:P=DJ8$-)X11M+!^[18UWU(9GD4#BRZ700N18S M5RZ]U<>DBS2*VF*'L.2JI1"^0X:F_>C>Y$[@HZQR M)]RHR#"Y$Y,[,;D3S8J#+/DNW;\4?$VRTSQA[,O14/<:IY,!D80S<-UX6S9" M,%#-]BY-G0X8B=E'1Z?V+*/"_*\WPBZ5V!$' :-NN.*R?1+T^/=/[YKN=TEN MQNG-Z@0'>_U[\K?;TX@]&09Y:J;1SFU33>1YE?)SRG%5Y:S6ON(I+R'&UC(-4J)1YT12RGSA,Z_I(R#WM!A!VD: M)]OK.%-7YP7TPRY;K=.B0R,)* 84(VE_Z,U>\F%G;]E3[%]&SR3-&&_MWQ+" M^)4;4OTHNC&GM,96/R9+]?SAJ :9;$@JHTS7!]\P&T)_:[CJ&!Z5 ??'.]S+ M%C"-,S'C&$>.&'*[)>(T]-)TL;K+XN5GM3VGZ#*&94_/14V9<$"I#TEGUXG: M.@:#3+4:B(@XP4Y<8G>GXHB/;*X+^8O:8D?'Y)K4%+Z444LAR7D4Y5ZX"U)? M$+)_!$6R4:B[(.\L3^BHZ9"#V)=/ M!&A_[(,6/62&#-F=,,W+FV/=$99->DR_\3TH/$M8?".-/Z#": M"63@TG;'Q5X[^YH6Y CU=/R!DOZ!#!A/ J"=K];:K:F.M6@!QL_90H<&>>U5)@(+HK*0ZVY.=,;K8E0"8&;,?NOX^@JP]]JW_NZHT1T[5CY0JI!0*-:2WJ7#N(ZCGO"T M*6#'< ="2"8:='_U5=V1,]]IU#?FID>*IQMSIK>!MD9W@-JML;>DX6[^R"2! MON8AG&E9"^\HO;?NQUKC?QQF7^RQ8'(1<;==%2KZ 5H]LJ XBZ,9HSF%B:8P MT10FFL)$;FQG4YAH"A--8:(CW2%S/3#DF.%]%4>/U<3^Z&5E>8!;LO&VW-]8 MK&Z2@)IT&R^\C*ZI^7?_A83/Y&,<94^*1:TGV3&9\(-(<%QZ\'^)E]Q_B0>" M?T<->X;;@[TAL!&B33^LL/V[TD//S+:+>%UHX\/\(LX54U272:"K\_ MMD*DL PZ]"J_(P^2CKJBKUD@=*KC:V?MBJZ&\"E*-V09K +BJPK *)H[4/M%I4 'Q7JD3-B)6EX$JVS+;/?S M/W-FV:74,@BYP:<,6NJ[H?FW:BFV Y90":#;N*\I46"Z^WJ,NZ\N5U6P>/=5 MLM2=E2X2*]<9^/P-TC@JWYZ1+'/J+N@A/%!Q!0C;KEVONB)>2D[C5)TA\Y,J M0X:3F#$:/3-B9-JT^S#_DNJ!%HZ"M#G.NK5[A'NQ 0 516[1]H ,,@@*RTF.\'/%/^/F[.'(GZ*7N,8N?1]3!PG1LZB+GZ&/L!ZM@R5F0S4I(1[1, M ]/)"9>"VW.TXX0TJ'H]?)+ T/-/6/"ZRPYX'O6:< ,C_3MA;!)__DQ_^TAN M"8LC5W]D[LQ;*/@02F@Y";VU 2XGQZ9R8^!,""S"S&*496BR(\!"2FCE[H8& M6"$GUZ*)%WE&6?Y(U7&=%]&'FS*I2>DS_J+R&0N:LY)H&6VLR$[>HS#(0G<) M6U%>C'YIL?V-*HW"_.W/WM2F'^F: ,:4Q^?M=Y?15*,=\E9%D M. UID!M3(*"7Q-"C =#1]X=X7-Z_J5P&/5EV2 4^17X9ZB#^^#X=10P:C MMJ\D+%['T;(CTO6NX+B-PVBW13'^6GB%/.C\T ^]%Y\&N;[[.^/I(;V5V MR22=+F4.B\$X+V7>LCJP\HN8M3^/0;R'(T:Y<,F_+[WV5PW0D=+,A_(2RW*@ M$LN=A%F>#*O$V6B"=N34%%=+F$)>[/@+.JEZ+UJI'C;!O(>JD:J(%W0O3.39 MMY-YS((?HOYCN8%J)@]T^%!S]/'OFYIFZ+L TA'B3XA74(V#3R-UJ1+,#:K.2'':1]W(8%U0=3N.(^VJ_!]G3:9YF M\9HD^H)&8 *3+VT^*0W1F;QK!]R_XWO7!@!<1DNJ./NQQ<7E#'5Q=V6G$4&B MY .]P+MD=+HJ[YIN;L #4#L85G9+*)5O%<]9-1-JTBRBA]A+V,LLQ6B4=92 M?;'M;Y"6'18=,9")I7HO=]Z*_,.CYF%RD\2/B;<&X*'I@UW"UQ@'D S0_:'+ MZ)FD65$A2 G13@SB]M@578W@T?#B##1%R28H,*+6:(DMO6"1\XT.BL; /W]9 MACE_:RQ-6?3*O_=>.KMB8F)CB=[UD-3X0Q*'L0?UH?O/;YM!B&:H ;UH\A1T MF((.4]!AE$&'E"R_?8R?O_-)4,B>_K 7.?W''U?DT0O/HXP]U"H.*]!6K49C M$+)HW(.&#?3"+3XMC0G0)H$/4.R#C)Y-0;6$=#/ M>:,5R(^!':CL#$B3:4N[S'S)[R>52VQ9 M+DY:"%'2&/U]+]"&HF;UB+NXP<:-'\KMOED[LYY3>-6-R%;%9C=J,DCO>U1@Q.^"K M,KKN4^2M\]49&#)3W,V!D- 4=YOB;E/<3;[=G)!H^;3VDL][^RJ]NCI5!MTT M?5R.N('8133RA[2#L['X70,.(+(X>-:-[QXF!-V#IVD7L@&TC"(:4/)(S\\5:XG4?=#;D-PV<)UI+DQ^^LZYUX2%7*X M>Z)R3D^\-%C.(_\L"/.,2DEU<^>]ZN9.27A&*<\*TO\YX\1G7N3/2O+8-WG* M0:85^_HL&GD/G 7VFI2AXZLX5?B*C6;(-HA.[(WU5 M-_2ZIU3Y&>Q06]'RRH(]DC16^8A]#[(#"N.QN M4\E8BG<(YR#_\&5$?7,OY%[]4QQ2V@-A8#. ^/+KMY10C MOR64[V#).&$:V'$7;%$9F&G:* MX@"K+%1D;D]0[("AM1Q(IP.&^,]V8"B%P9/-UNH9V%2+ 5YQ[GV\(%GVJX'_ MSE);H3W2T6&AEC&)O@)?1LN$'R][X6F\7L=1H3_SC&[\#WG&$F/N MXRJ S2QVG@\P9UP\\G[J4F&]::.]\M%M4@XG3K>,+'D(N(<98AHFMO"ZQ_%L M+KNQ9"=V:'=.C]ZB!["0CH]$UAOJ.0-G\>176V%1 MK(?X18F1]28O1K'+X%&^YO[SCZJCA]K'9X1_?>;QS_-4G6H LVH$,X;VK#:& M6KI/W\??QW\>(=M02BG6M+C0(6\_DD,$#1=6M^^]Z<#4E$1I*9R=_7"R M;5L73.47&WXY_5>5B3T4\3$=,@PK4,Q=O7/,^SX^(8/&O>4$1WR"T4%PH[;Q M0)Z,4536Q$4:($"+?H R%+^O0)GF41;X;.H$S^2.+'.6>D[TEM].PIJ7>03H'V M6KZ,%_#%?#V!Z6I^YZOY4'2FR_EV40'=&U<,?[JB]BQE)$YF/@9_&7Z-Q+,Z7P!.W0[$V !*5L61+C;R3Q"?FT<3 M@.,(Z_6"IX.)Z6!B.IB8#B:F@XGI8,+RP40]$NU%7I&5=WVE*QRL[^;R 0:4 M:7Q?L)IVIZ&7IJ69)ED\FC.UW64,2XF>BUK,#LF7JPU)NN!4SH^@K6,PR%2K MZ<8)..FY) WD5?.1S76O;(O:8H?ZY9HD]*%%C*(O4:=>^C2/?/8?=@7EF;J3 M49:JURA5'\=FAVJ14K%1BT)CE="NJDN(ARG^K6X6]:/J!K9ZC6T5ZN[#-/HB M28>E71QK;;#/5X907,%$=6S9O*>T%ZO:31CUBBEI[L:$ BV6$@YJIT-(R?.U MV^%4K:[CR-O_IA;ZU"Z-QH3< $^IB,V<>%,6[?BLL@"/JGUTV-$ L91Y=$:6":'?N2S3:)A?+,LMDK1U M/[]+,7A')OR*)&H&R:;NE^]E;TJ%+I8^0G566\KD*O(<@Y%?H87E9OS3S MLDI"LQJEXR5DM;D IV*INDY)6)V3L/2(3.E71XD?.I)^U0N HG8>LS?B2']Z MJ>DV1EC$G R:PM6I*M_AL'3)%I+FC@&B4K;FBUEBANQ$U6_RAS!85J7WE+%T M<5/L\)]26^I&JXI32PX!]4*>*?XWH;?D2@ 3LZ83=D0.+G 0][9$S]&>1WXY M"@,-EW?"#J@9ZKJ.>UNBO[PYAXE;T! [8@$7L91+2V*=/WA+#R1784OLDTZP M8!5\HH<6ILS<*3/7-@Q39B[::<>KR,PM>"@7T$5RR^+BH(<#]#W'DH\!E8&M M]T#*S4M]$%@O>=[ES ^Y%(V"2?0YP(]]^!&0Y@BN;(/M4ID=DQTPABYKX5P[ M?R'),DBK8[A=9?_BK^E;PT5(3P[;,^NW-$'%->YB&"+.=V6/=K663[TP)/[) MMBD$0Y4Q(8QM=O13'G,1HJ\9U<#FD5^,K+8WWY-D+<=:WQ,[@ &$RH$-TYT M:[7 O2#A->:*C#LZ_-IQW$?BL7,Z?\$R _(D*=]*5+\W]$%9*)Q^;L:_-RL^ MR-\9JI\'5]^[)@6)H3J,'_(0;;KZ91C26C &E@7\0/@0SK376C@9=N7;\/OC,LZ!H5RX= M^N\8.MF6PV?S[2(A?^8D6LHJLS2EH>K\E2F&2A3H&02[48K&J L1@SH[AK9> MJV4XJIC$#B>+!IGN5%<78(;UQ@ZV&:@J $*9=- ]OIJF\I6I")U#5]UF%\=F MG_VUMBD ]#.W!N\RM^]3%#^D).$IRI?1)L_HGV/J688!QZK.&'A9'OR+CFF3 M;(:H3;0!Y6$IT>P(62'V5VE+ZHZ:6'*L%$!KER:.BL[7E47XUMJ)R5%!P\Q$ MK.E#N7 FO"0'H^?.KL%#,)>N2_[G[\1\!'2O5 MT>T5>28AV!E5]G?,E[#OF2JE@5X.41@C:0^Y2TA00<8Q)0"I/"2X).?8F4@A M7]-2SMU;<(!0U D[):R3YLI E$O%G86Y-L;W79![;[H5CPVY]XXA5]M2=L/= M9W'(P=/U0TXRMG(LW8 7)CK7$G].J6>V91P799DHX[O!IXO51=5U7P5(F?7S MR_>JK)_J6[/R8SSI9Y\*E/+,H.J+L]HGIXR?(YG1)UY(I4_NG@C)?DWB?,/2 MUH#)/,K>;EA/P^3I*!EU* 5'-,K=]-K?3/)XFK]1UDUGRFZH@8G"2Y6@JPA< M39OA>UR7E)E:QU<$KX1#]"R8FSCATLQV0Q48&SI3VXB(^\QG,RK849#^ M:'>1&CK47VFTNM4(P3[V1JO_ BA"+$+[#%]G!30U96#A)[!->$[%P"9H:,K?K+-Z*S( M@ 2V8VH);F,ACKI&Q'RYY,<]^\+F1NH"[([MU=I:&4R$A[XZ7,5>E-YX6V.0 MM1V=L9B'A17.\RMLQRE#9=Y!?8Q4JS/IN4WFW8\2PCEUFRG[.PZNL,F5:):Y;<3CGDHPQ M2\(YEI L2KS^/6D)(#Z5P*#(N$4V:PO!?0DYW[N+# ^[Z#"']SA'/#=73 MV+_+O"1#38(94#"7:9H3B+L]W*>PS7JW-/,0 /05KW&=8.[_=U[$%^4JHNB" M[2<, +56(.B0C7>3^N,=OF/BUFJP$\L@.]5YY+MT.E?<.1-)JY".\ECNG>I8 MCE.>O:\?S]6HSPKRTW'<=!PW'<=-QW'3<=QT'#<=QTW'<=-QW'0VRAJ1A7NZ;?4)JR\ MAQM&24\+5LX>>A4\T=!T)JBJCQMXZ300@(\KY>N:8SM_(#HE. *\%L<4E$JWW>4R$'2'?U]Q]ZS0RD7YU"\#=+/%PFA M!FU&J*BS6^H;FD*IH@'UQJRY8[WQU$L('=3*F9]'_FWP^$3MW#Q+,R_RJ:7; M9$<.JQF5\2=)=9&:TU"S3:,;O$5/;(O2,J9U\;RFJ[ORY( 4D!WPOGMV0#JE M![AQACRE!TSI 5-ZP)0>,"8(I_2 *3W@]:0'X-YL>A6) V.YV30=DTW'9-,Q MF7(U;(70J)0R]>D)ZZ?OAKT>F@7SH6)P;DD#G;A(3_4Z'\*X&P.V=RP#G$%S MWP^8M+SPHY?E29!MJY79:$;IR6#?I>XWPZ!B6YF[B MP B.TII#9J%Q]A90%RQ%?='K'O<&42X1=/ 8+XO5G!T!/?(!J_TR27,WC/R> M3IF$MYJEA71+?C\B=DAW3??J_6_NZ4^IM^0U>G63S9B0&[ J5;1Y@=Z414M7 M7\J(S/R1+MWLTXN--F%?TP?;RNRHA8?/8 "D@KXBMBM9;^$)(:#.X\\#,9"1 M)6]/,(*ZQRF98]I>V-&2/MB &)2"@I"/<>^]E%D0UVPM8:,6)US\T$RXH#UW M&12S76>T7(IEO":,&8.'!I6=D([6JR$QC8E2D":A^-J MULU3GSX4&AZ11VKR-^NB'!?68B&ATV/')'-##H^;>,+(OMJ0P@'H1@U]6376 MB#Y20S=A((.?9Q>$W7?D3WWD= S;@\;]-$!+'/OZL!V% ,H473^J!SSIN(I3 MZOJ;+03P[*FT(_:QA3FN0%FX83']\R;T(IC-]&/39OKA^[=_^?P?,T;!'=NI M_H0L2T F65#X$":VE!$1M!E'S7;_-(ZR)'C(V4@9$!^]EV"=K^=1E'MA_8_, MVC]?;\)X2PC]<4DTCQ'W)XYLLW50A/9$'DK$+BS0(E[*X28?O8Q*,WH\^'O! MPF+%_VBL+":DL:TY:[IB+E]7-06D]?,U.Y2PLZY4M+$-/=QUY5#";M@0@@?L M%JLB$IO^RFX"$?\D]):?WZ3+)]H^?;,F219''V.?A,IK,3\!W[*C_RH_-RN_ M-RL^>%=^\"/_X(Q_$?NBS/F?>9!M]39(LQW.:K![ME%SO:79SHV#'K&L&].Q M.73\*RF[$;4BLPK!7[EVO42L.C+A7UF_*I(F64WX]%][P=-__''+CIXD9]7T M[[4_CT&\AR.V\G83Y,8B8<: 29Z,)FIW4 M%%=+F$)>[-B].JD6)I=2JH=-T,)1>JF*>$'W)O@!XXF7,G.W9C?O#_I/MOLF M9>6\.;N"4K_UDJ\+ZZXZ>#P+G@.?&JGJL/(1/HT^$E7(A_OR9 M)-YC[3[ $3=AS1BPCPIQ-!$$C!NZ^*!G^<'$ F$):&\UNF?IF]CEDLUTS:K@ M70M"WV7Q\G,1#^;Q^9 E3%U&JSA9\X\I0\X_JT+.G'(9:IYYD3\KB<]JU*?P M\E&VJ#+>7ZLL=IVK[RI8^!2R^P>+;MN2<.?J;:X\0SJ@9!I[\$%1Y:-HI'H MV([BL145 L?K4-\N&[M67K>$W42LLA4H8KD7LAW_G053J\]@L#U/N%KCP.2& MT=]C2O/#_/229J@U ;'\-V*8^R2^9FKXOHB3%0FR/"%'6-R$'\,N!G:4Q4TA MYE%?8^\][P2"05H8C4<"C@B[K;F6$!K]RHAY+/8'/#)KK\ >SM'8'Z+0:Y?3 MA?/(\:7QE1R-F>BJ \<(QQ'(Z]'@UK%+$8::Y]E3G 3_(OZGB&);BTJQ:YCI M@4!XSGWY&W;/9B%,NAKLQ QA@%#]=^",PP5QN9GSU)[ERBRG7U193M55VAJQ M*:G):.W9IZ()5VV0UIYLVWJKNX-K^;MNW'N$+1>61>' '>'N?+6YN@+<,[;T M/3>4ZCA3%F33]1[;ZU=?"]1:1^#TC6&#M+U^(,J1>45LO*4G'O@X_>?XGA -4:8R<#8@#4 MDM51 *)-#>;007/L+"D4D-KR.@9,%W&>P%&JM\9."L$ J2TM1X^9.HJA. )9 MK&IAHS*2="0[234 [$(=5IUUFW:3'E770J&W),WH\#/B<^X^14&6*H.A'U3! MT#VU\O8GIS?%0X>,AT(.]'N&/@T^X8:;-4B4TX!K5P.:@!/.SL%+,]INZ,7@ M[Y2T\W-@-PP,Z.A%B !.NJO C:GPIJZC"B3 M.1<J0B(;RU=TGP(3OJL7>RQH4R,KBB^CE(/=B762(#B MUW//O(SLJD"A3@G Z)Q?K!V>+F#P7\=,&BJ-L!T3,#:0Y@CI,0@_C5:*V3=I'Q$+%KRHQ>[[M82*]M8OS&;47, MY;PY C=S/9Q6:S&(K_L>]T#"WR>OVR20+G" MLP$<\?MNIHGUT=4C"W"\BA@D_19>ZX(V'"!V):(1JG(G%7C%]G=9S 37!!<, M KL(T@@M"BF4KU]]62T>)RUIL_&A%U :K]8;:< KGA#NY1PX4;IIA(HM$.,@ MYZ5N%M&!OUTP6';!D<: 7@KJR(>>-I'\RE7_JWE=Q5Y=*&_S0J"NS#R;$=S"BB#GJGW,JZUN@!PHYT;9@3PD?G#H3L0 M8*U&! F."MJZ(7RQZLB$;S^(F"993?CT7WO!TW_\H0KWT;^[%Z!3BO=PQ'9" M8!"!2NW6:H!0"]6R4 _E)99E-50K+H)&F!^]EV"=KU7B;#1!NZ7?%%=+F$)> M[%CD.JD&D5:JATW0+HGKI2KB!=W/89[;8E6S?M6Q+4GS,:RX:@[08U-U7YNZ MTM27\/:_N:<_I=1"8EZ&+M)@3,@-\)2*V(PKFK)H)[1_$2?,+[S)D^43=1;G MCPGA(U"&^'6=L&_L=]3#>A@?)A?TI6_4X7S(4B<.O[^?PN]3^'VTX??S]2:, MMX34XH"Z#5'1Q?G+S,.%W;6"0U^/;ZK@*!]B,_HKQU?7#SNX+0T6-1""\3]P M-!D3XALO621'S+NY-);N_=F!M!!1_0:K'U0$HC ,:A.V9%CD@74"2A^3-G!*#L+A6*F MHH!>2+0;>'JAH*.X']=BQ<=\1M)E$G"S3(Z:Z\#7 :& M/CIL,$M=V@$]Q-)Y-CEFH[?&!S+0U;WPZYIU1L>";2XYYJE]^A\D]$^V=_E# M&OB!EQ2Q.='9 >L(Z(=??DLK?R GK\"2F(><+G4BA%'9\Q?VHV*W@O;'KSL% MG71F$D%?(0>M=#(]]V2UVI.1M^*"R%[! MP0'\>OXF2DU\?!XA7DLFMZ/(O['^8WTM_\_\# M4$L! A0#% @ M8"M6/D@/N6M&0 QN, D ( ! M &5X,BTX+FAT;5!+ 0(4 Q0 ( +6 K5AEW2?B[@< .!" * M " =09 !E>#,Q+3$N:'1M4$L! A0#% @ M8"M6$#:.XWV!P MI4( H ( !ZB$ &5X,S$M,BYH=&U02P$"% ,4 " "U M@*U8DDOXZTT$ !A&@ "@ @ $(*@ 97@S,BTQ+FAT;5!+ M 0(4 Q0 ( +6 K5@#C>4B7 0 (@9 * " 7TN !E M>#,R+3(N:'1M4$L! A0#% @ M8"M6)>MSLM?.@( [)@7 P M ( ! 3, &9O&UL4$L! A0# M% @ MH"M6'_%U%[=E0 /+X( !4 ( !BO " '-H9G,M M,C R-# S,S%?;&%B+GAM;%!+ 0(4 Q0 ( +: K5C-J2@W0&@ &!\# end XML 115 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001854963 2024-01-01 2024-03-31 0001854963 SHFS:ClassCommonStock0.0001ParValuePerShareMember 2024-01-01 2024-03-31 0001854963 SHFS:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember 2024-01-01 2024-03-31 0001854963 2024-05-13 0001854963 2024-03-31 0001854963 2023-12-31 0001854963 us-gaap:NonrelatedPartyMember 2024-03-31 0001854963 us-gaap:NonrelatedPartyMember 2023-12-31 0001854963 us-gaap:RelatedPartyMember 2024-03-31 0001854963 us-gaap:RelatedPartyMember 2023-12-31 0001854963 2023-01-01 2023-03-31 0001854963 us-gaap:PreferredStockMember 2023-12-31 0001854963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-12-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001854963 us-gaap:RetainedEarningsMember 2023-12-31 0001854963 us-gaap:PreferredStockMember 2022-12-31 0001854963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001854963 us-gaap:RetainedEarningsMember 2022-12-31 0001854963 2022-12-31 0001854963 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001854963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001854963 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001854963 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001854963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001854963 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001854963 us-gaap:PreferredStockMember 2024-03-31 0001854963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-03-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001854963 us-gaap:RetainedEarningsMember 2024-03-31 0001854963 us-gaap:PreferredStockMember 2023-03-31 0001854963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001854963 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001854963 us-gaap:RetainedEarningsMember 2023-03-31 0001854963 2023-03-31 0001854963 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2024-03-31 0001854963 srt:MinimumMember SHFS:EquipmentAndFurnitureAndFixturesMember 2024-03-31 0001854963 srt:MaximumMember SHFS:EquipmentAndFurnitureAndFixturesMember 2024-03-31 0001854963 SHFS:CreditExpectedCreditLossesTransitionMember 2022-12-31 0001854963 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2023-01-01 2023-01-01 0001854963 SHFS:CreditExpectedCreditLossesTransitionMember 2023-01-01 0001854963 SHFS:AbacaMergerClosingMember 2024-01-01 2024-03-31 0001854963 us-gaap:CashMember SHFS:AbacaMergerClosingMember 2024-01-01 2024-03-31 0001854963 SHFS:AbacaMember us-gaap:CommonClassAMember SHFS:MergerAgreementMember 2024-01-01 2024-03-31 0001854963 SHFS:AbacaMember SHFS:MergerAgreementMember 2023-10-26 2023-10-26 0001854963 SHFS:AbacaMember SHFS:MergerAgreementMember 2023-10-26 0001854963 2023-01-01 2023-12-31 0001854963 us-gaap:DevelopedTechnologyRightsMember 2024-01-01 2024-03-31 0001854963 us-gaap:MarketingRelatedIntangibleAssetsMember 2024-03-31 0001854963 us-gaap:MarketingRelatedIntangibleAssetsMember 2023-12-31 0001854963 us-gaap:CustomerRelationshipsMember 2024-03-31 0001854963 us-gaap:CustomerRelationshipsMember 2023-12-31 0001854963 us-gaap:DevelopedTechnologyRightsMember 2024-03-31 0001854963 us-gaap:DevelopedTechnologyRightsMember 2023-12-31 0001854963 us-gaap:MarketingRelatedIntangibleAssetsMember 2022-12-31 0001854963 us-gaap:CustomerRelationshipsMember 2022-12-31 0001854963 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001854963 SHFS:CommercialRealEstateLoansReceivableMember 2024-03-31 0001854963 SHFS:CommercialRealEstateLoansReceivableMember 2023-12-31 0001854963 SHFS:RiskRateFourMember 2024-03-31 0001854963 SHFS:RiskRateFourMember 2023-12-31 0001854963 SHFS:PCCUAgreementMember 2024-03-31 0001854963 SHFS:PCCUAgreementMember 2023-12-31 0001854963 srt:MinimumMember us-gaap:SecuredDebtMember 2024-03-31 0001854963 srt:MaximumMember us-gaap:SecuredDebtMember 2024-03-31 0001854963 us-gaap:UnsecuredDebtMember 2024-01-01 2024-03-31 0001854963 us-gaap:UnsecuredDebtMember 2024-03-31 0001854963 us-gaap:UnsecuredDebtMember 2023-12-31 0001854963 SHFS:RiskRateThreeMember 2024-03-31 0001854963 SHFS:RiskRateThreeMember 2023-12-31 0001854963 SHFS:RiskRateFiveMember 2024-03-31 0001854963 SHFS:RiskRateFiveMember 2023-12-31 0001854963 SHFS:RiskRateSixMember 2024-03-31 0001854963 SHFS:RiskRateSixMember 2023-12-31 0001854963 SHFS:RiskRateSevenMember 2024-03-31 0001854963 SHFS:RiskRateSevenMember 2023-12-31 0001854963 SHFS:RiskRateEightMember 2024-03-31 0001854963 SHFS:RiskRateEightMember 2023-12-31 0001854963 us-gaap:CommercialRealEstatePortfolioSegmentMember 2024-01-01 2024-03-31 0001854963 SHFS:IndemnityLiabilitySegmentMember 2024-01-01 2024-03-31 0001854963 us-gaap:CommercialRealEstatePortfolioSegmentMember 2023-01-01 2023-03-31 0001854963 SHFS:IndemnityLiabilitySegmentMember 2023-01-01 2023-03-31 0001854963 us-gaap:EquipmentMember 2024-03-31 0001854963 us-gaap:EquipmentMember 2023-12-31 0001854963 us-gaap:SoftwareDevelopmentMember 2024-03-31 0001854963 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001854963 us-gaap:LeaseholdImprovementsMember 2024-03-31 0001854963 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001854963 us-gaap:FurnitureAndFixturesMember 2024-03-31 0001854963 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001854963 SHFS:PartnerColoradoCreditUnionMember SHFS:LoanServicingAgreementMember 2023-03-28 2023-03-29 0001854963 SHFS:SupportServicesAgreementMember 2024-01-01 2024-03-31 0001854963 SHFS:SeniorSecuredPromissoryNoteMember 2023-03-28 2023-03-29 0001854963 SHFS:SeniorSecuredPromissoryNoteMember 2023-03-29 0001854963 SHFS:PartnerColoradoCreditUnionMember us-gaap:CommonClassAMember SHFS:SecuritiesIssuanceAgreementMember 2023-03-28 2023-03-29 0001854963 SHFS:PartnerColoradoCreditUnionMember us-gaap:CommonClassAMember SHFS:SecuritiesIssuanceAgreementMember 2023-03-29 0001854963 SHFS:LoanServicingAgreementMember 2024-01-01 2024-03-31 0001854963 SHFS:CannabisRelatedBusinessesRelatedDepositsMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:CannabisRelatedBusinessesRelatedDepositsMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:CapacityAtSixtyPercentageMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:CapacityAtSixtyPercentageMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:PartnerColoradoCreditUnionMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:PartnerColoradoCreditUnionMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:CapacityAtOnePointThreeOneTwoFiveMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:CapacityAtOnePointThreeOneTwoFiveMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:LimitingCapacityMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:LimitingCapacityMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:PartnerColoradoCreditUnionLoansFundedMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:PartnerColoradoCreditUnionLoansFundedMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 us-gaap:LineOfCreditMember SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 us-gaap:LineOfCreditMember SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:LoanServicingAgreementMember 2024-03-31 0001854963 SHFS:LoanServicingAgreementMember 2023-12-31 0001854963 SHFS:AccountServicingAgreementMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 SHFS:AccountServicingAgreementMember us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 SHFS:CommercialAllianceAgreementMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 SHFS:CommercialAllianceAgreementMember us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 SHFS:SupportServicesAgreementMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 SHFS:SupportServicesAgreementMember us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 SHFS:LoanServicingAgreementMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001854963 SHFS:LoanServicingAgreementMember us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001854963 SHFS:SeniorSecuredPromissoryNoteCurrentMember SHFS:SecurityAgreementMember 2024-03-31 0001854963 SHFS:SeniorSecuredPromissoryNoteCurrentMember SHFS:SecurityAgreementMember 2023-12-31 0001854963 SHFS:SeniorSecuredPromissoryNoteNonCurrentMember SHFS:SecurityAgreementMember 2024-03-31 0001854963 SHFS:SeniorSecuredPromissoryNoteNonCurrentMember SHFS:SecurityAgreementMember 2023-12-31 0001854963 SHFS:SecurityAgreementMember 2024-03-31 0001854963 SHFS:SecurityAgreementMember 2023-12-31 0001854963 2023-03-29 0001854963 SHFS:FiftyFourEqualInstallmentsMember 2023-11-05 0001854963 SHFS:SeniorSecuredPromissoryNoteMember 2023-12-31 0001854963 srt:MinimumMember 2024-03-31 0001854963 srt:MaximumMember 2024-03-31 0001854963 SHFS:DepositActivityOnboardingIncomeMember 2024-01-01 2024-03-31 0001854963 SHFS:DepositActivityOnboardingIncomeMember 2023-01-01 2023-03-31 0001854963 SHFS:SafeHarborProgramIncomeMember 2024-01-01 2024-03-31 0001854963 SHFS:SafeHarborProgramIncomeMember 2023-01-01 2023-03-31 0001854963 us-gaap:InvestmentIncomeMember 2024-01-01 2024-03-31 0001854963 us-gaap:InvestmentIncomeMember 2023-01-01 2023-03-31 0001854963 us-gaap:InterestIncomeMember 2024-01-01 2024-03-31 0001854963 us-gaap:InterestIncomeMember 2023-01-01 2023-03-31 0001854963 SHFS:PartnerColoradoCreditUnionMember 2024-01-01 2024-03-31 0001854963 SHFS:PartnerColoradoCreditUnionMember 2023-01-01 2023-03-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-09-28 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-10-13 2022-10-14 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-10-31 2022-10-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-11-01 2022-11-30 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-12-31 2022-12-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2023-01-31 2023-01-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2022-12-31 0001854963 SHFS:BenchmarkInvestmentsLLCMember 2023-03-12 2023-03-13 0001854963 us-gaap:CommonClassAMember SHFS:MidtownEastManagementNLLLCMember 2022-06-16 0001854963 us-gaap:CommonClassAMember SHFS:MidtownEastManagementNLLLCMember 2022-06-15 2022-06-16 0001854963 us-gaap:CashMember 2022-06-16 0001854963 2022-06-15 2022-06-16 0001854963 2022-06-16 0001854963 SHFS:ForwardPurchaseAgreementMember 2022-09-30 0001854963 SHFS:VellarMember 2023-12-31 0001854963 SHFS:VellarMember 2024-01-01 2024-03-31 0001854963 SHFS:VellarMember 2024-03-31 0001854963 SHFS:MidtownEastMember 2023-12-31 0001854963 SHFS:MidtownEastMember 2024-01-01 2024-03-31 0001854963 SHFS:MidtownEastMember 2024-03-31 0001854963 SHFS:VerdunMember 2023-12-31 0001854963 SHFS:VerdunMember 2024-01-01 2024-03-31 0001854963 SHFS:VerdunMember 2024-03-31 0001854963 SHFS:PublicWarrantsMember 2024-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2023-12-31 0001854963 SHFS:PublicAndPrivateWarrantsMember 2024-01-01 2024-03-31 0001854963 us-gaap:CommonClassAMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember 2024-01-01 2024-03-31 0001854963 SHFS:AbacaWarrantsMember 2024-03-31 0001854963 SHFS:AbacaWarrantsMember 2023-12-31 0001854963 us-gaap:CommonClassAMember SHFS:AbacaWarrantsMember 2024-03-31 0001854963 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001854963 SHFS:PurchaseAgreementOptionMember 2024-01-01 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeLiabilityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeLiabilityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001854963 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-03-31 0001854963 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-03-31 0001854963 us-gaap:FairValueInputsLevel1Member 2024-03-31 0001854963 us-gaap:FairValueInputsLevel2Member 2024-03-31 0001854963 us-gaap:FairValueInputsLevel3Member 2024-03-31 0001854963 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001854963 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001854963 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001854963 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001854963 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001854963 SHFS:PIPEWarrantsMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember 2023-12-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember 2024-01-01 2024-03-31 0001854963 SHFS:AbacaWarrantMember 2024-01-01 2024-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2024-01-01 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2024-01-01 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2024-01-01 2024-03-31 0001854963 SHFS:PIPEWarrantsMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember 2024-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember 2022-12-31 0001854963 SHFS:AbacaWarrantMember 2022-12-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2022-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2022-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2022-12-31 0001854963 SHFS:PIPEWarrantsMember 2023-01-01 2023-03-31 0001854963 SHFS:AbacaWarrantMember 2023-01-01 2023-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2023-01-01 2023-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-01-01 2023-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2023-01-01 2023-03-31 0001854963 SHFS:PIPEWarrantsMember 2023-03-31 0001854963 SHFS:AbacaWarrantMember 2023-03-31 0001854963 SHFS:PrivatePlacementWarrantsMember 2023-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember 2023-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember 2023-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember SHFS:ExpectedTermMember 2024-03-31 0001854963 SHFS:PrivateWarrantsMember SHFS:ExpectedTermMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember SHFS:ExpectedTermMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember SHFS:ExpectedTermMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember SHFS:ExpectedTermMember 2023-12-31 0001854963 SHFS:PrivateWarrantsMember SHFS:ExpectedTermMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember SHFS:ExpectedTermMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember SHFS:ExpectedTermMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001854963 SHFS:PIPEWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001854963 SHFS:PrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001854963 SHFS:ThirdAnniversaryPaymentConsiderationMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001854963 SHFS:AbacaWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:MeasurementInputResetPriceMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:MeasurementInputResetPriceMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputExpectedTermMember 2024-01-01 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:MeasurementInputAdditionalMaturityPerShareMember SHFS:PurchaseAgreementOptionMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember SHFS:MeasurementInputAdditionalMaturityPerShareMember SHFS:PurchaseAgreementOptionMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputPriceVolatilityMember SHFS:PurchaseAgreementOptionMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputPriceVolatilityMember SHFS:PurchaseAgreementOptionMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputRiskFreeInterestRateMember SHFS:PurchaseAgreementOptionMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputRiskFreeInterestRateMember SHFS:PurchaseAgreementOptionMember 2023-12-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputDiscountRateMember SHFS:PurchaseAgreementOptionMember 2024-03-31 0001854963 SHFS:ForwardPurchaseDerivativeMember us-gaap:MeasurementInputDiscountRateMember SHFS:PurchaseAgreementOptionMember 2023-12-31 0001854963 srt:MaximumMember 2024-01-25 0001854963 srt:MinimumMember 2024-01-25 0001854963 SHFS:ForwardPurchaseAgreementMember 2024-03-31 0001854963 SHFS:ForwardPurchaseAgreementMember 2023-12-31 0001854963 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001854963 srt:MinimumMember 2024-01-01 2024-03-31 0001854963 srt:MaximumMember 2024-01-01 2024-03-31 0001854963 2022-10-01 2022-12-31 0001854963 SHFS:ExercisePriceOneMember 2024-03-31 0001854963 SHFS:ExercisePriceOneMember 2023-03-31 0001854963 SHFS:ExercisePriceTwoMember 2024-03-31 0001854963 SHFS:ExercisePriceTwoMember 2023-03-31 0001854963 SHFS:ExercisePriceThreeMember 2024-03-31 0001854963 SHFS:ExercisePriceThreeMember 2023-03-31 0001854963 SHFS:ExercisePriceFourMember 2024-03-31 0001854963 SHFS:ExercisePriceFourMember 2023-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember SHFS:ExercisePriceOneMember 2024-03-31 0001854963 us-gaap:RestrictedStockUnitsRSUMember SHFS:ExercisePriceOneMember 2023-03-31 0001854963 us-gaap:SubsequentEventMember 2024-04-05 iso4217:USD shares iso4217:USD shares pure false --12-31 Q1 0001854963 P5Y P1Y 10-Q true 2024-03-31 2024 false 001-40524 SHF Holdings, Inc. DE 86-2409612 1526 Cole Blvd Suite 250 Golden CO 80410 (303) 431-3435 Yes Yes Non-accelerated Filer true true false false Class A Common Stock, $0.0001 par value per share SHFS NASDAQ Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share SHFSW NASDAQ 55431001 5626362 4888769 153208 121875 1111390 2095320 1111390 2095320 506634 546437 16891 13780 12620 12391 82657 7427105 7761229 379863 381463 45366 84220 820777 859861 6058000 6058000 3564890 3721745 44278374 43829019 525000 562500 4584221 4584221 18875 18651 67702471 67860909 179242 217392 125693 577315 645635 1008987 2692 21922 142863 132546 3028738 3006991 2921257 2889792 62160 41639 7108280 7896584 2908642 4164129 594000 810000 7309580 7309580 10241884 11004175 421907 63275 835598 875447 1315263 1382408 30735154 33505598 0.0001 0.0001 1250000 1250000 111 111 1101 1101 0.0001 0.0001 130000000 130000000 55431001 55431001 54563372 54563372 5545 5458 107348166 105919674 -70386394 -71569821 36967317 34355311 67702471 67860909 4050799 4180379 2280038 3659520 984220 1538874 460950 449246 69437 87742 -68787 66666 3725858 5802048 324941 -1621669 184535 -190943 154172 643260 -1255487 -433148 1285850 -401055 1610791 -2022724 -438885 -609277 2049676 -1413447 55213609 25670730 0.04 -0.06 56268075 25670730 0.04 -0.06 1101 54563372 5458 105919674 -71569821 34355311 -990 792000 79 866170 -866249 75629 8 -14325 -14317 576647 576647 2049676 2049676 111 55431001 5545 107348166 -70386394 36967317 14616 1 23732889 2374 44806031 -39695281 5113125 14616 1 23732889 2374 44806031 -39695281 5113125 -581321 -581321 -3720 4726200 473 5004727 -5005200 629728 62 1570719 1570781 11200000 1120 38405288 38406408 900500 900500 -1413447 -1413447 10896 1 40288817 4029 90687265 -46695249 43996046 10896 1 40288817 4029 90687265 -46695249 43996046 2049676 -1413447 195709 751225 562330 1570781 27970 14104 873289 -68787 66666 9552 17762 -438885 -609277 184535 -190943 -1255487 -433148 31333 30716 -983930 -182824 13019 -77303 -77436 3111 146106 550000 -82657 -150817 10048 75000 -38153 -533945 -451622 -65288 -363347 -466849 -19230 78616 386602 8500 -224 1475123 -232040 548671 3014 1019268 3014 470597 740544 -740544 737593 238557 4888769 8390195 5626362 8628752 156414 38406408 581321 <p id="xdx_80F_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zG4Pzwx8rffi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1. <span id="xdx_825_zUrHsHLOk6ic">Organization and Business Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business Description</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHF Holdings, Inc. (the “Company”) originated as business operations conducted through Partner Colorado Credit Union (“PCCU”), which were transferred to SHF LLC (“SHF”), then an indirect wholly owned subsidiary of PCCU. The Company completed a strategic reorganization on July 1, 2021. This involved transferring select assets and operational activities from Partner Colorado Credit Union (“PCCU”) and its wholly owned subsidiary, Safe Harbor Services, to SHF Holding Co., LLC. Subsequently, these were consolidated into SHF, LLC (“SHF”), with PCCU’s investment managed at the SHF Holding Co., LLC level.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2022, the Company concluded a transaction wherein NLIT (“Northern Lights Acquisition Corp.”) acquired all outstanding membership interests of SHF. This acquisition prompted the renaming of NLIT to SHF Holdings, Inc. As a result, PCCU emerged as the largest shareholder of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company executed the Abaca Merger Agreement on October 31, 2022, facilitating a two-step merger through which Rockview Digital Solutions, Inc. (“Abaca”) became a direct wholly-owned subsidiary. The transaction expanded the Company’s fintech capabilities and market reach.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company generates fee income, investment income and loan interest income through providing a variety of services to financial institutions desiring to service the cannabis industry including, among other things, the origination, onboarding, and servicing of cannabis-related deposit business for and on behalf of those partner institutions; Bank Secrecy Act and other regulatory compliance and reporting related to these accounts; onboarding these accounts and responding to account and customer service inquiries; and sourcing, underwriting, and servicing, and administering loans issued to cannabis businesses and related entities. In addition, the Company provides these services to financial institutions under a Safe Harbor Master Program Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zET6MF8bL5E" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 22pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2. <span id="xdx_82D_zHDzVDAzHb84">Basis of Presentation and Summary of Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zdzSmGctzy5h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>i. <span id="xdx_862_z46EQK4FTTH5">Basis of Presentation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the “SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary to state fairly the consolidated financial condition, results of operations, statements of shareholders’ equity, and cash flows of the Company for the interim periods presented. Except as otherwise disclosed, all such adjustments consist only of those of a normal recurring nature. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results that may be expected for the current year ending December 31, 2024. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the years ended December 31, 2023, included in the Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company has made certain immaterial reclassifications to the statements of operations for the three months ended March 31, 2023, to conform to the presentation for the three months ended March 31, 2024. These reclassifications, totaling $<span id="xdx_904_eus-gaap--AccountsPayableTradeCurrent_iI_c20240331__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zpuJZVYgnfH6" title="Accounts receivable trade">190,943</span>, were moved from ‘Interest Expense’ to ‘Change in the Fair Value of Deferred Consideration’. Corresponding adjustments have been made to the statement of cash flows and the applicable notes to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of SHF Holdings, Inc., its subsidiaries where we have controlling financial interests. All intercompany balances and transactions have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC and the instructions to Form 10-Q.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zffGhqa66p88" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zSZG3ugK8ru2">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Material estimates that are particularly subject to change in the near term include the determination of the allowance for credit losses, indemnification liabilities, useful lives of intangibles and the fair value of financial instruments. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--LiquidityAndGoingConcernPolicyTextBlock_z1QnWOMCEru6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>iii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zxfIyKoBEpZj">Liquidity and Going Concern</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company had $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240331_zlhKYgfQ9MTf" title="Cash">5,626,362</span> in cash and net working capital of $<span id="xdx_90F_ecustom--WorkingCapital_iI_c20240331_zISA5Yb9iyC" title="Working capital deficit">318,825</span>, as compared to $<span id="xdx_902_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231_zb11dvqLovFf" title="Cash">4,888,769</span> in cash and net working capital deficit of $<span id="xdx_903_ecustom--WorkingCapital_iI_c20231231_zJ6vcSEPyLic" title="Working capital deficit">135,355</span> as of December 31, 2023. The retained deficit was $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240331_zBAVpPmvHin4" title="Retained deficit">70,386,394</span> on March 31, 2024, and $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20231231_zUK8G5t7paA5" title="Retained deficit">71,569,821</span> on December 31, 2023. The Company has also generated operating income of $<span id="xdx_90F_eus-gaap--OperatingIncomeLoss_c20240101__20240331_ztPc1UZVofm1" title="Operating income">324,941</span> for the period ended March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the period ending March 31, 2024, the Company reported positive operating income and net working capital. However, considering the historical data, where the Company experienced negative operating income and negative net working capital, management acknowledges the need to closely evaluate the financial performance in upcoming quarters to mitigate any going concern risks. As of March 31, 2024, due to these historical trends, there is substantial doubt about the Company’s ability to continue as a going concern for at least twelve months from the date these condensed unaudited consolidated financial statements were issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company is not able to sustain its present level of operations, it may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned expansion programs. Any of these actions could materially harm the Company’s business, results of operations and future prospects.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result should the Company not continue as a going concern as a result of this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zRoObVrAl74c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>iv.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zPZc41WNo6ma">Cash and Cash Equivalents</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash on hand, amounts due from financial institutions, and investments with maturities of three months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zMaJWKI4Fwj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>v.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zTpFkhxhrEw6">Concentrations of Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash. Cash balances are maintained substantially in accounts at Partner Colorado Credit Union (“PCCU”) which is insured by the National Credit Union Share Insurance Fund (“NCUSIF”) up to regulatory limits. From time to time, cash balances may exceed the NCUSIF insurance limit. The Company has not experienced any credit losses associated with its cash balances in the past.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently the Company only services the cannabis industry. Cannabis remains illegal under federal law, and therefore, strict enforcement of federal laws regarding cannabis would likely result in our inability to execute our business plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently the Company substantially relies on PCCU to hold customer deposits and fund its originated loans. As of this time, majority all of the Company’s revenue is generated by deposits and loans hosted by its PCCU pursuant to various services agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had only one loan on its balance sheet as of March 31, 2024, which comprises <span id="xdx_902_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_uPure_c20240331_zmQ3yQZazMDd" title="Percentage of total loans receivables">100</span>% of the total loan balance. The Company also indemnified 21 loans as of March 31, 2024; three of these indemnified loans were in excess of <span id="xdx_903_eus-gaap--LoansReceivableBasisSpreadOnVariableRateDuringPeriod_pid_dp_uPure_c20240101__20240331_zV3ucenYFB3a" title="Percentage of loans receivables">10</span>% of the total balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_zcVz88prJxf3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>vi.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zc5RgDjyQCXi">Accounts Receivable</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded based on account fee schedules. While fees are generated from accounts for individual cannabis-related businesses (“CRB”) related accounts, amounts are initially collected by the financial institutional partners and remitted in the subsequent month. Accounts receivable - related party represents amounts due from PCCU under related party contracts disclosed in Note 8 to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--PolicyLoansReceivablePolicy_zPCW5q6coZSf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>vii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zATeMsM1t7R2">Loans Receivable</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRB loans that significantly support the Company’s operations are recognized as assets on the balance sheet. These loans, intended to be held either for the foreseeable future or until their maturity or full repayment, are recorded at their outstanding principal balance. This amount is adjusted for any credit loss allowances and net of any deferred loan origination fees and costs, as applicable, to reflect the net investment in these loans. The Company recognizes interest income on CRB Loans over the loan term using the simple-interest method based on outstanding principal amounts. This approach ensures a systematic recognition of income, aligning with the time value of money principle.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest income recognition is suspended when there is uncertainty regarding full loan repayment, such as in cases of loan impairment or when payments are overdue by ninety days or more. Loans under these conditions are placed on nonaccrual status. Any accrued interest not received by the time a loan is placed on nonaccrual is reversed from interest income. Subsequent interest payments on nonaccrual loans are recorded using either the cash basis or the cost recovery method until the loan meets the criteria for reclassification to accrual status.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans are returned to accrual status when they become current (less than ninety days past due) and when there is reasonable assurance of future payment compliance, evidenced by the full satisfaction of both principal and interest payments due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans are assessed individually for potential charge-off, which typically occurs at the point of foreclosure. Charge offs are executed to reflect the realizable value of loans that are deemed uncollectible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The determination of a loan’s past-due status is based on its contractual repayment terms. Loans are either placed on nonaccrual status or charged-off ahead of their contractual delinquency dates if the collection of principal and interest is deemed doubtful, ceasing the recognition of interest income on such loans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--LoansAndLeasesReceivableAllowanceForLoanLossesPolicy_zpWrfwvfOQa4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>viii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zV0mNtkkur2l">Allowance for Credit Losses (ACL)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted Accounting Standards Codification Topic 326 - Financial Instruments - Credit Losses (ASC Topic 326), for estimation of probable credit losses with an expected credit loss methodology that is referred to as the current expected credit loss (“CECL”) methodology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ACL is a valuation account that is deducted from the amortized cost basis of financial assets carried at their amortized cost, including loans held for investment, to present the net amount that is expected to be collected throughout the life of the financial asset. The estimated ACL is recorded through a provision for credit losses charged against operations. Management periodically evaluates the adequacy of the ACL to maintain it at a level it believes to be reasonable. The Company uses the same methods used to determine the ACL to assess any reserves needed for off-balance sheet credit risks such as unfunded loan commitments including Indemnified loans to PCCU. These reserves for off-balance sheet credit risks are presented in the liabilities section in the unaudited condensed consolidated balance sheets as an “Indemnity liability.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ACL consists of two components: an asset-specific component for estimating credit losses for individual loans that do not share similar risk characteristics with other loans; and a pooled component for estimating credit losses for pools of loans that share similar risk characteristics. The ACL for the pooled component is derived from an estimate of expected credit losses primarily using an expected loss methodology that incorporates risk parameters such as probability of default (“PD”) and loss given default (“LGD”) which are derived from various vendor models and/or internally developed model estimation approaches for smaller homogenous loans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The PD is quantified by analyzing historical data to determine the rate at which loans have defaulted within the portfolio, relative to the total outstanding loans as of the end of the reporting period. This rate is expressed as a percentage and serves as a key indicator of the likelihood of default across the loan pool. LGD assessments are conducted to estimate the potential loss amount in the event of a default, considering the recoverable value from the collateral liquidation against the remaining loan balance. This involves a detailed analysis of two primary components: the loss on principal, which arises from the gap between the collateral’s liquidation value and the unpaid principal balance of the loan; and the loss associated with various ancillary costs to recover, including, but not limited to, foregone interest, transaction costs, legal and administrative fees, and expenses related to the maintenance and renovation of the property. The Company considers relevant current conditions and reasonable and supportable forecasts that relate to its lending practices and environment and the specific borrower and determines that the significant factor affecting the loan’s performance is the fact that these borrowers are involved in the cannabis business. Despite being legal at the state level in certain jurisdictions, cannabis remains federally illegal in the United States as of the date of this filing. As cannabis related lending is a new practice in the United States, there is very little historical or industry data on which to base a loss forecast. Therefore, significant judgement is required in creating a reasonable loss estimate, using similar non-MRB loans as a baseline and adjusting for the inherent risks in the cannabis industry. While the Company considers other qualitative factors, including national macroeconomic conditions, in its overall risk analysis, it has determined that they are not significant inputs to the overall loss estimate calculations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ACL estimation process also applies an economic forecast scenario, or a composite of scenarios based on management’s judgment and expectations around the current and future macroeconomic outlook. Expected credit losses are estimated over the contractual term of the loans, adjusted for expected prepayments when appropriate. The contractual term of a loan excludes expected extensions, renewals, and modification under certain conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoveries on loans represent collections received on amounts that were previously charged off against the ACL. Recoveries are credited to the ACL when received, to the extent of the amount previously charged off against the ACL on the related loan. Any amounts collected in excess of this limit are first recognized as interest income, then as a reduction of collection costs, and then as other income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--NetDeferredLoanOriginationFeesAndCostPolicyTextBlock_zQIeaey0Ekga" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ix.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span><span id="xdx_861_zA2z87bPAl7a">Net Deferred Loan Origination Fees and Cost</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When included with a new loan origination, the Company receives loan origination fees in conjunction with new loans funded and any indemnified liabilities which are not recorded on the balance sheet from the company financial institution partners. Where applicable, the loan origination fee is netted with loan origination costs associated with originating a specific loan. These loan origination costs are typically incremental direct costs (non-reimbursed) paid to third parties. Net loan origination fees are initially deferred and presented net of loans receivable asset for portfolio loans, or as a separate liability for indemnified loans, and recognized as interest income utilizing the interest method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--IndemnityLiabilityPolicyTextBlock_zsePYxTbkgc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>x.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zWBZAx05vOwe">Indemnity Liability</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Loan Servicing Agreement and Commercial Alliance Agreement with PCCU, the Company had agreed to indemnify PCCU from all claims related to Company’s cannabis-related business, including but not limited to default-related credit losses as defined in the Loan Servicing Agreement. The indemnification component of the Loan Servicing Agreement and the Commercial Alliance Agreement (refer to Note 8 to the unaudited condensed consolidated financial statements) is accounted for in accordance with accounting standards codification (“<i>ASC”) 460 Guarantees</i>. In determining the applicability of ASC 460, the Company considered that the agreement outlines a broad indemnification of all claims related to the cannabis-related business. The most immediate and potentially significant of these are potential default-related credit losses. In the lending industry, it is inherently anticipated future credit losses will result from currently issued debt. The Company’s indemnity obligation is subordinate to financial institution clients’ other means of collecting on the loans including foreclosure of the collateral, recourse against personal and/or corporate guarantors and other default remedies available in the loan agreements. Since borrowers are not party to the agreement between Company and PCCU, any indemnity payments do not relieve borrowers of their obligation to PCCU nor would such payments preclude PCCU’s right to future recoveries from the debtor. Therefore, as defined in ASC 460, the indemnification clause represents a general loss contingency in that it is an existing condition, situation or set of circumstances involving uncertainty as to possible loss to the Company that will ultimately be resolved when one or more future events occur or fail to occur. SHF’s indemnity liability reflects SHF management’s estimate of probable credit losses inherent under the agreement at the balance sheet date. The liability is measured and recognized in accordance with our accounting policies for ACL and ALL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to default-related credit losses, the Company continuously monitors all other circumstances pursuant to the agreement and identifies events that may necessitate a loss contingency under the Loan Servicing Agreement. A loss contingency is reported when it is both probable that a future event will confirm that a loss had been incurred on or before the related balance sheet date and the loss is reasonably estimable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z8V3CQpLXMF1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xi.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zHgG874JrMc9">Property and Equipment, net</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at historical cost, net of accumulated depreciation. Depreciation is provided over the assets’ useful lives on a straight-line basis <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zsiYdq7US0v7" title="Property and equipment useful life">3</span>-<span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zPpHtVeWarqe" title="Property and equipment useful life">5</span> years for equipment and furniture and fixtures. Repairs and maintenance costs are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company capitalize certain costs related to software developed for internal-use, primarily associated with the ongoing development and enhancement of our technology platform. Costs incurred in the preliminary development and post-development stages are expensed. These costs are amortized on a straight-line basis over the estimated useful life of the related asset, generally five years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--RightOfUseAssetsAndLeaseLliabilityPolicyTextBlock_zTw7dZWQRTX1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_ztAJPZOY4Pkl">Right of Use Assets and Lease Liabilities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into lease agreements for a certain facility and certain items of equipment, which provide the right to use the underlying asset and require lease payments over the term of the lease. At inception of the lease agreement, the Company assesses whether the agreement conveys the right to control the use of an identified asset for a period in exchange for consideration, in which case it is classified as a lease. Each lease is further analyzed to check whether it meets the classification criteria of a finance or operating lease. All identified leases are recorded on the consolidated balance sheet with a corresponding lease right-of-use asset, net, representing the right to use the underlying asset for the lease term and the operating lease liabilities representing the obligation to make lease payments arising from the lease. The Company has elected not to recognize lease assets and lease liabilities for short-term leases (leases with a term of 12 months or less) and leases of low-value assets. Lease right-of-use assets, net and lease liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term and include options to extend or terminate the lease when they are reasonably certain to be exercised. The present value of lease payments is determined primarily using the incremental borrowing rate based on the information available as of the lease commencement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease expense for operating leases is recorded on a straight-line basis over the lease term and variable lease costs are recorded as incurred. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. Finance lease interest expense is recognized based on an effective interest method and depreciation of assets is recorded on a straight-line basis over the shorter of the lease term and useful life of the asset. Both operating and finance lease right of use assets are reviewed for impairment, consistent with other finite-lived assets, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. After a right of use asset is impaired, any remaining balance of the asset is amortized on a straight-line basis over the shorter of the remaining lease term or the estimated useful life.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z7xTaVJmLWDe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xiii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z4ZhLczjjrw9">Goodwill and Other Intangible Assets</span> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s methodology for allocating the purchase price of an acquisition is based on established valuation techniques that reflect the consideration of a number of factors, including a valuation performed by a third-party appraiser. Goodwill is measured as the excess of the cost of an acquired business over the fair value assigned to identifiable assets acquired and liabilities assumed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is tested for impairment at least annually on the elected impairment test date of December 31 unless any events or circumstances indicate it is more likely than not that the fair value of the goodwill is less than its carrying value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived intangible assets are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. Intangible assets should be tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zC3rqwPPCEZh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xiv.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_z3QEg3sQneni">Stock-based Compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company measures all equity-based payment arrangements to employees and directors in accordance with ASC 718, Compensation–Stock Compensation. The Company’s stock-based compensation cost is measured based on the fair value at the grant date of the stock-based award. It is recognized as expense on a straight-line basis over the requisite service period for the entire award. Forfeitures are recognized as they occur. The Company estimates the fair value of each stock-based award on its measurement date using either the current market price of the stock or Black-Scholes option valuation model, whichever is most appropriate. The Black-Scholes valuation model incorporates assumptions such as expected term of the instrument, volatility of the Company’s future share price, risk free rates, future dividend yields and estimated forfeitures at the initial grant date, by reference to the underlying terms of the instrument, and the Company’s experience with similar instruments. Changes in assumptions used to estimate fair value could result in materially different results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The shares of the Company have been listed on the Nasdaq stock exchange for a limited period of the time and also the stock price has dropped significantly from the date of listing, based on which the Company has considered the expected volatility at <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240331_zJ5ixjoP94Vl" title="Expected volatility rate">100</span>% for the purpose of stock compensation. The risk-free interest rates are based on quoted U.S. Treasury rates for securities with maturities approximating the awards’ expected lives. The expected term of the options granted is calculated based on the simplified method by taking average of contractual term and vesting period the awards. The expected dividend yield is zero as the Company has never paid dividends and does not currently anticipate paying any in the foreseeable future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84A_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zIqjMdwbqYDj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xv.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zqO3LYwMTphb">Fair Value Measurements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 — Quoted prices for identical assets or liabilities in active markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 —Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zGzRF4Ib2mRb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xvi.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zOGloSqS2qRi">Revenue Recognition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHF recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which SHF expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is recorded at a point in time when the performance obligation is satisfied, and no contingencies exist. Majority of the revenue consists of fees earned on deposit accounts held at PCCU but serviced by SHF such as bank account charges, onboarding income, account activity fee income and other miscellaneous fees. Under the terms of the Loan Servicing Agreement and the Commercial Alliance Agreement, the Company is responsible for covering account hosting costs associated with the fees generated from deposits held at PCCU. These costs are classified as “General and Administrative Expenses” in the Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, SHF recognizes revenue from the Master Program Agreement. The Master Program Agreement is a non-exclusive and non-transferable right to implement and utilize the Safe Harbor Program. The Safe Harbor Program has two performance obligations; an implementation fee recognized when the contract is effective and a service fee recognized ratable over the contract term as the compliance program is executed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHF recognizes revenue from interest on loans and investment income distributed by PCCU, which is determined by particular customer account balances. As per the Loan Servicing Agreement and the Commercial Alliance Agreement, SHF bears the expenses for hosting investments and servicing loans related to this interest and investment income. These expenses are allocated to “General and Administrative Expenses” in the Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts received in advance of the service being provided is recorded as a liability under deferred revenue on the consolidated balance sheets. Typical Safe Harbor Program contracts are three-year contracts with amounts due monthly, quarterly or annually based on contract terms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customers consist of financial institutions providing services to CRBs. Revenues are concentrated in the United States of America.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--ContractLiabilitiesPolicyTextBlock_zzfGeneGAFDi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xvii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_znqJfLXTMLya">Contract Liabilities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes a contract liability if the customer’s payment of consideration precedes the reporting entity’s performance. As of March 31, 2024, the Company recorded contract liabilities amounting to $<span id="xdx_90A_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240331_zLIrdTPWtV8i" title="Contract liabilities">2,692</span> from contracts with customers. This compares to contract liabilities of $<span id="xdx_90D_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20231231_zdOokxBDgYVa" title="Contract liabilities">21,922</span> as reported on December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--WarrantsLiabilityPolicyTextBlock_zmvTTnFnmTn6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xviii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zlECNniLWybl">Warrants Liabilities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has evaluated each of the warrant arrangements separately in accordance with “Distinguishing Liabilities from Equity” (“ASC 480”) and “Derivatives and Hedging” (“ASC 815”), to determine classification as either equity instruments or liabilities based on the specific terms and features of each warrant. Warrants are recognized as equity if they are indexed to our own stock and meet the equity classification criteria in ASC 815-40. These warrants are recorded within stockholders’ equity at their issuance date and are not subsequently remeasured at fair value. Conversely, warrants that do not meet the criteria for equity classification under ASC 815-40 are classified as liabilities. Such warrants are initially recorded at fair value on the issuance date and are subject to remeasurement at each balance sheet date thereafter. Any changes in fair value are recognized in the statement of operations. None of our warrant contracts met criteria to be considered indexed to their own stock, and as a result, have each been accounted for as a liability financial instrument. The fair value of warrants classified as liabilities is determined using appropriate valuation models, such as the Black- Scholes model, which incorporates various inputs, including the current stock price, expected volatility, risk-free interest rate, and the expected term of the warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--DeferredChargesPolicyTextBlock_zt9FUcl8rPnj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xix.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zI06IqzXl043">Deferred consideration</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In line with ASC Topic 815, the Company treats the deferred consideration from the Abaca acquisition as a derivative liability, since it does not fulfill the equity classification criteria. As a result, this obligation is recognized as a liability on the balance sheet at fair value and is adjusted to reflect its fair value at the end of each reporting period. The liability will be reassessed at fair value on every balance sheet date until the obligation’s term concludes. Fluctuations in its fair value are recorded in the consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--ForwardPurchaseDerivativePolicyTextBlock_zydoIyA466C1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xx.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zuTQO7V04E81">Forward purchase derivative</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the forward purchase derivative assumed in the business combination in accordance with the guidance contained in ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company classifies the forward purchase derivatives as an assets or liabilities carried at their fair value and adjusts the forward purchase derivatives to fair value at each reporting period. This derivative asset or liability is subject to re-measurement at each balance sheet date until the conditions under the forward purchase agreement are exercised or expire, and any change in fair value is recognized in the unaudited condensed consolidated statement of operations. In December 2023, the company calculated its valuation using a Monte Carlo Simulation set within a risk-neutral environment. Initiated in December 2022, this strategy was applied to assess the fair value of the forward purchase agreement (FPA) derivatives, with an underlying assumption that future stock prices would adhere to a Geometric Brownian Motion trajectory. Throughout the first quarter of 2024, there were no transactions by FPA holders, and no considerable shifts in risk factors that could influence the valuation of FPA derivatives were observed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zoroaKgQ8AB5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xxi.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zYlzPGKUXIs7">Earnings Per Share</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted earnings per share are computed and disclosed in accordance with ASC Topic 260, Earnings Per Shares. The Company utilizes the two-class method to compute earnings available to common shareholders. Under the two-class method, earnings are adjusted by accretion amounts to redeemable noncontrolling interests recorded at redemption value. The adjustments represent dividend distributions, in substance, to the noncontrolling interest holder as the holders have contractual rights to receive an amount upon redemption other than the fair value of the applicable shares. As a result, earnings are adjusted to reflect this in substance distribution that is different from other common shareholders. In addition, the Company allocates net earnings to each class of common stock and participating security as if all of the net earnings for the period had been distributed. The Company’s participating securities consist of share-based payment awards that contain a non-forfeitable right to receive dividends and therefore are considered to participate in undistributed earnings with common shareholders. Basic earnings per common share excludes dilution and is calculated by dividing net earnings allocated to common shares by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is calculated by dividing net earnings allocable to common shares by the weighted-average number of common shares outstanding for the period, as adjusted for the potential dilutive effect of non-participating share-based awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_z4atAkVoNEYf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xxii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zyvnzX2SQU7b">Income Tax</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred tax assets and liabilities are adjusted through the provision for income taxes as changes in tax laws or rates are enacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods. If management is unable to estimate a portion of its ordinary income, but is otherwise able to reliably estimate the remainder, ASC 740-270-25-3 provides that the tax applicable to that item be reported in the interim period in which the item occurs. The tax (or benefit) related to ordinary income (or loss) shall be computed at an estimated annual effective tax rate and the tax (or benefit) related to all other items shall be individually computed and recognized when the items occur. Management is unable to estimate a portion of its ordinary income and as a result had computed the company’s tax provision in accordance with ASC 740-270-25-3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 740 also prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUxkDmD0Lb72" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xxiii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z6Y90rEw8Sm9">Recently Issued Accounting Standards</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position or results of operations upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Adopted Standards</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Expected Credit Losses</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduces a model based on expected losses to estimate credit losses for most financial assets and certain other instruments. In November 2019, the FASB issued ASU No. 2019-10 Financial Instruments — Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). The update allows the extension of the initial effective date for entities which have not yet adopted ASU No. 2016-02. The standard is effective for annual reporting periods beginning after December 15, 2022 for private companies and SEC filers classified as smaller reporting entities, with early adoption permitted. Entities apply the standard’s provisions by recording a cumulative effect adjustment to retained deficit. The Company has adopted ASU 2016-13 as of January 1, 2023, utilizing the modified retrospective method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CECL Transition Impact: The table below provides details on the transition impacts of adopting CECL. Other balance sheet lines not presented were not affected by CECL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CECL Transition Impact:</span></p> <p id="xdx_897_ecustom--ScheduleOfCurrentExpectedCreditLossesTransitionImpactTableTextBlock_zyauuty8QZH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zWv4LqnweUAl" style="display: none">Schedule of Current Expected Credit Losses Transition Impact</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Assets</b></td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31,<br/> 2022</b></td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Transition<br/> Adjustment</b></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>January 1,<br/> 2023</b></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Loans receivable, gross</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_982_ecustom--CommercialRealEstateLoansReceivableGross_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zDrtvti8Ioo2" style="width: 12%; text-align: right" title="Loans receivable, gross">1,432,560</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98B_ecustom--CommercialRealEstateLoansReceivableGrossAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_zom1aeESRTy5" style="width: 12%; text-align: right" title="Loans receivable, gross"><span style="-sec-ix-hidden: xdx2ixbrl0633">-</span></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98A_ecustom--CommercialRealEstateLoansReceivableGross_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zpdobTo8fJx4" style="width: 12%; text-align: right" title="Loans receivable, gross">1,432,560</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Allowance for credit loss</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_986_ecustom--AllowanceForLoanLosses_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zi3hAC5XY4yf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Allowance for credit loss">(21,488</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_980_ecustom--AllowanceForLoanLossesAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_zAWEiJ0JDdmf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Allowance for loan losses">(14,980</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98D_ecustom--AllowanceForLoanLosses_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zwWIZoqima6d" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Allowance for credit loss">(36,468</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td id="xdx_984_eus-gaap--NotesReceivableNet_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zaB825nmhZL8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Loans receivable, net">14,11,072</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td id="xdx_98E_ecustom--NotesReceivableNetAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_z8T0AMwptu4f" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Loans receivable, net">(14,980</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td id="xdx_98E_eus-gaap--NotesReceivableNet_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zpU2syquqWr5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Loans receivable, net">1,396,092</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Liabilities &amp; Equity</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31,<br/> 2022</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Transition<br/> Adjustment</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>January 1,<br/> 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Indemnity liability</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--IndemnityLiability_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zOW8qjEMIoo5" style="width: 12%; text-align: right" title="Indemnity liability">499,465</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--IndemnityLiabilityAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_ztCKYBsU1ejc" style="width: 12%; text-align: right" title="Indemnity liability">566,341</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--IndemnityLiability_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_z9MI4zvyb9c9" style="width: 12%; text-align: right" title="Indemnity liability">1,065,806</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Retained deficit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zRSGXxQ4c30h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Retained earning">(39,695,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--RetainedEarningsAccumulatedDeficitAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_zmfqRDXlpnr8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Retained earning">(581,321</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zSODsuba1cmb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Retained earning">(40,276,602</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--LiabilitiesAndStockholdersEquity_iNI_di_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zIWUMLBR5OPb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Liabilities &amp; Equity">(39,195,816</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--LiabilitiesAndStockholdersEquityAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_z6xZPea8m3Ui" style="border-bottom: Black 1.5pt solid; text-align: right" title="Liabilities &amp; Equity">(14,980</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesAndStockholdersEquity_iNI_di_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zITiZrYkNsWj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Liabilities &amp; Equity">(39,210,796</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AB_zOGWXpSHFpek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Troubled Debt Restructurings and Vintage Disclosures</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Accounting Standard Update (ASU 2022-02) eliminates the recognition and measurement guidance on troubled debt restructurings for creditors that have adopted ASC 326 and requires them to make enhanced disclosures about loan modifications for borrowers experiencing financial difficulty. The new guidance also requires public business entities to present current period gross write-offs (on a current year-to-date basis for interim-period disclosures) by year of origination in their vintage disclosures. For entities that have adopted ASU 2016-13, this ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2023 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Accounting Standard Update (ASU 2022-03) clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered when measuring fair value. Recognizing a contractual restriction on the sale of an equity security as a separate unit of account is not permitted. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2024 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Accounting Standard Update (ASU 2022-06) defers the Sunset Date of ASC Topic 848, Reference Rate Reform (Topic 848), which provides temporary optional relief in accounting for the impact of Reference Rate Reform. This ASU is effective upon issuance (December 21, 2022) and generally can be applied through December 31, 2024.This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investments-Equity Method and Joint Ventures</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the FASB issued ASU 2023-02, Investments-Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures using the Proportional Amortization Method. The FASB issued final guidance allowing entities to apply the proportional amortization method to equity investments in all tax credit programs that meet the conditions in ASC 323-740, rather than just investments in qualified affordable projects that generate low income housing tax credits, as was required under the legacy guidance. The guidance is effective for public business entities for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Standards Pending to be Adopted</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business Combinations-Joint Venture Formations</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2023, the FASB issued 2023-05, Business Combinations-Joint Venture Formations (Subtopic 805-60); Recognition and Initial Measurement. This ASU contains guidance requiring certain joint ventures to apply a new basis of accounting upon formation by recognizing and initially measuring most of their assets and liabilities at fair value. This guidance is effective for all joint venture formations with a formation date on or after January 1, 2025. Early adoption is permitted. Joint Ventures formed before the effective date have the option to apply it retrospectively, while those formed after the effective date are required to apply it prospectively. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.”</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ASU amends the disclosure or presentation requirements related to various subtopics in the FASB codification.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. For all other entities, the amendments will be effective two years later. The amendments in this Update should be applied prospectively. For all entities, if by June 30, 2027, the SEC has not removed the applicable requirement from Regulation S-X or Regulation S-K, the pending content of the related amendment will be removed from the Codification and will not become effective for any entity. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Segment Reporting</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280). This ASU requires public entities to provide disclosures of significant segment expenses and other segment items. It also requires public entities to provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Public entities with a single reportable segment will have to provide all the disclosures required by ASC 280, including the significant segment expense disclosures. This guidance is applied retrospectively to all periods presented, unless it is impractical. This ASU applies to all public entities and is effective for fiscal years beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income Taxes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This ASU requires public business entities to disclose in their rate reconciliation table additional categories of information about income taxes paid, including certain disclosures that would be disaggregated by jurisdiction and other categories. This ASU is effective for fiscal years after December 15, 2024. Early adoption would be permitted. The Company does not expect this ASU to have a material impact on its condensed unaudited consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ASU 2024-01: Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU 2024-01 clarifies the scope applications of profits interest awards by adding illustrative guidance to ASC 718 “Compensation-Stock Compensation.” The amendments in the ASU apply to all reporting entities that account for profits interest awards as compensation to employees or non-employees in return for goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The term “profits interest” is not explicitly defined in US GAAP. Rather, an IRS Revenue Procedure (Rev Proc 93-27) defines a “Profits Interest” as a “partnership interest other than a capital interest.” Unlike a capital interest, which provides rights to existing net assets of an entity, a profits interest only provides rights to future profits and/or equity appreciation of an entity. This distinction, along with other terms, conditions and characteristics of profits interests often complicates accounting decisions for profits interests, leading to diversity in practice whether to account for profits interests under ASC 718 or other US GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ASU introduces four (4) illustrative examples of fact patterns that demonstrate how an entity would apply the scope guidance in paragraph 718-10-15-3 to a profits interest or similar award with certain features.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ASUs are effective for public entities for fiscal years beginning after December 15, 2024, including interim periods within those years. For all other entities, adoption is required for fiscal years beginning after December 15, 2025. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ASU 2024-02: Codification Improvements—Amendments to Remove References to the Concepts Statements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #242424"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The ASU contains amendments to the Codification that remove references to various FASB Concepts Statements. The Board has a standing project on its agenda to address suggestions received from stakeholders on the Accounting Standards Codification and other incremental improvements to GAAP. This effort facilitates Codification updates for technical corrections such as conforming amendments, clarifications to guidance, simplifications to wording or the structure of guidance and other minor improvements. In the Board’s view, removing all references to Concept Statements in the guidance will simplify the codification and draw a distinction between authoritative and non-authoritative literature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; color: #242424"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The amendments in the Update are effective for public business entities for fiscal years beginning after December 15, 2024. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2025. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p id="xdx_85C_zFSVbiESn1Y4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #242424"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zdzSmGctzy5h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>i. <span id="xdx_862_z46EQK4FTTH5">Basis of Presentation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the “SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary to state fairly the consolidated financial condition, results of operations, statements of shareholders’ equity, and cash flows of the Company for the interim periods presented. Except as otherwise disclosed, all such adjustments consist only of those of a normal recurring nature. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results that may be expected for the current year ending December 31, 2024. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the years ended December 31, 2023, included in the Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company has made certain immaterial reclassifications to the statements of operations for the three months ended March 31, 2023, to conform to the presentation for the three months ended March 31, 2024. These reclassifications, totaling $<span id="xdx_904_eus-gaap--AccountsPayableTradeCurrent_iI_c20240331__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zpuJZVYgnfH6" title="Accounts receivable trade">190,943</span>, were moved from ‘Interest Expense’ to ‘Change in the Fair Value of Deferred Consideration’. Corresponding adjustments have been made to the statement of cash flows and the applicable notes to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of SHF Holdings, Inc., its subsidiaries where we have controlling financial interests. All intercompany balances and transactions have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC and the instructions to Form 10-Q.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 190943 <p id="xdx_84B_eus-gaap--UseOfEstimates_zffGhqa66p88" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zSZG3ugK8ru2">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Material estimates that are particularly subject to change in the near term include the determination of the allowance for credit losses, indemnification liabilities, useful lives of intangibles and the fair value of financial instruments. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--LiquidityAndGoingConcernPolicyTextBlock_z1QnWOMCEru6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>iii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zxfIyKoBEpZj">Liquidity and Going Concern</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company had $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240331_zlhKYgfQ9MTf" title="Cash">5,626,362</span> in cash and net working capital of $<span id="xdx_90F_ecustom--WorkingCapital_iI_c20240331_zISA5Yb9iyC" title="Working capital deficit">318,825</span>, as compared to $<span id="xdx_902_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231_zb11dvqLovFf" title="Cash">4,888,769</span> in cash and net working capital deficit of $<span id="xdx_903_ecustom--WorkingCapital_iI_c20231231_zJ6vcSEPyLic" title="Working capital deficit">135,355</span> as of December 31, 2023. The retained deficit was $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240331_zBAVpPmvHin4" title="Retained deficit">70,386,394</span> on March 31, 2024, and $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20231231_zUK8G5t7paA5" title="Retained deficit">71,569,821</span> on December 31, 2023. The Company has also generated operating income of $<span id="xdx_90F_eus-gaap--OperatingIncomeLoss_c20240101__20240331_ztPc1UZVofm1" title="Operating income">324,941</span> for the period ended March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the period ending March 31, 2024, the Company reported positive operating income and net working capital. However, considering the historical data, where the Company experienced negative operating income and negative net working capital, management acknowledges the need to closely evaluate the financial performance in upcoming quarters to mitigate any going concern risks. As of March 31, 2024, due to these historical trends, there is substantial doubt about the Company’s ability to continue as a going concern for at least twelve months from the date these condensed unaudited consolidated financial statements were issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company is not able to sustain its present level of operations, it may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned expansion programs. Any of these actions could materially harm the Company’s business, results of operations and future prospects.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may result should the Company not continue as a going concern as a result of this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 5626362 318825 4888769 135355 -70386394 -71569821 324941 <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zRoObVrAl74c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>iv.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zPZc41WNo6ma">Cash and Cash Equivalents</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash on hand, amounts due from financial institutions, and investments with maturities of three months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zMaJWKI4Fwj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>v.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zTpFkhxhrEw6">Concentrations of Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash. Cash balances are maintained substantially in accounts at Partner Colorado Credit Union (“PCCU”) which is insured by the National Credit Union Share Insurance Fund (“NCUSIF”) up to regulatory limits. From time to time, cash balances may exceed the NCUSIF insurance limit. The Company has not experienced any credit losses associated with its cash balances in the past.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently the Company only services the cannabis industry. Cannabis remains illegal under federal law, and therefore, strict enforcement of federal laws regarding cannabis would likely result in our inability to execute our business plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently the Company substantially relies on PCCU to hold customer deposits and fund its originated loans. As of this time, majority all of the Company’s revenue is generated by deposits and loans hosted by its PCCU pursuant to various services agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had only one loan on its balance sheet as of March 31, 2024, which comprises <span id="xdx_902_eus-gaap--LoansReceivableBasisSpreadOnVariableRate_iI_pid_dp_uPure_c20240331_zmQ3yQZazMDd" title="Percentage of total loans receivables">100</span>% of the total loan balance. The Company also indemnified 21 loans as of March 31, 2024; three of these indemnified loans were in excess of <span id="xdx_903_eus-gaap--LoansReceivableBasisSpreadOnVariableRateDuringPeriod_pid_dp_uPure_c20240101__20240331_zV3ucenYFB3a" title="Percentage of loans receivables">10</span>% of the total balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 0.10 <p id="xdx_84C_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_zcVz88prJxf3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>vi.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zc5RgDjyQCXi">Accounts Receivable</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded based on account fee schedules. While fees are generated from accounts for individual cannabis-related businesses (“CRB”) related accounts, amounts are initially collected by the financial institutional partners and remitted in the subsequent month. Accounts receivable - related party represents amounts due from PCCU under related party contracts disclosed in Note 8 to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--PolicyLoansReceivablePolicy_zPCW5q6coZSf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>vii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zATeMsM1t7R2">Loans Receivable</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRB loans that significantly support the Company’s operations are recognized as assets on the balance sheet. These loans, intended to be held either for the foreseeable future or until their maturity or full repayment, are recorded at their outstanding principal balance. This amount is adjusted for any credit loss allowances and net of any deferred loan origination fees and costs, as applicable, to reflect the net investment in these loans. The Company recognizes interest income on CRB Loans over the loan term using the simple-interest method based on outstanding principal amounts. This approach ensures a systematic recognition of income, aligning with the time value of money principle.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest income recognition is suspended when there is uncertainty regarding full loan repayment, such as in cases of loan impairment or when payments are overdue by ninety days or more. Loans under these conditions are placed on nonaccrual status. Any accrued interest not received by the time a loan is placed on nonaccrual is reversed from interest income. Subsequent interest payments on nonaccrual loans are recorded using either the cash basis or the cost recovery method until the loan meets the criteria for reclassification to accrual status.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans are returned to accrual status when they become current (less than ninety days past due) and when there is reasonable assurance of future payment compliance, evidenced by the full satisfaction of both principal and interest payments due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans are assessed individually for potential charge-off, which typically occurs at the point of foreclosure. Charge offs are executed to reflect the realizable value of loans that are deemed uncollectible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The determination of a loan’s past-due status is based on its contractual repayment terms. Loans are either placed on nonaccrual status or charged-off ahead of their contractual delinquency dates if the collection of principal and interest is deemed doubtful, ceasing the recognition of interest income on such loans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--LoansAndLeasesReceivableAllowanceForLoanLossesPolicy_zpWrfwvfOQa4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>viii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zV0mNtkkur2l">Allowance for Credit Losses (ACL)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted Accounting Standards Codification Topic 326 - Financial Instruments - Credit Losses (ASC Topic 326), for estimation of probable credit losses with an expected credit loss methodology that is referred to as the current expected credit loss (“CECL”) methodology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ACL is a valuation account that is deducted from the amortized cost basis of financial assets carried at their amortized cost, including loans held for investment, to present the net amount that is expected to be collected throughout the life of the financial asset. The estimated ACL is recorded through a provision for credit losses charged against operations. Management periodically evaluates the adequacy of the ACL to maintain it at a level it believes to be reasonable. The Company uses the same methods used to determine the ACL to assess any reserves needed for off-balance sheet credit risks such as unfunded loan commitments including Indemnified loans to PCCU. These reserves for off-balance sheet credit risks are presented in the liabilities section in the unaudited condensed consolidated balance sheets as an “Indemnity liability.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ACL consists of two components: an asset-specific component for estimating credit losses for individual loans that do not share similar risk characteristics with other loans; and a pooled component for estimating credit losses for pools of loans that share similar risk characteristics. The ACL for the pooled component is derived from an estimate of expected credit losses primarily using an expected loss methodology that incorporates risk parameters such as probability of default (“PD”) and loss given default (“LGD”) which are derived from various vendor models and/or internally developed model estimation approaches for smaller homogenous loans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The PD is quantified by analyzing historical data to determine the rate at which loans have defaulted within the portfolio, relative to the total outstanding loans as of the end of the reporting period. This rate is expressed as a percentage and serves as a key indicator of the likelihood of default across the loan pool. LGD assessments are conducted to estimate the potential loss amount in the event of a default, considering the recoverable value from the collateral liquidation against the remaining loan balance. This involves a detailed analysis of two primary components: the loss on principal, which arises from the gap between the collateral’s liquidation value and the unpaid principal balance of the loan; and the loss associated with various ancillary costs to recover, including, but not limited to, foregone interest, transaction costs, legal and administrative fees, and expenses related to the maintenance and renovation of the property. The Company considers relevant current conditions and reasonable and supportable forecasts that relate to its lending practices and environment and the specific borrower and determines that the significant factor affecting the loan’s performance is the fact that these borrowers are involved in the cannabis business. Despite being legal at the state level in certain jurisdictions, cannabis remains federally illegal in the United States as of the date of this filing. As cannabis related lending is a new practice in the United States, there is very little historical or industry data on which to base a loss forecast. Therefore, significant judgement is required in creating a reasonable loss estimate, using similar non-MRB loans as a baseline and adjusting for the inherent risks in the cannabis industry. While the Company considers other qualitative factors, including national macroeconomic conditions, in its overall risk analysis, it has determined that they are not significant inputs to the overall loss estimate calculations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ACL estimation process also applies an economic forecast scenario, or a composite of scenarios based on management’s judgment and expectations around the current and future macroeconomic outlook. Expected credit losses are estimated over the contractual term of the loans, adjusted for expected prepayments when appropriate. The contractual term of a loan excludes expected extensions, renewals, and modification under certain conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoveries on loans represent collections received on amounts that were previously charged off against the ACL. Recoveries are credited to the ACL when received, to the extent of the amount previously charged off against the ACL on the related loan. Any amounts collected in excess of this limit are first recognized as interest income, then as a reduction of collection costs, and then as other income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--NetDeferredLoanOriginationFeesAndCostPolicyTextBlock_zQIeaey0Ekga" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ix.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span><span id="xdx_861_zA2z87bPAl7a">Net Deferred Loan Origination Fees and Cost</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When included with a new loan origination, the Company receives loan origination fees in conjunction with new loans funded and any indemnified liabilities which are not recorded on the balance sheet from the company financial institution partners. Where applicable, the loan origination fee is netted with loan origination costs associated with originating a specific loan. These loan origination costs are typically incremental direct costs (non-reimbursed) paid to third parties. Net loan origination fees are initially deferred and presented net of loans receivable asset for portfolio loans, or as a separate liability for indemnified loans, and recognized as interest income utilizing the interest method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--IndemnityLiabilityPolicyTextBlock_zsePYxTbkgc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>x.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zWBZAx05vOwe">Indemnity Liability</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Loan Servicing Agreement and Commercial Alliance Agreement with PCCU, the Company had agreed to indemnify PCCU from all claims related to Company’s cannabis-related business, including but not limited to default-related credit losses as defined in the Loan Servicing Agreement. The indemnification component of the Loan Servicing Agreement and the Commercial Alliance Agreement (refer to Note 8 to the unaudited condensed consolidated financial statements) is accounted for in accordance with accounting standards codification (“<i>ASC”) 460 Guarantees</i>. In determining the applicability of ASC 460, the Company considered that the agreement outlines a broad indemnification of all claims related to the cannabis-related business. The most immediate and potentially significant of these are potential default-related credit losses. In the lending industry, it is inherently anticipated future credit losses will result from currently issued debt. The Company’s indemnity obligation is subordinate to financial institution clients’ other means of collecting on the loans including foreclosure of the collateral, recourse against personal and/or corporate guarantors and other default remedies available in the loan agreements. Since borrowers are not party to the agreement between Company and PCCU, any indemnity payments do not relieve borrowers of their obligation to PCCU nor would such payments preclude PCCU’s right to future recoveries from the debtor. Therefore, as defined in ASC 460, the indemnification clause represents a general loss contingency in that it is an existing condition, situation or set of circumstances involving uncertainty as to possible loss to the Company that will ultimately be resolved when one or more future events occur or fail to occur. SHF’s indemnity liability reflects SHF management’s estimate of probable credit losses inherent under the agreement at the balance sheet date. The liability is measured and recognized in accordance with our accounting policies for ACL and ALL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to default-related credit losses, the Company continuously monitors all other circumstances pursuant to the agreement and identifies events that may necessitate a loss contingency under the Loan Servicing Agreement. A loss contingency is reported when it is both probable that a future event will confirm that a loss had been incurred on or before the related balance sheet date and the loss is reasonably estimable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z8V3CQpLXMF1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xi.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zHgG874JrMc9">Property and Equipment, net</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at historical cost, net of accumulated depreciation. Depreciation is provided over the assets’ useful lives on a straight-line basis <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zsiYdq7US0v7" title="Property and equipment useful life">3</span>-<span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zPpHtVeWarqe" title="Property and equipment useful life">5</span> years for equipment and furniture and fixtures. Repairs and maintenance costs are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management periodically assesses the estimated useful life over which assets are depreciated or amortized. If the analysis warrants a change in the estimated useful life of property and equipment, management will reduce the estimated useful life and depreciate or amortize the carrying value prospectively over the shorter remaining useful life.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the period of disposal and the resulting gains and losses are included in the results of operations during the same period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company capitalize certain costs related to software developed for internal-use, primarily associated with the ongoing development and enhancement of our technology platform. Costs incurred in the preliminary development and post-development stages are expensed. These costs are amortized on a straight-line basis over the estimated useful life of the related asset, generally five years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P3Y P5Y <p id="xdx_848_ecustom--RightOfUseAssetsAndLeaseLliabilityPolicyTextBlock_zTw7dZWQRTX1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_ztAJPZOY4Pkl">Right of Use Assets and Lease Liabilities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into lease agreements for a certain facility and certain items of equipment, which provide the right to use the underlying asset and require lease payments over the term of the lease. At inception of the lease agreement, the Company assesses whether the agreement conveys the right to control the use of an identified asset for a period in exchange for consideration, in which case it is classified as a lease. Each lease is further analyzed to check whether it meets the classification criteria of a finance or operating lease. All identified leases are recorded on the consolidated balance sheet with a corresponding lease right-of-use asset, net, representing the right to use the underlying asset for the lease term and the operating lease liabilities representing the obligation to make lease payments arising from the lease. The Company has elected not to recognize lease assets and lease liabilities for short-term leases (leases with a term of 12 months or less) and leases of low-value assets. Lease right-of-use assets, net and lease liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term and include options to extend or terminate the lease when they are reasonably certain to be exercised. The present value of lease payments is determined primarily using the incremental borrowing rate based on the information available as of the lease commencement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease expense for operating leases is recorded on a straight-line basis over the lease term and variable lease costs are recorded as incurred. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. Finance lease interest expense is recognized based on an effective interest method and depreciation of assets is recorded on a straight-line basis over the shorter of the lease term and useful life of the asset. Both operating and finance lease right of use assets are reviewed for impairment, consistent with other finite-lived assets, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. After a right of use asset is impaired, any remaining balance of the asset is amortized on a straight-line basis over the shorter of the remaining lease term or the estimated useful life.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z7xTaVJmLWDe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xiii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z4ZhLczjjrw9">Goodwill and Other Intangible Assets</span> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s methodology for allocating the purchase price of an acquisition is based on established valuation techniques that reflect the consideration of a number of factors, including a valuation performed by a third-party appraiser. Goodwill is measured as the excess of the cost of an acquired business over the fair value assigned to identifiable assets acquired and liabilities assumed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is tested for impairment at least annually on the elected impairment test date of December 31 unless any events or circumstances indicate it is more likely than not that the fair value of the goodwill is less than its carrying value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-lived intangible assets are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. Intangible assets should be tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zC3rqwPPCEZh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xiv.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_z3QEg3sQneni">Stock-based Compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company measures all equity-based payment arrangements to employees and directors in accordance with ASC 718, Compensation–Stock Compensation. The Company’s stock-based compensation cost is measured based on the fair value at the grant date of the stock-based award. It is recognized as expense on a straight-line basis over the requisite service period for the entire award. Forfeitures are recognized as they occur. The Company estimates the fair value of each stock-based award on its measurement date using either the current market price of the stock or Black-Scholes option valuation model, whichever is most appropriate. The Black-Scholes valuation model incorporates assumptions such as expected term of the instrument, volatility of the Company’s future share price, risk free rates, future dividend yields and estimated forfeitures at the initial grant date, by reference to the underlying terms of the instrument, and the Company’s experience with similar instruments. Changes in assumptions used to estimate fair value could result in materially different results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The shares of the Company have been listed on the Nasdaq stock exchange for a limited period of the time and also the stock price has dropped significantly from the date of listing, based on which the Company has considered the expected volatility at <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240331_zJ5ixjoP94Vl" title="Expected volatility rate">100</span>% for the purpose of stock compensation. The risk-free interest rates are based on quoted U.S. Treasury rates for securities with maturities approximating the awards’ expected lives. The expected term of the options granted is calculated based on the simplified method by taking average of contractual term and vesting period the awards. The expected dividend yield is zero as the Company has never paid dividends and does not currently anticipate paying any in the foreseeable future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> 1 <p id="xdx_84A_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zIqjMdwbqYDj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xv.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zqO3LYwMTphb">Fair Value Measurements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 — Quoted prices for identical assets or liabilities in active markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 — Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 —Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zGzRF4Ib2mRb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xvi.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zOGloSqS2qRi">Revenue Recognition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHF recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which SHF expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue is recorded at a point in time when the performance obligation is satisfied, and no contingencies exist. Majority of the revenue consists of fees earned on deposit accounts held at PCCU but serviced by SHF such as bank account charges, onboarding income, account activity fee income and other miscellaneous fees. Under the terms of the Loan Servicing Agreement and the Commercial Alliance Agreement, the Company is responsible for covering account hosting costs associated with the fees generated from deposits held at PCCU. These costs are classified as “General and Administrative Expenses” in the Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, SHF recognizes revenue from the Master Program Agreement. The Master Program Agreement is a non-exclusive and non-transferable right to implement and utilize the Safe Harbor Program. The Safe Harbor Program has two performance obligations; an implementation fee recognized when the contract is effective and a service fee recognized ratable over the contract term as the compliance program is executed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHF recognizes revenue from interest on loans and investment income distributed by PCCU, which is determined by particular customer account balances. As per the Loan Servicing Agreement and the Commercial Alliance Agreement, SHF bears the expenses for hosting investments and servicing loans related to this interest and investment income. These expenses are allocated to “General and Administrative Expenses” in the Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts received in advance of the service being provided is recorded as a liability under deferred revenue on the consolidated balance sheets. Typical Safe Harbor Program contracts are three-year contracts with amounts due monthly, quarterly or annually based on contract terms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customers consist of financial institutions providing services to CRBs. Revenues are concentrated in the United States of America.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--ContractLiabilitiesPolicyTextBlock_zzfGeneGAFDi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xvii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_znqJfLXTMLya">Contract Liabilities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes a contract liability if the customer’s payment of consideration precedes the reporting entity’s performance. As of March 31, 2024, the Company recorded contract liabilities amounting to $<span id="xdx_90A_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240331_zLIrdTPWtV8i" title="Contract liabilities">2,692</span> from contracts with customers. This compares to contract liabilities of $<span id="xdx_90D_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20231231_zdOokxBDgYVa" title="Contract liabilities">21,922</span> as reported on December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2692 21922 <p id="xdx_84C_ecustom--WarrantsLiabilityPolicyTextBlock_zmvTTnFnmTn6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xviii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zlECNniLWybl">Warrants Liabilities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has evaluated each of the warrant arrangements separately in accordance with “Distinguishing Liabilities from Equity” (“ASC 480”) and “Derivatives and Hedging” (“ASC 815”), to determine classification as either equity instruments or liabilities based on the specific terms and features of each warrant. Warrants are recognized as equity if they are indexed to our own stock and meet the equity classification criteria in ASC 815-40. These warrants are recorded within stockholders’ equity at their issuance date and are not subsequently remeasured at fair value. Conversely, warrants that do not meet the criteria for equity classification under ASC 815-40 are classified as liabilities. Such warrants are initially recorded at fair value on the issuance date and are subject to remeasurement at each balance sheet date thereafter. Any changes in fair value are recognized in the statement of operations. None of our warrant contracts met criteria to be considered indexed to their own stock, and as a result, have each been accounted for as a liability financial instrument. The fair value of warrants classified as liabilities is determined using appropriate valuation models, such as the Black- Scholes model, which incorporates various inputs, including the current stock price, expected volatility, risk-free interest rate, and the expected term of the warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--DeferredChargesPolicyTextBlock_zt9FUcl8rPnj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xix.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zI06IqzXl043">Deferred consideration</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In line with ASC Topic 815, the Company treats the deferred consideration from the Abaca acquisition as a derivative liability, since it does not fulfill the equity classification criteria. As a result, this obligation is recognized as a liability on the balance sheet at fair value and is adjusted to reflect its fair value at the end of each reporting period. The liability will be reassessed at fair value on every balance sheet date until the obligation’s term concludes. Fluctuations in its fair value are recorded in the consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--ForwardPurchaseDerivativePolicyTextBlock_zydoIyA466C1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xx.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zuTQO7V04E81">Forward purchase derivative</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the forward purchase derivative assumed in the business combination in accordance with the guidance contained in ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company classifies the forward purchase derivatives as an assets or liabilities carried at their fair value and adjusts the forward purchase derivatives to fair value at each reporting period. This derivative asset or liability is subject to re-measurement at each balance sheet date until the conditions under the forward purchase agreement are exercised or expire, and any change in fair value is recognized in the unaudited condensed consolidated statement of operations. In December 2023, the company calculated its valuation using a Monte Carlo Simulation set within a risk-neutral environment. Initiated in December 2022, this strategy was applied to assess the fair value of the forward purchase agreement (FPA) derivatives, with an underlying assumption that future stock prices would adhere to a Geometric Brownian Motion trajectory. Throughout the first quarter of 2024, there were no transactions by FPA holders, and no considerable shifts in risk factors that could influence the valuation of FPA derivatives were observed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zoroaKgQ8AB5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xxi.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zYlzPGKUXIs7">Earnings Per Share</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted earnings per share are computed and disclosed in accordance with ASC Topic 260, Earnings Per Shares. The Company utilizes the two-class method to compute earnings available to common shareholders. Under the two-class method, earnings are adjusted by accretion amounts to redeemable noncontrolling interests recorded at redemption value. The adjustments represent dividend distributions, in substance, to the noncontrolling interest holder as the holders have contractual rights to receive an amount upon redemption other than the fair value of the applicable shares. As a result, earnings are adjusted to reflect this in substance distribution that is different from other common shareholders. In addition, the Company allocates net earnings to each class of common stock and participating security as if all of the net earnings for the period had been distributed. The Company’s participating securities consist of share-based payment awards that contain a non-forfeitable right to receive dividends and therefore are considered to participate in undistributed earnings with common shareholders. Basic earnings per common share excludes dilution and is calculated by dividing net earnings allocated to common shares by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is calculated by dividing net earnings allocable to common shares by the weighted-average number of common shares outstanding for the period, as adjusted for the potential dilutive effect of non-participating share-based awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_z4atAkVoNEYf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xxii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zyvnzX2SQU7b">Income Tax</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred tax assets and liabilities are adjusted through the provision for income taxes as changes in tax laws or rates are enacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods. If management is unable to estimate a portion of its ordinary income, but is otherwise able to reliably estimate the remainder, ASC 740-270-25-3 provides that the tax applicable to that item be reported in the interim period in which the item occurs. The tax (or benefit) related to ordinary income (or loss) shall be computed at an estimated annual effective tax rate and the tax (or benefit) related to all other items shall be individually computed and recognized when the items occur. Management is unable to estimate a portion of its ordinary income and as a result had computed the company’s tax provision in accordance with ASC 740-270-25-3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 740 also prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUxkDmD0Lb72" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>xxiii.</i></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z6Y90rEw8Sm9">Recently Issued Accounting Standards</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position or results of operations upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Adopted Standards</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Expected Credit Losses</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduces a model based on expected losses to estimate credit losses for most financial assets and certain other instruments. In November 2019, the FASB issued ASU No. 2019-10 Financial Instruments — Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). The update allows the extension of the initial effective date for entities which have not yet adopted ASU No. 2016-02. The standard is effective for annual reporting periods beginning after December 15, 2022 for private companies and SEC filers classified as smaller reporting entities, with early adoption permitted. Entities apply the standard’s provisions by recording a cumulative effect adjustment to retained deficit. The Company has adopted ASU 2016-13 as of January 1, 2023, utilizing the modified retrospective method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CECL Transition Impact: The table below provides details on the transition impacts of adopting CECL. Other balance sheet lines not presented were not affected by CECL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CECL Transition Impact:</span></p> <p id="xdx_897_ecustom--ScheduleOfCurrentExpectedCreditLossesTransitionImpactTableTextBlock_zyauuty8QZH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zWv4LqnweUAl" style="display: none">Schedule of Current Expected Credit Losses Transition Impact</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Assets</b></td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31,<br/> 2022</b></td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Transition<br/> Adjustment</b></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>January 1,<br/> 2023</b></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Loans receivable, gross</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_982_ecustom--CommercialRealEstateLoansReceivableGross_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zDrtvti8Ioo2" style="width: 12%; text-align: right" title="Loans receivable, gross">1,432,560</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98B_ecustom--CommercialRealEstateLoansReceivableGrossAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_zom1aeESRTy5" style="width: 12%; text-align: right" title="Loans receivable, gross"><span style="-sec-ix-hidden: xdx2ixbrl0633">-</span></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98A_ecustom--CommercialRealEstateLoansReceivableGross_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zpdobTo8fJx4" style="width: 12%; text-align: right" title="Loans receivable, gross">1,432,560</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Allowance for credit loss</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_986_ecustom--AllowanceForLoanLosses_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zi3hAC5XY4yf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Allowance for credit loss">(21,488</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_980_ecustom--AllowanceForLoanLossesAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_zAWEiJ0JDdmf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Allowance for loan losses">(14,980</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98D_ecustom--AllowanceForLoanLosses_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zwWIZoqima6d" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Allowance for credit loss">(36,468</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td id="xdx_984_eus-gaap--NotesReceivableNet_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zaB825nmhZL8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Loans receivable, net">14,11,072</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td id="xdx_98E_ecustom--NotesReceivableNetAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_z8T0AMwptu4f" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Loans receivable, net">(14,980</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td id="xdx_98E_eus-gaap--NotesReceivableNet_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zpU2syquqWr5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Loans receivable, net">1,396,092</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Liabilities &amp; Equity</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31,<br/> 2022</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Transition<br/> Adjustment</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>January 1,<br/> 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Indemnity liability</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--IndemnityLiability_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zOW8qjEMIoo5" style="width: 12%; text-align: right" title="Indemnity liability">499,465</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--IndemnityLiabilityAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_ztCKYBsU1ejc" style="width: 12%; text-align: right" title="Indemnity liability">566,341</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--IndemnityLiability_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_z9MI4zvyb9c9" style="width: 12%; text-align: right" title="Indemnity liability">1,065,806</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Retained deficit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zRSGXxQ4c30h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Retained earning">(39,695,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--RetainedEarningsAccumulatedDeficitAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_zmfqRDXlpnr8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Retained earning">(581,321</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zSODsuba1cmb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Retained earning">(40,276,602</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--LiabilitiesAndStockholdersEquity_iNI_di_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zIWUMLBR5OPb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Liabilities &amp; Equity">(39,195,816</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--LiabilitiesAndStockholdersEquityAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_z6xZPea8m3Ui" style="border-bottom: Black 1.5pt solid; text-align: right" title="Liabilities &amp; Equity">(14,980</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesAndStockholdersEquity_iNI_di_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zITiZrYkNsWj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Liabilities &amp; Equity">(39,210,796</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AB_zOGWXpSHFpek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Troubled Debt Restructurings and Vintage Disclosures</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Accounting Standard Update (ASU 2022-02) eliminates the recognition and measurement guidance on troubled debt restructurings for creditors that have adopted ASC 326 and requires them to make enhanced disclosures about loan modifications for borrowers experiencing financial difficulty. The new guidance also requires public business entities to present current period gross write-offs (on a current year-to-date basis for interim-period disclosures) by year of origination in their vintage disclosures. For entities that have adopted ASU 2016-13, this ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2023 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Accounting Standard Update (ASU 2022-03) clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered when measuring fair value. Recognizing a contractual restriction on the sale of an equity security as a separate unit of account is not permitted. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company has adopted this standard as of January 1, 2024 and the ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Accounting Standard Update (ASU 2022-06) defers the Sunset Date of ASC Topic 848, Reference Rate Reform (Topic 848), which provides temporary optional relief in accounting for the impact of Reference Rate Reform. This ASU is effective upon issuance (December 21, 2022) and generally can be applied through December 31, 2024.This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investments-Equity Method and Joint Ventures</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the FASB issued ASU 2023-02, Investments-Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures using the Proportional Amortization Method. The FASB issued final guidance allowing entities to apply the proportional amortization method to equity investments in all tax credit programs that meet the conditions in ASC 323-740, rather than just investments in qualified affordable projects that generate low income housing tax credits, as was required under the legacy guidance. The guidance is effective for public business entities for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. This ASU has not had a material impact on the Company’s unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Standards Pending to be Adopted</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business Combinations-Joint Venture Formations</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2023, the FASB issued 2023-05, Business Combinations-Joint Venture Formations (Subtopic 805-60); Recognition and Initial Measurement. This ASU contains guidance requiring certain joint ventures to apply a new basis of accounting upon formation by recognizing and initially measuring most of their assets and liabilities at fair value. This guidance is effective for all joint venture formations with a formation date on or after January 1, 2025. Early adoption is permitted. Joint Ventures formed before the effective date have the option to apply it retrospectively, while those formed after the effective date are required to apply it prospectively. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.”</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements, “Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ASU amends the disclosure or presentation requirements related to various subtopics in the FASB codification.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. For all other entities, the amendments will be effective two years later. The amendments in this Update should be applied prospectively. For all entities, if by June 30, 2027, the SEC has not removed the applicable requirement from Regulation S-X or Regulation S-K, the pending content of the related amendment will be removed from the Codification and will not become effective for any entity. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Segment Reporting</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280). This ASU requires public entities to provide disclosures of significant segment expenses and other segment items. It also requires public entities to provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Public entities with a single reportable segment will have to provide all the disclosures required by ASC 280, including the significant segment expense disclosures. This guidance is applied retrospectively to all periods presented, unless it is impractical. This ASU applies to all public entities and is effective for fiscal years beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income Taxes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This ASU requires public business entities to disclose in their rate reconciliation table additional categories of information about income taxes paid, including certain disclosures that would be disaggregated by jurisdiction and other categories. This ASU is effective for fiscal years after December 15, 2024. Early adoption would be permitted. The Company does not expect this ASU to have a material impact on its condensed unaudited consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ASU 2024-01: Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU 2024-01 clarifies the scope applications of profits interest awards by adding illustrative guidance to ASC 718 “Compensation-Stock Compensation.” The amendments in the ASU apply to all reporting entities that account for profits interest awards as compensation to employees or non-employees in return for goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The term “profits interest” is not explicitly defined in US GAAP. Rather, an IRS Revenue Procedure (Rev Proc 93-27) defines a “Profits Interest” as a “partnership interest other than a capital interest.” Unlike a capital interest, which provides rights to existing net assets of an entity, a profits interest only provides rights to future profits and/or equity appreciation of an entity. This distinction, along with other terms, conditions and characteristics of profits interests often complicates accounting decisions for profits interests, leading to diversity in practice whether to account for profits interests under ASC 718 or other US GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ASU introduces four (4) illustrative examples of fact patterns that demonstrate how an entity would apply the scope guidance in paragraph 718-10-15-3 to a profits interest or similar award with certain features.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ASUs are effective for public entities for fiscal years beginning after December 15, 2024, including interim periods within those years. For all other entities, adoption is required for fiscal years beginning after December 15, 2025. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ASU 2024-02: Codification Improvements—Amendments to Remove References to the Concepts Statements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #242424"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The ASU contains amendments to the Codification that remove references to various FASB Concepts Statements. The Board has a standing project on its agenda to address suggestions received from stakeholders on the Accounting Standards Codification and other incremental improvements to GAAP. This effort facilitates Codification updates for technical corrections such as conforming amendments, clarifications to guidance, simplifications to wording or the structure of guidance and other minor improvements. In the Board’s view, removing all references to Concept Statements in the guidance will simplify the codification and draw a distinction between authoritative and non-authoritative literature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; color: #242424"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The amendments in the Update are effective for public business entities for fiscal years beginning after December 15, 2024. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2025. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not expect this ASU to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p id="xdx_897_ecustom--ScheduleOfCurrentExpectedCreditLossesTransitionImpactTableTextBlock_zyauuty8QZH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zWv4LqnweUAl" style="display: none">Schedule of Current Expected Credit Losses Transition Impact</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Assets</b></td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31,<br/> 2022</b></td> <td style="padding-bottom: 1.5pt"><b> </b></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Transition<br/> Adjustment</b></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>January 1,<br/> 2023</b></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Loans receivable, gross</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_982_ecustom--CommercialRealEstateLoansReceivableGross_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zDrtvti8Ioo2" style="width: 12%; text-align: right" title="Loans receivable, gross">1,432,560</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98B_ecustom--CommercialRealEstateLoansReceivableGrossAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_zom1aeESRTy5" style="width: 12%; text-align: right" title="Loans receivable, gross"><span style="-sec-ix-hidden: xdx2ixbrl0633">-</span></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98A_ecustom--CommercialRealEstateLoansReceivableGross_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zpdobTo8fJx4" style="width: 12%; text-align: right" title="Loans receivable, gross">1,432,560</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Allowance for credit loss</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_986_ecustom--AllowanceForLoanLosses_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zi3hAC5XY4yf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Allowance for credit loss">(21,488</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_980_ecustom--AllowanceForLoanLossesAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_zAWEiJ0JDdmf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Allowance for loan losses">(14,980</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98D_ecustom--AllowanceForLoanLosses_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zwWIZoqima6d" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Allowance for credit loss">(36,468</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td id="xdx_984_eus-gaap--NotesReceivableNet_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zaB825nmhZL8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Loans receivable, net">14,11,072</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td id="xdx_98E_ecustom--NotesReceivableNetAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_z8T0AMwptu4f" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Loans receivable, net">(14,980</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td id="xdx_98E_eus-gaap--NotesReceivableNet_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zpU2syquqWr5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Loans receivable, net">1,396,092</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Liabilities &amp; Equity</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31,<br/> 2022</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Transition<br/> Adjustment</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>January 1,<br/> 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Indemnity liability</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--IndemnityLiability_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zOW8qjEMIoo5" style="width: 12%; text-align: right" title="Indemnity liability">499,465</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--IndemnityLiabilityAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_ztCKYBsU1ejc" style="width: 12%; text-align: right" title="Indemnity liability">566,341</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--IndemnityLiability_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_z9MI4zvyb9c9" style="width: 12%; text-align: right" title="Indemnity liability">1,065,806</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Retained deficit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zRSGXxQ4c30h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Retained earning">(39,695,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--RetainedEarningsAccumulatedDeficitAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_zmfqRDXlpnr8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Retained earning">(581,321</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zSODsuba1cmb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Retained earning">(40,276,602</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--LiabilitiesAndStockholdersEquity_iNI_di_c20221231__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zIWUMLBR5OPb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Liabilities &amp; Equity">(39,195,816</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--LiabilitiesAndStockholdersEquityAdjustment_c20230101__20230101__srt--CumulativeEffectPeriodOfAdoptionAxis__srt--CumulativeEffectPeriodOfAdoptionAdjustmentMember_z6xZPea8m3Ui" style="border-bottom: Black 1.5pt solid; text-align: right" title="Liabilities &amp; Equity">(14,980</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesAndStockholdersEquity_iNI_di_c20230101__us-gaap--FinancialInstrumentAxis__custom--CreditExpectedCreditLossesTransitionMember_zITiZrYkNsWj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Liabilities &amp; Equity">(39,210,796</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> 1432560 1432560 -21488 -14980 -36468 1411072 -14980 1396092 499465 566341 1065806 -39695281 -581321 -40276602 39195816 -14980 39210796 <p id="xdx_80D_ecustom--DeferredConsiderationDisclosureTextBlock_z9N9GrVFSORi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3. <span id="xdx_825_z0oLv4jLAGEa">Deferred Consideration</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the revised Abaca Merger Agreement, the Company compensated Abaca with $<span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesGross_pn6n6_c20240101__20240331__us-gaap--TypeOfArrangementAxis__custom--AbacaMergerClosingMember_z4txESDmMX78" title="Payments to acquire businesses">30</span> million through a mix of cash and stock. The payment structure included $<span id="xdx_909_eus-gaap--PaymentsToAcquireBusinessesGross_pn6n6_c20240101__20240331__us-gaap--TypeOfArrangementAxis__custom--AbacaMergerClosingMember__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_z3HcyWiAt7ne" title="Payments to acquire businesses">9</span> million in cash, distributed in three equal installments, with the first installment occurring at the merger closing and the other installments being paid on the first and second anniversaries of the merger closing. Additionally, the common stock consideration was settled through <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240101__20240331__us-gaap--BusinessAcquisitionAxis__custom--AbacaMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zhEJIatsRxV" title="Stock issued during period, shares, acquisitions">2,100,000</span> shares which represented a monetary equivalent calculated against the closing trading price, alongside deferred stock consideration calculated with a 10-day VWAP formula. Adjustments were made via amendments to redefine the terms and conditions of the deferred stock and cash considerations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The revised terms, as of the second amendment on October 26, 2023, stipulated new deferred stock consideration of <span id="xdx_900_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20231026__20231026__us-gaap--BusinessAcquisitionAxis__custom--AbacaMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zwwLqCZI2rW8" title="Number of shares issued for acquisition">5,835,822</span> shares of Class A common stock issued at the first anniversary based on a recalculated value of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20231026__us-gaap--BusinessAcquisitionAxis__custom--AbacaMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z7FLJ1WG1gFi" title="Share issued price per share">2.00 </span>per share. No changes affected the scheduled cash payments. Furthermore, a third-anniversary consideration of $<span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesGross_pn5n6_c20231026__20231026__us-gaap--BusinessAcquisitionAxis__custom--AbacaMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zt9IuajIW2J7" title="Payments to acquire businesses">1.5</span> million was introduced, payable in cash or stock at the Company’s discretion, alongside an issue of <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pn6n6_c20231026__us-gaap--BusinessAcquisitionAxis__custom--AbacaMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zGt8UVPWBFY5" title="Number of warrant issued">5</span> million stock warrants at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231026__us-gaap--BusinessAcquisitionAxis__custom--AbacaMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z0fqPCzeaWt2" title="Warrant exercise price">2.00</span> each. The adjustments and additional considerations have been valued and recorded according to ASC 815, reflecting changes in the fair value of deferred consideration in the consolidated statements of operations for the periods ending December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_ecustom--ScheduleOfDeferredConsiderationTableTextBlock_zWCx7yLuHX9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in the amount of deferred consideration from January 1, 2023, to March 31, 2024, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zrUiHZQAnGR3" style="display: none">Schedule of Change in Deferred Consideration</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock<br/> consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cash<br/> consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Third Anniversary<br/> Consideration Payment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%">January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--DeferredStockConsideration_iS_c20230101__20231231_zVnDowz099yi" style="width: 12%; text-align: right" title="Deferred stock consideration, Balance">11,456,639</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--DeferredCashConsideration_iS_c20230101__20231231_zeJiPG6wsEle" style="width: 12%; text-align: right" title="Deferred cash consideration, Balance">5,650,775</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--DeferredConsiderationPayment_iS_c20230101__20231231_zlUdMEEaXVqf" style="width: 14%; text-align: right" title="Deferred consideration payment, Balance"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: Working capital adjustment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--DeferredStockConsiderationWorkingCapitalAdjustment_iN_di_c20230101__20231231_zHRJutvQFxEc" style="text-align: right" title="Stock consideration, Working capital adjustment">(108,691</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--DeferredCashConsiderationWorkingCapitalAdjustment_c20230101__20231231_z16DhoMNZQff" style="text-align: right" title="Cash consideration, Working capital adjustment"><span style="-sec-ix-hidden: xdx2ixbrl0695">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: Issuance of shares and payment to shareholders</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--DeferredStockConsiderationIssuanceOfPaymentToShareHolders_iN_di_c20230101__20231231_z4J9g2UjeEr9" style="text-align: right" title="Stock consideration, Issuance of shares and payment to shareholders">(4,085,075</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--DeferredCashConsiderationIssuanceOfPaymentToShareHolders_iN_di_c20230101__20231231_zokj59datU71" style="text-align: right" title="Cash consideration, Issuance of shares and payment to shareholders">(3,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: Issuance of Abaca warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--DeferredStockConsiderationIssuanceOfWarrants_iN_di_c20230101__20231231_zRqpzdC5j3o4" style="text-align: right" title="Stock consideration, Issuance of payment consideration">(1,643,699</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: Issuance of third anniversary payment consideration</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--DeferredStockConsiderationIssuanceOfPaymentConsideration_iN_di_c20230101__20231231_zDS3Gpk5opG2" style="text-align: right" title="Stock consideration, Issuance of payment consideration">(430,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--DeferredConsiderationPaymentIssuanceOfPaymentConsideration_iN_di_c20230101__20231231_zMDC6jA0Jfke" style="text-align: right" title="Consideration payment, Issuance of payment consideration">430,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: Gain recognized in the consolidated statements of operations</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--DeferredStockConsiderationGainRecognized_iN_di_c20230101__20231231_z9pjoTwg0Yj8" style="text-align: right" title="Stock consideration, Gain recognized in the consolidated statements of operations">(5,645,107</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Add: Fair value adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--DeferredStockConsiderationFairValueAdjustment_c20230101__20231231_znAkvNuLIWCb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock consideration, Fair value adjustment">455,933</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_ecustom--DeferredCashConsiderationFairValueAdjustment_c20230101__20231231_zyQj4uqkp9Gc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cash consideration, Fair value adjustment">239,017</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--DeferredConsiderationPaymentFairValueAdjustment_c20230101__20231231_zJdPtcu8oIol" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consideration payment, Fair value adjustment">380,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--DeferredStockConsideration_iS_c20240101__20240331_zimsMNeH8Et1" style="text-align: right" title="Deferred stock consideration, Balance"><span style="-sec-ix-hidden: xdx2ixbrl0715">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--DeferredCashConsideration_iS_c20240101__20240331_zIL2cgXBKBxc" style="text-align: right" title="Deferred cash consideration, Balance">2,889,792</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--DeferredConsiderationPayment_iS_c20240101__20240331_zUEB3VEanHq4" style="text-align: right" title="Deferred consideration payment, Balance">810,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Add: Fair value adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--DeferredStockConsiderationFairValueAdjustment_c20240101__20240331_zgVx2NwlBvLl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock consideration, Fair value adjustment"><span style="-sec-ix-hidden: xdx2ixbrl0721">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--DeferredCashConsiderationFairValueAdjustment_c20240101__20240331_z6dDsLZqIMck" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cash consideration, Fair value adjustment">31,465</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_ecustom--DeferredConsiderationPaymentFairValueAdjustment_c20240101__20240331_zuxG881zawK2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consideration payment, Fair value adjustment">(216,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--DeferredStockConsideration_iE_c20240101__20240331_zldPC2Nyzbw3" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred stock consideration, Balance"><span style="-sec-ix-hidden: xdx2ixbrl0727">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--DeferredCashConsideration_iE_c20240101__20240331_zBBxGCSbCyD8" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred cash consideration, Balance">2,921,257</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--DeferredConsiderationPayment_iE_c20240101__20240331_zQQFNaTM2a48" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred consideration payment, Balance">594,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zuypP3JFFx1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 30000000 9000000 2100000 5835822 2.00 1500000 5000000 2.00 <p id="xdx_890_ecustom--ScheduleOfDeferredConsiderationTableTextBlock_zWCx7yLuHX9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in the amount of deferred consideration from January 1, 2023, to March 31, 2024, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zrUiHZQAnGR3" style="display: none">Schedule of Change in Deferred Consideration</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock<br/> consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cash<br/> consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Third Anniversary<br/> Consideration Payment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%">January 1, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--DeferredStockConsideration_iS_c20230101__20231231_zVnDowz099yi" style="width: 12%; text-align: right" title="Deferred stock consideration, Balance">11,456,639</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--DeferredCashConsideration_iS_c20230101__20231231_zeJiPG6wsEle" style="width: 12%; text-align: right" title="Deferred cash consideration, Balance">5,650,775</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--DeferredConsiderationPayment_iS_c20230101__20231231_zlUdMEEaXVqf" style="width: 14%; text-align: right" title="Deferred consideration payment, Balance"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: Working capital adjustment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--DeferredStockConsiderationWorkingCapitalAdjustment_iN_di_c20230101__20231231_zHRJutvQFxEc" style="text-align: right" title="Stock consideration, Working capital adjustment">(108,691</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--DeferredCashConsiderationWorkingCapitalAdjustment_c20230101__20231231_z16DhoMNZQff" style="text-align: right" title="Cash consideration, Working capital adjustment"><span style="-sec-ix-hidden: xdx2ixbrl0695">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: Issuance of shares and payment to shareholders</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--DeferredStockConsiderationIssuanceOfPaymentToShareHolders_iN_di_c20230101__20231231_z4J9g2UjeEr9" style="text-align: right" title="Stock consideration, Issuance of shares and payment to shareholders">(4,085,075</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--DeferredCashConsiderationIssuanceOfPaymentToShareHolders_iN_di_c20230101__20231231_zokj59datU71" style="text-align: right" title="Cash consideration, Issuance of shares and payment to shareholders">(3,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: Issuance of Abaca warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--DeferredStockConsiderationIssuanceOfWarrants_iN_di_c20230101__20231231_zRqpzdC5j3o4" style="text-align: right" title="Stock consideration, Issuance of payment consideration">(1,643,699</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: Issuance of third anniversary payment consideration</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--DeferredStockConsiderationIssuanceOfPaymentConsideration_iN_di_c20230101__20231231_zDS3Gpk5opG2" style="text-align: right" title="Stock consideration, Issuance of payment consideration">(430,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--DeferredConsiderationPaymentIssuanceOfPaymentConsideration_iN_di_c20230101__20231231_zMDC6jA0Jfke" style="text-align: right" title="Consideration payment, Issuance of payment consideration">430,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: Gain recognized in the consolidated statements of operations</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--DeferredStockConsiderationGainRecognized_iN_di_c20230101__20231231_z9pjoTwg0Yj8" style="text-align: right" title="Stock consideration, Gain recognized in the consolidated statements of operations">(5,645,107</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Add: Fair value adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--DeferredStockConsiderationFairValueAdjustment_c20230101__20231231_znAkvNuLIWCb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock consideration, Fair value adjustment">455,933</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_ecustom--DeferredCashConsiderationFairValueAdjustment_c20230101__20231231_zyQj4uqkp9Gc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cash consideration, Fair value adjustment">239,017</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--DeferredConsiderationPaymentFairValueAdjustment_c20230101__20231231_zJdPtcu8oIol" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consideration payment, Fair value adjustment">380,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--DeferredStockConsideration_iS_c20240101__20240331_zimsMNeH8Et1" style="text-align: right" title="Deferred stock consideration, Balance"><span style="-sec-ix-hidden: xdx2ixbrl0715">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--DeferredCashConsideration_iS_c20240101__20240331_zIL2cgXBKBxc" style="text-align: right" title="Deferred cash consideration, Balance">2,889,792</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--DeferredConsiderationPayment_iS_c20240101__20240331_zUEB3VEanHq4" style="text-align: right" title="Deferred consideration payment, Balance">810,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Add: Fair value adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--DeferredStockConsiderationFairValueAdjustment_c20240101__20240331_zgVx2NwlBvLl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock consideration, Fair value adjustment"><span style="-sec-ix-hidden: xdx2ixbrl0721">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--DeferredCashConsiderationFairValueAdjustment_c20240101__20240331_z6dDsLZqIMck" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cash consideration, Fair value adjustment">31,465</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_ecustom--DeferredConsiderationPaymentFairValueAdjustment_c20240101__20240331_zuxG881zawK2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Consideration payment, Fair value adjustment">(216,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--DeferredStockConsideration_iE_c20240101__20240331_zldPC2Nyzbw3" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred stock consideration, Balance"><span style="-sec-ix-hidden: xdx2ixbrl0727">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--DeferredCashConsideration_iE_c20240101__20240331_zBBxGCSbCyD8" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred cash consideration, Balance">2,921,257</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--DeferredConsiderationPayment_iE_c20240101__20240331_zQQFNaTM2a48" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred consideration payment, Balance">594,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 11456639 5650775 108691 4085075 3000000 1643699 430000 -430000 5645107 455933 239017 380000 2889792 810000 31465 -216000 2921257 594000 <p id="xdx_806_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zixEniZgK0vh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -37pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4. <span id="xdx_825_zuaG2iBjFWPl">Goodwill and Finite-lived Intangible Assets</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -37pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s goodwill was derived from the Abaca acquisition transaction executed on November 15, 2022, where the purchase price exceeded the fair value of the net identifiable assets acquired. Goodwill is tested for impairment at least annually, or more frequently if a triggering event occurs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2023, the Company conducted an interim impairment assessment on June 30, 2023, and found that the carrying value of goodwill exceeded its fair value, leading to the recognition of a $<span id="xdx_90B_eus-gaap--GoodwillImpairmentLoss_pn4n6_c20230101__20231231_zZ3lnSUCp5I2" title="Non-cash goodwill impairment charge">13.21</span> million non-cash goodwill impairment charge in the Company’s consolidated statements of operations. The December 31, 2023, annual impairment test resulted in no additional impairment change recognized, as the fair value did not surpass the carrying value. As of March 31, 2024, and December 31, 2023, the carrying value of the company’s goodwill was $<span id="xdx_90D_eus-gaap--Goodwill_iI_c20240331_zQqebYsxRu1" title="Goodwill"><span id="xdx_905_eus-gaap--Goodwill_iI_c20231231_zb3qJwAScpk5" title="Goodwill">6,058,000</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company has not conducted an interim impairment assessment of its assets, due to the absence of any triggering events. Therefore, no additional impairment charges have been recognized in this reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, and December 31, 2023, the Company’s accumulated goodwill impairment was $<span id="xdx_90A_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iI_c20240331_zRaqZGBhEWgf" title="Goodwill impairment"><span id="xdx_902_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iI_c20231231_zC4vnB3rTy1c" title="Goodwill impairment">13,208,276</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Finite-lived intangible assets</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews its finite-lived intangible assets for impairment at least annually on December 31<sup>st</sup> unless any events or circumstances indicate it is more likely than not that the fair value of the finite-lived intangible assets is less than its carrying value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2023, following a triggering event in the second quarter, the Company performed an interim goodwill analysis. In accordance with our established policy, an annual review was also conducted on December 31, 2023. The finite-lived intangible assets evaluated include market-related intangibles, customer relationships, and developed technologies. The interim analysis resulted in an impairment charge of $<span id="xdx_902_eus-gaap--AssetImpairmentCharges_c20240101__20240331_zfCTX3qwSRZb" title="Impairment charge">3,680,463</span>, attributed to the carrying values of market-related intangibles and customer relationships surpassing their fair values. The annual review further identified an impairment charge of $<span id="xdx_909_eus-gaap--AssetImpairmentCharges_c20240101__20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zzwKujjp36mh" title="Impairment charge">2,019,000</span> related to developed technologies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company has not conducted an interim impairment assessment of its assets, due to the absence of any triggering events. Therefore, no additional impairment changes have been recognized in this reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zSjJBXiB2j18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following is a summary of the Company’s finite-lived intangible assets as of March 31, 2024 and December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zk4PJf4HcuJd" style="display: none">Schedule of Finite Lived Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Remaining<br/> Useful life in<br/> Years</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2023<br/> (A)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_480_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_zdKV5eRNtm7b" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Acquired in<br/> Acquisition<br/> (B)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_48A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_z5JOavD3EFgj" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amortization<br/> (C)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_489_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_zV3au8hQnFj2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Impairment<br/> (D)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_484_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zp46D0F879rl" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2024<br/> (A+B-C-D)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_416_20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zmdUarq7XSsk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: left">Market related intangible assets</td><td style="width: 2%"> </td> <td style="width: 8%; text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zdbHGzHI0hg8" title="Remaining useful life in years">6.62</span> Years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zNiCAZEmUou4" title="Finite-lived intangible assets, net">65,216</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0750">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2,540</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">62,676</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_412_20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zgCahqmDJB2j" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: center"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlTkcG2pAyq" title="Remaining useful life in years">8.62</span> Years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zz7M0RKgp5Vk" title="Finite-lived intangible assets, net">56,775</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,687</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,088</td><td style="text-align: left"> </td></tr> <tr id="xdx_41C_20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zRXd1D3FBSVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Developed technology</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zoGoTWW3sNpa" title="Remaining useful life in years">5.62</span> Years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zjPsmOMjQU7l" title="Finite-lived intangible assets, net">3,599,754</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0766">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">152,628</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,447,126</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_41F_20240331_zpZaddXlTVjf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20231231_zJbf2zxhNlEe">3,721,745</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0774">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">156,855</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0776">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,564,890</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Remaining<br/> Useful life in<br/> Years</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2022<br/> (A)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" id="xdx_480_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_zunmO9CVxoS6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Acquired in<br/> Acquisition<br/> (B)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" id="xdx_48A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zGSevFMIaBW7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amortization<br/> (C)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" id="xdx_489_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_zmPlHMup3qha" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Impairment<br/> (D)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" id="xdx_484_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_z3tICcMCzax6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2023<br/> (A+B-C-D)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td></tr> <tr id="xdx_41A_20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zX29o8q5UV29" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: left">Market related intangible assets</td><td style="width: 2%"> </td> <td style="width: 8%; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zy9vuv59fM78" title="Remaining useful life in years">6.87</span> Years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zhm07ogpZIH6" title="Finite-lived intangible assets, net">2,066,918</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0779">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">136,034</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">1,865,668</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">65,216</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_418_20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zSXY9xPT4TBl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zdjT3NqY26j6" title="Remaining useful life in years">8.87</span> Years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXHdA7RVn8j4" title="Finite-lived intangible assets, net">1,974,795</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0787">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">103,225</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,814,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,775</td><td style="text-align: left"> </td></tr> <tr id="xdx_411_20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zYCSCx8h6XNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Developed technology</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zi5LJ7XbUXze" title="Remaining useful life in years">5.87</span> Years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zsDCPvrEJba9" title="Finite-lived intangible assets, net">6,579,374</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">960,619</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,019,001</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,599,754</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_41B_20231231_zctqmKOToiDl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231_zGicEUq4FUWc">10,621,087</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0803">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,199,878</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,699,464</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,721,745</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zoLbXMvdlGrf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, amortization expense and impairment of finite lived intangible assets were $<span id="xdx_90A_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20240101__20240331_zHyyixtdcIA7" title="Impairment">354,911</span> and $<span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20230101__20230331_zmdeHvcfznAe" title="Impairment">0</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 13210000 6058000 6058000 13208276 13208276 3680463 2019000 <p id="xdx_896_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zSjJBXiB2j18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following is a summary of the Company’s finite-lived intangible assets as of March 31, 2024 and December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zk4PJf4HcuJd" style="display: none">Schedule of Finite Lived Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Remaining<br/> Useful life in<br/> Years</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2023<br/> (A)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_480_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_zdKV5eRNtm7b" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Acquired in<br/> Acquisition<br/> (B)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_48A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_z5JOavD3EFgj" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amortization<br/> (C)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_489_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_zV3au8hQnFj2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Impairment<br/> (D)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_484_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zp46D0F879rl" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2024<br/> (A+B-C-D)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_416_20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zmdUarq7XSsk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: left">Market related intangible assets</td><td style="width: 2%"> </td> <td style="width: 8%; text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zdbHGzHI0hg8" title="Remaining useful life in years">6.62</span> Years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zNiCAZEmUou4" title="Finite-lived intangible assets, net">65,216</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0750">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">2,540</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">62,676</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_412_20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zgCahqmDJB2j" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: center"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlTkcG2pAyq" title="Remaining useful life in years">8.62</span> Years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zz7M0RKgp5Vk" title="Finite-lived intangible assets, net">56,775</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,687</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,088</td><td style="text-align: left"> </td></tr> <tr id="xdx_41C_20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zRXd1D3FBSVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Developed technology</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20240331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zoGoTWW3sNpa" title="Remaining useful life in years">5.62</span> Years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zjPsmOMjQU7l" title="Finite-lived intangible assets, net">3,599,754</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0766">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">152,628</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,447,126</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_41F_20240331_zpZaddXlTVjf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20231231_zJbf2zxhNlEe">3,721,745</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0774">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">156,855</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0776">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,564,890</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Remaining<br/> Useful life in<br/> Years</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2022<br/> (A)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" id="xdx_480_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_zunmO9CVxoS6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Acquired in<br/> Acquisition<br/> (B)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" id="xdx_48A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_zGSevFMIaBW7" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amortization<br/> (C)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" id="xdx_489_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_zmPlHMup3qha" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Impairment<br/> (D)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" id="xdx_484_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_z3tICcMCzax6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2023<br/> (A+B-C-D)</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td></tr> <tr id="xdx_41A_20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zX29o8q5UV29" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: left">Market related intangible assets</td><td style="width: 2%"> </td> <td style="width: 8%; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zy9vuv59fM78" title="Remaining useful life in years">6.87</span> Years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--MarketingRelatedIntangibleAssetsMember_zhm07ogpZIH6" title="Finite-lived intangible assets, net">2,066,918</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0779">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">136,034</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">1,865,668</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">65,216</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_418_20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zSXY9xPT4TBl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zdjT3NqY26j6" title="Remaining useful life in years">8.87</span> Years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXHdA7RVn8j4" title="Finite-lived intangible assets, net">1,974,795</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0787">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">103,225</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,814,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,775</td><td style="text-align: left"> </td></tr> <tr id="xdx_411_20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zYCSCx8h6XNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Developed technology</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zi5LJ7XbUXze" title="Remaining useful life in years">5.87</span> Years</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zsDCPvrEJba9" title="Finite-lived intangible assets, net">6,579,374</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">960,619</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,019,001</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,599,754</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_41B_20231231_zctqmKOToiDl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intangible assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231_zGicEUq4FUWc">10,621,087</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0803">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,199,878</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,699,464</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,721,745</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> P6Y7M13D 65216 2540 62676 P8Y7M13D 56775 1687 55088 P5Y7M13D 3599754 152628 3447126 3721745 156855 3564890 P6Y10M13D 2066918 136034 1865668 65216 P8Y10M13D 1974795 103225 1814795 56775 P5Y10M13D 6579374 960619 2019001 3599754 10621087 1199878 5699464 3721745 354911 0 <p id="xdx_80B_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z7UmdgkcnPbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5. <span id="xdx_822_zaZLRUFcfk4f">Loans Receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfRealEstatePropertiesTableTextBlock_zFh3pLcjf2Kf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial real estate loans receivable, net consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zBcjAgJNAo3d" style="display: none">Schedule of Commercial Real Estate Loans Receivable</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_49C_20240331__us-gaap--DebtInstrumentAxis__custom--CommercialRealEstateLoansReceivableMember_zN2fNZesXzJh" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_490_20231231__us-gaap--DebtInstrumentAxis__custom--CommercialRealEstateLoansReceivableMember_zXAnsUMNCWff" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_405_eus-gaap--NotesReceivableGross_iI_zsbMr0Connoj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Commercial real estate loans receivable, gross</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">401,564</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">404,577</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--AllowanceForLoanLosses_iNI_di_zwRJ54z5nzIg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Allowance for credit losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,081</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,723</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--NotesReceivableNet_iI_z6U82ZYSJHEj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Commercial real estate loans receivable, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">392,483</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">393,854</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--CommercialRealEstateLoansReceivableCurrent_iI_zTlVQd0PYDa4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,620</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,391</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--CommercialRealEstateLoansReceivableNonCurrent_iI_zgDS4tBFwHAf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Noncurrent portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">379,863</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">381,463</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zkLwHRAWXR8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Allowance for Credit Losses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allowance for credit losses is maintained at a level believed to be sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the loan portfolio. The Company’s estimated the allowance for credit losses on the reporting date in accordance with the credit loss policy described in Note 2 to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zKzonSdaKCD5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allowance for credit losses consists of the following activity for the three months ended March 31, 2024 and three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_z3WNEb0l5zO1" style="display: none">Schedule of Allowance For Loan Losses</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Allowance for credit losses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iS_c20240101__20240331_zFqJokQqRuqf" style="width: 12%; text-align: right" title="Allowance for credit losses, beginning balance">10,723</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iS_c20230101__20230331_ztc5WlZxiO4d" style="width: 12%; text-align: right" title="Allowance for credit losses, beginning balance">21,488</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Cumulative effect from adoption of CECL</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--AllowanceForLoanAndLeaseLossesFromCumulativeEffect_c20240101__20240331_zsiygSQQtw7g" style="text-align: right" title="Cumulative effect from adoption of CECL"><span style="-sec-ix-hidden: xdx2ixbrl0838">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--AllowanceForLoanAndLeaseLossesFromCumulativeEffect_c20230101__20230331_zzAswBj3agU" style="text-align: right" title="Cumulative effect from adoption of CECL">14,980</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Charge-offs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--AllowanceForLoansAndLeaseLossesWriteOffs_c20240101__20240331_zdfWRgGNULO9" style="text-align: right" title="Charge-offs"><span style="-sec-ix-hidden: xdx2ixbrl0842">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--AllowanceForLoansAndLeaseLossesWriteOffs_c20230101__20230331_ziKBbn3K8X1l" style="text-align: right" title="Charge-offs"><span style="-sec-ix-hidden: xdx2ixbrl0844">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Recoveries</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--AllowanceForLoanAndLeaseLossRecoveryOfBadDebt_c20240101__20240331_zsvVSntNHaK5" style="text-align: right" title="Recoveries"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--AllowanceForLoanAndLeaseLossRecoveryOfBadDebt_c20230101__20230331_zw4N0qG1V2xg" style="text-align: right" title="Recoveries">(15,390</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Benefit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery_iN_di_c20240101__20240331_zQk8TgZaH0zl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Provision">(1,642</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery_iN_di_c20230101__20230331_zJy2nMTn69oj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Provision"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Ending balance</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iE_c20240101__20240331_zTnQJ639KVKj" style="text-align: right" title="Allowance for credit losses,ending balance">9,081</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iE_c20230101__20230331_zB6Otp1pn4qd" style="text-align: right" title="Allowance for credit losses,ending balance">21,078</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Loans receivable:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Individually evaluated for an allowance for credit loss</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--FinancingReceivableIndividuallyEvaluatedForImpairment_iI_c20240331_zvG99pmDB1il" style="text-align: right" title="Individually evaluated for impairment"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--FinancingReceivableIndividuallyEvaluatedForImpairment_iI_c20230331_zQzaTWgwQuA3" style="text-align: right" title="Individually evaluated for impairment"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Collectively evaluated for an allowance for credit loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--FinancingReceivableCollectivelyEvaluatedForImpairment_iI_c20240331_z1nPdxiUoNje" style="border-bottom: Black 1.5pt solid; text-align: right" title="Collectively evaluated for impairment">401,564</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FinancingReceivableCollectivelyEvaluatedForImpairment_iI_c20230331_zvkgBl9e9qlb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Collectively evaluated for impairment">413,292</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--LoansAndLeasesReceivablesGrossCarryingAmount_iI_c20240331_zRTA9mlKl2si" style="border-bottom: Black 2.5pt double; text-align: right" title="Loans receivable">401,564</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--LoansAndLeasesReceivablesGrossCarryingAmount_iI_c20230331_z4jVfDtOWEIf" style="border-bottom: Black 2.5pt double; text-align: right" title="Loans receivable">413,292</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Allowance for credit losses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Individually evaluated for an allowance for credit loss</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1_iI_c20240331_zQOV8pi1jRa9" style="text-align: right" title="Individually evaluated for impairment"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1_iI_c20230331_zzyCvHPhNzt3" style="text-align: right" title="Individually evaluated for impairment"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Collectively evaluated for an allowance for credit loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment_iI_c20240331_zdWsCo33121e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Collectively evaluated for impairment">9,081</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment_iI_c20230331_z0l4R6pj6zf1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Collectively evaluated for impairment">21,078</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iI_c20240331_zMwh9oz842vd" style="border-bottom: Black 2.5pt double; text-align: right" title="Allowance for loan losses">9,081</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iI_c20230331_zVtcrbDf5FM1" style="border-bottom: Black 2.5pt double; text-align: right" title="Allowance for loan losses">21,078</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zMopF6yWhrsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2024 and December 31, 2023, no loans were past due or classified as non-accrual.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Credit quality of loans:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the on-going monitoring of the credit quality of the Company’s loan portfolio, management tracks credit quality indicators based on the loan payment status on monthly basis. The Company continuously evaluates the credit quality of each indemnified loan by assessing the risk factors and assigning a risk rating based on a variety of factors. The detailed breakdown of risk factors described in Note 6 to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfRiskRatingTableTextBlock_zM6TTCOI5UC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value, excluding the CECL Reserve, of the Company’s loans held at carrying value within each risk rating is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zcPMYdy2Hbol" style="display: none">Schedule of Risk Rating</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>Risk rating</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20240331_z8dfvbqCAH2j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20231231_z48gH8WHtwk2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--FinancingReceivableCollectivelyEvaluatedForImpairment_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateFourMember_zvXVpnbwnly8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">4</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">401,564</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">404,577</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinancingReceivableCollectivelyEvaluatedForImpairment_iI_zjBwwmdR8WX4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Grand total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">401,564</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">404,577</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_ztyhQMI8YT2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfRealEstatePropertiesTableTextBlock_zFh3pLcjf2Kf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial real estate loans receivable, net consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zBcjAgJNAo3d" style="display: none">Schedule of Commercial Real Estate Loans Receivable</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_49C_20240331__us-gaap--DebtInstrumentAxis__custom--CommercialRealEstateLoansReceivableMember_zN2fNZesXzJh" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_490_20231231__us-gaap--DebtInstrumentAxis__custom--CommercialRealEstateLoansReceivableMember_zXAnsUMNCWff" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_405_eus-gaap--NotesReceivableGross_iI_zsbMr0Connoj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Commercial real estate loans receivable, gross</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">401,564</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">404,577</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--AllowanceForLoanLosses_iNI_di_zwRJ54z5nzIg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Allowance for credit losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,081</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,723</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--NotesReceivableNet_iI_z6U82ZYSJHEj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Commercial real estate loans receivable, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">392,483</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">393,854</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--CommercialRealEstateLoansReceivableCurrent_iI_zTlVQd0PYDa4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,620</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,391</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--CommercialRealEstateLoansReceivableNonCurrent_iI_zgDS4tBFwHAf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Noncurrent portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">379,863</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">381,463</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 401564 404577 9081 10723 392483 393854 -12620 -12391 379863 381463 <p id="xdx_89C_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zKzonSdaKCD5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allowance for credit losses consists of the following activity for the three months ended March 31, 2024 and three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_z3WNEb0l5zO1" style="display: none">Schedule of Allowance For Loan Losses</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Allowance for credit losses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iS_c20240101__20240331_zFqJokQqRuqf" style="width: 12%; text-align: right" title="Allowance for credit losses, beginning balance">10,723</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iS_c20230101__20230331_ztc5WlZxiO4d" style="width: 12%; text-align: right" title="Allowance for credit losses, beginning balance">21,488</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Cumulative effect from adoption of CECL</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--AllowanceForLoanAndLeaseLossesFromCumulativeEffect_c20240101__20240331_zsiygSQQtw7g" style="text-align: right" title="Cumulative effect from adoption of CECL"><span style="-sec-ix-hidden: xdx2ixbrl0838">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--AllowanceForLoanAndLeaseLossesFromCumulativeEffect_c20230101__20230331_zzAswBj3agU" style="text-align: right" title="Cumulative effect from adoption of CECL">14,980</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 10pt">Charge-offs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--AllowanceForLoansAndLeaseLossesWriteOffs_c20240101__20240331_zdfWRgGNULO9" style="text-align: right" title="Charge-offs"><span style="-sec-ix-hidden: xdx2ixbrl0842">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--AllowanceForLoansAndLeaseLossesWriteOffs_c20230101__20230331_ziKBbn3K8X1l" style="text-align: right" title="Charge-offs"><span style="-sec-ix-hidden: xdx2ixbrl0844">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt">Recoveries</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--AllowanceForLoanAndLeaseLossRecoveryOfBadDebt_c20240101__20240331_zsvVSntNHaK5" style="text-align: right" title="Recoveries"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--AllowanceForLoanAndLeaseLossRecoveryOfBadDebt_c20230101__20230331_zw4N0qG1V2xg" style="text-align: right" title="Recoveries">(15,390</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Benefit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery_iN_di_c20240101__20240331_zQk8TgZaH0zl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Provision">(1,642</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery_iN_di_c20230101__20230331_zJy2nMTn69oj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Provision"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Ending balance</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iE_c20240101__20240331_zTnQJ639KVKj" style="text-align: right" title="Allowance for credit losses,ending balance">9,081</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iE_c20230101__20230331_zB6Otp1pn4qd" style="text-align: right" title="Allowance for credit losses,ending balance">21,078</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Loans receivable:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Individually evaluated for an allowance for credit loss</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--FinancingReceivableIndividuallyEvaluatedForImpairment_iI_c20240331_zvG99pmDB1il" style="text-align: right" title="Individually evaluated for impairment"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--FinancingReceivableIndividuallyEvaluatedForImpairment_iI_c20230331_zQzaTWgwQuA3" style="text-align: right" title="Individually evaluated for impairment"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Collectively evaluated for an allowance for credit loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--FinancingReceivableCollectivelyEvaluatedForImpairment_iI_c20240331_z1nPdxiUoNje" style="border-bottom: Black 1.5pt solid; text-align: right" title="Collectively evaluated for impairment">401,564</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--FinancingReceivableCollectivelyEvaluatedForImpairment_iI_c20230331_zvkgBl9e9qlb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Collectively evaluated for impairment">413,292</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--LoansAndLeasesReceivablesGrossCarryingAmount_iI_c20240331_zRTA9mlKl2si" style="border-bottom: Black 2.5pt double; text-align: right" title="Loans receivable">401,564</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--LoansAndLeasesReceivablesGrossCarryingAmount_iI_c20230331_z4jVfDtOWEIf" style="border-bottom: Black 2.5pt double; text-align: right" title="Loans receivable">413,292</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Allowance for credit losses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Individually evaluated for an allowance for credit loss</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1_iI_c20240331_zQOV8pi1jRa9" style="text-align: right" title="Individually evaluated for impairment"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1_iI_c20230331_zzyCvHPhNzt3" style="text-align: right" title="Individually evaluated for impairment"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Collectively evaluated for an allowance for credit loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment_iI_c20240331_zdWsCo33121e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Collectively evaluated for impairment">9,081</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment_iI_c20230331_z0l4R6pj6zf1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Collectively evaluated for impairment">21,078</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iI_c20240331_zMwh9oz842vd" style="border-bottom: Black 2.5pt double; text-align: right" title="Allowance for loan losses">9,081</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancingReceivableAllowanceForCreditLosses_iI_c20230331_zVtcrbDf5FM1" style="border-bottom: Black 2.5pt double; text-align: right" title="Allowance for loan losses">21,078</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 10723 21488 14980 -15390 1642 9081 21078 401564 413292 401564 413292 9081 21078 9081 21078 <p id="xdx_89C_ecustom--ScheduleOfRiskRatingTableTextBlock_zM6TTCOI5UC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value, excluding the CECL Reserve, of the Company’s loans held at carrying value within each risk rating is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zcPMYdy2Hbol" style="display: none">Schedule of Risk Rating</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td>Risk rating</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20240331_z8dfvbqCAH2j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20231231_z48gH8WHtwk2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--FinancingReceivableCollectivelyEvaluatedForImpairment_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateFourMember_zvXVpnbwnly8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">4</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">401,564</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">404,577</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FinancingReceivableCollectivelyEvaluatedForImpairment_iI_zjBwwmdR8WX4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Grand total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">401,564</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">404,577</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 401564 404577 401564 404577 <p id="xdx_802_ecustom--IndemnificationLiabilityTextBlock_z48UFbdjEjhl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6. <span id="xdx_827_zYvDYsxCNr41">Indemnification Liability</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As discussed at Note 8 to the unaudited condensed consolidated financial statements, and pursuant to the Commercial Alliance Agreement with PCCU, PCCU funds loans through a third-party vendor. SHF earns the associated interest and pays PCCU a loan hosting payment at an annual rate of 0.35% of the outstanding loan principal funded and serviced by PCCU and 0.25% of the outstanding loan principle serviced by SHF. The below schedule details outstanding amounts funded by PCCU and categorized as either collateralized loans or unsecured loans and lines of credit.</span></p> <p id="xdx_895_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_ztrlTE5ZCLTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_ziis9pwoF05" style="display: none">Schedule of Outstanding Amounts</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240331__us-gaap--TypeOfArrangementAxis__custom--PCCUAgreementMember_zIijhUZ0H5O6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20231231__us-gaap--TypeOfArrangementAxis__custom--PCCUAgreementMember_zvHHDGQZaN4d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--SecuredLongTermDebt_iI_maLTDz516_zSeKB2c8qZz9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Secured term loans</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">57,737,288</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">55,215,013</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--UnsecuredLoansAndLinesOfCredit_iI_maLTDz516_zuBqe2VSmC58" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Unsecured loans and lines of credit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">431,640</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">431,640</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebt_iTI_mtLTDz516_zssnpsnaZQ7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total loans funded by PCCU</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">58,168,928</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55,646,653</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zcOEFj1GQ6G3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secured loans contained an interest rate ranging from <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240331__us-gaap--LongtermDebtTypeAxis__us-gaap--SecuredDebtMember__srt--RangeAxis__srt--MinimumMember_zFhaUUgla2zd" title="Interest rate">7.35</span>% to <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240331__us-gaap--LongtermDebtTypeAxis__us-gaap--SecuredDebtMember__srt--RangeAxis__srt--MaximumMember_zZYcNefNUmm6" title="Interest rate">15.25</span>%. <span id="xdx_90A_eus-gaap--DebtInstrumentDescriptionOfVariableRateBasis_c20240101__20240331__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_z6XBc4WfnAxk" title="Variable rate description">Unsecured loans and lines of credit contain variable rates ranging from Prime +1.50% to Prime +6.00%.</span> Unsecured lines of credit had incremental availability of $<span id="xdx_901_eus-gaap--LineOfCredit_iI_c20240331__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_z7Y4Gae24h1j" title="Lines of credit">525,000</span> and $<span id="xdx_90C_eus-gaap--LineOfCredit_iI_c20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zP7XiJOrwY3g" title="Lines of credit">996,958</span> on March 31, 2024 and December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHF has agreed to indemnify PCCU for losses on certain PCCU loans. The indemnity liability reflects SHF management’s estimate of probable credit losses inherent under the agreement at the balance sheet date. The Company’s estimated indemnity liability on the reporting date was calculated in accordance with the allowance for credit loss policy described in Note 2 to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfLossContingenciesByContingencyTextBlock_zgstkDe5LBU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The indemnity liability activity are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_z5wkY7vxDmkh" style="display: none">Schedule of Indemnity Liability</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_49C_20240101__20240331_zBMOFfOAcKsj" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three Months ended<br/> March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_49C_20230101__20230331_zRUpYy1I9BUe" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three Months ended<br/> March 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_404_eus-gaap--LossContingencyAccrualAtCarryingValue_iS_zApdhsX6KPX" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,382,408</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">499,465</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--LossContingencyAccrualCumulativeEffect_zmafMeNoyUj1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Cumulative effect from adoption of CECL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">566,341</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LossContingencyAccrualPayments_zAopPAxIUlO" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Charge-offs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0921">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--LossContingencyAccrualRecoveries_ztfYHOnUfyF3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Recoveries</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0925">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LossContingencyAccrualProvision_zkKS37Q7Cwo1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">(Benefit)/ Provision</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(67,145</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">82,026</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LossContingencyAccrualAtCarryingValue_iE_zNKpfkkjZYb7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,315,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,147,832</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zcS6Riibz8hj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, all loans within the Company’s portfolio were current and performing. This is in contrast to the situation as of December 31, 2023, when one loan was under nonaccrual status. The Company successfully negotiated an amendment agreement on December 29, 2023, which brought this loan back to current status through the payment of all overdue amounts. Under the terms of the amendment, the loan’s maturity date was extended to November 1, 2024. Interest income from this loan is now recognized on a cash basis. Given that the loan was delinquent for over 300 days, it has been incorporated into the Company’s Current Expected Credit Losses (CECL) methodology, which aids in estimating credit losses for this particular loan and the overall loan portfolio collectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Credit quality of indemnified loans:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the on-going monitoring of the credit quality of the Company’s indemnified loan portfolio, management tracks credit quality indicators based on the loan payment status on monthly basis. The Company continuously evaluates the credit quality of each indemnified loan by assessing the risk factors and assigning a risk rating based on a variety of factors. Risk factors include property type, geographic and local market dynamics, physical condition, projected cash flow, loan structure and exit plan, loan-to-value ratio, fixed charge coverage ratio, project sponsorship, and other factors deemed necessary. Based on a 10-point scale, the Company’s loans are rated “0” through “10,” from less risk to greater risk, which ratings are defined as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk<br/> rating</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 84%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Free</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Free of repayment risk. The loan is fully guaranteed by the full faith and backing of the US Government or entirely secured by cash controlled by SHF.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Highest Quality</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High caliber loan with the lowest risk of default. Significant excess cash flow after debt service and moderate to low leverage.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excellent</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High quality loan that carry’s a low risk of default. Strong cash flow and relatively few negative individual risk factors.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans with lower-than-average level of risk. Excess cash flow and other factors contributing to the overall low level of risk in the loan.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors may be mixed with some negative and some positive aspects, but the overall rating will indicate an average level of risk.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans in this category have the maximum level of risk that can be accepted while still recommending a new loan for origination. The loan risk factors may contain multiple negative factors, but they are generally outweighed by the positive aspects of the loan.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Watch List</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is a temporary and curable condition resulting in a lower risk rating.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special Mention</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is a potential weakness that may result in the deterioration of the prospect of repayment that are not temporary and may require additional collection or workout efforts.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substandard</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans in this category are inadequately protected by the current net worth and paying capacity of the obligors or of the collateral pledged and have well-defined weaknesses that jeopardize the liquidation of the debt with distinct possibility of loss. SHF may be required to advance additional funds to manage the loan. Escalated collection activities such as foreclosure have been scheduled with anticipated losses up to 20% of the outstanding balance.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doubtful</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collection or liquidation in full highly questionable and improbable. Escalated collection activities such as foreclosure have commenced with anticipated losses from 20% to 50% of the outstanding balance.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncollectable loans. A complete write-off is imminent although a partial recovery may be affected in the future.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHF has agreed to indemnify PCCU from all claims related to SHF’s cannabis-related business. Other than potential credit losses, no other circumstances were identified meeting the requirements of a loss contingency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--ScheduleOfIndemnifiedLoansRiskRatingTableTextBlock_zC6B3wUuSSzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value, excluding the CECL Reserve, of the Company’s indemnified loans held at carrying value within each risk rating is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zO7AcG56meg7" style="display: none">Schedule of Indemnified Loans Risk Rating</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Risk rating</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240331_zF7Ssq9wb2h6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20231231_zCzQpyd2IuBh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateThreeMember_zuqi84T8Puud" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 69%; text-align: justify">3</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,988,588</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">10,100,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateFourMember_z5bs9vKA9iPj" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">4</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,425,158</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,431,640</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateFiveMember_z2ne1NJZCH9k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">5</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,553,007</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,115,013</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateSixMember_zKmOiw8mVUV6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">6</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,900,000</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,900,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateSevenMember_zQBP2sVedVE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">7</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">-</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,100,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateEightMember_zMnDnitBSxE3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">8</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,302,175</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0951">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iI_zCSWGOzwVLd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">58,168,928</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55,646,653</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zHYpugFkHh0g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_ecustom--ScheduleOfProvisionForLoanLossesTableTextBlock_zMvKQb6sKMIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for credit losses on the statement of operations consists of the following activity for the period ended March 31, 2024 and March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zPj3r00Pz9f2" style="display: none">Schedule of Provision for Loan Losses</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20240101__20240331__us-gaap--FinancingReceivablePortfolioSegmentAxis__us-gaap--CommercialRealEstatePortfolioSegmentMember_zysMcBaCcuCk" style="border-bottom: Black 1.5pt solid; text-align: center">Commercial<br/> real estate<br/> loans</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20240101__20240331__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--IndemnityLiabilitySegmentMember_zGXYJ3D15Eil" style="border-bottom: Black 1.5pt solid; text-align: center">Indemnity<br/> liability</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20240101__20240331_zR0ZO01jWAX4" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230331__us-gaap--FinancingReceivablePortfolioSegmentAxis__us-gaap--CommercialRealEstatePortfolioSegmentMember_zbpsCG09SX3" style="border-bottom: Black 1.5pt solid; text-align: center">Commercial<br/> real estate<br/> loans</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230101__20230331__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--IndemnityLiabilitySegmentMember_zweoLQfjIwgi" style="border-bottom: Black 1.5pt solid; text-align: center">Indemnity<br/> liability</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230101__20230331_zgSwM8QJ1fI4" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Commercial<br/> real estate<br/> loans</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Indemnity<br/> liability</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Commercial<br/> real estate<br/> loans</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Indemnity<br/> liability</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40D_eus-gaap--ProvisionForLoanLeaseAndOtherLosses_z7YW1E4dbWxd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Provision (benefit)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">(1,642</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">(67,145</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">(68,787</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">(15,390</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">82,056</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">66,666</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zMJZKBU1gN5l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_ztrlTE5ZCLTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_ziis9pwoF05" style="display: none">Schedule of Outstanding Amounts</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240331__us-gaap--TypeOfArrangementAxis__custom--PCCUAgreementMember_zIijhUZ0H5O6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20231231__us-gaap--TypeOfArrangementAxis__custom--PCCUAgreementMember_zvHHDGQZaN4d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--SecuredLongTermDebt_iI_maLTDz516_zSeKB2c8qZz9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Secured term loans</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">57,737,288</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">55,215,013</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--UnsecuredLoansAndLinesOfCredit_iI_maLTDz516_zuBqe2VSmC58" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Unsecured loans and lines of credit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">431,640</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">431,640</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebt_iTI_mtLTDz516_zssnpsnaZQ7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total loans funded by PCCU</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">58,168,928</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55,646,653</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 57737288 55215013 431640 431640 58168928 55646653 0.0735 0.1525 Unsecured loans and lines of credit contain variable rates ranging from Prime +1.50% to Prime +6.00%. 525000 996958 <p id="xdx_89B_eus-gaap--ScheduleOfLossContingenciesByContingencyTextBlock_zgstkDe5LBU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The indemnity liability activity are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_z5wkY7vxDmkh" style="display: none">Schedule of Indemnity Liability</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_49C_20240101__20240331_zBMOFfOAcKsj" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three Months ended<br/> March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_49C_20230101__20230331_zRUpYy1I9BUe" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three Months ended<br/> March 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_404_eus-gaap--LossContingencyAccrualAtCarryingValue_iS_zApdhsX6KPX" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,382,408</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">499,465</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--LossContingencyAccrualCumulativeEffect_zmafMeNoyUj1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Cumulative effect from adoption of CECL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">566,341</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LossContingencyAccrualPayments_zAopPAxIUlO" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Charge-offs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0921">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--LossContingencyAccrualRecoveries_ztfYHOnUfyF3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Recoveries</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0925">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LossContingencyAccrualProvision_zkKS37Q7Cwo1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">(Benefit)/ Provision</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(67,145</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">82,026</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LossContingencyAccrualAtCarryingValue_iE_zNKpfkkjZYb7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,315,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,147,832</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1382408 499465 566341 -67145 82026 1315263 1147832 <p id="xdx_898_ecustom--ScheduleOfIndemnifiedLoansRiskRatingTableTextBlock_zC6B3wUuSSzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value, excluding the CECL Reserve, of the Company’s indemnified loans held at carrying value within each risk rating is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zO7AcG56meg7" style="display: none">Schedule of Indemnified Loans Risk Rating</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify">Risk rating</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240331_zF7Ssq9wb2h6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20231231_zCzQpyd2IuBh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateThreeMember_zuqi84T8Puud" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 69%; text-align: justify">3</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,988,588</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">10,100,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateFourMember_z5bs9vKA9iPj" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">4</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,425,158</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,431,640</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateFiveMember_z2ne1NJZCH9k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">5</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,553,007</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,115,013</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateSixMember_zKmOiw8mVUV6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">6</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,900,000</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,900,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateSevenMember_zQBP2sVedVE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">7</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0947">-</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,100,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LongTermDebt_iI_hus-gaap--InternalCreditAssessmentAxis__custom--RiskRateEightMember_zMnDnitBSxE3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">8</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,302,175</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0951">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iI_zCSWGOzwVLd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">58,168,928</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">55,646,653</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 9988588 10100000 3425158 3431640 30553007 28115013 10900000 10900000 3100000 3302175 58168928 55646653 <p id="xdx_89A_ecustom--ScheduleOfProvisionForLoanLossesTableTextBlock_zMvKQb6sKMIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision for credit losses on the statement of operations consists of the following activity for the period ended March 31, 2024 and March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zPj3r00Pz9f2" style="display: none">Schedule of Provision for Loan Losses</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20240101__20240331__us-gaap--FinancingReceivablePortfolioSegmentAxis__us-gaap--CommercialRealEstatePortfolioSegmentMember_zysMcBaCcuCk" style="border-bottom: Black 1.5pt solid; text-align: center">Commercial<br/> real estate<br/> loans</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20240101__20240331__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--IndemnityLiabilitySegmentMember_zGXYJ3D15Eil" style="border-bottom: Black 1.5pt solid; text-align: center">Indemnity<br/> liability</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20240101__20240331_zR0ZO01jWAX4" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230331__us-gaap--FinancingReceivablePortfolioSegmentAxis__us-gaap--CommercialRealEstatePortfolioSegmentMember_zbpsCG09SX3" style="border-bottom: Black 1.5pt solid; text-align: center">Commercial<br/> real estate<br/> loans</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230101__20230331__us-gaap--FinancingReceivablePortfolioSegmentAxis__custom--IndemnityLiabilitySegmentMember_zweoLQfjIwgi" style="border-bottom: Black 1.5pt solid; text-align: center">Indemnity<br/> liability</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230101__20230331_zgSwM8QJ1fI4" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Commercial<br/> real estate<br/> loans</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Indemnity<br/> liability</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Commercial<br/> real estate<br/> loans</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Indemnity<br/> liability</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40D_eus-gaap--ProvisionForLoanLeaseAndOtherLosses_z7YW1E4dbWxd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Provision (benefit)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">(1,642</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">(67,145</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">(68,787</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">(15,390</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">82,056</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">66,666</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> -1642 -67145 -68787 -15390 82056 66666 <p id="xdx_803_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zLGbsM4aaXc5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 31pt 0pt 21.5pt; text-align: justify; text-indent: -22.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7. <span id="xdx_826_zNxkMlrEWQ3d">Property and Equipment, Net</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zqBTSmi9cxS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zGs2aDQHX5Pj" style="display: none">Schedule of Property and Equipment</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_499_20240331_zrSdRpi4Fr9f" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_490_20231231_z1IfACMDJp67" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z98jQKGP4gQa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%">Equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">45,397</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">45,397</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zp6TPr6NrQq1" style="vertical-align: bottom; background-color: White"> <td>Software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,692</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,692</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zn84CeWWO1D3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Improvement</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71,635</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71,635</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zQcUSRj1qLQh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Office furniture</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">215,504</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">215,504</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzxZo_zoy36VLkCgS" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">384,228</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">384,228</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzxZo_zVmcvuEmtz14" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(338,862</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(300,008</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzxZo_ztKN666Xedjl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">45,366</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">84,220</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zXjVcNCEs6r9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zqBTSmi9cxS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zGs2aDQHX5Pj" style="display: none">Schedule of Property and Equipment</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_499_20240331_zrSdRpi4Fr9f" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_490_20231231_z1IfACMDJp67" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z98jQKGP4gQa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%">Equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">45,397</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">45,397</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zp6TPr6NrQq1" style="vertical-align: bottom; background-color: White"> <td>Software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,692</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,692</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zn84CeWWO1D3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Improvement</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71,635</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71,635</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zQcUSRj1qLQh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Office furniture</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">215,504</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">215,504</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzxZo_zoy36VLkCgS" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">384,228</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">384,228</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzxZo_zVmcvuEmtz14" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(338,862</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(300,008</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzxZo_ztKN666Xedjl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">45,366</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">84,220</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 45397 45397 51692 51692 71635 71635 215504 215504 384228 384228 338862 300008 45366 84220 <p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4fAWo4rlD9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8. <span id="xdx_82F_z9cQWVpExAyh">Related Party Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Commercial Alliance Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 29, 2023, the Company and PCCU entered into the Commercial Alliance Agreement. This Agreement sets forth the terms and conditions of the lending and account-related services, governing the relationship between the Company and PCCU. The Commercial Alliance Agreement sets forth the application, underwriting, loan approval, and foreclosure process for loans from PCCU to borrowers that are cannabis-related businesses and the loan servicing and monitoring responsibilities provided by the Company and PCCU. In particular, the Commercial Alliance Agreement provides for procedures to be followed upon the default of a loan to ensure that neither the Company nor PCCU will take title to or possession of any cannabis-related assets, including real property, that may be collateral for a loan funded by PCCU pursuant to the Commercial Alliance Agreement. Under the Commercial Alliance agreement, the PCCU has the right to receive monthly fees for managing loans. For SHF-serviced loans, which are CRB loans provided by the PCCU but primarily handled by SHF, a yearly fee of <span id="xdx_904_ecustom--AnnualServicingFeePercentage_dp_uPure_c20230328__20230329__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember__srt--ConsolidatedEntitiesAxis__custom--PartnerColoradoCreditUnionMember_zDpYhnUpKIw7" title="Servicing fee">0.25</span>% of the remaining loan balance is applied. On the other hand, loans both financed and serviced by the PCCU are charged a yearly fee of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20230328__20230329__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember__srt--ConsolidatedEntitiesAxis__custom--PartnerColoradoCreditUnionMember_zOldAwX5Amd2" title="Yearly fee percentage">0.35</span>% on their outstanding balance. These fees are calculated using the average daily balance of each loan for the preceding month. In addition, the Company’s is obligated by the Commercial Alliance Agreement to indemnify PCCU from certain default-related loan losses (as fully defined in the Commercial Alliance Agreement).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--AllianceAgreementDescription_c20240101__20240331__us-gaap--TypeOfArrangementAxis__custom--SupportServicesAgreementMember_zQjt18UrL9Sc" title="Alliance agreement, description">In addition, the Commercial Alliance Agreement provides for certain fees to be paid to the Company for certain identified account related services to include: all cannabis-related income, including all lending-related income (such as loan origination fees, interest income on CRB-related loans, participation fees and servicing fees), investment income, interest income, account activity fees, processing fees, flat fees, and other revenue generated from cannabis and multi-state hemp accounts that are hosted on PCCU’s core system for a monthly fee equal to $30.96 per account in 2022, $25.32-$27.85 per account in 2023, and $26.08-$28.69 in 2024. In addition, as it pertains to CRB deposits held at PCCU, investment and interest income earned on these deposits (excluding interest income on loans funded by PCCU) will be shared 25% to PCCU and 75% to the Company. Finally, under the Commercial Alliance Agreement, PCCU will continue to allow its ratio of CRB-related deposits to total assets to equal at least 60% unless otherwise dictated by regulatory, regulator or policy requirements. The initial term of the Commercial Alliance Agreement is for a period of two years, with a one-year automatic renewal unless a party provides one hundred twenty days’ written notice prior to the end of the term.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_ecustom--ScheduleOfDemonstratesDepositCapacityTableTextBlock_hus-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zXmteXx1c0J7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below schedule demonstrates the ratio of CRB related loans funded by PCCU to the relative lending limits:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zpEzWuMenM0j" style="display: none">Schedule of Demonstrated Deposit Capacity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240331_zPF26wEo8Na4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024<br/> (Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_ztw5bqlN80d6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023<br/> (Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--CannabisRelatedBusinessesRelatedDepositsMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_z8U8Wbcqijxk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">CRB related deposits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">106,692,488</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">129,350,998</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--CapacityAtSixtyPercentageMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_z7dBSrdOJqn2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Capacity at 60%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,015,493</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77,610,599</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--PartnerColoradoCreditUnionMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zLgN3VemX1n2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">PCCU net worth</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">83,739,916</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">81,087,746</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--CapacityAtOnePointThreeOneTwoFiveMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zNYlxMNP73Di" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Capacity at 1.3125</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">109,908,640</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">106,670,306</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--LimitingCapacityMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zcLEuELMEH3h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Limiting capacity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,015,493</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77,610,599</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--PartnerColoradoCreditUnionLoansFundedMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zL7A5MF0gTF6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">PCCU loans funded</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,737,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,660,039</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__us-gaap--LineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zLZDTQxfCiUa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Amounts available under lines of credit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">775,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">525,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zWlU41waaAjl" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Incremental capacity</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,503,206</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,425,560</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_ztVFJeecUbcl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_ecustom--ScheduleOfRevenueFromOperationsTableTextBlock_zqIfFuyCvR46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The revenue from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_z7e4WIUYu512" style="display: none">Schedule of Revenue from Operations</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_499_20240101__20240331_zhMHDKBT7MYg" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20230101__20230331_zAhT9ZcnBSub" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--AccountServicingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVuFMsWGIc9l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Account servicing agreement</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1026">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,261,284</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--CommercialAllianceAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zowA3mf2jIx6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Commercial alliance agreement</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,585,856</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Revenues_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zGQ6MGbNQcq8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,585,856</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,261,284</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zW61u5vgta0k" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,585,856</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,261,284</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_z50Fg81YRVZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_ecustom--ScheduleOfOperatingExpenseFromOperationsTableTextBlock_zxHlCeTmFBB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The operating expense from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zMlncSN5wYwd" style="display: none">Schedule of Operating Expense from Operations</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_499_20240101__20240331_zFy8tqXvYT2f" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20230101__20230331_zkKlKMOxaof6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_409_eus-gaap--OperatingExpenses_hsrt--ProductOrServiceAxis__custom--SupportServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z6aYVYlHXsM4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Support services agreement</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1040">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">378,730</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingExpenses_hsrt--ProductOrServiceAxis__custom--LoanServicingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLdJOetjY9lf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loan servicing agreement</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,929</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingExpenses_hsrt--ProductOrServiceAxis__custom--CommercialAllianceAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1gPlJZcHLTb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commercial alliance agreement</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">300,261</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1047">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingExpenses_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zl6PKZYVUpcl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">300,261</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">390,659</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingExpenses_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zs3MH4V7URS8" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Operating expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">300,261</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">390,659</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zzOTORUVfag7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance of shares to PCCU </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 29, 2023, the Company and PCCU entered into the following definitive transaction documents to settle and restructure the deferred obligation:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A <span id="xdx_904_eus-gaap--DebtInstrumentTerm_dxL_c20230328__20230329__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNoteMember_zQLpNiAbjWjk" title="Debt instrument term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1055">five</span></span>-year Senior Secured Promissory Note (the “Note”) in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20230329__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNoteMember_zTFU74XvsZX1" title="Debt instrument, face amount">14,500,000</span> bearing interest at the rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230329__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNoteMember_zlG3ivzwjYP8" title="Debt instrument, interest rate, effective percentage">4.25</span>% and a Security Agreement pursuant to which the Company will grant, as collateral for the Note, a first priority security interest in substantially all of the assets of the Company.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Securities Issuance Agreement, pursuant to which the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230328__20230329__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--PartnerColoradoCreditUnionMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesIssuanceAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zzZiUt3XlX96" title="Number of shares issued">11,200,000</span> shares of the Company’s Class A Common Stock to PCCU. Following the issuance of the Shares, PCCU own <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230329__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--PartnerColoradoCreditUnionMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesIssuanceAgreementMember_znjFvFvWlCQb" title="Ownwership percentage">46.39</span>% of the outstanding Class A Common Stock. In connection with the Securities Issuance Agreement, the parties also entered into a Registration Rights Agreement and a Lock-Up Agreement.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registration Rights Agreement requires the Company to register the Shares for resale pursuant to the Securities Act of 1933, as amended (the “Securities Act”); and the Lock-Up Agreement restricts PCCU from transferring the Shares until the earlier of (i) six (6) months after the date of the Securities Issuance Documents or (ii) the consummation of a transaction with an unaffiliated third party in which all of the Company’s stockholders have the right to exchange their shares of Class A Common Stock for cash, securities, or other property; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Commercial Alliance Agreement that sets forth the terms and conditions of the lending-related and account-related services governing the relationship between the Company and PCCU which supersedes the Loan Servicing Agreement, as well as the Amended and Restated Support Services Agreement and the Amended and Restated Account Servicing Agreement.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--ScheduleOfOutstandingBalancesFromBalanceSheetTableTextBlock_zUD4cCzs0Rkg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The outstanding balances associated with the PCCU disclosed in the balance sheet are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zjXlDOn1LPZj" style="display: none">Schedule of Outstanding Balances from Balance Sheet</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqaSGPZGrYsi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdYPw6iua3Nd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_iI_zX9mUQqptOJj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,111,390</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,095,320</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccountsPayableCurrent_iI_ziWQTuzuO1a7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125,693</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">577,315</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--SecuredDebt_iI_zvsyqtnosp93" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Senior Secured Promissory Note (Refer to Note 9 to the unaudited condensed consolidated financial statements)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,270,622</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,011,166</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A2_zvp36nOR6e68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of the $<span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn5n6_c20240331_zHlp9EK3fcAk" title="Cash and cash equivalents">5.6 </span>million and $<span id="xdx_90A_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn5n6_c20231231_zFVxGrtFP3T6" title="Cash and cash equivalents">8.6</span> million of cash and cash equivalents on March 31, 2024 and December 31, 2023, $<span id="xdx_90D_eus-gaap--Deposits_iI_pn5n6_c20240331_zyImBR2sPnE8" title="Deposits">5</span> million and $<span id="xdx_907_eus-gaap--Deposits_iI_pn5n6_c20231231_zaH5QsnwYrW6" title="Deposits">4.6</span> million of the cash and cash equivalents were held in deposit accounts at PCCU as a related party.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.0025 0.0035 In addition, the Commercial Alliance Agreement provides for certain fees to be paid to the Company for certain identified account related services to include: all cannabis-related income, including all lending-related income (such as loan origination fees, interest income on CRB-related loans, participation fees and servicing fees), investment income, interest income, account activity fees, processing fees, flat fees, and other revenue generated from cannabis and multi-state hemp accounts that are hosted on PCCU’s core system for a monthly fee equal to $30.96 per account in 2022, $25.32-$27.85 per account in 2023, and $26.08-$28.69 in 2024. In addition, as it pertains to CRB deposits held at PCCU, investment and interest income earned on these deposits (excluding interest income on loans funded by PCCU) will be shared 25% to PCCU and 75% to the Company. Finally, under the Commercial Alliance Agreement, PCCU will continue to allow its ratio of CRB-related deposits to total assets to equal at least 60% unless otherwise dictated by regulatory, regulator or policy requirements. The initial term of the Commercial Alliance Agreement is for a period of two years, with a one-year automatic renewal unless a party provides one hundred twenty days’ written notice prior to the end of the term. <p id="xdx_890_ecustom--ScheduleOfDemonstratesDepositCapacityTableTextBlock_hus-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zXmteXx1c0J7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below schedule demonstrates the ratio of CRB related loans funded by PCCU to the relative lending limits:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zpEzWuMenM0j" style="display: none">Schedule of Demonstrated Deposit Capacity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240331_zPF26wEo8Na4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024<br/> (Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_ztw5bqlN80d6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023<br/> (Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--CannabisRelatedBusinessesRelatedDepositsMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_z8U8Wbcqijxk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">CRB related deposits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">106,692,488</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">129,350,998</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--CapacityAtSixtyPercentageMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_z7dBSrdOJqn2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Capacity at 60%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,015,493</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77,610,599</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--PartnerColoradoCreditUnionMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zLgN3VemX1n2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">PCCU net worth</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">83,739,916</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">81,087,746</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--CapacityAtOnePointThreeOneTwoFiveMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zNYlxMNP73Di" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Capacity at 1.3125</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">109,908,640</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">106,670,306</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--LimitingCapacityMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zcLEuELMEH3h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Limiting capacity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,015,493</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77,610,599</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__custom--PartnerColoradoCreditUnionLoansFundedMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zL7A5MF0gTF6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">PCCU loans funded</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,737,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,660,039</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--RelatedPartyTransactionAxis__us-gaap--LineOfCreditMember__us-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zLZDTQxfCiUa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Amounts available under lines of credit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">775,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">525,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_hus-gaap--TypeOfArrangementAxis__custom--LoanServicingAgreementMember_zWlU41waaAjl" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Incremental capacity</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,503,206</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,425,560</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 106692488 129350998 64015493 77610599 83739916 81087746 109908640 106670306 64015493 77610599 57737287 55660039 775000 525000 5503206 21425560 <p id="xdx_89A_ecustom--ScheduleOfRevenueFromOperationsTableTextBlock_zqIfFuyCvR46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The revenue from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_z7e4WIUYu512" style="display: none">Schedule of Revenue from Operations</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_499_20240101__20240331_zhMHDKBT7MYg" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20230101__20230331_zAhT9ZcnBSub" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--AccountServicingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVuFMsWGIc9l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Account servicing agreement</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1026">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,261,284</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--CommercialAllianceAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zowA3mf2jIx6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Commercial alliance agreement</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,585,856</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Revenues_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zGQ6MGbNQcq8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,585,856</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,261,284</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--Revenues_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zW61u5vgta0k" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,585,856</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,261,284</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3261284 3585856 3585856 3261284 3585856 3261284 <p id="xdx_896_ecustom--ScheduleOfOperatingExpenseFromOperationsTableTextBlock_zxHlCeTmFBB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The operating expense from the PCCU Agreements recognized in the statements of operations consists of the following for the three months ended March 31, 2024, and March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zMlncSN5wYwd" style="display: none">Schedule of Operating Expense from Operations</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_499_20240101__20240331_zFy8tqXvYT2f" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31, 2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20230101__20230331_zkKlKMOxaof6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31, 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_409_eus-gaap--OperatingExpenses_hsrt--ProductOrServiceAxis__custom--SupportServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z6aYVYlHXsM4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Support services agreement</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1040">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">378,730</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingExpenses_hsrt--ProductOrServiceAxis__custom--LoanServicingAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLdJOetjY9lf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loan servicing agreement</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,929</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingExpenses_hsrt--ProductOrServiceAxis__custom--CommercialAllianceAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1gPlJZcHLTb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commercial alliance agreement</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">300,261</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1047">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingExpenses_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zl6PKZYVUpcl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">300,261</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">390,659</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingExpenses_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zs3MH4V7URS8" style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Operating expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">300,261</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">390,659</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 378730 11929 300261 300261 390659 300261 390659 14500000 0.0425 11200000 0.4639 <p id="xdx_895_ecustom--ScheduleOfOutstandingBalancesFromBalanceSheetTableTextBlock_zUD4cCzs0Rkg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The outstanding balances associated with the PCCU disclosed in the balance sheet are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zjXlDOn1LPZj" style="display: none">Schedule of Outstanding Balances from Balance Sheet</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqaSGPZGrYsi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdYPw6iua3Nd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_iI_zX9mUQqptOJj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,111,390</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,095,320</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccountsPayableCurrent_iI_ziWQTuzuO1a7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">125,693</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">577,315</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--SecuredDebt_iI_zvsyqtnosp93" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Senior Secured Promissory Note (Refer to Note 9 to the unaudited condensed consolidated financial statements)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,270,622</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,011,166</td><td style="text-align: left"> </td></tr> </table> 1111390 2095320 125693 577315 13270622 14011166 5600000 8600000 5000000 4600000 <p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zUc3bYMPESI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9. <span id="xdx_822_zabY16reEwj3">Senior Secured Promissory Note</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span> </span></b></span></p> <p id="xdx_896_eus-gaap--ScheduleOfDebtTableTextBlock_zSLcoyGAzjMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z9jHIBNFajob" style="display: none">Schedule of Senior Secured Promissory Note</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240331_zVi28WIwEJlb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20231231_zvzMasf6kEn2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNoteCurrentMember__us-gaap--TypeOfArrangementAxis__custom--SecurityAgreementMember_ztXgJ3nFuBp9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Senior Secured Promissory Note (Current)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,028,738</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,006,991</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNoteNonCurrentMember__us-gaap--TypeOfArrangementAxis__custom--SecurityAgreementMember_znlwPKMGLtvj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Senior Secured Promissory Note (long term)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,241,884</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,004,175</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--TypeOfArrangementAxis__custom--SecurityAgreementMember_z2IFy4s37NU1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,270,622</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,011,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zr1fraXX3i5d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 29, 2023, the Company and PCCU entered into definitive transaction documents to settle and restructure the deferred obligation related to business Combination under which the Company has issued the five-year Senior Secured Promissory Note (the “Note”) in the principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20230329_zfUaLginjnC3" title="Debt instrument, face amount">14,500,000</span> bearing interest at the rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230329_zf654uvyQnTe" title="Debt instrument, interest rate, effective percentage">4.25</span>% and a Security Agreement pursuant to which the Company will grant, as collateral for the Note, a first priority security interest in substantially all of the assets of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Note amount will be paid in 54 installments of principal and interest of $<span id="xdx_904_ecustom--DeferredConsiderationPayable_iI_c20231105__srt--StatementScenarioAxis__custom--FiftyFourEqualInstallmentsMember_z02BN7CAtrSh" title="Deferred consideration payable">295,487</span> each starting from November 5, 2023 and for the period between March 29, 2023, to October 05, 2023, the Company has paid the interest portion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zlB5WpT3jiej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The repayment schedule of the outstanding principal amount on March 31, 2024, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_znJMVsnwOOaj" style="display: none">Schedule of Outstanding Amount on Debt</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; font-weight: bold"> </td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" id="xdx_49A_20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNoteMember_zWaXtOy3EKKk"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; font-weight: bold">Year of payment</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maLTDzTyN_zcyOqFVACuWg" style="vertical-align: bottom; background-color: White"> <td style="width: 84%; text-align: justify">2024</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,266,449</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maLTDzTyN_zdS8RxcGJOPa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,138,931</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_maLTDzTyN_zwSIXr2ZVyVa" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,274,966</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_maLTDzTyN_zFTVZLie57I9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,416,896</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_maLTDzTyN_zDMP2NQF9Itk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2028</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,173,380</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebt_iTI_mtLTDzTyN_zvNdZG7ypRj6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,270,622</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zzRGK7EpQONj" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_896_eus-gaap--ScheduleOfDebtTableTextBlock_zSLcoyGAzjMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z9jHIBNFajob" style="display: none">Schedule of Senior Secured Promissory Note</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240331_zVi28WIwEJlb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20231231_zvzMasf6kEn2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNoteCurrentMember__us-gaap--TypeOfArrangementAxis__custom--SecurityAgreementMember_ztXgJ3nFuBp9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Senior Secured Promissory Note (Current)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,028,738</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,006,991</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNoteNonCurrentMember__us-gaap--TypeOfArrangementAxis__custom--SecurityAgreementMember_znlwPKMGLtvj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Senior Secured Promissory Note (long term)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,241,884</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,004,175</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DebtInstrumentFaceAmount_iI_hus-gaap--TypeOfArrangementAxis__custom--SecurityAgreementMember_z2IFy4s37NU1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,270,622</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,011,166</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3028738 3006991 10241884 11004175 13270622 14011166 14500000 0.0425 295487 <p id="xdx_892_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zlB5WpT3jiej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The repayment schedule of the outstanding principal amount on March 31, 2024, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_znJMVsnwOOaj" style="display: none">Schedule of Outstanding Amount on Debt</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; font-weight: bold"> </td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" id="xdx_49A_20231231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNoteMember_zWaXtOy3EKKk"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; font-weight: bold">Year of payment</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maLTDzTyN_zcyOqFVACuWg" style="vertical-align: bottom; background-color: White"> <td style="width: 84%; text-align: justify">2024</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,266,449</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maLTDzTyN_zdS8RxcGJOPa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,138,931</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_maLTDzTyN_zwSIXr2ZVyVa" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,274,966</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_maLTDzTyN_zFTVZLie57I9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,416,896</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_maLTDzTyN_zDMP2NQF9Itk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2028</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,173,380</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebt_iTI_mtLTDzTyN_zvNdZG7ypRj6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand total</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,270,622</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2266449 3138931 3274966 3416896 1173380 13270622 <p id="xdx_805_eus-gaap--LesseeOperatingLeasesTextBlock_zRN68LtwNv41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10. <span><span id="xdx_829_zV9xAD0OzJt9">Leases</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has non-cancellable operating leases for facility space with varying terms. All of the active leases for facility space qualified for capitalization under FASB ASC 842, Leases. These leases have remaining lease terms between <span id="xdx_909_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20240331__srt--RangeAxis__srt--MinimumMember_z6YyiXdHsVk4" title="Lease term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl1119">one</span></span> to <span id="xdx_902_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dc_c20240331__srt--RangeAxis__srt--MaximumMember_zGIXlgCbnree" title="Lease term">seven years</span> and may include options to extend the leases for up to ten years. The extension terms are not recognized as part of the right-of-use assets. The Company has elected not to capitalize leases with terms equal to, or less than, one year. As of March 31, 2024, and December 31, 2023, net assets recorded under operating leases were $<span id="xdx_909_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20240331_zlvT84soJ0p8" title="Operating lease right to use assets">820,777</span> and $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20231231_zrEsuecvCJYf" title="Operating lease right to use assets">859,861</span> on, respectively, and net lease liabilities were $<span id="xdx_90F_eus-gaap--OperatingLeaseLiability_iI_c20240331_ztEyrPSLKSg" title="Operating lease liablities">978,461</span> and $<span id="xdx_903_eus-gaap--OperatingLeaseLiability_iI_c20231231_ztf9zTwoG7gi" title="Operating lease liablities">1,007,993</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company analyzes contracts above certain thresholds to identify leases and lease components. Lease and non-lease components are not separated for facility space leases. The Company uses its contractual borrowing rate to determine lease discount rates when an implicit rate is not available. Total lease cost for the three months ended March 31, 2024 and March 31, 2023, included in Unaudited Condensed Consolidated Statements of Operations, is detailed in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_ecustom--ScheduleOfLeaseCostRightOfUseAssetsRelatedToLeaseAndFutureMinimumLeasePaymentsTableTextBlock_zM3DzhvUe9fl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zKIeuQITZMLd" style="display: none">Schedule of Lease Cost</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240101__20240331_zia7Rxd48ya3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended<br/> March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20230331_zTn1fqpKrPNj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended<br/> March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseCost_maLCzHDl_zz7oURKhYLqh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease cost</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1133">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1134">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_maLCzHDl_ztaCG35WqmMg" style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: left; padding-bottom: 1.5pt">Short-term lease cost</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">69,437</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">87,742</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LeaseCost_iT_mtLCzHDl_zLWXS6TqLSn9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Lease Cost</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">69,437</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">87,742</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zZdcYbLOjsB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_892_ecustom--ScheduleOfRightOfUseAssetsTableTextBlock_zCC027tFNnbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zgV63QkRdjwf" style="display: none">Schedule of Right Of Use Assets</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20240101__20240331_zFHReWzNxjX6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231_z3jObev8qwP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">ROU assets that are related to lease properties are presented as follows:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_iS_zSqqcoyfxVw4" style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">859,861</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,016,198</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--AdditionsToRightOfUseAssets_zsqETC2Ny4Z" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additions to right-of-use assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1147">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_di_ziU7ahCk3ZRi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Amortization charge for the period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(39,084</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(156,337</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_ecustom--RightOfUseAssetsLeaseModifications_zYSxyJgon6ki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Lease modifications</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1153">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1154">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iE_znrzxsssIp8a" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">820,777</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">859,861</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Further information related to leases is as follows:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240331_zE2OT2Viohu8" title="Weighted-average remaining lease term">3.17</span> Years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zRiXOYH0oSs7" title="Weighted-average remaining lease term">3.42</span> Years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20240331_zSryWIliImBk" title="Weighted-average discount rate">6.87</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_zcpm10skNMYd" title="Weighted-average discount rate">6.87</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AC_zzauaXUZyYO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--ScheduleOfFutureMinimumRentalPaymentForOperatingLeasesTableTextBlock_z0bCZFCfy9xg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payments as of March 31, 2024, and December 31, 2023, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zD1T5F2fKKL4" style="display: none">Schedule of Future Minimum Lease Payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Year</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20240331_zwVrkCueFo4e" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" id="xdx_498_20231231_zPFJv4XplQul" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzCPs_zwP5YbiPDu77" style="vertical-align: bottom; background-color: White"> <td style="width: 69%; text-align: justify">2024</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">151,111</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">197,520</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzCPs_zXCqq41Myhpi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">217,925</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">217,925</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzCPs_zaM7UIugi3ab" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">222,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">222,275</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzCPs_zHu9I8Gdw5ul" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">226,705</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">226,705</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzCPs_zxPpUeSDZM03" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2028</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">231,216</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">231,216</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzCPs_zMbLyJFAL2Yk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">117,710</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">117,710</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzCPs_zqtXdVA9FNYk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,166,942</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,213,351</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zCDEw1W1k0Af" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">188,481</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">205,358</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_zu7Vjpm1gO58" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liabilities</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">978,461</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,007,993</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zBVSPTRhBwmh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Current portion</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">142,863</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">132,546</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_z719H7tQgebd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current portion of lease liabilities</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">835,598</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">875,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zCtFcPTDQlBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> P7Y 820777 859861 978461 1007993 <p id="xdx_89E_ecustom--ScheduleOfLeaseCostRightOfUseAssetsRelatedToLeaseAndFutureMinimumLeasePaymentsTableTextBlock_zM3DzhvUe9fl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zKIeuQITZMLd" style="display: none">Schedule of Lease Cost</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240101__20240331_zia7Rxd48ya3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended<br/> March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20230331_zTn1fqpKrPNj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended<br/> March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseCost_maLCzHDl_zz7oURKhYLqh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease cost</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1133">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1134">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_maLCzHDl_ztaCG35WqmMg" style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: left; padding-bottom: 1.5pt">Short-term lease cost</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">69,437</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">87,742</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LeaseCost_iT_mtLCzHDl_zLWXS6TqLSn9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Lease Cost</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">69,437</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">87,742</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 69437 87742 69437 87742 <p id="xdx_892_ecustom--ScheduleOfRightOfUseAssetsTableTextBlock_zCC027tFNnbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zgV63QkRdjwf" style="display: none">Schedule of Right Of Use Assets</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20240101__20240331_zFHReWzNxjX6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231_z3jObev8qwP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">ROU assets that are related to lease properties are presented as follows:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_iS_zSqqcoyfxVw4" style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">859,861</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,016,198</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--AdditionsToRightOfUseAssets_zsqETC2Ny4Z" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additions to right-of-use assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1147">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_di_ziU7ahCk3ZRi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Amortization charge for the period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(39,084</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(156,337</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_ecustom--RightOfUseAssetsLeaseModifications_zYSxyJgon6ki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Lease modifications</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1153">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1154">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iE_znrzxsssIp8a" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">820,777</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">859,861</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Further information related to leases is as follows:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240331_zE2OT2Viohu8" title="Weighted-average remaining lease term">3.17</span> Years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zRiXOYH0oSs7" title="Weighted-average remaining lease term">3.42</span> Years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20240331_zSryWIliImBk" title="Weighted-average discount rate">6.87</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_zcpm10skNMYd" title="Weighted-average discount rate">6.87</span></td><td style="text-align: left">%</td></tr> </table> 859861 1016198 39084 156337 820777 859861 P3Y2M1D P3Y5M1D 0.0687 0.0687 <p id="xdx_891_ecustom--ScheduleOfFutureMinimumRentalPaymentForOperatingLeasesTableTextBlock_z0bCZFCfy9xg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payments as of March 31, 2024, and December 31, 2023, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zD1T5F2fKKL4" style="display: none">Schedule of Future Minimum Lease Payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Year</td><td> </td><td> </td> <td colspan="2" id="xdx_494_20240331_zwVrkCueFo4e" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" id="xdx_498_20231231_zPFJv4XplQul" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzCPs_zwP5YbiPDu77" style="vertical-align: bottom; background-color: White"> <td style="width: 69%; text-align: justify">2024</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">151,111</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">197,520</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzCPs_zXCqq41Myhpi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">217,925</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">217,925</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzCPs_zaM7UIugi3ab" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">222,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">222,275</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzCPs_zHu9I8Gdw5ul" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">226,705</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">226,705</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_maLOLLPzCPs_zxPpUeSDZM03" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2028</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">231,216</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">231,216</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzCPs_zMbLyJFAL2Yk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">117,710</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">117,710</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzCPs_zqtXdVA9FNYk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,166,942</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,213,351</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zCDEw1W1k0Af" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">188,481</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">205,358</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_zu7Vjpm1gO58" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease liabilities</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">978,461</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,007,993</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zBVSPTRhBwmh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Current portion</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">142,863</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">132,546</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_z719H7tQgebd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current portion of lease liabilities</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">835,598</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">875,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 151111 197520 217925 217925 222275 222275 226705 226705 231216 231216 117710 117710 1166942 1213351 188481 205358 978461 1007993 142863 132546 835598 875447 <p id="xdx_809_eus-gaap--RevenueFromContractWithCustomerTextBlock_zxFOtnxGa2Uc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11. <span id="xdx_826_zG6TTCIXGMQ7">Revenue</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_z5GSrxGpY5Hl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue by type are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zzskKOuxRNLj" style="display: none">Schedule of Disaggregated Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20240101__20240331_zLxgNZr2dlNc" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_49F_20230101__20230331_z6nE4LVjo5xa" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--IncomeStatementLocationAxis__custom--DepositActivityOnboardingIncomeMember_zBbeXCZgqNk3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Deposit, activity, onboarding income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,620,994</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,245,831</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--IncomeStatementLocationAxis__custom--SafeHarborProgramIncomeMember_zJsMfOz0DaM3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Safe Harbor Program income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,230</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,103</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--IncomeStatementLocationAxis__us-gaap--InvestmentIncomeMember_z5YetErIeNqj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Investment income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">773,819</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,417,152</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--IncomeStatementLocationAxis__us-gaap--InterestIncomeMember_zD48qfXv3ZC4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Loan interest income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,636,756</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">466,293</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zsVJkLS11xx6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,050,799</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,180,379</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zTweTiKhMkOh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account fee income consists of deposit account fees, activity fees and onboarding income, which are recognized on periodic basis as per the fee schedule with financial partner institutions. Safe Harbor Program income consists of outsourced support to other financial institutions providing banking to the cannabis industry whose income is recognized on the basis of usage as per the agreements. Loan interest income consist of interest earned on both direct and indemnified loans pursuant to a commercial alliance agreement with PCCU. Investment income consist of interest earned on the daily deposits balance with financial institution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under our Commercial Alliance Agreement, we are obligated to remit <span id="xdx_90A_ecustom--InvestmentHostingFeesRemitPercent_pid_dp_uPure_c20240101__20240331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zVUfmmzVY1ja" title="Investment hosting fees remit percent">25</span>% of the investment hosting fees to PCCU based on this income which is classified as “General and Administrative Expenses” in the Consolidated Statements of Operations. In 2024, PCCU’s contributions to the Company’s revenues included $<span id="xdx_902_eus-gaap--ProceedsFromDepositsWithOtherInstitutions_c20240101__20240331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_ziRDhrvOivBl" title="Proceeds from deposits">1,217,675</span> from deposits, activities, and client onboarding, $<span id="xdx_903_eus-gaap--InvestmentIncomeNet_c20240101__20240331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zlrfx7YcPrIf" title="Investment income">731,425</span> from investment income, and $<span id="xdx_905_eus-gaap--InvestmentIncomeInterest_c20240101__20240331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zJVXkx8IQQIa" title="Loan interest income">1,636,756</span> from loan interest income. The associated expenses for these revenues were $<span id="xdx_90C_ecustom--AccountHostingExpenses_c20240101__20240331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zo7mtoZHsAF3" title="Account hosting expenses">104,259</span> for account hosting, $<span id="xdx_90D_ecustom--InvestmentHostingFee_c20240101__20240331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zkM1uApEXW4i" title="Investment hosting fee">160,101</span> for investment hosting fees, and $<span id="xdx_902_eus-gaap--LoanProcessingFee_c20240101__20240331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zF9HLQOEfo9a" title="Loan servicing fees">35,901</span> for loan servicing fees, all in accordance with the Loan Servicing Agreement and the Commercial Alliance Agreement, classified as “General and Administrative Expenses” in the Consolidated Statements of Operations. In first quarter March 2023, contributed to the Company’s revenues with $<span id="xdx_908_eus-gaap--ProceedsFromDepositsWithOtherInstitutions_c20230101__20230331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zDuXf3iqNpMd" title="Proceeds from deposits">2,245,831</span> from deposits, activities, and client onboarding, $<span id="xdx_906_eus-gaap--InvestmentIncomeNet_c20230101__20230331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_z7OhtlLfVoC9" title="Investment income">1,417,152</span> from investment income, and $<span id="xdx_90A_eus-gaap--InvestmentIncomeInterest_c20230101__20230331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zE5zWhfwGdL7" title="Loan interest income">466,293</span> from loan interest income. The related expenses for these revenue streams were $<span id="xdx_90D_ecustom--AccountHostingExpenses_c20230101__20230331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zh2UydaXDhD3" title="Account hosting expenses">55,425</span> for account hosting, $<span id="xdx_906_ecustom--InvestmentHostingFee_c20230101__20230331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zRvWoff7cVCe" title="Investment hosting fee">323,305</span> for investment hosting fees, and $<span id="xdx_902_eus-gaap--LoanProcessingFee_c20230101__20230331__dei--LegalEntityAxis__custom--PartnerColoradoCreditUnionMember_zbbRTcPFEjye" title="Loan servicing fees">11,929</span> for loan servicing fees, all in compliance with the Loan Servicing Agreement, classified as “General and Administrative Expenses” in the Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_z5GSrxGpY5Hl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue by type are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zzskKOuxRNLj" style="display: none">Schedule of Disaggregated Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20240101__20240331_zLxgNZr2dlNc" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_49F_20230101__20230331_z6nE4LVjo5xa" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Three months ended<br/> March 31</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--IncomeStatementLocationAxis__custom--DepositActivityOnboardingIncomeMember_zBbeXCZgqNk3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Deposit, activity, onboarding income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,620,994</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,245,831</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--IncomeStatementLocationAxis__custom--SafeHarborProgramIncomeMember_zJsMfOz0DaM3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Safe Harbor Program income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,230</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,103</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--IncomeStatementLocationAxis__us-gaap--InvestmentIncomeMember_z5YetErIeNqj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Investment income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">773,819</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,417,152</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hus-gaap--IncomeStatementLocationAxis__us-gaap--InterestIncomeMember_zD48qfXv3ZC4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Loan interest income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,636,756</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">466,293</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zsVJkLS11xx6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,050,799</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,180,379</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1620994 2245831 19230 51103 773819 1417152 1636756 466293 4050799 4180379 0.25 1217675 731425 1636756 104259 160101 35901 2245831 1417152 466293 55425 323305 11929 <p id="xdx_80A_ecustom--DeferredUnderwriterFeeTextBlock_zndJFE7xMdf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12. <span id="xdx_82C_z30SbJPMz5qb">Deferred Underwriter Fee</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the business combination, the Company executed a note on September 28, 2022 with EF Hutton related to PIPE financing under which the Company was obligated to pay the principal sum of $<span id="xdx_903_eus-gaap--ConvertibleNotesPayable_iI_c20220928__dei--LegalEntityAxis__custom--BenchmarkInvestmentsLLCMember_z5OcShWf6m12" title="Notes payable">2,166,250</span> on the following schedule: (i) $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_c20221013__20221014__dei--LegalEntityAxis__custom--BenchmarkInvestmentsLLCMember_zgfli17ZAuMa" title="Periodic payment">715,750</span> on October 14, 2022, and (ii) $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPayment_c20221031__20221031__dei--LegalEntityAxis__custom--BenchmarkInvestmentsLLCMember_zfhN48z4nlnj" title="Periodic payment"><span id="xdx_90B_eus-gaap--DebtInstrumentPeriodicPayment_c20221101__20221130__dei--LegalEntityAxis__custom--BenchmarkInvestmentsLLCMember_zzqfS2AXGQTl" title="Periodic payment"><span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20221231__20221231__dei--LegalEntityAxis__custom--BenchmarkInvestmentsLLCMember_zVF4TfOKZdqe" title="Periodic payment"><span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPayment_c20230131__20230131__dei--LegalEntityAxis__custom--BenchmarkInvestmentsLLCMember_zbAhwaGNqVbj" title="Periodic payment">362,625</span></span></span></span> on each of October 31, 2022, November 30, 2022, December 31, 2022, and January 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company made the payment of its first installment of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20221013__20221014__dei--LegalEntityAxis__custom--BenchmarkInvestmentsLLCMember_zVaNLapMHGOa" title="Periodic payment">715,750</span> and defaulted on the remaining outstanding amounts. The outstanding balance of the note on December 31, 2022 was $<span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_c20221231__dei--LegalEntityAxis__custom--BenchmarkInvestmentsLLCMember_zmjCgJae0P9c" title="Notes payable">1,450,500</span>. On March 13, 2023, the Company and EF Hutton entered into a settlement agreement pursuant to which the Company paid $<span id="xdx_903_eus-gaap--RepaymentsOfDebt_c20230312__20230313__dei--LegalEntityAxis__custom--BenchmarkInvestmentsLLCMember_zKhw56qxjGca" title="Repayments of debt">550,000</span> to EF Hutton in full settlement of the amount due and the difference of $<span id="xdx_905_ecustom--StockIssuedDuringPeriodValueReversalOfDeferredUnderwritingCost_c20230101__20230331_zoe5w0ipFZAk" title="Deferred underwriting cost">900,500</span> has been accounted for in the “Unaudited Condensed Consolidated Statements of Stockholders’ Equity.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2166250 715750 362625 362625 362625 362625 715750 1450500 550000 900500 <p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zB6WLCWtPeb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 13. <span id="xdx_828_zsjbwQVHmGuc">Commitments and contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is involved in, or has been involved in, arbitrations or various other legal proceedings that arise from the normal course of its business. The ultimate outcome of any litigation is uncertain, and either unfavorable or favorable outcomes could have a material impact on the Company’s results of operations, balance sheets and cash flows due to defense costs, and divert management resources. The Company cannot predict the timing or outcome of these claims and other proceedings.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Company’s initial public offering (“IPO”), the Company entered into a registration rights agreement dated June 23, 2021 with the Sponsor and the individuals serving as directors and executive officers of the Company at the time of the IPO. Pursuant to this registration rights agreement, the Company has agreed to register for resale upon the expiration of the applicable lock-up period the Company securities acquired by the Sponsor and such individuals in connection with the organization of the Company and the IPO.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the issuance of common stock to Abaca shareholders, the Company commits to registering the stock upon the exercise of Warrants if required by law or regulation to ensure the shares can be sold without restrictive legends, known as the Warrant Registration Requirement. Should this requirement arise, the Company is obliged to file a registration statement with the SEC within 45 calendar days of notification of the Warrant Registration Requirement. The failure to file within this timeframe constitutes an event of default. Moreover, the Company is dedicated to making the registration statement effective as promptly as possible and maintaining its effectiveness, along with a current prospectus, until the Warrants expire according to this Agreement’s terms. In the event a registration statement triggered by a Warrant Registration Requirement is not declared effective by the SEC within one year from its filing date, Warrant holders are entitled to exercise their Warrants on a cashless basis from the 366th day post-filing until the statement becomes effective.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80C_eus-gaap--EarningsPerShareTextBlock_zDhQb0z5iq6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 14. <span id="xdx_829_zvBetyC5ywWg">Earnings Per Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net income (loss) per common share is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net income (loss) per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period. For the Company’s diluted earnings per share calculation, the Company uses the “if-converted” method for preferred stock and convertible debt and the “treasury stock” method for Warrants and Options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the Business Combination and related transactions are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted net income per share assumes that the shares issued in connection with the Business Combination have been outstanding for the entire period presented.</span></p> <p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQHm3AtL6YQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zN8pZqxDE3we" style="display: none">Schedule of Earning Per Shares, Basic and Diluted</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">For the three month period ended March 31</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20240101__20240331_zYFfctD8Pap8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_zPkiuvhTG94" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--NetIncomeLoss_zdog44fTa6mi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Net Income/ (loss)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,049,676</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,413,447</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zgBhdoOCwbkj" style="vertical-align: bottom; background-color: White"> <td>Weighted average shares outstanding – basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,213,609</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,670,730</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_zrxkExKaqvGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic net income/ (loss) per share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zsASCmfJP4N7" style="vertical-align: bottom; background-color: White"> <td>Weighted average shares outstanding – diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,268,075</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,670,730</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--EarningsPerShareDiluted_zVCeYzpaZ6m8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Diluted net income/ (loss) per share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td></tr> </table> <p id="xdx_8A8_zt9dMr5QdN33" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zzfoddOKmuXh" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_z9Qw664tQ1Hf">Schedule of Weighted Average Shares Outstanding - Basic And Diluted</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average shares calculation - basic</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240331_znr0idjHkuth" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230331_zTjUPul8fiqh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three months ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average shares calculation - basic</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesIssuedBasic_zh43yoqwxiNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%">Company public shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">3,926,598</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">3,926,598</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--WeightedAverageSharesBasicInitialStockholders_zRAGp2CiJze8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Company initial stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,403,175</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,403,175</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--WeightedAverageNumberOfDilutedRelatedPartyStockholders_zHpE43izOiG8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">PCCU stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,586,139</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,759,472</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--WeightedAverageSharesDilutedSharesIssuedForAcquisition_zKgTAl1iq7sh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Shares issued for abaca acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,935,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,099,977</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_zWzhtjjD8uyc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Restricted stock units issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,308,089</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">566,755</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--WeightedAverageNumberOfSharesConversionOfPreferredStock_zXFdAlgJBUS8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Conversion of preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,053,808</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,914,753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_iT_zBLZ0JOio5ug" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Grand total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">55,213,609</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">25,670,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_iT_zmP35H6lpLLa" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted average shares outstanding - basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">55,213,609</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">25,670,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average shares calculation - diluted</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240331_z7siKb9duYP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2023</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Three months ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average shares calculation - diluted</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2023</b></td> <td> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z0TNXXFETNJ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%">Shares used in computation of basic earnings per share</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">55,213,609</td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 12%">-</td> <td style="width: 1%"> </td></tr> <tr id="xdx_409_ecustom--NumberOfWarrants_zO7I38G0Q1o5" style="vertical-align: bottom; background-color: White"> <td>Shares to be issued to Abaca shareholders</td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">750,000</td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr id="xdx_406_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_zngW3w2NUWT7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Share based payments</td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">215,666</td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr id="xdx_408_ecustom--WeightedAverageNumberOfSharesConversionOfPreferredStockDiluted_zsu0Pl8qdzyk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Conversion of preferred stock</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin: 0">88,800</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; margin: 0; text-align: right">-</td> <td> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_iT_zIxMRQ9Xl49g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Grand total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="margin: 0">56,268,075</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">       -</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> <p id="xdx_8A6_zkwB2XimDnoa" style="margin: 0"> </p> <p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvCrLYtTjnd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain share-based equity awards and warrants were excluded from the computation of dilutive earnings/ (loss) per share because inclusion of these awards would have had an anti-dilutive effect. The following table reflects the awards excluded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zFNvEgck0A5" style="display: none">Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240331_zxrykBhomo7j" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2024</b></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_ziVxBSOECuyg" style="border-bottom: Black 1.5pt solid; text-align: left"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><b>March 31, 2023</b></p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--WarrantsOutstandingNumber_iI_zL3ctshGzPpd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">12,036,588</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">7,036,588</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrants_z5HiMGmB20T1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Share based payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">2,284,080</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">2,775,655</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--WeightedAverageSharesDilutedSharesToBeIssuedForAcquisition_zqPL17MqrV06" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 68%">Shares to be issued to Abaca shareholders</td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"><span style="-sec-ix-hidden: xdx2ixbrl1334">-</span></td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%">6,433,839</td><td style="text-align: left; width: 1%"> </td></tr> <tr id="xdx_408_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_z1eItxSUYXvk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Conversion of preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1337">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,896,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_iT_z9fy63NiYR73" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Grand total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">14,320,668</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27,142,082</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zuRACrJ16ULh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of Series A Convertible preferred stock shall be entitled to receive, and the Company shall pay, dividends on shares of Series A Convertible preferred stock equal (on an as-if-converted-to-Class-A-common stock basis) to and in the same form as dividends actually paid on shares of the Class A common stock when, as and if such dividends are paid on shares of the Class A common stock. No other dividends shall be paid on shares of Series A convertible preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQHm3AtL6YQ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zN8pZqxDE3we" style="display: none">Schedule of Earning Per Shares, Basic and Diluted</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">For the three month period ended March 31</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20240101__20240331_zYFfctD8Pap8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_zPkiuvhTG94" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--NetIncomeLoss_zdog44fTa6mi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Net Income/ (loss)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,049,676</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,413,447</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zgBhdoOCwbkj" style="vertical-align: bottom; background-color: White"> <td>Weighted average shares outstanding – basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,213,609</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,670,730</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_zrxkExKaqvGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic net income/ (loss) per share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zsASCmfJP4N7" style="vertical-align: bottom; background-color: White"> <td>Weighted average shares outstanding – diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">56,268,075</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,670,730</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--EarningsPerShareDiluted_zVCeYzpaZ6m8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Diluted net income/ (loss) per share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td></tr> </table> 2049676 -1413447 55213609 25670730 0.04 -0.06 56268075 25670730 0.04 -0.06 <p id="xdx_890_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zzfoddOKmuXh" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_z9Qw664tQ1Hf">Schedule of Weighted Average Shares Outstanding - Basic And Diluted</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average shares calculation - basic</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240331_znr0idjHkuth" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230331_zTjUPul8fiqh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three months ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average shares calculation - basic</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesIssuedBasic_zh43yoqwxiNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%">Company public shares</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">3,926,598</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">3,926,598</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--WeightedAverageSharesBasicInitialStockholders_zRAGp2CiJze8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Company initial stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,403,175</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,403,175</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--WeightedAverageNumberOfDilutedRelatedPartyStockholders_zHpE43izOiG8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">PCCU stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,586,139</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,759,472</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--WeightedAverageSharesDilutedSharesIssuedForAcquisition_zKgTAl1iq7sh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Shares issued for abaca acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,935,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,099,977</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesRestrictedStock_zWzhtjjD8uyc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Restricted stock units issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,308,089</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">566,755</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--WeightedAverageNumberOfSharesConversionOfPreferredStock_zXFdAlgJBUS8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Conversion of preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,053,808</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,914,753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_iT_zBLZ0JOio5ug" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Grand total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">55,213,609</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">25,670,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_iT_zmP35H6lpLLa" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted average shares outstanding - basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">55,213,609</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">25,670,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average shares calculation - diluted</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240331_z7siKb9duYP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2023</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0">Three months ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average shares calculation - diluted</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2023</b></td> <td> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z0TNXXFETNJ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%">Shares used in computation of basic earnings per share</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">55,213,609</td><td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 12%">-</td> <td style="width: 1%"> </td></tr> <tr id="xdx_409_ecustom--NumberOfWarrants_zO7I38G0Q1o5" style="vertical-align: bottom; background-color: White"> <td>Shares to be issued to Abaca shareholders</td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">750,000</td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr id="xdx_406_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_zngW3w2NUWT7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Share based payments</td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">215,666</td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr id="xdx_408_ecustom--WeightedAverageNumberOfSharesConversionOfPreferredStockDiluted_zsu0Pl8qdzyk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Conversion of preferred stock</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin: 0">88,800</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; margin: 0; text-align: right">-</td> <td> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_iT_zIxMRQ9Xl49g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Grand total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="margin: 0">56,268,075</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">       -</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> 3926598 3926598 3403175 3403175 22586139 11759472 7935800 2099977 1308089 566755 16053808 3914753 55213609 25670730 55213609 25670730 55213609 750000 215666 88800 56268075 <p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvCrLYtTjnd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain share-based equity awards and warrants were excluded from the computation of dilutive earnings/ (loss) per share because inclusion of these awards would have had an anti-dilutive effect. The following table reflects the awards excluded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zFNvEgck0A5" style="display: none">Schedule of Share-based equity awards and Warrants Excluded from Computation of Earnings</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240331_zxrykBhomo7j" style="border-bottom: Black 1.5pt solid; text-align: center"><b>March 31, 2024</b></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_ziVxBSOECuyg" style="border-bottom: Black 1.5pt solid; text-align: left"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><b>March 31, 2023</b></p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--WarrantsOutstandingNumber_iI_zL3ctshGzPpd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">12,036,588</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">7,036,588</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrants_z5HiMGmB20T1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Share based payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">2,284,080</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="margin: 0">2,775,655</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--WeightedAverageSharesDilutedSharesToBeIssuedForAcquisition_zqPL17MqrV06" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 68%">Shares to be issued to Abaca shareholders</td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"><span style="-sec-ix-hidden: xdx2ixbrl1334">-</span></td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%">6,433,839</td><td style="text-align: left; width: 1%"> </td></tr> <tr id="xdx_408_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_z1eItxSUYXvk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Conversion of preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1337">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,896,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_iT_z9fy63NiYR73" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Grand total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">14,320,668</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27,142,082</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12036588 7036588 2284080 2775655 6433839 10896000 14320668 27142082 <p id="xdx_80E_ecustom--ForwardPurchaseAgreementTextBlock_zBTgEZtTXgte" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 15. <span id="xdx_823_z790AOw2raCf">Forward Purchase Agreement</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 16, 2022, the Company entered into a Forward Purchase Agreement with Midtown East Management NL, LLC (“Midtown East”). Subsequent to entering into the Forward Purchase Agreement, the Company and Midtown East entered into assignment and novation agreements with Verdun Investments LLC (“Verdun”) and Vellar Opportunity Fund SPV LLC – Series 1 (“Vellar”), pursuant to which Midtown East assigned its obligations as to <span id="xdx_904_eus-gaap--SharesIssued_iI_pid_c20220616__dei--LegalEntityAxis__custom--MidtownEastManagementNLLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQPsdxRuFw4e" title="Shares, issued">1,666,666</span> shares of the shares of Class A Stock to be purchased under the Forward Purchase Agreement to each of Verdun and Vellar. As contemplated by the Forward Purchase Agreement:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to the closing, Midtown East, Verdun and Vellar purchased approximately <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pn5n6_c20220615__20220616__dei--LegalEntityAxis__custom--MidtownEastManagementNLLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zCCONQOowPHl" title="Number of new stock issued">3.8</span> million shares of Class A common stock directly from investors at market price in the public market. Midtown East and other counter parties waived their redemption rights with respect to the acquired shares;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One business day following the closing, the Company paid approximately $<span id="xdx_90F_eus-gaap--AssetsHeldInTrustCurrent_iI_pn5n6_c20220616__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zRf456vt8fBj" title="Asset held with trust">39.3</span> million from the cash held in its trust account to Midtown East; Verdun and Vellar for the shares purchased and approximately $<span id="xdx_90F_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_pn5n6_c20220615__20220616_z6lNIWsZe3K1" title="Related expense amounts">0.3</span> million in related expense amounts.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DebtInstrumentMaturityDateDescription_c20240101__20240331_zZfzVI47wmS3" title="Maturity date, description">At the Maturity Date, Midtown East, Verdun and Vellar shall be entitled to (1) the product of the shares then held by them multiplied by the Forward Price, and (2) an amount, in cash or shares at the sole discretion of the Company, equal to (a) in the case of cash, the product of (i)(x) <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pn5n6_c20220615__20220616__dei--LegalEntityAxis__custom--MidtownEastManagementNLLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zTBMgB2zOtK3" title="Number of new stock issued">3.8</span> million shares less (y) the number of Terminated Shares and (ii) $2.00 (the “Maturity Cash Consideration”) and (b) in the case of shares, (i) the Maturity Cash Consideration divided by (ii) the VWAP Price for the 30 Scheduled Trading Days prior to the Maturity Date.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At any time prior to the Maturity Date (defined as the earlier of i) the third anniversary of the Closing of the Business Combination, ii) the shares are delisted from The Nasdaq Stock Market or (iii) during any 30 consecutive Scheduled Trading Day-period following the closing of the Business Combination, the Volume Weighted Average Share Price (VWAP) Price for 20 Scheduled Trading Days during such period shall be less than $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20220616_zMJCQaj54i31" title="Shares per share">3.00</span> per share), Midtown East, Verdun and Vellar may elect an optional early termination to sell some or all of the shares (the “Terminated Shares”) of Class A Stock in the open market. If Midtown East, Verdun and Vellar sell any shares prior to the Maturity Date, the pro-rata portion of the Reset Price will be released from the escrow account and paid to SHF. Midtown East, Verdun and Vellar shall retain any proceeds in excess of the Reset Price that is paid to SHF.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2022, an agreement was reached among the Company, its common shareholders, and preferred investors, leading to a reduction in the make-whole price to $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231_zt1qAEXtXv82">1.25</span> per share. This reset resulted in a significant decrease in the FPA receivable, from $<span id="xdx_909_ecustom--DecreaseInReceivables_iI_pn5n6_c20220930__us-gaap--TypeOfArrangementAxis__custom--ForwardPurchaseAgreementMember_zU7l08miTIU1" title="Decrease in receivables">37.9</span> million as of September 30, 2022, to $<span id="xdx_90F_eus-gaap--OtherReceivables_iI_pn5n6_c20220930__us-gaap--TypeOfArrangementAxis__custom--ForwardPurchaseAgreementMember_zMuB6o17Zy01" title="Receivables">4.6</span> million. During the year 2023 and the first quarter of 2024, there were no share transactions by FPA holders, and management identified no additional impacts on the FPA receivable’s value on December 31, 2023 and March 31, 2024.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--ScheduleOfForwardPurchaseAgreeementTableTextBlock_zvfyKimBliB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation statement of the Class A common stock held by the parties are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zYblJUrP1Rpg" style="display: none">Schedule of Forward Purchase Agreement</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As at<br/> December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares sold during<br/> the three months ended <br/> March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As at<br/> March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">S.no</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of the party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Opening<br/> Shares<br/> (a)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/> (b)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/> (c=a-b)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Rest price<br/> (iii)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount<br/> (c x iii)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 5%; text-align: justify">1</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 16%">Vellar</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_ecustom--NumberOfSharesOnTheDateOfAcquisition_iI_c20231231__dei--LegalEntityAxis__custom--VellarMember_zseygVAUPmPe" style="width: 7%; text-align: right" title="Number of shares on the date of acquisition">971,204</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--NumberOfSharesOnTheDateOfAcquisitionValue_iI_c20231231__dei--LegalEntityAxis__custom--VellarMember_zvmWlic7YnDg" style="width: 7%; text-align: right" title="Number of shares on the date of acquisition value">1,214,005</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--VellarMember_zjimjAJipPM2" style="width: 7%; text-align: right" title="Sale of stock, number of shares issued in transaction"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--VellarMember_zGpPvQCITfk6" style="width: 7%; text-align: right" title="Sale of stock, consideration received on transaction"><span style="-sec-ix-hidden: xdx2ixbrl1372">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20240331__dei--LegalEntityAxis__custom--VellarMember_zkFsnawtDhRg" style="width: 7%; text-align: right" title="Common stock held by subsidiary shares">971,204</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240331__dei--LegalEntityAxis__custom--VellarMember_zq0GI0Gl6j73" style="width: 7%; text-align: right" title="Share price">1.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CommonStockHeldBySubsidiary_iI_c20240331__dei--LegalEntityAxis__custom--VellarMember_ziBXeRxXUhKc" style="width: 7%; text-align: right" title="Common stock held by subsidiary">1,214,005</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">Midtown East</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--NumberOfSharesOnTheDateOfAcquisition_iI_c20231231__dei--LegalEntityAxis__custom--MidtownEastMember_z3j4coM3HYn5" style="text-align: right" title="Number of shares on the date of acquisition">1,517,924</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--NumberOfSharesOnTheDateOfAcquisitionValue_iI_c20231231__dei--LegalEntityAxis__custom--MidtownEastMember_zEV91G1Q6rH7" style="text-align: right" title="Number of shares on the date of acquisition value">1,897,405</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--MidtownEastMember_zjPme2Tc5wb4" style="text-align: right" title="Sale of stock, number of shares issued in transaction"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--MidtownEastMember_zUH3nu3bzpYb" style="text-align: right" title="Sale of stock, consideration received on transaction"><span style="-sec-ix-hidden: xdx2ixbrl1386">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20240331__dei--LegalEntityAxis__custom--MidtownEastMember_z3GAZTW25mC5" style="text-align: right" title="Common stock held by subsidiary shares">1,517,924</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240331__dei--LegalEntityAxis__custom--MidtownEastMember_z5uOelZFeIRk" style="text-align: right" title="Share price">1.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--CommonStockHeldBySubsidiary_iI_c20240331__dei--LegalEntityAxis__custom--MidtownEastMember_zWJDiPmVUYS4" style="text-align: right" title="Common stock held by subsidiary">1,897,405</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">3</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">Verdun</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--NumberOfSharesOnTheDateOfAcquisition_iI_c20231231__dei--LegalEntityAxis__custom--VerdunMember_zSbTJiMl0Ia6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares on the date of acquisition">1,178,249</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--NumberOfSharesOnTheDateOfAcquisitionValue_iI_c20231231__dei--LegalEntityAxis__custom--VerdunMember_zGAu7j0rxJnd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares on the date of acquisition value">1,472,811</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--VerdunMember_zOobPEetyiR7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sale of stock, number of shares issued in transaction"><span style="-sec-ix-hidden: xdx2ixbrl1398">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--VerdunMember_ztUlp41DS3s8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sale of stock, consideration received on transaction"><span style="-sec-ix-hidden: xdx2ixbrl1400">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20240331__dei--LegalEntityAxis__custom--VerdunMember_zZnaOWEbIhYj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common stock held by subsidiary shares">1,178,249</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_985_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240331__dei--LegalEntityAxis__custom--VerdunMember_zyFQYG4Wj8w2" style="padding-bottom: 1.5pt; text-align: right" title="Share price">1.25</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--CommonStockHeldBySubsidiary_iI_c20240331__dei--LegalEntityAxis__custom--VerdunMember_zA1nExIpmWBe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common stock held by subsidiary">1,472,811</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="4" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grand total</b></span></td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98B_ecustom--NumberOfSharesOnTheDateOfAcquisition_iI_c20231231_zM84xK4tYbB2" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Number of shares on the date of acquisition">3,667,377</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_986_ecustom--NumberOfSharesOnTheDateOfAcquisitionValue_iI_c20231231_zQsJffGF1Bqa" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Number of shares on the date of acquisition value">4,584,221</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_ecustom--SaleOfStockConsiderationReceivedOnTransactionShares_c20240101__20240331_zY877nuMQn8k" style="border-bottom: Black 2.5pt double; text-align: right" title="Sale of stock, number of shares issued in transaction shares"><span style="-sec-ix-hidden: xdx2ixbrl1412">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240101__20240331_zKbMgSCYmWB2" style="border-bottom: Black 2.5pt double; text-align: right" title="Sale of stock, consideration received on transaction"><span style="-sec-ix-hidden: xdx2ixbrl1414">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_989_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20240331_zUXnO6mqIbOb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Common stock held by subsidiary shares">3,667,377</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockHeldBySubsidiary_iI_c20240331_zLZhyrHgfOze" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Common stock held by subsidiary">4,584,221</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zTWi91a5cpbi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1666666 3800000 39300000 300000 At the Maturity Date, Midtown East, Verdun and Vellar shall be entitled to (1) the product of the shares then held by them multiplied by the Forward Price, and (2) an amount, in cash or shares at the sole discretion of the Company, equal to (a) in the case of cash, the product of (i)(x) 3.8 million shares less (y) the number of Terminated Shares and (ii) $2.00 (the “Maturity Cash Consideration”) and (b) in the case of shares, (i) the Maturity Cash Consideration divided by (ii) the VWAP Price for the 30 Scheduled Trading Days prior to the Maturity Date. 3800000 3.00 1.25 37900000 4600000 <p id="xdx_89F_ecustom--ScheduleOfForwardPurchaseAgreeementTableTextBlock_zvfyKimBliB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation statement of the Class A common stock held by the parties are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zYblJUrP1Rpg" style="display: none">Schedule of Forward Purchase Agreement</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As at<br/> December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares sold during<br/> the three months ended <br/> March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As at<br/> March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">S.no</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of the party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Opening<br/> Shares<br/> (a)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/> (b)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/> (c=a-b)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Rest price<br/> (iii)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount<br/> (c x iii)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 5%; text-align: justify">1</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 16%">Vellar</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_ecustom--NumberOfSharesOnTheDateOfAcquisition_iI_c20231231__dei--LegalEntityAxis__custom--VellarMember_zseygVAUPmPe" style="width: 7%; text-align: right" title="Number of shares on the date of acquisition">971,204</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--NumberOfSharesOnTheDateOfAcquisitionValue_iI_c20231231__dei--LegalEntityAxis__custom--VellarMember_zvmWlic7YnDg" style="width: 7%; text-align: right" title="Number of shares on the date of acquisition value">1,214,005</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--VellarMember_zjimjAJipPM2" style="width: 7%; text-align: right" title="Sale of stock, number of shares issued in transaction"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--VellarMember_zGpPvQCITfk6" style="width: 7%; text-align: right" title="Sale of stock, consideration received on transaction"><span style="-sec-ix-hidden: xdx2ixbrl1372">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20240331__dei--LegalEntityAxis__custom--VellarMember_zkFsnawtDhRg" style="width: 7%; text-align: right" title="Common stock held by subsidiary shares">971,204</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240331__dei--LegalEntityAxis__custom--VellarMember_zq0GI0Gl6j73" style="width: 7%; text-align: right" title="Share price">1.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CommonStockHeldBySubsidiary_iI_c20240331__dei--LegalEntityAxis__custom--VellarMember_ziBXeRxXUhKc" style="width: 7%; text-align: right" title="Common stock held by subsidiary">1,214,005</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">Midtown East</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--NumberOfSharesOnTheDateOfAcquisition_iI_c20231231__dei--LegalEntityAxis__custom--MidtownEastMember_z3j4coM3HYn5" style="text-align: right" title="Number of shares on the date of acquisition">1,517,924</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--NumberOfSharesOnTheDateOfAcquisitionValue_iI_c20231231__dei--LegalEntityAxis__custom--MidtownEastMember_zEV91G1Q6rH7" style="text-align: right" title="Number of shares on the date of acquisition value">1,897,405</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--MidtownEastMember_zjPme2Tc5wb4" style="text-align: right" title="Sale of stock, number of shares issued in transaction"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--MidtownEastMember_zUH3nu3bzpYb" style="text-align: right" title="Sale of stock, consideration received on transaction"><span style="-sec-ix-hidden: xdx2ixbrl1386">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20240331__dei--LegalEntityAxis__custom--MidtownEastMember_z3GAZTW25mC5" style="text-align: right" title="Common stock held by subsidiary shares">1,517,924</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240331__dei--LegalEntityAxis__custom--MidtownEastMember_z5uOelZFeIRk" style="text-align: right" title="Share price">1.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--CommonStockHeldBySubsidiary_iI_c20240331__dei--LegalEntityAxis__custom--MidtownEastMember_zWJDiPmVUYS4" style="text-align: right" title="Common stock held by subsidiary">1,897,405</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">3</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">Verdun</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--NumberOfSharesOnTheDateOfAcquisition_iI_c20231231__dei--LegalEntityAxis__custom--VerdunMember_zSbTJiMl0Ia6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares on the date of acquisition">1,178,249</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--NumberOfSharesOnTheDateOfAcquisitionValue_iI_c20231231__dei--LegalEntityAxis__custom--VerdunMember_zGAu7j0rxJnd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares on the date of acquisition value">1,472,811</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--VerdunMember_zOobPEetyiR7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sale of stock, number of shares issued in transaction"><span style="-sec-ix-hidden: xdx2ixbrl1398">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240101__20240331__dei--LegalEntityAxis__custom--VerdunMember_ztUlp41DS3s8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sale of stock, consideration received on transaction"><span style="-sec-ix-hidden: xdx2ixbrl1400">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20240331__dei--LegalEntityAxis__custom--VerdunMember_zZnaOWEbIhYj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common stock held by subsidiary shares">1,178,249</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_985_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240331__dei--LegalEntityAxis__custom--VerdunMember_zyFQYG4Wj8w2" style="padding-bottom: 1.5pt; text-align: right" title="Share price">1.25</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--CommonStockHeldBySubsidiary_iI_c20240331__dei--LegalEntityAxis__custom--VerdunMember_zA1nExIpmWBe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common stock held by subsidiary">1,472,811</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="4" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grand total</b></span></td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98B_ecustom--NumberOfSharesOnTheDateOfAcquisition_iI_c20231231_zM84xK4tYbB2" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Number of shares on the date of acquisition">3,667,377</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_986_ecustom--NumberOfSharesOnTheDateOfAcquisitionValue_iI_c20231231_zQsJffGF1Bqa" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Number of shares on the date of acquisition value">4,584,221</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_ecustom--SaleOfStockConsiderationReceivedOnTransactionShares_c20240101__20240331_zY877nuMQn8k" style="border-bottom: Black 2.5pt double; text-align: right" title="Sale of stock, number of shares issued in transaction shares"><span style="-sec-ix-hidden: xdx2ixbrl1412">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240101__20240331_zKbMgSCYmWB2" style="border-bottom: Black 2.5pt double; text-align: right" title="Sale of stock, consideration received on transaction"><span style="-sec-ix-hidden: xdx2ixbrl1414">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_989_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20240331_zUXnO6mqIbOb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Common stock held by subsidiary shares">3,667,377</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockHeldBySubsidiary_iI_c20240331_zLZhyrHgfOze" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Common stock held by subsidiary">4,584,221</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 971204 1214005 971204 1.25 1214005 1517924 1897405 1517924 1.25 1897405 1178249 1472811 1178249 1.25 1472811 3667377 4584221 3667377 4584221 <p id="xdx_80F_ecustom--WarrantLiabilitiesTextBlock_zT0Udi8r4VEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 16. <span id="xdx_827_zv0QPuzR1i53">Warrant Liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 31pt 0pt 3.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public and Private Placement Warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, and December 31, 2023, the Company has <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zOBUSeKhzxj7" title="Number of warrants outstanding">5,750,000</span> Public warrants and <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zU33VIwHHBz7" title="Number of warrants outstanding">264,088</span> Private Placement Warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Public and Private Placement Warrants may only be exercised for a whole number of shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--WarrantsDescription_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__custom--PublicAndPrivateWarrantsMember_zFNodiIS8Kpa" title="Warrants description">The Public and Private Placement Warrants became exercisable on September 28, 2022, the date of the Business Combination and will expire on September 28, 2027, or earlier upon redemption or liquidation.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 31pt 0pt 7.1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption of warrants become exercisable when the price per Class A Common Stock equals or exceeds $<span id="xdx_909_eus-gaap--SharePrice_iI_c20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zAuK8Xl4fAwg" title="Shares issued, price per share">18.00</span>. Once the warrants become exercisable, the Company may redeem the warrants:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in whole and not in part;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240331__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zDVVcUgrNTV4" title="Warrants price per share">0.01</span> per warrant;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon not less than 30 days’ prior written notice of redemption to each warrant holder; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the reported last sale price of the Class A Common Stock equals or exceeds $<span id="xdx_907_eus-gaap--SharePrice_iI_c20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zz5lw8vhkEc1" title="Shares issued, price per share">18.00</span> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A Common Stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If and when the warrants become redeemable by the Company, the Company may exercise its redemption rights; this is also the case if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise the Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The private placement warrants are identical to the public warrants, except that the private placement warrants and the Class A Common Stock issuable upon the exercise of the private placement warrants were not transferable, assignable or saleable, subject to certain limited exceptions. Additionally, the private placement warrants are exercisable on a cashless basis and non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the private placement warrants are held by someone other than the initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIPE Warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024 and December 31, 2023, the Company has <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240331__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zOUundUIi58c" title="Warrants outstanding"><span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zAPO1jC1Ixz9" title="Warrants outstanding">1,022,500</span></span> PIPE Warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The PIPE Warrants have an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJuy7b0Ned0a" title="Warrants execise price">11.50</span> per share of Class A Common Stock to be paid in cash (except if the shares underlying the warrants are not covered by an effective registration statement after the six-month anniversary of the closing date, in which case cashless exercise is permitted), subject to adjustment to a price equal to the greater of <span id="xdx_903_ecustom--WarrantsDescription_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zwUbxJFwUb5f" title="Warrants description">(i)125% of the conversion price if at any time there is an adjustment to the Conversion Price and the exercise price after such adjustment is greater than 125% of the Conversion Price as adjusted and (ii) $5.00.</span> The PIPE Warrants are also subject to adjustment for other customary adjustments for stock dividends, stock splits and similar corporate actions. The PIPE Warrants are exercisable for a period of five years following the Closing, or September 28, 2027. After exercise of a PIPE Warrant, the Company may be required to pay certain penalties if it fails to deliver the Class A Common Stock within a specified period of time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abaca Warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31,2024, and December 31, 2023, the Company has <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--AbacaWarrantsMember_znwHvozeV1qi" title="Warrants outstanding"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--AbacaWarrantsMember_zrsehCtKF2hd" title="Warrants outstanding">5,000,000</span></span> Abaca warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Abaca <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--AbacaWarrantsMember_zc8eNjV7Lee7" title="Number of warrant issued">5,000,000</span> warrants have an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--AbacaWarrantsMember_zP0KewVqUnNh" title="Warrants execise price">2.00</span> per share of Class A common stock to be paid in cash. An Abaca Warrant may be exercised only during the period commencing 1 year of the Effective Date and terminating five (<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--AbacaWarrantsMember_zkqETmtkNaYc" title="Warrants term">5</span>) years from the effective date of the registration statement. The Company may, in its sole discretion, settle the Abaca Warrant when exercised, in whole or in part, in cash in lieu of issuing shares of common stock underlying the Warrant. The Company may elect to pay the Registered Holder in cash in the amount equal to the difference between the fair market value of the Company’s Class A common stock on the date of exercise and the warrant price ($<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--AbacaWarrantsMember_zf1rRHBdhNUl" title="Warrants execise price">2.00</span>) multiplied by the number of shares of Class A common stock. The Company commits to promptly registering shares of Class A common stock issued upon Abaca Warrant exercises if required by law, ensuring these shares can be sold without restrictions. This registration must be filed within 45 days of receiving a notification of such a requirement, with failure to do so constituting a default. The Company will endeavor to keep the registration effective until the Warrants expire. If the registration isn’t effective within one year, Abaca Warrant holders may exercise their Warrants on a cashless basis, receiving shares based on a defined fair market value calculation. This process aims to facilitate the straightforward and lawful exercise of the Abaca Warrants, ensuring the shares issued are readily tradable without the need for restrictive legends.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 5750000 264088 The Public and Private Placement Warrants became exercisable on September 28, 2022, the date of the Business Combination and will expire on September 28, 2027, or earlier upon redemption or liquidation. 18.00 0.01 18.00 1022500 1022500 11.50 (i)125% of the conversion price if at any time there is an adjustment to the Conversion Price and the exercise price after such adjustment is greater than 125% of the Conversion Price as adjusted and (ii) $5.00. 5000000 5000000 5000000 2.00 P5Y 2.00 <p id="xdx_80B_eus-gaap--FinancialInstrumentsDisclosureTextBlock_zq5Ive4LqJG2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 17. <span id="xdx_82D_zhCUZ6mqJtUj">Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The fair value hierarchy ranks the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">○</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Observable, unadjusted quoted prices in active markets</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">○</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">○</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Unobservable inputs with little or no market activity that require the Company to use reasonable inputs and assumptions</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses fair value measurements to record adjustments to certain financial assets and liabilities on a recurring basis. The Company may be required to record certain assets at fair value on a nonrecurring basis in specific circumstances, such as evidence of impairment. Methodologies used to determine fair value might be highly subjective and judgmental in nature; therefore, valuations may not be precise. If the Company determines that a valuation technique change is necessary, the change is assumed to have occurred at the end of the respective reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Assets and Liabilities Reported at Fair Value on a Recurring Basis</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public Warrants: </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public warrants are recorded at fair value on a recurring basis. The Company obtains exchange traded price, of Level 1 inputs, based on observable data to value these warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private Placement Warrants:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Placement Warrants are recorded at fair value on a recurring basis. In the first quarter of 2024, the Company internally assessed the value of these derivatives with Level 3 inputs, which are derived from Black-Scholes model. This is a change from the first quarter of 2023, when the valuation was based on third-party reports, also utilizing Level 3 inputs for these derivatives. Management believes that this change was necessary to enhance the precision and control over the valuation process, allowing for a more tailored and responsive approach to the unique characteristics of the derivatives and the evolving market conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PIPE Warrants:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIPE Warrants are recorded at fair value on a recurring basis. In the first quarter of 2024, the Company internally assessed the value of these derivatives with Level 3 inputs, which are derived from Black-Scholes model. This is a change the first quarter of 2023, when the valuation was based on third-party reports, also utilizing Level 3 inputs for these derivatives. Management believes that this change was necessary to enhance the precision and control over the valuation process, allowing for a more tailored and responsive approach to the unique characteristics of the derivatives and the evolving market conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Abaca Warrants:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abaca Warrants are recorded at fair value on a recurring basis. The Company internally assessed the value of these derivatives with Level 3 inputs. Level 3 inputs, based on unobservable data derived from Black-Scholes model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Third Anniversary Payment Consideration:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third anniversary payment consideration are recorded at fair value on a recurring basis. The Company value these derivatives based on third party reports for Level 3 inputs. Level 3 inputs, based on unobservable data derived from Black Scholes-Merton model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Forward Purchase Option Derivatives:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward purchase option derivatives are recorded at fair value on a recurring basis. In 2022, the Company values these derivatives based on third party reports for Level 3 inputs. In 2023 and 2024, no significant risk factor changes affecting FPA derivative values were noted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zc7CWNoJgkvg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize financial assets and liabilities recorded at fair value on a recurring basis, by the level of valuation inputs in the fair value hierarchy on March 31, 2024 and December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zymE3l93HN8j" style="display: none">Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_493_20240331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRcZxuqVdB5d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Fair<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zeRc71eBmQjj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_496_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zrpALogMtuI7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7NFxZyVF5Rk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Fair<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zjdOgnUoSK6l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_492_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziMPUxRGGSD8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Fair<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Fair<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-style: italic">Liabilities:</td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zZVNArAsAZHc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">PIPE warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">189,220</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1459">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">189,220</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">273,124</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1462">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">273,124</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--PublicWarrantsMember_zPIO40NW6Xd9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Public warrants</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">430,675</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">430,675</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1467">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">481,850</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">481,850</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--PrivatePlacementWarrantsMember_zIKRyGFSid44" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Private placement warrants</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">20,315</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1473">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,315</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">25,070</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1476">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,070</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zh0fsfE8KX0b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Abaca warrant</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,268,432</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,268,432</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,384,085</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1483">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,384,085</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeLiabilityMember_zFZfjR9C9m13" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forward purchase derivative liability</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1487">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zX1M7QAtMk8c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Third anniversary payment consideration</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">594,000</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></span></td><td style="font-size: 12pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">594,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">810,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1497">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">810,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zth50bXI42i1" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">594,000</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1501">-</span></td><td style="font-size: 12pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">594,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">810,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1504">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">810,000</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AE_zN1NkePDSNm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Assets Measured at Fair Value on a Nonrecurring Basis</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets that are measured at fair value on a nonrecurring basis primarily comprises of property, plant and equipment, right-to-use assets, finite lived intangible assets and goodwill. The Company does not record these at fair value on a recurring basis, however, the carrying value of the assets may be reduced to fair value when the Company determines that impairment has occurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no assets or liabilities recorded at fair value on a nonrecurring basis for the period ended March 31, 2024 and March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair Value of Financial Instruments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various methodologies and assumptions to estimate the fair value of certain financial instruments. With the exceptions of loans receivable, warrants and forward purchase option derivatives, the Company considers the carrying amounts of its financial instruments (cash, accounts receivable and accounts payable) in the balance sheet to approximate fair value because of the short-term or highly liquid nature of these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zCycMQArnrh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables present the carrying amounts and fair values of financial instruments, by the level of valuation inputs in the fair value hierarchy, as of the dates indicated:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span id="xdx_8B4_zOMTy1Em0uoc" style="display: none">Schedule of Carrying Amounts and Fair Values of Financial Instruments</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20240331__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_za0cJAZUafDb" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20240331__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_zdjXtA4bCXwb" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z97P6oO8Dr2d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNpHF6UNVoE9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuaTSvGRu6qa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">As on March 31, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Carrying<br/> amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Fair value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Fair value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zwPYsmRLOOLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt"><i>Assets</i></span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_z6vNZw3Uiuk2" style="vertical-align: bottom; background-color: White"> <td style="width: 35%; text-align: left"><span style="font-size: 10pt">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">5,626,362</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">5,626,362</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">5,626,362</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1518">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1519">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableFairValueDisclosure_iI_zD3iLp4dsnV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Forward purchase receivables</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">4,584,221</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">4,584,221</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">4,584,221</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1524">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1525">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--LoansPayableFairValueDisclosure_iI_zAqRZ9dSYh34" style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Loans</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">392,483</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">362,671</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">362,671</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_zRpCPcJeWWC3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt"><i>Liabilities</i></span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredCompensationLiabilityCurrent_iI_zVQ4aut8cF52" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Deferred consideration</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,921,257</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,921,257</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,921,257</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1542">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1543">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--DebtInstrumentFairValue_i01I_maLzJOP_zVMcGVNgTnbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Senior Secured Promissory note</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">13,270,622</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">12,137,875</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1547">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1548">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">12,137,875</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--IndemnityLiability_i01I_z2PEEVhzVVo9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Indemnity liability</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,315,263</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,315,263</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,315,263</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1554">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1555">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--PublicWarrantsFairValueDisclosure_iI_zYkVwAbXtsK3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Public warrants</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">430,675</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">430,675</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">430,675</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1560">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1561">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--PrivatePlacementWarrantsFairValueDisclosure_iI_z9XOoa0jaLah" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Private placement warrants</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">20,315</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">20,315</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1565">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1566">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">20,315</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--PipeWarrantsFairValueDisclosure_iI_zNsXixPXUiUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">PIPE Warrants</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">189,220</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">189,220</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1571">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1572">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">189,220</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--WarrantsFairValueDisclosure_iI_zEjwnXj7jmYb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Abaca Warrants</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,268,432</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,268,432</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1577">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1578">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,268,432</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_ecustom--ThirdAnniversaryPaymentConsiderationFairValueDisclosure_iI_z4jJSujlu3d2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Third anniversary payment consideration</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">594,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">594,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1583">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1584">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">594,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_zqoizBxqSpgc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Forward purchase derivative</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1589">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1590">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20231231__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_z5dX8Rejk8C2" style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_490_20231231__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_zT01Ok5QhL4e" style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvy0Qj7IVuPl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 1</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_490_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKtuJ8sH97Ti" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 2</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_492_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCDqAQjf8bQe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 3</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>As on December 31, 2023</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Carrying<br/> amount</b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Fair value</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Fair value measurement using</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 1</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 2</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 3</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr id="xdx_40B_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zQLoEBIkUkJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Assets</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_402_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zHoZeKWMUjRk" style="vertical-align: bottom; background-color: White"> <td style="width: 35%; text-align: left">Cash and cash equivalents</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,888,769</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,888,769</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,888,769</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1602">-</span></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1603">-</span></td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableFairValueDisclosure_iI_zvOr9e9Se28" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forward purchase receivables</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">4,584,221</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">4,584,221</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">4,584,221</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1608">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1609">-</span></td> <td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LoansPayableFairValueDisclosure_iI_zekfgecEDJM7" style="vertical-align: bottom; background-color: White"> <td>Loans</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">330,579</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">363,561</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1613">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1614">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">363,561</td> <td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_z00flWIE94Fe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Liabilities</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredCompensationLiabilityCurrent_iI_zk2LNXeomHJe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred consideration</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,889,792</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,889,792</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,889,792</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1626">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1627">-</span></td> <td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DebtInstrumentFairValue_i01I_maLzJOP_zXYVSa6vQc44" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Senior secured promissory note</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">14,011,166</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">12,750,204</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1631">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1632">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">12,750,204</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--PublicWarrantsFairValueDisclosure_iI_zynNo8eYCmm" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Public warrants</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">481,850</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">481,850</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">481,850</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1638">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1639">-</span></td> <td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--PrivatePlacementWarrantsFairValueDisclosure_iI_zq6C3JRtXSOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Private placement warrants</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,070</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,070</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1643">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1644">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,070</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--PipeWarrantsFairValueDisclosure_iI_zEzNznyiyBai" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">PIPE warrants</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">273,124</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">273,124</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1649">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1650">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">273,124</td> <td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--WarrantsFairValueDisclosure_iI_zOJq1NVk8Kmj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Abaca warrants</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,384,085</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,384,085</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1655">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1656">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,384,085</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_zkYeS3lh0rcb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Forward purchase derivative</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">7,309,580</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">7,309,580</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1661">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1662">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">7,309,580</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ThirdAnniversaryPaymentConsiderationFairValueDisclosure_iI_zCMtFMNqJouc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Third anniversary payment consideration</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">810,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">810,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1667">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1668">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">810,000</td> <td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zLrGC4G0HkW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zuZYvx9ifAF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in the assets measured at fair value on a recurring basis for which the Company have utilized Level 3 inputs to determine fair value are presented in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zyqX82jdzt9f" style="display: none">Schedule of Fair Value Assets Measured on Recurring Basis</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_495_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_z6QqGAES5PR9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_49E_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zWgbQqJ1Xt0b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrant</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_490_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--PrivatePlacementWarrantsMember_zBelqAARJZii" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Placement<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_497_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zd5XdeDrcIe2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_492_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember_zZkw0CEjVF22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Forward<br/> Purchase<br/> Derivative</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the period ended March 31, 2024</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrant</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Placement<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Forward<br/> Purchase<br/> Derivative</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_405_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_z7Y8stG3hySh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left"><span style="font-size: 10pt">Balance at the beginning of the period</span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">273,124</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">3,384,085</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">25,070</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">810,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_zSpEdrQt8m4j" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Issued to Abaca shareholders</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1679">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1680">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1681">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1682">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1683">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AssetsFairValueAdjustment_zxv1QEBMSsR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Fair value adjustment</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(83,904</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(1,115,653</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(4,755</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(216,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1689">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_zTgAeFzqQ943" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">Balance at the end of the period</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">189,220</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">2,268,432</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">20,315</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">594,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_497_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zOrGfKK6LAz3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_492_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zTep8aYdHat4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrant</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49C_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--PrivatePlacementWarrantsMember_zK0T9WyknAyi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Placement<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_497_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zbKqt9r4wFd4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_494_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember_zSB8MLXnd8Cd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Forward<br/> Purchase<br/> Derivative</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the period ended March 31, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrant</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Placement<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Forward<br/> Purchase<br/> Derivative</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr id="xdx_405_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_zQ7sBtJYIFN5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Balance at the beginning of the period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">286,300</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1698">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,110</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1700">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,309,580</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AssetsFairValueAdjustment_z0Xav40EvQih" style="vertical-align: bottom; background-color: White"> <td>Fair value adjustment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(211,538</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1704">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,157</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1707">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_zTlCEBXOUgRi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance at the end of the period</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">74,762</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1710">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,953</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1712">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A7_zJdrWeGr47Y5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024 and on December 31, 2023, the valuation of private placement warrants, PIPE warrants, and Abaca warrants was carried out using the Black-Scholes model, while the fair value of the Abaca third anniversary payment consideration was determined using the Black Scholes Merton Option pricing model. Contrastingly, in the first quarter of 2023, the fair value assessments for both the private placement warrants and PIPE warrants were conducted using the Black-Scholes model and the Black Scholes-Merton model, respectively. Management believes that the change in method for PIPE warrants was necessary to enhance the precision and control over the valuation process, allowing for a more tailored and responsive approach to the unique characteristics of the derivatives and the evolving market conditions. As of March 31, 2024 and December 31, 2023, these warrants were valued for Level 3 inputs, which are based on observable data to value these derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company assessed the fair value of its forward purchase agreement (FPA) derivative utilizing a Monte Carlo Simulation within a risk-neutral setting, which is a particular instance of the Income Approach, based on calculations from December 31, 2022. Throughout the first quarters of both 2023 and 2024, there were no notable alterations in risk factors that would impact the valuation of the FPA derivative. Consequently, management retained the December 31, 2022, valuation for December 31, 2023 and March 31, 2024. The Company will continue to monitor the fair value of the forward option derivative each reporting period with subsequent revisions to be recorded in the Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first quarters of both 2023 and 2024, there were no changes in the classification of financial instruments within Level 2 and Level 3 of the fair value hierarchy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zQ2RQftQqTb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the private placement warrants and public warrants as of their measurement dates:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zxaM4aw7mAVd" style="display: none">Schedule of Level 3 Fair Value Measurement Inputs</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49D_20240331__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zE42nbEpa8i4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_496_20240331__us-gaap--FairValueByAssetClassAxis__custom--PrivateWarrantsMember_zUtTOFW7ISae" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49D_20240331__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zhyqil6Tv7Ah" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_496_20240331__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zwMmbV2UHis" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49F_20231231__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zgtYGlfbshcg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_498_20231231__us-gaap--FairValueByAssetClassAxis__custom--PrivateWarrantsMember_zqIi2OVV3oSd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_497_20231231__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zkGwT6tZuSpi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_490_20231231__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_z2cwXCm4jYu6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr id="xdx_407_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uUSDPShares_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zKqfAescE4C5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%">Exercise price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">11.5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1719">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">2</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">11.5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1723">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">2</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uUSDPShares_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zr08KpPYZot9" style="vertical-align: bottom; background-color: White"> <td>Share Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.97</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.97</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.97</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.97</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.42</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zQmaoVZGyuhd" style="text-align: right" title="Expected term (years)">3.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--PrivateWarrantsMember_zg7nE7YQY1ik" style="text-align: right" title="Expected term (years)">3.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zaLc1gw9pwKg" style="text-align: right" title="Expected term (years)">1.51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zaaCqZpjRzt8" style="text-align: right" title="Expected term (years)">4.57</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zP4cTDnPfNyf" style="text-align: right" title="Expected term (years)">3.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--PrivateWarrantsMember_zRkL0FrQPZpd" style="text-align: right" title="Expected term (years)">3.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zVWMaEXMqtS2" style="text-align: right" title="Expected term (years)">1.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zMzlCsymP0aa" style="text-align: right" title="Expected term (years)">4.84</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zQB7fCL04vr" style="vertical-align: bottom; background-color: White"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76.00</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76.00</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76.00</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76.00</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62.95</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62.95</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62.95</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62.95</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zdXltaRGY9Yd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.36</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUq7W4pvPMa2" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants and rights outstanding, measurement input</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.36</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AB_zwdx39KgF1y9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember_zEYOIrZO7v0b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the forward purchase derivatives as of their measurement dates on March 31, 2024 and December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zp3elA5dflj6" style="display: none">Schedule of Level 3 Fair Value Measurements Inputs</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240331__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember_zZ5qSLmmCXm3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember_zYYDalZg4LJh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uUSDPShares_hus-gaap--MeasurementInputTypeAxis__custom--MeasurementInputResetPriceMember_z64HO01VMpw2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: justify">Reset Price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1.25</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--DerivativeLiabilityExpectedTerm_dtY_c20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zoZbCzGjLww3" style="text-align: right" title="Expected term (years)">1.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--DerivativeLiabilityExpectedTerm_dtY_c20230101__20231231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zTQWsNlrJgA2" style="text-align: right" title="Expected term (years)">1.74</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uUSDPShares_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputAdditionalMaturityPerShareMember_zfUnfCoVpe95" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Additional Maturity Consideration per share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.00</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zqTbI4JpodF2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46</td><td style="text-align: left">%</td></tr> <tr id="xdx_408_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zGNfTsYLniVh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.2</td><td style="text-align: left">%</td></tr> <tr id="xdx_405_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z0GiwoS78tEk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk-adjusted discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13.4</td><td style="text-align: left">%</td></tr> <tr id="xdx_406_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_ziPXRRpHc4pb" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify">Derivative liability, measurement input</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13.4</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AD_zdM4oNALTJ4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zc7CWNoJgkvg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize financial assets and liabilities recorded at fair value on a recurring basis, by the level of valuation inputs in the fair value hierarchy on March 31, 2024 and December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zymE3l93HN8j" style="display: none">Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_493_20240331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRcZxuqVdB5d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Fair<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zeRc71eBmQjj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_496_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zrpALogMtuI7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7NFxZyVF5Rk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Fair<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zjdOgnUoSK6l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_492_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ziMPUxRGGSD8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Fair<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Fair<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices in<br/> Active<br/> Markets<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-style: italic">Liabilities:</td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt"> </td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zZVNArAsAZHc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">PIPE warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">189,220</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1459">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">189,220</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">273,124</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1462">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">273,124</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--PublicWarrantsMember_zPIO40NW6Xd9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Public warrants</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">430,675</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">430,675</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1467">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">481,850</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">481,850</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--PrivatePlacementWarrantsMember_zIKRyGFSid44" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Private placement warrants</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">20,315</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1473">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,315</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">25,070</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1476">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,070</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zh0fsfE8KX0b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Abaca warrant</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,268,432</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,268,432</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,384,085</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1483">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,384,085</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeLiabilityMember_zFZfjR9C9m13" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forward purchase derivative liability</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1487">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zX1M7QAtMk8c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Third anniversary payment consideration</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">594,000</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></span></td><td style="font-size: 12pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">594,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">810,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1497">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">810,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zth50bXI42i1" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">594,000</td><td style="text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1501">-</span></td><td style="font-size: 12pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">594,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">810,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1504">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">810,000</td><td style="text-align: left"> </td></tr> </table> 189220 189220 273124 273124 430675 430675 481850 481850 20315 20315 25070 25070 2268432 2268432 3384085 3384085 7309580 7309580 7309580 7309580 594000 594000 810000 810000 594000 594000 810000 810000 <p id="xdx_899_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zCycMQArnrh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables present the carrying amounts and fair values of financial instruments, by the level of valuation inputs in the fair value hierarchy, as of the dates indicated:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span id="xdx_8B4_zOMTy1Em0uoc" style="display: none">Schedule of Carrying Amounts and Fair Values of Financial Instruments</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20240331__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_za0cJAZUafDb" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20240331__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_zdjXtA4bCXwb" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z97P6oO8Dr2d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNpHF6UNVoE9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuaTSvGRu6qa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">As on March 31, 2024</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Carrying<br/> amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Fair value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Fair value measurement using</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Level 3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zwPYsmRLOOLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt"><i>Assets</i></span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_z6vNZw3Uiuk2" style="vertical-align: bottom; background-color: White"> <td style="width: 35%; text-align: left"><span style="font-size: 10pt">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">5,626,362</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">5,626,362</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">5,626,362</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1518">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1519">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableFairValueDisclosure_iI_zD3iLp4dsnV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Forward purchase receivables</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">4,584,221</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">4,584,221</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">4,584,221</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1524">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1525">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--LoansPayableFairValueDisclosure_iI_zAqRZ9dSYh34" style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Loans</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">392,483</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">362,671</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">362,671</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_zRpCPcJeWWC3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt"><i>Liabilities</i></span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredCompensationLiabilityCurrent_iI_zVQ4aut8cF52" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Deferred consideration</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,921,257</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,921,257</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,921,257</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1542">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1543">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--DebtInstrumentFairValue_i01I_maLzJOP_zVMcGVNgTnbj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Senior Secured Promissory note</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">13,270,622</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">12,137,875</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1547">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1548">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">12,137,875</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--IndemnityLiability_i01I_z2PEEVhzVVo9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Indemnity liability</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,315,263</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,315,263</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,315,263</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1554">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1555">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--PublicWarrantsFairValueDisclosure_iI_zYkVwAbXtsK3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Public warrants</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">430,675</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">430,675</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">430,675</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1560">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1561">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--PrivatePlacementWarrantsFairValueDisclosure_iI_z9XOoa0jaLah" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Private placement warrants</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">20,315</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">20,315</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1565">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1566">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">20,315</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--PipeWarrantsFairValueDisclosure_iI_zNsXixPXUiUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">PIPE Warrants</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">189,220</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">189,220</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1571">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1572">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">189,220</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--WarrantsFairValueDisclosure_iI_zEjwnXj7jmYb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Abaca Warrants</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,268,432</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,268,432</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1577">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1578">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,268,432</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_ecustom--ThirdAnniversaryPaymentConsiderationFairValueDisclosure_iI_z4jJSujlu3d2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Third anniversary payment consideration</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">594,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">594,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1583">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1584">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">594,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_zqoizBxqSpgc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Forward purchase derivative</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1589">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1590">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20231231__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--CarryingReportedAmountFairValueDisclosureMember_z5dX8Rejk8C2" style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_490_20231231__us-gaap--FairValueByMeasurementBasisAxis__us-gaap--EstimateOfFairValueFairValueDisclosureMember_zT01Ok5QhL4e" style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_494_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvy0Qj7IVuPl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 1</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_490_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKtuJ8sH97Ti" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 2</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" id="xdx_492_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCDqAQjf8bQe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 3</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>As on December 31, 2023</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Carrying<br/> amount</b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Fair value</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Fair value measurement using</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="text-align: center"><b> </b></td> <td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 1</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 2</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Level 3</b></td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr id="xdx_40B_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zQLoEBIkUkJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Assets</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_402_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zHoZeKWMUjRk" style="vertical-align: bottom; background-color: White"> <td style="width: 35%; text-align: left">Cash and cash equivalents</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,888,769</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,888,769</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,888,769</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1602">-</span></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1603">-</span></td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableFairValueDisclosure_iI_zvOr9e9Se28" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forward purchase receivables</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">4,584,221</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">4,584,221</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">4,584,221</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1608">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1609">-</span></td> <td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LoansPayableFairValueDisclosure_iI_zekfgecEDJM7" style="vertical-align: bottom; background-color: White"> <td>Loans</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">330,579</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">363,561</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1613">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1614">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">363,561</td> <td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_z00flWIE94Fe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Liabilities</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredCompensationLiabilityCurrent_iI_zk2LNXeomHJe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred consideration</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,889,792</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,889,792</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,889,792</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1626">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1627">-</span></td> <td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DebtInstrumentFairValue_i01I_maLzJOP_zXYVSa6vQc44" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Senior secured promissory note</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">14,011,166</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">12,750,204</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1631">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1632">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">12,750,204</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--PublicWarrantsFairValueDisclosure_iI_zynNo8eYCmm" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Public warrants</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">481,850</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">481,850</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">481,850</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1638">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1639">-</span></td> <td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--PrivatePlacementWarrantsFairValueDisclosure_iI_zq6C3JRtXSOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Private placement warrants</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,070</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,070</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1643">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1644">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25,070</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--PipeWarrantsFairValueDisclosure_iI_zEzNznyiyBai" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">PIPE warrants</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">273,124</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">273,124</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1649">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1650">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">273,124</td> <td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--WarrantsFairValueDisclosure_iI_zOJq1NVk8Kmj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Abaca warrants</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,384,085</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,384,085</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1655">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1656">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,384,085</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_zkYeS3lh0rcb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Forward purchase derivative</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">7,309,580</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">7,309,580</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1661">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1662">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">7,309,580</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ThirdAnniversaryPaymentConsiderationFairValueDisclosure_iI_zCMtFMNqJouc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Third anniversary payment consideration</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">810,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">810,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1667">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1668">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">810,000</td> <td style="text-align: left"> </td></tr> </table> 5626362 5626362 5626362 4584221 4584221 4584221 392483 362671 362671 2921257 2921257 2921257 13270622 12137875 12137875 1315263 1315263 1315263 430675 430675 430675 20315 20315 20315 189220 189220 189220 2268432 2268432 2268432 594000 594000 594000 7309580 7309580 7309580 4888769 4888769 4888769 4584221 4584221 4584221 330579 363561 363561 2889792 2889792 2889792 14011166 12750204 12750204 481850 481850 481850 25070 25070 25070 273124 273124 273124 3384085 3384085 3384085 7309580 7309580 7309580 810000 810000 810000 <p id="xdx_89A_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zuZYvx9ifAF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in the assets measured at fair value on a recurring basis for which the Company have utilized Level 3 inputs to determine fair value are presented in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zyqX82jdzt9f" style="display: none">Schedule of Fair Value Assets Measured on Recurring Basis</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_495_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_z6QqGAES5PR9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_49E_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zWgbQqJ1Xt0b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrant</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_490_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--PrivatePlacementWarrantsMember_zBelqAARJZii" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Placement<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_497_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zd5XdeDrcIe2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td id="xdx_492_20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember_zZkw0CEjVF22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Forward<br/> Purchase<br/> Derivative</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>For the period ended March 31, 2024</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrant</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Placement<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Forward<br/> Purchase<br/> Derivative</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_405_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_z7Y8stG3hySh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left"><span style="font-size: 10pt">Balance at the beginning of the period</span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">273,124</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">3,384,085</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">25,070</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">810,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_zSpEdrQt8m4j" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">Issued to Abaca shareholders</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1679">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1680">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1681">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1682">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1683">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AssetsFairValueAdjustment_zxv1QEBMSsR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Fair value adjustment</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(83,904</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(1,115,653</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(4,755</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(216,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1689">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_zTgAeFzqQ943" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">Balance at the end of the period</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">189,220</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">2,268,432</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">20,315</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">594,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">7,309,580</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_497_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zOrGfKK6LAz3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_492_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zTep8aYdHat4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrant</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49C_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--PrivatePlacementWarrantsMember_zK0T9WyknAyi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Placement<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_497_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zbKqt9r4wFd4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_494_20230101__20230331__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember_zSB8MLXnd8Cd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Forward<br/> Purchase<br/> Derivative</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the period ended March 31, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrant</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Placement<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Forward<br/> Purchase<br/> Derivative</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr id="xdx_405_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_zQ7sBtJYIFN5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Balance at the beginning of the period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">286,300</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1698">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,110</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1700">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,309,580</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AssetsFairValueAdjustment_z0Xav40EvQih" style="vertical-align: bottom; background-color: White"> <td>Fair value adjustment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(211,538</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1704">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11,157</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1707">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_zTlCEBXOUgRi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance at the end of the period</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">74,762</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1710">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,953</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1712">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">7,309,580</td><td style="text-align: left"> </td></tr> </table> 273124 3384085 25070 810000 7309580 -83904 -1115653 -4755 -216000 189220 2268432 20315 594000 7309580 286300 19110 7309580 -211538 -11157 74762 7953 7309580 <p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FinancialInstrumentAxis__us-gaap--WarrantMember_zQ2RQftQqTb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the private placement warrants and public warrants as of their measurement dates:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zxaM4aw7mAVd" style="display: none">Schedule of Level 3 Fair Value Measurement Inputs</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49D_20240331__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zE42nbEpa8i4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_496_20240331__us-gaap--FairValueByAssetClassAxis__custom--PrivateWarrantsMember_zUtTOFW7ISae" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49D_20240331__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zhyqil6Tv7Ah" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_496_20240331__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zwMmbV2UHis" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49F_20231231__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zgtYGlfbshcg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_498_20231231__us-gaap--FairValueByAssetClassAxis__custom--PrivateWarrantsMember_zqIi2OVV3oSd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_497_20231231__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zkGwT6tZuSpi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_490_20231231__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_z2cwXCm4jYu6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-size: 12pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>PIPE<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Private<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Third<br/> Anniversary<br/> Payment<br/> Consideration</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Abaca<br/> Warrants</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr id="xdx_407_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uUSDPShares_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zKqfAescE4C5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%">Exercise price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">11.5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1719">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">2</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">11.5</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1723">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">2</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uUSDPShares_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zr08KpPYZot9" style="vertical-align: bottom; background-color: White"> <td>Share Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.97</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.97</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.97</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.97</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.42</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zQmaoVZGyuhd" style="text-align: right" title="Expected term (years)">3.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--PrivateWarrantsMember_zg7nE7YQY1ik" style="text-align: right" title="Expected term (years)">3.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zaLc1gw9pwKg" style="text-align: right" title="Expected term (years)">1.51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zaaCqZpjRzt8" style="text-align: right" title="Expected term (years)">4.57</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--PIPEWarrantsMember_zP4cTDnPfNyf" style="text-align: right" title="Expected term (years)">3.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--PrivateWarrantsMember_zRkL0FrQPZpd" style="text-align: right" title="Expected term (years)">3.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--ThirdAnniversaryPaymentConsiderationMember_zVWMaEXMqtS2" style="text-align: right" title="Expected term (years)">1.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__custom--ExpectedTermMember__us-gaap--FairValueByAssetClassAxis__custom--AbacaWarrantMember_zMzlCsymP0aa" style="text-align: right" title="Expected term (years)">4.84</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zQB7fCL04vr" style="vertical-align: bottom; background-color: White"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76.00</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76.00</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76.00</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">76.00</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62.95</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62.95</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62.95</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62.95</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zdXltaRGY9Yd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.36</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUq7W4pvPMa2" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants and rights outstanding, measurement input</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.36</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.25</td><td style="text-align: left"> </td></tr> </table> 5 11.5 2 5 11.5 2 0.97 0.97 0.97 0.97 1.42 1.42 1.42 1.42 P3Y5M26D P3Y5M26D P1Y6M3D P4Y6M25D P3Y8M26D P3Y8M26D P1Y9M3D P4Y10M2D 76.00 76.00 76.00 76.00 62.95 62.95 62.95 62.95 4.26 4.26 4.26 4.36 4.25 4.25 4.25 4.25 4.26 4.26 4.26 4.36 4.25 4.25 4.25 4.25 <p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember_zEYOIrZO7v0b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the forward purchase derivatives as of their measurement dates on March 31, 2024 and December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zp3elA5dflj6" style="display: none">Schedule of Level 3 Fair Value Measurements Inputs</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20240331__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember_zZ5qSLmmCXm3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember_zYYDalZg4LJh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--DerivativeLiabilityMeasurementInput_iI_uUSDPShares_hus-gaap--MeasurementInputTypeAxis__custom--MeasurementInputResetPriceMember_z64HO01VMpw2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: justify">Reset Price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1.25</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--DerivativeLiabilityExpectedTerm_dtY_c20240101__20240331__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zoZbCzGjLww3" style="text-align: right" title="Expected term (years)">1.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--DerivativeLiabilityExpectedTerm_dtY_c20230101__20231231__us-gaap--FairValueByAssetClassAxis__custom--ForwardPurchaseDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zTQWsNlrJgA2" style="text-align: right" title="Expected term (years)">1.74</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uUSDPShares_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputAdditionalMaturityPerShareMember_zfUnfCoVpe95" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Additional Maturity Consideration per share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.00</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zqTbI4JpodF2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46</td><td style="text-align: left">%</td></tr> <tr id="xdx_408_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zGNfTsYLniVh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.2</td><td style="text-align: left">%</td></tr> <tr id="xdx_405_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_z0GiwoS78tEk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk-adjusted discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13.4</td><td style="text-align: left">%</td></tr> <tr id="xdx_406_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_hus-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementOptionMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_ziPXRRpHc4pb" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify">Derivative liability, measurement input</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13.4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13.4</td><td style="text-align: left">%</td></tr> </table> 1.25 1.25 P1Y5M26D P1Y8M26D 2.00 2.00 46 46 4.2 4.2 13.4 13.4 13.4 13.4 <p id="xdx_805_eus-gaap--IncomeTaxDisclosureTextBlock_zEELuWRgcEP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 18. <span id="xdx_829_z3xqD5U0Aul1">Tax</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2024, the Company recorded income tax benefit of $<span id="xdx_907_eus-gaap--IncomeTaxExpenseBenefit_iN_di_c20240101__20240331_zZQH88MsARK2" title="Income tax benefit">438,885</span> for continuing operations. The effective tax rate of <span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_c20240101__20240331_zrWDMBiYmwuh" title="Effective income tax rate reconciliation other adjustments">28.14</span>% for the three months ended March 31, 2024, varied from the statutory United States federal income tax rate of <span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20240101__20240331_zUxCm1wSTy3c" title="Effective income tax rate, federal">21.0</span>% primarily because of state income taxes, net of the federal benefit, and adjustments to the fair market value of warrant liabilities. The Company has net deferred tax assets of $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_c20240331_zazsVUyCedXj" title="Deferred tax assets liabilities net">44,278,374</span> and $<span id="xdx_907_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_c20231231_zp7xKA0QtYb6" title="Deferred tax assets liabilities net">43,829,019</span> as of March 31, 2024, and December 31, 2023, respectively. The Company considers their deferred tax assets to be realizable and has not established a valuation allowance, as it is considered more likely than not that the Company will utilize deferred tax assets in future periods through future taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes income tax benefits from uncertain tax positions where the realization of the ultimate benefit is uncertain. As of both March 31, 2024, and December 31, 2023, the Company has no unrecognized income tax benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> -438885 0.2814 0.210 44278374 43829019 <p id="xdx_804_eus-gaap--DefinedContributionPlanTextBlock_z55CDneBV9D6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 19. <span id="xdx_82E_z8tzTaR20d59">401(k) Plan</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers to all employees a tax-qualified retirement contribution plan, with the Company’s <span id="xdx_906_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_dp_uPure_c20240101__20240331_zFJvLhaIAfpe" title="Defined contribution plan employee percent">100</span>% matching contribution up to <span id="xdx_909_eus-gaap--DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_dp_uPure_c20240101__20240331_zfDPMzZl4if6" title="Defined contribution plan employee matching contribution">4</span>% of a participant’s eligible compensation. The Company’s consolidated matching contributions for the three months ended March 31, 2024, amounting to $<span id="xdx_909_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_c20240101__20240331_zZ2bhsArA9Oc" title="Defined contribution plan amount">35,233</span>, and March 31, 2023, amounting to $<span id="xdx_90B_eus-gaap--DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_c20230101__20230331_zsJj06s0qFpd" title="Defined contribution plan amount">20,663</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 0.04 35233 20663 <p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z1kTDpJE4DI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 20. <span id="xdx_825_zHdIjNHIPJ5l">Stockholders’ Equity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized to issue <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240331_z4XJTjrlMuVc" title="Preferred stock, shares authorized">1,250,000</span> preferred shares with a par value of $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240331_z4IdWMlnr2K3" title="Preferred stock, par value">0.0001</span> per share with such designation rights and preferences as may be determined from time to time by the Company’s Board of Directors. As of March 31, 2024, there were <span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_pid_c20240331_z3wkq0xqP3Gd" title="Convertible preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20240331_zQT5MSSckwwd" title="Convertible preferred stock, shares outstanding">111</span></span> Class A preferred shares issued and outstanding and <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_pid_c20231231_zfha8W2NQnVa" title="Convertible preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20231231_zREnDBNSlM2j" title="Convertible preferred stock, shares outstanding">1,101</span></span> preferred shares issued and outstanding on December 31, 2023. The holders of preferred stock shall be entitled to receive, and the Company shall pay, dividends on shares of preferred stock equal(on an as-if-converted-to-Class-A-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Class A Common Stock when, as and if such dividends are paid on shares of the Class A Common Stock. No other dividends shall be paid on the preferred stock. The terms of the preferred stock provide for an initial conversion price of $ <span id="xdx_909_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20240331_ztRLOV8AEGu3" title="Conversion Price">10.00</span> per share of Class A Common Stock, which conversion price is subject to downward adjustment on each of the dates that are 10 days, 55 days, 100days, 145 days and 190 days after the effectiveness of a registration statement registering the shares of Class A Common Stock issuable upon conversion of the preferred stock to the lower of the Conversion Price and the greater of (i) <span id="xdx_900_eus-gaap--ConversionOfStockDescription_c20240101__20240331_zS9StOPByeRk" title="Conversion of stock description">80% of the volume weighted average price of the Class A Common Stock for the prior five trading days and (ii) $2.00 (the “Floor Price”), provided that, so long as a preferred stock holders continues to hold any preferred shares, such preferred stock holder will be entitled to receive the aggregate shares of Class A Common Stock that would be issuable based upon its initial purchase of preferred stock at the adjusted Conversion Price</span>. Additionally, on January 25, 2023, at a special meeting of the Company’s stockholders, the stockholders approved a reduction in the floor conversion price of the outstanding preferred stock from $ <span id="xdx_906_eus-gaap--SharePrice_iI_pid_c20240125__srt--RangeAxis__srt--MaximumMember_zDF1tDyWOwC7" title="Share price">2.00</span> per share to $ <span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20240125__srt--RangeAxis__srt--MinimumMember_zvxlvNI5DzI1" title="Share price">1.25</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized to issue up to <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240331_zDT6fvLw1Wqg" title="Class A common stock, shares authorized">130,000,000</span> shares of Class A Common Stock with a par value of $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240331_zIMlmPZpE08j" title="Class A common stock, par value">.0001</span> per share. Holders of the Company’s Class A Common Stock are entitled to one vote for each share. As of March 31, 2024 and December 31, 2023, there were <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20240331_zvjvEKi7TVd3" title="Class A common stock, shares issued"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240331_zsts9ETzIAE2" title="Class A common stock, shares outstanding">55,431,001</span></span> and <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zeYi51samYy3" title="Class A common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zasv3RY94qyi" title="Class A common stock, shares outstanding">54,563,372</span></span> shares of Class A Common Stock issued or outstanding. As of March 31, 2024 and December 31, 2023, <span id="xdx_903_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20240331__us-gaap--TypeOfArrangementAxis__custom--ForwardPurchaseAgreementMember_z8sqvuhlWDIl" title="Common stock held for purchase"><span id="xdx_908_ecustom--CommonStockHeldBySubsidiaryShares_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--ForwardPurchaseAgreementMember_zjc9hGlJ5Q4h" title="Common stock held for purchase">3,667,377</span></span> Class A Common Stock are held by the purchasers under forward purchase agreement dated June 16, 2022, by and among the Company and such purchasers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022 Equity Incentive Plan</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation expense recognized for the three months ended March 31, 2024 and March 31, 2023 totaled $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20240331_zvi1j4c9FUmd" title="Share based compensation">0.6</span> million and $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230331_zGwbBCXEynT5" title="Share based compensation">1.6</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2022 Plan was approved by the Company’s stockholders on June 28, 2022. The 2022 Plan permits the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, stock bonus awards, and performance compensation awards. The Company has not issued stock appreciation rights, restricted stock, stock bonus awards, or performance compensation awards in the three months ended March 31, 2024 and March 31, 2023. In conjunction with the 2024 Plan, as of March 31, 2024, the Company had granted stock options and restricted stock units which are described in more detail below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Options</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options are awarded to encourage ownership of the Company’s Class A common stock by employees and to provide increased incentive for employees to render services and to exert maximum effort for the success of the Company. The Company’s incentive stock options generally permit net-share settlement upon exercise. The option exercise price, vesting schedule and exercise period are determined for each grant by the administrator (person appointed by board to administer the stock plans) of the applicable plan. The Company’s stock options generally have a <span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zoX0k4rttYg7" title="Contractual term">10</span>-year contractual term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zKl6wGuZwPK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assumptions used to determine the fair value of options granted in the three months ended March 31, 2024, using the Black-Scholes-Merton model are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zUYGBiHkA4jb" style="display: none">Schedule of Fair Value of Options Granted Black-Scholes-Merton Model</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Dividend yield</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 17%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20240331_zXjSHGOGubB3" title="Dividend yield">0</span></td><td style="width: 2%; text-align: left">%</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20240331_zLWiisoN0Lwc" title="Risk-free interest rate, minimum">3.62</span> % to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240331_zyrykaJGxM4g" title="Risk-free interest rate, maximum">4.23</span></span></td><td style="text-align: left">%</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility (weighted-average and range, if applicable)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_c20240101__20240331_z214WiskrJ24" title="Expected volatility">100</span></td><td style="text-align: left">%</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331__srt--RangeAxis__srt--MinimumMember_zHJ8amgBa8jj" title="Expected term">6</span> to <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331__srt--RangeAxis__srt--MaximumMember_zICfSP7c7kOl" title="Expected term">6.5</span> years</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td></tr> </table> <p id="xdx_8AC_zVieEsMvMw6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expected term of the options granted is calculated based on the simplified method by taking average of contractual term and vesting period the awards. The shares of the Company were listed on the stock exchange for a limited period of the time and the share price has also dropped significantly from the date of listing. Based on these factors Management has considered the expected volatility at <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240331_zJWMk8v0CKpd" title="Expected volatility">100</span>% for the current period. The risk-free interest rate used is the current yield on US Treasury notes with a term equal to the expected term of the options at the grant date. The expected dividend yield is based on annualized dividends on the underlying share during the expected term of the option.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zDOSZLAv8h8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s stock option activities and related information for the three months ended March 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z03ckJEVjMN2" style="display: none">Schedule of Stock Option and Related Information</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><b>Stock Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>No. of Stock <br/> Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted-<br/> Average Grant<br/> Date Fair Value<br/> Per Stock<br/> Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted-<br/> Average<br/> Remaining<br/> Contractual Life<br/> (in Years)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: justify">December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240331_zGr1qTSgRvb2" style="width: 12%; text-align: right" title="No. of Stock Option, Beginning Balance">2,286,010</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240331_zgCGiDAzJhya" title="Weighted Average Grant Date Fair Value Per Stock Option, Beginning Balance">5.43</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zyQ3NYUowXSl" title="Weighted-Average Remaining Contractual Life, Ending">1.65</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331_zmNnqw65dKji" style="text-align: right" title="No. of Stock Option, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zm2S3oGF9mq9" title="Weighted Average Grant Date Fair Value Per Stock Option, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1894">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240331_zvapCwwHxA3e" style="text-align: right" title="No. of Stock Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zYFq0BIsb6X2" title="Weighted Average Grant Date Fair Value Per Stock Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1898">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20240101__20240331_z9tsEpj7CIfe" style="text-align: right" title="No. of Stock Option, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zK2mnvQXMtY8" title="Weighted Average Grant Date Fair Value Per Stock Option, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1902">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Cancelled / Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240331_zn1X1UYUAgm6" style="border-bottom: Black 1.5pt solid; text-align: right" title="No. of Stock Option, Cancelled/Forfeited">(1,930</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zIpUuQnP3CG" title="Weighted Average Grant Date Fair Value Per Stock Option, Cancelled/Forfeited">1.56</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20240331_zMo4dGL32tQ3" style="border-bottom: Black 2.5pt double; text-align: right" title="No. of Stock Option, Ending Balance">2,284,080</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240331_zp9AhwEAlJI7" title="Weighted Average Grant Date Fair Value Per Stock Option, Ending Balance">5.43</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zZcwksalYOb7" title="Weighted-Average Remaining Contractual Life, Ending">1.40</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s stock option activities and related information for the three months ended March 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><b>Stock Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>No. of Stock<br/> Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted-<br/> Average Grant<br/> Date Fair Value<br/> Per Stock Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted-<br/> Average<br/> Remaining<br/> Contractual Life<br/> (in Years)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: justify">December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230331_zV3Wvwu0gkEj" style="width: 12%; text-align: right" title="No. of Stock Option, Beginning Balance">2,170,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331_zbx570Jj6FT3" title="Weighted Average Grant Date Fair Value Per Stock Option, Beginning Balance">3.53</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20221001__20221231_zAA7JM2qriGe" title="Weighted-Average Remaining Contractual Life, Ending">2.02</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331_zIiTLndtNhQl" style="text-align: right" title="No. of Stock Option, Granted">336,730</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zXCVMhTwGiVl" title="Weighted Average Grant Date Fair Value Per Stock Option, Granted">1.03</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331_zJWBb6nNA2cd" title="Weighted-Average Remaining Contractual Life, Granted">2.76</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230331_z2SrsyveMfuc" style="text-align: right" title="No. of Stock Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1926">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_z8ILtSs1D7vk" title="Weighted Average Grant Date Fair Value Per Stock Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1928">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230331_zREJDAGzKphk" style="text-align: right" title="No. of Stock Option, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1930">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zmWAODP7pf07" title="Weighted Average Grant Date Fair Value Per Stock Option, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1932">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Cancelled / Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230331_zOocCPDyJzN2" style="border-bottom: Black 1.5pt solid; text-align: right" title="No. of Stock Option, Cancelled/Forfeited">(64,875</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zIHKT492Dqzb" title="Weighted Average Grant Date Fair Value Per Stock Option, Cancelled/Forfeited">3.13</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230331_zYjajon1vuDe" style="border-bottom: Black 2.5pt double; text-align: right" title="No. of Stock Option, Ending Balance">2,441,855</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331_zyYim1nvWGyi" title="Weighted Average Grant Date Fair Value Per Stock Option, Ending Balance">3.20</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331_zBQM1gCZ9f4l" title="Weighted-Average Remaining Contractual Life, Ending">2.39</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zhfPXnI6DbQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zqeN46SxLYl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following options were outstanding at their respective exercise price:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zmUDXVZkEjAg" style="display: none">Schedule of Options Outstanding</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Exercise price options outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: justify">$</td><td style="width: 68%; text-align: justify">1.56</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zLOiRA3w0Lx6" style="width: 12%; text-align: right" title="Exercise price options">374,580</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zJfLmDeQFO44" style="width: 12%; text-align: right" title="Exercise price options">359,355</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">$</td><td style="text-align: justify">2.58</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zvzKXBc4rlta" style="text-align: right" title="Exercise price options">350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_z2Ws5okNl7P6" style="text-align: right" title="Exercise price options">350,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">$</td><td style="text-align: justify">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_znnFneXpx2Ai" style="text-align: right" title="Exercise price options">309,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zrfAI2tbAFmj" style="text-align: right" title="Exercise price options">482,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">$</td><td style="text-align: justify">6.67</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zL1M4WoOyF3b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price options">1,250,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zt3W0mVp7xw5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price options">1,250,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331_zWqMkOk3My4d" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Exercise price options">2,284,080</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331_zfQoVMFg6FJd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Exercise price options">2,441,855</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zq5WuVp7GgHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted Stock Units (“RSUs”)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zEw4zIfIFbm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s RSU activities and related information for the three months ended March 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_z91xdvMfhUM3" style="display: none">Schedule of Restricted Stock Units</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted Stock Units</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No. of RSU</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-<br/> Average Grant<br/> Date Fair Value<br/> Per RSU</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Life<br/> (in Years)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zv39cGF9TNKf" style="width: 12%; text-align: right" title="No. of RSU, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKQZt3ze0oe5" style="width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYHFoj1THLhg" title="Weighted-Average Remaining Contractual Life, Beginning">2.00</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGDoilcHvIDb" style="text-align: right" title="No. of RSU, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1974">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkJgW6D1yV6f" style="text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1976">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIOU2BQwWWYh" style="text-align: right" title="No. of RSU, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(107,833</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHBfE4dwAjgi" style="text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpriedInPeriod_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXxfpYuToZK4" title="No. of RSU, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1982">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6T27T0xTbtj" title="Weighted Average Grant Date Fair Value Per RSU, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1984">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled / Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zorfeH5y5oe4" style="border-bottom: Black 1.5pt solid; text-align: right" title="No. of RSU, Cancelled/Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1986">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqoDq756vjfg" title="Weighted Average Grant Date Fair Value Per RSU, Cancelled/Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1988">-</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zuOS84uYrC58" style="border-bottom: Black 2.5pt double; text-align: right" title="No. of RSU, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,667</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zoS3mFwVCyI4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXIM6Kupf7j5" title="Weighted-Average Remaining Contractual Life, Ending">1.75</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted Stock Units</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No. of RSU</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/> Average Grant<br/> Date Fair Value<br/> Per RSU</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Life<br/> (in Years)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGIF0Bqsgmcf" style="text-align: right" title="No. of RSU, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1996">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpmVI5vVLNO2" style="text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1998">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z13UY5D8UiZ5" title="Weighted-Average Remaining Contractual Life, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl2000">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZxXlh2F7ADb" style="width: 12%; text-align: right" title="No. of RSU, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">963,528</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFcSEbtwKXtj" style="width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3ptOG6iUeyi" title="Weighted-Average Remaining Contractual Life, Granted">2.76</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYLI4OUAt2r3" style="text-align: right" title="No. of RSU, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2008">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQq0YTxKv922" style="text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2010">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpriedInPeriod_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTaXKm9bEdnc" title="No. of RSU, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2012">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6cCde0Zqycg" title="Weighted Average Grant Date Fair Value Per RSU, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2014">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled / Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOdhbwoIUAM2" style="border-bottom: Black 1.5pt solid; text-align: right" title="No. of RSU, Cancelled/Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2016">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zaA5i8Y72F36" title="Weighted Average Grant Date Fair Value Per RSU, Cancelled/Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2018">-</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztfBnqru5MHb" style="border-bottom: Black 2.5pt double; text-align: right" title="No. of RSU, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">963,528</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zho1KIvBLj8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5vFFlPT2r1b" title="Weighted-Average Remaining Contractual Life, Ending">2.76</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zcP7K6Smngi7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_zTYCgWHkh92i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following RSU were outstanding at their respective vest price:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zo12z8mmkDRl" style="display: none">Schedule of Exercise Price of Restricted Stock Units</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vest price RSU outstanding</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.31</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zyu6aQWH4Tgi" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Exercise price options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,667</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zf4wJSM2GOm2" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Exercise price options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">963,528</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_c20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfzhNQgkm7Jd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Exercise price options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,667</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_c20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWOluhJYyGwc" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Exercise price options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">963,528</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zJ8fLwFKsfo" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1250000 0.0001 111 111 1101 1101 10.00 80% of the volume weighted average price of the Class A Common Stock for the prior five trading days and (ii) $2.00 (the “Floor Price”), provided that, so long as a preferred stock holders continues to hold any preferred shares, such preferred stock holder will be entitled to receive the aggregate shares of Class A Common Stock that would be issuable based upon its initial purchase of preferred stock at the adjusted Conversion Price 2.00 1.25 130000000 0.0001 55431001 55431001 54563372 54563372 3667377 3667377 600000 1600000 P10Y <p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zKl6wGuZwPK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assumptions used to determine the fair value of options granted in the three months ended March 31, 2024, using the Black-Scholes-Merton model are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zUYGBiHkA4jb" style="display: none">Schedule of Fair Value of Options Granted Black-Scholes-Merton Model</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Dividend yield</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 17%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20240331_zXjSHGOGubB3" title="Dividend yield">0</span></td><td style="width: 2%; text-align: left">%</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20240331_zLWiisoN0Lwc" title="Risk-free interest rate, minimum">3.62</span> % to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240331_zyrykaJGxM4g" title="Risk-free interest rate, maximum">4.23</span></span></td><td style="text-align: left">%</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility (weighted-average and range, if applicable)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_c20240101__20240331_z214WiskrJ24" title="Expected volatility">100</span></td><td style="text-align: left">%</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331__srt--RangeAxis__srt--MinimumMember_zHJ8amgBa8jj" title="Expected term">6</span> to <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331__srt--RangeAxis__srt--MaximumMember_zICfSP7c7kOl" title="Expected term">6.5</span> years</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td></tr> </table> 0 0.0362 0.0423 1 P6Y P6Y6M 1 <p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zDOSZLAv8h8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s stock option activities and related information for the three months ended March 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z03ckJEVjMN2" style="display: none">Schedule of Stock Option and Related Information</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><b>Stock Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>No. of Stock <br/> Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted-<br/> Average Grant<br/> Date Fair Value<br/> Per Stock<br/> Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted-<br/> Average<br/> Remaining<br/> Contractual Life<br/> (in Years)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: justify">December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240331_zGr1qTSgRvb2" style="width: 12%; text-align: right" title="No. of Stock Option, Beginning Balance">2,286,010</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240331_zgCGiDAzJhya" title="Weighted Average Grant Date Fair Value Per Stock Option, Beginning Balance">5.43</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zyQ3NYUowXSl" title="Weighted-Average Remaining Contractual Life, Ending">1.65</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331_zmNnqw65dKji" style="text-align: right" title="No. of Stock Option, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zm2S3oGF9mq9" title="Weighted Average Grant Date Fair Value Per Stock Option, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1894">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240331_zvapCwwHxA3e" style="text-align: right" title="No. of Stock Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zYFq0BIsb6X2" title="Weighted Average Grant Date Fair Value Per Stock Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1898">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20240101__20240331_z9tsEpj7CIfe" style="text-align: right" title="No. of Stock Option, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zK2mnvQXMtY8" title="Weighted Average Grant Date Fair Value Per Stock Option, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1902">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Cancelled / Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240331_zn1X1UYUAgm6" style="border-bottom: Black 1.5pt solid; text-align: right" title="No. of Stock Option, Cancelled/Forfeited">(1,930</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zIpUuQnP3CG" title="Weighted Average Grant Date Fair Value Per Stock Option, Cancelled/Forfeited">1.56</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20240331_zMo4dGL32tQ3" style="border-bottom: Black 2.5pt double; text-align: right" title="No. of Stock Option, Ending Balance">2,284,080</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240331_zp9AhwEAlJI7" title="Weighted Average Grant Date Fair Value Per Stock Option, Ending Balance">5.43</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zZcwksalYOb7" title="Weighted-Average Remaining Contractual Life, Ending">1.40</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s stock option activities and related information for the three months ended March 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><b>Stock Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>No. of Stock<br/> Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted-<br/> Average Grant<br/> Date Fair Value<br/> Per Stock Option</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted-<br/> Average<br/> Remaining<br/> Contractual Life<br/> (in Years)</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: justify">December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230331_zV3Wvwu0gkEj" style="width: 12%; text-align: right" title="No. of Stock Option, Beginning Balance">2,170,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331_zbx570Jj6FT3" title="Weighted Average Grant Date Fair Value Per Stock Option, Beginning Balance">3.53</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20221001__20221231_zAA7JM2qriGe" title="Weighted-Average Remaining Contractual Life, Ending">2.02</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331_zIiTLndtNhQl" style="text-align: right" title="No. of Stock Option, Granted">336,730</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zXCVMhTwGiVl" title="Weighted Average Grant Date Fair Value Per Stock Option, Granted">1.03</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331_zJWBb6nNA2cd" title="Weighted-Average Remaining Contractual Life, Granted">2.76</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230331_z2SrsyveMfuc" style="text-align: right" title="No. of Stock Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1926">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_z8ILtSs1D7vk" title="Weighted Average Grant Date Fair Value Per Stock Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1928">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230331_zREJDAGzKphk" style="text-align: right" title="No. of Stock Option, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1930">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zmWAODP7pf07" title="Weighted Average Grant Date Fair Value Per Stock Option, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1932">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Cancelled / Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230331_zOocCPDyJzN2" style="border-bottom: Black 1.5pt solid; text-align: right" title="No. of Stock Option, Cancelled/Forfeited">(64,875</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331_zIHKT492Dqzb" title="Weighted Average Grant Date Fair Value Per Stock Option, Cancelled/Forfeited">3.13</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230331_zYjajon1vuDe" style="border-bottom: Black 2.5pt double; text-align: right" title="No. of Stock Option, Ending Balance">2,441,855</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331_zyYim1nvWGyi" title="Weighted Average Grant Date Fair Value Per Stock Option, Ending Balance">3.20</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331_zBQM1gCZ9f4l" title="Weighted-Average Remaining Contractual Life, Ending">2.39</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2286010 5.43 P1Y7M24D 1930 1.56 2284080 5.43 P1Y4M24D 2170000 3.53 P2Y7D 336730 1.03 P2Y9M3D 64875 3.13 2441855 3.20 P2Y4M20D <p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zqeN46SxLYl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following options were outstanding at their respective exercise price:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zmUDXVZkEjAg" style="display: none">Schedule of Options Outstanding</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Exercise price options outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: justify">$</td><td style="width: 68%; text-align: justify">1.56</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zLOiRA3w0Lx6" style="width: 12%; text-align: right" title="Exercise price options">374,580</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember_zJfLmDeQFO44" style="width: 12%; text-align: right" title="Exercise price options">359,355</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">$</td><td style="text-align: justify">2.58</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_zvzKXBc4rlta" style="text-align: right" title="Exercise price options">350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceTwoMember_z2Ws5okNl7P6" style="text-align: right" title="Exercise price options">350,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">$</td><td style="text-align: justify">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_znnFneXpx2Ai" style="text-align: right" title="Exercise price options">309,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceThreeMember_zrfAI2tbAFmj" style="text-align: right" title="Exercise price options">482,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">$</td><td style="text-align: justify">6.67</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zL1M4WoOyF3b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price options">1,250,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceFourMember_zt3W0mVp7xw5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price options">1,250,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="2" style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20240331_zWqMkOk3My4d" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Exercise price options">2,284,080</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20230331_zfQoVMFg6FJd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Exercise price options">2,441,855</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 374580 359355 350000 350000 309500 482500 1250000 1250000 2284080 2441855 <p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zEw4zIfIFbm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s RSU activities and related information for the three months ended March 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_z91xdvMfhUM3" style="display: none">Schedule of Restricted Stock Units</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted Stock Units</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No. of RSU</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-<br/> Average Grant<br/> Date Fair Value<br/> Per RSU</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Life<br/> (in Years)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zv39cGF9TNKf" style="width: 12%; text-align: right" title="No. of RSU, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKQZt3ze0oe5" style="width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYHFoj1THLhg" title="Weighted-Average Remaining Contractual Life, Beginning">2.00</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGDoilcHvIDb" style="text-align: right" title="No. of RSU, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1974">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkJgW6D1yV6f" style="text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1976">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIOU2BQwWWYh" style="text-align: right" title="No. of RSU, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(107,833</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHBfE4dwAjgi" style="text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpriedInPeriod_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXxfpYuToZK4" title="No. of RSU, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1982">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6T27T0xTbtj" title="Weighted Average Grant Date Fair Value Per RSU, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1984">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled / Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zorfeH5y5oe4" style="border-bottom: Black 1.5pt solid; text-align: right" title="No. of RSU, Cancelled/Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1986">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqoDq756vjfg" title="Weighted Average Grant Date Fair Value Per RSU, Cancelled/Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1988">-</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zuOS84uYrC58" style="border-bottom: Black 2.5pt double; text-align: right" title="No. of RSU, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,667</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zoS3mFwVCyI4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXIM6Kupf7j5" title="Weighted-Average Remaining Contractual Life, Ending">1.75</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted Stock Units</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No. of RSU</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/> Average Grant<br/> Date Fair Value<br/> Per RSU</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Life<br/> (in Years)</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGIF0Bqsgmcf" style="text-align: right" title="No. of RSU, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1996">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpmVI5vVLNO2" style="text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1998">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z13UY5D8UiZ5" title="Weighted-Average Remaining Contractual Life, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl2000">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZxXlh2F7ADb" style="width: 12%; text-align: right" title="No. of RSU, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">963,528</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFcSEbtwKXtj" style="width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3ptOG6iUeyi" title="Weighted-Average Remaining Contractual Life, Granted">2.76</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYLI4OUAt2r3" style="text-align: right" title="No. of RSU, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2008">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQq0YTxKv922" style="text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2010">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpriedInPeriod_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTaXKm9bEdnc" title="No. of RSU, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2012">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6cCde0Zqycg" title="Weighted Average Grant Date Fair Value Per RSU, Expired"><span style="-sec-ix-hidden: xdx2ixbrl2014">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled / Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOdhbwoIUAM2" style="border-bottom: Black 1.5pt solid; text-align: right" title="No. of RSU, Cancelled/Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2016">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zaA5i8Y72F36" title="Weighted Average Grant Date Fair Value Per RSU, Cancelled/Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2018">-</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztfBnqru5MHb" style="border-bottom: Black 2.5pt double; text-align: right" title="No. of RSU, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">963,528</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zho1KIvBLj8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value Per RSU, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.31</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5vFFlPT2r1b" title="Weighted-Average Remaining Contractual Life, Ending">2.76</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 323500 1.31 P2Y 107833 1.31 215667 1.31 P1Y9M 963528 1.31 P2Y9M3D 963528 1.31 P2Y9M3D <p id="xdx_897_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_zTYCgWHkh92i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following RSU were outstanding at their respective vest price:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zo12z8mmkDRl" style="display: none">Schedule of Exercise Price of Restricted Stock Units</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vest price RSU outstanding</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.31</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zyu6aQWH4Tgi" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Exercise price options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,667</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceOneMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zf4wJSM2GOm2" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Exercise price options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">963,528</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_c20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfzhNQgkm7Jd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Exercise price options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,667</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_c20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWOluhJYyGwc" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Exercise price options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">963,528</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 215667 963528 215667 963528 <p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zJ1tKx9IvbJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 21. <span id="xdx_826_zC5dilNwZgc7">Subsequent events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 5, 2024, the Company received a letter from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $<span id="xdx_905_eus-gaap--SharePrice_iI_c20240405__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zkIFBJMh5Tqk" title="Share price">1.00</span> per share for its common stock, as required by Nasdaq Marketplace Rule 5550(a)(2). The Company has been granted a period of 180 days, ending on October 2, 2024, to regain compliance with this requirement. If the Company does not regain compliance by October 2, 2024, the Company may be eligible for second compliance period for up to an additional 180 days. In connection with any extension periods, if it appears that the Company will not be able to regain compliance with Nasdaq Marketplace Rule 5550(a)(2), or if the Company is not otherwise eligible, the Nasdaq staff will provide notice to the Company that its securities will be subject to delisting. At that time, the Company may appeal any such delisting determination to a Hearings Panel. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company’s Class A</span> common stock maintains a closing bid price of at least $<span id="xdx_905_eus-gaap--SharePrice_iI_c20240405__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWLZLtIJRJvf" title="Share price">1.00</span> for 10 consecutive business days at any point before the deadline, Nasdaq will confirm compliance, and the matter will be resolved. The Company’s Class A common stock will continue to be listed and traded on The Nasdaq Capital Market under the symbol “SHFS” during this period. There is no assurance that the Company will achieve compliance within the given timeframe or maintain compliance with other Nasdaq Listing Rules thereafter.</span></p> 1.00 1.00

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